Identifier,StructureData,,,,,,,,,,,,,,,Polymer EntityData,,,,,,
Entry ID,EM Resolution (Å),Experimental Method,Matthews Coefficient,Percent Solvent Content,Crystallization Method,pH,Crystal Growth Procedure,Temp (K),DOI,Ligand,PDB ID,Molecular Weight per Deposited Model,Resolution (Å),High Resolution Limit,Structure Title,Sequence,Source Organism,Gene Name,Macromolecule Name,Entity ID,Entry Id (Polymer Entity Identifiers),
"5Q1Q",,"X-RAY DIFFRACTION",2.19,43.8,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q1Q",39.32,"1.44","1.44","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000294a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q1Q"
"5Q1R",,"X-RAY DIFFRACTION",2.19,43.75,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q1R",39.31,"1.49","1.49","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000291a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q1R"
"5Q1S",,"X-RAY DIFFRACTION",2.23,44.73,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q1S",39.33,"1.62","1.62","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with BDOOA011525c","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q1S"
"5Q1T",,"X-RAY DIFFRACTION",2.22,44.65,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q1T",39.32,"1.49","1.49","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000492a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q1T"
"5Q1U",,"X-RAY DIFFRACTION",2.21,44.44,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q1U",39.32,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000351a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q1U"
"5Q1V",,"X-RAY DIFFRACTION",2.21,44.26,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q1V",39.29,"1.57","1.57","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000166a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q1V"
"5Q1W",,"X-RAY DIFFRACTION",2.2,44.05,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q1W",39.56,"1.68","1.68","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000546a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q1W"
"5Q1X",,"X-RAY DIFFRACTION",2.21,44.25,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q1X",39.67,"1.42","1.42","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000085a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q1X"
"5Q1Y",,"X-RAY DIFFRACTION",2.19,43.9,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q1Y",39.32,"1.42","1.42","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000032a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q1Y"
"5Q1Z",,"X-RAY DIFFRACTION",2.19,43.83,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q1Z",39.33,"1.41","1.41","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000150a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q1Z"
"5Q20",,"X-RAY DIFFRACTION",2.18,43.53,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q20",39.31,"1.76","1.76","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000524a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q20"
"5Q22",,"X-RAY DIFFRACTION",2.2,44.17,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q22",39.32,"1.18","1.18","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000728a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q22"
"5Q23",,"X-RAY DIFFRACTION",2.2,44.07,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q23",39.32,"1.32","1.32","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000543a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q23"
"5Q24",,"X-RAY DIFFRACTION",2.19,43.75,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q24",39.32,"1.35","1.35","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000676a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q24"
"5Q25",,"X-RAY DIFFRACTION",2.17,43.28,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q25",39.33,"1.43","1.43","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000532a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q25"
"5Q26",,"X-RAY DIFFRACTION",2.17,43.44,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q26",39.29,"1.66","1.66","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000710a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q26"
"5Q27",,"X-RAY DIFFRACTION",2.19,43.95,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q27",39.41,"1.83","1.83","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000421a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q27"
"5Q28",,"X-RAY DIFFRACTION",2.19,43.75,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q28",39.31,"1.52","1.52","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000186a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q28"
"5Q29",,"X-RAY DIFFRACTION",2.18,43.61,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG1000, 0.1 M MIB buffer",298,,,"5Q29",39.29,"1.46","1.46","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A in complex with FMOPL000058a","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q29"
"5Q2A",,"X-RAY DIFFRACTION",2.22,44.65,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2A",39.08,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 1)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5Q2A"
"5Q2B",,"X-RAY DIFFRACTION",2.22,44.57,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2B",39.08,"1.33","1.33","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 3)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2B"
"5Q2C",,"X-RAY DIFFRACTION",2.22,44.66,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2C",39.08,"1.53","1.53","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 4)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2C"
"5Q2D",,"X-RAY DIFFRACTION",2.22,44.54,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2D",39.08,"1.4","1.4","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 5)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2D"
"5Q2E",,"X-RAY DIFFRACTION",2.21,44.35,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2E",39.08,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 6)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2E"
"5Q2F",,"X-RAY DIFFRACTION",2.2,44.21,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2F",39.08,"1.47","1.47","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 7)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2F"
"5Q2G",,"X-RAY DIFFRACTION",2.23,44.72,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2G",39.08,"1.49","1.49","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 8)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2G"
"5Q2H",,"X-RAY DIFFRACTION",2.21,44.44,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2H",39.08,"1.72","1.72","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 9)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2H"
"5Q2I",,"X-RAY DIFFRACTION",2.21,44.36,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2I",39.08,"2.33","2.33","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 10)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2I"
"5Q2J",,"X-RAY DIFFRACTION",2.21,44.47,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2J",39.08,"1.3","1.3","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 11)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2J"
"5Q2K",,"X-RAY DIFFRACTION",2.22,44.54,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2K",39.08,"1.65","1.65","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 12)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2K"
"5Q2L",,"X-RAY DIFFRACTION",2.23,44.75,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2L",39.08,"1.42","1.42","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 13)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2L"
"5Q2M",,"X-RAY DIFFRACTION",2.22,44.65,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2M",39.08,"1.28","1.28","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 14)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2M"
"5Q2N",,"X-RAY DIFFRACTION",2.22,44.58,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2N",39.08,"1.38","1.38","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 15)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2N"
"5Q2O",,"X-RAY DIFFRACTION",2.23,44.83,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2O",39.08,"1.75","1.75","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 16)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2O"
"5Q2P",,"X-RAY DIFFRACTION",2.22,44.66,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2P",39.08,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 17)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2P"
"5Q2Q",,"X-RAY DIFFRACTION",2.21,44.35,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2Q",39.08,"1.44","1.44","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 18)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2Q"
"5Q2R",,"X-RAY DIFFRACTION",2.21,44.4,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2R",39.08,"1.37","1.37","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 19)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2R"
"5Q2S",,"X-RAY DIFFRACTION",2.19,43.73,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2S",39.08,"1.52","1.52","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 20)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2S"
"5Q2T",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2T",39.08,"1.52","1.52","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 21)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2T"
"5Q2U",,"X-RAY DIFFRACTION",2.21,44.22,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2U",39.08,"1.37","1.37","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 22)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2U"
"5Q2V",,"X-RAY DIFFRACTION",2.19,43.9,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2V",39.08,"1.58","1.58","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 23)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2V"
"5Q2W",,"X-RAY DIFFRACTION",2.19,43.77,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2W",39.08,"1.53","1.53","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 24)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2W"
"5Q2X",,"X-RAY DIFFRACTION",2.19,43.85,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2X",39.08,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 25)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2X"
"5Q2Y",,"X-RAY DIFFRACTION",2.19,43.92,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2Y",39.08,"1.61","1.61","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 26)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2Y"
"5Q2Z",,"X-RAY DIFFRACTION",2.18,43.62,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q2Z",39.08,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 27)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q2Z"
"5Q30",,"X-RAY DIFFRACTION",2.17,43.24,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q30",39.08,"1.8","1.8","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 28)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q30"
"5Q31",,"X-RAY DIFFRACTION",2.21,44.29,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q31",39.08,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 29)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q31"
"5Q32",,"X-RAY DIFFRACTION",2.22,44.51,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q32",39.08,"1.87","1.87","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 30)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q32"
"5Q33",,"X-RAY DIFFRACTION",2.19,43.87,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q33",39.08,"1.37","1.37","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 31)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q33"
"5Q34",,"X-RAY DIFFRACTION",2.18,43.56,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q34",39.08,"1.49","1.49","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 32)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q34"
"5Q35",,"X-RAY DIFFRACTION",2.19,43.9,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q35",39.08,"1.47","1.47","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 33)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q35"
"5Q36",,"X-RAY DIFFRACTION",2.18,43.64,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q36",39.08,"1.39","1.39","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 34)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q36"
"5Q37",,"X-RAY DIFFRACTION",2.19,43.91,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q37",39.08,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 35)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q37"
"5Q38",,"X-RAY DIFFRACTION",2.18,43.55,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q38",39.08,"1.39","1.39","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 36)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q38"
"5Q39",,"X-RAY DIFFRACTION",2.18,43.63,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q39",39.08,"1.7","1.7","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 37)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q39"
"5Q3A",,"X-RAY DIFFRACTION",2.19,43.94,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3A",39.08,"1.48","1.48","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 38)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3A"
"5Q3B",,"X-RAY DIFFRACTION",2.15,42.84,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3B",39.08,"2.52","2.52","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 39)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3B"
"5Q3C",,"X-RAY DIFFRACTION",2.18,43.6,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3C",39.08,"1.41","1.41","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 40)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3C"
"5Q3D",,"X-RAY DIFFRACTION",2.18,43.7,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3D",39.08,"1.71","1.71","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 41)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3D"
"5Q3E",,"X-RAY DIFFRACTION",2.18,43.57,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3E",39.08,"1.49","1.49","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 42)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3E"
"5Q3F",,"X-RAY DIFFRACTION",2.2,44.15,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3F",39.08,"1.39","1.39","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 43)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3F"
"5Q3G",,"X-RAY DIFFRACTION",2.2,44,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3G",39.08,"1.29","1.29","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 44)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3G"
"5Q3H",,"X-RAY DIFFRACTION",2.19,43.95,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3H",39.08,"1.56","1.56","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 45)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3H"
"5Q3I",,"X-RAY DIFFRACTION",2.18,43.62,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3I",39.08,"1.53","1.53","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 46)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3I"
"5Q3J",,"X-RAY DIFFRACTION",2.18,43.48,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3J",39.08,"1.44","1.44","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 47)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3J"
"5Q3K",,"X-RAY DIFFRACTION",2.19,43.87,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3K",39.08,"1.39","1.39","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 48)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3K"
"5Q3L",,"X-RAY DIFFRACTION",2.18,43.55,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3L",39.08,"1.61","1.61","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 49)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3L"
"5Q3M",,"X-RAY DIFFRACTION",2.2,44.12,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3M",39.08,"1.34","1.34","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 50)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3M"
"5Q3N",,"X-RAY DIFFRACTION",2.19,43.92,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3N",39.08,"1.62","1.62","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 51)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3N"
"5Q3O",,"X-RAY DIFFRACTION",2.21,44.27,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3O",39.08,"1.6","1.6","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 52)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3O"
"5Q3P",,"X-RAY DIFFRACTION",2.16,43.18,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3P",39.08,"1.44","1.44","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 53)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3P"
"5Q3Q",,"X-RAY DIFFRACTION",2.18,43.62,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3Q",39.08,"1.39","1.39","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 54)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3Q"
"5Q3R",,"X-RAY DIFFRACTION",2.18,43.55,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3R",39.08,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 55)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3R"
"5Q3S",,"X-RAY DIFFRACTION",2.19,43.83,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3S",39.08,"1.72","1.72","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 56)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3S"
"5Q3T",,"X-RAY DIFFRACTION",2.18,43.67,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3T",39.08,"1.52","1.52","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 57)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3T"
"5Q3U",,"X-RAY DIFFRACTION",2.19,43.84,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3U",39.08,"1.49","1.49","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 58)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3U"
"5Q3V",,"X-RAY DIFFRACTION",2.19,43.93,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3V",39.08,"1.52","1.52","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 59)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3V"
"5Q3W",,"X-RAY DIFFRACTION",2.19,43.96,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3W",39.08,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 60)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3W"
"5Q3X",,"X-RAY DIFFRACTION",2.18,43.59,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3X",39.08,"1.38","1.38","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 61)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3X"
"5Q3Y",,"X-RAY DIFFRACTION",2.18,43.66,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3Y",39.08,"1.45","1.45","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 62)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3Y"
"5Q3Z",,"X-RAY DIFFRACTION",2.16,43.18,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q3Z",39.08,"1.84","1.84","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 63)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q3Z"
"5Q40",,"X-RAY DIFFRACTION",2.16,43.14,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q40",39.08,"2.04","2.04","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 64)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q40"
"5Q41",,"X-RAY DIFFRACTION",2.17,43.3,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q41",39.08,"1.95","1.95","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 65)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q41"
"5Q42",,"X-RAY DIFFRACTION",2.18,43.53,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q42",39.08,"1.68","1.68","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 66)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q42"
"5Q43",,"X-RAY DIFFRACTION",2.22,44.67,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q43",39.08,"1.47","1.47","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 67)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q43"
"5Q44",,"X-RAY DIFFRACTION",2.22,44.49,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q44",39.08,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 69)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q44"
"5Q45",,"X-RAY DIFFRACTION",2.23,44.81,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q45",39.08,"1.64","1.64","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 70)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q45"
"5Q46",,"X-RAY DIFFRACTION",2.17,43.27,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q46",39.08,"2.01","2.01","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 71)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q46"
"5Q47",,"X-RAY DIFFRACTION",2.24,44.99,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q47",39.08,"1.38","1.38","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 72)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q47"
"5Q48",,"X-RAY DIFFRACTION",2.22,44.6,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q48",39.08,"1.44","1.44","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 73)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q48"
"5Q49",,"X-RAY DIFFRACTION",2.22,44.7,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q49",39.08,"1.38","1.38","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 74)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q49"
"5Q4A",,"X-RAY DIFFRACTION",2.22,44.55,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4A",39.08,"1.83","1.83","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 75)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4A"
"5Q4B",,"X-RAY DIFFRACTION",2.24,45.11,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4B",39.08,"1.6","1.6","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 76)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4B"
"5Q4C",,"X-RAY DIFFRACTION",2.24,45.01,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4C",39.08,"2.73","2.73","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 77)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4C"
"5Q4D",,"X-RAY DIFFRACTION",2.21,44.36,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4D",39.08,"1.8","1.8","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 78)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4D"
"5Q4E",,"X-RAY DIFFRACTION",2.22,44.49,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4E",39.08,"1.39","1.39","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 79)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4E"
"5Q4F",,"X-RAY DIFFRACTION",2.22,44.61,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4F",39.08,"1.97","1.97","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 80)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4F"
"5Q4G",,"X-RAY DIFFRACTION",2.22,44.68,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4G",39.08,"1.75","1.75","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 81)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4G"
"5Q4H",,"X-RAY DIFFRACTION",2.22,44.69,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4H",39.08,"1.53","1.53","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 82)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4H"
"5Q4I",,"X-RAY DIFFRACTION",2.21,44.28,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4I",39.08,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 83)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4I"
"5Q4J",,"X-RAY DIFFRACTION",2.2,44.11,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4J",39.08,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 84)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4J"
"5Q4K",,"X-RAY DIFFRACTION",2.2,44.22,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4K",39.08,"1.47","1.47","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 85)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4K"
"5Q4L",,"X-RAY DIFFRACTION",2.21,44.29,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4L",39.08,"1.6","1.6","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 86)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4L"
"5Q4M",,"X-RAY DIFFRACTION",2.22,44.57,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4M",39.08,"1.6","1.6","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 87)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4M"
"5Q4N",,"X-RAY DIFFRACTION",2.22,44.48,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4N",39.08,"1.71","1.71","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 88)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4N"
"5Q4O",,"X-RAY DIFFRACTION",2.2,44.08,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4O",39.08,"1.83","1.83","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 89)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4O"
"5Q4P",,"X-RAY DIFFRACTION",2.21,44.43,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4P",39.08,"1.4","1.4","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 90)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4P"
"5Q4Q",,"X-RAY DIFFRACTION",2.21,44.37,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4Q",39.08,"1.42","1.42","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 91)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4Q"
"5Q4R",,"X-RAY DIFFRACTION",2.23,44.83,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4R",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 92)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4R"
"5Q4S",,"X-RAY DIFFRACTION",2.21,44.23,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4S",39.08,"1.72","1.72","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 93)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4S"
"5Q4T",,"X-RAY DIFFRACTION",2.19,43.78,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4T",39.08,"1.77","1.77","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 94)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4T"
"5Q4U",,"X-RAY DIFFRACTION",2.22,44.57,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4U",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 95)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4U"
"5Q4V",,"X-RAY DIFFRACTION",2.21,44.46,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4V",39.08,"1.59","1.59","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 96)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4V"
"5Q4W",,"X-RAY DIFFRACTION",2.18,43.65,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4W",39.08,"1.8","1.8","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 97)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4W"
"5Q4X",,"X-RAY DIFFRACTION",2.19,43.93,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4X",39.08,"1.66","1.66","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 98)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4X"
"5Q4Y",,"X-RAY DIFFRACTION",2.19,43.73,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4Y",39.08,"1.69","1.69","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 99)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4Y"
"5Q4Z",,"X-RAY DIFFRACTION",2.21,44.26,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q4Z",39.08,"1.6","1.6","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 100)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q4Z"
"5Q50",,"X-RAY DIFFRACTION",2.21,44.35,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q50",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 101)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q50"
"5Q51",,"X-RAY DIFFRACTION",2.17,43.44,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q51",39.08,"1.34","1.34","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 102)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q51"
"5Q52",,"X-RAY DIFFRACTION",2.19,43.73,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q52",39.08,"1.7","1.7","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 103)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q52"
"5Q53",,"X-RAY DIFFRACTION",2.2,44.05,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q53",39.08,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 104)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q53"
"5Q54",,"X-RAY DIFFRACTION",2.19,43.94,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q54",39.08,"1.3","1.3","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 105)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q54"
"5Q55",,"X-RAY DIFFRACTION",2.21,44.41,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q55",39.08,"1.39","1.39","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 106)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q55"
"5Q56",,"X-RAY DIFFRACTION",2.17,43.39,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q56",39.08,"1.87","1.87","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 107)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q56"
"5Q57",,"X-RAY DIFFRACTION",2.19,43.81,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q57",39.08,"1.65","1.65","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 108)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q57"
"5Q58",,"X-RAY DIFFRACTION",2.19,43.75,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q58",39.08,"1.75","1.75","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 109)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q58"
"5Q59",,"X-RAY DIFFRACTION",2.17,43.43,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q59",39.08,"1.86","1.86","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 110)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q59"
"5Q5A",,"X-RAY DIFFRACTION",2.19,43.82,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5A",39.08,"2.26","2.26","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 111)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5A"
"5Q5B",,"X-RAY DIFFRACTION",2.17,43.37,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5B",39.08,"1.58","1.58","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 112)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5B"
"5Q5C",,"X-RAY DIFFRACTION",2.19,43.82,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5C",39.08,"1.38","1.38","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 113)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5C"
"5Q5D",,"X-RAY DIFFRACTION",2.19,43.87,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5D",39.08,"1.71","1.71","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 114)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5D"
"5Q5E",,"X-RAY DIFFRACTION",2.19,43.82,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5E",39.08,"1.49","1.49","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 115)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5E"
"5Q5F",,"X-RAY DIFFRACTION",2.19,43.79,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5F",39.08,"1.47","1.47","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 116)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5F"
"5Q5G",,"X-RAY DIFFRACTION",2.23,44.94,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5G",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 117)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5G"
"5Q5H",,"X-RAY DIFFRACTION",2.19,43.93,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5H",39.08,"1.36","1.36","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 118)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5H"
"5Q5I",,"X-RAY DIFFRACTION",2.2,44.15,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5I",39.08,"1.65","1.65","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 119)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5I"
"5Q5J",,"X-RAY DIFFRACTION",2.21,44.4,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5J",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 120)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5J"
"5Q5K",,"X-RAY DIFFRACTION",2.17,43.44,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5K",39.08,"2.81","2.81","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 121)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5K"
"5Q5L",,"X-RAY DIFFRACTION",2.21,44.24,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5L",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 122)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5L"
"5Q5M",,"X-RAY DIFFRACTION",2.21,44.25,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5M",39.08,"1.57","1.57","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 123)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5M"
"5Q5N",,"X-RAY DIFFRACTION",2.2,44.02,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5N",39.08,"2.42","2.42","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 124)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5N"
"5Q5O",,"X-RAY DIFFRACTION",2.23,44.77,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5O",39.08,"2.07","2.07","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 125)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5O"
"5Q5P",,"X-RAY DIFFRACTION",2.18,43.58,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5P",39.08,"1.58","1.58","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 126)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5P"
"5Q5Q",,"X-RAY DIFFRACTION",2.18,43.64,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5Q",39.08,"1.45","1.45","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 127)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5Q"
"5Q5R",,"X-RAY DIFFRACTION",2.18,43.6,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5R",39.08,"1.39","1.39","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 128)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5R"
"5Q5S",,"X-RAY DIFFRACTION",2.19,43.92,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5S",39.08,"1.7","1.7","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 129)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5S"
"5Q5T",,"X-RAY DIFFRACTION",2.19,43.88,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5T",39.08,"1.8","1.8","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 130)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5T"
"5Q5U",,"X-RAY DIFFRACTION",2.17,43.25,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5U",39.08,"1.88","1.88","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 131)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5U"
"5Q5V",,"X-RAY DIFFRACTION",2.19,43.78,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5V",39.08,"1.86","1.86","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 132)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5V"
"5Q5W",,"X-RAY DIFFRACTION",2.17,43.43,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5W",39.08,"1.42","1.42","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 133)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5W"
"5Q5X",,"X-RAY DIFFRACTION",2.17,43.23,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5X",39.08,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 134)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5X"
"5Q5Y",,"X-RAY DIFFRACTION",2.18,43.59,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5Y",39.08,"1.82","1.82","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 135)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5Y"
"5Q5Z",,"X-RAY DIFFRACTION",2.18,43.68,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q5Z",39.08,"1.48","1.48","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 136)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q5Z"
"5Q60",,"X-RAY DIFFRACTION",2.2,44.16,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q60",39.08,"1.4","1.4","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 137)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q60"
"5Q61",,"X-RAY DIFFRACTION",2.18,43.55,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q61",39.08,"1.71","1.71","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 138)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q61"
"5Q62",,"X-RAY DIFFRACTION",2.18,43.51,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q62",39.08,"1.52","1.52","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 139)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q62"
"5Q63",,"X-RAY DIFFRACTION",2.21,44.27,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q63",39.08,"1.82","1.82","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 140)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q63"
"5Q64",,"X-RAY DIFFRACTION",2.18,43.62,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q64",39.08,"1.42","1.42","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 141)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q64"
"5Q65",,"X-RAY DIFFRACTION",2.18,43.6,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q65",39.08,"1.78","1.78","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 142)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q65"
"5Q66",,"X-RAY DIFFRACTION",2.19,43.84,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q66",39.08,"1.51","1.51","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 143)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q66"
"5Q67",,"X-RAY DIFFRACTION",2.18,43.57,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q67",39.08,"1.65","1.65","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 144)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q67"
"5Q68",,"X-RAY DIFFRACTION",2.19,43.84,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q68",39.08,"1.86","1.86","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 145)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q68"
"5Q69",,"X-RAY DIFFRACTION",2.18,43.64,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q69",39.08,"1.84","1.84","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 146)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q69"
"5Q6A",,"X-RAY DIFFRACTION",2.18,43.63,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6A",39.08,"1.71","1.71","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 147)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6A"
"5Q6B",,"X-RAY DIFFRACTION",2.17,43.44,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6B",39.08,"2.62","2.62","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 148)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6B"
"5Q6C",,"X-RAY DIFFRACTION",2.18,43.68,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6C",39.08,"1.53","1.53","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 149)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6C"
"5Q6D",,"X-RAY DIFFRACTION",2.18,43.7,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6D",39.08,"1.48","1.48","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 150)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6D"
"5Q6E",,"X-RAY DIFFRACTION",2.17,43.43,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6E",39.08,"1.47","1.47","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 151)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6E"
"5Q6F",,"X-RAY DIFFRACTION",2.17,43.2,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6F",39.08,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 152)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6F"
"5Q6G",,"X-RAY DIFFRACTION",2.18,43.62,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6G",39.08,"1.48","1.48","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 153)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6G"
"5Q6H",,"X-RAY DIFFRACTION",2.18,43.62,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6H",39.08,"1.42","1.42","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 154)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6H"
"5Q6I",,"X-RAY DIFFRACTION",2.17,43.29,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6I",39.08,"1.68","1.68","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 155)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6I"
"5Q6J",,"X-RAY DIFFRACTION",2.18,43.66,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6J",39.08,"1.7","1.7","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 156)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6J"
"5Q6K",,"X-RAY DIFFRACTION",2.17,43.33,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6K",39.08,"1.67","1.67","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 157)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6K"
"5Q6L",,"X-RAY DIFFRACTION",2.19,43.75,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6L",39.08,"1.82","1.82","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 158)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6L"
"5Q6M",,"X-RAY DIFFRACTION",2.18,43.59,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6M",39.08,"1.47","1.47","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 159)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6M"
"5Q6N",,"X-RAY DIFFRACTION",2.19,43.77,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6N",39.08,"1.52","1.52","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 160)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6N"
"5Q6O",,"X-RAY DIFFRACTION",2.18,43.62,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6O",39.08,"1.4","1.4","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 161)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6O"
"5Q6P",,"X-RAY DIFFRACTION",2.18,43.64,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6P",39.08,"1.54","1.54","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 162)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6P"
"5Q6Q",,"X-RAY DIFFRACTION",2.18,43.51,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6Q",39.08,"1.36","1.36","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 163)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6Q"
"5Q6R",,"X-RAY DIFFRACTION",2.18,43.49,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6R",39.08,"1.42","1.42","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 164)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6R"
"5Q6S",,"X-RAY DIFFRACTION",2.17,43.41,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6S",39.08,"1.56","1.56","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 165)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6S"
"5Q6T",,"X-RAY DIFFRACTION",2.16,43.13,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6T",39.08,"1.59","1.59","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 166)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6T"
"5Q6U",,"X-RAY DIFFRACTION",2.17,43.41,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6U",39.08,"1.33","1.33","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 167)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6U"
"5Q6V",,"X-RAY DIFFRACTION",2.18,43.51,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6V",39.08,"1.29","1.29","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 168)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6V"
"5Q6W",,"X-RAY DIFFRACTION",2.17,43.39,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6W",39.08,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 169)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6W"
"5Q6X",,"X-RAY DIFFRACTION",2.19,43.94,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6X",39.08,"1.43","1.43","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 170)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6X"
"5Q6Y",,"X-RAY DIFFRACTION",2.17,43.37,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6Y",39.08,"1.67","1.67","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 171)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6Y"
"5Q6Z",,"X-RAY DIFFRACTION",2.18,43.54,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q6Z",39.08,"1.62","1.62","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 172)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q6Z"
"5Q70",,"X-RAY DIFFRACTION",2.2,44.11,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q70",39.08,"1.31","1.31","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 173)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q70"
"5Q71",,"X-RAY DIFFRACTION",2.23,44.84,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q71",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 174)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q71"
"5Q72",,"X-RAY DIFFRACTION",2.21,44.35,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q72",39.08,"1.31","1.31","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 175)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q72"
"5Q73",,"X-RAY DIFFRACTION",2.2,44.05,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q73",39.08,"1.36","1.36","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 176)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q73"
"5Q74",,"X-RAY DIFFRACTION",2.2,44.18,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q74",39.08,"1.21","1.21","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 177)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q74"
"5Q75",,"X-RAY DIFFRACTION",2.2,44.18,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q75",39.08,"1.36","1.36","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 178)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q75"
"5Q76",,"X-RAY DIFFRACTION",2.2,44.14,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q76",39.08,"1.28","1.28","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 179)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q76"
"5Q77",,"X-RAY DIFFRACTION",2.21,44.43,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q77",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 180)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q77"
"5Q78",,"X-RAY DIFFRACTION",2.19,43.78,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q78",39.08,"1.25","1.25","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 181)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q78"
"5Q79",,"X-RAY DIFFRACTION",2.18,43.7,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q79",39.08,"1.83","1.83","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 182)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q79"
"5Q7A",,"X-RAY DIFFRACTION",2.19,43.79,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7A",39.08,"1.39","1.39","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 183)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7A"
"5Q7B",,"X-RAY DIFFRACTION",2.19,43.88,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7B",39.08,"1.25","1.25","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 184)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7B"
"5Q7C",,"X-RAY DIFFRACTION",2.19,43.89,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7C",39.08,"1.2","1.2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 185)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7C"
"5Q7D",,"X-RAY DIFFRACTION",2.2,43.96,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7D",39.08,"1.32","1.32","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 186)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7D"
"5Q7E",,"X-RAY DIFFRACTION",2.18,43.56,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7E",39.08,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 187)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7E"
"5Q7F",,"X-RAY DIFFRACTION",2.19,43.73,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7F",39.08,"1.64","1.64","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 188)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7F"
"5Q7G",,"X-RAY DIFFRACTION",2.22,44.6,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7G",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 189)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7G"
"5Q7H",,"X-RAY DIFFRACTION",2.21,44.32,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7H",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 190)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7H"
"5Q7I",,"X-RAY DIFFRACTION",2.19,43.85,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7I",39.08,"1.26","1.26","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 191)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7I"
"5Q7J",,"X-RAY DIFFRACTION",2.21,44.22,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7J",39.08,"1.54","1.54","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 192)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7J"
"5Q7K",,"X-RAY DIFFRACTION",2.21,44.41,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7K",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 193)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7K"
"5Q7L",,"X-RAY DIFFRACTION",2.18,43.7,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7L",39.08,"1.61","1.61","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 194)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7L"
"5Q7M",,"X-RAY DIFFRACTION",2.17,43.41,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7M",39.08,"1.26","1.26","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 195)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7M"
"5Q7N",,"X-RAY DIFFRACTION",2.27,45.92,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7N",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 196)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7N"
"5Q7O",,"X-RAY DIFFRACTION",2.21,44.34,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7O",39.08,"1.32","1.32","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 197)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7O"
"5Q7P",,"X-RAY DIFFRACTION",2.22,44.65,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7P",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 198)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7P"
"5Q7Q",,"X-RAY DIFFRACTION",2.22,44.49,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7Q",39.08,"1.76","1.76","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 199)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7Q"
"5Q7R",,"X-RAY DIFFRACTION",2.18,43.54,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7R",39.08,"1.62","1.62","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 200)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7R"
"5Q7S",,"X-RAY DIFFRACTION",2.22,44.52,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7S",39.08,"1.31","1.31","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 201)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7S"
"5Q7T",,"X-RAY DIFFRACTION",2.2,43.97,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7T",39.08,"1.67","1.67","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 202)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7T"
"5Q7U",,"X-RAY DIFFRACTION",2.2,43.98,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7U",39.08,"2.11","2.11","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 203)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7U"
"5Q7V",,"X-RAY DIFFRACTION",2.19,43.86,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7V",39.08,"1.62","1.62","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 204)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7V"
"5Q7W",,"X-RAY DIFFRACTION",2.17,43.42,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7W",39.08,"1.27","1.27","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 205)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7W"
"5Q7X",,"X-RAY DIFFRACTION",2.2,44.08,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7X",39.08,"1.69","1.69","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 206)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7X"
"5Q7Y",,"X-RAY DIFFRACTION",2.18,43.51,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7Y",39.08,"1.39","1.39","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 207)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7Y"
"5Q7Z",,"X-RAY DIFFRACTION",2.16,43.18,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q7Z",39.08,"1.65","1.65","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 208)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q7Z"
"5Q80",,"X-RAY DIFFRACTION",2.19,43.82,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q80",39.08,"1.43","1.43","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 209)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q80"
"5Q81",,"X-RAY DIFFRACTION",2.17,43.37,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q81",39.08,"1.51","1.51","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 210)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q81"
"5Q82",,"X-RAY DIFFRACTION",2.18,43.63,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q82",39.08,"1.2","1.2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 211)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q82"
"5Q83",,"X-RAY DIFFRACTION",2.17,43.37,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q83",39.08,"1.28","1.28","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 212)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q83"
"5Q84",,"X-RAY DIFFRACTION",2.17,43.29,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q84",39.08,"1.88","1.88","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 213)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q84"
"5Q85",,"X-RAY DIFFRACTION",2.18,43.69,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q85",39.08,"1.8","1.8","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 214)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q85"
"5Q86",,"X-RAY DIFFRACTION",2.18,43.7,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q86",39.08,"1.31","1.31","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 215)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q86"
"5Q87",,"X-RAY DIFFRACTION",2.19,43.78,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q87",39.08,"1.34","1.34","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 216)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q87"
"5Q88",,"X-RAY DIFFRACTION",2.17,43.19,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q88",39.08,"1.78","1.78","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 217)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q88"
"5Q89",,"X-RAY DIFFRACTION",2.18,43.46,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q89",39.08,"1.91","1.91","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 218)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q89"
"5Q8A",,"X-RAY DIFFRACTION",2.19,43.75,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8A",39.08,"1.43","1.43","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 219)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8A"
"5Q8B",,"X-RAY DIFFRACTION",2.19,43.75,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8B",39.08,"1.63","1.63","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 220)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8B"
"5Q8C",,"X-RAY DIFFRACTION",2.22,44.51,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8C",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 221)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8C"
"5Q8D",,"X-RAY DIFFRACTION",2.2,43.99,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8D",39.08,"1.23","1.23","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 222)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8D"
"5Q8E",,"X-RAY DIFFRACTION",2.21,44.23,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8E",39.08,"1.63","1.63","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 223)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8E"
"5Q8F",,"X-RAY DIFFRACTION",2.2,44.01,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8F",39.08,"1.36","1.36","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 224)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8F"
"5Q8G",,"X-RAY DIFFRACTION",2.21,44.31,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8G",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 225)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8G"
"5Q8H",,"X-RAY DIFFRACTION",2.23,44.73,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8H",39.08,"1.9","1.9","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 227)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8H"
"5Q8I",,"X-RAY DIFFRACTION",2.19,43.86,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8I",39.08,"1.35","1.35","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 228)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8I"
"5Q8J",,"X-RAY DIFFRACTION",2.2,44.09,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8J",39.08,"1.79","1.79","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 229)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8J"
"5Q8K",,"X-RAY DIFFRACTION",2.17,43.23,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8K",39.08,"1.79","1.79","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 230)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8K"
"5Q8L",,"X-RAY DIFFRACTION",2.18,43.57,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8L",39.08,"1.42","1.42","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 231)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8L"
"5Q8M",,"X-RAY DIFFRACTION",2.18,43.68,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8M",39.08,"1.71","1.71","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 232)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8M"
"5Q8N",,"X-RAY DIFFRACTION",2.19,43.89,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8N",39.08,"1.41","1.41","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 233)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8N"
"5Q8O",,"X-RAY DIFFRACTION",2.19,43.93,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8O",39.08,"1.67","1.67","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 234)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8O"
"5Q8P",,"X-RAY DIFFRACTION",2.19,43.81,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8P",39.08,"1.45","1.45","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 235)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8P"
"5Q8Q",,"X-RAY DIFFRACTION",2.19,43.87,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8Q",39.08,"1.89","1.89","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 236)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8Q"
"5Q8R",,"X-RAY DIFFRACTION",2.2,43.98,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8R",39.08,"1.9","1.9","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 237)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8R"
"5Q8S",,"X-RAY DIFFRACTION",2.21,44.29,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8S",39.08,"1.61","1.61","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 238)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8S"
"5Q8T",,"X-RAY DIFFRACTION",2.22,44.59,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8T",39.08,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 239)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8T"
"5Q8U",,"X-RAY DIFFRACTION",2.21,44.44,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8U",39.08,"1.54","1.54","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 240)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8U"
"5Q8V",,"X-RAY DIFFRACTION",2.18,43.52,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8V",39.08,"1.32","1.32","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 241)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8V"
"5Q8W",,"X-RAY DIFFRACTION",2.16,43.13,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8W",39.08,"1.57","1.57","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 242)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8W"
"5Q8X",,"X-RAY DIFFRACTION",2.18,43.66,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8X",39.08,"1.23","1.23","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 243)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8X"
"5Q8Y",,"X-RAY DIFFRACTION",2.18,43.63,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8Y",39.08,"1.51","1.51","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 244)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8Y"
"5Q8Z",,"X-RAY DIFFRACTION",2.17,43.4,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q8Z",39.08,"1.47","1.47","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 245)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q8Z"
"5Q90",,"X-RAY DIFFRACTION",2.18,43.67,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q90",39.08,"1.49","1.49","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 246)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q90"
"5Q91",,"X-RAY DIFFRACTION",2.17,43.29,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q91",39.08,"1.46","1.46","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 247)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q91"
"5Q92",,"X-RAY DIFFRACTION",2.18,43.55,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q92",39.08,"2.11","2.11","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 248)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q92"
"5Q93",,"X-RAY DIFFRACTION",2.19,43.83,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q93",39.08,"1.68","1.68","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 249)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q93"
"5Q94",,"X-RAY DIFFRACTION",2.18,43.54,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q94",39.08,"1.9","1.9","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 250)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q94"
"5Q95",,"X-RAY DIFFRACTION",2.17,43.37,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q95",39.08,"1.47","1.47","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 251)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q95"
"5Q96",,"X-RAY DIFFRACTION",2.16,43.16,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q96",39.08,"1.83","1.83","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 252)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q96"
"5Q97",,"X-RAY DIFFRACTION",2.2,44,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q97",39.08,"1.97","1.97","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 253)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q97"
"5Q98",,"X-RAY DIFFRACTION",2.17,43.41,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q98",39.08,"1.76","1.76","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 254)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q98"
"5Q99",,"X-RAY DIFFRACTION",2.18,43.66,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q99",39.08,"1.31","1.31","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 255)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q99"
"5Q9A",,"X-RAY DIFFRACTION",2.16,43.1,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9A",39.08,"1.67","1.67","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 256)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9A"
"5Q9B",,"X-RAY DIFFRACTION",2.19,43.78,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9B",39.08,"1.45","1.45","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 257)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9B"
"5Q9C",,"X-RAY DIFFRACTION",2.18,43.62,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9C",39.08,"1.46","1.46","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 258)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9C"
"5Q9D",,"X-RAY DIFFRACTION",2.17,43.21,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9D",39.08,"1.69","1.69","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 259)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9D"
"5Q9E",,"X-RAY DIFFRACTION",2.19,43.71,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9E",39.08,"1.45","1.45","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 260)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9E"
"5Q9F",,"X-RAY DIFFRACTION",2.17,43.44,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9F",39.08,"1.28","1.28","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 261)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9F"
"5Q9G",,"X-RAY DIFFRACTION",2.21,44.41,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9G",39.08,"1.6","1.6","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 262)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9G"
"5Q9H",,"X-RAY DIFFRACTION",2.15,42.84,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9H",39.08,"1.81","1.81","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 263)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9H"
"5Q9I",,"X-RAY DIFFRACTION",2.18,43.59,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9I",39.08,"1.46","1.46","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 264)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9I"
"5Q9J",,"X-RAY DIFFRACTION",2.18,43.46,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9J",39.08,"1.76","1.76","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 265)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9J"
"5Q9K",,"X-RAY DIFFRACTION",2.17,43.22,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9K",39.08,"1.78","1.78","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 266)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9K"
"5Q9L",,"X-RAY DIFFRACTION",2.17,43.44,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9L",39.08,"1.59","1.59","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 267)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9L"
"5Q9M",,"X-RAY DIFFRACTION",2.18,43.7,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9M",39.08,"1.3","1.3","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 268)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9M"
"5Q9N",,"X-RAY DIFFRACTION",2.17,43.26,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9N",39.08,"1.47","1.47","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 269)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9N"
"5Q9O",,"X-RAY DIFFRACTION",2.19,43.73,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9O",39.08,"1.37","1.37","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 270)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9O"
"5Q9P",,"X-RAY DIFFRACTION",2.18,43.66,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9P",39.08,"1.48","1.48","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 271)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9P"
"5Q9Q",,"X-RAY DIFFRACTION",2.19,43.72,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9Q",39.08,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 272)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9Q"
"5Q9R",,"X-RAY DIFFRACTION",2.18,43.52,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9R",39.08,"1.72","1.72","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 273)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9R"
"5Q9S",,"X-RAY DIFFRACTION",2.17,43.32,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9S",39.08,"1.43","1.43","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 274)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9S"
"5Q9T",,"X-RAY DIFFRACTION",2.18,43.65,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9T",39.08,"1.37","1.37","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 275)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9T"
"5Q9U",,"X-RAY DIFFRACTION",2.19,43.8,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9U",39.08,"1.49","1.49","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 276)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9U"
"5Q9V",,"X-RAY DIFFRACTION",2.17,43.39,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9V",39.08,"1.43","1.43","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 277)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9V"
"5Q9W",,"X-RAY DIFFRACTION",2.17,43.43,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9W",39.08,"1.53","1.53","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 278)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9W"
"5Q9X",,"X-RAY DIFFRACTION",2.18,43.53,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9X",39.08,"1.67","1.67","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 279)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9X"
"5Q9Y",,"X-RAY DIFFRACTION",2.17,43.4,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9Y",39.08,"1.64","1.64","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 280)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9Y"
"5Q9Z",,"X-RAY DIFFRACTION",2.18,43.51,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5Q9Z",39.08,"1.77","1.77","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 281)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5Q9Z"
"5QA0",,"X-RAY DIFFRACTION",2.19,43.79,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5QA0",39.08,"1.47","1.47","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 282)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5QA0"
"5QA1",,"X-RAY DIFFRACTION",2.17,43.38,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5QA1",39.08,"1.46","1.46","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 283)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DCLRE1A","1","5QA1"
"5QA2",,"X-RAY DIFFRACTION",2.17,43.39,"VAPOR DIFFUSION, SITTING DROP",6,"30% PEG 1000, 0.1M MIB buffer",298,,,"5QA2",39.08,"1.56","1.56","PanDDA analysis group deposition -- Crystal Structure of DCLRE1A after initial refinement with no ligand modelled (structure 284)","KKTCPFYKKIPGTGFTVDAFQYGVVEGCTAYFLTHFHSDHYAGLSKHFTFPVYCSEITGNLLKNKLHVQEQYIHPLPLDTECIVNGVKVVLLDANHCPGAVMILFYLPNGTVILHTGDFRADPSMERSLLADQKVHMLYLDTTYCSPEYTFPSQQEVIRFAINTAFEAVTLNPHALVVCGTYSIGKEKVFLAIADVLGSKVGMSQEKYKTLQCLNIPEINSLITTDMCSSLVHLLPMMQINFKGLQSHLKKCGGKYNQILAFRPTGWTHSNKFTRIADVIPQTKGNISIYGIPYSEHSSYLEMKRFVQWLKPQKIIPTVNVGTWKSRSTMEKYFREWKLEAGY","Homo sapiens","DCLRE1A, KIAA0086, SNM1, SNM1A","DNA cross-link repair 1A protein","1","5QA2"
"5QBU",,"X-RAY DIFFRACTION",2.18,43.68,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QBU",50.3,"2.78","2.78","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QBU"
"5QBV",,"X-RAY DIFFRACTION",2.59,52.51,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1016/j.bmcl.2010.05.086","N2D","5QBV",50.32,"1.796","1.796","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QBV"
"5QBW",,"X-RAY DIFFRACTION",2.32,46.99,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,"B8S","5QBW",25.18,"3.01","3.01","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QBW"
"5QBX",,"X-RAY DIFFRACTION",2.3,46.5,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QBX",50.35,"2.1","2.1","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QBX"
"5QBY",,"X-RAY DIFFRACTION",2.59,52.42,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1016/j.bmcl.2010.05.086","N2A","5QBY",50.36,"2.25","2.25","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QBY"
"5QBZ",,"X-RAY DIFFRACTION",2.33,47.25,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,"B8Y","5QBZ",25.18,"2.8","2.8","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QBZ"
"5QC0",,"X-RAY DIFFRACTION",2.07,40.65,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QC0",50.36,"1.9","1.9","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QC0"
"5QC1",,"X-RAY DIFFRACTION",2.16,43.12,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QC1",50.34,"2.082","2.082","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QC1"
"5QC2",,"X-RAY DIFFRACTION",2.1,41.55,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QC2",50.45,"2.26","2.26","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QC2"
"5QC3",,"X-RAY DIFFRACTION",2.18,43.49,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,"B9Y","5QC3",50.29,"1.998","1.998","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QC3"
"5QC4",,"X-RAY DIFFRACTION",2.07,40.54,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1016/j.bmcl.2010.01.103","BC7","5QC4",50.34,"2","2","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QC4"
"5QC5",,"X-RAY DIFFRACTION",2.15,42.87,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QC5",50.36,"2.4","2.4","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QC5"
"5QC6",,"X-RAY DIFFRACTION",2.25,45.35,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QC6",50.52,"2.1","2.1","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QC6"
"5QC7",,"X-RAY DIFFRACTION",2.23,44.86,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QC7",50.69,"1.9","1.9","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QC7"
"5QC8",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QC8",50.35,"1.74","1.74","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QC8"
"5QC9",,"X-RAY DIFFRACTION",2.25,45.41,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QC9",50.21,"2","2","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QC9"
"5QCA",,"X-RAY DIFFRACTION",2.72,54.72,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QCA",50.88,"2.29","2.29","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QCA"
"5QCB",,"X-RAY DIFFRACTION",2.25,45.33,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QCB",50.49,"2.2","2.2","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QCB"
"5QCC",,"X-RAY DIFFRACTION",2.26,45.51,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QCC",50.46,"1.8","1.8","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QCC"
"5QCD",,"X-RAY DIFFRACTION",2.49,50.66,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QCD",25.32,"1.95","1.95","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QCD"
"5QCE",,"X-RAY DIFFRACTION",2.17,43.28,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QCE",50.42,"2.78","2.78","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QCE"
"5QCF",,"X-RAY DIFFRACTION",2.6,52.65,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QCF",25.4,"2.1","2.1","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QCF"
"5QCG",,"X-RAY DIFFRACTION",2.81,56.16,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QCG",50.62,"2.7","2.7","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QCG"
"5QCH",,"X-RAY DIFFRACTION",2.84,56.76,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QCH",101.43,"2.2","2.2","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QCH"
"5QCI",,"X-RAY DIFFRACTION",2.56,51.89,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QCI",25.39,"2.179","2.179","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QCI"
"5QCJ",,"X-RAY DIFFRACTION",2.5,50.76,"VAPOR DIFFUSION, SITTING DROP",4.5,"100MM SODIUM ACETATE PH 4.5, 200MM AMMONIUM ACETATE, 25% PEG 8000. PROTEIN CONCENTRATION 7 MG/ML, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,,,"5QCJ",75.7,"2","2","Crystal structure of human Cathepsin-S with bound ligand","ILPDSVDWREKGCVTEVKYQGSCGASWAFSAVGALEAQLKLKTGKLVSLSAQNLVDCSTEKYGNKGCNGGFMTTAFQYIIDNKGIDSDASYPYKAMDQKCQYDSKYRAATCSKYTELPYGREDVLKEAVANKGPVSVGVDARHPSFFLYRSGVYYEPSCTQNVNHGVLVVGYGDLNGKEYWLVKNSWGHNFGEEGYIRMARNKGNHCGIASFPSYPEILQGGG","Homo sapiens","CTSS","Cathepsin S","1","5QCJ"
"5QCK",,"X-RAY DIFFRACTION",3.52,65.08,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium acetate, pH 4.6, 25% (w/v) MePEG2000, 200 mM ammonium sulfate, then transferred to 100 mM Tris-HCl, pH 7.0, 25% (w/v) MePEG2000, 200 MM ammonium sulfate",277,"10.1021/acs.jmedchem.7b01171","BUV","5QCK",28.43,"2.64","2.64","FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-[[(2~{S},3~{R})-1-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3-phenyl-pyrrolidin-2-yl]carbonylamino]benzoic acid","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","5QCK"
"5QCL",,"X-RAY DIFFRACTION",3.47,64.6,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium acetate, pH 4.6, 25% (w/v) MePEG2000, 200 mM ammonium sulfate, then transferred to 100 mM Tris-HCl, pH 7.0, 25% (w/v) MePEG2000, 200 MM ammonium sulfate",277,"10.1021/acs.jmedchem.7b01171","BUY","5QCL",28.85,"2.11","2.11","FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-[[(1~{S})-2-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]benzoic acid","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","5QCL"
"5QCM",,"X-RAY DIFFRACTION",3.48,64.64,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium acetate, pH 4.6, 25% (w/v) MePEG2000, 200 mM ammonium sulfate, then transferred to 100 mM Tris-HCl, pH 7.0, 25% (w/v) MePEG2000, 200 MM ammonium sulfate",277,"10.1021/acs.jmedchem.7b01171","BVJ","5QCM",29.2,"2.2","2.2","FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl ~{N}-[4-[[(1~{S})-2-[(~{E})-3-[3-chloranyl-2-fluoranyl-6-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]phenyl]carbamate","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","5QCM"
"5QCN",,"X-RAY DIFFRACTION",3.42,64.09,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium acetate, pH 4.6, 25% (w/v) MePEG2000, 200 mM ammonium sulfate, then transferred to 100 mM Tris-HCl, pH 7.0, 25% (w/v) MePEG2000, 200 MM ammonium sulfate",277,"10.1021/acs.jmedchem.7b01171","BVM","5QCN",29.34,"2.3","2.3","FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-[[(1~{S})-2-[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]-5-[(3~{S})-3-ethoxycarbonylpiperidin-1-yl]carbonyl-3,4-dihydro-1~{H}-isoquinolin-1-yl]carbonylamino]benzoic acid","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","5QCN"
"5QCO",,"X-RAY DIFFRACTION",3.01,59.11,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM SULFATE. PROTEIN STOCK WAS BACE
MUT46B BATCH XIV 6.3MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 7-FOLD EXCESS OF BMC016 ADDED FROM A 50MM STOCK
SOLUTION IN DMSO (2.0% DMSO IN DROP). CRYO- PROTECTANT WAS 1.2M AMMONIUM SULFATE, 25%(V/V)GLYCEROL, 2.0% DMSO, 1MM
BMC016.",292,"10.1007/s10822-020-00289-y",,"5QCO",136.04,"2.7","2.7","Crystal structure of BACE complex with BMC016","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QCO"
"5QCP",,"X-RAY DIFFRACTION",3.01,59.11,"hanging drop",5,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM PHOSPHATE, 0.1M SODIUM CITRATE PH
5.0. PROTEIN STOCK WAS BACE MUT46B BATCH XIII 8.3MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 5-FOLD EXCESS OF
BMC018 ADDED FROM A 50MM STOCK SOLUTION IN DMSO (2.0% DMSO IN DROP). CRYO-PROTECTANT WAS 1.2M AMMONIUM PHOSPHATE, 0.1M
SODIUM CITRATE PH 5.0, 25%(V/V) GLYCEROL, 2.0% DMSO, 1MM BMC018.",292,"10.1007/s10822-020-00289-y",,"5QCP",136.06,"2.45","2.45","Crystal structure of BACE complex with BMC018","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QCP"
"5QCQ",,"X-RAY DIFFRACTION",3.1,60.26,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM SULFATE IN WATER. PROTEIN STOCK WAS
BACE MUT46B BATCH XII 8.5MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 5-FOLD EXCESS OF BMC025 ADDED FROM A 50MM
STOCK SOLUTION IN 90% DMSO-D6 (1.8% DMSO IN DROP). A SOLUTION CONTAINING 1.2M AMMONIUM SULFATE, 25% GLYCEROL, 1MM BMC025
AND 1.8% DMSO WAS USED AS CRYO-PROTECTANT.",292,"10.1007/s10822-020-00289-y",,"5QCQ",135.8,"1.97","1.97","Crystal structure of BACE complex with BMC025","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QCQ"
"5QCR",,"X-RAY DIFFRACTION",3.04,59.56,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS USING 1.0M UNBUFFERED AMMONIUM SULFATE AS PRECIPITANT.
PROTEIN STOCK WAS BACE MUT46B BATCH IX 8.1MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL WITH A 4-FOLD EXCESS OF BMC026 ADDED
FROM A 100MM STOCK SOLUTION IN DMSO. CRYO-PROTECTANT WAS 2.0M LI2SO4, 2%(V/V) PEG 400, 0.1M CITRATE PH 5.5, 0.5MM
BMC026, 1% DMSO.",292,"10.1007/s10822-020-00289-y",,"5QCR",136.12,"2.2","2.2","Crystal structure of BACE complex with BMC026","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QCR"
"5QCS",,"X-RAY DIFFRACTION",3.11,60.44,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM SULFATE. PROTEIN STOCK WAS BACE
MUT46B BATCH XII 8.45MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 2-FOLD EXCESS OF BMC024 ADDED FROM A 10MM STOCK
SOLUTION IN DMSO (2% DMSO IN DROP). CRYO-PROTECTANT WAS 1.2M AMMONIUM SULFATE, 25% GLYCEROL, 0.4MM BMC024, 4% DMSO.",292,"10.1007/s10822-020-00289-y",,"5QCS",135.88,"2.31","2.31","Crystal structure of BACE complex with BMC024","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QCS"
"5QCT",,"X-RAY DIFFRACTION",3.12,60.6,"hanging drop",5.6,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS USING 1.0M AMMONIUM PHOSPHATE, 0.1M NA CITRATE PH 5.6
AS PRECIPITANT. PROTEIN STOCK WAS BACE MUT46B BATCH X 8.3MG/ML IN 10MM TRIS-HCL PH 7. 25MM NACL, WITH A 4-FOLD EXCESS OF
BMC001 ADDED FROM A 50MM STOCK SOLUTION IN DMSO (1.4% DMSO IN DROP). CRYO-PROTECTANT WAS 20% (V/V) 1,2-PROPANEDIOL, 80%
RESERVOIR SOLUTION.",292,"10.1007/s10822-020-00289-y",,"5QCT",136.02,"2.05","2.05","Crystal structure of BACE complex with BMC001","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QCT"
"5QCU",,"X-RAY DIFFRACTION",3.02,59.3,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS USING 1.0M UNBUFFERED AMMONIUM SULFATE AS PRECIPITANT.
PROTEIN STOCK WAS BACE MUT46B BATCH X 8.3MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 4-FOLD EXCESS OF BMC022 ADDED
FROM A 50MM STOCK SOLUTION IN DMSO (1.4% DMSO IN DROP). CRYO-PROTECTANT WAS 2.0M LI2SO4, 0.2M SUCROSE, 0.1M CITRATE PH
5.5.",292,"10.1007/s10822-020-00289-y",,"5QCU",135.82,"1.951","1.951","Crystal structure of BACE complex with BMC022","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QCU"
"5QCV",,"X-RAY DIFFRACTION",3.11,60.4,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM SULFATE. PROTEIN STOCK WAS BACE
MUT46B BATCH XII 8.45MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 3.8-FOLD EXCESS OF BMC012-AA-3 ADDED FROM A 50MM
STOCK SOLUTION IN DMSO (1.4% DMSO IN DROP). CRYO-PROTECTANT WAS 20%(V/V) GLYCEROL, 80% (V/V) RESERVOIR SOLUTION",292,"10.1007/s10822-020-00289-y",,"5QCV",135.86,"2.25","2.25","Crystal structure of BACE complex with BMC023","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QCV"
"5QCW",,"X-RAY DIFFRACTION",3.05,59.69,"sitting drop",5.5,"PROTEIN STOCK WAS BACE MUT46B (14-447)7.3MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL. CRYSTALLIZATION SOLUTION WAS 1.0M
AMMONIUM SULFATE IN WATER (JBS 6 A2). CRYSTALS WERE GROWN BY VAPOR DIFFUSION IN SITTING DROPS IN 96-WELL CORNING
MICROTITER PLATES. CRYO-PROTECTANT WAS 80% WELL SOLUTION, 20% 1,2-PROPANEDIOL.",292,"10.1007/s10822-020-00289-y",,"5QCW",135.65,"2.1","2.1","Crystal structure of BACE complex with BMC021","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QCW"
"5QCX",,"X-RAY DIFFRACTION",3.11,60.44,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM SULFATE. PROTEIN STOCK WAS BACE
MUT46B BATCH XII 8.45MG/ML IN 10MM TRIS-HCL PH 7.4,25MM NACL, WITH A 3.8-FOLD EXCESS OF BMC007 ADDED FROM A 50MM STOCK
SOLUTION IN DMSO (1.4% DMSO IN DROP). CRYO-PROTECTANT WAS 20%(V/V) 1,2-PROPANEDIOL, 80% (V/V) RESERVOIR SOLUTION.",292,"10.1007/s10822-020-00289-y",,"5QCX",135.86,"2.2","2.2","Crystal structure of BACE complex with BMC007","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QCX"
"5QCY",,"X-RAY DIFFRACTION",3.08,60.11,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM SULFATE. PROTEIN STOCK WAS BACE
MUT46B BATCH XII 8.45MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 5-FOLD EXCESS OF BMC008 ADDED FROM A 50MM STOCK
SOLUTION IN DMSO (2.0% DMSO IN DROP). CRYO- PROTECTANT WAS 1.2M AMMONIUM SULFATE, 25%(V/V)GLYCEROL, 2.0% DMSO, 1MM
BMC008.",292,"10.1007/s10822-020-00289-y",,"5QCY",136.28,"2.15","2.15","Crystal structure of BACE complex with BMC008","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QCY"
"5QCZ",,"X-RAY DIFFRACTION",2.97,58.56,"hanging drop",5,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS, FROM 1.0M AMMONIUM PHOSPHATE, 0.1M SODIUM CITRATE, PH
5.0. PROTEIN STOCK WAS BACE MUT46B BATCH XVI 7.0MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 6-FOLD EXCESS OF BMC015
ADDED FROM A 50MM STOCK SOLUTION IN 90% DMSO-D6 (1.7% DMSO IN DROP). A SOLUTION CONTAINING 1.2M AMMONIUM PHOSPHATE, 0.1M
SODIUM CITRATE PH 5.0, 25% GLYCEROL, 1MM BMC015 AND 1.8% DMSO WAS USED AS CRYO-PROTECTANT.",292,"10.1007/s10822-020-00289-y",,"5QCZ",135.87,"2.3","2.3","Crystal structure of BACE complex with BMC015","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QCZ"
"5QD0",,"X-RAY DIFFRACTION",2.91,57.67,"hanging drop",5,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS, FROM 1.0M AMMONIUM PHOSPHATE, 0.1M SODIUM CITRATE, PH
5.0. PROTEIN STOCK WAS BACE MUT46B BATCH XIV 6.3MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 7-FOLD EXCESS OF BMC006
ADDED FROM A 50MM STOCK SOLUTION IN 90% DMSO-D6 (2.0% DMSO IN DROP). A SOLUTION CONTAINING 1.2M AMMONIUM PHOSPHATE, 0.1M
SODIUM CITRATE PH 5.0, 25% GLYCEROL, 1MM BMC006 AND 2.0% DMSO WAS USED AS CRYO-PROTECTANT.",292,"10.1007/s10822-020-00289-y",,"5QD0",135.77,"2.6","2.6","Crystal structure of BACE complex withBMC006","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QD0"
"5QD1",,"X-RAY DIFFRACTION",3.14,60.82,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM SULFATE IN WATER. PROTEIN STOCK WAS
BACE MUT46B BATCH XVI 7.0MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 6-FOLD EXCESS OF BMC011 ADDED FROM A 50MM
STOCK SOLUTION IN 90% DMSO-D6 (1.7% DMSO IN DROP). A SOLUTION CONTAINING 1.2M AMMONIUM SULFATE, 25% GLYCEROL, 1MM BMC011
AND 1.8% DMSO WAS USED AS CRYO-PROTECTANT.",292,"10.1007/s10822-020-00289-y",,"5QD1",135.91,"2.4","2.4","Crystal structure of BACE complex with BMC011","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QD1"
"5QD2",,"X-RAY DIFFRACTION",3.07,59.88,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM SULFATE. PROTEIN STOCK WAS BACE
MUT46B BATCH XII 8.45MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 5-FOLD EXCESS OF BMC017 ADDED FROM A 50MM STOCK
SOLUTION IN DMSO (2.0% DMSO IN DROP). CRYO- PROTECTANT WAS 1.2M AMMONIUM SULFATE, 25%(V/V)GLYCEROL, 2.0% DMSO, 1MM
BMC017.",292,"10.1007/s10822-020-00289-y",,"5QD2",135.97,"2.5","2.5","Crystal structure of BACE complex with BMC017","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QD2"
"5QD3",,"X-RAY DIFFRACTION",3.16,61.08,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM SULFATE IN WATER. PROTEIN STOCK WAS
BACE MUT46B BATCH XVI 7.0MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 6-FOLD EXCESS OF BMC010 ADDED FROM A 50MM
STOCK SOLUTION IN 90% DMSO-D6 (1.7% DMSO IN DROP). A SOLUTION CONTAINING 1.2M AMMONIUM SULFATE, 25% GLYCEROL, 1MM BMC010
AND 1.8% DMSO WAS USED AS CRYO-PROTECTANT.",292,"10.1007/s10822-020-00289-y",,"5QD3",135.9,"2.46","2.46","Crystal structure of BACE complex with BMC010","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QD3"
"5QD4",,"X-RAY DIFFRACTION",3.12,60.64,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM PHOSPHATE, 0.1M SODIUM CITRATE PH
5.0. PROTEIN STOCK WAS BACE MUT46B BATCH XII 8.45MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 2.5-FOLD EXCESS OF
BMC023 ADDED FROM A 25MM STOCK SOLUTION IN DMSO (2% DMSO IN DROP). CRYO-PROTECTANT WAS 1.2M AMMONIUM PHOSPHATE, 0.1M
SODIUM CITRATE PH 5.0, 25% GLYCEROL, 0.5MM BMC023, 2% DMSO.",292,"10.1007/s10822-020-00289-y",,"5QD4",136.35,"2.112","2.112","Crystal structure of BACE complex with BMC023","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QD4"
"5QD5",,"X-RAY DIFFRACTION",3.05,59.69,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM SULFATE. PROTEIN STOCK WAS BACE
MUT46B BATCH XIV 6.3MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 7-FOLD EXCESS OF BMC009 ADDED FROM A 50MM STOCK
SOLUTION IN DMSO (2.0% DMSO IN DROP). CRYO- PROTECTANT WAS 1.2M AMMONIUM SULFATE, 25%(V/V)GLYCEROL, 2.0% DMSO, 1MM
BMC009.",292,"10.1007/s10822-020-00289-y",,"5QD5",135.88,"2.3","2.3","Crystal structure of BACE complex with BMC009","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QD5"
"5QD6",,"X-RAY DIFFRACTION",3.01,59.1,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM SULFATE. PROTEIN STOCK WAS BACE
MUT46B BATCH XII 8.45MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 5-FOLD EXCESS OF BMC004 ADDED FROM A 50MM STOCK
SOLUTION IN 90% DMSO, 10% H2O (1.8% DMSO IN DROP). CRYO-PROTECTANT WAS 1.2M AMMONIUM SULFATE, 25%(V/V) GLYCEROL, 1.8%
DMSO, 1MM BMC004.",292,"10.1007/s10822-020-00289-y",,"5QD6",135.84,"2.51","2.51","Crystal structure of BACE complex with BMC004","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QD6"
"5QD7",,"X-RAY DIFFRACTION",3.05,59.61,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM SULFATE IN WATER. PROTEIN STOCK WAS
BACE MUT46B BATCH XVI 7.0MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 6-FOLD EXCESS OF BMC014 ADDED FROM A 50MM
STOCK SOLUTION IN 90% DMSO-D6 (1.7% DMSO IN DROP). A SOLUTION CONTAINING 1.2M AMMONIUM SULFATE, 25% (V/V) GLYCEROL,
1.0MM BMC014 WAS USED AS CRYO-PROTECTANT.",292,"10.1007/s10822-020-00289-y",,"5QD7",136.05,"2.12","2.12","Crystal structure of BACE complex with BMC014","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QD7"
"5QD8",,"X-RAY DIFFRACTION",3.15,60.96,"hanging drop",,"HANGING DROP, VAPOR DIFFUSION, 1 UL PROTEIN + 1 UL RESERVOIR; PROTEIN SOLUTION: 9.3 MG/ML BACE MUT46B, 10 MM TRIS PH
7.4, 25 MM NACL, 1MM BMC003; RESERVOIR SOLUTION: 1.1M AMMONIUM SULFATE; CRYO: DROP PLUS 2 UL RESERVOIR SOLUTION PLUS 0.5
UL GLYCEROL.",292,"10.1007/s10822-020-00289-y",,"5QD8",136.01,"2.45","2.45","Crystal structure of BACE complex with BMC003","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QD8"
"5QD9",,"X-RAY DIFFRACTION",3.02,59.31,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM SULFATE. PROTEIN STOCK WAS BACE
MUT46B BATCH XIV 6.3MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 7-FOLD EXCESS OF BMC005 ADDED FROM A 50MM STOCK
SOLUTION IN DMSO (2.0% DMSO IN DROP). CRYO- PROTECTANT WAS 1.2M AMMONIUM SULFATE, 25%(V/V)GLYCEROL, 2.0% DMSO, 1MM
BMC005.",292,"10.1007/s10822-020-00289-y",,"5QD9",135.92,"2.602","2.602","Crystal structure of BACE complex with BMC005","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QD9"
"5QDA",,"X-RAY DIFFRACTION",3.1,60.28,"hanging drop",,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM SULFATE. PROTEIN STOCK WAS BACE
MUT46B BATCH XII 8.45MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 4-FOLD EXCESS OF BMC013 ADDED FROM A 50MM STOCK
SOLUTION IN DMSO (1.4% DMSO IN DROP). CRYO-PROTECTANT WAS 20%(V/V) GLYCEROL, 80% (V/V) RESERVOIR SOLUTION",292,"10.1007/s10822-020-00289-y",,"5QDA",135.88,"2.1","2.1","Crystal structure of BACE complex with BMC013","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QDA"
"5QDB",,"X-RAY DIFFRACTION",3.04,59.48,"hanging drop",5.1,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS USING 1.0M AMMONIUM PHOSPHATE, 0.1M NA CITRATE PH 5.1
AS PRECIPITANT. PROTEIN STOCK WAS BACE MUT46B BATCH XII 8.45MG/ML IN 10MM TRIS-HCL PH 7.4,25MM NACL, WITH A 3.8-FOLD
EXCESS OF BMC002 ADDED FROM A 50MM STOCK SOLUTION IN DMSO (1.4% DMSO IN DROP). CRYO-PROTECTANT WAS 20% (V/V)
1,2-PROPANEDIOL, 80% RESERVOIR SOLUTION.",292,"10.1007/s10822-020-00289-y",,"5QDB",135.8,"2.1","2.1","Crystal structure of BACE complex with BMC002","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QDB"
"5QDC",,"X-RAY DIFFRACTION",3.05,59.7,"hanging drop",5,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM PHOSPHATE, 0.1M SODIUM CITRATE PH
5.0. PROTEIN STOCK WAS BACE MUT46B BATCH XIV 7.4MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 6-FOLD EXCESS OF BMC019
ADDED FROM A 50MM STOCK SOLUTION IN DMSO. CRYO-PROTECTANT WAS 1.0M AMMONIUM PHOSPHATE, 0.1M SODIUM CITRATE,
25%(V/V)GLYCEROL, 2.0% DMSO, 1MM BMC019.",292,"10.1007/s10822-020-00289-y",,"5QDC",135.94,"2.1","2.1","Crystal structure of BACE complex with BMC019 hydrolyzed","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QDC"
"5QDD",,"X-RAY DIFFRACTION",3.03,59.38,"hanging drop",5,"CRYSTALS WERE GROWN AT 19C BY VAPOUR DIFFUSION IN HANGING DROPS FROM 1.0M AMMONIUM PHOSPHATE, 0.1M SODIUM CITRATE PH
5.0. PROTEIN STOCK WAS BACE MUT46B BATCH XIV 6.3MG/ML IN 10MM TRIS-HCL PH 7.4, 25MM NACL, WITH A 7-FOLD EXCESS OF BMC020
ADDED FROM A 50MM STOCK SOLUTION IN 90% DMSO, 10% H2O. CRYO-PROTECTANT WAS 1.2M AMMONIUM PHOSPHATE, 0.1M SODIUM CITRATE,
25%(V/V)GLYCEROL, 2.0% DMSO, 1MM BMC020.",292,"10.1007/s10822-020-00289-y",,"5QDD",135.87,"2","2","Crystal structure of BACE complex with BMC020 hydrolyzed","GPDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNI","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5QDD"
"5QDE",,"X-RAY DIFFRACTION",3.32,62.97,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDE",37.7,"1.764","1.764","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000740a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDE"
"5QDF",,"X-RAY DIFFRACTION",3.31,62.89,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDF",37.69,"1.712","1.712","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000295a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDF"
"5QDG",,"X-RAY DIFFRACTION",3.33,63.03,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDG",37.7,"1.79","1.79","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000294a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDG"
"5QDH",,"X-RAY DIFFRACTION",3.32,62.99,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDH",37.62,"1.682","1.682","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000004a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDH"
"5QDI",,"X-RAY DIFFRACTION",3.33,63.05,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDI",37.87,"1.623","1.623","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000157a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDI"
"5QDJ",,"X-RAY DIFFRACTION",3.32,62.95,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDJ",37.98,"1.761","1.761","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000211a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDJ"
"5QDK",,"X-RAY DIFFRACTION",3.34,63.19,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDK",37.69,"1.555","1.555","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000069a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDK"
"5QDL",,"X-RAY DIFFRACTION",3.33,63.02,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDL",37.71,"1.833","1.833","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000072a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDL"
"5QDM",,"X-RAY DIFFRACTION",3.29,62.61,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDM",37.71,"2.647","2.647","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000074a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDM"
"5QDN",,"X-RAY DIFFRACTION",3.3,62.67,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDN",37.7,"1.821","1.821","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000163a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDN"
"5QDO",,"X-RAY DIFFRACTION",3.28,62.45,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDO",37.62,"1.792","1.792","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOCR000171b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDO"
"5QDP",,"X-RAY DIFFRACTION",3.29,62.63,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDP",37.64,"1.744","1.744","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000207a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDP"
"5QDQ",,"X-RAY DIFFRACTION",3.34,63.2,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDQ",37.59,"1.575","1.575","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_XST00000847b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDQ"
"5QDR",,"X-RAY DIFFRACTION",3.34,63.12,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDR",37.7,"1.784","1.784","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000089a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDR"
"5QDS",,"X-RAY DIFFRACTION",3.34,63.22,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDS",37.96,"1.751","1.751","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000108a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDS"
"5QDT",,"X-RAY DIFFRACTION",3.32,62.9,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDT",37.69,"1.821","1.821","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000475a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDT"
"5QDU",,"X-RAY DIFFRACTION",3.32,62.97,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDU",38.3,"1.672","1.672","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000466a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDU"
"5QDV",,"X-RAY DIFFRACTION",3.38,63.61,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDV",37.69,"1.773","1.773","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000574a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDV"
"5QDW",,"X-RAY DIFFRACTION",3.34,63.19,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDW",37.66,"2.212","2.212","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000465a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDW"
"5QDX",,"X-RAY DIFFRACTION",3.35,63.32,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDX",37.7,"2.062","2.062","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000484a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDX"
"5QDY",,"X-RAY DIFFRACTION",3.38,63.57,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDY",37.65,"1.835","1.835","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_XST00000599c","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDY"
"5QDZ",,"X-RAY DIFFRACTION",3.34,63.23,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QDZ",37.71,"2.141","2.141","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000435a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QDZ"
"5QE0",,"X-RAY DIFFRACTION",3.29,62.58,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QE0",37.93,"1.98","1.98","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000648a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QE0"
"5QE1",,"X-RAY DIFFRACTION",3.33,63.08,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QE1",37.72,"1.685","1.685","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000645a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QE1"
"5QE2",,"X-RAY DIFFRACTION",3.35,63.27,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QE2",37.68,"1.787","1.787","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000398a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QE2"
"5QE3",,"X-RAY DIFFRACTION",3.34,63.18,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QE3",37.71,"1.742","1.742","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000449a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QE3"
"5QE4",,"X-RAY DIFFRACTION",3.34,63.22,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QE4",37.58,"1.852","1.852","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000514a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QE4"
"5QE5",,"X-RAY DIFFRACTION",3.33,63.08,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QE5",37.85,"1.773","1.773","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000632a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QE5"
"5QE6",,"X-RAY DIFFRACTION",3.29,62.66,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QE6",37.69,"1.774","1.774","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000608a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QE6"
"5QE7",,"X-RAY DIFFRACTION",3.32,62.9,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QE7",37.63,"1.713","1.713","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000601a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QE7"
"5QE8",,"X-RAY DIFFRACTION",3.33,63.03,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QE8",38.2,"1.813","1.813","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000127a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QE8"
"5QE9",,"X-RAY DIFFRACTION",3.33,63.05,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QE9",37.7,"1.692","1.692","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000232a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QE9"
"5QEA",,"X-RAY DIFFRACTION",3.34,63.15,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEA",37.7,"1.743","1.743","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000733a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEA"
"5QEB",,"X-RAY DIFFRACTION",3.35,63.33,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEB",37.69,"1.733","1.733","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000639a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEB"
"5QEC",,"X-RAY DIFFRACTION",3.33,63.1,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEC",37.7,"1.673","1.673","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000270a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEC"
"5QED",,"X-RAY DIFFRACTION",3.32,62.93,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QED",37.98,"1.755","1.755","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000538a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QED"
"5QEE",,"X-RAY DIFFRACTION",3.26,62.23,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEE",37.71,"1.932","1.932","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000240a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEE"
"5QEF",,"X-RAY DIFFRACTION",3.32,62.95,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEF",37.87,"1.605","1.605","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000134a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEF"
"5QEG",,"X-RAY DIFFRACTION",3.28,62.55,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEG",37.9,"1.97","1.97","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000278a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEG"
"5QEH",,"X-RAY DIFFRACTION",3.33,63.02,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEH",37.69,"1.941","1.941","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000323a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEH"
"5QEI",,"X-RAY DIFFRACTION",3.31,62.85,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEI",37.95,"1.743","1.743","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_PKTTA024495b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEI"
"5QEJ",,"X-RAY DIFFRACTION",3.34,63.14,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEJ",37.66,"1.924","1.924","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA001247b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEJ"
"5QEK",,"X-RAY DIFFRACTION",3.33,63.04,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEK",37.61,"1.904","1.904","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOZE000092b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEK"
"5QEL",,"X-RAY DIFFRACTION",3.31,62.87,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEL",37.64,"1.654","1.654","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA000675b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEL"
"5QEM",,"X-RAY DIFFRACTION",3.31,62.8,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEM",38.1,"1.754","1.754","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_XST00000217b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEM"
"5QEN",,"X-RAY DIFFRACTION",3.35,63.25,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEN",37.69,"1.775","1.775","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA000955b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEN"
"5QEO",,"X-RAY DIFFRACTION",3.32,63,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEO",37.67,"1.721","1.721","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA000657b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEO"
"5QEP",,"X-RAY DIFFRACTION",3.33,63.06,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEP",37.74,"1.774","1.774","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_XST00000692b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEP"
"5QEQ",,"X-RAY DIFFRACTION",3.3,62.69,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEQ",37.69,"1.972","1.972","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_XST00000245b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEQ"
"5QER",,"X-RAY DIFFRACTION",3.31,62.82,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QER",37.96,"1.733","1.733","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA000847b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QER"
"5QES",,"X-RAY DIFFRACTION",3.33,63.12,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QES",37.67,"1.745","1.745","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOMB000141a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QES"
"5QET",,"X-RAY DIFFRACTION",3.33,63.01,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QET",37.77,"1.724","1.724","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOMB000017a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QET"
"5QEU",,"X-RAY DIFFRACTION",3.35,63.32,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEU",37.69,"1.735","1.735","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOMB000149a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEU"
"5QEV",,"X-RAY DIFFRACTION",3.28,62.45,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEV",37.66,"1.723","1.723","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_XST00000603b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEV"
"5QEW",,"X-RAY DIFFRACTION",3.29,62.64,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEW",37.65,"1.826","1.826","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA000470b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEW"
"5QEX",,"X-RAY DIFFRACTION",3.33,63.03,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEX",37.72,"1.673","1.673","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000123a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEX"
"5QEY",,"X-RAY DIFFRACTION",3.35,63.24,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEY",37.71,"1.775","1.775","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000708a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEY"
"5QEZ",,"X-RAY DIFFRACTION",3.33,63.1,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QEZ",37.69,"1.654","1.654","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_XST00000713b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QEZ"
"5QF0",,"X-RAY DIFFRACTION",3.34,63.19,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QF0",38.08,"1.707","1.707","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_XST00000216b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QF0"
"5QF1",,"X-RAY DIFFRACTION",3.37,63.45,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QF1",37.61,"1.844","1.844","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA000272b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QF1"
"5QF2",,"X-RAY DIFFRACTION",3.36,63.44,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QF2",37.73,"1.772","1.772","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOMB000187a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QF2"
"5QF3",,"X-RAY DIFFRACTION",3.35,63.25,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QF3",37.71,"1.563","1.563","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOMB000194a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QF3"
"5QF4",,"X-RAY DIFFRACTION",3.35,63.23,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QF4",37.64,"1.832","1.832","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOMB000144a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QF4"
"5QF5",,"X-RAY DIFFRACTION",3.31,62.89,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QF5",37.64,"1.725","1.725","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA001440b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QF5"
"5QF6",,"X-RAY DIFFRACTION",3.28,62.55,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QF6",37.67,"1.765","1.765","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA000281b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QF6"
"5QF7",,"X-RAY DIFFRACTION",3.31,62.84,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QF7",37.67,"1.75","1.75","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA000951b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QF7"
"5QF8",,"X-RAY DIFFRACTION",3.39,63.69,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QF8",37.66,"1.987","1.987","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOMB000114a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QF8"
"5QF9",,"X-RAY DIFFRACTION",3.41,63.97,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QF9",37.66,"1.94","1.94","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOMB000242a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QF9"
"5QFA",,"X-RAY DIFFRACTION",3.39,63.68,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFA",37.67,"1.742","1.742","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_XST00000752b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFA"
"5QFB",,"X-RAY DIFFRACTION",3.31,62.82,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFB",37.65,"1.851","1.851","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_PKOOA000283c","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFB"
"5QFC",,"X-RAY DIFFRACTION",3.32,62.97,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFC",37.72,"1.841","1.841","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOMB000140a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFC"
"5QFD",,"X-RAY DIFFRACTION",3.33,63.12,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFD",37.71,"1.693","1.693","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000505a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFD"
"5QFE",,"X-RAY DIFFRACTION",3.33,63.02,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFE",37.95,"1.563","1.563","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000509a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFE"
"5QFF",,"X-RAY DIFFRACTION",3.32,63,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFF",37.97,"1.703","1.703","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000515a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFF"
"5QFG",,"X-RAY DIFFRACTION",3.33,63.01,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFG",37.73,"1.654","1.654","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000523a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFG"
"5QFH",,"X-RAY DIFFRACTION",3.31,62.86,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFH",37.65,"1.591","1.591","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000525a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFH"
"5QFI",,"X-RAY DIFFRACTION",3.31,62.79,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFI",37.74,"1.68","1.68","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000531a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFI"
"5QFJ",,"X-RAY DIFFRACTION",3.39,63.75,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFJ",37.68,"1.954","1.954","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA000814b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFJ"
"5QFK",,"X-RAY DIFFRACTION",3.33,63.05,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFK",37.95,"1.594","1.594","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000509a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFK"
"5QFL",,"X-RAY DIFFRACTION",3.35,63.26,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFL",38.02,"1.824","1.824","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOMB000206a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFL"
"5QFM",,"X-RAY DIFFRACTION",3.37,63.51,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFM",37.7,"1.83","1.83","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOMB000269a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFM"
"5QFN",,"X-RAY DIFFRACTION",3.37,63.45,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFN",38.15,"1.675","1.675","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000324a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFN"
"5QFO",,"X-RAY DIFFRACTION",3.34,63.21,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFO",37.6,"1.851","1.851","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_XST00000644b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFO"
"5QFP",,"X-RAY DIFFRACTION",3.37,63.45,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFP",37.68,"1.771","1.771","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOMB000293a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFP"
"5QFQ",,"X-RAY DIFFRACTION",3.31,62.9,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFQ",37.73,"1.621","1.621","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000491a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFQ"
"5QFR",,"X-RAY DIFFRACTION",3.31,62.89,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFR",37.94,"1.622","1.622","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000497a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFR"
"5QFS",,"X-RAY DIFFRACTION",3.39,63.74,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFS",37.68,"1.853","1.853","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOMB000293a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFS"
"5QFT",,"X-RAY DIFFRACTION",3.38,63.61,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFT",37.65,"1.96","1.96","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA000683b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFT"
"5QFU",,"X-RAY DIFFRACTION",3.33,63.08,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFU",37.97,"1.613","1.613","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000487a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFU"
"5QFV",,"X-RAY DIFFRACTION",3.32,62.91,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFV",37.73,"1.641","1.641","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000491a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFV"
"5QFW",,"X-RAY DIFFRACTION",3.32,62.92,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFW",37.7,"1.662","1.662","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000497a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFW"
"5QFX",,"X-RAY DIFFRACTION",3.3,62.7,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFX",37.68,"1.824","1.824","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA000953b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFX"
"5QFY",,"X-RAY DIFFRACTION",3.32,62.94,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFY",37.69,"1.769","1.769","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000396a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFY"
"5QFZ",,"X-RAY DIFFRACTION",3.32,63,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QFZ",37.92,"1.723","1.723","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000711a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QFZ"
"5QG0",,"X-RAY DIFFRACTION",3.35,63.3,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QG0",37.66,"1.753","1.753","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_XST00000280c","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QG0"
"5QG1",,"X-RAY DIFFRACTION",3.35,63.32,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QG1",37.69,"2.209","2.209","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000619a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QG1"
"5QG2",,"X-RAY DIFFRACTION",3.36,63.35,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QG2",37.68,"2.122","2.122","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000275a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QG2"
"5QG3",,"X-RAY DIFFRACTION",3.33,63.08,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QG3",37.73,"1.654","1.654","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000662a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QG3"
"5QG4",,"X-RAY DIFFRACTION",3.31,62.82,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QG4",37.71,"1.788","1.788","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000666a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QG4"
"5QG5",,"X-RAY DIFFRACTION",3.26,62.21,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QG5",37.59,"2.07","2.07","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA000811b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QG5"
"5QG6",,"X-RAY DIFFRACTION",3.3,62.73,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QG6",37.68,"1.734","1.734","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMSOA001176b","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QG6"
"5QG7",,"X-RAY DIFFRACTION",3.33,63.11,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QG7",37.72,"1.811","1.811","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000611a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QG7"
"5QG8",,"X-RAY DIFFRACTION",3.35,63.27,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QG8",37.7,"1.634","1.634","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000555a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QG8"
"5QG9",,"X-RAY DIFFRACTION",3.34,63.12,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QG9",37.99,"1.671","1.671","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000595a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QG9"
"5QGA",,"X-RAY DIFFRACTION",3.31,62.89,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QGA",37.72,"1.653","1.653","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000540a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QGA"
"5QGB",,"X-RAY DIFFRACTION",3.32,62.96,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QGB",37.74,"1.552","1.552","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000628a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QGB"
"5QGC",,"X-RAY DIFFRACTION",3.34,63.2,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QGC",37.73,"1.586","1.586","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000650a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QGC"
"5QGD",,"X-RAY DIFFRACTION",3.33,63.05,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QGD",37.72,"1.661","1.661","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000611a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QGD"
"5QGE",,"X-RAY DIFFRACTION",3.36,63.34,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QGE",37.69,"1.703","1.703","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOPL000619a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QGE"
"5QGF",,"X-RAY DIFFRACTION",3.32,62.94,"VAPOR DIFFUSION",7.5,"well solution: 0.3 M magnesium acetate, 0.1 M HEPES pH 7.5, 0.1% beta-mercaptoethanol, 13-14% PEG 8000, 2% ethanol",277,"10.7554/eLife.36307",,"5QGF",38,"1.513","1.513","PanDDA analysis group deposition -- Crystal structure of PTP1B in complex with compound_FMOOA000539a","MEMEKEFEQIDKSGSWAAIYQDIRHEASDFPSRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTVGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5QGF"
"5QGG",,"X-RAY DIFFRACTION",4.29,71.35,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGG",22.66,"1.91","1.91","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000693a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGG"
"5QGH",,"X-RAY DIFFRACTION",4.29,71.33,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGH",22.7,"1.82","1.82","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000420a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGH"
"5QGI",,"X-RAY DIFFRACTION",4.34,71.66,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGI",22.68,"1.95","1.95","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000710a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGI"
"5QGJ",,"X-RAY DIFFRACTION",4.35,71.75,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGJ",22.68,"1.95","1.95","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000706a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGJ"
"5QGK",,"X-RAY DIFFRACTION",4.36,71.78,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGK",23.01,"1.81","1.81","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000679a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGK"
"5QGL",,"X-RAY DIFFRACTION",4.56,73,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGL",22.68,"2.27","2.27","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000275a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGL"
"5QGM",,"X-RAY DIFFRACTION",4.33,71.56,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGM",22.74,"1.96","1.96","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-160","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGM"
"5QGN",,"X-RAY DIFFRACTION",4.31,71.48,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGN",23.08,"1.95","1.95","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-210","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGN"
"5QGO",,"X-RAY DIFFRACTION",4.32,71.54,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGO",22.72,"1.82","1.82","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-220","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGO"
"5QGP",,"X-RAY DIFFRACTION",4.59,73.2,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGP",22.72,"2.09","2.09","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-221","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGP"
"5QGQ",,"X-RAY DIFFRACTION",4.33,71.59,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGQ",22.66,"1.95","1.95","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with OX-65","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGQ"
"5QGR",,"X-RAY DIFFRACTION",4.32,71.54,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGR",22.91,"1.96","1.96","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000022a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGR"
"5QGS",,"X-RAY DIFFRACTION",4.28,71.23,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGS",22.71,"1.55","1.55","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000476a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGS"
"5QGT",,"X-RAY DIFFRACTION",4.36,71.82,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGT",22.68,"1.97","1.97","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000609a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGT"
"5QGU",,"X-RAY DIFFRACTION",4.3,71.39,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGU",22.72,"1.71","1.71","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with FMOPL000747a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGU"
"5QGV",,"X-RAY DIFFRACTION",4.12,70.16,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGV",22.75,"1.59","1.59","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with UNUYB062989","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGV"
"5QGW",,"X-RAY DIFFRACTION",4.3,71.37,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGW",22.71,"1.94","1.94","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000154","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGW"
"5QGX",,"X-RAY DIFFRACTION",4.1,69.97,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGX",22.75,"1.61","1.61","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000155","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGX"
"5QGY",,"X-RAY DIFFRACTION",4.1,70.03,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGY",22.72,"1.72","1.72","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000158","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGY"
"5QGZ",,"X-RAY DIFFRACTION",4.08,69.88,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QGZ",22.74,"1.65","1.65","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000161","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QGZ"
"5QH0",,"X-RAY DIFFRACTION",4.09,69.91,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QH0",22.7,"1.57","1.57","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000180","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QH0"
"5QH1",,"X-RAY DIFFRACTION",4.07,69.78,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QH1",22.73,"1.65","1.65","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000181","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QH1"
"5QH2",,"X-RAY DIFFRACTION",4.08,69.85,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QH2",22.7,"1.74","1.74","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000188","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QH2"
"5QH3",,"X-RAY DIFFRACTION",4.08,69.87,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QH3",22.97,"1.65","1.65","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000191","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QH3"
"5QH4",,"X-RAY DIFFRACTION",4.16,70.41,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QH4",22.7,"1.67","1.67","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000220a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QH4"
"5QH5",,"X-RAY DIFFRACTION",4.21,70.77,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QH5",22.67,"1.85","1.85","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000224a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QH5"
"5QH6",,"X-RAY DIFFRACTION",4.11,70.08,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QH6",22.7,"2","2","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000259a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QH6"
"5QH7",,"X-RAY DIFFRACTION",4.12,70.13,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QH7",22.69,"1.74","1.74","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000194a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QH7"
"5QH8",,"X-RAY DIFFRACTION",4.19,70.61,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QH8",22.56,"1.75","1.75","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with PCM-0102558","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QH8"
"5QH9",,"X-RAY DIFFRACTION",4.16,70.44,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QH9",22.53,"1.72","1.72","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with PCM-0102716","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QH9"
"5QHA",,"X-RAY DIFFRACTION",4.09,69.94,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QHA",22.58,"1.57","1.57","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with PCM-0102951","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QHA"
"5QHB",,"X-RAY DIFFRACTION",4.16,70.47,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QHB",22.72,"1.57","1.57","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with RK4-332","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QHB"
"5QHC",,"X-RAY DIFFRACTION",4.4,72.05,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QHC",22.78,"2.21","2.21","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with RK4-337","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QHC"
"5QHE",,"X-RAY DIFFRACTION",4.21,70.77,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QHE",22.73,"1.74","1.74","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with RK4-350","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QHE"
"5QHF",,"X-RAY DIFFRACTION",4.15,70.39,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QHF",22.87,"1.67","1.67","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NUOOA000301a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QHF"
"5QHG",,"X-RAY DIFFRACTION",4.21,70.82,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QHG",22.84,"1.92","1.92","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NU000442a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QHG"
"5QHH",,"X-RAY DIFFRACTION",4.14,70.26,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 -- 0.1M ammonium acetate -- 5%(w/v) PEG10K",293,,,"5QHH",22.83,"1.52","1.52","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT7 in complex with NU000443a","SMLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5QHH"
"5QHI",,"X-RAY DIFFRACTION",2.1,41.33,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.8M NaP monobasic, 0.8M KP dibasic, 0.1M HEPES pH 7.5 5%(w/v) PEG10K",293,,,"5QHI",42.73,"1.73","1.73","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000271a","SMGGTHIDLLFHPPRAHLLTIKETIRKMIKEARKVIALVMDIFTDVDIFKEIVEASTRGVSVYILLDESNFNHFLNMTEKQGCSVQRLRNIRVRTVKGQDYLSKTGAKFHGKMEQKFLLVDCQKVMYGSYSYMWSFEKAHLSMVQIITGQLVESFDEEFRTLYARSCVPSSFAQEESARV","Homo sapiens","FAM83B, C6orf143","Protein FAM83B","1","5QHI"
"5QHJ",,"X-RAY DIFFRACTION",2.12,42.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.8M NaP monobasic, 0.8M KP dibasic, 0.1M HEPES pH 7.5 5%(w/v) PEG10K",293,,,"5QHJ",42.93,"1.68","1.68","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000709a","SMGGTHIDLLFHPPRAHLLTIKETIRKMIKEARKVIALVMDIFTDVDIFKEIVEASTRGVSVYILLDESNFNHFLNMTEKQGCSVQRLRNIRVRTVKGQDYLSKTGAKFHGKMEQKFLLVDCQKVMYGSYSYMWSFEKAHLSMVQIITGQLVESFDEEFRTLYARSCVPSSFAQEESARV","Homo sapiens","FAM83B, C6orf143","Protein FAM83B","1","5QHJ"
"5QHK",,"X-RAY DIFFRACTION",2.09,41.13,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.8M NaP monobasic, 0.8M KP dibasic, 0.1M HEPES pH 7.5 5%(w/v) PEG10K",293,,,"5QHK",42.84,"1.61","1.61","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000010a","SMGGTHIDLLFHPPRAHLLTIKETIRKMIKEARKVIALVMDIFTDVDIFKEIVEASTRGVSVYILLDESNFNHFLNMTEKQGCSVQRLRNIRVRTVKGQDYLSKTGAKFHGKMEQKFLLVDCQKVMYGSYSYMWSFEKAHLSMVQIITGQLVESFDEEFRTLYARSCVPSSFAQEESARV","Homo sapiens","FAM83B, C6orf143","Protein FAM83B","1","5QHK"
"5QHL",,"X-RAY DIFFRACTION",2.12,41.94,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.8M NaP monobasic, 0.8M KP dibasic, 0.1M HEPES pH 7.5 5%(w/v) PEG10K",293,,,"5QHL",42.76,"1.68","1.68","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000551a","SMGGTHIDLLFHPPRAHLLTIKETIRKMIKEARKVIALVMDIFTDVDIFKEIVEASTRGVSVYILLDESNFNHFLNMTEKQGCSVQRLRNIRVRTVKGQDYLSKTGAKFHGKMEQKFLLVDCQKVMYGSYSYMWSFEKAHLSMVQIITGQLVESFDEEFRTLYARSCVPSSFAQEESARV","Homo sapiens","FAM83B, C6orf143","Protein FAM83B","1","5QHL"
"5QHM",,"X-RAY DIFFRACTION",2.36,47.89,"VAPOR DIFFUSION, SITTING DROP",7,"27.3% Tacsimate pH 7.0, 0.15 M NaCl",293,,,"5QHM",21.05,"1.79","1.79","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with OX-145","SMGGTHIDLLFHPPRAHLLTIKETIRKMIKEARKVIALVMDIFTDVDIFKEIVEASTRGVSVYILLDESNFNHFLNMTEKQGCSVQRLRNIRVRTVKGQDYLSKTGAKFHGKMEQKFLLVDCQKVMYGSYSYMWSFEKAHLSMVQIITGQLVESFDEEFRTLYARSCVPSSFAQEESARV","Homo sapiens","FAM83B, C6orf143","Protein FAM83B","1","5QHM"
"5QHN",,"X-RAY DIFFRACTION",2.35,47.72,"VAPOR DIFFUSION, SITTING DROP",7,"27.3% Tacsimate pH 7.0, 0.15 M NaCl",293,,,"5QHN",21.15,"1.73","1.73","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000622a","SMGGTHIDLLFHPPRAHLLTIKETIRKMIKEARKVIALVMDIFTDVDIFKEIVEASTRGVSVYILLDESNFNHFLNMTEKQGCSVQRLRNIRVRTVKGQDYLSKTGAKFHGKMEQKFLLVDCQKVMYGSYSYMWSFEKAHLSMVQIITGQLVESFDEEFRTLYARSCVPSSFAQEESARV","Homo sapiens","FAM83B, C6orf143","Protein FAM83B","1","5QHN"
"5QHO",,"X-RAY DIFFRACTION",2.35,47.58,"VAPOR DIFFUSION, SITTING DROP",7,"27.3% Tacsimate pH 7.0, 0.15 M NaCl",293,,,"5QHO",21.1,"1.66","1.66","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000010a","SMGGTHIDLLFHPPRAHLLTIKETIRKMIKEARKVIALVMDIFTDVDIFKEIVEASTRGVSVYILLDESNFNHFLNMTEKQGCSVQRLRNIRVRTVKGQDYLSKTGAKFHGKMEQKFLLVDCQKVMYGSYSYMWSFEKAHLSMVQIITGQLVESFDEEFRTLYARSCVPSSFAQEESARV","Homo sapiens","FAM83B, C6orf143","Protein FAM83B","1","5QHO"
"5QHP",,"X-RAY DIFFRACTION",2.35,47.56,"VAPOR DIFFUSION, SITTING DROP",7,"27.3% Tacsimate pH 7.0, 0.15 M NaCl",293,,,"5QHP",21.1,"2.06","2.06","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000554a","SMGGTHIDLLFHPPRAHLLTIKETIRKMIKEARKVIALVMDIFTDVDIFKEIVEASTRGVSVYILLDESNFNHFLNMTEKQGCSVQRLRNIRVRTVKGQDYLSKTGAKFHGKMEQKFLLVDCQKVMYGSYSYMWSFEKAHLSMVQIITGQLVESFDEEFRTLYARSCVPSSFAQEESARV","Homo sapiens","FAM83B, C6orf143","Protein FAM83B","1","5QHP"
"5QHQ",,"X-RAY DIFFRACTION",2.36,47.97,"VAPOR DIFFUSION, SITTING DROP",7,"27.3% Tacsimate pH 7.0, 0.15 M NaCl",293,,,"5QHQ",21.36,"1.96","1.96","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000574a","SMGGTHIDLLFHPPRAHLLTIKETIRKMIKEARKVIALVMDIFTDVDIFKEIVEASTRGVSVYILLDESNFNHFLNMTEKQGCSVQRLRNIRVRTVKGQDYLSKTGAKFHGKMEQKFLLVDCQKVMYGSYSYMWSFEKAHLSMVQIITGQLVESFDEEFRTLYARSCVPSSFAQEESARV","Homo sapiens","FAM83B, C6orf143","Protein FAM83B","1","5QHQ"
"5QHR",,"X-RAY DIFFRACTION",2.35,47.63,"VAPOR DIFFUSION, SITTING DROP",7,"27.3% Tacsimate pH 7.0, 0.15 M NaCl",293,,,"5QHR",21.12,"1.68","1.68","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FMOPL000635a","SMGGTHIDLLFHPPRAHLLTIKETIRKMIKEARKVIALVMDIFTDVDIFKEIVEASTRGVSVYILLDESNFNHFLNMTEKQGCSVQRLRNIRVRTVKGQDYLSKTGAKFHGKMEQKFLLVDCQKVMYGSYSYMWSFEKAHLSMVQIITGQLVESFDEEFRTLYARSCVPSSFAQEESARV","Homo sapiens","FAM83B, C6orf143","Protein FAM83B","1","5QHR"
"5QHS",,"X-RAY DIFFRACTION",2.39,48.51,"VAPOR DIFFUSION, SITTING DROP",7,"27.3% Tacsimate pH 7.0, 0.15 M NaCl",293,,,"5QHS",21.03,"1.95","1.95","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human FAM83B in complex with FF000014a","SMGGTHIDLLFHPPRAHLLTIKETIRKMIKEARKVIALVMDIFTDVDIFKEIVEASTRGVSVYILLDESNFNHFLNMTEKQGCSVQRLRNIRVRTVKGQDYLSKTGAKFHGKMEQKFLLVDCQKVMYGSYSYMWSFEKAHLSMVQIITGQLVESFDEEFRTLYARSCVPSSFAQEESARV","Homo sapiens","FAM83B, C6orf143","Protein FAM83B","1","5QHS"
"5QHT",,"X-RAY DIFFRACTION",1.99,38.18,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QHT",20.17,"1.05","1.05","PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000065a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QHT"
"5QHU",,"X-RAY DIFFRACTION",1.99,38.17,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QHU",20.11,"1.05","1.05","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMSOA000341b","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QHU"
"5QHV",,"X-RAY DIFFRACTION",1.99,38.19,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QHV",20.2,"1.05","1.05","PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000299a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QHV"
"5QHW",,"X-RAY DIFFRACTION",1.98,37.77,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QHW",20.19,"1.12","1.12","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000347a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QHW"
"5QHX",,"X-RAY DIFFRACTION",1.98,37.73,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QHX",20.17,"1.11","1.11","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000278a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QHX"
"5QHY",,"X-RAY DIFFRACTION",2,38.63,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QHY",20.14,"1.17","1.17","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000462a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QHY"
"5QHZ",,"X-RAY DIFFRACTION",2.01,38.83,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QHZ",20.2,"1.15","1.15","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000385a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QHZ"
"5QI0",,"X-RAY DIFFRACTION",2.01,38.67,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QI0",20.19,"1.05","1.05","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000352a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QI0"
"5QI1",,"X-RAY DIFFRACTION",2,38.62,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QI1",20.17,"1.05","1.05","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000474a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QI1"
"5QI2",,"X-RAY DIFFRACTION",2.01,38.77,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QI2",20.2,"1.08","1.08","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000110a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QI2"
"5QI3",,"X-RAY DIFFRACTION",2,38.64,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QI3",20.18,"1.05","1.05","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000475a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QI3"
"5QI4",,"X-RAY DIFFRACTION",1.98,37.91,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QI4",20.16,"1.2","1.2","PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000466a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QI4"
"5QI5",,"X-RAY DIFFRACTION",2.01,38.72,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QI5",20.15,"1.05","1.05","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000633a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QI5"
"5QI6",,"X-RAY DIFFRACTION",2.01,38.85,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QI6",20.2,"1.1","1.1","PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000597a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QI6"
"5QI7",,"X-RAY DIFFRACTION",1.99,38.31,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QI7",20.14,"1.05","1.05","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000506a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QI7"
"5QI8",,"X-RAY DIFFRACTION",2.02,39.01,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QI8",20.15,"1.09","1.09","PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000605a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QI8"
"5QI9",,"X-RAY DIFFRACTION",2,38.6,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QI9",20.19,"1.05","1.05","PanDDA analysis group deposition -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000711a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QI9"
"5QIA",,"X-RAY DIFFRACTION",2,38.56,"VAPOR DIFFUSION, SITTING DROP",7.4,"80 mM KBr, 30 % PEG2kMME",277,,,"5QIA",20.18,"1.14","1.14","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of human PARP14 Macrodomain 3 in complex with FMOPL000242a","SMFYGTVSSPDSGVYEMKIGSIIFQVASGDITKEEADVIVNSTSNSFNLKAGVSKAILECAGQNVERECSQQAQQRKNDYIITGGGFLRCKNIIHVIGGNDVKSSVSSVLQECEKKNYSSICLPAIGTGNAKQHPDKVAEAIIDAIEDFVQKGSAQSVKKVKVVIFLPQVLDVFYANMKKREG","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5QIA"
"5QIB",,"X-RAY DIFFRACTION",2.4,48.83,"VAPOR DIFFUSION, SITTING DROP",5.75,"0.1M MIB pH 5.75 - 7.0, 27.5-35% PEG1000",293,,,"5QIB",41.49,"1.48","1.48","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with FMOPL000388a","SMLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVS","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","5QIB"
"5QIC",,"X-RAY DIFFRACTION",2.36,47.85,"VAPOR DIFFUSION, SITTING DROP",5.75,"0.1M MIB pH 5.75 - 7.0, 27.5-35% PEG1000",293,,,"5QIC",41.53,"1.34","1.34","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z30620520","SMLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVS","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","5QIC"
"5QID",,"X-RAY DIFFRACTION",2.34,47.42,"VAPOR DIFFUSION, SITTING DROP",5.75,"0.1M MIB pH 5.75 - 7.0, 27.5-35% PEG1000",293,,,"5QID",41.51,"1.45","1.45","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z1787627869","SMLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVS","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","5QID"
"5QIE",,"X-RAY DIFFRACTION",2.35,47.64,"VAPOR DIFFUSION, SITTING DROP",5.75,"0.1M MIB pH 5.75 - 7.0, 27.5-35% PEG1000",293,,,"5QIE",41.47,"1.34","1.34","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z2856434894","SMLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVS","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","5QIE"
"5QIF",,"X-RAY DIFFRACTION",2.38,48.3,"VAPOR DIFFUSION, SITTING DROP",5.75,"0.1M MIB pH 5.75 - 7.0, 27.5-35% PEG1000",293,,,"5QIF",41.5,"1.2","1.2","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z31792168","SMLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVS","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","5QIF"
"5QIG",,"X-RAY DIFFRACTION",2.35,47.65,"VAPOR DIFFUSION, SITTING DROP",5.75,"0.1M MIB pH 5.75 - 7.0, 27.5-35% PEG1000",293,,,"5QIG",41.58,"1.42","1.42","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z1407672867","SMLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVS","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","5QIG"
"5QIH",,"X-RAY DIFFRACTION",2.34,47.48,"VAPOR DIFFUSION, SITTING DROP",5.75,"0.1M MIB pH 5.75 - 7.0, 27.5-35% PEG1000",293,,,"5QIH",41.45,"1.33","1.33","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of HAO1 in complex with Z2697514548","SMLPRLICINDYEQHAKSVLPKSIYDYYRSGANDEETLADNIAAFSRWKLYPRMLRNVAETDLSTSVLGQRVSMPICVGATAMQRMAHVDGELATVRACQSLGTGMMLSSWATSSIEEVAEAGPEALRWLQLYIYKDREVTKKLVRQAEKMGYKAIFVTVDTPYLGNRLDDVRNRFKLPPQLRMKNFETSTLSFSPEENFGDDSGLAAYVAKAIDPSISWEDIKWLRRLTSLPIVAKGILRGDDAREAVKHGLNGILVSNHGARQLDGVPATIDVLPEIVEAVEGKVEVFLDGGVRKGTDVLKALALGAKAVFVGRPIVWGLAFQGEKGVQDVLEILKEEFRLAMALSGCQNVKVIDKTLVRKNPLAVS","Homo sapiens","HAO1, GOX1, HAOX1","Hydroxyacid oxidase 1","1","5QIH"
"5QII",,"X-RAY DIFFRACTION",2.27,45.8,"VAPOR DIFFUSION, HANGING DROP",7.3,"200 mM potassium formate, pH 7.3, 22% (W/V) PEG3350, 1.5 mM Zwittergent 3-12",277,"10.1021/acsmedchemlett.8b00307",,"5QII",129.67,"2.45","2.45","CRYSTAL STRUCTURE OF 11BETA-HSD1 DOUBLE MUTANT (L262R, F278E) COMPLEXED WITH 2-(3-(1-(4-CHLOROPHENYL)CYCLOPROPYL) -[1,2,4]TRIAZOLO[4,3-A]PYRIDIN-8-YL)PROPAN-2-OL","GSHMASMTGGQQMGRGSNEEFRPEMLQGKKVIVTGASKGIGREMAYHLAKMGAHVVVTARSKETLQKVVSHCLELGAASAHYIAGTMEDMTFAEQFVAQAGKLMGGLDMLILNHITNTSLNLFHDDIHHVRKSMEVNFLSYVVLTVAALPMLKQSNGSIVVVSSLAGKVAYPMVAAYSASKFALDGFFSSIRKEYSVSRVNVSITLCVLGLIDTETAMKAVSGIVHMQAAPKEECALEIIKGGALRQEEVYYDSSRWTTLLIRNPCRKILEELYSTSYNMDRFINK","Homo sapiens","HSD11B1, HSD11, HSD11L, SDR26C1","Corticosteroid 11-beta-dehydrogenase isozyme 1","1","5QII"
"5QIK",,"X-RAY DIFFRACTION",2.07,40.49,"VAPOR DIFFUSION, HANGING DROP",5.6,"23%(w/v) PEG3350, 3%(v/v) glcyerol",277,"10.1021/acsmedchemlett.8b00357",,"5QIK",35.72,"1.58","1.58","TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(6-fluoropyridin-3-yl)-4-oxo-4,5,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-2-yl]pyridin-2-yl}acetamide","GHMTIARDIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","5QIK"
"5QIL",,"X-RAY DIFFRACTION",2.03,39.35,"VAPOR DIFFUSION, HANGING DROP",5.6,"23%(w/v) PEG3350, 3%(v/v) glcyerol",277,"10.1021/acsmedchemlett.8b00357","J2V","5QIL",35.52,"1.98","1.98","TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-PYRROLO[3,2-B]PYRIDIN-2-YL]PYRIDIN-2-YL}ACETAMIDE","GHMTIARDIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","5QIL"
"5QIM",,"X-RAY DIFFRACTION",2.11,41.74,"VAPOR DIFFUSION, HANGING DROP",5.6,"23%(w/v) PEG3350, 3%(v/v) glcyerol",277,"10.1021/acsmedchemlett.8b00357","J2Y","5QIM",35.39,"1.75","1.75","TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH N-{4-[3-(5-METHOXYPYRIDIN-2-YL)-1H-PYRROLO[3,2-B] PYRIDIN-2-YL]PYRIDIN-2-YL}ACETAMIDE","GGTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","5QIM"
"5QIN",,"X-RAY DIFFRACTION",2.54,51.52,"VAPOR DIFFUSION, HANGING DROP",8.5,"23%(w/v) PEG3350, 3%(v/v) glcyerol",277,"10.1021/acsmedchemlett.8b00357","J2V","5QIN",36.32,"1.57","1.57","TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN IN COMPLEX WITH N- {4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-PYRROLO[3,2-B]PYRIDIN-2- YL]PYRIDIN-2-YL}ACETAMIDE","GHMHNTELLPIELDTLVGKGRFAEVYKAKLKQNTSEQFETVAVKIFPYEEYASWKTEKDIFSDINLKHENILQFLTAEERKTELGKQYWLITAFHAKGNLQEYLTRHVISWEDLRKLGSSLARGIAHLHSDHTPCGRPKMPIVHRDLKSSNILVKNDLTCCLCDFGLSLRLDPTLSVDDLANSGQVGTARYMAPEVLASAMNLENVESFKQTDVYSMALVLWEMTSRCNAVGEVKDYEPPFGSKVREHPCVASMADNVLADAGRPEIPSFWLNHQGIQMVCETLTECWDHDPEARLTAQCVAERFSELEHLDRLSG","Homo sapiens","TGFBR2","TGF-beta receptor type-2","1","5QIN"
"5QIO",,"X-RAY DIFFRACTION",2.28,46.09,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG4K, 0.1M HEPES pH 7.0, 8% 2-propanol, 5 mM DTT",293,,,"5QIO",26.61,"1.46","1.46","Covalent fragment group deposition -- Crystal Structure of OUTB2 in complex with P11","FNLISEKCDILSILRDHPENRIYRRKIEELSKRFTAIRKTKGDRNCFYRALGYSYLESLLGKSREIFKFKERVLQTPNDLLAAGFEEHKFRNFFNAFYSVVELVEKDGSVSSLLKVFNDQSASDHIVQFLRLLTSAFIRNRADFFRHFIDEEMDIKDFCTHEVEPMATECDHIQITALSQALSIALQVEYVDEMDTALNHHVFPEAATPSVYLLYKTSHYNILYA","Homo sapiens","OTUB2, C14orf137, OTB2, OTU2","Ubiquitin thioesterase OTUB2","1","5QIO"
"5QIP",,"X-RAY DIFFRACTION",2.35,47.7,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG4K, 0.1M HEPES pH 7.0, 8% 2-propanol, 5 mM DTT",293,,,"5QIP",26.97,"1.63","1.63","Covalent fragment group deposition -- Crystal Structure of OUTB2 in complex with PCM-0102153","FNLISEKCDILSILRDHPENRIYRRKIEELSKRFTAIRKTKGDRNCFYRALGYSYLESLLGKSREIFKFKERVLQTPNDLLAAGFEEHKFRNFFNAFYSVVELVEKDGSVSSLLKVFNDQSASDHIVQFLRLLTSAFIRNRADFFRHFIDEEMDIKDFCTHEVEPMATECDHIQITALSQALSIALQVEYVDEMDTALNHHVFPEAATPSVYLLYKTSHYNILYA","Homo sapiens","OTUB2, C14orf137, OTB2, OTU2","Ubiquitin thioesterase OTUB2","1","5QIP"
"5QIQ",,"X-RAY DIFFRACTION",2.39,48.58,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG4K, 0.1M HEPES pH 7.0, 8% 2-propanol, 5 mM DTT",293,,,"5QIQ",26.76,"1.44","1.44","Covalent fragment group deposition -- Crystal Structure of OUTB2 in complex with PCM-0103050","FNLISEKCDILSILRDHPENRIYRRKIEELSKRFTAIRKTKGDRNCFYRALGYSYLESLLGKSREIFKFKERVLQTPNDLLAAGFEEHKFRNFFNAFYSVVELVEKDGSVSSLLKVFNDQSASDHIVQFLRLLTSAFIRNRADFFRHFIDEEMDIKDFCTHEVEPMATECDHIQITALSQALSIALQVEYVDEMDTALNHHVFPEAATPSVYLLYKTSHYNILYA","Homo sapiens","OTUB2, C14orf137, OTB2, OTU2","Ubiquitin thioesterase OTUB2","1","5QIQ"
"5QIR",,"X-RAY DIFFRACTION",2.35,47.63,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG4K, 0.1M HEPES pH 7.0, 8% 2-propanol, 5 mM DTT",293,,,"5QIR",26.96,"1.43","1.43","Covalent fragment group deposition -- Crystal Structure of OUTB2 in complex with PCM-0102305","FNLISEKCDILSILRDHPENRIYRRKIEELSKRFTAIRKTKGDRNCFYRALGYSYLESLLGKSREIFKFKERVLQTPNDLLAAGFEEHKFRNFFNAFYSVVELVEKDGSVSSLLKVFNDQSASDHIVQFLRLLTSAFIRNRADFFRHFIDEEMDIKDFCTHEVEPMATECDHIQITALSQALSIALQVEYVDEMDTALNHHVFPEAATPSVYLLYKTSHYNILYA","Homo sapiens","OTUB2, C14orf137, OTB2, OTU2","Ubiquitin thioesterase OTUB2","1","5QIR"
"5QIS",,"X-RAY DIFFRACTION",2.37,48.15,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG4K, 0.1M HEPES pH 7.0, 8% 2-propanol, 5 mM DTT",293,,,"5QIS",26.79,"1.53","1.53","Covalent fragment group deposition -- Crystal Structure of OUTB2 in complex with PCM-0102500","FNLISEKCDILSILRDHPENRIYRRKIEELSKRFTAIRKTKGDRNCFYRALGYSYLESLLGKSREIFKFKERVLQTPNDLLAAGFEEHKFRNFFNAFYSVVELVEKDGSVSSLLKVFNDQSASDHIVQFLRLLTSAFIRNRADFFRHFIDEEMDIKDFCTHEVEPMATECDHIQITALSQALSIALQVEYVDEMDTALNHHVFPEAATPSVYLLYKTSHYNILYA","Homo sapiens","OTUB2, C14orf137, OTB2, OTU2","Ubiquitin thioesterase OTUB2","1","5QIS"
"5QIT",,"X-RAY DIFFRACTION",2.34,47.54,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG4K, 0.1M HEPES pH 7.0, 8% 2-propanol, 5 mM DTT",293,,,"5QIT",26.82,"1.46","1.46","Covalent fragment group deposition -- Crystal Structure of OUTB2 in complex with PCM-0102821","FNLISEKCDILSILRDHPENRIYRRKIEELSKRFTAIRKTKGDRNCFYRALGYSYLESLLGKSREIFKFKERVLQTPNDLLAAGFEEHKFRNFFNAFYSVVELVEKDGSVSSLLKVFNDQSASDHIVQFLRLLTSAFIRNRADFFRHFIDEEMDIKDFCTHEVEPMATECDHIQITALSQALSIALQVEYVDEMDTALNHHVFPEAATPSVYLLYKTSHYNILYA","Homo sapiens","OTUB2, C14orf137, OTB2, OTU2","Ubiquitin thioesterase OTUB2","1","5QIT"
"5QIU",,"X-RAY DIFFRACTION",2.36,47.96,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG4K, 0.1M HEPES pH 7.0, 8% 2-propanol, 5 mM DTT",293,,,"5QIU",26.67,"1.56","1.56","Covalent fragment group deposition -- Crystal Structure of OUTB2 in complex with PCM-0103011","FNLISEKCDILSILRDHPENRIYRRKIEELSKRFTAIRKTKGDRNCFYRALGYSYLESLLGKSREIFKFKERVLQTPNDLLAAGFEEHKFRNFFNAFYSVVELVEKDGSVSSLLKVFNDQSASDHIVQFLRLLTSAFIRNRADFFRHFIDEEMDIKDFCTHEVEPMATECDHIQITALSQALSIALQVEYVDEMDTALNHHVFPEAATPSVYLLYKTSHYNILYA","Homo sapiens","OTUB2, C14orf137, OTB2, OTU2","Ubiquitin thioesterase OTUB2","1","5QIU"
"5QIV",,"X-RAY DIFFRACTION",2.35,47.6,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG4K, 0.1M HEPES pH 7.0, 8% 2-propanol, 5 mM DTT",293,,,"5QIV",26.91,"1.39","1.39","Covalent fragment group deposition -- Crystal Structure of OUTB2 in complex with PCM-0102998","FNLISEKCDILSILRDHPENRIYRRKIEELSKRFTAIRKTKGDRNCFYRALGYSYLESLLGKSREIFKFKERVLQTPNDLLAAGFEEHKFRNFFNAFYSVVELVEKDGSVSSLLKVFNDQSASDHIVQFLRLLTSAFIRNRADFFRHFIDEEMDIKDFCTHEVEPMATECDHIQITALSQALSIALQVEYVDEMDTALNHHVFPEAATPSVYLLYKTSHYNILYA","Homo sapiens","OTUB2, C14orf137, OTB2, OTU2","Ubiquitin thioesterase OTUB2","1","5QIV"
"5QIW",,"X-RAY DIFFRACTION",2.36,47.83,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG4K, 0.1M HEPES pH 7.0, 8% 2-propanol, 5 mM DTT",293,,,"5QIW",26.52,"1.71","1.71","Covalent fragment group deposition -- Crystal Structure of OUTB2 in complex with PCM-0102660","FNLISEKCDILSILRDHPENRIYRRKIEELSKRFTAIRKTKGDRNCFYRALGYSYLESLLGKSREIFKFKERVLQTPNDLLAAGFEEHKFRNFFNAFYSVVELVEKDGSVSSLLKVFNDQSASDHIVQFLRLLTSAFIRNRADFFRHFIDEEMDIKDFCTHEVEPMATECDHIQITALSQALSIALQVEYVDEMDTALNHHVFPEAATPSVYLLYKTSHYNILYA","Homo sapiens","OTUB2, C14orf137, OTB2, OTU2","Ubiquitin thioesterase OTUB2","1","5QIW"
"5QIX",,"X-RAY DIFFRACTION",2.37,48.15,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG4K, 0.1M HEPES pH 7.0, 8% 2-propanol, 5 mM DTT",293,,,"5QIX",26.97,"1.39","1.39","Covalent fragment group deposition -- Crystal Structure of OUTB2 in complex with PCM-0103007","FNLISEKCDILSILRDHPENRIYRRKIEELSKRFTAIRKTKGDRNCFYRALGYSYLESLLGKSREIFKFKERVLQTPNDLLAAGFEEHKFRNFFNAFYSVVELVEKDGSVSSLLKVFNDQSASDHIVQFLRLLTSAFIRNRADFFRHFIDEEMDIKDFCTHEVEPMATECDHIQITALSQALSIALQVEYVDEMDTALNHHVFPEAATPSVYLLYKTSHYNILYA","Homo sapiens","OTUB2, C14orf137, OTB2, OTU2","Ubiquitin thioesterase OTUB2","1","5QIX"
"5QIY",,"X-RAY DIFFRACTION",2.31,46.78,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG4K, 0.1M HEPES pH 7.0, 8% 2-propanol, 5 mM DTT",293,,,"5QIY",26.57,"1.58","1.58","Covalent fragment group deposition -- Crystal Structure of OUTB2 in complex with PCM-0102954","FNLISEKCDILSILRDHPENRIYRRKIEELSKRFTAIRKTKGDRNCFYRALGYSYLESLLGKSREIFKFKERVLQTPNDLLAAGFEEHKFRNFFNAFYSVVELVEKDGSVSSLLKVFNDQSASDHIVQFLRLLTSAFIRNRADFFRHFIDEEMDIKDFCTHEVEPMATECDHIQITALSQALSIALQVEYVDEMDTALNHHVFPEAATPSVYLLYKTSHYNILYA","Homo sapiens","OTUB2, C14orf137, OTB2, OTU2","Ubiquitin thioesterase OTUB2","1","5QIY"
"5QIZ",,"X-RAY DIFFRACTION",2.33,47.29,"VAPOR DIFFUSION, SITTING DROP",7,"16% PEG4K, 0.1M HEPES pH 7.0, 8% 2-propanol, 5 mM DTT",293,,,"5QIZ",26.55,"1.63","1.63","Covalent fragment group deposition -- Crystal Structure of OUTB2 in complex with PCM-0103080","FNLISEKCDILSILRDHPENRIYRRKIEELSKRFTAIRKTKGDRNCFYRALGYSYLESLLGKSREIFKFKERVLQTPNDLLAAGFEEHKFRNFFNAFYSVVELVEKDGSVSSLLKVFNDQSASDHIVQFLRLLTSAFIRNRADFFRHFIDEEMDIKDFCTHEVEPMATECDHIQITALSQALSIALQVEYVDEMDTALNHHVFPEAATPSVYLLYKTSHYNILYA","Homo sapiens","OTUB2, C14orf137, OTB2, OTU2","Ubiquitin thioesterase OTUB2","1","5QIZ"
"5QJ2",,"X-RAY DIFFRACTION",2.42,49.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes pH 7.5, 150mM NaCl, 20-25%(V/V)PEG3350.Crystals were cryoprotected by supplementing the mother liquor with 15% (v/v) ethylene glycol and harvested by flash-cooling in liquid nitrogen",296,"10.1021/acsmedchemlett.8b00308",,"5QJ2",272.4,"2.82","2.82","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) OMPLEX WITH COMPOUND-20 AKA 7-((3-(1-METHYL-1H-PYRAZOL-3- YL)BENZYL)OXY)- 1H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN-5-AMINE","CPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAA","Homo sapiens","MPO","Myeloperoxidase","1","5QJ2"
,,,,,,,,,,,,,,,,"AVNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREA","Homo sapiens","MPO","Myeloperoxidase","2","5QJ2"
"5QJ3",,"X-RAY DIFFRACTION",2.59,52.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M Hepes pH 7.5, 150mM NaCl, 20-25%(V/V)PEG3350.Crystals were cryoprotected by supplementing the mother liquor with 15% (v/v) ethylene glycol and harvested by flash-cooling in liquid nitrogen",296,"10.1021/acsmedchemlett.8b00308",,"5QJ3",135.69,"2.76","2.76","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-24 AKA 7-({4-CHLORO-3'-FLUORO-[1,1'- BIPHENYL]-3-YL}METHOXY)-3H-[1,2,3]TRIAZOLO[4,5-B]PYRIDIN- 5-AMINE","CPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAA","Homo sapiens","MPO","Myeloperoxidase","1","5QJ3"
,,,,,,,,,,,,,,,,"AVNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREA","Homo sapiens","MPO","Myeloperoxidase","2","5QJ3"
"5QJ4",,"X-RAY DIFFRACTION",2.42,49.26,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJ4",93.94,"1.89","1.89","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1827602749","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJ4"
"5QJ5",,"X-RAY DIFFRACTION",2.41,48.97,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJ5",93.75,"1.72","1.72","PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with Z44592329","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJ5"
"5QJ6",,"X-RAY DIFFRACTION",2.41,49.03,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJ6",93.59,"1.65","1.65","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1614545742","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJ6"
"5QJ7",,"X-RAY DIFFRACTION",2.41,49.03,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJ7",94.14,"1.56","1.56","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z32327641","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJ7"
"5QJ8",,"X-RAY DIFFRACTION",2.42,49.14,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJ8",93.14,"1.76","1.76","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z2856434829","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJ8"
"5QJ9",,"X-RAY DIFFRACTION",2.42,49.1,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJ9",93.87,"1.85","1.85","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z768399682","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJ9"
"5QJA",,"X-RAY DIFFRACTION",2.42,49.28,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJA",93.93,"1.64","1.64","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1497321453","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJA"
"5QJB",,"X-RAY DIFFRACTION",2.43,49.39,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJB",93.64,"1.66","1.66","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1787627869","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJB"
"5QJC",,"X-RAY DIFFRACTION",2.42,49.13,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJC",93.43,"1.47","1.47","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z755044716","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJC"
"5QJD",,"X-RAY DIFFRACTION",2.39,48.57,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJD",93.5,"1.61","1.61","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z240297434","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJD"
"5QJE",,"X-RAY DIFFRACTION",2.4,48.7,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJE",93.61,"1.75","1.75","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z275181224","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJE"
"5QJF",,"X-RAY DIFFRACTION",2.37,48.01,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJF",93.83,"1.63","1.63","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z52425517","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJF"
"5QJG",,"X-RAY DIFFRACTION",2.39,48.63,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJG",94.12,"1.57","1.57","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z44567722","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJG"
"5QJH",,"X-RAY DIFFRACTION",2.39,48.51,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJH",93.16,"2.03","2.03","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z375990520","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJH"
"5QJI",,"X-RAY DIFFRACTION",2.38,48.39,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJI",93.41,"1.69","1.69","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1899842917","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJI"
"5QJJ",,"X-RAY DIFFRACTION",2.39,48.47,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJJ",93.54,"1.71","1.71","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z24758179","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJJ"
"5QJK",,"X-RAY DIFFRACTION",2.4,48.85,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJK",93.85,"1.65","1.65","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z373221060","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJK"
"5QJL",,"X-RAY DIFFRACTION",2.39,48.54,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJL",94.17,"1.66","1.66","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z56983806","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJL"
"5QJM",,"X-RAY DIFFRACTION",2.44,49.55,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJM",93.78,"1.75","1.75","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z328695024","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJM"
"5QJN",,"X-RAY DIFFRACTION",2.42,49.09,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJN",93.51,"1.77","1.77","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1439422127","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJN"
"5QJO",,"X-RAY DIFFRACTION",2.39,48.64,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJO",93.64,"1.98","1.98","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z57292369","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJO"
"5QJP",,"X-RAY DIFFRACTION",2.39,48.62,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJP",93.69,"1.5","1.5","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1578665941","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJP"
"5QJQ",,"X-RAY DIFFRACTION",2.39,48.6,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJQ",93.91,"1.55","1.55","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z56791867","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJQ"
"5QJR",,"X-RAY DIFFRACTION",2.43,49.32,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJR",93.36,"1.62","1.62","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z220816104","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJR"
"5QJS",,"X-RAY DIFFRACTION",2.42,49.22,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJS",93.27,"1.58","1.58","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z979145504","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJS"
"5QJT",,"X-RAY DIFFRACTION",2.43,49.32,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJT",93.33,"1.62","1.62","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z969560582","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJT"
"5QJU",,"X-RAY DIFFRACTION",2.4,48.69,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJU",93.88,"1.77","1.77","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z906021418","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJU"
"5QJV",,"X-RAY DIFFRACTION",2.38,48.31,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJV",93.38,"1.61","1.61","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z281802060","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJV"
"5QJW",,"X-RAY DIFFRACTION",2.43,49.32,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJW",93.69,"1.57","1.57","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z198194396","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJW"
"5QJX",,"X-RAY DIFFRACTION",2.39,48.63,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJX",93.17,"1.73","1.73","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z2856434778","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJX"
"5QJY",,"X-RAY DIFFRACTION",2.43,49.39,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJY",93.63,"1.77","1.77","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z94597856","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJY"
"5QJZ",,"X-RAY DIFFRACTION",2.42,49.23,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QJZ",93.36,"1.52","1.52","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1696822287","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QJZ"
"5QK0",,"X-RAY DIFFRACTION",2.43,49.38,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QK0",93.4,"1.44","1.44","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1270312110","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QK0"
"5QK1",,"X-RAY DIFFRACTION",2.43,49.3,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QK1",93.69,"1.49","1.49","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z2027049478","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QK1"
"5QK2",,"X-RAY DIFFRACTION",2.37,48.15,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QK2",93.13,"1.65","1.65","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z54628578","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QK2"
"5QK3",,"X-RAY DIFFRACTION",2.43,49.39,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QK3",93.1,"1.71","1.71","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z239136710","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QK3"
"5QK4",,"X-RAY DIFFRACTION",2.42,49.22,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QK4",93.62,"1.62","1.62","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z44590919","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QK4"
"5QK5",,"X-RAY DIFFRACTION",2.42,49.23,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QK5",93.63,"1.63","1.63","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1267773786","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QK5"
"5QK6",,"X-RAY DIFFRACTION",2.42,49.16,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QK6",93.3,"1.51","1.51","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1343633025","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QK6"
"5QK7",,"X-RAY DIFFRACTION",2.38,48.42,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QK7",93.86,"1.66","1.66","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1918536193","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QK7"
"5QK8",,"X-RAY DIFFRACTION",2.42,49.12,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QK8",93.16,"1.71","1.71","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z1271660837","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QK8"
"5QK9",,"X-RAY DIFFRACTION",2.43,49.36,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QK9",93.91,"1.56","1.56","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z102895082","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QK9"
"5QKA",,"X-RAY DIFFRACTION",2.43,49.29,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QKA",93.23,"1.55","1.55","PanDDA analysis group deposition of models with modelled events (e.g. bound ligands) -- Crystal Structure of NUDT5 in complex with Z2377835233","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QKA"
"5QKB",,"X-RAY DIFFRACTION",2.41,48.99,"VAPOR DIFFUSION, SITTING DROP",,"33 % PEG4k, 0.2 MgCl2 and 0.1 M Tris",293.15,,,"5QKB",92.9,"1.58","1.58","Ground-state model of NUDT5 and corresponding apo datasets for PanDDA analysis","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QKB"
"5QOH",,"X-RAY DIFFRACTION",2.6,52.77,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOH",19.62,"1.93","1.93","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with XST00000847b","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOH"
"5QOI",,"X-RAY DIFFRACTION",2.55,51.72,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOI",19.59,"1.99","1.99","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000213a","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOI"
"5QOJ",,"X-RAY DIFFRACTION",2.6,52.67,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOJ",19.59,"2.05","2.05","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOCR000171b","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOJ"
"5QOK",,"X-RAY DIFFRACTION",2.53,51.47,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOK",19.67,"2.28","2.28","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000294a","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOK"
"5QOL",,"X-RAY DIFFRACTION",2.54,51.48,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOL",19.64,"1.85","1.85","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000435a","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOL"
"5QOM",,"X-RAY DIFFRACTION",2.52,51.24,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOM",19.73,"1.87","1.87","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000576a","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOM"
"5QON",,"X-RAY DIFFRACTION",2.56,51.87,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QON",19.68,"1.8","1.8","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000446a","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QON"
"5QOO",,"X-RAY DIFFRACTION",2.58,52.3,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOO",19.62,"1.56","1.56","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000144a","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOO"
"5QOP",,"X-RAY DIFFRACTION",2.6,52.61,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOP",19.63,"1.86","1.86","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with NUOOA000023a","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOP"
"5QOQ",,"X-RAY DIFFRACTION",2.52,51.13,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOQ",19.64,"1.49","1.49","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2895259680","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOQ"
"5QOR",,"X-RAY DIFFRACTION",2.5,50.8,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOR",19.66,"1.95","1.95","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1203490773","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOR"
"5QOS",,"X-RAY DIFFRACTION",2.47,50.21,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOS",19.59,"1.7","1.7","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1187701032","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOS"
"5QOT",,"X-RAY DIFFRACTION",2.48,50.37,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOT",19.66,"1.68","1.68","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1592710382","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOT"
"5QOU",,"X-RAY DIFFRACTION",2.51,51.04,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOU",19.66,"2.19","2.19","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z296300542","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOU"
"5QOV",,"X-RAY DIFFRACTION",2.48,50.45,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOV",19.62,"1.65","1.65","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1699011516","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOV"
"5QOW",,"X-RAY DIFFRACTION",2.5,50.82,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOW",19.66,"1.82","1.82","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2895259675","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOW"
"5QOX",,"X-RAY DIFFRACTION",2.51,50.95,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOX",19.67,"1.95","1.95","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2212124043","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOX"
"5QOY",,"X-RAY DIFFRACTION",2.49,50.65,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOY",19.68,"1.69","1.69","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with YW-FY-378","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOY"
"5QOZ",,"X-RAY DIFFRACTION",2.48,50.35,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QOZ",19.62,"1.7","1.7","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with PB1787571279","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QOZ"
"5QP0",,"X-RAY DIFFRACTION",2.53,51.4,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QP0",19.66,"2","2","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z454376544","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QP0"
"5QP1",,"X-RAY DIFFRACTION",2.51,51.03,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QP1",19.66,"1.79","1.79","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1190363272","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QP1"
"5QP2",,"X-RAY DIFFRACTION",2.48,50.45,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QP2",19.66,"1.83","1.83","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1170065264","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QP2"
"5QP3",,"X-RAY DIFFRACTION",2.52,51.17,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QP3",19.67,"1.75","1.75","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1494850193","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QP3"
"5QP4",,"X-RAY DIFFRACTION",2.49,50.56,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QP4",19.75,"1.71","1.71","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z450133538","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QP4"
"5QP5",,"X-RAY DIFFRACTION",2.52,51.1,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QP5",19.64,"1.9","1.9","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z2895259681","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QP5"
"5QP6",,"X-RAY DIFFRACTION",2.5,50.82,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QP6",19.66,"1.65","1.65","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z1662802141","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QP6"
"5QP7",,"X-RAY DIFFRACTION",2.5,50.89,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QP7",19.59,"1.88","1.88","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with PB1230873739","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QP7"
"5QP8",,"X-RAY DIFFRACTION",2.5,50.8,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QP8",19.62,"1.64","1.64","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with PB1787571279","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QP8"
"5QP9",,"X-RAY DIFFRACTION",2.51,51.06,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QP9",19.64,"1.72","1.72","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with Z100435060","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QP9"
"5QPA",,"X-RAY DIFFRACTION",2.54,51.51,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QPA",19.64,"1.61","1.61","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000449a","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QPA"
"5QPB",,"X-RAY DIFFRACTION",2.47,50.29,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QPB",19.69,"1.68","1.68","PanDDA analysis group deposition -- Crystal Structure of DCP2 (NUDT20) in complex with FMOPL000701a","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QPB"
"5QPC",,"X-RAY DIFFRACTION",2.55,51.85,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M acetate, pH 4.5, 5-25% PEG3350",277,,,"5QPC",19.5,"1.66","1.66","Crystal Structure of DCP2 (NUDT20) after initial refinement with no ligand modelled (structure $n)","SMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTP","Homo sapiens","DCP2, NUDT20","DCP2 (NUDT20)","1","5QPC"
"5QQP",,"X-RAY DIFFRACTION",3.44,64.27,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium acetate, pH 4.6, 25% (w/v) MePEG2000, 200 mM ammonium sulfate, then transferred to 100 mM Tris-HCl, pH 7.0, 25% (w/v) MePEG2000, 200 MM ammonium sulfate",277,"10.1016/j.bmcl.2019.08.008","NR7","5QQP",28.74,"2.08","2.08","FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(5E,8S)-8-[(4S)-4-(3-chlorophenyl)-2-oxopiperidin-1-yl]-2-oxo-1,3,4,7,8,10-hexahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","5QQP"
"5QQQ",,"X-RAY DIFFRACTION",2.33,47.31,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QQQ",105.2,"1.93","1.93","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434857","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QQQ"
"5QQR",,"X-RAY DIFFRACTION",2.33,47.15,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QQR",105.19,"1.46","1.46","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1171217421","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QQR"
"5QQS",,"X-RAY DIFFRACTION",2.32,47.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QQS",105.22,"1.85","1.85","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z275151340","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QQS"
"5QQT",,"X-RAY DIFFRACTION",2.34,47.47,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QQT",105.24,"1.67","1.67","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434834","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QQT"
"5QQU",,"X-RAY DIFFRACTION",2.34,47.52,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QQU",105.61,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1348371854","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QQU"
"5QQV",,"X-RAY DIFFRACTION",2.35,47.69,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QQV",105.24,"1.52","1.52","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1545312521","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QQV"
"5QQW",,"X-RAY DIFFRACTION",2.36,47.81,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QQW",105.4,"1.56","1.56","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z136583524","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QQW"
"5QQX",,"X-RAY DIFFRACTION",2.31,46.76,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QQX",105.58,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z373768900","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QQX"
"5QQY",,"X-RAY DIFFRACTION",2.33,47.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QQY",105.39,"1.49","1.49","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434899","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QQY"
"5QQZ",,"X-RAY DIFFRACTION",2.34,47.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QQZ",105.2,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1675346324","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QQZ"
"5QR0",,"X-RAY DIFFRACTION",2.34,47.39,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QR0",105.48,"1.65","1.65","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z730649594","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QR0"
"5QR1",,"X-RAY DIFFRACTION",2.33,47.31,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QR1",105.2,"1.44","1.44","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z396380540","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QR1"
"5QR2",,"X-RAY DIFFRACTION",2.32,46.92,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QR2",105.2,"1.66","1.66","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1348371854","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QR2"
"5QR3",,"X-RAY DIFFRACTION",2.36,47.94,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QR3",105.22,"1.71","1.71","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z915492990","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QR3"
"5QR4",,"X-RAY DIFFRACTION",2.38,48.41,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QR4",105.23,"1.57","1.57","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434826","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QR4"
"5QR5",,"X-RAY DIFFRACTION",2.33,47.14,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QR5",105.24,"1.49","1.49","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2241115980","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QR5"
"5QR6",,"X-RAY DIFFRACTION",2.34,47.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QR6",105.24,"1.52","1.52","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z44567722","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QR6"
"5QR7",,"X-RAY DIFFRACTION",2.32,46.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QR7",105.47,"1.74","1.74","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z57299529","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QR7"
"5QR8",,"X-RAY DIFFRACTION",2.32,46.99,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QR8",105.21,"1.85","1.85","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z57258487","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QR8"
"5QR9",,"X-RAY DIFFRACTION",2.33,47.11,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QR9",105.17,"1.62","1.62","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z31478129","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QR9"
"5QRA",,"X-RAY DIFFRACTION",2.34,47.37,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QRA",105.22,"1.72","1.72","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1101755952","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QRA"
"5QRB",,"X-RAY DIFFRACTION",2.32,46.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QRB",105.22,"1.72","1.72","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z2856434868","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QRB"
"5QRC",,"X-RAY DIFFRACTION",2.33,47.11,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QRC",105.22,"1.82","1.82","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z31721798","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QRC"
"5QRD",,"X-RAY DIFFRACTION",2.39,48.63,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QRD",105.24,"1.76","1.76","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z1328968520","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QRD"
"5QRE",,"X-RAY DIFFRACTION",2.34,47.38,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QRE",105.23,"1.67","1.67","PanDDA analysis group deposition -- Crystal Structure of human ALAS2A in complex with Z117233350","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QRE"
"5QRF",,"X-RAY DIFFRACTION",2.54,51.51,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRF",20.35,"2.03","2.03","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z373768900","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRF"
"5QRG",,"X-RAY DIFFRACTION",2.51,51.03,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRG",20.39,"1.95","1.95","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z275151340","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRG"
"5QRH",,"X-RAY DIFFRACTION",2.52,51.15,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRH",20.41,"1.81","1.81","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z32327641","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRH"
"5QRI",,"X-RAY DIFFRACTION",2.53,51.3,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRI",20.4,"1.83","1.83","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z2856434826","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRI"
"5QRJ",,"X-RAY DIFFRACTION",2.53,51.39,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRJ",20.4,"1.81","1.81","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z416341642","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRJ"
"5QRK",,"X-RAY DIFFRACTION",2.55,51.76,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRK",20.36,"1.63","1.63","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z275179758","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRK"
"5QRL",,"X-RAY DIFFRACTION",2.54,51.58,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRL",20.36,"1.76","1.76","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z437516460","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRL"
"5QRM",,"X-RAY DIFFRACTION",2.53,51.44,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRM",20.38,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1899842917","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRM"
"5QRN",,"X-RAY DIFFRACTION",2.52,51.26,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRN",20.37,"1.62","1.62","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z54226006","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRN"
"5QRO",,"X-RAY DIFFRACTION",2.54,51.66,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRO",20.36,"1.61","1.61","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1506050651","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRO"
"5QRP",,"X-RAY DIFFRACTION",2.55,51.72,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRP",20.37,"1.67","1.67","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z2442270563","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRP"
"5QRQ",,"X-RAY DIFFRACTION",2.51,51.09,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRQ",20.35,"2.1","2.1","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z645232558","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRQ"
"5QRR",,"X-RAY DIFFRACTION",2.52,51.17,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRR",20.39,"1.69","1.69","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z31720228","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRR"
"5QRS",,"X-RAY DIFFRACTION",2.52,51.21,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRS",20.36,"2.06","2.06","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1891773393","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRS"
"5QRT",,"X-RAY DIFFRACTION",2.53,51.36,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRT",20.38,"1.77","1.77","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z31735562","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRT"
"5QRU",,"X-RAY DIFFRACTION",2.54,51.49,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRU",20.35,"1.76","1.76","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z235341991","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRU"
"5QRV",,"X-RAY DIFFRACTION",2.53,51.36,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRV",20.38,"1.67","1.67","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z198194396","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRV"
"5QRW",,"X-RAY DIFFRACTION",2.54,51.53,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRW",20.43,"1.74","1.74","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1509882419","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRW"
"5QRX",,"X-RAY DIFFRACTION",2.5,50.7,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRX",20.36,"1.87","1.87","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z364328788","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRX"
"5QRY",,"X-RAY DIFFRACTION",2.54,51.57,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRY",20.38,"1.58","1.58","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z2856434890","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRY"
"5QRZ",,"X-RAY DIFFRACTION",2.51,51.07,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QRZ",20.37,"1.96","1.96","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1998104358","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QRZ"
"5QS0",,"X-RAY DIFFRACTION",2.52,51.18,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QS0",20.66,"1.6","1.6","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z274555794","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QS0"
"5QS1",,"X-RAY DIFFRACTION",2.49,50.64,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QS1",20.34,"1.66","1.66","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1954800564","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QS1"
"5QS2",,"X-RAY DIFFRACTION",2.55,51.78,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QS2",20.4,"1.68","1.68","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z291279160","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QS2"
"5QS3",,"X-RAY DIFFRACTION",2.53,51.42,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QS3",20.35,"1.71","1.71","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z198195770","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QS3"
"5QS4",,"X-RAY DIFFRACTION",2.53,51.38,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QS4",20.33,"1.65","1.65","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z30820160","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QS4"
"5QS5",,"X-RAY DIFFRACTION",2.54,51.57,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QS5",20.41,"1.81","1.81","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z32400357","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QS5"
"5QS6",,"X-RAY DIFFRACTION",2.42,49.27,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QS6",19.87,"1.67","1.67","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z44592329","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QS6"
"5QS7",,"X-RAY DIFFRACTION",2.41,48.94,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QS7",19.9,"1.66","1.66","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z32327641","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QS7"
"5QS8",,"X-RAY DIFFRACTION",2.43,49.34,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QS8",19.86,"1.47","1.47","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z1432018343","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QS8"
"5QS9",,"X-RAY DIFFRACTION",2.4,48.72,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QS9",20.12,"1.43","1.43","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z48847594","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QS9"
"5QSA",,"X-RAY DIFFRACTION",2.44,49.63,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QSA",19.86,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434778","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QSA"
"5QSB",,"X-RAY DIFFRACTION",2.39,48.58,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QSB",19.89,"1.82","1.82","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434874","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QSB"
"5QSC",,"X-RAY DIFFRACTION",2.43,49.43,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QSC",20.09,"1.62","1.62","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z300245038","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QSC"
"5QSD",,"X-RAY DIFFRACTION",2.43,49.41,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QSD",19.88,"1.87","1.87","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z54571979","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QSD"
"5QSE",,"X-RAY DIFFRACTION",2.42,49.07,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QSE",19.84,"2.01","2.01","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2017168803","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QSE"
"5QSF",,"X-RAY DIFFRACTION",2.42,49.08,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QSF",19.82,"1.96","1.96","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434814","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QSF"
"5QSG",,"X-RAY DIFFRACTION",2.42,49.23,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QSG",19.89,"1.87","1.87","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434903","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QSG"
"5QSH",,"X-RAY DIFFRACTION",2.4,48.76,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QSH",19.88,"1.9","1.9","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434868","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QSH"
"5QSI",,"X-RAY DIFFRACTION",2.42,49.14,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QSI",19.85,"1.64","1.64","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z933326822","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QSI"
"5QSJ",,"X-RAY DIFFRACTION",2.43,49.35,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QSJ",19.88,"1.49","1.49","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z198194394","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QSJ"
"5QSK",,"X-RAY DIFFRACTION",2.41,48.95,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QSK",19.82,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z2856434906","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QSK"
"5QSL",,"X-RAY DIFFRACTION",2.51,51.01,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M CdCl, 0.1 M Acetate pH 4.5, 32% PEG 400",298,,,"5QSL",20.45,"2.2","2.2","PanDDA analysis group deposition -- Crystal Structure of human Brachyury in complex with Z1273312153","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGGPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QSL"
"5QSM",,"X-RAY DIFFRACTION",2.9,57.65,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",298,,,"5QSM",105.71,"2.74","2.74","PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z57261895","SMSPNGNLIRMLVLFFLESELHEHAAYLVDSLWESSQELLKDWECMTELLLEEPVQGEEAMSDRQESALIELMVCTIRQAAEAHPPVGRGTGKRVLTAKERKTQIDDRNKLTEHFIITLPMLLSKYSADAEKVANLLQIPQYFDLEIYSTGRMEKHLDALLKQIKFVVEKHVESDVLEACSKTYSILCSEEYTIQNRVDIARSQLIDEFVDRFNHSVEDLLQEGEEADDDDIYNVLSTLKRLTSFHNAHDLTKWDLFGNCYRLLKTGIEHGAMPEQIVVQALQCSHYSILWQLVKITDGSPSKEDLLVLRKTVKSFLAVCQQCLSNVNTPVKEQAFMLLCDLLMIFSHQLMTGGREGLQPLVFNPDTGLQSELLSFVMDHVFIDQDEENQSMEGDEEDEANKIEALHKRRNLLAAFSKLIIYDIVDMHAAADIFKHYMKYYNDYGDIIKETLSKTRQID","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","5QSM"
"5QSN",,"X-RAY DIFFRACTION",2.9,57.6,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",298,,,"5QSN",105.71,"2.66","2.66","PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z1272480091","SMSPNGNLIRMLVLFFLESELHEHAAYLVDSLWESSQELLKDWECMTELLLEEPVQGEEAMSDRQESALIELMVCTIRQAAEAHPPVGRGTGKRVLTAKERKTQIDDRNKLTEHFIITLPMLLSKYSADAEKVANLLQIPQYFDLEIYSTGRMEKHLDALLKQIKFVVEKHVESDVLEACSKTYSILCSEEYTIQNRVDIARSQLIDEFVDRFNHSVEDLLQEGEEADDDDIYNVLSTLKRLTSFHNAHDLTKWDLFGNCYRLLKTGIEHGAMPEQIVVQALQCSHYSILWQLVKITDGSPSKEDLLVLRKTVKSFLAVCQQCLSNVNTPVKEQAFMLLCDLLMIFSHQLMTGGREGLQPLVFNPDTGLQSELLSFVMDHVFIDQDEENQSMEGDEEDEANKIEALHKRRNLLAAFSKLIIYDIVDMHAAADIFKHYMKYYNDYGDIIKETLSKTRQID","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","5QSN"
"5QSO",,"X-RAY DIFFRACTION",2.96,58.51,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",298,,,"5QSO",105.73,"2.7","2.7","PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z466628048","SMSPNGNLIRMLVLFFLESELHEHAAYLVDSLWESSQELLKDWECMTELLLEEPVQGEEAMSDRQESALIELMVCTIRQAAEAHPPVGRGTGKRVLTAKERKTQIDDRNKLTEHFIITLPMLLSKYSADAEKVANLLQIPQYFDLEIYSTGRMEKHLDALLKQIKFVVEKHVESDVLEACSKTYSILCSEEYTIQNRVDIARSQLIDEFVDRFNHSVEDLLQEGEEADDDDIYNVLSTLKRLTSFHNAHDLTKWDLFGNCYRLLKTGIEHGAMPEQIVVQALQCSHYSILWQLVKITDGSPSKEDLLVLRKTVKSFLAVCQQCLSNVNTPVKEQAFMLLCDLLMIFSHQLMTGGREGLQPLVFNPDTGLQSELLSFVMDHVFIDQDEENQSMEGDEEDEANKIEALHKRRNLLAAFSKLIIYDIVDMHAAADIFKHYMKYYNDYGDIIKETLSKTRQID","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","5QSO"
"5QSP",,"X-RAY DIFFRACTION",2.85,56.88,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",298,,,"5QSP",105.75,"2.89","2.89","PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434929","SMSPNGNLIRMLVLFFLESELHEHAAYLVDSLWESSQELLKDWECMTELLLEEPVQGEEAMSDRQESALIELMVCTIRQAAEAHPPVGRGTGKRVLTAKERKTQIDDRNKLTEHFIITLPMLLSKYSADAEKVANLLQIPQYFDLEIYSTGRMEKHLDALLKQIKFVVEKHVESDVLEACSKTYSILCSEEYTIQNRVDIARSQLIDEFVDRFNHSVEDLLQEGEEADDDDIYNVLSTLKRLTSFHNAHDLTKWDLFGNCYRLLKTGIEHGAMPEQIVVQALQCSHYSILWQLVKITDGSPSKEDLLVLRKTVKSFLAVCQQCLSNVNTPVKEQAFMLLCDLLMIFSHQLMTGGREGLQPLVFNPDTGLQSELLSFVMDHVFIDQDEENQSMEGDEEDEANKIEALHKRRNLLAAFSKLIIYDIVDMHAAADIFKHYMKYYNDYGDIIKETLSKTRQID","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","5QSP"
"5QSQ",,"X-RAY DIFFRACTION",2.93,57.99,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",298,,,"5QSQ",105.92,"2.48","2.48","PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z396380540","SMSPNGNLIRMLVLFFLESELHEHAAYLVDSLWESSQELLKDWECMTELLLEEPVQGEEAMSDRQESALIELMVCTIRQAAEAHPPVGRGTGKRVLTAKERKTQIDDRNKLTEHFIITLPMLLSKYSADAEKVANLLQIPQYFDLEIYSTGRMEKHLDALLKQIKFVVEKHVESDVLEACSKTYSILCSEEYTIQNRVDIARSQLIDEFVDRFNHSVEDLLQEGEEADDDDIYNVLSTLKRLTSFHNAHDLTKWDLFGNCYRLLKTGIEHGAMPEQIVVQALQCSHYSILWQLVKITDGSPSKEDLLVLRKTVKSFLAVCQQCLSNVNTPVKEQAFMLLCDLLMIFSHQLMTGGREGLQPLVFNPDTGLQSELLSFVMDHVFIDQDEENQSMEGDEEDEANKIEALHKRRNLLAAFSKLIIYDIVDMHAAADIFKHYMKYYNDYGDIIKETLSKTRQID","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","5QSQ"
"5QSR",,"X-RAY DIFFRACTION",2.97,58.6,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",298,,,"5QSR",105.91,"3.28","3.28","PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z136583524","SMSPNGNLIRMLVLFFLESELHEHAAYLVDSLWESSQELLKDWECMTELLLEEPVQGEEAMSDRQESALIELMVCTIRQAAEAHPPVGRGTGKRVLTAKERKTQIDDRNKLTEHFIITLPMLLSKYSADAEKVANLLQIPQYFDLEIYSTGRMEKHLDALLKQIKFVVEKHVESDVLEACSKTYSILCSEEYTIQNRVDIARSQLIDEFVDRFNHSVEDLLQEGEEADDDDIYNVLSTLKRLTSFHNAHDLTKWDLFGNCYRLLKTGIEHGAMPEQIVVQALQCSHYSILWQLVKITDGSPSKEDLLVLRKTVKSFLAVCQQCLSNVNTPVKEQAFMLLCDLLMIFSHQLMTGGREGLQPLVFNPDTGLQSELLSFVMDHVFIDQDEENQSMEGDEEDEANKIEALHKRRNLLAAFSKLIIYDIVDMHAAADIFKHYMKYYNDYGDIIKETLSKTRQID","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","5QSR"
"5QSS",,"X-RAY DIFFRACTION",2.97,58.52,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",298,,,"5QSS",105.75,"3.08","3.08","PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z33452282","SMSPNGNLIRMLVLFFLESELHEHAAYLVDSLWESSQELLKDWECMTELLLEEPVQGEEAMSDRQESALIELMVCTIRQAAEAHPPVGRGTGKRVLTAKERKTQIDDRNKLTEHFIITLPMLLSKYSADAEKVANLLQIPQYFDLEIYSTGRMEKHLDALLKQIKFVVEKHVESDVLEACSKTYSILCSEEYTIQNRVDIARSQLIDEFVDRFNHSVEDLLQEGEEADDDDIYNVLSTLKRLTSFHNAHDLTKWDLFGNCYRLLKTGIEHGAMPEQIVVQALQCSHYSILWQLVKITDGSPSKEDLLVLRKTVKSFLAVCQQCLSNVNTPVKEQAFMLLCDLLMIFSHQLMTGGREGLQPLVFNPDTGLQSELLSFVMDHVFIDQDEENQSMEGDEEDEANKIEALHKRRNLLAAFSKLIIYDIVDMHAAADIFKHYMKYYNDYGDIIKETLSKTRQID","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","5QSS"
"5QST",,"X-RAY DIFFRACTION",3.16,61.1,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",298,,,"5QST",158.72,"2.58","2.58","PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2447286438","SMGGTLFEVVKLGKSAMQSVVDDWIESYKQDRDIALLDLINFFIQCSGCRGTVRIEMFRNMQNAEIIRKMTEEFDEDSGDYPLTMPGPQWKKFRSNFCEFIGVLIRQCQYSIIYDEYMMDTVISLLTGLSDSQVRAFRHTSTLAAMKLMTALVNVALNLSIHQDNTQRQYEAERNKMIGKRANERLELLLQKRKELQENQDEIENMMNSIFKGIFVHRYRDAIAEIRAICIEEIGVWMKMYSDAFLNDSYLKYVGWTLHDRQGEVRLKCLKALQSLYTNRELFPKLELFTNRFKDRIVSMTLDKEYDVAVEAIRLVTLILHGSEEALSNEDCENVYHLV","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","5QST"
"5QSU",,"X-RAY DIFFRACTION",2.96,58.39,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",298,,,"5QSU",158.73,"2.73","2.73","PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434926","SMGGTLFEVVKLGKSAMQSVVDDWIESYKQDRDIALLDLINFFIQCSGCRGTVRIEMFRNMQNAEIIRKMTEEFDEDSGDYPLTMPGPQWKKFRSNFCEFIGVLIRQCQYSIIYDEYMMDTVISLLTGLSDSQVRAFRHTSTLAAMKLMTALVNVALNLSIHQDNTQRQYEAERNKMIGKRANERLELLLQKRKELQENQDEIENMMNSIFKGIFVHRYRDAIAEIRAICIEEIGVWMKMYSDAFLNDSYLKYVGWTLHDRQGEVRLKCLKALQSLYTNRELFPKLELFTNRFKDRIVSMTLDKEYDVAVEAIRLVTLILHGSEEALSNEDCENVYHLV","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","5QSU"
"5QSV",,"X-RAY DIFFRACTION",3.14,60.81,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",298,,,"5QSV",158.73,"2.76","2.76","PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434783","SMGGTLFEVVKLGKSAMQSVVDDWIESYKQDRDIALLDLINFFIQCSGCRGTVRIEMFRNMQNAEIIRKMTEEFDEDSGDYPLTMPGPQWKKFRSNFCEFIGVLIRQCQYSIIYDEYMMDTVISLLTGLSDSQVRAFRHTSTLAAMKLMTALVNVALNLSIHQDNTQRQYEAERNKMIGKRANERLELLLQKRKELQENQDEIENMMNSIFKGIFVHRYRDAIAEIRAICIEEIGVWMKMYSDAFLNDSYLKYVGWTLHDRQGEVRLKCLKALQSLYTNRELFPKLELFTNRFKDRIVSMTLDKEYDVAVEAIRLVTLILHGSEEALSNEDCENVYHLV","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","5QSV"
"5QSW",,"X-RAY DIFFRACTION",3.16,61.13,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",298,,,"5QSW",159.5,"3.03","3.03","PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434884","SMGGTLFEVVKLGKSAMQSVVDDWIESYKQDRDIALLDLINFFIQCSGCRGTVRIEMFRNMQNAEIIRKMTEEFDEDSGDYPLTMPGPQWKKFRSNFCEFIGVLIRQCQYSIIYDEYMMDTVISLLTGLSDSQVRAFRHTSTLAAMKLMTALVNVALNLSIHQDNTQRQYEAERNKMIGKRANERLELLLQKRKELQENQDEIENMMNSIFKGIFVHRYRDAIAEIRAICIEEIGVWMKMYSDAFLNDSYLKYVGWTLHDRQGEVRLKCLKALQSLYTNRELFPKLELFTNRFKDRIVSMTLDKEYDVAVEAIRLVTLILHGSEEALSNEDCENVYHLV","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","5QSW"
"5QSX",,"X-RAY DIFFRACTION",3.18,61.3,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",298,,,"5QSX",159.24,"2.34","2.34","PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z2856434812","SMGGTLFEVVKLGKSAMQSVVDDWIESYKQDRDIALLDLINFFIQCSGCRGTVRIEMFRNMQNAEIIRKMTEEFDEDSGDYPLTMPGPQWKKFRSNFCEFIGVLIRQCQYSIIYDEYMMDTVISLLTGLSDSQVRAFRHTSTLAAMKLMTALVNVALNLSIHQDNTQRQYEAERNKMIGKRANERLELLLQKRKELQENQDEIENMMNSIFKGIFVHRYRDAIAEIRAICIEEIGVWMKMYSDAFLNDSYLKYVGWTLHDRQGEVRLKCLKALQSLYTNRELFPKLELFTNRFKDRIVSMTLDKEYDVAVEAIRLVTLILHGSEEALSNEDCENVYHLV","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","5QSX"
"5QSY",,"X-RAY DIFFRACTION",2.94,58.18,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",298,,,"5QSY",105.65,"2.4","2.4","PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z755044716","SMSPNGNLIRMLVLFFLESELHEHAAYLVDSLWESSQELLKDWECMTELLLEEPVQGEEAMSDRQESALIELMVCTIRQAAEAHPPVGRGTGKRVLTAKERKTQIDDRNKLTEHFIITLPMLLSKYSADAEKVANLLQIPQYFDLEIYSTGRMEKHLDALLKQIKFVVEKHVESDVLEACSKTYSILCSEEYTIQNRVDIARSQLIDEFVDRFNHSVEDLLQEGEEADDDDIYNVLSTLKRLTSFHNAHDLTKWDLFGNCYRLLKTGIEHGAMPEQIVVQALQCSHYSILWQLVKITDGSPSKEDLLVLRKTVKSFLAVCQQCLSNVNTPVKEQAFMLLCDLLMIFSHQLMTGGREGLQPLVFNPDTGLQSELLSFVMDHVFIDQDEENQSMEGDEEDEANKIEALHKRRNLLAAFSKLIIYDIVDMHAAADIFKHYMKYYNDYGDIIKETLSKTRQID","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","5QSY"
"5QSZ",,"X-RAY DIFFRACTION",2.93,58.02,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M Bis Tris Propane pH 7.0, 0.2 M Sodium Malonate, 20 % PEG 3350, 10 % Ethylene Glycol",298,,,"5QSZ",105.64,"3.08","3.08","PanDDA analysis group deposition -- Crystal Structure of human STAG1 in complex with Z1267773786","SMSPNGNLIRMLVLFFLESELHEHAAYLVDSLWESSQELLKDWECMTELLLEEPVQGEEAMSDRQESALIELMVCTIRQAAEAHPPVGRGTGKRVLTAKERKTQIDDRNKLTEHFIITLPMLLSKYSADAEKVANLLQIPQYFDLEIYSTGRMEKHLDALLKQIKFVVEKHVESDVLEACSKTYSILCSEEYTIQNRVDIARSQLIDEFVDRFNHSVEDLLQEGEEADDDDIYNVLSTLKRLTSFHNAHDLTKWDLFGNCYRLLKTGIEHGAMPEQIVVQALQCSHYSILWQLVKITDGSPSKEDLLVLRKTVKSFLAVCQQCLSNVNTPVKEQAFMLLCDLLMIFSHQLMTGGREGLQPLVFNPDTGLQSELLSFVMDHVFIDQDEENQSMEGDEEDEANKIEALHKRRNLLAAFSKLIIYDIVDMHAAADIFKHYMKYYNDYGDIIKETLSKTRQID","Homo sapiens","STAG1, SA1, SCC3","Cohesin subunit SA-1","1","5QSZ"
"5QT0",,"X-RAY DIFFRACTION",2.4,48.66,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M SPG pH 7.0, 30 % PEG 1000",298,,,"5QT0",19.9,"2.1","2.1","PanDDA analysis group deposition -- Crystal Structure of human Brachyury G177D variant in complex with Z321318226","GELRVGLEESELWLRFKELTNEMIVTKNGRRMFPVLKVNVSGLDPNAMYSFLLDFVAADNHRWKYVNGEWVPGGKPEPQAPSCVYIHPDSPNFGAHWMKAPVSFSKVKLTNKLNGGGQIMLNSLHKYEPRIHIVRVGDPQRMITSHCFPETQFIAVTAYQNEEITALKIKYN","Homo sapiens","TBXT, T","T-box transcription factor T","1","5QT0"
"5QT1",,"X-RAY DIFFRACTION",2.4,48.79,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG-3350, 0.2M lithium sulfate, 0.1M Bis-tris",291,,,"5QT1",26.9,"1.58","1.58","PanDDA analysis group deposition -- Partial occupancy interpretation of PanDDA event map: SETDB1 in complex with FMOMB000017a","MHHHHHHSSGRENLYFQGDLIVSMRILGKKRTKTWHKGTLIAIQTVGPGKKYKVKFDNKGKSLLSGNHIAYDYHPPADKLYVGSRVVAKYKDGNQVWLYAGIVAETPNVKNKLRFLIFFDDGYASYVTQSELYPICRPLKKTWEDIEDISCRDFIEEYVTAYPNRPMVLLKSGQLIKTEWEGTWWKSRVEEVDGSLVRILFLDDKRCEWIYRGSTRLEPMFSMKT","Homo sapiens","SETDB1, ESET, KIAA0067, KMT1E","Histone-lysine N-methyltransferase SETDB1","1","5QT1"
"5QT2",,"X-RAY DIFFRACTION",2.38,48.37,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG-3350, 0.2M lithium sulfate, 0.1M Bis-tris",291,,,"5QT2",27.22,"1.59","1.59","PanDDA analysis group deposition -- Partial occupancy interpretation of PanDDA event map: SETDB1 in complex with FMOPL000074a","MHHHHHHSSGRENLYFQGDLIVSMRILGKKRTKTWHKGTLIAIQTVGPGKKYKVKFDNKGKSLLSGNHIAYDYHPPADKLYVGSRVVAKYKDGNQVWLYAGIVAETPNVKNKLRFLIFFDDGYASYVTQSELYPICRPLKKTWEDIEDISCRDFIEEYVTAYPNRPMVLLKSGQLIKTEWEGTWWKSRVEEVDGSLVRILFLDDKRCEWIYRGSTRLEPMFSMKT","Homo sapiens","SETDB1, ESET, KIAA0067, KMT1E","Histone-lysine N-methyltransferase SETDB1","1","5QT2"
"5QT3",,"X-RAY DIFFRACTION",2.31,46.74,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 0.2 M magnesium chloride, 20% PEG3350",298,,,"5QT3",105,"1.95","1.95","Ground state model of human erythroid-specific 5'-aminolevulinate synthase, ALAS2 - SGC Diamond Xchem fragment screening","MGHHHHHHSSGVDLGTENLYFQSMFSYDQFFRDKIMEKKQDHTYRVFKTVNRWADAYPFAQHFSEASVASKDVSVWCSNDYLGMSRHPQVLQATQETLQRHGVGAGGTRNISGTSKFHVELEQELAELHQKDSALLFSSCFVANDSTLFTLAKILPGCEIYSDAGNHASMIQGIRNSGAAKFVFRHNDPDHLKKLLEKSNPKIPKIVAFETVHSMDGAICPLEELCDVSHQYGALTFVDEVHAVGLYGSRGAGIGERDGIMHKIDIISGTLGKAFGCVGGYIASTRDLVDMVRSYAAGFIFTTSLPPMVLSGALESVRLLKGEEGQALRRAHQRNVKHMRQLLMDRGLPVIPCPSHIIPIRVGNAALNSKLCDLLLSKHGIYVQAINYPTVPRGEELLRLAPSPHHSPQMMEDFVEKLLLAWTAVGLPLQDVSVAACNFCRRPVHFELMSEWERSYFGNMGPQYVTTYA","Homo sapiens","ALAS2, ALASE, ASB","5-aminolevulinate synthase, erythroid-specific, mitochondrial","1","5QT3"
"5QTL",,"X-RAY DIFFRACTION",2.42,49.17,"VAPOR DIFFUSION, SITTING DROP",8,"33% PEG4000, 0.2 magnesium chloride, 0.1 M Tris",293.15,,,"5QTL",93.8,"1.73","1.73","PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with GB-0804","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","NUDT5","1","5QTL"
"5QTM",,"X-RAY DIFFRACTION",2.41,49.03,"VAPOR DIFFUSION, SITTING DROP",8,"33% PEG4000, 0.2 magnesium chloride, 0.1 M Tris",293.15,,,"5QTM",93.93,"1.79","1.79","PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-2639","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QTM"
"5QTN",,"X-RAY DIFFRACTION",2.39,48.57,"VAPOR DIFFUSION, SITTING DROP",8,"33% PEG4000, 0.2 magnesium chloride, 0.1 M Tris",293.15,,,"5QTN",93.37,"1.83","1.83","PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with SS-4432","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QTN"
"5QTO",,"X-RAY DIFFRACTION",2.41,48.96,"VAPOR DIFFUSION, SITTING DROP",8,"33% PEG4000, 0.2 magnesium chloride, 0.1 M Tris",293.15,,,"5QTO",94.03,"1.67","1.67","PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with 1R-0641","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QTO"
"5QTP",,"X-RAY DIFFRACTION",2.41,49.04,"VAPOR DIFFUSION, SITTING DROP",8,"33% PEG4000, 0.2 magnesium chloride, 0.1 M Tris",293.15,,,"5QTP",94.25,"1.73","1.73","PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with AE-0227","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QTP"
"5QTQ",,"X-RAY DIFFRACTION",2.4,48.81,"VAPOR DIFFUSION, SITTING DROP",8,"33% PEG4000, 0.2 magnesium chloride, 0.1 M Tris",293.15,,,"5QTQ",93.8,"1.82","1.82","PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-1169","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QTQ"
"5QTR",,"X-RAY DIFFRACTION",2.41,48.96,"VAPOR DIFFUSION, SITTING DROP",8,"33% PEG4000, 0.2 magnesium chloride, 0.1 M Tris",293.15,,,"5QTR",93.83,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with FS-3764","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","NUDT5","1","5QTR"
"5QTS",,"X-RAY DIFFRACTION",2.42,49.14,"VAPOR DIFFUSION, SITTING DROP",8,"33% PEG4000, 0.2 magnesium chloride, 0.1 M Tris",293.15,,,"5QTS",94.17,"1.85","1.85","PanDDA analysis group deposition -- Crystal Structure of NUDT5 in complex with 8J-537S","SMESQEPTESSQNGKQYIISEELISEGKWVKLEKTTYMDPTGKTRTWESVKRTTRKEQTADGVAVIPVLQRTLHYECIVLVKQFRPPMGGYCIEFPAGLIDDGETPEAAALRELEEETGYKGDIAECSPAVCMDPGLSNCTIHIVTVTINGDDAENARPKPKPGDGEFVEVISLPKNDLLQRLDALVAEEHLTVDARVYSYALALKHAN","Homo sapiens","NUDT5, NUDIX5, HSPC115","ADP-sugar pyrophosphatase","1","5QTS"
"5QTT",,"X-RAY DIFFRACTION",3.45,64.34,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium acetate, pH 4.6, 25% (w/v) MePEG2000, 200 mM ammonium sulfate, then transferred to 100 mM Tris-HCl, pH 7.0, 25% (w/v) MePEG2000, 200 MM ammonium sulfate",277,"10.1021/acs.jmedchem.9b01768","QEY","5QTT",28.99,"2.23","2.23","FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(3R,7S)-7-{[5-amino-1-(3-chloro-2-fluorophenyl)-1H-pyrazole-4-carbonyl]amino}-3-methyl-2-oxo-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecin-15-yl]carbamate","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","5QTT"
"5QTU",,"X-RAY DIFFRACTION",3.23,61.92,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium acetate, pH 4.6, 25% (w/v) MePEG2000, 200 mM ammonium sulfate, then transferred to 100 mM Tris-HCl, pH 7.0, 25% (w/v) MePEG2000, 200 MM ammonium sulfate",277,"10.1021/acs.jmedchem.9b01768",,"5QTU",31.02,"2.53","2.53","FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(3R,7S)-7-{[1-(3-chloro-2-fluorophenyl)-5-methyl-1H-imidazole-4-carbonyl]amino}-3-methyl-2-oxo-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecin-15-yl]carbamate","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","5QTU"
,,,,,,,,,,,,,,,,"MDDDDKMDNECTTKIKPR","Homo sapiens","F11","Coagulation factor XI","2","5QTU"
"5QTV",,"X-RAY DIFFRACTION",3.45,64.3,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium acetate, pH 4.6, 25% (w/v) MePEG2000, 200 mM ammonium sulfate, then transferred to 100 mM Tris-HCl, pH 7.0, 25% (w/v) MePEG2000, 200 MM ammonium sulfate",277,"10.1016/j.bmcl.2020.126949","QLS","5QTV",29.23,"2.2","2.2","FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-2-(trifluoromethyl)-2,3,4,5,6,7-hexahydro-1H-8,11-epimino-1,9-benzodiazacyclotridecin-14-yl]carbamate","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","5QTV"
"5QTW",,"X-RAY DIFFRACTION",3.44,64.2,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium acetate, pH 4.6, 25% (w/v) MePEG2000, 200 mM ammonium sulfate, then transferred to 100 mM Tris-HCl, pH 7.0, 25% (w/v) MePEG2000, 200 MM ammonium sulfate",277,"10.1016/j.bmcl.2020.126949","QLM","5QTW",29.28,"2.12","2.12","FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl (2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-14-[(methoxycarbonyl)amino]-2,3,4,5,6,7-hexahydro-1H-8,11-epimino-1,9-benzodiazacyclotridecine-2-carboxylate","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","5QTW"
"5QTX",,"X-RAY DIFFRACTION",3.19,61.48,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium acetate, pH 4.6, 25% (w/v) MePEG2000, 200 mM ammonium sulfate, then transferred to 100 mM Tris-HCl, pH 7.0, 25% (w/v) MePEG2000, 200 MM ammonium sulfate",277,"10.1016/j.bmcl.2020.126949","QLD","5QTX",31.39,"2.07","2.07","FACTOR XIA IN COMPLEX WITH THE INHIBITOR ethyl (2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-14-[(methoxycarbonyl)amino]-1,2,3,4,5,6,7,9-octahydro-11,8-(azeno)-1,9-benzodiazacyclotridecine-2-carboxylate","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","5QTX"
,,,,,,,,,,,,,,,,"MDDDDKMDNECTTKIKPR","Homo sapiens","F11","Coagulation factor XI","2","5QTX"
"5QTY",,"X-RAY DIFFRACTION",3.42,64,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM sodium acetate, pH 4.6, 25% (w/v) MePEG2000, 200 mM ammonium sulfate, then transferred to 100 mM Tris-HCl, pH 7.0, 25% (w/v) MePEG2000, 200 MM ammonium sulfate",277,"10.1016/j.bmcl.2020.126949","QLJ","5QTY",29.24,"1.89","1.89","FACTOR XIA IN COMPLEX WITH THE INHIBITOR ethyl (2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-15-[(methoxycarbonyl)amino]-2,3,4,5,6,7-hexahydro-1H-12,8-(metheno)-1,9-benzodiazacyclotetradecine-2-carboxylate","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","5QTY"
"5QTZ",,"X-RAY DIFFRACTION",2.08,40.75,"VAPOR DIFFUSION, HANGING DROP",5.6,"23%(w/v) PEG3350, 3%(v/v) glcyerol",277,"10.1021/acsmedchemlett.9b00552","QMY","5QTZ",35.78,"1.83","1.83","TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[1-(2,2-DIFLUOROETHYL)-4-(6-METHYLPYRIDIN-2-YL)-1H-IMIDAZOL-5-YL]IMIDAZO[1,2-A]PYRIDINE","GHMTIARDIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","5QTZ"
"5QU0",,"X-RAY DIFFRACTION",2.1,41.33,"VAPOR DIFFUSION, HANGING DROP",5.6,"23%(w/v) PEG3350, 3%(v/v) glcyerol",277,"10.1021/acsmedchemlett.9b00552","QMV","5QU0",35.64,"1.67","1.67","TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[4-(3-CHLORO-4-FLUOROPHENYL)-1-(2-HYDROXYETHYL)-1H-IMIDAZOL-5-YL]IMIDAZO[1,2-B]PYRIDAZINE-3-CARBONITRILE","GHMTIARDIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","5QU0"
"5QU1",,"X-RAY DIFFRACTION",1.77,30.55,"VAPOR DIFFUSION, SITTING DROP",6.5,"5-20 mg/mL protein in 25mM HEPES\/NaOH pH7.8, 150mM NaCl mixed 60-70% with 40-30% reservoir consisting of 0.1M BIS-TRIS\/HCl pH6.5, 2M Ammonium sulfate",293,"10.1074/jbc.RA120.012788",,"5QU1",19.73,"1.08","1.08","Crystal Structure of the monomeric human Nck SH3.1 domain, triclinic, 1.08A","SGGLNDIFEAQKIEWHEGSENLYFQSEVVVVAKFDYVAQQEQELDIKKNERLWLLDDSKSWWRVRNSMNKTGFVPSNYVERK","Homo sapiens","NCK1, NCK","Cytoplasmic protein NCK1","1","5QU1"
"5QU3",,"X-RAY DIFFRACTION",1.66,25.81,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Tris/HCl pH 8.0, 0.15 M NaCl, 8% PEG 8000",293,"10.1074/jbc.RA120.012788",,"5QU3",19.53,"1.02","1.02","Crystal Structure of domain swapped human Nck SH3.1, 1.01A, monoclinic","SGGLNDIFEAQKIEWHEGSENLYFQSEVVVVAKFDYVAQQEQELDIKKNERLWLLDDSKSWWRVRNSMNKTGFVPSNYVERK","Homo sapiens","NCK1, NCK","Cytoplasmic protein NCK1","1","5QU3"
"5QU4",,"X-RAY DIFFRACTION",1.56,20.93,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M KSCN, 30% PEG-MME 2000",293,"10.1074/jbc.RA120.012788",,"5QU4",41.2,"1.05","1.05","Crystal Structure of swapped human Nck SH3.1 domain, 1.05A, orthorhombic form I","SGGLNDIFEAQKIEWHEGSENLYFQSMAEEVVVVAKFDYVAQQEQELDIKKNERLWLLDDSKSWWRVRNSMNKTGFVPSNYVERKNS","Homo sapiens","NCK1, NCK","Cytoplasmic protein NCK1","1","5QU4"
"5QU5",,"X-RAY DIFFRACTION",2.07,40.53,"VAPOR DIFFUSION, SITTING DROP",5.5,"5-20 mg/mL protein in 25mM HEPES\/NaOH pH7.8, 150mM NaCl mixed 60-70% with 40-30% reservoir consisting of 0.1M Bis-Tris/HCl pH5.5, 2M NaCl, 25% PEG3350",293,"10.1074/jbc.RA120.012788",,"5QU5",23.74,"1.11","1.11","Domain Swap in the first SH3 domain of human Nck1","MGHHHHHHHHHHSGGLNDIFEAQKIEWHEGSENLYFQSMAEEVVVVAKFDYVAQQEQELDIKKNERLWLLDDSKSWWRVRNSMNKTGFVPSNYVERKNS","Homo sapiens","NCK1, NCK","Cytoplasmic protein NCK1","1","5QU5"
"5QU6",,"X-RAY DIFFRACTION",1.75,29.74,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Bis-Tris/HCl pH 6.5, 2% tacsimate pH 6.0, 20% PEG 3350",293,"10.1074/jbc.RA120.012788",,"5QU6",288.38,"1.816","1.816","Crystal Structure of swapped human Nck SH3.1 domain, 1.8A, triclinic","SGGLNDIFEAQKIEWHEGSENLYFQSMAEEVVVVAKFDYVAQQEQELDIKKNERLWLLDDSKSWWRVRNSMNKTGFVPSNYVERKNS","Homo sapiens","NCK1, NCK","Cytoplasmic protein NCK1","1","5QU6"
"5QU7",,"X-RAY DIFFRACTION",1.38,10.93,"VAPOR DIFFUSION, SITTING DROP",5,"8% tacsimate pH 5, 20% PEG 3350",293,"10.1074/jbc.RA120.012788",,"5QU7",19.53,"1.27","1.27","Crystal Structure of swapped human Nck SH3.1 domain, 1.3A, orthorhombic form III","SGGLNDIFEAQKIEWHEGSENLYFQSEVVVVAKFDYVAQQEQELDIKKNERLWLLDDSKSWWRVRNSMNKTGFVPSNYVERK","Homo sapiens","NCK1, NCK","Cytoplasmic protein NCK1","1","5QU7"
"5QU8",,"X-RAY DIFFRACTION",1.45,15.17,"VAPOR DIFFUSION, SITTING DROP",7,"60% tacsimate pH 7.0",293,"10.1074/jbc.RA120.012788",,"5QU8",10.32,"0.93","0.93","Crystal Structure of symmetric swapped human Nck SH3.1 domain, 0.93A, orthorhombic form IV","SGGLNDIFEAQKIEWHEGSENLYFQSMAEEVVVVAKFDYVAQQEQELDIKKNERLWLLDDSKSWWRVRNSMNKTGFVPSNYVERKNS","Homo sapiens","NCK1, NCK","Cytoplasmic protein NCK1","1","5QU8"
"5QUA",,"X-RAY DIFFRACTION",1.56,21,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Bis-Tris/HCl pH 6.5, 2 M ammonium sulfate",293,"10.1074/jbc.RA120.012788",,"5QUA",20.6,"1.51","1.51","Crystal Structure of swapped human Nck SH3.1 domain, 1.5A, C2221","SGGLNDIFEAQKIEWHEGSENLYFQSMAEEVVVVAKFDYVAQQEQELDIKKNERLWLLDDSKSWWRVRNSMNKTGFVPSNYVERKNS","Homo sapiens","NCK1, NCK","Cytoplasmic protein NCK1","1","5QUA"
"5QXI",,"X-RAY DIFFRACTION",4.15,70.37,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXI",16.3,"1.64","1.64","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with PC587","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXI"
"5QXJ",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXJ",16.14,"1.46","1.46","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with PC578","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXJ"
"5QXK",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXK",16.21,"1.72","1.72","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with PC581","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXK"
"5QXL",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXL",16.16,"1.57","1.57","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with DF776","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXL"
"5QXM",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXM",16.35,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with DF789","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXM"
"5QXN",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXN",16.79,"1.41","1.41","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with DF826","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXN"
"5QXO",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXO",16.21,"1.47","1.47","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with DF848","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXO"
"5QXP",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXP",16.18,"1.41","1.41","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with TCJ732","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXP"
"5QXQ",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXQ",16.14,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with TCJ779","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXQ"
"5QXR",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXR",16.12,"1.66","1.66","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with DF849","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXR"
"5QXS",,"X-RAY DIFFRACTION",4.21,70.75,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXS",16.27,"1.62","1.62","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with DF852","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXS"
"5QXT",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXT",16.32,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with JKH47","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXT"
"5QXU",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXU",16.31,"1.65","1.65","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with RZ373","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXU"
"5QXV",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXV",16.15,"1.74","1.74","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with PC631","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXV"
"5QXW",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXW",16.23,"1.78","1.78","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with RZ189","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXW"
"5QXX",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXX",16.12,"1.58","1.58","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with RZ99","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXX"
"5QXY",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXY",16.18,"1.54","1.54","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with JKH93A","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXY"
"5QXZ",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QXZ",16.26,"1.64","1.64","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with DF853","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QXZ"
"5QY0",,"X-RAY DIFFRACTION",4.2,70.68,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5QY0",16.36,"1.89","1.89","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with PC591","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5QY0"
"5R4E",,"X-RAY DIFFRACTION",4.08,69.88,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5R4E",16.08,"1.83","1.83","PanDDA analysis group deposition -- Crystal Structure of ATAD2 in complex with RZ201","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5R4E"
"5R4F",,"X-RAY DIFFRACTION",4.21,70.76,"VAPOR DIFFUSION, SITTING DROP",5.5,"1.6M Ammonium Sulfate, 0.1M bis-tris pH 5.5",277,,,"5R4F",15.89,"1.44","1.44","PanDDA analysis group deposition of ground-state model of ATAD2","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5R4F"
"5R4G",,"X-RAY DIFFRACTION",2.04,39.67,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG4000, 0.1M Tris pH 8.5, 0.2M MgCl2",293,,,"5R4G",14.78,"1.25","1.25","PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000621a","SMSTEDAMTVLTPLTEKDYEGLKRVLRSLQAHKMAWPFLEPVDPNDAPDYYGVIKEPMDLATMEERVQRRYYEKLTEFVADMTKIFDNCRYYNPSDSPFYQCAEVLESFFVQKLKGFKASRSH","Homo sapiens","BPTF, FAC1, FALZ","Nucleosome-remodeling factor subunit BPTF","1","5R4G"
"5R4H",,"X-RAY DIFFRACTION",2.03,39.52,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG4000, 0.1M Tris pH 8.5, 0.2M MgCl2",293,,,"5R4H",14.88,"1.18","1.18","PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000287a","SMSTEDAMTVLTPLTEKDYEGLKRVLRSLQAHKMAWPFLEPVDPNDAPDYYGVIKEPMDLATMEERVQRRYYEKLTEFVADMTKIFDNCRYYNPSDSPFYQCAEVLESFFVQKLKGFKASRSH","Homo sapiens","BPTF, FAC1, FALZ","Nucleosome-remodeling factor subunit BPTF","1","5R4H"
"5R4I",,"X-RAY DIFFRACTION",2.03,39.5,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG4000, 0.1M Tris pH 8.5, 0.2M MgCl2",293,,,"5R4I",14.9,"1.28","1.28","PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000443a","SMSTEDAMTVLTPLTEKDYEGLKRVLRSLQAHKMAWPFLEPVDPNDAPDYYGVIKEPMDLATMEERVQRRYYEKLTEFVADMTKIFDNCRYYNPSDSPFYQCAEVLESFFVQKLKGFKASRSH","Homo sapiens","BPTF, FAC1, FALZ","Nucleosome-remodeling factor subunit BPTF","1","5R4I"
"5R4J",,"X-RAY DIFFRACTION",2.02,39.14,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG4000, 0.1M Tris pH 8.5, 0.2M MgCl2",293,,,"5R4J",14.82,"1.39","1.39","PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000280a","SMSTEDAMTVLTPLTEKDYEGLKRVLRSLQAHKMAWPFLEPVDPNDAPDYYGVIKEPMDLATMEERVQRRYYEKLTEFVADMTKIFDNCRYYNPSDSPFYQCAEVLESFFVQKLKGFKASRSH","Homo sapiens","BPTF, FAC1, FALZ","Nucleosome-remodeling factor subunit BPTF","1","5R4J"
"5R4K",,"X-RAY DIFFRACTION",2,38.54,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG4000, 0.1M Tris pH 8.5, 0.2M MgCl2",293,,,"5R4K",14.9,"1.17","1.17","PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000292a","SMSTEDAMTVLTPLTEKDYEGLKRVLRSLQAHKMAWPFLEPVDPNDAPDYYGVIKEPMDLATMEERVQRRYYEKLTEFVADMTKIFDNCRYYNPSDSPFYQCAEVLESFFVQKLKGFKASRSH","Homo sapiens","BPTF, FAC1, FALZ","Nucleosome-remodeling factor subunit BPTF","1","5R4K"
"5R4L",,"X-RAY DIFFRACTION",2.02,39.05,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG4000, 0.1M Tris pH 8.5, 0.2M MgCl2",293,,,"5R4L",14.89,"1.13","1.13","PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000349a","SMSTEDAMTVLTPLTEKDYEGLKRVLRSLQAHKMAWPFLEPVDPNDAPDYYGVIKEPMDLATMEERVQRRYYEKLTEFVADMTKIFDNCRYYNPSDSPFYQCAEVLESFFVQKLKGFKASRSH","Homo sapiens","BPTF, FAC1, FALZ","Nucleosome-remodeling factor subunit BPTF","1","5R4L"
"5R4M",,"X-RAY DIFFRACTION",2.01,38.94,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG4000, 0.1M Tris pH 8.5, 0.2M MgCl2",293,,,"5R4M",14.9,"1.11","1.11","PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000513a","SMSTEDAMTVLTPLTEKDYEGLKRVLRSLQAHKMAWPFLEPVDPNDAPDYYGVIKEPMDLATMEERVQRRYYEKLTEFVADMTKIFDNCRYYNPSDSPFYQCAEVLESFFVQKLKGFKASRSH","Homo sapiens","BPTF, FAC1, FALZ","Nucleosome-remodeling factor subunit BPTF","1","5R4M"
"5R4N",,"X-RAY DIFFRACTION",2.01,38.94,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG4000, 0.1M Tris pH 8.5, 0.2M MgCl2",293,,,"5R4N",14.85,"1.28","1.28","PanDDA analysis group deposition -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF in complex with FMOPL000061a","SMSTEDAMTVLTPLTEKDYEGLKRVLRSLQAHKMAWPFLEPVDPNDAPDYYGVIKEPMDLATMEERVQRRYYEKLTEFVADMTKIFDNCRYYNPSDSPFYQCAEVLESFFVQKLKGFKASRSH","Homo sapiens","BPTF, FAC1, FALZ","Nucleosome-remodeling factor subunit BPTF","1","5R4N"
"5R4O",,"X-RAY DIFFRACTION",2.02,38.99,"VAPOR DIFFUSION, SITTING DROP",8.5,"30% PEG4000, 0.1M Tris pH 8.5, 0.2M MgCl2",293,,,"5R4O",14.73,"1.05","1.05","PanDDA analysis group deposition of ground-state model of BROMODOMAIN OF HUMAN NUCLEOSOME-REMODELING FACTOR SUBUNIT BPTF","SMSTEDAMTVLTPLTEKDYEGLKRVLRSLQAHKMAWPFLEPVDPNDAPDYYGVIKEPMDLATMEERVQRRYYEKLTEFVADMTKIFDNCRYYNPSDSPFYQCAEVLESFFVQKLKGFKASRSH","Homo sapiens","BPTF, FAC1, FALZ","Nucleosome-remodeling factor subunit BPTF","1","5R4O"
"5R4P",,"X-RAY DIFFRACTION",2.24,45.07,"VAPOR DIFFUSION, SITTING DROP",5.1,"0.1M acetate pH 5.1, 0.0025M ZnAC, 6% PEG3K",277,,,"5R4P",46.47,"1.78","1.78","PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with NM450-1","SMLERTINLYPLTNYTFGTKEPLYEKDSSVAARFQRMREEFDKIGMRRTVEGVLIVHEHRLPHVLLLQLGTTFFKLPGGELNPGEDEVEGLKRLMTEILGRQDGVLQDWVIDDCIGNWWRPNFEPPQYPYIPAHITKPKEHKKLFLVQLQEKALFAVPKNYKLVAAPLFELYDNAPGYGPIISSLPQLLSRFNFIYN","Homo sapiens","NUDT21, CFIM25, CPSF25, CPSF5","Cleavage and polyadenylation specificity factor subunit 5","1","5R4P"
"5R4Q",,"X-RAY DIFFRACTION",2.24,45.05,"VAPOR DIFFUSION, SITTING DROP",5.1,"0.1M acetate pH 5.1, 0.0025M ZnAC, 6% PEG3K",277,,,"5R4Q",46.51,"1.49","1.49","PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with NM466-1","SMLERTINLYPLTNYTFGTKEPLYEKDSSVAARFQRMREEFDKIGMRRTVEGVLIVHEHRLPHVLLLQLGTTFFKLPGGELNPGEDEVEGLKRLMTEILGRQDGVLQDWVIDDCIGNWWRPNFEPPQYPYIPAHITKPKEHKKLFLVQLQEKALFAVPKNYKLVAAPLFELYDNAPGYGPIISSLPQLLSRFNFIYN","Homo sapiens","NUDT21, CFIM25, CPSF25, CPSF5","Cleavage and polyadenylation specificity factor subunit 5","1","5R4Q"
"5R4R",,"X-RAY DIFFRACTION",2.18,43.52,"VAPOR DIFFUSION, SITTING DROP",5.1,"0.1M acetate pH 5.1, 0.0025M ZnAC, 6% PEG3K",277,,,"5R4R",46.92,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with EN08775-42","SMLERTINLYPLTNYTFGTKEPLYEKDSSVAARFQRMREEFDKIGMRRTVEGVLIVHEHRLPHVLLLQLGTTFFKLPGGELNPGEDEVEGLKRLMTEILGRQDGVLQDWVIDDCIGNWWRPNFEPPQYPYIPAHITKPKEHKKLFLVQLQEKALFAVPKNYKLVAAPLFELYDNAPGYGPIISSLPQLLSRFNFIYN","Homo sapiens","NUDT21, CFIM25, CPSF25, CPSF5","Cleavage and polyadenylation specificity factor subunit 5","1","5R4R"
"5R4S",,"X-RAY DIFFRACTION",2.16,43.04,"VAPOR DIFFUSION, SITTING DROP",5.1,"0.1M acetate pH 5.1, 0.0025M ZnAC, 6% PEG3K",277,,,"5R4S",46.59,"1.61","1.61","PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with EN08775-45","SMLERTINLYPLTNYTFGTKEPLYEKDSSVAARFQRMREEFDKIGMRRTVEGVLIVHEHRLPHVLLLQLGTTFFKLPGGELNPGEDEVEGLKRLMTEILGRQDGVLQDWVIDDCIGNWWRPNFEPPQYPYIPAHITKPKEHKKLFLVQLQEKALFAVPKNYKLVAAPLFELYDNAPGYGPIISSLPQLLSRFNFIYN","Homo sapiens","NUDT21, CFIM25, CPSF25, CPSF5","Cleavage and polyadenylation specificity factor subunit 5","1","5R4S"
"5R4T",,"X-RAY DIFFRACTION",2.17,43.4,"VAPOR DIFFUSION, SITTING DROP",5.1,"0.1M acetate pH 5.1, 0.0025M ZnAC, 6% PEG3K",277,,,"5R4T",46.89,"1.68","1.68","PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with SK-430","SMLERTINLYPLTNYTFGTKEPLYEKDSSVAARFQRMREEFDKIGMRRTVEGVLIVHEHRLPHVLLLQLGTTFFKLPGGELNPGEDEVEGLKRLMTEILGRQDGVLQDWVIDDCIGNWWRPNFEPPQYPYIPAHITKPKEHKKLFLVQLQEKALFAVPKNYKLVAAPLFELYDNAPGYGPIISSLPQLLSRFNFIYN","Homo sapiens","NUDT21, CFIM25, CPSF25, CPSF5","Cleavage and polyadenylation specificity factor subunit 5","1","5R4T"
"5R4U",,"X-RAY DIFFRACTION",2.17,43.43,"VAPOR DIFFUSION, SITTING DROP",5.1,"0.1M acetate pH 5.1, 0.0025M ZnAC, 6% PEG3K",277,,,"5R4U",46.59,"1.92","1.92","PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with EN08775-43","SMLERTINLYPLTNYTFGTKEPLYEKDSSVAARFQRMREEFDKIGMRRTVEGVLIVHEHRLPHVLLLQLGTTFFKLPGGELNPGEDEVEGLKRLMTEILGRQDGVLQDWVIDDCIGNWWRPNFEPPQYPYIPAHITKPKEHKKLFLVQLQEKALFAVPKNYKLVAAPLFELYDNAPGYGPIISSLPQLLSRFNFIYN","Homo sapiens","NUDT21, CFIM25, CPSF25, CPSF5","Cleavage and polyadenylation specificity factor subunit 5","1","5R4U"
"5R4V",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"2.2M ammonium sulfate, 0.1M bis-tris pH 5.5",277,,,"5R4V",16.39,"1.29","1.29","XChem fragment screen -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF THE HUMAN ATAD2 in complex with N13475a","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5R4V"
"5R4W",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"2.2M ammonium sulfate, 0.1M bis-tris pH 5.5",277,,,"5R4W",16.2,"1.47","1.47","XChem fragment screen -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF THE HUMAN ATAD2 in complex with N13501a","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5R4W"
"5R4X",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"2.2M ammonium sulfate, 0.1M bis-tris pH 5.5",277,,,"5R4X",16.15,"1.4","1.4","XChem fragment screen -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF THE HUMAN ATAD2 in complex with N13413a","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5R4X"
"5R4Y",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"2.2M ammonium sulfate, 0.1M bis-tris pH 5.5",277,,,"5R4Y",16.2,"1.84","1.84","XChem fragment screen -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF THE HUMAN ATAD2 in complex with N13612a","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5R4Y"
"5R4Z",,"X-RAY DIFFRACTION",4.2,70.7,"VAPOR DIFFUSION, SITTING DROP",5.5,"2.2M ammonium sulfate, 0.1M bis-tris pH 5.5",277,,,"5R4Z",16.18,"1.46","1.46","XChem fragment screen -- CRYSTAL STRUCTURE OF THE BROMODOMAIN OF THE HUMAN ATAD2 in complex with N13605a","SMQEEDTFRELRIFLRNVTHRLAIDKRFRVFTKPVDPDEVPDYRTVIKEPMDLSSVISKIDLHKYLTVKDYLRDIDLICSNALEYNPDRDPGDRLIRHRACALRDTAYAIIKEELDEDFEQLCEEIQESR","Homo sapiens","ATAD2, L16, PRO2000","ATPase family AAA domain-containing protein 2","1","5R4Z"
"5R50",,"X-RAY DIFFRACTION",2.03,39.37,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R50",33.42,"1.87","1.87","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13371a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R50"
"5R51",,"X-RAY DIFFRACTION",2.02,39.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R51",33.27,"1.65","1.65","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14003a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R51"
"5R52",,"X-RAY DIFFRACTION",2.02,39.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R52",33.26,"1.48","1.48","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14004a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R52"
"5R53",,"X-RAY DIFFRACTION",2.02,39.25,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R53",33.24,"1.4","1.4","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13854a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R53"
"5R54",,"X-RAY DIFFRACTION",2.02,38.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R54",33.25,"1.79","1.79","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13582a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R54"
"5R55",,"X-RAY DIFFRACTION",2.03,39.35,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R55",33.06,"1.48","1.48","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13369a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R55"
"5R56",,"X-RAY DIFFRACTION",2.01,38.94,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R56",33.43,"1.51","1.51","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13688a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R56"
"5R57",,"X-RAY DIFFRACTION",2.01,38.95,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R57",33.18,"1.44","1.44","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N08253b","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R57"
"5R58",,"X-RAY DIFFRACTION",2.01,38.85,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R58",33.26,"1.98","1.98","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13542a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R58"
"5R59",,"X-RAY DIFFRACTION",2.02,38.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R59",33.25,"2.11","2.11","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13441a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R59"
"5R5A",,"X-RAY DIFFRACTION",2.02,39,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5A",33.22,"1.44","1.44","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13663a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5A"
"5R5B",,"X-RAY DIFFRACTION",2.02,39,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5B",33.25,"1.53","1.53","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13725a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5B"
"5R5C",,"X-RAY DIFFRACTION",2.01,38.86,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5C",33.25,"1.68","1.68","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13956a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5C"
"5R5D",,"X-RAY DIFFRACTION",2.01,38.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5D",33.26,"1.65","1.65","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13564a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5D"
"5R5E",,"X-RAY DIFFRACTION",2.02,39,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5E",33.23,"1.58","1.58","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13848a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5E"
"5R5F",,"X-RAY DIFFRACTION",2,38.61,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5F",33.25,"1.63","1.63","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13793a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5F"
"5R5G",,"X-RAY DIFFRACTION",2.01,38.72,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5G",33.23,"1.77","1.77","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13707a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5G"
"5R5H",,"X-RAY DIFFRACTION",2,38.64,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5H",33.25,"1.79","1.79","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13706a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5H"
"5R5I",,"X-RAY DIFFRACTION",2.02,39.17,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5I",33.17,"1.7","1.7","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N06325b","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5I"
"5R5J",,"X-RAY DIFFRACTION",2.02,39.15,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5J",33.27,"1.98","1.98","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13964a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5J"
"5R5K",,"X-RAY DIFFRACTION",2.01,38.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5K",33.26,"1.6","1.6","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13960a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5K"
"5R5L",,"X-RAY DIFFRACTION",2.02,39.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5L",33.23,"1.63","1.63","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13589a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5L"
"5R5M",,"X-RAY DIFFRACTION",2.01,38.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5M",33.26,"1.6","1.6","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14123a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5M"
"5R5N",,"X-RAY DIFFRACTION",2.01,38.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5N",33.25,"1.87","1.87","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13595a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5N"
"5R5O",,"X-RAY DIFFRACTION",2.03,39.47,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5O",33.27,"1.79","1.79","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14027a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5O"
"5R5P",,"X-RAY DIFFRACTION",2.01,38.66,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5P",33.25,"1.53","1.53","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13910a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5P"
"5R5Q",,"X-RAY DIFFRACTION",2.02,39.15,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5Q",33.19,"1.71","1.71","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13920a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5Q"
"5R5R",,"X-RAY DIFFRACTION",2.02,39.02,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5R",33.37,"1.65","1.65","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N14078a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5R"
"5R5S",,"X-RAY DIFFRACTION",2.01,38.81,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5R5S",33.22,"1.5","1.5","PanDDA analysis group deposition -- Crystal Structure of human NUDT22 in complex with N13775a","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5R5S"
"5R5T",,"X-RAY DIFFRACTION",2.14,42.41,"VAPOR DIFFUSION, SITTING DROP",8.5,"MORPHEUS 0.09M NPS, 0.1M BUFFER SYSTEM 3 PH = 8.5, 50% V/V PRECIPITANT MIX 1",293,,,"5R5T",25.37,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1251207602","SMPFPKDCSQAMLNGDTTSGLYTIYLNGDKAQALEVFCDMTSDGGGWIVFLRRKNGRENFYQNWKAYAAGFGDRREEFWLGLDNLNKITAQGQYELRVDLRDHGETAFAVYDKFSVGDAKTRYKLKVEGYSGTAGDSMAYHNGRSFSTFDKDTDSAITNCALSYKGAFWYRNCHRVNLMGRYGDNNHSQGVNWFHWKGHEHSIQFAEMKLRPSNFRNLEG","Homo sapiens","TNC, hCG_29852, HXB","Tenascin C (Hexabrachion), isoform CRA_a","1","5R5T"
"5R5U",,"X-RAY DIFFRACTION",2.14,42.43,"VAPOR DIFFUSION, SITTING DROP",8.5,"MORPHEUS 0.09M NPS, 0.1M BUFFER SYSTEM 3 PH = 8.5, 50% V/V PRECIPITANT MIX 1",293,,,"5R5U",25.42,"1.52","1.52","PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1545312521","SMPFPKDCSQAMLNGDTTSGLYTIYLNGDKAQALEVFCDMTSDGGGWIVFLRRKNGRENFYQNWKAYAAGFGDRREEFWLGLDNLNKITAQGQYELRVDLRDHGETAFAVYDKFSVGDAKTRYKLKVEGYSGTAGDSMAYHNGRSFSTFDKDTDSAITNCALSYKGAFWYRNCHRVNLMGRYGDNNHSQGVNWFHWKGHEHSIQFAEMKLRPSNFRNLEG","Homo sapiens","TNC, hCG_29852, HXB","Tenascin C (Hexabrachion), isoform CRA_a","1","5R5U"
"5R5V",,"X-RAY DIFFRACTION",2.09,41.22,"VAPOR DIFFUSION, SITTING DROP",8.5,"MORPHEUS 0.09M NPS, 0.1M BUFFER SYSTEM 3 PH = 8.5, 50% V/V PRECIPITANT MIX 1",293,,,"5R5V",25.39,"1.7","1.7","PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434824","SMPFPKDCSQAMLNGDTTSGLYTIYLNGDKAQALEVFCDMTSDGGGWIVFLRRKNGRENFYQNWKAYAAGFGDRREEFWLGLDNLNKITAQGQYELRVDLRDHGETAFAVYDKFSVGDAKTRYKLKVEGYSGTAGDSMAYHNGRSFSTFDKDTDSAITNCALSYKGAFWYRNCHRVNLMGRYGDNNHSQGVNWFHWKGHEHSIQFAEMKLRPSNFRNLEG","Homo sapiens","TNC, hCG_29852, HXB","Tenascin C (Hexabrachion), isoform CRA_a","1","5R5V"
"5R5W",,"X-RAY DIFFRACTION",2.12,42.1,"VAPOR DIFFUSION, SITTING DROP",8.5,"MORPHEUS 0.09M NPS, 0.1M BUFFER SYSTEM 3 PH = 8.5, 50% V/V PRECIPITANT MIX 1",293,,,"5R5W",25.41,"1.6","1.6","PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434942","SMPFPKDCSQAMLNGDTTSGLYTIYLNGDKAQALEVFCDMTSDGGGWIVFLRRKNGRENFYQNWKAYAAGFGDRREEFWLGLDNLNKITAQGQYELRVDLRDHGETAFAVYDKFSVGDAKTRYKLKVEGYSGTAGDSMAYHNGRSFSTFDKDTDSAITNCALSYKGAFWYRNCHRVNLMGRYGDNNHSQGVNWFHWKGHEHSIQFAEMKLRPSNFRNLEG","Homo sapiens","TNC, hCG_29852, HXB","Tenascin C (Hexabrachion), isoform CRA_a","1","5R5W"
"5R5X",,"X-RAY DIFFRACTION",2.12,41.96,"VAPOR DIFFUSION, SITTING DROP",8.5,"MORPHEUS 0.09M NPS, 0.1M BUFFER SYSTEM 3 PH = 8.5, 50% V/V PRECIPITANT MIX 1",293,,,"5R5X",25.41,"1.56","1.56","PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1259335913","SMPFPKDCSQAMLNGDTTSGLYTIYLNGDKAQALEVFCDMTSDGGGWIVFLRRKNGRENFYQNWKAYAAGFGDRREEFWLGLDNLNKITAQGQYELRVDLRDHGETAFAVYDKFSVGDAKTRYKLKVEGYSGTAGDSMAYHNGRSFSTFDKDTDSAITNCALSYKGAFWYRNCHRVNLMGRYGDNNHSQGVNWFHWKGHEHSIQFAEMKLRPSNFRNLEG","Homo sapiens","TNC, hCG_29852, HXB","Tenascin C (Hexabrachion), isoform CRA_a","1","5R5X"
"5R5Y",,"X-RAY DIFFRACTION",2.12,41.97,"VAPOR DIFFUSION, SITTING DROP",8.5,"MORPHEUS 0.09M NPS, 0.1M BUFFER SYSTEM 3 PH = 8.5, 50% V/V PRECIPITANT MIX 1",293,,,"5R5Y",25.43,"1.57","1.57","PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z509756472","SMPFPKDCSQAMLNGDTTSGLYTIYLNGDKAQALEVFCDMTSDGGGWIVFLRRKNGRENFYQNWKAYAAGFGDRREEFWLGLDNLNKITAQGQYELRVDLRDHGETAFAVYDKFSVGDAKTRYKLKVEGYSGTAGDSMAYHNGRSFSTFDKDTDSAITNCALSYKGAFWYRNCHRVNLMGRYGDNNHSQGVNWFHWKGHEHSIQFAEMKLRPSNFRNLEG","Homo sapiens","TNC, hCG_29852, HXB","Tenascin C (Hexabrachion), isoform CRA_a","1","5R5Y"
"5R5Z",,"X-RAY DIFFRACTION",2.11,41.78,"VAPOR DIFFUSION, SITTING DROP",8.5,"MORPHEUS 0.09M NPS, 0.1M BUFFER SYSTEM 3 PH = 8.5, 50% V/V PRECIPITANT MIX 1",293,,,"5R5Z",25.38,"1.67","1.67","PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434821","SMPFPKDCSQAMLNGDTTSGLYTIYLNGDKAQALEVFCDMTSDGGGWIVFLRRKNGRENFYQNWKAYAAGFGDRREEFWLGLDNLNKITAQGQYELRVDLRDHGETAFAVYDKFSVGDAKTRYKLKVEGYSGTAGDSMAYHNGRSFSTFDKDTDSAITNCALSYKGAFWYRNCHRVNLMGRYGDNNHSQGVNWFHWKGHEHSIQFAEMKLRPSNFRNLEG","Homo sapiens","TNC, hCG_29852, HXB","Tenascin C (Hexabrachion), isoform CRA_a","1","5R5Z"
"5R60",,"X-RAY DIFFRACTION",2.13,42.15,"VAPOR DIFFUSION, SITTING DROP",8.5,"MORPHEUS 0.09M NPS, 0.1M BUFFER SYSTEM 3 PH = 8.5, 50% V/V PRECIPITANT MIX 1",293,,,"5R60",25.4,"1.79","1.79","PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z19735067","SMPFPKDCSQAMLNGDTTSGLYTIYLNGDKAQALEVFCDMTSDGGGWIVFLRRKNGRENFYQNWKAYAAGFGDRREEFWLGLDNLNKITAQGQYELRVDLRDHGETAFAVYDKFSVGDAKTRYKLKVEGYSGTAGDSMAYHNGRSFSTFDKDTDSAITNCALSYKGAFWYRNCHRVNLMGRYGDNNHSQGVNWFHWKGHEHSIQFAEMKLRPSNFRNLEG","Homo sapiens","TNC, hCG_29852, HXB","Tenascin C (Hexabrachion), isoform CRA_a","1","5R60"
"5R61",,"X-RAY DIFFRACTION",2.13,42.19,"VAPOR DIFFUSION, SITTING DROP",8.5,"MORPHEUS 0.09M NPS, 0.1M BUFFER SYSTEM 3 PH = 8.5, 50% V/V PRECIPITANT MIX 1",293,,,"5R61",25.38,"1.38","1.38","PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z1578665941","SMPFPKDCSQAMLNGDTTSGLYTIYLNGDKAQALEVFCDMTSDGGGWIVFLRRKNGRENFYQNWKAYAAGFGDRREEFWLGLDNLNKITAQGQYELRVDLRDHGETAFAVYDKFSVGDAKTRYKLKVEGYSGTAGDSMAYHNGRSFSTFDKDTDSAITNCALSYKGAFWYRNCHRVNLMGRYGDNNHSQGVNWFHWKGHEHSIQFAEMKLRPSNFRNLEG","Homo sapiens","TNC, hCG_29852, HXB","Tenascin C (Hexabrachion), isoform CRA_a","1","5R61"
"5R62",,"X-RAY DIFFRACTION",2.12,42.11,"VAPOR DIFFUSION, SITTING DROP",8.5,"MORPHEUS 0.09M NPS, 0.1M BUFFER SYSTEM 3 PH = 8.5, 50% V/V PRECIPITANT MIX 1",293,,,"5R62",25.39,"1.4","1.4","PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z2856434840","SMPFPKDCSQAMLNGDTTSGLYTIYLNGDKAQALEVFCDMTSDGGGWIVFLRRKNGRENFYQNWKAYAAGFGDRREEFWLGLDNLNKITAQGQYELRVDLRDHGETAFAVYDKFSVGDAKTRYKLKVEGYSGTAGDSMAYHNGRSFSTFDKDTDSAITNCALSYKGAFWYRNCHRVNLMGRYGDNNHSQGVNWFHWKGHEHSIQFAEMKLRPSNFRNLEG","Homo sapiens","TNC, hCG_29852, HXB","Tenascin C (Hexabrachion), isoform CRA_a","1","5R62"
"5R63",,"X-RAY DIFFRACTION",2.13,42.31,"VAPOR DIFFUSION, SITTING DROP",8.5,"MORPHEUS 0.09M NPS, 0.1M BUFFER SYSTEM 3 PH = 8.5, 50% V/V PRECIPITANT MIX 1",293,,,"5R63",25.38,"1.59","1.59","PanDDA analysis group deposition -- Crystal Structure of FIBRINOGEN-LIKE GLOBE DOMAIN OF HUMAN TENASCIN-C in complex with Z319545618","SMPFPKDCSQAMLNGDTTSGLYTIYLNGDKAQALEVFCDMTSDGGGWIVFLRRKNGRENFYQNWKAYAAGFGDRREEFWLGLDNLNKITAQGQYELRVDLRDHGETAFAVYDKFSVGDAKTRYKLKVEGYSGTAGDSMAYHNGRSFSTFDKDTDSAITNCALSYKGAFWYRNCHRVNLMGRYGDNNHSQGVNWFHWKGHEHSIQFAEMKLRPSNFRNLEG","Homo sapiens","TNC, hCG_29852, HXB","Tenascin C (Hexabrachion), isoform CRA_a","1","5R63"
"5R64",,"X-RAY DIFFRACTION",2.26,45.55,"VAPOR DIFFUSION, SITTING DROP",5.1,"0.1M acetate pH 5.1, 0.0025M ZnAC, 6% PEG3K",277,,,"5R64",46.51,"1.84","1.84","PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000464a","SMLERTINLYPLTNYTFGTKEPLYEKDSSVAARFQRMREEFDKIGMRRTVEGVLIVHEHRLPHVLLLQLGTTFFKLPGGELNPGEDEVEGLKRLMTEILGRQDGVLQDWVIDDCIGNWWRPNFEPPQYPYIPAHITKPKEHKKLFLVQLQEKALFAVPKNYKLVAAPLFELYDNAPGYGPIISSLPQLLSRFNFIYN","Homo sapiens","NUDT21, CFIM25, CPSF25, CPSF5","Cleavage and polyadenylation specificity factor subunit 5","1","5R64"
"5R65",,"X-RAY DIFFRACTION",2.24,45.11,"VAPOR DIFFUSION, SITTING DROP",5.1,"0.1M acetate pH 5.1, 0.0025M ZnAC, 6% PEG3K",277,,,"5R65",46.71,"2.28","2.28","PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000387a","SMLERTINLYPLTNYTFGTKEPLYEKDSSVAARFQRMREEFDKIGMRRTVEGVLIVHEHRLPHVLLLQLGTTFFKLPGGELNPGEDEVEGLKRLMTEILGRQDGVLQDWVIDDCIGNWWRPNFEPPQYPYIPAHITKPKEHKKLFLVQLQEKALFAVPKNYKLVAAPLFELYDNAPGYGPIISSLPQLLSRFNFIYN","Homo sapiens","NUDT21, CFIM25, CPSF25, CPSF5","Cleavage and polyadenylation specificity factor subunit 5","1","5R65"
"5R66",,"X-RAY DIFFRACTION",2.24,45.14,"VAPOR DIFFUSION, SITTING DROP",5.1,"0.1M acetate pH 5.1, 0.0025M ZnAC, 6% PEG3K",277,,,"5R66",46.51,"2.02","2.02","PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000198a","SMLERTINLYPLTNYTFGTKEPLYEKDSSVAARFQRMREEFDKIGMRRTVEGVLIVHEHRLPHVLLLQLGTTFFKLPGGELNPGEDEVEGLKRLMTEILGRQDGVLQDWVIDDCIGNWWRPNFEPPQYPYIPAHITKPKEHKKLFLVQLQEKALFAVPKNYKLVAAPLFELYDNAPGYGPIISSLPQLLSRFNFIYN","Homo sapiens","NUDT21, CFIM25, CPSF25, CPSF5","Cleavage and polyadenylation specificity factor subunit 5","1","5R66"
"5R67",,"X-RAY DIFFRACTION",2.24,45.16,"VAPOR DIFFUSION, SITTING DROP",5.1,"0.1M acetate pH 5.1, 0.0025M ZnAC, 6% PEG3K",277,,,"5R67",46.57,"1.52","1.52","PanDDA analysis group deposition -- Crystal Structure of HUMAN CLEAVAGE FACTOR IM in complex with FMOPL000589a","SMLERTINLYPLTNYTFGTKEPLYEKDSSVAARFQRMREEFDKIGMRRTVEGVLIVHEHRLPHVLLLQLGTTFFKLPGGELNPGEDEVEGLKRLMTEILGRQDGVLQDWVIDDCIGNWWRPNFEPPQYPYIPAHITKPKEHKKLFLVQLQEKALFAVPKNYKLVAAPLFELYDNAPGYGPIISSLPQLLSRFNFIYN","Homo sapiens","NUDT21, CFIM25, CPSF25, CPSF5","Cleavage and polyadenylation specificity factor subunit 5","1","5R67"
"5R68",,"X-RAY DIFFRACTION",2.4,48.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M tris pH 7.5, 0.15M lithium sulfate, 40% PEG400",293,,,"5R68",43.25,"1.64","1.64","XChem group deposition -- Crystal Structure of human YEATS4 in complex with FM000199e","MGVTIVKPIVYGNVARYFGKKREEDGHTHQWTVYVKPYRNEDMSAYVKKIQFKLHESYGNPLRVVTKPPYEITETGWGEFEIIIKIFFIDPNERPVTLYHLLKLFQSDTNAMLGKKTVVSEFYDEMIFQDPTAMMQQLLTTSRQLTLGAYKHETEFAELEVKTREKLEAAKKKTAHHHHHH","Homo sapiens","YEATS4, GAS41","YEATS domain-containing protein 4","1","5R68"
"5R69",,"X-RAY DIFFRACTION",2.47,50.19,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M tris pH 7.5, 0.15M lithium sulfate, 40% PEG400",293,,,"5R69",43.21,"1.83","1.83","XChem group deposition -- Crystal Structure of human YEATS4 in complex with XS038644e","MGVTIVKPIVYGNVARYFGKKREEDGHTHQWTVYVKPYRNEDMSAYVKKIQFKLHESYGNPLRVVTKPPYEITETGWGEFEIIIKIFFIDPNERPVTLYHLLKLFQSDTNAMLGKKTVVSEFYDEMIFQDPTAMMQQLLTTSRQLTLGAYKHETEFAELEVKTREKLEAAKKKTAHHHHHH","Homo sapiens","YEATS4, GAS41","YEATS domain-containing protein 4","1","5R69"
"5R7W",,"X-RAY DIFFRACTION",3.25,62.1,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,,,"5R7W",17.59,"1.27","1.27","PanDDA analysis group deposition of ground-state model of INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R7W"
"5R7X",,"X-RAY DIFFRACTION",2.79,55.94,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5R7X",86.44,"1.44","1.44","PanDDA analysis group deposition of ground-state model of Human JMJD1B","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5R7X"
"5R85",,"X-RAY DIFFRACTION",3.24,61.98,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R85",17.78,"1.44","1.44","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1262246195 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R85"
"5R86",,"X-RAY DIFFRACTION",3.23,61.87,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R86",17.77,"1.5","1.5","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z943693514 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R86"
"5R87",,"X-RAY DIFFRACTION",3.22,61.82,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R87",17.8,"1.47","1.47","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z44592329 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R87"
"5R88",,"X-RAY DIFFRACTION",3.22,61.79,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R88",17.82,"1.48","1.48","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1545313172 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R88"
"5R89",,"X-RAY DIFFRACTION",3.22,61.75,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R89",17.8,"1.65","1.65","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z217038356 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R89"
"5R8A",,"X-RAY DIFFRACTION",3.22,61.85,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8A",17.78,"1.47","1.47","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1492796719 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8A"
"5R8B",,"X-RAY DIFFRACTION",3.22,61.83,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8B",17.89,"1.49","1.49","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z2027049478 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8B"
"5R8C",,"X-RAY DIFFRACTION",3.23,61.87,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8C",17.83,"1.54","1.54","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z30857828 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8C"
"5R8D",,"X-RAY DIFFRACTION",3.22,61.83,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8D",17.78,"1.47","1.47","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1745658474 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8D"
"5R8E",,"X-RAY DIFFRACTION",3.22,61.76,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8E",17.77,"1.35","1.35","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z57475877 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8E"
"5R8F",,"X-RAY DIFFRACTION",3.24,62.03,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8F",17.8,"1.41","1.41","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z2377835233 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8F"
"5R8G",,"X-RAY DIFFRACTION",3.24,62.05,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8G",17.8,"1.43","1.43","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1259086950 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8G"
"5R8H",,"X-RAY DIFFRACTION",3.23,61.97,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8H",17.83,"1.5","1.5","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z111716368 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8H"
"5R8I",,"X-RAY DIFFRACTION",3.21,61.74,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8I",17.75,"1.47","1.47","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z210803634 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8I"
"5R8J",,"X-RAY DIFFRACTION",3.23,61.87,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8J",17.79,"1.62","1.62","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z355728146 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8J"
"5R8K",,"X-RAY DIFFRACTION",3.23,61.93,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8K",17.79,"1.47","1.47","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z355728146 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8K"
"5R8L",,"X-RAY DIFFRACTION",3.25,62.2,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8L",17.79,"1.56","1.56","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1891773393 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8L"
"5R8M",,"X-RAY DIFFRACTION",3.23,61.95,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8M",17.81,"1.39","1.39","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1818332938 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8M"
"5R8N",,"X-RAY DIFFRACTION",3.22,61.8,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8N",17.84,"1.48","1.48","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z57292400 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8N"
"5R8O",,"X-RAY DIFFRACTION",3.22,61.78,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8O",17.81,"1.42","1.42","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z1881545321 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8O"
"5R8P",,"X-RAY DIFFRACTION",3.23,61.92,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8P",17.73,"1.53","1.53","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z818727262 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8P"
"5R8Q",,"X-RAY DIFFRACTION",3.21,61.68,"VAPOR DIFFUSION, SITTING DROP",7.9,"2.8M ammonium sulphate, 0.1M Tris pH7.9",291,"10.1021/acs.jmedchem.0c00403",,"5R8Q",17.8,"1.23","1.23","PanDDA analysis group deposition INTERLEUKIN-1 BETA -- Fragment Z2643472210 in complex with INTERLEUKIN-1 BETA","APVRSLNCTLRDSQQKSLVMSGPYELKALHLQGQDMEQQVVFSMSFVQGEESNDKIPVALGLKEKNLYLSCVLKDDKPTLQLESVDPKNYPKKKMEKRFVFNKIEINNKLEFESAQFPNWYISTSQAENMPVFLGGTKGGQDITDFTMQFVSS","Homo sapiens","IL1B, IL1F2","Interleukin-1 beta","1","5R8Q"
"5RAA",,"X-RAY DIFFRACTION",2.77,55.6,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAA",86.65,"1.57","1.57","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM009990a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAA"
"5RAB",,"X-RAY DIFFRACTION",2.79,55.89,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAB",86.68,"1.52","1.52","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001726a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAB"
"5RAC",,"X-RAY DIFFRACTION",2.8,56.06,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAC",86.92,"1.73","1.73","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001810a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAC"
"5RAD",,"X-RAY DIFFRACTION",2.79,55.86,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAD",86.67,"1.9","1.9","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001568a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAD"
"5RAE",,"X-RAY DIFFRACTION",2.75,55.26,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAE",86.68,"1.88","1.88","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001558a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAE"
"5RAF",,"X-RAY DIFFRACTION",2.79,55.92,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAF",86.63,"1.62","1.62","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001559a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAF"
"5RAG",,"X-RAY DIFFRACTION",2.79,55.99,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAG",86.65,"1.52","1.52","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001767a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAG"
"5RAH",,"X-RAY DIFFRACTION",2.78,55.69,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAH",86.69,"1.66","1.66","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM010032a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAH"
"5RAI",,"X-RAY DIFFRACTION",2.78,55.75,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAI",86.63,"1.54","1.54","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with XS040404c","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAI"
"5RAJ",,"X-RAY DIFFRACTION",2.78,55.79,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAJ",86.71,"1.61","1.61","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with BD009815a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAJ"
"5RAK",,"X-RAY DIFFRACTION",2.8,56.06,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAK",86.61,"1.69","1.69","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with XS040486b","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAK"
"5RAL",,"X-RAY DIFFRACTION",2.78,55.8,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAL",86.62,"1.68","1.68","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with XS039332c","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAL"
"5RAM",,"X-RAY DIFFRACTION",2.73,55.01,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAM",86.68,"2.05","2.05","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with XS038544d","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAM"
"5RAN",,"X-RAY DIFFRACTION",2.78,55.81,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAN",86.68,"1.95","1.95","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with XS039080d","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAN"
"5RAO",,"X-RAY DIFFRACTION",2.78,55.72,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAO",86.77,"1.59","1.59","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001084a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAO"
"5RAP",,"X-RAY DIFFRACTION",2.77,55.64,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAP",86.69,"1.9","1.9","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM000707a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAP"
"5RAQ",,"X-RAY DIFFRACTION",2.77,55.63,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAQ",86.9,"1.85","1.85","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001577a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAQ"
"5RAR",,"X-RAY DIFFRACTION",2.81,56.2,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAR",86.92,"1.47","1.47","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with TD000005c","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAR"
"5RAS",,"X-RAY DIFFRACTION",2.81,56.23,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAS",86.66,"1.58","1.58","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with XS036302b","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAS"
"5RAU",,"X-RAY DIFFRACTION",2.79,55.89,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAU",86.67,"1.73","1.73","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with DA000165b","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAU"
"5RAV",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAV",86.69,"1.77","1.77","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001763a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAV"
"5RAW",,"X-RAY DIFFRACTION",2.79,55.97,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAW",86.64,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM009970a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAW"
"5RAX",,"X-RAY DIFFRACTION",2.79,55.86,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAX",86.63,"2.01","2.01","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM010054a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAX"
"5RAY",,"X-RAY DIFFRACTION",2.8,56.06,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAY",86.64,"1.63","1.63","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001469a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAY"
"5RAZ",,"X-RAY DIFFRACTION",2.78,55.77,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RAZ",87.08,"1.81","1.81","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM010013a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RAZ"
"5RB0",,"X-RAY DIFFRACTION",2.77,55.63,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RB0",86.66,"1.95","1.95","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM010020a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RB0"
"5RB1",,"X-RAY DIFFRACTION",2.79,55.85,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RB1",86.62,"1.76","1.76","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001700a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RB1"
"5RB2",,"X-RAY DIFFRACTION",2.79,55.96,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RB2",86.74,"1.52","1.52","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001784a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RB2"
"5RB3",,"X-RAY DIFFRACTION",2.83,56.49,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RB3",86.98,"1.53","1.53","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with XS039249d","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RB3"
"5RB4",,"X-RAY DIFFRACTION",2.8,56.15,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RB4",86.67,"1.55","1.55","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001677a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RB4"
"5RB5",,"X-RAY DIFFRACTION",2.81,56.24,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RB5",87.09,"1.51","1.51","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM010010a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RB5"
"5RB6",,"X-RAY DIFFRACTION",2.8,56.1,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RB6",86.68,"1.63","1.63","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001569a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RB6"
"5RB7",,"X-RAY DIFFRACTION",2.81,56.24,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M bis-tris pH 5.5 21% PEG3350  0.3M magnesium chloride",277,,,"5RB7",86.67,"1.57","1.57","PanDDA analysis group deposition -- Crystal Structure of JMJD1B in complex with FM001648a","MHHHHHHSSGVDLGTENLYFQSMTSHSWLCDGRLLCLHDPSNKNNWKIFRECWKQGQPVLVSGVHKKLKSELWKPEAFSQEFGDQDVDLVNCRNCAIISDVKVRDFWDGFEIICKRLRSEDGQPMVLKLKDWPPGEDFRDMMPTRFEDLMENLPLPEYTKRDGRLNLASRLPSYFVRPDLGPKMYNAYGLITAEDRRVGTTNLHLDVSDAVNVMVYVGIPIGEGAHDEEVLKTIDEGDADEVTKERIHDHKEKPGALWHIYAAKDAEKIRELLRKVGEEQGQENPPDHDPIHDQSWYLDQTLRKRLYEEYGVQGWAIVQFLGDAVFIPAGAPHQVHNLYSCIKVAEDFVSPEHVKHCFRLTQEFRHLSNTHT","Homo sapiens","KDM3B, C5orf7, JHDM2B, JMJD1B, KIAA1082","Lysine-specific demethylase 3B","1","5RB7"
"5RJI",,"X-RAY DIFFRACTION",1.73,28.91,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJI",17.63,"1.24","1.24","PanDDA analysis group deposition of ground-state model of PHIP","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJI"
"5RJJ",,"X-RAY DIFFRACTION",1.75,29.59,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJJ",18.05,"1.151","1.151","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with NCL-00023833","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJJ"
"5RJK",,"X-RAY DIFFRACTION",1.72,28.59,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJK",17.83,"1.21","1.21","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with NCL-00024661","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJK"
"5RJL",,"X-RAY DIFFRACTION",1.73,28.95,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJL",17.84,"1.31","1.31","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with NCL-00024662","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJL"
"5RJM",,"X-RAY DIFFRACTION",1.75,29.7,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJM",17.82,"1.407","1.407","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with NCL-00024671","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJM"
"5RJN",,"X-RAY DIFFRACTION",1.76,29.97,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJN",17.83,"1.435","1.435","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with NCL-00024673","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJN"
"5RJO",,"X-RAY DIFFRACTION",1.68,26.82,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJO",17.84,"1.22","1.22","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with NCL-00023827","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJO"
"5RJP",,"X-RAY DIFFRACTION",1.73,29.03,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJP",17.85,"1.242","1.242","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with NCL-00024672","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJP"
"5RJQ",,"X-RAY DIFFRACTION",1.72,28.28,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJQ",18.12,"1.35","1.35","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with NCL-00024665","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJQ"
"5RJR",,"X-RAY DIFFRACTION",1.73,28.77,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJR",17.85,"1.27","1.27","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z45705015","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJR"
"5RJS",,"X-RAY DIFFRACTION",1.73,28.97,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJS",17.83,"1.37","1.37","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z285642082","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJS"
"5RJT",,"X-RAY DIFFRACTION",1.74,29.42,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJT",17.83,"1.169","1.169","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z404993336","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJT"
"5RJU",,"X-RAY DIFFRACTION",1.72,28.52,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJU",17.84,"1.32","1.32","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z57261895","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJU"
"5RJV",,"X-RAY DIFFRACTION",1.75,29.52,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJV",17.87,"1.45","1.45","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z57190020","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJV"
"5RJW",,"X-RAY DIFFRACTION",1.73,28.92,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJW",17.77,"1.514","1.514","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z256709556","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJW"
"5RJX",,"X-RAY DIFFRACTION",1.76,30.09,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJX",17.81,"1.291","1.291","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z285782452","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJX"
"5RJY",,"X-RAY DIFFRACTION",1.74,29.33,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJY",17.77,"1.25","1.25","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z383325512","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJY"
"5RJZ",,"X-RAY DIFFRACTION",1.74,29.29,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RJZ",17.77,"1.275","1.275","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z755044716","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RJZ"
"5RK0",,"X-RAY DIFFRACTION",1.75,29.59,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RK0",17.86,"1.24","1.24","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z30932204","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RK0"
"5RK1",,"X-RAY DIFFRACTION",1.72,28.36,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RK1",17.82,"1.271","1.271","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z1507502062","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RK1"
"5RK2",,"X-RAY DIFFRACTION",1.75,29.6,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RK2",17.78,"1.235","1.235","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z54633859","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RK2"
"5RK3",,"X-RAY DIFFRACTION",1.73,29.04,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RK3",17.77,"1.31","1.31","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z1501469697","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RK3"
"5RK4",,"X-RAY DIFFRACTION",1.74,29.45,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RK4",17.83,"1.284","1.284","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z56791867","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RK4"
"5RK5",,"X-RAY DIFFRACTION",1.75,29.75,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RK5",17.77,"1.243","1.243","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z57478994","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RK5"
"5RK6",,"X-RAY DIFFRACTION",1.73,29.02,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RK6",17.85,"1.241","1.241","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194394","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RK6"
"5RK7",,"X-RAY DIFFRACTION",1.73,28.92,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RK7",17.79,"1.304","1.304","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z31721097","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RK7"
"5RK8",,"X-RAY DIFFRACTION",1.71,28.18,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RK8",17.83,"1.272","1.272","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z53116498","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RK8"
"5RK9",,"X-RAY DIFFRACTION",1.74,29.22,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RK9",17.77,"1.48","1.48","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z461898648","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RK9"
"5RKA",,"X-RAY DIFFRACTION",1.73,28.78,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKA",17.84,"1.33","1.33","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z126932614","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKA"
"5RKB",,"X-RAY DIFFRACTION",1.73,28.77,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKB",17.81,"1.279","1.279","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z2004563941","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKB"
"5RKC",,"X-RAY DIFFRACTION",1.75,29.61,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKC",17.79,"1.24","1.24","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z234898257","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKC"
"5RKD",,"X-RAY DIFFRACTION",1.71,28.19,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKD",17.81,"1.237","1.237","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z2168282707","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKD"
"5RKE",,"X-RAY DIFFRACTION",1.72,28.46,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKE",17.83,"1.291","1.291","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z906021418","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKE"
"5RKF",,"X-RAY DIFFRACTION",1.74,29.37,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKF",17.77,"1.264","1.264","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z1674937530","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKF"
"5RKG",,"X-RAY DIFFRACTION",1.73,28.86,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKG",17.77,"1.282","1.282","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z1124201124","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKG"
"5RKH",,"X-RAY DIFFRACTION",1.76,30.21,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKH",17.88,"1.252","1.252","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z31432917","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKH"
"5RKI",,"X-RAY DIFFRACTION",1.75,29.65,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKI",17.85,"1.268","1.268","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKI"
"5RKJ",,"X-RAY DIFFRACTION",1.72,28.36,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKJ",17.84,"1.46","1.46","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z373768898","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKJ"
"5RKK",,"X-RAY DIFFRACTION",1.72,28.28,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKK",17.86,"1.43","1.43","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z275181224","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKK"
"5RKL",,"X-RAY DIFFRACTION",1.73,29.07,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKL",17.82,"1.36","1.36","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z1545196403","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKL"
"5RKM",,"X-RAY DIFFRACTION",1.71,28.25,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKM",17.81,"1.28","1.28","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z2017168803","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKM"
"5RKN",,"X-RAY DIFFRACTION",1.72,28.5,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKN",17.82,"1.23","1.23","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z373768900","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKN"
"5RKO",,"X-RAY DIFFRACTION",1.72,28.63,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKO",17.88,"1.42","1.42","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z30620520","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKO"
"5RKP",,"X-RAY DIFFRACTION",1.74,29.31,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKP",17.83,"1.35","1.35","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z1079512010","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKP"
"5RKQ",,"X-RAY DIFFRACTION",1.72,28.6,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKQ",17.83,"1.3","1.3","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z1545196101","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKQ"
"5RKR",,"X-RAY DIFFRACTION",1.72,28.44,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKR",17.83,"1.37","1.37","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z1432018343","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKR"
"5RKS",,"X-RAY DIFFRACTION",1.73,29.04,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKS",17.87,"1.24","1.24","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z1696844792","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKS"
"5RKT",,"X-RAY DIFFRACTION",1.71,28.21,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKT",17.79,"1.241","1.241","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z1266933824","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKT"
"5RKU",,"X-RAY DIFFRACTION",1.74,29.26,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKU",17.83,"1.4","1.4","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z32367954","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKU"
"5RKV",,"X-RAY DIFFRACTION",1.73,28.84,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKV",17.99,"1.277","1.277","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z56877838","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKV"
"5RKW",,"X-RAY DIFFRACTION",1.73,28.86,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKW",17.88,"1.242","1.242","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z27678561","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKW"
"5RKX",,"X-RAY DIFFRACTION",1.75,29.85,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKX",18.01,"1.24","1.24","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z1324080698","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKX"
"5RKY",,"X-RAY DIFFRACTION",1.75,29.68,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M potassium phosphate",277,,,"5RKY",17.84,"1.38","1.38","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z1796014543","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5RKY"
"5RKZ",,"X-RAY DIFFRACTION",2.02,39.07,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5, 0.3M sodium/potassium phosphate, 15% PEG Smear High, 20% ethylene glycol",277,,,"5RKZ",33.02,"1.38","1.38","PanDDA analysis group deposition of ground-state model of human NUDT22 screened against the DSPL fragment library by X-ray Crystallography","SMDPEVTLLLQCPGGGLPQEQIQAELSPAHDRRPLPGGDEAITAIWETRLKAQPWLFDAPKFRLHSATLAPIGSRGPQLLLRLGLTSYRDFLGTNWSSSAAWLRQQGATDWGDTQAYLADPLGVGAALATADDFLVFLRRSRQVAEAPGLVDVPGGHPEPQALCPGGSPQHQDLAGQLVVHELFSSVLQEICDEVNLPLLTLSQPLLLGIARNETSAGRASAEFYVQCSLTSEQVRKHYLSGGPEAHESTGIFFVETQNVRRLPETEMWAELCPSAKGAIILYNRVQGSPTGAALGSPALLPPL","Homo sapiens","NUDT22, PP11246","Uridine diphosphate glucose pyrophosphatase NUDT22","1","5RKZ"
"5RVW",,"X-RAY DIFFRACTION",2.42,49.25,"VAPOR DIFFUSION, SITTING DROP",7.1,"0.1M Hepes, 0.1M Magnesium chloride, 20% PEG 6K, 10% ethylene glycol",293,,,"5RVW",203.02,"1.614","1.614","PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z1587220559","MHHHHHHSSGVDLGTENLYFQSMGALERPPVDHGLARLVTVYCEHGHKAAKINPLFTGQALLENVPEIQALVQTLQGPFHTAGLLNMGKEEASLEEVLVYLNQIYCGQISIETSQLQSQDEKDWFAKRFEELQKETFTTEERKHLSKLMLESQEFDHFLATKFSTVKRYGGEGAESMMGFFHELLKMSAYSGITDVIIGMPHRGRLNLLTGLLQFPPELMFRKMRGLSEFPENFSATGDVLSHLTSSVDLYFGAHHPLHVTMLPNPSHLEAVNPVAVGKTRGRQQSRQDGDYSPDNSAQPGDRVICLQVHGDASFCGQGIVPETFTLSNLPHFRIGGSVHLIVNNQLGYTTPAERGRSSLYCSDIGKLVGCAIIHVNGDSPEEVVRATRLAFEYQRQFRKDVIIDLLCYRQWGHNELDEPFYTNPIMYKIIRARKSIPDTYAEHLIAGGLMTQEEVSEIKSSYYAKLNDHLNNMAHYRPPALNLQAHWQGLAQPEAQITTWSTGVPLDLLRFVGMKSVEVPRELQMHSHLLKTHVQSRMEKMMDGIKLDWATAEALALGSLLAQGFNVRLSGQDVGRGTFSQRHAIVVCQETDDTYIPLNHMDPNQKGFLEVSNSPLSEEAVLGFEYGMSIESPKLLPLWEAQFGDFFNGAQIIFDTFISGGEAKWLLQSGIVILLPHGYDGAGPDHSSCRIERFLQMCDSAEEGVDGDTVNMFVVHPTTPAQYFHLLRRQMVRNFRKPLIVASPKMLLRLPAAVSTLQEMAPGTTFNPVIGDSSVDPKKVKTLVFCSGKHFYSLVKQRESLGAKKHDFAIIRVEELCPFPLDSLQQEMSKYKHVKDHIWSQEEPQNMGPWSFVSPRFEKQLACKLRLVGRPPLPVPAVGIGTVHLHQHEDILAKTFA","Homo sapiens","DHTKD1, KIAA1630","Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial","1","5RVW"
"5RVX",,"X-RAY DIFFRACTION",2.44,49.56,"VAPOR DIFFUSION, SITTING DROP",7.1,"0.1M Hepes, 0.1M Magnesium chloride, 20% PEG 6K, 10% ethylene glycol",293,,,"5RVX",203.27,"1.661","1.661","PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z804566442","MHHHHHHSSGVDLGTENLYFQSMGALERPPVDHGLARLVTVYCEHGHKAAKINPLFTGQALLENVPEIQALVQTLQGPFHTAGLLNMGKEEASLEEVLVYLNQIYCGQISIETSQLQSQDEKDWFAKRFEELQKETFTTEERKHLSKLMLESQEFDHFLATKFSTVKRYGGEGAESMMGFFHELLKMSAYSGITDVIIGMPHRGRLNLLTGLLQFPPELMFRKMRGLSEFPENFSATGDVLSHLTSSVDLYFGAHHPLHVTMLPNPSHLEAVNPVAVGKTRGRQQSRQDGDYSPDNSAQPGDRVICLQVHGDASFCGQGIVPETFTLSNLPHFRIGGSVHLIVNNQLGYTTPAERGRSSLYCSDIGKLVGCAIIHVNGDSPEEVVRATRLAFEYQRQFRKDVIIDLLCYRQWGHNELDEPFYTNPIMYKIIRARKSIPDTYAEHLIAGGLMTQEEVSEIKSSYYAKLNDHLNNMAHYRPPALNLQAHWQGLAQPEAQITTWSTGVPLDLLRFVGMKSVEVPRELQMHSHLLKTHVQSRMEKMMDGIKLDWATAEALALGSLLAQGFNVRLSGQDVGRGTFSQRHAIVVCQETDDTYIPLNHMDPNQKGFLEVSNSPLSEEAVLGFEYGMSIESPKLLPLWEAQFGDFFNGAQIIFDTFISGGEAKWLLQSGIVILLPHGYDGAGPDHSSCRIERFLQMCDSAEEGVDGDTVNMFVVHPTTPAQYFHLLRRQMVRNFRKPLIVASPKMLLRLPAAVSTLQEMAPGTTFNPVIGDSSVDPKKVKTLVFCSGKHFYSLVKQRESLGAKKHDFAIIRVEELCPFPLDSLQQEMSKYKHVKDHIWSQEEPQNMGPWSFVSPRFEKQLACKLRLVGRPPLPVPAVGIGTVHLHQHEDILAKTFA","Homo sapiens","DHTKD1, KIAA1630","Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial","1","5RVX"
"5RVY",,"X-RAY DIFFRACTION",2.43,49.44,"VAPOR DIFFUSION, SITTING DROP",7.1,"0.1M Hepes, 0.1M Magnesium chloride, 20% PEG 6K, 10% ethylene glycol",293,,,"5RVY",202.98,"1.609","1.609","PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z437516460","MHHHHHHSSGVDLGTENLYFQSMGALERPPVDHGLARLVTVYCEHGHKAAKINPLFTGQALLENVPEIQALVQTLQGPFHTAGLLNMGKEEASLEEVLVYLNQIYCGQISIETSQLQSQDEKDWFAKRFEELQKETFTTEERKHLSKLMLESQEFDHFLATKFSTVKRYGGEGAESMMGFFHELLKMSAYSGITDVIIGMPHRGRLNLLTGLLQFPPELMFRKMRGLSEFPENFSATGDVLSHLTSSVDLYFGAHHPLHVTMLPNPSHLEAVNPVAVGKTRGRQQSRQDGDYSPDNSAQPGDRVICLQVHGDASFCGQGIVPETFTLSNLPHFRIGGSVHLIVNNQLGYTTPAERGRSSLYCSDIGKLVGCAIIHVNGDSPEEVVRATRLAFEYQRQFRKDVIIDLLCYRQWGHNELDEPFYTNPIMYKIIRARKSIPDTYAEHLIAGGLMTQEEVSEIKSSYYAKLNDHLNNMAHYRPPALNLQAHWQGLAQPEAQITTWSTGVPLDLLRFVGMKSVEVPRELQMHSHLLKTHVQSRMEKMMDGIKLDWATAEALALGSLLAQGFNVRLSGQDVGRGTFSQRHAIVVCQETDDTYIPLNHMDPNQKGFLEVSNSPLSEEAVLGFEYGMSIESPKLLPLWEAQFGDFFNGAQIIFDTFISGGEAKWLLQSGIVILLPHGYDGAGPDHSSCRIERFLQMCDSAEEGVDGDTVNMFVVHPTTPAQYFHLLRRQMVRNFRKPLIVASPKMLLRLPAAVSTLQEMAPGTTFNPVIGDSSVDPKKVKTLVFCSGKHFYSLVKQRESLGAKKHDFAIIRVEELCPFPLDSLQQEMSKYKHVKDHIWSQEEPQNMGPWSFVSPRFEKQLACKLRLVGRPPLPVPAVGIGTVHLHQHEDILAKTFA","Homo sapiens","DHTKD1, KIAA1630","Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial","1","5RVY"
"5RVZ",,"X-RAY DIFFRACTION",2.42,49.19,"VAPOR DIFFUSION, SITTING DROP",7.1,"0.1M Hepes, 0.1M Magnesium chloride, 20% PEG 6K, 10% ethylene glycol",293,,,"5RVZ",202.99,"1.98","1.98","PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z1929757385","MHHHHHHSSGVDLGTENLYFQSMGALERPPVDHGLARLVTVYCEHGHKAAKINPLFTGQALLENVPEIQALVQTLQGPFHTAGLLNMGKEEASLEEVLVYLNQIYCGQISIETSQLQSQDEKDWFAKRFEELQKETFTTEERKHLSKLMLESQEFDHFLATKFSTVKRYGGEGAESMMGFFHELLKMSAYSGITDVIIGMPHRGRLNLLTGLLQFPPELMFRKMRGLSEFPENFSATGDVLSHLTSSVDLYFGAHHPLHVTMLPNPSHLEAVNPVAVGKTRGRQQSRQDGDYSPDNSAQPGDRVICLQVHGDASFCGQGIVPETFTLSNLPHFRIGGSVHLIVNNQLGYTTPAERGRSSLYCSDIGKLVGCAIIHVNGDSPEEVVRATRLAFEYQRQFRKDVIIDLLCYRQWGHNELDEPFYTNPIMYKIIRARKSIPDTYAEHLIAGGLMTQEEVSEIKSSYYAKLNDHLNNMAHYRPPALNLQAHWQGLAQPEAQITTWSTGVPLDLLRFVGMKSVEVPRELQMHSHLLKTHVQSRMEKMMDGIKLDWATAEALALGSLLAQGFNVRLSGQDVGRGTFSQRHAIVVCQETDDTYIPLNHMDPNQKGFLEVSNSPLSEEAVLGFEYGMSIESPKLLPLWEAQFGDFFNGAQIIFDTFISGGEAKWLLQSGIVILLPHGYDGAGPDHSSCRIERFLQMCDSAEEGVDGDTVNMFVVHPTTPAQYFHLLRRQMVRNFRKPLIVASPKMLLRLPAAVSTLQEMAPGTTFNPVIGDSSVDPKKVKTLVFCSGKHFYSLVKQRESLGAKKHDFAIIRVEELCPFPLDSLQQEMSKYKHVKDHIWSQEEPQNMGPWSFVSPRFEKQLACKLRLVGRPPLPVPAVGIGTVHLHQHEDILAKTFA","Homo sapiens","DHTKD1, KIAA1630","Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial","1","5RVZ"
"5RW0",,"X-RAY DIFFRACTION",2.42,49.22,"VAPOR DIFFUSION, SITTING DROP",7.1,"0.1M Hepes, 0.1M Magnesium chloride, 20% PEG 6K, 10% ethylene glycol",293,,,"5RW0",203.92,"1.673","1.673","PanDDA analysis group deposition -- Crystal Structure of DHTKD1 in complex with Z2444997446","MHHHHHHSSGVDLGTENLYFQSMGALERPPVDHGLARLVTVYCEHGHKAAKINPLFTGQALLENVPEIQALVQTLQGPFHTAGLLNMGKEEASLEEVLVYLNQIYCGQISIETSQLQSQDEKDWFAKRFEELQKETFTTEERKHLSKLMLESQEFDHFLATKFSTVKRYGGEGAESMMGFFHELLKMSAYSGITDVIIGMPHRGRLNLLTGLLQFPPELMFRKMRGLSEFPENFSATGDVLSHLTSSVDLYFGAHHPLHVTMLPNPSHLEAVNPVAVGKTRGRQQSRQDGDYSPDNSAQPGDRVICLQVHGDASFCGQGIVPETFTLSNLPHFRIGGSVHLIVNNQLGYTTPAERGRSSLYCSDIGKLVGCAIIHVNGDSPEEVVRATRLAFEYQRQFRKDVIIDLLCYRQWGHNELDEPFYTNPIMYKIIRARKSIPDTYAEHLIAGGLMTQEEVSEIKSSYYAKLNDHLNNMAHYRPPALNLQAHWQGLAQPEAQITTWSTGVPLDLLRFVGMKSVEVPRELQMHSHLLKTHVQSRMEKMMDGIKLDWATAEALALGSLLAQGFNVRLSGQDVGRGTFSQRHAIVVCQETDDTYIPLNHMDPNQKGFLEVSNSPLSEEAVLGFEYGMSIESPKLLPLWEAQFGDFFNGAQIIFDTFISGGEAKWLLQSGIVILLPHGYDGAGPDHSSCRIERFLQMCDSAEEGVDGDTVNMFVVHPTTPAQYFHLLRRQMVRNFRKPLIVASPKMLLRLPAAVSTLQEMAPGTTFNPVIGDSSVDPKKVKTLVFCSGKHFYSLVKQRESLGAKKHDFAIIRVEELCPFPLDSLQQEMSKYKHVKDHIWSQEEPQNMGPWSFVSPRFEKQLACKLRLVGRPPLPVPAVGIGTVHLHQHEDILAKTFA","Homo sapiens","DHTKD1, KIAA1630","Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial","1","5RW0"
"5RW1",,"X-RAY DIFFRACTION",2.44,49.53,"VAPOR DIFFUSION, SITTING DROP",7.1,"0.1M Hepes, 0.1M Magnesium chloride, 20% PEG 6K, 10% ethylene glycol",293,,,"5RW1",202.78,"1.52","1.52","PanDDA analysis group deposition of ground-state model of DHTKD1","MHHHHHHSSGVDLGTENLYFQSMGALERPPVDHGLARLVTVYCEHGHKAAKINPLFTGQALLENVPEIQALVQTLQGPFHTAGLLNMGKEEASLEEVLVYLNQIYCGQISIETSQLQSQDEKDWFAKRFEELQKETFTTEERKHLSKLMLESQEFDHFLATKFSTVKRYGGEGAESMMGFFHELLKMSAYSGITDVIIGMPHRGRLNLLTGLLQFPPELMFRKMRGLSEFPENFSATGDVLSHLTSSVDLYFGAHHPLHVTMLPNPSHLEAVNPVAVGKTRGRQQSRQDGDYSPDNSAQPGDRVICLQVHGDASFCGQGIVPETFTLSNLPHFRIGGSVHLIVNNQLGYTTPAERGRSSLYCSDIGKLVGCAIIHVNGDSPEEVVRATRLAFEYQRQFRKDVIIDLLCYRQWGHNELDEPFYTNPIMYKIIRARKSIPDTYAEHLIAGGLMTQEEVSEIKSSYYAKLNDHLNNMAHYRPPALNLQAHWQGLAQPEAQITTWSTGVPLDLLRFVGMKSVEVPRELQMHSHLLKTHVQSRMEKMMDGIKLDWATAEALALGSLLAQGFNVRLSGQDVGRGTFSQRHAIVVCQETDDTYIPLNHMDPNQKGFLEVSNSPLSEEAVLGFEYGMSIESPKLLPLWEAQFGDFFNGAQIIFDTFISGGEAKWLLQSGIVILLPHGYDGAGPDHSSCRIERFLQMCDSAEEGVDGDTVNMFVVHPTTPAQYFHLLRRQMVRNFRKPLIVASPKMLLRLPAAVSTLQEMAPGTTFNPVIGDSSVDPKKVKTLVFCSGKHFYSLVKQRESLGAKKHDFAIIRVEELCPFPLDSLQQEMSKYKHVKDHIWSQEEPQNMGPWSFVSPRFEKQLACKLRLVGRPPLPVPAVGIGTVHLHQHEDILAKTFA","Homo sapiens","DHTKD1, KIAA1630","Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial","1","5RW1"
"5RW2",,"X-RAY DIFFRACTION",2.11,41.63,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RW2",53.32,"1.22","1.22","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2737076969","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RW2"
"5RW3",,"X-RAY DIFFRACTION",2.11,41.62,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RW3",53.35,"1.37","1.37","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2064898339","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RW3"
"5RW4",,"X-RAY DIFFRACTION",2.11,41.65,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RW4",53.36,"1.31","1.31","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z19735192","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RW4"
"5RW5",,"X-RAY DIFFRACTION",2.11,41.61,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RW5",53.36,"1.38","1.38","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z69092635","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RW5"
"5RW6",,"X-RAY DIFFRACTION",2.11,41.79,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RW6",53.32,"1.32","1.32","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434816","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RW6"
"5RW7",,"X-RAY DIFFRACTION",2.11,41.69,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RW7",53.33,"1.23","1.23","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z86622311","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RW7"
"5RW8",,"X-RAY DIFFRACTION",2.11,41.63,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RW8",53.36,"1.27","1.27","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z28290384","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RW8"
"5RW9",,"X-RAY DIFFRACTION",2.1,41.51,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RW9",53.45,"1.45","1.45","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z203581214","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RW9"
"5RWA",,"X-RAY DIFFRACTION",2.11,41.62,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWA",53.83,"1.29","1.29","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434812","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWA"
"5RWB",,"X-RAY DIFFRACTION",2.09,41.17,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWB",53.51,"1.25","1.25","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434899","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWB"
"5RWC",,"X-RAY DIFFRACTION",2.11,41.59,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWC",53.34,"1.4","1.4","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434879","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWC"
"5RWD",,"X-RAY DIFFRACTION",2.09,41.11,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWD",53.53,"1.29","1.29","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1675346324","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWD"
"5RWE",,"X-RAY DIFFRACTION",2.09,41.2,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWE",53.34,"1.34","1.34","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434865","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWE"
"5RWF",,"X-RAY DIFFRACTION",2.12,41.94,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWF",53.34,"1.35","1.35","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1983897532","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWF"
"5RWG",,"X-RAY DIFFRACTION",2.11,41.83,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWG",53.36,"1.46","1.46","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z17497990","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWG"
"5RWH",,"X-RAY DIFFRACTION",2.11,41.67,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWH",53.36,"1.56","1.56","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1152242726","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWH"
"5RWI",,"X-RAY DIFFRACTION",2.12,41.91,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWI",53.33,"1.29","1.29","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434926","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWI"
"5RWJ",,"X-RAY DIFFRACTION",2.11,41.59,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWJ",53.42,"1.26","1.26","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434824","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWJ"
"5RWK",,"X-RAY DIFFRACTION",2.1,41.55,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWK",53.32,"1.32","1.32","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1267881672","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWK"
"5RWL",,"X-RAY DIFFRACTION",2.12,42,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWL",53.32,"1.37","1.37","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1348371854","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWL"
"5RWM",,"X-RAY DIFFRACTION",2.12,42.04,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWM",53.52,"1.36","1.36","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z136583524","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWM"
"5RWN",,"X-RAY DIFFRACTION",2.11,41.6,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWN",53.36,"1.38","1.38","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1310876699","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWN"
"5RWO",,"X-RAY DIFFRACTION",2.1,41.47,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWO",53.35,"1.29","1.29","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434898","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWO"
"5RWP",,"X-RAY DIFFRACTION",2.11,41.74,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWP",53.33,"1.48","1.48","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z915492990","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWP"
"5RWQ",,"X-RAY DIFFRACTION",2.11,41.73,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWQ",53.33,"1.32","1.32","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z44592329","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWQ"
"5RWR",,"X-RAY DIFFRACTION",2.11,41.83,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWR",53.33,"1.43","1.43","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434783","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWR"
"5RWS",,"X-RAY DIFFRACTION",2.11,41.6,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWS",53.41,"1.28","1.28","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1478435544","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWS"
"5RWT",,"X-RAY DIFFRACTION",2.1,41.57,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWT",53.36,"1.43","1.43","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z32327641","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWT"
"5RWU",,"X-RAY DIFFRACTION",2.11,41.69,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWU",53.32,"1.37","1.37","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z57778470","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWU"
"5RWV",,"X-RAY DIFFRACTION",2.09,41.13,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWV",53.29,"1.25","1.25","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1103351268","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWV"
"5RWW",,"X-RAY DIFFRACTION",2.09,41.14,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWW",53.36,"1.16","1.16","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2241115980","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWW"
"5RWX",,"X-RAY DIFFRACTION",2.1,41.34,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWX",53.35,"1.34","1.34","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z44567722","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWX"
"5RWY",,"X-RAY DIFFRACTION",2.1,41.4,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWY",53.34,"1.35","1.35","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1259335913","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWY"
"5RWZ",,"X-RAY DIFFRACTION",2.09,41.24,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RWZ",53.35,"1.42","1.42","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z57299529","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RWZ"
"5RX0",,"X-RAY DIFFRACTION",2.1,41.38,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RX0",53.45,"1.43","1.43","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z57258487","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RX0"
"5RX1",,"X-RAY DIFFRACTION",2.1,41.44,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RX1",53.53,"1.31","1.31","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2466069494","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RX1"
"5RX2",,"X-RAY DIFFRACTION",2.09,41.26,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RX2",53.54,"1.27","1.27","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1827898537","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RX2"
"5RX3",,"X-RAY DIFFRACTION",2.09,41.18,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RX3",53.29,"1.45","1.45","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1262327505","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RX3"
"5RX4",,"X-RAY DIFFRACTION",2.1,41.33,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RX4",53.6,"1.35","1.35","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1593306637","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RX4"
"5RX5",,"X-RAY DIFFRACTION",2.11,41.71,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RX5",53.34,"1.28","1.28","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2443429438","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RX5"
"5RX6",,"X-RAY DIFFRACTION",2.12,42.03,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RX6",53.36,"1.45","1.45","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z30620520","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RX6"
"5RX7",,"X-RAY DIFFRACTION",2.11,41.72,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RX7",53.3,"1.36","1.36","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1545196403","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RX7"
"5RX8",,"X-RAY DIFFRACTION",2.09,41.24,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RX8",53.6,"1.34","1.34","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434884","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RX8"
"5RX9",,"X-RAY DIFFRACTION",2.1,41.45,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RX9",53.35,"1.29","1.29","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z54226095","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RX9"
"5RXA",,"X-RAY DIFFRACTION",2.1,41.48,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXA",53.59,"1.24","1.24","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434829","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXA"
"5RXB",,"X-RAY DIFFRACTION",2.11,41.57,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXB",53.31,"1.58","1.58","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434821","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXB"
"5RXC",,"X-RAY DIFFRACTION",2.09,41.27,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXC",53.56,"1.59","1.59","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434868","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXC"
"5RXD",,"X-RAY DIFFRACTION",2.08,40.98,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXD",53.34,"1.33","1.33","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z111810692","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXD"
"5RXE",,"X-RAY DIFFRACTION",2.06,40.41,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXE",53.31,"1.25","1.25","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z240654968","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXE"
"5RXF",,"X-RAY DIFFRACTION",2.06,40.28,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXF",53.33,"1.26","1.26","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2074076908","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXF"
"5RXG",,"X-RAY DIFFRACTION",2.06,40.26,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXG",53.35,"1.52","1.52","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434909","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXG"
"5RXH",,"X-RAY DIFFRACTION",2.04,39.85,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXH",53.52,"1.42","1.42","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z939944666","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXH"
"5RXI",,"X-RAY DIFFRACTION",2.08,40.96,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXI",53.32,"1.74","1.74","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2447286438","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXI"
"5RXJ",,"X-RAY DIFFRACTION",2.08,40.92,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXJ",53.3,"1.52","1.52","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1722836661","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXJ"
"5RXK",,"X-RAY DIFFRACTION",2.07,40.51,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXK",53.31,"1.46","1.46","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434840","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXK"
"5RXL",,"X-RAY DIFFRACTION",2.08,40.99,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXL",53.34,"1.49","1.49","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1673618163","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXL"
"5RXM",,"X-RAY DIFFRACTION",2.07,40.69,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXM",53.38,"1.46","1.46","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434894","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXM"
"5RXO",,"X-RAY DIFFRACTION",2.08,40.99,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXO",53.34,"1.71","1.71","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z68299550","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXO"
"5RXP",,"X-RAY DIFFRACTION",2.1,41.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXP",53.35,"1.53","1.53","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434944","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXP"
"5RXQ",,"X-RAY DIFFRACTION",2.06,40.4,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXQ",53.3,"1.65","1.65","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z26548083","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXQ"
"5RXR",,"X-RAY DIFFRACTION",2.08,40.84,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXR",53.26,"1.4","1.4","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1148747945","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXR"
"5RXS",,"X-RAY DIFFRACTION",2.09,41.05,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXS",53.56,"1.37","1.37","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1818332938","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXS"
"5RXT",,"X-RAY DIFFRACTION",2.11,41.64,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXT",53.31,"1.63","1.63","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z319545618","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXT"
"5RXU",,"X-RAY DIFFRACTION",2.06,40.36,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXU",53.32,"1.64","1.64","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434858","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXU"
"5RXV",,"X-RAY DIFFRACTION",2.08,40.95,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXV",53.26,"1.5","1.5","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z45527714","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXV"
"5RXW",,"X-RAY DIFFRACTION",2.09,41.11,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXW",53.32,"1.34","1.34","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2856434856","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXW"
"5RXX",,"X-RAY DIFFRACTION",2.09,41.17,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXX",53.32,"1.43","1.43","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1275599911","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXX"
"5RXY",,"X-RAY DIFFRACTION",2.09,41.06,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXY",53.29,"1.4","1.4","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z32014663","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXY"
"5RXZ",,"X-RAY DIFFRACTION",2.09,41.12,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RXZ",53.3,"1.56","1.56","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z19739650","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RXZ"
"5RY0",,"X-RAY DIFFRACTION",2.08,40.82,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RY0",53.35,"1.98","1.98","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z275165822","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RY0"
"5RY1",,"X-RAY DIFFRACTION",2.05,40.06,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RY1",53.32,"1.52","1.52","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2940170964","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RY1"
"5RY2",,"X-RAY DIFFRACTION",2.07,40.46,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RY2",53.31,"1.54","1.54","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z19727416","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RY2"
"5RY3",,"X-RAY DIFFRACTION",2.08,40.98,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RY3",53.29,"1.5","1.5","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2027158783","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RY3"
"5RY4",,"X-RAY DIFFRACTION",2.09,41.11,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RY4",53.33,"1.47","1.47","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z300245038","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RY4"
"5RY5",,"X-RAY DIFFRACTION",2.1,41.53,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RY5",53.42,"1.54","1.54","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z166605480","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RY5"
"5RY6",,"X-RAY DIFFRACTION",2.09,41.2,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RY6",53.56,"1.74","1.74","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z198194394","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RY6"
"5RY7",,"X-RAY DIFFRACTION",2.09,41.06,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RY7",53.3,"1.6","1.6","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1267773591","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RY7"
"5RY8",,"X-RAY DIFFRACTION",2.08,40.92,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RY8",53.68,"1.43","1.43","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1374778753","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RY8"
"5RY9",,"X-RAY DIFFRACTION",2.07,40.7,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RY9",53.59,"1.52","1.52","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z274575916","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RY9"
"5RYA",,"X-RAY DIFFRACTION",2.08,40.73,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RYA",53.77,"1.32","1.32","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1741973467","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RYA"
"5RYB",,"X-RAY DIFFRACTION",2.08,40.84,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RYB",53.3,"1.55","1.55","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z927400026","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RYB"
"5RYC",,"X-RAY DIFFRACTION",2.1,41.44,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RYC",53.28,"1.56","1.56","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z18197050","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RYC"
"5RYD",,"X-RAY DIFFRACTION",2.09,41.01,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RYD",53.37,"1.6","1.6","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z955369596","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RYD"
"5RYE",,"X-RAY DIFFRACTION",2.1,41.43,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RYE",53.36,"1.7","1.7","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z33545544","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RYE"
"5RYF",,"X-RAY DIFFRACTION",2.08,40.9,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RYF",53.28,"1.49","1.49","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1266823232","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RYF"
"5RYG",,"X-RAY DIFFRACTION",2.08,40.94,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RYG",53.25,"1.47","1.47","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z168883358","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RYG"
"5RYH",,"X-RAY DIFFRACTION",2.1,41.39,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RYH",53.32,"1.72","1.72","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1212984951","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RYH"
"5RYI",,"X-RAY DIFFRACTION",2.09,41.25,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RYI",53.36,"1.45","1.45","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z274555794","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RYI"
"5RYJ",,"X-RAY DIFFRACTION",2.09,41.13,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RYJ",53.29,"1.42","1.42","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z2177153697","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RYJ"
"5RYK",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RYK",53.3,"1.55","1.55","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1346370629","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RYK"
"5RYL",,"X-RAY DIFFRACTION",2.07,40.65,"VAPOR DIFFUSION, SITTING DROP",6.5,"30 mM sodium nitrate, 30 mM dibasic sodium phosphate, 30 mM ammonium sulfate, 100 mM MES/imidazole, pH 6.5, 20% PEG500 MME, 10% PEG20000",293,,,"5RYL",53.3,"1.55","1.55","INPP5D PanDDA analysis group deposition -- Crystal Structure of the phosphatase and C2 domains of SHIP1 in complex with Z1745658474","SMEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQ","Homo sapiens","INPP5D, SHIP, SHIP1","Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1","1","5RYL"
"5RYM",,"X-RAY DIFFRACTION",2.22,44.5,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RYM",34.1,"1.64","1.64","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z31217395","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RYM"
"5RYN",,"X-RAY DIFFRACTION",2.24,45.06,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RYN",34.16,"1.88","1.88","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1545312521","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RYN"
"5RYO",,"X-RAY DIFFRACTION",2.22,44.72,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RYO",34.13,"1.58","1.58","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z136583524","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RYO"
"5RYP",,"X-RAY DIFFRACTION",2.22,44.63,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RYP",34.21,"1.63","1.63","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1929757385","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RYP"
"5RYQ",,"X-RAY DIFFRACTION",2.21,44.47,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RYQ",34.22,"1.64","1.64","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z57258487","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RYQ"
"5RYR",,"X-RAY DIFFRACTION",2.23,44.91,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RYR",34.1,"1.87","1.87","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z104584152","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RYR"
"5RYS",,"X-RAY DIFFRACTION",2.24,45.08,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RYS",34.17,"1.75","1.75","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1593306637","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RYS"
"5RYT",,"X-RAY DIFFRACTION",2.22,44.72,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RYT",34.42,"1.72","1.72","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z54226006","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RYT"
"5RYU",,"X-RAY DIFFRACTION",2.21,44.39,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RYU",34.12,"1.63","1.63","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1545196403","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RYU"
"5RYV",,"X-RAY DIFFRACTION",2.22,44.62,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RYV",34.13,"1.69","1.69","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1373430305","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RYV"
"5RYW",,"X-RAY DIFFRACTION",2.22,44.63,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RYW",34.24,"1.66","1.66","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2856434829","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RYW"
"5RYX",,"X-RAY DIFFRACTION",2.22,44.53,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RYX",34.11,"1.63","1.63","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2234920345","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RYX"
"5RYY",,"X-RAY DIFFRACTION",2.23,44.87,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RYY",34.05,"1.69","1.69","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z57257264","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RYY"
"5RYZ",,"X-RAY DIFFRACTION",2.23,44.75,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RYZ",34.07,"1.61","1.61","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2856434868","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RYZ"
"5RZ0",,"X-RAY DIFFRACTION",2.21,44.46,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZ0",34.2,"1.74","1.74","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1497321453","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZ0"
"5RZ1",,"X-RAY DIFFRACTION",2.22,44.69,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZ1",34.03,"1.62","1.62","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z27682767","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZ1"
"5RZ2",,"X-RAY DIFFRACTION",2.24,45.1,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZ2",34.16,"1.77","1.77","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z68277692","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZ2"
"5RZ3",,"X-RAY DIFFRACTION",2.21,44.42,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZ3",34.14,"1.74","1.74","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1259341037","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZ3"
"5RZ4",,"X-RAY DIFFRACTION",2.22,44.52,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZ4",34.47,"1.61","1.61","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2856434909","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZ4"
"5RZ5",,"X-RAY DIFFRACTION",2.22,44.69,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZ5",34.16,"1.63","1.63","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2856434851","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZ5"
"5RZ6",,"X-RAY DIFFRACTION",2.23,44.85,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZ6",34.16,"1.64","1.64","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2856434944","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZ6"
"5RZ7",,"X-RAY DIFFRACTION",2.22,44.7,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZ7",34.37,"1.76","1.76","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z57472297","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZ7"
"5RZ8",,"X-RAY DIFFRACTION",2.22,44.68,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZ8",34.09,"1.66","1.66","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1263714198","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZ8"
"5RZ9",,"X-RAY DIFFRACTION",2.23,44.76,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZ9",34.11,"1.79","1.79","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z943693514","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZ9"
"5RZA",,"X-RAY DIFFRACTION",2.25,45.25,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZA",34.38,"1.89","1.89","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z729352906","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZA"
"5RZB",,"X-RAY DIFFRACTION",2.22,44.56,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZB",34.1,"1.59","1.59","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z271004858","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZB"
"5RZC",,"X-RAY DIFFRACTION",2.21,44.33,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZC",34.3,"1.75","1.75","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z300245038","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZC"
"5RZD",,"X-RAY DIFFRACTION",2.23,44.93,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZD",34.15,"1.81","1.81","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z198194394","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZD"
"5RZE",,"X-RAY DIFFRACTION",2.22,44.68,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZE",34.11,"1.69","1.69","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2856434786","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZE"
"5RZF",,"X-RAY DIFFRACTION",2.23,44.78,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZF",34.08,"1.76","1.76","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z57040482","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZF"
"5RZG",,"X-RAY DIFFRACTION",2.23,44.85,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZG",34.16,"1.7","1.7","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z133729708","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZG"
"5RZH",,"X-RAY DIFFRACTION",2.22,44.63,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZH",34.07,"1.88","1.88","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2856434890","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZH"
"5RZI",,"X-RAY DIFFRACTION",2.22,44.56,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZI",34.2,"2.09","2.09","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z48852953","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZI"
"5RZJ",,"X-RAY DIFFRACTION",2.23,44.75,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZJ",34.13,"1.68","1.68","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2856434938","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZJ"
"5RZK",,"X-RAY DIFFRACTION",2.24,45.04,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZK",34.09,"1.84","1.84","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1266823232","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZK"
"5RZL",,"X-RAY DIFFRACTION",2.23,44.8,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZL",34.11,"1.71","1.71","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1492796719","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZL"
"5RZM",,"X-RAY DIFFRACTION",2.23,44.87,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZM",34.15,"1.71","1.71","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2856434815","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZM"
"5RZN",,"X-RAY DIFFRACTION",2.24,45.17,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZN",34.31,"1.83","1.83","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1745658474","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZN"
"5RZO",,"X-RAY DIFFRACTION",2.23,44.86,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZO",33.96,"1.97","1.97","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2856434925","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZO"
"5RZP",,"X-RAY DIFFRACTION",2.23,44.79,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZP",34.13,"1.7","1.7","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z33546965","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZP"
"5RZQ",,"X-RAY DIFFRACTION",2.23,44.88,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZQ",34.17,"1.88","1.88","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z100642432","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZQ"
"5RZR",,"X-RAY DIFFRACTION",2.24,45.06,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZR",34.13,"1.78","1.78","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z53825177","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZR"
"5RZS",,"X-RAY DIFFRACTION",2.23,44.91,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZS",34.28,"1.69","1.69","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1703168683","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZS"
"5RZT",,"X-RAY DIFFRACTION",2.23,44.83,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZT",34.11,"1.79","1.79","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z763030030","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZT"
"5RZU",,"X-RAY DIFFRACTION",2.23,44.91,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZU",34.17,"1.66","1.66","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z32400357","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZU"
"5RZV",,"X-RAY DIFFRACTION",2.23,44.85,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZV",34.09,"1.75","1.75","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z31504642","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZV"
"5RZW",,"X-RAY DIFFRACTION",2.23,44.89,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZW",34.14,"1.62","1.62","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2574937229","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZW"
"5RZX",,"X-RAY DIFFRACTION",2.21,44.24,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZX",34.09,"1.74","1.74","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2856434814","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZX"
"5RZY",,"X-RAY DIFFRACTION",2.23,44.91,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZY",34.01,"1.75","1.75","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z219104216","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZY"
"5RZZ",,"X-RAY DIFFRACTION",2.21,44.45,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5RZZ",34.17,"1.76","1.76","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z1551999220","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5RZZ"
"5S00",,"X-RAY DIFFRACTION",2.22,44.68,"VAPOR DIFFUSION, SITTING DROP",6,"0.075M ammonium nitrate, 0.1M MES pH 6.0, 6.5% PEG 2000, 6.5% PEG 3350, 6.5% PEG 4000, 6.5% PEG 5000, 10% ethylene glycol",298,,,"5S00",34.16,"1.77","1.77","EPB41L3 PanDDA analysis group deposition -- Crystal Structure of the FERM domain of human EPB41L3 in complex with Z2856434793","SMPKSMQCKVILLDGSEYTCDVEKRSRGQVLFDKVCEHLNLLEKDYFGLTYRDAENQKNWLDPAKEIKKQVRSGAWHFSFNVKFYPPDPAQLSEDITRYYLCLQLRDDIVSGRLPCSFVTLALLGSYTVQSELGDYDPDECGSDYISEFRFAPNHTKELEDKVIELHKSHRGMTPAEAEMHFLENAKKLSMYGVDLHHAKDSEGVEIMLGVCASGLLIYRDRLRINRFAWPKVLKISYKRNNFYIKIRPGEFEQFESTIGFKLPNHRAAKRLWKVCVEHHTFFRLL","Homo sapiens","EPB41L3, DAL1, KIAA0987","Isoform 2 of Band 4.1-like protein 3","1","5S00"
"5S75",,"X-RAY DIFFRACTION",2.6,52.65,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S75",72.77,"1.3","1.3","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010913a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S75"
"5S76",,"X-RAY DIFFRACTION",2.59,52.55,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S76",72.52,"1.31","1.31","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010916a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S76"
"5S77",,"X-RAY DIFFRACTION",2.6,52.6,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S77",72.52,"1.31","1.31","XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035133b","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S77"
"5S78",,"X-RAY DIFFRACTION",2.6,52.78,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S78",72.37,"1.3","1.3","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010934a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S78"
"5S79",,"X-RAY DIFFRACTION",2.6,52.61,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S79",72.46,"1.5","1.5","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010910a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S79"
"5S7A",,"X-RAY DIFFRACTION",2.6,52.72,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7A",72.53,"1.3","1.3","XChem group deposition -- Crystal Structure of human ACVR1 in complex with PK012456b","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7A"
"5S7B",,"X-RAY DIFFRACTION",2.59,52.49,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7B",72.73,"1.32","1.32","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000329d","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7B"
"5S7C",,"X-RAY DIFFRACTION",2.59,52.52,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7C",72.47,"1.31","1.31","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000274c","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7C"
"5S7D",,"X-RAY DIFFRACTION",2.62,53.04,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7D",72.57,"1.31","1.31","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010923a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7D"
"5S7E",,"X-RAY DIFFRACTION",2.59,52.56,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7E",72.59,"1.32","1.32","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010930a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7E"
"5S7F",,"X-RAY DIFFRACTION",2.59,52.59,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7F",72.6,"1.31","1.31","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010935a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7F"
"5S7G",,"X-RAY DIFFRACTION",2.65,53.64,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7G",72.51,"1.78","1.78","XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035844b","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7G"
"5S7H",,"X-RAY DIFFRACTION",2.58,52.35,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7H",72.49,"1.3","1.3","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010914a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7H"
"5S7I",,"X-RAY DIFFRACTION",2.59,52.46,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7I",73.74,"1.3","1.3","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010928a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7I"
"5S7J",,"X-RAY DIFFRACTION",2.58,52.3,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7J",72.35,"1.31","1.31","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000893d","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7J"
"5S7K",,"X-RAY DIFFRACTION",2.59,52.44,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7K",72.3,"1.31","1.31","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010936a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7K"
"5S7L",,"X-RAY DIFFRACTION",2.59,52.48,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7L",72.56,"1.36","1.36","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010943a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7L"
"5S7M",,"X-RAY DIFFRACTION",2.59,52.57,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7M",72.13,"1.32","1.32","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000275d","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7M"
"5S7N",,"X-RAY DIFFRACTION",2.59,52.46,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7N",72.61,"1.3","1.3","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010920a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7N"
"5S7O",,"X-RAY DIFFRACTION",2.6,52.76,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7O",72.26,"1.43","1.43","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM007391c","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7O"
"5S7P",,"X-RAY DIFFRACTION",2.58,52.35,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7P",72.19,"1.31","1.31","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010937a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7P"
"5S7Q",,"X-RAY DIFFRACTION",2.59,52.58,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7Q",72.51,"1.53","1.53","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010944a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7Q"
"5S7R",,"X-RAY DIFFRACTION",2.6,52.72,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7R",73.47,"1.46","1.46","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010918a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7R"
"5S7S",,"X-RAY DIFFRACTION",2.6,52.63,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7S",72.64,"1.3","1.3","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010921a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7S"
"5S7T",,"X-RAY DIFFRACTION",2.61,52.78,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7T",72.72,"1.3","1.3","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010926a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7T"
"5S7U",,"X-RAY DIFFRACTION",2.62,53.03,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7U",72.61,"1.59","1.59","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010938a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7U"
"5S7V",,"X-RAY DIFFRACTION",2.59,52.48,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7V",72.26,"1.31","1.31","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010942a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7V"
"5S7W",,"X-RAY DIFFRACTION",2.61,52.92,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7W",72.57,"1.33","1.33","XChem group deposition -- Crystal Structure of human ACVR1 in complex with HM000007h","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7W"
"5S7X",,"X-RAY DIFFRACTION",2.58,52.3,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7X",72.59,"1.3","1.3","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000376d","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7X"
"5S7Y",,"X-RAY DIFFRACTION",2.6,52.68,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7Y",73.04,"1.37","1.37","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010933a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7Y"
"5S7Z",,"X-RAY DIFFRACTION",2.58,52.35,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S7Z",72.94,"1.3","1.3","XChem group deposition -- Crystal Structure of human ACVR1 in complex with NU074488b","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S7Z"
"5S80",,"X-RAY DIFFRACTION",2.57,52.21,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S80",72.67,"1.67","1.67","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010946a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S80"
"5S81",,"X-RAY DIFFRACTION",2.6,52.62,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S81",72.85,"1.43","1.43","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010947a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S81"
"5S82",,"X-RAY DIFFRACTION",2.66,53.84,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S82",72.44,"1.71","1.71","XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035128c","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S82"
"5S83",,"X-RAY DIFFRACTION",2.59,52.52,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S83",72.6,"1.33","1.33","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010948a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S83"
"5S84",,"X-RAY DIFFRACTION",2.58,52.32,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S84",72.42,"1.35","1.35","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010949a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S84"
"5S85",,"X-RAY DIFFRACTION",2.59,52.43,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S85",72.96,"1.33","1.33","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000884c","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S85"
"5S86",,"X-RAY DIFFRACTION",2.59,52.58,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S86",72.55,"1.31","1.31","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010952a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S86"
"5S87",,"X-RAY DIFFRACTION",2.59,52.58,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S87",72.45,"1.3","1.3","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010953a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S87"
"5S88",,"X-RAY DIFFRACTION",2.6,52.69,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S88",72.36,"1.31","1.31","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010954a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S88"
"5S89",,"X-RAY DIFFRACTION",2.59,52.58,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S89",72.45,"1.3","1.3","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010957a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S89"
"5S8A",,"X-RAY DIFFRACTION",2.6,52.67,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S8A",72.69,"1.3","1.3","XChem group deposition -- Crystal Structure of human ACVR1 in complex with NU074484b","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S8A"
"5S8B",,"X-RAY DIFFRACTION",2.6,52.67,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S8B",73.03,"1.64","1.64","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010960a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S8B"
"5S8C",,"X-RAY DIFFRACTION",2.11,41.58,"VAPOR DIFFUSION, SITTING DROP",5,"0.04M potassium phosphate monobasic -- 9% PEG8K",277,,,"5S8C",15.32,"1.25","1.25","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with N00322e (space group C2)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8C"
"5S8D",,"X-RAY DIFFRACTION",2.1,41.32,"VAPOR DIFFUSION, SITTING DROP",5,"0.04M potassium phosphate monobasic -- 11% PEG8K",277,,,"5S8D",15.34,"1.26","1.26","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with N00539e (space group C2)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8D"
"5S8E",,"X-RAY DIFFRACTION",2.1,41.31,"VAPOR DIFFUSION, SITTING DROP",5,"0.04M potassium phosphate monobasic -- 12% PEG8K",277,,,"5S8E",15.34,"1.24","1.24","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with N00531b (space group C2)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8E"
"5S8F",,"X-RAY DIFFRACTION",2.1,41.49,"VAPOR DIFFUSION, SITTING DROP",5,"0.04M potassium phosphate monobasic -- 12% PEG8K",277,,,"5S8F",15.36,"1.18","1.18","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with N00572d (space group C2)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8F"
"5S8G",,"X-RAY DIFFRACTION",2.07,40.59,"VAPOR DIFFUSION, SITTING DROP",5,"0.04M potassium phosphate monobasic -- 8% PEG8K",277,,,"5S8G",15.34,"1.19","1.19","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with N00804d (space group C2)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8G"
"5S8H",,"X-RAY DIFFRACTION",2.09,41.13,"VAPOR DIFFUSION, SITTING DROP",5,"0.04M potassium phosphate monobasic -- 12% PEG8K",277,,,"5S8H",15.27,"1.29","1.29","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with N00964e (space group C2)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8H"
"5S8I",,"X-RAY DIFFRACTION",2.1,41.34,"VAPOR DIFFUSION, SITTING DROP",5,"0.04M potassium phosphate monobasic -- 17% PEG8K",277,,,"5S8I",15.36,"1.3","1.3","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with N01186d (space group C2)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8I"
"5S8J",,"X-RAY DIFFRACTION",2.09,41.1,"VAPOR DIFFUSION, SITTING DROP",5,"0.04M potassium phosphate monobasic -- 18% PEG8K",277,,,"5S8J",15.33,"1.21","1.21","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with N01207d (space group C2)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8J"
"5S8K",,"X-RAY DIFFRACTION",2.08,40.89,"VAPOR DIFFUSION, SITTING DROP",5,"0.04M potassium phosphate monobasic -- 10% PEG8K",277,,,"5S8K",15.27,"1.24","1.24","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with N01225c (space group C2)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8K"
"5S8L",,"X-RAY DIFFRACTION",2.1,41.42,"VAPOR DIFFUSION, SITTING DROP",5,"0.04M potassium phosphate monobasic -- 10% PEG8K",277,,,"5S8L",15.32,"1.23","1.23","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with E11289c (space group C2)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8L"
"5S8M",,"X-RAY DIFFRACTION",2.09,41.02,"VAPOR DIFFUSION, SITTING DROP",5,"0.04M potassium phosphate monobasic -- 12% PEG8K",277,,,"5S8M",15.31,"1.2","1.2","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with N11511a (space group C2)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8M"
"5S8N",,"X-RAY DIFFRACTION",2.08,40.98,"VAPOR DIFFUSION, SITTING DROP",5,"0.04M potassium phosphate monobasic -- 14% PEG8K",277,,,"5S8N",15.32,"1.23","1.23","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with E07179c (space group C2)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8N"
"5S8O",,"X-RAY DIFFRACTION",2.04,39.83,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5 -- 0.1M calcium chloride -- 10% ethylene glycol -- 17% PEG6K",277,,,"5S8O",30.95,"1.67","1.67","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with N01460c (space group P212121)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8O"
"5S8P",,"X-RAY DIFFRACTION",2.03,39.27,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5 -- 0.1M calcium chloride -- 10% ethylene glycol -- 12% PEG6K",277,,,"5S8P",30.93,"1.41","1.41","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with E07179c (space group P212121)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8P"
"5S8Q",,"X-RAY DIFFRACTION",1.99,38.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M HEPES pH 7.5 -- 0.1M calcium chloride -- 34% PEG3350 -- 4% ethylene glycol",277,,,"5S8Q",31.11,"1.5","1.5","XChem group deposition -- Crystal Structure of the second bromodomain of pleckstrin homology domain interacting protein (PHIP) in complex with FMO3D000185a (space group P212121)","SMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8Q"
"5S8R",,"X-RAY DIFFRACTION",1.73,28.86,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S8R",17.91,"1.22","1.22","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8R"
"5S8S",,"X-RAY DIFFRACTION",1.73,28.9,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S8S",17.98,"1.22","1.22","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8S"
"5S8T",,"X-RAY DIFFRACTION",1.73,28.84,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S8T",17.97,"1.22","1.22","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8T"
"5S8U",,"X-RAY DIFFRACTION",1.73,28.85,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S8U",17.96,"1.33","1.33","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8U"
"5S8V",,"X-RAY DIFFRACTION",1.75,29.61,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S8V",17.89,"1.18","1.18","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8V"
"5S8W",,"X-RAY DIFFRACTION",1.73,28.91,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S8W",17.96,"1.2","1.2","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8W"
"5S8X",,"X-RAY DIFFRACTION",1.71,28.09,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S8X",17.82,"1.15","1.15","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with starting material","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8X"
"5S8Y",,"X-RAY DIFFRACTION",1.72,28.48,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S8Y",17.91,"1.24","1.24","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8Y"
"5S8Z",,"X-RAY DIFFRACTION",1.72,28.58,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S8Z",17.95,"1.25","1.25","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S8Z"
"5S90",,"X-RAY DIFFRACTION",1.74,29.19,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S90",17.91,"1.1","1.1","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S90"
"5S91",,"X-RAY DIFFRACTION",1.69,27.32,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S91",17.93,"1.29","1.29","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S91"
"5S92",,"X-RAY DIFFRACTION",1.72,28.41,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S92",17.92,"1.19","1.19","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S92"
"5S93",,"X-RAY DIFFRACTION",1.71,28.12,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S93",17.94,"1.19","1.19","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S93"
"5S94",,"X-RAY DIFFRACTION",1.71,28.1,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S94",17.92,"1.2","1.2","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S94"
"5S95",,"X-RAY DIFFRACTION",1.71,27.97,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S95",17.94,"1.21","1.21","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S95"
"5S96",,"X-RAY DIFFRACTION",1.69,27.27,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S96",17.77,"1.17","1.17","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with starting material","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S96"
"5S97",,"X-RAY DIFFRACTION",1.72,28.67,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S97",17.95,"1.15","1.15","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S97"
"5S98",,"X-RAY DIFFRACTION",1.69,27.17,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S98",17.83,"1.1","1.1","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with starting material","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S98"
"5S99",,"X-RAY DIFFRACTION",1.71,28.08,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S99",17.81,"1.18","1.18","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with starting material","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S99"
"5S9A",,"X-RAY DIFFRACTION",1.71,27.89,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S9A",17.97,"1.36","1.36","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S9A"
"5S9B",,"X-RAY DIFFRACTION",1.71,27.95,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S9B",17.78,"1.153","1.153","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex withstarting material","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S9B"
"5S9C",,"X-RAY DIFFRACTION",1.73,28.77,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S9C",17.92,"1.14","1.14","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S9C"
"5S9D",,"X-RAY DIFFRACTION",1.71,28.17,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S9D",17.96,"1.19","1.19","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S9D"
"5S9E",,"X-RAY DIFFRACTION",1.71,28.19,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S9E",17.96,"1.18","1.18","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with Z198194396 synthetic derivative","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S9E"
"5S9G",,"X-RAY DIFFRACTION",1.69,27.17,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S9G",17.81,"1.091","1.091","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with starting material","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S9G"
"5S9J",,"X-RAY DIFFRACTION",1.7,27.51,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 8000, 0.04M POTASSIUM PHOSPHATE",277,,,"5S9J",17.78,"1.15","1.15","PanDDA analysis group deposition -- Crystal Structure of PHIP in complex with starting material","MHHHHHHSSGVDLGTENLYFQSMSYDIQAWKKQCEELLNLIFQCEDSEPFRQPVDLLEYPDYRDIIDTPMDFATVRETLEAGNYESPMELCKDVRLIFSNSKAYTPSKRSRIYSMSLRLSAFFEEHISSVLSDYKSALRFHKRNTITKR","Homo sapiens","PHIP, DCAF14, WDR11","PH-interacting protein","1","5S9J"
"5S9K",,"X-RAY DIFFRACTION",2.6,52.71,"VAPOR DIFFUSION, SITTING DROP",6,"0.1M citrate pH 6.0, 1.4M ammonium sulfate, 0.2M sodium/potassium tartrate",277,,,"5S9K",72.45,"1.35","1.35","XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010955a","SMQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID","Homo sapiens","ACVR1, ACVRLK2","Activin receptor type-1","1","5S9K"
"5S9O",,"X-RAY DIFFRACTION",2.97,58.58,"VAPOR DIFFUSION, HANGING DROP",6.5,"200 mM Ammonium Citrate Dibasic, 16%(w/v) PEG 3350",293,"10.1021/acs.jmedchem.1c00625",,"5S9O",35.53,"2.49","2.49","CRYSTAL STRUCTURE OF THE HUMAN BRD2 BD1 BROMODOMAIN IN COMPLEX WITH 9-(cyclopropylmethyl)-7-[(2R,6S)-2,6-dimethylmorpholine-4-carbonyl]-3-(3,5-dimethyl-1,2-oxazol-4-yl)-9H-carbazole-1-carboxamide","MGSSHHHHHHSSGETVRFQGHMGRVTNQLQYLHKVVMKALWKHQFAWPFRQPVDAVKLGLPDYHKIIKQPMDMGTIKRRLENNYYWAASECMQDFNTMFTNCYIYNKPTDDIVLMAQTLEKIFLQKVASMPQEEQELVVTIPKN","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","5S9O"
"5S9P",,"X-RAY DIFFRACTION",2.3,46.42,"VAPOR DIFFUSION, SITTING DROP",5.6,"1%(w/v) Tryptone, 50mM HEPES, pH 7.0, 20%(w/v) PEG3350",293,"10.1021/acs.jmedchem.1c00625",,"5S9P",62.77,"2.1","2.1","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH 9-benzyl-2-(3,5-dimethyl-1,2-oxazol-4-yl)-7-(2-hydroxypropan-2-yl)-9H-carbazole-4-carboxamide","GHMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5S9P"
"5S9Q",,"X-RAY DIFFRACTION",2.37,48.11,"VAPOR DIFFUSION, SITTING DROP",5.6,"200mM Sodium Formate, pH 7.0, 20%(w/v) PEG3350",293,"10.1021/acs.jmedchem.1c00625",,"5S9Q",63.23,"1.85","1.85","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH 2-(3,5-dimethyl-1,2-oxazol-4-yl)-7-(2-hydroxypropan-2-yl)-9-[(S)-(oxan-4-yl)(phenyl)methyl]-9H-carbazole-4-carboxamide","GHMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5S9Q"
"5S9R",,"X-RAY DIFFRACTION",1.83,32.95,"VAPOR DIFFUSION, SITTING DROP",7.8,"100mM Bis-Tris Propane, pH 7.82, 200mM sodium iodide, 20%(w/v) PEG3350, 10% (v/v) ethylene glycol",293,"10.1021/acs.jmedchem.1c00625",,"5S9R",16.21,"1.85","1.85","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH BMS-986158, 2-{3-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-5-[(S)-(oxan-4-yl)(phenyl)methyl]-5H-pyrido[3,2-b]indol-7-yl}propan-2-ol","GHMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5S9R"
"5SAU",,"X-RAY DIFFRACTION",2.38,48.42,"VAPOR DIFFUSION, SITTING DROP",6.5,"7.6 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed with reservoir consisting of 0.1M MES/NaOH pH 6.5, 0.2M KI, 25% PEG 4000",293,,,"5SAU",36.99,"1.8","1.8","DDR1, 3-[2-(6-aminopyridin-3-yl)ethynyl]-N-[3-(trifluoromethyl)phenyl]benzamide, 1.800A, P212121, Rfree=23.1%","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","5SAU"
"5SAV",,"X-RAY DIFFRACTION",2.06,40.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"7.6 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed with reservoir consisting of 0.1M MES/NaOH pH 6.5, 0.2M KI, 25% PEG 4000",293,,,"5SAV",37.3,"1.76","1.76","DDR1, N-[2-[3-(2-aminopyrimidin-5-yl)oxyphenyl]ethyl]-3-(trifluoromethoxy)benzamide, 1.760A, P212121, Rfree=23.5%","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","5SAV"
"5SAW",,"X-RAY DIFFRACTION",2.34,47.33,"VAPOR DIFFUSION, SITTING DROP",6.5,"9.2 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed with reservoir consisting of 0.1M MES/NaOH pH 6.5, 0.2M KI, 25% PEG 4000",293,,,"5SAW",38.15,"1.601","1.601","DDR1, 2-[3-(2-pyridin-3-ylethynyl)phenyl]-N-[3-(trifluoromethyl)phenyl]acetamide, 1.601A, P212121, Rfree=22.6%","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","5SAW"
"5SAX",,"X-RAY DIFFRACTION",2.34,47.36,"VAPOR DIFFUSION, SITTING DROP",6.5,"9.2 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed with reservoir consisting of 0.1M MES/NaOH pH 6.5, 0.2M KI, 25% PEG 4000",293,,,"5SAX",37.9,"1.902","1.902","DDR1, 2-[3-(2-pyridin-3-ylethynyl)phenyl]-N-[3-(trifluoromethyl)phenyl]acetamide, 1.902A, second P212121 form, Rfree=25.4%, second form","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","5SAX"
"5SAY",,"X-RAY DIFFRACTION",2.31,46.7,"VAPOR DIFFUSION, SITTING DROP",6.5,"9.2 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed with reservoir consisting of 0.1M MES/NaOH pH 6.5, 0.2M KI, 25% PEG 4000",293,,,"5SAY",75.75,"2.19","2.19","DDR1, N-[2-[3-(2-aminopyrimidin-5-yl)oxyphenyl]ethyl]-3-(trifluoromethoxy)benzamide, 2.190A, P1211, Rfree=27.7%","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","5SAY"
"5SAZ",,"X-RAY DIFFRACTION",2.4,48.78,"VAPOR DIFFUSION, SITTING DROP",6.5,"7.6 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed with reservoir consisting of 0.1M MES/NaOH pH 6.5, 0.2M KI, 25% PEG 4000",293,,,"5SAZ",37.22,"1.8","1.8","DDR1, 3-chloro-N-[4-chloro-3-(1H-pyrrolo[2,3-b]pyridin-5-ylcarbamoyl)phenyl]-4-(2-hydroxyethylamino)benzamide, 1.802A, P212121, Rfree=22.2%","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","5SAZ"
"5SB0",,"X-RAY DIFFRACTION",2.53,51.47,"VAPOR DIFFUSION, SITTING DROP",5.5,"11.6 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed with reservoir consisting of 0.1M Sodium Citrate pH 5.5, 0.2M Sodium Acetate, 10% PEG 4000",293,,,"5SB0",37.09,"1.97","1.97","DDR1, N-[[2-(2-pyridin-3-yloxyethyl)cyclohexyl]methyl]-3-(trifluoromethoxy)benzamide, 1.970A, P212121, Rfree=25.6%","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","5SB0"
"5SB1",,"X-RAY DIFFRACTION",2.42,49.21,"VAPOR DIFFUSION, SITTING DROP",6,"11.4 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed with reservoir consisting of 0.1M MES pH 6.0, 0.1M MgChloride, 8% PEG 6000",293,,,"5SB1",37.05,"1.53","1.53","DDR1, 4-chloro-N-[(3S,4R)-4-phenylpyrrolidin-3-yl]-3-(1H-pyrrolo[2,3-b]pyridin-5-yloxymethyl)benzamide, 1.530A, P212121, Rfree=21.4%","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","5SB1"
"5SB2",,"X-RAY DIFFRACTION",2.17,43.34,"VAPOR DIFFUSION, SITTING DROP",6.5,"11.5 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed with reservoir consisting of 0.1M MES/NaOH pH 6.5, 0.2M KI, 25% PEG 4000",293,,,"5SB2",37.56,"1.6","1.6","DDR1, 3-chloro-N-[(1R,2S)-2-phenylcyclopropyl]-5-(1H-pyrrolo[2,3-b]pyridin-5-yloxymethyl)benzamide, 1.600A, P212121, Rfree=23.2%","PGAVGDGPPRVDFPRSRLRFKEKLGEGQFGEVHLCEVDSPQDLVSLDFPLNVRKGHPLLVAVKILRPDATKNARNDFLKEVKIMSRLKDPNIIRLLGVCVQDDPLCMITDYMENGDLNQFLSAHQLEDKAAEGAPGDPTISYPMLLHVAAQIASGMRYLATLNFVHRDLATRNCLVGENFTIKIADFGMSRNLYAGDYYRVQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEVLMLCRAQPFGQLTDEQVIENAGEFFRDQGRQVYLSRPPACPQGLYELMLRCWSRESEQRPPFSQLHRFLAEDALNTVHHHHHH","Homo sapiens","DDR1, CAK, EDDR1, NEP, NTRK4, PTK3A, RTK6, TRKE","Epithelial discoidin domain-containing receptor 1","1","5SB2"
"5SC8",,"X-RAY DIFFRACTION",2.86,56.93,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SC8",391.89,"1.77","1.77","Structure of liver pyruvate kinase in complex with anthraquinone derivative 17","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SC8"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SC9",,"X-RAY DIFFRACTION",2.85,56.89,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SC9",392.97,"1.685","1.685","Structure of liver pyruvate kinase in complex with anthraquinone derivative 29","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SC9"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SCA",,"X-RAY DIFFRACTION",2.86,57.02,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SCA",392.4,"1.918","1.918","Structure of liver pyruvate kinase in complex with anthraquinone derivative 36","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SCA"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SCB",,"X-RAY DIFFRACTION",2.84,56.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SCB",392.8,"1.8","1.8","Structure of liver pyruvate kinase in complex with anthraquinone derivative 28","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SCB"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SCC",,"X-RAY DIFFRACTION",2.84,56.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SCC",391.17,"1.885","1.885","Structure of liver pyruvate kinase in complex with anthraquinone derivative 57","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SCC"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SCD",,"X-RAY DIFFRACTION",2.87,57.11,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SCD",391.74,"2.041","2.041","Structure of liver pyruvate kinase in complex with anthraquinone derivative 58","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SCD"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SCE",,"X-RAY DIFFRACTION",2.88,57.34,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SCE",391.49,"2.147","2.147","Structure of liver pyruvate kinase in complex with anthraquinone derivative 55","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SCE"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SCF",,"X-RAY DIFFRACTION",2.85,56.9,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SCF",391.66,"2.185","2.185","Structure of liver pyruvate kinase in complex with anthraquinone derivative 99","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SCF"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SCG",,"X-RAY DIFFRACTION",2.87,57.14,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SCG",392.71,"1.937","1.937","Structure of liver pyruvate kinase in complex with anthraquinone derivative 101","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SCG"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SCH",,"X-RAY DIFFRACTION",2.91,57.7,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SCH",391.72,"2.089","2.089","Structure of liver pyruvate kinase in complex with anthraquinone derivative 100","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SCH"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SCI",,"X-RAY DIFFRACTION",2.86,56.92,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SCI",392.51,"2.155","2.155","Structure of liver pyruvate kinase in complex with anthraquinone derivative 105","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SCI"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SCJ",,"X-RAY DIFFRACTION",2.88,57.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SCJ",392.4,"2.354","2.354","Structure of liver pyruvate kinase in complex with anthraquinone derivative 106","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SCJ"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SCK",,"X-RAY DIFFRACTION",2.83,56.56,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SCK",392.16,"1.717","1.717","Structure of liver pyruvate kinase in complex with anthraquinone derivative 42","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SCK"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SCL",,"X-RAY DIFFRACTION",2.82,56.42,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SCL",392.14,"2.134","2.134","Structure of liver pyruvate kinase in complex with anthraquinone derivative 1","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SCL"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SD6",,"X-RAY DIFFRACTION",4.59,73.18,"VAPOR DIFFUSION, SITTING DROP",,"MCSG2 E5 (273901e5): 200mM Lithium sulfate, 100mM Sodium acetate:Acetic acid pH4.5, 20% (w/v) PEG8000; prot conc 26mg/mL, cryo 20% EG, puck ogi6-6",289,,,"5SD6",23.14,"2.15","2.15","Crystal Structure of Dihydrofolate Reductase from Homo sapiens bound to NADP and SDDC Inhibitor SDDC-892","MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","5SD6"
"5SD7",,"X-RAY DIFFRACTION",4.59,73.2,"VAPOR DIFFUSION, SITTING DROP",,"MCSG1 H9 (271587h9): 100mM Bis-Tris pH5.5, 25% (w/v) PEG3350, prot conc 26mg/mL, cryo 15% EG, puck yrc3-1",289,,,"5SD7",23.14,"1.8","1.8","Crystal Structure of Dihydrofolate Reductase from Homo sapiens bound to NADP and SDDC Inhibitor SDDC-735","MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","5SD7"
"5SD8",,"X-RAY DIFFRACTION",4.57,73.08,"VAPOR DIFFUSION, SITTING DROP",,"JCSG+ D9 (284871d9): 170mM Ammonium sulfate, 25.5% (w/v) PEG4000, 15% (v/v) glycerol, 10mg/mL, dc, puck rfh2-7",289,,,"5SD8",23.27,"2.05","2.05","Crystal Structure of Dihydrofolate Reductase from Homo sapiens bound to NADP and SDDC Inhibitor SDDC-1190 (racemic mixture)","MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","5SD8"
"5SD9",,"X-RAY DIFFRACTION",4.64,73.5,"VAPOR DIFFUSION, SITTING DROP",6.5,"MCSG2 E5 (284882e5): 1600mM Ammonium sulfate, 100mM MES pH6.5, 10% dioxane, 10mg/mL, 20% eg, puck rfh2-6",289,,,"5SD9",22.97,"2.1","2.1","Crystal Structure of Dihydrofolate Reductase from Homo sapiens bound to NADP and SDDC Inhibitor SDDC-1096","MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","5SD9"
"5SDA",,"X-RAY DIFFRACTION",4.61,73.34,"VAPOR DIFFUSION, SITTING DROP",,"MCSG2 E5 (273949e5): 200mM Lithium sulfate, 100mM Sodium acetate:acetic acid pH4.5, 30% (w/v) PEG8000; prot conc 26mg/mL, cryo 20% EG, puck ogi6-2",289,,,"5SDA",23.05,"2.45","2.45","Crystal Structure of Dihydrofolate Reductase from Homo sapiens bound to NADP and SDDC Inhibitor SDDC-774","MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","5SDA"
"5SDB",,"X-RAY DIFFRACTION",2.24,45,"VAPOR DIFFUSION, SITTING DROP",8.5,"Wizard 3/4 H10 (296175h10): 100 mM Tris base/ Hydrochloric acid pH 8.5, 30% (w/v) PEG3350, 30% (v/v) 2-propanol, protein conc. 28.74 mg/mL, protein batch ID XP819, 10 mM NADP, 3.75 mM BSI108214, seeded from 293949g10, cryoprotected with 20% eg, puck izs6-6",290,,,"5SDB",45.58,"1.55","1.55","Crystal Structure of Human DHFR complexed with NADP and N10-formyl-tetrahydrofolate","MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND","Homo sapiens","DHFR","Dihydrofolate reductase","1","5SDB"
"5SDT",,"X-RAY DIFFRACTION",2.84,56.64,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES/MOPS, 10% PEG8000, 20% ethylene glycol, 10 mM phenylalanine, 20 mM sodium oxalate",291,"10.1016/j.ejmech.2022.114270",,"5SDT",392.56,"1.944","1.944","Structure of liver pyruvate kinase in complex with anthraquinone derivative 15","GSMEGPAGYLRRADVAQLTQELGTAFFQQQQLPAAMADTFLEHLCLLDIDSEPVAARSTSIIATIGPASRSVERLKEMIKAGMNIARLNFSHGSHEYHAESIANVREAVESFAGSPLSYRPVAIALDTKGPGSGPGLSEQDVRDLRFGVEHGVDIVFASFVRKASDVAAVRAALGPEGHGIKIISKIENHEGVKRFDEILEVSDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNLAGKPVVCATQMLESMITKPRPTRAETSDVANAVLDGADCIMLSGETAKGNFPVEAVKMQHAIAREAEAAVYHRQLFEELRRAAPLSRDPTEVTAIGAVEAAFKCCAAAIIVLTTTGRSAQLLSRYRPRAAVIAVTRSAQAARQVHLCRGVFPLLYREPPEAIWADDVDRRVQFGIESGKLRGFLRVGDLVIVVTGWRPGSGYTNIMRVLSIS","Homo sapiens","PKLR","Pyruvate kinase","1","5SDT"
,,,,,,,,,,,,,,,,,"Homo sapiens","PKLR"
"5SDU",,"X-RAY DIFFRACTION",2.63,53.25,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SDU",159.39,"2.15","2.15","Crystal Structure of human phosphodiesterase 10 in complex with 5-methyl-4-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]-2-phenyl-1,3-oxazole","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SDU"
"5SDV",,"X-RAY DIFFRACTION",2.63,53.31,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SDV",159.78,"2.15","2.15","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-N-(1,3-oxazol-4-ylmethyl)-3-N-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)pyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SDV"
"5SDW",,"X-RAY DIFFRACTION",2.69,54.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SDW",159.57,"2.35","2.35","Crystal Structure of human phosphodiesterase 10 in complex with 4-N,4-N,2-trimethyl-3-N-(2-phenyl-1H-benzimidazol-5-yl)pyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SDW"
"5SDX",,"X-RAY DIFFRACTION",2.63,53.28,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SDX",159.41,"2.19","2.19","Crystal Structure of human phosphodiesterase 10 in complex with 4-[6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyridin-2-yl]morpholine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SDX"
"5SDY",,"X-RAY DIFFRACTION",3,58.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SDY",39.95,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[5-(dimethylcarbamoyl)-1-(2-methoxyethyl)pyrazol-4-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SDY"
"5SDZ",,"X-RAY DIFFRACTION",2.64,53.36,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SDZ",159.88,"2.35","2.35","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[3-[2,3-dihydroxypropyl(methyl)carbamoyl]-1-methylpyrazol-4-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SDZ"
"5SE0",,"X-RAY DIFFRACTION",2.65,53.51,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SE0",159.78,"2.01","2.01","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[2-(2-hydroxyethyl)-5-pyridin-2-ylpyrazol-3-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SE0"
"5SE1",,"X-RAY DIFFRACTION",2.93,58.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SE1",39.91,"2.3","2.3","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[3-(dimethylcarbamoyl)-1-methylpyrazol-4-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SE1"
"5SE2",,"X-RAY DIFFRACTION",2.62,53.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SE2",159.27,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]quinoline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SE2"
"5SE3",,"X-RAY DIFFRACTION",2.63,53.25,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SE3",159.41,"2.14","2.14","Crystal Structure of human phosphodiesterase 10 in complex with 2-chloro-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyridine-4-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SE3"
"5SE4",,"X-RAY DIFFRACTION",2.66,53.68,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SE4",159.45,"2.5","2.5","Crystal Structure of human phosphodiesterase 10 in complex with 5-cyclopropyl-7-methyl-2-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyrimidine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SE4"
"5SE5",,"X-RAY DIFFRACTION",2.61,52.87,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SE5",159.59,"2.08","2.08","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[1-methyl-5-(methylcarbamoyl)pyrazol-4-yl]-3-(pyrimidin-5-ylamino)pyrazine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SE5"
"5SE6",,"X-RAY DIFFRACTION",2.6,52.71,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SE6",159.35,"1.95","1.95","Crystal Structure of human phosphodiesterase 10 in complex with 2,9-dimethyl-6-[(1-methyl-4-phenylimidazol-2-yl)methoxy]purine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SE6"
"5SE7",,"X-RAY DIFFRACTION",2.64,53.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SE7",159.62,"2.17","2.17","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SE7"
"5SE8",,"X-RAY DIFFRACTION",2.66,53.7,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SE8",159.59,"1.99","1.99","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-[2-(2-methyl-5-phenyl-1,2,4-triazol-3-yl)ethyl]pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SE8"
"5SE9",,"X-RAY DIFFRACTION",2.64,53.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SE9",159.35,"1.94","1.94","Crystal Structure of human phosphodiesterase 10 in complex with 2,3-dimethyl-6-[(1-methyl-4-phenylimidazol-2-yl)methoxy]imidazo[1,2-b]pyridazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SE9"
"5SEA",,"X-RAY DIFFRACTION",2.66,53.81,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEA",159.6,"2","2","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-(2-phenylpyrazol-3-yl)-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEA"
"5SEB",,"X-RAY DIFFRACTION",2.63,53.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEB",159.3,"2.28","2.28","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-3-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]quinoxaline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEB"
"5SEC",,"X-RAY DIFFRACTION",2.65,53.66,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEC",159.57,"2.03","2.03","Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-(1,4-diphenylimidazol-2-yl)ethyl]-3-methylquinoxaline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEC"
"5SED",,"X-RAY DIFFRACTION",2.63,53.25,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SED",159.76,"2.32","2.32","Crystal Structure of human phosphodiesterase 10 in complex with 4-[6-chloro-2-[(1-methyl-4-phenylimidazol-2-yl)methoxy]quinazolin-4-yl]morpholine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SED"
"5SEE",,"X-RAY DIFFRACTION",3.09,60.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEE",39.94,"2.35","2.35","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-(2-pyridin-2-ylpyrazol-3-yl)-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEE"
"5SEF",,"X-RAY DIFFRACTION",2.64,53.34,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEF",159.37,"2.29","2.29","Crystal Structure of human phosphodiesterase 10 in complex with 5,7,8-trimethyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEF"
"5SEG",,"X-RAY DIFFRACTION",2.63,53.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEG",160.1,"2.29","2.29","Crystal Structure of human phosphodiesterase 10 in complex with 6-[(5-bromo-1-methyl-2-oxopyridine-3-carbonyl)amino]-N-(oxetan-3-yl)-2-phenyl-3H-benzimidazole-5-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEG"
"5SEH",,"X-RAY DIFFRACTION",2.65,53.61,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEH",159.65,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-(2-morpholin-4-yl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEH"
"5SEI",,"X-RAY DIFFRACTION",2.63,53.17,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEI",159.33,"2.37","2.37","Crystal Structure of human phosphodiesterase 10 in complex with 6-chloro-2-[(E)-2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethenyl]-[1,2,4]triazolo[1,5-a]pyridine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEI"
"5SEJ",,"X-RAY DIFFRACTION",2.63,53.28,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEJ",159.34,"2.44","2.44","Crystal Structure of human phosphodiesterase 10 in complex with 6-chloro-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyridine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEJ"
"5SEK",,"X-RAY DIFFRACTION",2.66,53.71,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEK",159.33,"2.15","2.15","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-3-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]quinoxaline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEK"
"5SEL",,"X-RAY DIFFRACTION",2.61,52.83,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEL",159.57,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-(2-methyl-5-pyridin-2-ylpyrazol-3-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEL"
"5SEM",,"X-RAY DIFFRACTION",2.64,53.36,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEM",159.55,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 3-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]-2-(trifluoromethyl)imidazo[1,2-b]pyridazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEM"
"5SEN",,"X-RAY DIFFRACTION",2.63,53.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEN",159.62,"2.04","2.04","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-(1-quinolin-2-ylimidazol-4-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEN"
"5SEO",,"X-RAY DIFFRACTION",2.63,53.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEO",159.34,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-(5-methyl-2-phenyl-1H-imidazol-4-yl)ethyl]isoindole-1,3-dione","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEO"
"5SEP",,"X-RAY DIFFRACTION",2.63,53.25,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEP",159.31,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-(4-cyclopentyl-1-methylimidazol-2-yl)ethyl]-5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEP"
"5SEQ",,"X-RAY DIFFRACTION",2.63,53.21,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEQ",159.37,"2.18","2.18","Crystal Structure of human phosphodiesterase 10 in complex with 5,6,8-trimethyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyrazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEQ"
"5SER",,"X-RAY DIFFRACTION",2.62,53.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SER",159.7,"2.25","2.25","Crystal Structure of human phosphodiesterase 10 in complex with 4-N-(2-fluoroethyl)-4-N,2-dimethyl-3-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SER"
"5SES",,"X-RAY DIFFRACTION",2.64,53.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SES",159.63,"2.11","2.11","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-(2-phenyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SES"
"5SET",,"X-RAY DIFFRACTION",2.99,58.92,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SET",39.92,"2.4","2.4","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-(2-methyl-5-pyridin-2-ylpyrazol-3-yl)-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SET"
"5SEU",,"X-RAY DIFFRACTION",2.62,53.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEU",159.47,"2.09","2.09","Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-6-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEU"
"5SEV",,"X-RAY DIFFRACTION",2.64,53.42,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEV",159.25,"2.31","2.31","Crystal Structure of human phosphodiesterase 10 in complex with 2,3,5-trimethyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEV"
"5SEW",,"X-RAY DIFFRACTION",2.88,57.24,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEW",40.02,"2.3","2.3","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[1-(2-methoxyethyl)-5-(methylcarbamoyl)pyrazol-4-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEW"
"5SEX",,"X-RAY DIFFRACTION",2.62,53.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEX",159.55,"1.99","1.99","Crystal Structure of human phosphodiesterase 10 in complex with N-methyl-6-[(6-methylpyridine-2-carbonyl)amino]-2-phenyl-3H-benzimidazole-5-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEX"
"5SEY",,"X-RAY DIFFRACTION",2.63,53.15,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEY",159.49,"2.29","2.29","Crystal Structure of human phosphodiesterase 10 in complex with [2-cyclopropyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethynyl]imidazo[1,2-b]pyridazin-3-yl]methanol","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEY"
"5SEZ",,"X-RAY DIFFRACTION",2.64,53.49,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SEZ",159.52,"1.99","1.99","Crystal Structure of human phosphodiesterase 10 in complex with 2-chloro-6-ethyl-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyridine-4-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SEZ"
"5SF0",,"X-RAY DIFFRACTION",2.59,52.54,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SF0",159.51,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-(3-pyridin-2-yl-1H-pyrazol-5-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SF0"
"5SF1",,"X-RAY DIFFRACTION",2.64,53.39,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SF1",159.47,"2.11","2.11","Crystal Structure of human phosphodiesterase 10 in complex with 2-(difluoromethyl)-3-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethynyl]imidazo[1,2-b]pyridazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SF1"
"5SF2",,"X-RAY DIFFRACTION",3.03,59.36,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SF2",39.97,"2.02","2.02","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-(3-oxo-1,2-dihydroisoindol-5-yl)-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SF2"
"5SF3",,"X-RAY DIFFRACTION",2.63,53.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SF3",159.78,"2.15","2.15","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-3-N-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)-4-N-(1H-pyrazol-5-ylmethyl)pyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SF3"
"5SF4",,"X-RAY DIFFRACTION",2.59,52.52,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SF4",159.89,"2.25","2.25","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[2-[2-(dimethylamino)ethyl]-5-pyridin-2-ylpyrazol-3-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SF4"
"5SF5",,"X-RAY DIFFRACTION",2.66,53.84,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SF5",159.34,"1.98","1.98","Crystal Structure of human phosphodiesterase 10 in complex with 2,3-dimethyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]imidazo[1,2-b]pyridazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SF5"
"5SF6",,"X-RAY DIFFRACTION",2.63,53.27,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SF6",159.55,"2.03","2.03","Crystal Structure of human phosphodiesterase 10 in complex with 6,7-dimethyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-N-propan-2-ylimidazo[2,1-f][1,2,4]triazin-4-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SF6"
"5SF7",,"X-RAY DIFFRACTION",2.63,53.21,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SF7",159.43,"2.08","2.08","Crystal Structure of human phosphodiesterase 10 in complex with 1-(2-chlorophenyl)-8-methoxy-3,4-dimethylimidazo[1,5-a]quinazolin-5-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SF7"
"5SF8",,"X-RAY DIFFRACTION",2.63,53.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SF8",159.84,"2.15","2.15","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-[2-(5-phenyl-2-pyridin-2-yl-1,2,4-triazol-3-yl)ethyl]pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SF8"
"5SF9",,"X-RAY DIFFRACTION",2.65,53.57,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SF9",159.34,"2.37","2.37","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-3-[(1-methyl-4-phenylimidazol-2-yl)methoxy]quinoxaline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SF9"
"5SFA",,"X-RAY DIFFRACTION",2.59,52.6,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFA",159.7,"2.32","2.32","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-3-[(1-methyl-4-phenylimidazol-2-yl)methoxy]-N-(oxolan-3-yl)pyrazine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFA"
"5SFB",,"X-RAY DIFFRACTION",2.66,53.71,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFB",159.54,"1.98","1.98","Crystal Structure of human phosphodiesterase 10 in complex with N,2,3-trimethyl-6-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]imidazo[1,2-b]pyridazine-8-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFB"
"5SFC",,"X-RAY DIFFRACTION",2.63,53.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFC",159.64,"2.18","2.18","Crystal Structure of human phosphodiesterase 10 in complex with","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFC"
"5SFD",,"X-RAY DIFFRACTION",2.62,53.08,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFD",159.37,"2.05","2.05","Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-(2-methyl-5-piperidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyrazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFD"
"5SFE",,"X-RAY DIFFRACTION",2.65,53.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SFE",159.64,"1.86","1.86","Crystal Structure of human phosphodiesterase 10 in complex with 3-N-[2-(3-fluorophenyl)imidazo[1,2-a]pyrimidin-7-yl]-4-N,4-N,2-trimethylpyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFE"
"5SFF",,"X-RAY DIFFRACTION",2.61,52.93,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFF",159.39,"2.16","2.16","Crystal Structure of human phosphodiesterase 10 in complex with [2-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethynyl]imidazo[1,2-b]pyridazin-3-yl]methanol","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFF"
"5SFG",,"X-RAY DIFFRACTION",2.67,53.93,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFG",159.76,"2.31","2.31","Crystal Structure of human phosphodiesterase 10 in complex with N-[(3R)-1-(5-chloropyridin-2-yl)pyrrolidin-3-yl]-6-cyclopropyl-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFG"
"5SFH",,"X-RAY DIFFRACTION",2.64,53.42,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFH",159.32,"2.29","2.29","Crystal Structure of human phosphodiesterase 10 in complex with N-cyclopropyl-5-[2-(5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)ethyl]-N,1-dimethyl-1,2,4-triazol-3-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFH"
"5SFI",,"X-RAY DIFFRACTION",2.63,53.21,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFI",159.57,"2.01","2.01","Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-[2-methyl-5-(2-methylpyrrolidin-1-yl)-1,2,4-triazol-3-yl]ethyl]-[1,2,4]triazolo[1,5-a]pyrazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFI"
"5SFJ",,"X-RAY DIFFRACTION",2.61,52.85,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFJ",159.82,"2.41","2.41","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-3-N-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)-4-N-(pyridin-2-ylmethyl)pyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFJ"
"5SFK",,"X-RAY DIFFRACTION",2.62,53.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFK",159.63,"2.33","2.33","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-3-(pyrimidin-5-ylamino)-N-[1-(2,2,2-trifluoroethyl)pyrazol-3-yl]pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFK"
"5SFL",,"X-RAY DIFFRACTION",2.61,52.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFL",159.82,"2.13","2.13","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[5-[(2-hydroxy-2-methylpropyl)carbamoyl]-1-methylpyrazol-4-yl]-3-(pyrimidin-5-ylamino)pyrazine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFL"
"5SFM",,"X-RAY DIFFRACTION",2.62,53.1,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFM",159.74,"2.16","2.16","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-(morpholine-4-carbonyl)-N-(2-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-7-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFM"
"5SFN",,"X-RAY DIFFRACTION",2.64,53.48,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFN",159.48,"2.02","2.02","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-[2-(1-methylbenzimidazol-2-yl)ethyl]pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFN"
"5SFO",,"X-RAY DIFFRACTION",2.61,52.91,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFO",159.6,"1.96","1.96","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFO"
"5SFP",,"X-RAY DIFFRACTION",2.64,53.48,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFP",159.41,"2","2","Crystal Structure of human phosphodiesterase 10 in complex with N-(2-chloropyridin-4-yl)-2-phenylpyrazolo[1,5-a]pyridine-6-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFP"
"5SFQ",,"X-RAY DIFFRACTION",2.59,52.48,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFQ",159.36,"2.21","2.21","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-N-[1-(2,2-difluoroethyl)pyrazol-3-yl]-2-methylpyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFQ"
"5SFR",,"X-RAY DIFFRACTION",2.65,53.55,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFR",159.87,"2.04","2.04","Crystal Structure of human phosphodiesterase 10 in complex with 4-N-ethyl-3-N-[2-[3-(2-fluoroethoxy)phenyl]imidazo[1,2-a]pyrimidin-7-yl]-4-N,2-dimethylpyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFR"
"5SFS",,"X-RAY DIFFRACTION",2.64,53.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFS",159.37,"2.24","2.24","Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-[2-methyl-5-[(3S)-3-methylpyrrolidin-1-yl]-1,2,4-triazol-3-yl]ethyl]-[1,2,4]triazolo[1,5-a]pyrazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFS"
"5SFT",,"X-RAY DIFFRACTION",2.62,53.14,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFT",159.32,"2.32","2.32","Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-(1-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyrazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFT"
"5SFU",,"X-RAY DIFFRACTION",2.61,52.9,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFU",159.73,"2.4","2.4","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-3-(pyrimidin-5-ylamino)-N-[4-(pyrrolidine-1-carbonyl)pyridin-3-yl]pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFU"
"5SFV",,"X-RAY DIFFRACTION",2.61,52.86,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFV",159.38,"2.41","2.41","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-N-(1-cyclopentylpyrazol-3-yl)-2-methylpyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFV"
"5SFW",,"X-RAY DIFFRACTION",2.62,53.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFW",159.37,"2.15","2.15","Crystal Structure of human phosphodiesterase 10 in complex with 5-ethyl-8-methyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFW"
"5SFX",,"X-RAY DIFFRACTION",2.66,53.72,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFX",159.61,"2.04","2.04","Crystal Structure of human phosphodiesterase 10 in complex with N-(2-acetamido-1,3-benzothiazol-5-yl)-4-(azetidine-1-carbonyl)-2-methylpyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFX"
"5SFY",,"X-RAY DIFFRACTION",2.62,53.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,"10.1007/s10822-022-00478-x",,"5SFY",159.56,"2.08","2.08","Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[(E)-2-[2-methyl-5-(1H-pyrazol-4-yl)-1,2,4-triazol-3-yl]ethenyl]-[1,2,4]triazolo[1,5-a]pyrazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFY"
"5SFZ",,"X-RAY DIFFRACTION",2.62,53.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SFZ",159.56,"2.16","2.16","Crystal Structure of human phosphodiesterase 10 in complex with 1-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl]-3-(2-phenylpyrazol-3-yl)urea","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SFZ"
"5SG0",,"X-RAY DIFFRACTION",2.64,53.38,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SG0",159.66,"2.06","2.06","Crystal Structure of human phosphodiesterase 10 in complex with 1-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl]-3-(2-phenylpyrazol-3-yl)imidazolidin-2-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SG0"
"5SG1",,"X-RAY DIFFRACTION",2.71,54.58,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SG1",159.4,"2.41","2.41","Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-a]quinoline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SG1"
"5SG2",,"X-RAY DIFFRACTION",2.6,52.65,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SG2",158.41,"2.15","2.15","Crystal Structure of human phosphodiesterase 10 in complex with 3-methylimidazo[4,5-f]quinolin-2-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SG2"
"5SG3",,"X-RAY DIFFRACTION",2.63,53.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SG3",160.05,"1.98","1.98","Crystal Structure of human phosphodiesterase 10 in complex with N-[(E)-(4-bromo-3,5-dimethoxyphenyl)methylideneamino]-2-ethoxy-2-(4-morpholin-4-ylphenyl)acetamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SG3"
"5SG4",,"X-RAY DIFFRACTION",3,58.95,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SG4",39.9,"2.3","2.3","Crystal Structure of human phosphodiesterase 10 in complex with 3-N-[2-(3-chlorophenyl)-1H-benzimidazol-5-yl]-2-methylpyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SG4"
"5SG5",,"X-RAY DIFFRACTION",2.64,53.34,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SG5",159.73,"2.17","2.17","Crystal Structure of human phosphodiesterase 10 in complex with 1-[(4-methoxyphenyl)methyl]-3-(4-methylphenyl)-1-[(4-oxo-3H-quinazolin-2-yl)methyl]urea","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SG5"
"5SG6",,"X-RAY DIFFRACTION",2.64,53.36,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SG6",159.32,"1.96","1.96","Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyrazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SG6"
"5SG7",,"X-RAY DIFFRACTION",2.68,54.19,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SG7",159.31,"2.3","2.3","Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(2-fluorophenyl)pyrazol-3-yl]-1-[3-(trifluoromethyl)phenyl]pyridazin-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SG7"
"5SG8",,"X-RAY DIFFRACTION",2.62,53.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SG8",158.86,"2.16","2.16","Crystal Structure of human phosphodiesterase 10 in complex with 5-butoxy-4-ethoxypyrimidin-2-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SG8"
"5SG9",,"X-RAY DIFFRACTION",2.61,52.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SG9",159.28,"2.13","2.13","Crystal Structure of human phosphodiesterase 10 in complex with 2-[(E)-2-(4-methyl-6-pyrrolidin-1-ylpyrimidin-2-yl)ethenyl]quinoline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SG9"
"5SGB",,"X-RAY DIFFRACTION",2.61,52.87,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGB",159.06,"2.39","2.39","Crystal Structure of human phosphodiesterase 10 in complex with 5-(4-chloronaphthalen-1-yl)oxythiadiazole","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGB"
"5SGC",,"X-RAY DIFFRACTION",2.63,53.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGC",159.66,"2.09","2.09","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-(2-morpholin-4-yl-[1,2,4]triazolo[1,5-c]pyrimidin-7-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGC"
"5SGD",,"X-RAY DIFFRACTION",2.64,53.45,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGD",159.46,"2.54","2.54","Crystal Structure of human phosphodiesterase 10 in complex with 4-(methoxymethyl)-2-methyl-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGD"
"5SGE",,"X-RAY DIFFRACTION",2.63,53.17,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGE",158.75,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with 6H-imidazo[1,2-c]quinazolin-5-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGE"
"5SGF",,"X-RAY DIFFRACTION",2.61,52.94,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGF",159.06,"2.3","2.3","Crystal Structure of human phosphodiesterase 10 in complex with ethyl 1-methyl-5-(propylcarbamoyl)pyrazole-4-carboxylate","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGF"
"5SGG",,"X-RAY DIFFRACTION",2.63,53.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGG",159.4,"2.09","2.09","Crystal Structure of human phosphodiesterase 10 in complex with 2-[(4-chloro-3,5-dimethylpyridin-2-yl)methylsulfanyl]-6,7-dihydro-3H-furo[3,2-f]benzimidazole","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGG"
"5SGH",,"X-RAY DIFFRACTION",2.6,52.78,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGH",159.63,"1.97","1.97","Crystal Structure of human phosphodiesterase 10 in complex with 4-[1-methyl-6-[(1-methyl-4-phenylimidazol-2-yl)methoxy]pyrazolo[3,4-d]pyrimidin-4-yl]morpholine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGH"
"5SGI",,"X-RAY DIFFRACTION",2.65,53.6,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGI",159.75,"1.97","1.97","Crystal Structure of human phosphodiesterase 10 in complex with 6-(3-methylphenoxy)-2-(4-pyridin-2-ylpiperazin-1-yl)-9H-purine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGI"
"5SGJ",,"X-RAY DIFFRACTION",2.64,53.48,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGJ",159.61,"2.66","2.66","Crystal Structure of human phosphodiesterase 10 in complex with 6-[(3,6-dimethylpyridine-2-carbonyl)amino]-N-methyl-2-phenyl-3H-benzimidazole-5-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGJ"
"5SGK",,"X-RAY DIFFRACTION",2.63,53.27,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGK",159.69,"2.13","2.13","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-[(7R)-2-(2-methylphenyl)-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-7-yl]pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGK"
"5SGL",,"X-RAY DIFFRACTION",2.64,53.45,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGL",159.96,"2.28","2.28","Crystal Structure of human phosphodiesterase 10 in complex with N-[(E)-(4-bromo-3,5-dimethoxyphenyl)methylideneamino]-2-ethoxy-2-(4-pyrazol-1-ylphenyl)acetamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGL"
"5SGM",,"X-RAY DIFFRACTION",2.99,58.9,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGM",39.91,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with 3-N-[2-(4-fluorophenyl)imidazo[1,2-a]pyridin-7-yl]-4-N,4-N,2-trimethylpyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGM"
"5SGN",,"X-RAY DIFFRACTION",2.63,53.28,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGN",159.59,"2.07","2.07","Crystal Structure of human phosphodiesterase 10 in complex with 2,3-dimethyl-6-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-7-(trifluoromethyl)imidazo[1,2-b]pyridazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGN"
"5SGO",,"X-RAY DIFFRACTION",2.66,53.83,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGO",159.44,"2.3","2.3","Crystal Structure of human phosphodiesterase 10 in complex with N-[3-[3-[5-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxypropoxy]phenyl]acetamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGO"
"5SGP",,"X-RAY DIFFRACTION",2.64,53.35,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGP",159.83,"1.95","1.95","Crystal Structure of human phosphodiesterase 10 in complex with 4-N-(2-methoxyethyl)-4-N,2-dimethyl-3-N-(2-phenylimidazo[1,2-a]pyridin-7-yl)pyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGP"
"5SGQ",,"X-RAY DIFFRACTION",2.64,53.44,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGQ",159.04,"2.04","2.04","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-3-(pyrimidin-5-ylamino)pyrazine-2-carboxylic acid","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGQ"
"5SGR",,"X-RAY DIFFRACTION",2.64,53.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGR",159.41,"2.04","2.04","Crystal Structure of human phosphodiesterase 10 in complex with 2-chloro-3-[(1-methyl-4-phenylimidazol-2-yl)methoxy]quinoxaline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGR"
"5SGS",,"X-RAY DIFFRACTION",2.65,53.64,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGS",159.29,"2.03","2.03","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-3-[2-(1-pyridin-2-ylpyrrolidin-3-yl)ethyl]quinoxaline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGS"
"5SGT",,"X-RAY DIFFRACTION",2.63,53.18,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGT",159.71,"2.26","2.26","Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-[3-(4-methoxyphenyl)-4-oxoquinazolin-2-yl]ethyl]isoindole-1,3-dione","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGT"
"5SGU",,"X-RAY DIFFRACTION",2.65,53.5,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGU",159.09,"2.14","2.14","Crystal Structure of human phosphodiesterase 10 in complex with 12-methoxy-5,7-dimethyl-3-propyl-2,4,8,13-tetrazatricyclo[7.4.0.02,6]trideca-1(13),3,5,7,9,11-hexaene","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGU"
"5SGV",,"X-RAY DIFFRACTION",2.61,52.92,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGV",159.42,"2","2","Crystal Structure of human phosphodiesterase 10 in complex with 1-benzyl-3-(2-phenylpyrazol-3-yl)pyridazin-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGV"
"5SGW",,"X-RAY DIFFRACTION",2.64,53.42,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGW",159.28,"1.9","1.9","Crystal Structure of human phosphodiesterase 10 in complex with 2-phenyl-6-(2-phenylpyrazol-3-yl)-3,4-dihydropyridazin-5-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGW"
"5SGX",,"X-RAY DIFFRACTION",2.64,53.43,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGX",159.74,"1.93","1.93","Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-[2-methyl-5-[(2R)-2-(trifluoromethyl)pyrrolidin-1-yl]-1,2,4-triazol-3-yl]ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGX"
,,,,,,,,,,,,,,,,"GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","2","5SGX"
"5SGY",,"X-RAY DIFFRACTION",2.63,53.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGY",159.59,"2.36","2.36","Crystal Structure of human phosphodiesterase 10 in complex with 4-chloro-2-(2-methylpropyl)-N-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGY"
"5SGZ",,"X-RAY DIFFRACTION",2.62,52.97,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SGZ",159.37,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with 3-(2-chlorophenyl)-12-methoxy-5-methyl-2,4,8,13-tetrazatricyclo[7.4.0.02,6]trideca-1(13),3,5,9,11-pentaen-7-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SGZ"
"5SH0",,"X-RAY DIFFRACTION",2.61,52.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SH0",159.77,"2.29","2.29","Crystal Structure of human phosphodiesterase 10 in complex with N-(1,3-dimethyl-2-oxobenzimidazol-5-yl)-2-[methylsulfonyl(naphthalen-1-yl)amino]acetamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SH0"
"5SH1",,"X-RAY DIFFRACTION",2.64,53.45,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SH1",159.33,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with 5-methyl-2-phenyl-4-(2-quinolin-8-yloxyethyl)-1,3-oxazole","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SH1"
"5SH2",,"X-RAY DIFFRACTION",2.63,53.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SH2",159.72,"2.19","2.19","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-(2-morpholin-4-yl-1,3-benzothiazol-5-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SH2"
"5SH3",,"X-RAY DIFFRACTION",2.63,53.2,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SH3",159.63,"1.98","1.98","Crystal Structure of human phosphodiesterase 10 in complex with 2,3-dimethyl-6-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-8-methylsulfonylimidazo[1,2-b]pyridazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SH3"
"5SH4",,"X-RAY DIFFRACTION",2.64,53.35,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SH4",159.44,"2.22","2.22","Crystal Structure of human phosphodiesterase 10 in complex with 6-[(5-methoxy-3,4,6-trimethylpyridin-2-yl)methylsulfanyl]-5H-[1,3]dioxolo[4,5-f]benzimidazole","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SH4"
"5SH5",,"X-RAY DIFFRACTION",2.61,52.91,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SH5",159.07,"2.3","2.3","Crystal Structure of human phosphodiesterase 10 in complex with 2-amino-4-cyclohexyloxyquinoline-3-carbonitrile","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SH5"
"5SH6",,"X-RAY DIFFRACTION",2.61,52.78,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SH6",159.3,"1.98","1.98","Crystal Structure of human phosphodiesterase 10 in complex with 4-[2-(1-methylbenzimidazol-2-yl)ethyl]-2,3-dihydro-1,4-benzoxazepin-5-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SH6"
"5SH7",,"X-RAY DIFFRACTION",2.64,53.47,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SH7",159.89,"2.66","2.66","Crystal Structure of human phosphodiesterase 10 in complex with 6-[(5-cyclopropyl-2-oxo-1H-pyridine-3-carbonyl)amino]-N-(oxetan-3-yl)-2-phenyl-3H-benzimidazole-5-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SH7"
"5SH8",,"X-RAY DIFFRACTION",2.64,53.36,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SH8",160.07,"2","2","Crystal Structure of human phosphodiesterase 10 in complex with 6-methyl-N-(5-methyl-2-phenylpyrazol-3-yl)-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SH8"
"5SH9",,"X-RAY DIFFRACTION",2.64,53.48,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SH9",159.58,"2.06","2.06","Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-[5-[(3R)-3-fluoropyrrolidin-1-yl]-2-methyl-1,2,4-triazol-3-yl]ethyl]-5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SH9"
"5SHA",,"X-RAY DIFFRACTION",2.6,52.73,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHA",159.52,"2.24","2.24","Crystal Structure of human phosphodiesterase 10 in complex with 2-[2-[5-[3-(difluoromethyl)pyrrolidin-1-yl]-2-methyl-1,2,4-triazol-3-yl]ethyl]-5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHA"
"5SHB",,"X-RAY DIFFRACTION",2.63,53.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHB",159.59,"1.95","1.95","Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(3-bromophenyl)pyrazol-3-yl]-1-pyridin-4-ylpyridazin-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHB"
"5SHC",,"X-RAY DIFFRACTION",2.63,53.22,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHC",158.81,"2.33","2.33","Crystal Structure of human phosphodiesterase 10 in complex with 1-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl]-2-oxo-N-pyrimidin-5-ylpyridine-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHC"
"5SHD",,"X-RAY DIFFRACTION",2.63,53.28,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHD",159.57,"2.6","2.6","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[4-(methylcarbamoyl)pyridin-3-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHD"
"5SHE",,"X-RAY DIFFRACTION",2.61,52.86,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHE",158.7,"2.19","2.19","Crystal Structure of human phosphodiesterase 10 in complex with 2,3-dimethylquinoxalin-6-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHE"
"5SHF",,"X-RAY DIFFRACTION",2.66,53.81,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHF",159.38,"2.28","2.28","Crystal Structure of human phosphodiesterase 10 in complex with 3,6-dimethyl-N-(2-phenylpyrazolo[1,5-a]pyridin-6-yl)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHF"
"5SHG",,"X-RAY DIFFRACTION",2.62,53.03,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHG",159.37,"2.12","2.12","Crystal Structure of human phosphodiesterase 10 in complex with 3-(2-chlorophenyl)-12-methoxy-5-methyl-2,4,8,13-tetrazatricyclo[7.4.0.02,6]trideca-1(9),3,5,7,10,12-hexaen-7-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHG"
"5SHH",,"X-RAY DIFFRACTION",2.66,53.77,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHH",159.44,"2.15","2.15","Crystal Structure of human phosphodiesterase 10 in complex with 7-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-6H-imidazo[4,5-g][1,3]benzothiazole","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHH"
"5SHI",,"X-RAY DIFFRACTION",2.65,53.58,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHI",159.39,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 2,3,5-trimethyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]imidazo[1,2-a]pyridine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHI"
"5SHJ",,"X-RAY DIFFRACTION",2.67,54.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHJ",159.72,"2.3","2.3","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-[3-(phenylcarbamoyl)phenyl]pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHJ"
"5SHK",,"X-RAY DIFFRACTION",2.61,52.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHK",159.27,"2","2","Crystal Structure of human phosphodiesterase 10 in complex with N-(6-methylpyridin-2-yl)-5-pyridin-3-yl-1,7-naphthyridin-8-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHK"
"5SHL",,"X-RAY DIFFRACTION",2.61,52.9,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHL",159.01,"2.35","2.35","Crystal Structure of human phosphodiesterase 10 in complex with 6-chloro-2,3-dimethyl-8-pyrrolidin-1-ylimidazo[1,2-b]pyridazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHL"
"5SHM",,"X-RAY DIFFRACTION",2.63,53.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHM",159.51,"2.26","2.26","Crystal Structure of human phosphodiesterase 10 in complex with N-[(3R)-1-(5-chloropyridin-2-yl)pyrrolidin-3-yl]-6-cyclopropyl-3-methoxypyrazine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHM"
"5SHN",,"X-RAY DIFFRACTION",2.63,53.27,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHN",159.8,"2.03","2.03","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-N-(1,3-oxazol-2-ylmethyl)-3-N-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)pyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHN"
"5SHO",,"X-RAY DIFFRACTION",2.97,58.55,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHO",39.9,"1.9","1.9","Crystal Structure of human phosphodiesterase 10 in complex with 4-N-cyclopropyl-2-methyl-3-N-(2-phenylimidazo[1,2-a]pyridin-7-yl)pyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHO"
"5SHP",,"X-RAY DIFFRACTION",2.68,54.08,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHP",159.41,"2.18","2.18","Crystal Structure of human phosphodiesterase 10 in complex with 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-3H-imidazo[4,5-h]quinoline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHP"
"5SHQ",,"X-RAY DIFFRACTION",2.61,52.86,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHQ",158.76,"2.08","2.08","Crystal Structure of human phosphodiesterase 10 in complex with 4-pyrrolidin-1-yl-7H-pyrrolo[2,3-d]pyrimidine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHQ"
"5SHS",,"X-RAY DIFFRACTION",2.64,53.35,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHS",159.48,"2.3","2.3","Crystal Structure of human phosphodiesterase 10 in complex with 3-(naphthalen-1-ylmethyl)-7-piperidin-1-yltriazolo[4,5-d]pyrimidine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHS"
"5SHT",,"X-RAY DIFFRACTION",2.63,53.29,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHT",159.46,"2.27","2.27","Crystal Structure of human phosphodiesterase 10 in complex with 8-chloro-5,7-dimethyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHT"
"5SHU",,"X-RAY DIFFRACTION",2.65,53.55,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHU",159.37,"1.98","1.98","Crystal Structure of human phosphodiesterase 10 in complex with 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-3,5,6,7-tetrahydropyrrolo[3,2-f]benzimidazole","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHU"
"5SHV",,"X-RAY DIFFRACTION",2.62,53.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHV",158.59,"1.95","1.95","Crystal Structure of human phosphodiesterase 10 in complex with 1-(6-fluoropyridin-2-yl)piperidin-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHV"
"5SHW",,"X-RAY DIFFRACTION",2.62,53.01,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHW",158.91,"2.19","2.19","Crystal Structure of human phosphodiesterase 10 in complex with (2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)methanol","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHW"
"5SHX",,"X-RAY DIFFRACTION",2.63,53.21,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHX",158.86,"2.16","2.16","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-3-pyrrolidin-1-ylquinoxaline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHX"
"5SHY",,"X-RAY DIFFRACTION",3.03,59.43,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHY",40,"2.3","2.3","Crystal Structure of human phosphodiesterase 10 in complex with [8-[(2-methyl-1,3-thiazol-4-yl)amino]-5-pyridin-3-yl-1,7-naphthyridin-2-yl]methanol","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHY"
"5SHZ",,"X-RAY DIFFRACTION",2.63,53.24,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SHZ",159.37,"2.55","2.55","Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(3-ethynylphenyl)pyrazol-3-yl]-1-phenylpyridazin-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SHZ"
"5SI0",,"X-RAY DIFFRACTION",2.63,53.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SI0",159.97,"2.27","2.27","Crystal Structure of human phosphodiesterase 10 in complex with 7-methyl-2,5-bis[2-(1-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-c]pyrimidine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SI0"
"5SI1",,"X-RAY DIFFRACTION",3.04,59.55,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SI1",39.93,"1.75","1.75","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-(morpholine-4-carbonyl)-N-(2-phenylimidazo[1,2-a]pyridin-7-yl)pyrazole-3-carboxamide, space group I23","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SI1"
"5SI2",,"X-RAY DIFFRACTION",2.59,52.55,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SI2",159.22,"2.4","2.4","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-(1-pyridin-2-ylpyrrolidin-3-yl)-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SI2"
"5SI3",,"X-RAY DIFFRACTION",2.63,53.17,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SI3",159.46,"2.4","2.4","Crystal Structure of human phosphodiesterase 10 in complex with 1-methyl-5-[(2-phenylimidazo[1,2-a]pyrimidin-7-yl)carbamoyl]pyrazole-4-carboxylic acid","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SI3"
"5SI4",,"X-RAY DIFFRACTION",2.65,53.66,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SI4",159.81,"2.39","2.39","Crystal Structure of human phosphodiesterase 10 in complex with 3-(2-naphthalen-1-ylpyrazol-3-yl)-1-[3-(trifluoromethoxy)phenyl]pyridazin-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SI4"
"5SI5",,"X-RAY DIFFRACTION",2.6,52.76,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SI5",159.41,"2.27","2.27","Crystal Structure of human phosphodiesterase 10 in complex with N-(12-methoxy-5-methyl-3-propyl-2,4,8,13-tetrazatricyclo[7.4.0.02,6]trideca-1(13),3,5,7,9,11-hexaen-7-yl)methanesulfonamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SI5"
"5SI6",,"X-RAY DIFFRACTION",2.64,53.38,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SI6",159.71,"2","2","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-N-(6-cyano-2-phenylimidazo[1,2-a]pyridin-7-yl)-2-methylpyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SI6"
"5SI7",,"X-RAY DIFFRACTION",2.63,53.22,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SI7",159.29,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 2-benzyl-6,6-dimethyl-1H-imidazo[4,5-h]isoquinoline-7,9-dione","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SI7"
"5SI8",,"X-RAY DIFFRACTION",2.62,53,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SI8",159.83,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with N-(6-cyano-2-phenylimidazo[1,2-a]pyridin-7-yl)-1-methyl-4-(morpholine-4-carbonyl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SI8"
"5SI9",,"X-RAY DIFFRACTION",2.68,54.11,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SI9",159.63,"2.01","2.01","Crystal Structure of human phosphodiesterase 10 in complex with 4-N-(2-hydroxyethyl)-2-methyl-3-N-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)pyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SI9"
"5SIA",,"X-RAY DIFFRACTION",2.62,53.14,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIA",159.3,"2.27","2.27","Crystal Structure of human phosphodiesterase 10 in complex with 1-(2,3-dimethylquinoxalin-6-yl)-3-(3-methoxyphenyl)urea","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIA"
"5SIB",,"X-RAY DIFFRACTION",2.64,53.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIB",159.53,"2.54","2.54","Crystal Structure of human phosphodiesterase 10 in complex with 3-methyl-6-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-2-(trifluoromethyl)imidazo[1,2-b]pyridazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIB"
"5SID",,"X-RAY DIFFRACTION",2.65,53.55,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SID",159.6,"1.98","1.98","Crystal Structure of human phosphodiesterase 10 in complex with 5-chloro-2-[2-(6,8-dichloro-5-methyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)ethyl]-1,3-benzothiazole","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SID"
"5SIE",,"X-RAY DIFFRACTION",2.62,53.04,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIE",158.96,"2.12","2.12","Crystal Structure of human phosphodiesterase 10 in complex with 5-chloro-8-hydroxy-2-methyl-1,4-dihydropyrrolo[3,4-b]indol-3-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIE"
"5SIF",,"X-RAY DIFFRACTION",2.62,53.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIF",160.98,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(2,5-difluorophenyl)pyrazol-3-yl]-1-(3-methylsulfonylphenyl)pyridazin-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIF"
"5SIG",,"X-RAY DIFFRACTION",2.61,52.95,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIG",159.67,"2.03","2.03","Crystal Structure of human phosphodiesterase 10 in complex with 1-[(4-methoxyphenyl)methyl]-1-[(4-oxo-3H-quinazolin-2-yl)methyl]-3-phenylurea","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIG"
"5SIH",,"X-RAY DIFFRACTION",2.65,53.59,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIH",159.81,"1.9","1.9","Crystal Structure of human phosphodiesterase 10 in complex with 6-(3-methylphenyl)sulfanyl-2-(4-pyridin-2-ylpiperazin-1-yl)-9H-purine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIH"
"5SII",,"X-RAY DIFFRACTION",2.64,53.41,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SII",159.54,"2.18","2.18","Crystal Structure of human phosphodiesterase 10 in complex with 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SII"
"5SIJ",,"X-RAY DIFFRACTION",2.65,53.56,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIJ",159.34,"2.55","2.55","Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyrazine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIJ"
"5SIK",,"X-RAY DIFFRACTION",2.6,52.63,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIK",158.78,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 5-(cyclopentylmethoxy)pyrimidin-2-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIK"
"5SIL",,"X-RAY DIFFRACTION",3,58.96,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIL",39.88,"2.5","2.5","Crystal Structure of human phosphodiesterase 10 in complex with 4-chloro-N-[2-(3,5-dimethylphenyl)-1H-benzimidazol-5-yl]-2-methylpyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIL"
"5SIM",,"X-RAY DIFFRACTION",3.02,59.31,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIM",39.93,"1.75","1.75","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-(2-methylpyrrolidine-1-carbonyl)-N-(2-phenylimidazo[1,2-a]pyridin-7-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIM"
"5SIN",,"X-RAY DIFFRACTION",2.65,53.55,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIN",159.35,"2.4","2.4","Crystal Structure of human phosphodiesterase 10 in complex with N-(3-methyl-1-pyridin-2-ylthieno[2,3-c]pyrazol-5-yl)benzamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIN"
"5SIO",,"X-RAY DIFFRACTION",2.63,53.27,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIO",160.47,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-(2-methylpyrrolidine-1-carbonyl)-N-(2-phenylimidazo[1,2-a]pyridin-7-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIO"
"5SIP",,"X-RAY DIFFRACTION",2.63,53.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIP",159.62,"2.03","2.03","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-N-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIP"
"5SIQ",,"X-RAY DIFFRACTION",2.66,53.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIQ",159.78,"1.97","1.97","Crystal Structure of human phosphodiesterase 10 in complex with 2-ethyl-3-[4-(4-methylphenyl)sulfonylpiperazin-1-yl]quinoxaline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIQ"
"5SIR",,"X-RAY DIFFRACTION",2.67,53.9,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIR",159.39,"2.5","2.5","Crystal Structure of human phosphodiesterase 10 in complex with 3,6-dimethyl-N-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIR"
"5SIS",,"X-RAY DIFFRACTION",3,59,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIS",39.93,"1.85","1.85","Crystal Structure of human phosphodiesterase 10 in complex with 4-N,2-dimethyl-4-N-[2-(methylamino)ethyl]-3-N-(2-phenylimidazo[1,2-a]pyridin-7-yl)pyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIS"
"5SIT",,"X-RAY DIFFRACTION",2.62,53,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIT",158.81,"1.99","1.99","Crystal Structure of human phosphodiesterase 10 in complex with 6-methyl-N-(4-methylphenyl)pyrimidin-4-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIT"
"5SIU",,"X-RAY DIFFRACTION",2.62,53.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIU",159.51,"2.01","2.01","Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(6,8-dichloro-5-methyl-[1,2,4]triazolo[1,5-a]pyridin-2-yl)ethyl]-1H-quinoxalin-2-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIU"
"5SIV",,"X-RAY DIFFRACTION",2.59,52.43,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIV",159.09,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with N-(thiophen-2-ylmethyl)quinoxaline-6-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIV"
"5SIW",,"X-RAY DIFFRACTION",2.61,52.9,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIW",159.53,"2.13","2.13","5-methyl-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-8-(trifluoromethyl)-[1,2,4]triazolo[1,5-c]pyrimidine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIW"
"5SIX",,"X-RAY DIFFRACTION",2.98,58.72,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIX",40.03,"2.29","2.29","Crystal Structure of human phosphodiesterase 10 in complex with 5-[(3R)-3-fluoropyrrolidin-1-yl]-2-(3-methylquinoxalin-2-yl)-N-(oxan-4-yl)pyrazolo[1,5-a]pyrimidin-7-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIX"
"5SIY",,"X-RAY DIFFRACTION",2.63,53.2,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIY",159.86,"2.03","2.03","Crystal Structure of human phosphodiesterase 10 in complex with 5-[(3R)-3-fluoropyrrolidin-1-yl]-N-methyl-2-(3-methylquinoxalin-2-yl)-N-(oxan-4-yl)pyrazolo[1,5-a]pyrimidin-7-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIY"
"5SIZ",,"X-RAY DIFFRACTION",2.61,52.82,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SIZ",159.47,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-3-methoxy-N-[2-(3-pyridin-3-yl-1H-1,2,4-triazol-5-yl)ethyl]pyrazine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SIZ"
"5SJ0",,"X-RAY DIFFRACTION",2.59,52.57,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJ0",158.94,"2.35","2.35","Crystal Structure of human phosphodiesterase 10 in complex with N-cyclohexyl-N-methyl-9H-purin-6-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJ0"
"5SJ1",,"X-RAY DIFFRACTION",2.62,53,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJ1",159.61,"2.16","2.16","Crystal Structure of human phosphodiesterase 10 in complex with 7-[(3,5-dimethyl-4-propan-2-yloxypyridin-2-yl)methylsulfinyl]-6H-imidazo[4,5-g][1,3]benzothiazole","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJ1"
"5SJ2",,"X-RAY DIFFRACTION",2.65,53.59,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJ2",159.55,"1.99","1.99","Crystal Structure of human phosphodiesterase 10 in complex with 2,3-dichloro-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyridine-4-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJ2"
"5SJ3",,"X-RAY DIFFRACTION",2.64,53.44,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJ3",159.73,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with [1-(4-chlorophenyl)-3-methylthieno[2,3-c]pyrazol-5-yl]-piperidin-1-ylmethanone","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJ3"
"5SJ4",,"X-RAY DIFFRACTION",2.63,53.21,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJ4",159.37,"2.77","2.77","Crystal Structure of human phosphodiesterase 10 in complex with 1-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]-5H-pyrazolo[3,4-d]pyrimidin-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJ4"
"5SJ5",,"X-RAY DIFFRACTION",2.61,52.87,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJ5",158.73,"2.49","2.49","Crystal Structure of human phosphodiesterase 10 in complex with 6-chloroquinoxalin-2-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJ5"
"5SJ6",,"X-RAY DIFFRACTION",2.59,52.54,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJ6",159.01,"2.15","2.15","Crystal Structure of human phosphodiesterase 10 in complex with 4-(2-chloroquinazolin-4-yl)morpholine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJ6"
"5SJ7",,"X-RAY DIFFRACTION",2.64,53.36,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJ7",159.49,"2.14","2.14","Crystal Structure of human phosphodiesterase 10 in complex with 7-[(5-methyl-4-propan-2-yloxypyridin-2-yl)methylsulfanyl]-6H-imidazo[4,5-g][1,3]benzothiazole","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJ7"
"5SJ8",,"X-RAY DIFFRACTION",2.62,53.03,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJ8",159.14,"2.49","2.49","Crystal Structure of human phosphodiesterase 10 in complex with 12-methoxy-5-methyl-3-propyl-2,4,8,13-tetrazatricyclo[7.4.0.02,6]trideca-1(13),3,5,7,9,11-hexaene-7-carbonitrile","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJ8"
"5SJ9",,"X-RAY DIFFRACTION",2.63,53.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJ9",159.57,"2.39","2.39","Crystal Structure of human phosphodiesterase 10 in complex with N-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]-3-propan-2-yl-[1,2,4]triazolo[4,3-a]pyridine-8-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJ9"
"5SJA",,"X-RAY DIFFRACTION",2.67,53.9,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJA",159.96,"2.13","2.13","Crystal Structure of human phosphodiesterase 10 in complex with N-(2-tert-butyl-5-methylpyrazol-3-yl)-1-phenyl-3-(pyridin-2-yloxymethyl)thieno[2,3-c]pyrazole-5-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJA"
"5SJB",,"X-RAY DIFFRACTION",2.64,53.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJB",159.41,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with 2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfanyl]-3H-imidazo[4,5-f]quinoline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJB"
"5SJC",,"X-RAY DIFFRACTION",2.98,58.68,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJC",39.96,"2.08","2.08","Crystal Structure of human phosphodiesterase 10 in complex with 4-chloro-2,5-dimethyl-N-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJC"
"5SJD",,"X-RAY DIFFRACTION",2.65,53.65,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJD",159.31,"2.16","2.16","Crystal Structure of human phosphodiesterase 10 in complex with 1-[2-(3,5-dimethylpyrazol-1-yl)ethyl]-3-(2-phenylpyrazol-3-yl)urea","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJD"
"5SJE",,"X-RAY DIFFRACTION",2.63,53.16,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJE",161.16,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(2,2-difluoro-1,3-benzodioxol-4-yl)pyrazol-3-yl]-1-(3-methylsulfonylphenyl)pyridazin-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJE"
"5SJF",,"X-RAY DIFFRACTION",2.7,54.48,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJF",159.94,"2.05","2.05","Crystal Structure of human phosphodiesterase 10 in complex with 3-(2-quinolin-4-ylpyrazol-3-yl)-1-[3-(trifluoromethoxy)phenyl]pyridazin-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJF"
"5SJH",,"X-RAY DIFFRACTION",2.68,54.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJH",157.71,"2.1","2.1","Crystal Structure of human phosphodiesterase 10","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJH"
"5SJI",,"X-RAY DIFFRACTION",2.64,53.33,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJI",159.51,"1.98","1.98","Crystal Structure of human phosphodiesterase 10 in complex with 4-chloro-2-methyl-N-(2-phenyl-1H-benzimidazol-5-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJI"
"5SJJ",,"X-RAY DIFFRACTION",2.69,54.19,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJJ",159.39,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 4-N-ethyl-5-[3-(trifluoromethyl)phenyl]-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJJ"
"5SJK",,"X-RAY DIFFRACTION",2.6,52.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJK",159.03,"2.24","2.24","Crystal Structure of human phosphodiesterase 10 in complex with 5,8-dichloro-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJK"
"5SJL",,"X-RAY DIFFRACTION",2.66,53.73,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJL",159.8,"2.64","2.64","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[4-[(2-hydroxy-2-methylpropyl)carbamoyl]pyridin-3-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJL"
"5SJM",,"X-RAY DIFFRACTION",2.58,52.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJM",159.12,"2.3","2.3","Crystal Structure of human phosphodiesterase 10 in complex with 3-(2-phenylethyl)-5-pyridin-4-yl-1H-pyridin-2-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJM"
"5SJN",,"X-RAY DIFFRACTION",2.63,53.15,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJN",159.51,"2.05","2.05","Crystal Structure of human phosphodiesterase 10 in complex with 6,8-dichloro-2-[2-(6,7-dimethyl-1H-benzimidazol-2-yl)ethyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyridine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJN"
"5SJO",,"X-RAY DIFFRACTION",2.62,53.04,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJO",161,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(2,4-difluorophenyl)pyrazol-3-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJO"
"5SJP",,"X-RAY DIFFRACTION",2.62,53.1,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJP",159.79,"2.25","2.25","Crystal Structure of human phosphodiesterase 10 in complex with ethyl N-[[4-[[4-(azetidine-1-carbonyl)-2-methylpyrazole-3-carbonyl]amino]-6-methylpyridin-2-yl]carbamothioyl]carbamate","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJP"
"5SJQ",,"X-RAY DIFFRACTION",2.63,53.18,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJQ",158.78,"2.12","2.12","Crystal Structure of human phosphodiesterase 10 in complex with 6-chloro-2,3-dimethylquinoxaline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJQ"
"5SJR",,"X-RAY DIFFRACTION",2.64,53.35,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJR",160.05,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with (2R)-2-[[3-cyano-2-[4-(2-ethoxyphenyl)phenyl]-6-fluoroquinolin-4-yl]amino]propanoic acid","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJR"
"5SJS",,"X-RAY DIFFRACTION",2.61,52.94,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJS",159.75,"2.7","2.7","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[4-(dimethylcarbamoyl)pyridin-3-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJS"
"5SJT",,"X-RAY DIFFRACTION",2.6,52.7,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJT",160.82,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 4-N,4-N,2-trimethyl-3-N-(2-phenylimidazo[1,2-a]pyridin-7-yl)pyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJT"
"5SJU",,"X-RAY DIFFRACTION",2.65,53.51,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJU",159.77,"1.97","1.97","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[4-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]-3-(pyrimidin-5-ylamino)pyrazine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJU"
"5SJV",,"X-RAY DIFFRACTION",2.67,53.94,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJV",159.27,"1.94","1.94","Crystal Structure of human phosphodiesterase 10 in complex with 5-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]quinoxaline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJV"
"5SJW",,"X-RAY DIFFRACTION",2.62,53.1,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJW",159.71,"1.95","1.95","Crystal Structure of human phosphodiesterase 10 in complex with 4-chloro-2-(2-methylpropyl)-N-(2-phenyl-1H-benzimidazol-5-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJW"
"5SJX",,"X-RAY DIFFRACTION",2.65,53.58,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJX",159.77,"2.06","2.06","Crystal Structure of human phosphodiesterase 10 in complex with 2-[[4-(1-methyl-4-pyridin-4-ylpyrazol-3-yl)phenoxy]methyl]quinoline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJX"
"5SJY",,"X-RAY DIFFRACTION",2.67,53.87,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJY",159.66,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with 4-bromo-2,5-dimethyl-N-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJY"
"5SJZ",,"X-RAY DIFFRACTION",2.63,53.25,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SJZ",159.71,"2.19","2.19","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-(morpholine-4-carbonyl)-N-(2-pyrrolidin-1-yl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SJZ"
"5SK0",,"X-RAY DIFFRACTION",2.7,54.37,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SK0",159.54,"2.02","2.02","Crystal Structure of human phosphodiesterase 10 in complex with N-[(3R)-1-(5-chloropyridin-2-yl)pyrrolidin-3-yl]-1-methyl-4-pyridin-4-ylpyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SK0"
"5SK1",,"X-RAY DIFFRACTION",2.6,52.73,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SK1",159.55,"2.3","2.3","Crystal Structure of human phosphodiesterase 10 in complex with 4-N,2-dimethyl-3-N-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)pyrazole-3,4-dicarboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SK1"
"5SK2",,"X-RAY DIFFRACTION",2.63,53.26,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SK2",159.41,"2.14","2.14","Crystal Structure of human phosphodiesterase 10 in complex with 2-(4-fluorophenyl)-4-(2-isoquinolin-3-yloxyethyl)-5-methyl-1,3-oxazole","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SK2"
"5SK3",,"X-RAY DIFFRACTION",2.63,53.25,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SK3",159.49,"2.32","2.32","Crystal Structure of human phosphodiesterase 10 in complex with [2-cyclopropyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]imidazo[1,2-b]pyridazin-3-yl]methanol","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SK3"
"5SK4",,"X-RAY DIFFRACTION",2.64,53.35,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SK4",159.66,"2","2","Crystal Structure of human phosphodiesterase 10 in complex with 6-methyl-3-(2-phenylpyrazol-3-yl)-1-[3-(trifluoromethoxy)phenyl]pyridazin-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SK4"
"5SK5",,"X-RAY DIFFRACTION",2.63,53.18,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SK5",159.83,"1.95","1.95","Crystal Structure of human phosphodiesterase 10 in complex with 2-methyl-4-(morpholine-4-carbonyl)-N-(2-phenylimidazo[1,2-a]pyridin-7-yl)pyrazole-3-carboxamide, space group H3","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SK5"
"5SK6",,"X-RAY DIFFRACTION",2.62,53.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SK6",159.71,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-N-[3-(1,3-benzoxazol-2-yl)phenyl]-2-methylpyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SK6"
"5SK7",,"X-RAY DIFFRACTION",2.61,52.95,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SK7",159.14,"2.29","2.29","Crystal Structure of human phosphodiesterase 10 in complex with 7-bromo-N,N-dimethyl-[1,2,4]triazolo[1,5-a]pyridin-2-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SK7"
"5SK8",,"X-RAY DIFFRACTION",2.97,58.58,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SK8",39.96,"2.3","2.3","Crystal Structure of human phosphodiesterase 10 in complex with 4-chloro-N-(2-phenyl-1H-benzimidazol-5-yl)-2-propylpyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SK8"
"5SK9",,"X-RAY DIFFRACTION",2.64,53.4,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SK9",158.54,"2.82","2.82","Crystal Structure of human phosphodiesterase 10 in complex with 2-chloro-5-methoxy-3-methylquinoxaline","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SK9"
"5SKA",,"X-RAY DIFFRACTION",2.62,53.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKA",159.44,"2.21","2.21","Crystal Structure of human phosphodiesterase 10 in complex with 7-[(4-ethoxy-5-methylpyridin-2-yl)methylsulfanyl]-6H-imidazo[4,5-g][1,3]benzothiazole","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKA"
"5SKB",,"X-RAY DIFFRACTION",2.62,53.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKB",158.66,"2.35","2.35","Crystal Structure of human phosphodiesterase 10 in complex with 9-methoxy-3,5-dihydropyrimido[5,4-b]indol-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKB"
"5SKC",,"X-RAY DIFFRACTION",2.69,54.33,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKC",159.36,"2.6","2.6","Crystal Structure of human phosphodiesterase 10 in complex with 6-methyl-N-(1-propan-2-ylpyrazol-3-yl)-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKC"
"5SKD",,"X-RAY DIFFRACTION",2.64,53.36,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKD",160.97,"2.3","2.3","Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(2,5-difluorophenyl)pyrazol-3-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKD"
"5SKE",,"X-RAY DIFFRACTION",2.62,53.02,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKE",159.74,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with 2-tert-butyl-5-(pyrimidin-5-ylamino)-N-[3-(trifluoromethoxy)phenyl]pyrimidine-4-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKE"
"5SKF",,"X-RAY DIFFRACTION",2.61,52.86,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKF",160.94,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 3-[5-[1-(2,2-difluoro-1,3-benzodioxol-4-yl)-4-oxopyridazin-3-yl]pyrazol-1-yl]benzonitrile","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKF"
"5SKG",,"X-RAY DIFFRACTION",2.62,53.12,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKG",159.63,"2.03","2.03","Crystal Structure of human phosphodiesterase 10 in complex with 2-chloro-6-(cyclopropylamino)-N-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyridine-4-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKG"
"5SKH",,"X-RAY DIFFRACTION",2.61,52.91,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKH",160.93,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with 3-[2-(3-fluorophenyl)pyrazol-3-yl]-1-[3-(trifluoromethoxy)phenyl]pyridazin-4-one","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKH"
"5SKI",,"X-RAY DIFFRACTION",2.63,53.15,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKI",159.35,"2.16","2.16","Crystal Structure of human phosphodiesterase 10 in complex with N-[(5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)methyl]-2-methyl-5-phenyl-1,2,4-triazol-3-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKI"
"5SKJ",,"X-RAY DIFFRACTION",2.6,52.74,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKJ",159.22,"2.74","2.74","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[2-[2-(methylamino)-2-oxoethyl]phenyl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKJ"
"5SKK",,"X-RAY DIFFRACTION",2.62,53.05,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKK",159.71,"2.15","2.15","Crystal Structure of human phosphodiesterase 10 in complex with N-[1-methyl-5-(methylcarbamoyl)pyrazol-4-yl]-6-[(3S)-oxolan-3-yl]-3-(pyrimidin-5-ylamino)pyrazine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKK"
"5SKL",,"X-RAY DIFFRACTION",2.6,52.72,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKL",159.83,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with N-(6-cyano-2-phenylimidazo[1,2-a]pyridin-7-yl)-2-methyl-4-(morpholine-4-carbonyl)pyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKL"
"5SKM",,"X-RAY DIFFRACTION",2.67,53.87,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKM",159.54,"1.91","1.91","Crystal Structure of human phosphodiesterase 10 in complex with 6-chloro-N,N-dimethyl-2-[2-(1-pyridin-2-ylpyrrolidin-3-yl)ethyl]quinazolin-4-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKM"
"5SKN",,"X-RAY DIFFRACTION",2.64,53.35,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKN",159.64,"1.9","1.9","Crystal Structure of human phosphodiesterase 10 in complex with N-[3-[3-[2-(2-fluorophenyl)pyrazol-3-yl]-4-oxopyridazin-1-yl]phenyl]acetamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKN"
"5SKO",,"X-RAY DIFFRACTION",3.05,59.61,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKO",40.02,"2.1","2.1","Crystal Structure of human phosphodiesterase 10 in complex with N-(3-imidazo[1,2-a]pyridin-2-ylphenyl)-1-methyl-3-(pyrimidin-5-ylamino)pyrazole-4-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKO"
"5SKP",,"X-RAY DIFFRACTION",2.67,53.92,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKP",159.83,"2","2","Crystal Structure of human phosphodiesterase 10 in complex with [4-(2-methoxyphenyl)piperazin-1-yl]-(3-methyl-1-phenylthieno[2,3-c]pyrazol-5-yl)methanone","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKP"
"5SKQ",,"X-RAY DIFFRACTION",2.63,53.31,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKQ",159.01,"2","2","Crystal Structure of human phosphodiesterase 10 in complex with N-ethyl-6-(4-fluorophenyl)sulfanyl-N-methyl-9H-purin-2-amine","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKQ"
"5SKR",,"X-RAY DIFFRACTION",2.64,53.34,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKR",159.45,"1.99","1.99","Crystal Structure of human phosphodiesterase 10 in complex with 1-methyl-N-(2-methyl-5-pyridin-2-ylpyrazol-3-yl)-4-pyridin-4-ylpyrazole-3-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKR"
"5SKS",,"X-RAY DIFFRACTION",2.61,52.94,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKS",160,"2.31","2.31","Crystal Structure of human phosphodiesterase 10 in complex with ethyl 1-[3-[3-(4-ethoxycarbonyl-5-methyl-imidazol-1-yl)phenoxy]phenyl]-5-methyl-imidazole-4-carboxylate","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKS"
"5SKT",,"X-RAY DIFFRACTION",2.63,53.25,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKT",159.15,"2.02","2.02","Crystal Structure of human phosphodiesterase 10 in complex with 7-(cyclopropylmethoxy)-2-methyl-4-pyrrolidin-1-ylquinazoline:hydrochloride","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKT"
"5SKU",,"X-RAY DIFFRACTION",2.62,53.06,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKU",159.99,"2.2","2.2","Crystal Structure of human phosphodiesterase 10 in complex with 3-[4-[2-[2-(2-ethoxy-4-fluorophenyl)-5-methyl-1,3-oxazol-4-yl]ethoxy]naphthalen-1-yl]-2-methoxypropanoic acid","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKU"
"5SKV",,"X-RAY DIFFRACTION",2.62,53.09,"VAPOR DIFFUSION, SITTING DROP",7.5,"5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2",295,,,"5SKV",159.81,"2.6","2.6","Crystal Structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-N-[3-[(2-hydroxy-2-methylpropyl)carbamoyl]-1-methylpyrazol-4-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide","GSSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5SKV"
"5SUN",,"X-RAY DIFFRACTION",2.75,55.23,"EVAPORATION",7.5,"27% PEG3350, 0.22M lithium sulfate",293,"10.1016/j.str.2016.12.017","70Q","5SUN",96.91,"2.477","2.477","IDH1 R132H in complex with IDH146","GPGMSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","5SUN"
"5SUR",,"X-RAY DIFFRACTION",3.13,60.76,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris buffer at pH 7.83, 0.2 M MgCl2, 3.32 M 1,6-hexanediol",296.15,,,"5SUR",7.73,"1.801","1.801","X-ray crystallographic structure of a covalent trimer derived from A-beta 17_36. Synchrotron data set. (ORN)CVF(MEA)CED(ORN)AIIGL(ORN)V.","ACVFFCEDAAIIGLAV","Homo sapiens",,"16mer A-beta peptide: ORN-CYS-VAL-PHE-MEA-CYS-GLU-ASP-ORN-ALA-ILE-ILE-GLY-LEU-ORN-VAL","1","5SUR"
"5SUS",,"X-RAY DIFFRACTION",3.09,60.13,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris buffer at pH 7.7, 0.2 M MgCl2, 3.45 M 1,6-hexanediol",296.15,,,"5SUS",7.2,"2.349","2.349","X-ray crystallographic structure of a covalent trimer derived from A-beta 17_36. X-ray diffractometer data set. (ORN)CVF(MEA)CED(ORN)AIIGL(ORN)V.","ACVFFCEDAAIIGLAV","Homo sapiens",,"16mer A-beta peptide: ORN-CYS-VAL-PHE-MEA-CYS-GLU-ASP-ORN-ALA-ILE-ILE-GLY-LEU-ORN-VAL","1","5SUS"
"5SUT",,"X-RAY DIFFRACTION",2.13,42.17,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES buffer at pH 7.3, 34% Jeffamine M-600",298,,,"5SUT",3.61,"1.902","1.902","X-ray crystallographic structure of a covalent trimer derived from A-beta 17_36. Synchrotron data set. (ORN)CVFFCED(ORN)AII(SAR)L(ORN)V.","ACVFFCEDAAIIGLAV","Homo sapiens",,"16mer A-beta peptide: ORN-CYS-VAL-PHE-PHE-CYS-GLU-ASP-ORN-ALA-ILE-ILE-SAR-LEU-ORN-VAL","1","5SUT"
"5SUU",,"X-RAY DIFFRACTION",2.2,44.2,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES buffer at pH 6.5, 32% Jeffamine M-600",298,,,"5SUU",3.84,"2.032","2.032","X-ray crystallographic structure of a covalent trimer derived from A-beta 17-36. X-ray diffractometer data set. (ORN)CVFFCED(ORN)AII(SAR)L(ORN)V.","ACVFFCEDAAIIGLAV","Homo sapiens",,"16mer A-beta peptide: ORN-CYS-VAL-PHE-PHE-CYS-GLU-ASP-ORN-ALA-ILE-ILE-SAR-LEU-ORN-VAL","1","5SUU"
"5SUY",,"X-RAY DIFFRACTION",2.51,50.91,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MES
0.1 M NaCl
0.1 M Li2SO4
22-26% PEG400",293,"10.1016/j.molcel.2016.08.026",,"5SUY",43.67,"1.88","1.88","Domain-swapped dimer of human Dishevelled2 DEP domain: monoclinic crystal form crystallised from dimeric fraction","SSGLSVHTDMASVTKAMAAPESGLEVRDRMWLKITIPNAFLGSDVVDWLYHHVEGFPERREARKYASGLLKAGLIRHTVNKITFSEQCYYVFGDLSG","Homo sapiens","DVL2","Segment polarity protein dishevelled homolog DVL-2","1","5SUY"
"5SUZ",,"X-RAY DIFFRACTION",2.45,49.78,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES, pH=6.5
0.2 M CaCl2
23% PEG350 MME",298,"10.1016/j.molcel.2016.08.026",,"5SUZ",21.69,"1.84","1.84","Domain-swapped dimer of human Dishevelled2 DEP domain: C-centered monoclinic crystal form crystallised from monomeric fraction","SGLSVHTDMASVTKAMAAPESGLEVRDRMWLKITIPNAFLGSDVVDWLYHHVEGFPERREARKYASGLLKAGLIRHTVNKITFSEQCYYVFGDLS","Homo sapiens","DVL2","Segment polarity protein dishevelled homolog DVL-2","1","5SUZ"
"5SV7",,"X-RAY DIFFRACTION",3.35,63.27,"VAPOR DIFFUSION, HANGING DROP",6,"MES 0.1M, PEG 3350",293,"10.1107/S2059798316018064",,"5SV7",146.1,"3.209","3.209","The Crystal structure of a chaperone","ETELRPRGRSLVIISTLDGRIAALDPENHGKKQWDLDVGSGSLVSSSLSKPEVFGNKMIIPSLDGALFQWDQDRESMETVPFTVESLLESSYKFGDDVVLVGGKSLTTYGLSAYSGKVRYICSALGCRQWDSDEMEQEEDILLLQRTQKTVRAVGPRSGNEKWNFSVGHFELRYIPDMETRAGFIESTFKPNENTEESKIISDVEEQEAAIMDIVIKVSVADWKVMAFSKKGGHLEWEYQFCTPIASAWLLKDGKVIPISLFDDTSYTSNDDVLEDEEDIVEAARGATENSVYLGMYRGQLYLQSSVRISEKFPSSPKALESVTNE","Homo sapiens","EIF2AK3, PEK, PERK","Eukaryotic translation initiation factor 2-alpha kinase 3","1","5SV7"
"5SVF",,"X-RAY DIFFRACTION",2.76,55.42,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Bis-Tris pH6.5, 1.45M tri-sodium citrate dihydrate",293,"10.1016/j.str.2016.12.017","70P","5SVF",192.69,"2.34","2.34","IDH1 R132H in complex with IDH125","GPGMSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","5SVF"
"5SVJ",,"X-RAY DIFFRACTION",4.01,69.32,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 400, 100 mM MES, pH 6.85, 50 mM MgCl2",277.15,"10.1038/nature19367",,"5SVJ",41.71,"2.984","2.984","Crystal structure of the ATP-gated human P2X3 ion channel in the closed, apo state","GSRADFFTYETPKVIVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNET","Homo sapiens","P2RX3","P2X purinoceptor 3","1","5SVJ"
"5SVK",,"X-RAY DIFFRACTION",5.36,77.04,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 400, 50 mM ADA, pH 6.5",277.15,"10.1038/nature19367","ATP","5SVK",85.74,"2.773","2.773","Crystal structure of the ATP-gated human P2X3 ion channel in the ATP-bound, open state","GSRADFFTYETPKVIVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNET","Homo sapiens","P2RX3","P2X purinoceptor 3","1","5SVK"
"5SVL",,"X-RAY DIFFRACTION",5.27,76.65,"VAPOR DIFFUSION, HANGING DROP",,"21% PEG 400, 100 mM Tris, pH 8.0, 325 mM Sodium Acetate, 100 mM NaCl",277.15,"10.1038/nature19367","ATP","5SVL",84.87,"2.9","2.9","Crystal structure of the ATP-gated human P2X3 ion channel in the ATP-bound, closed (desensitized) state","GSRADFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNET","Homo sapiens","P2RX3","P2X purinoceptor 3","1","5SVL"
"5SVM",,"X-RAY DIFFRACTION",5.31,76.85,"VAPOR DIFFUSION, HANGING DROP",,"21% PEG 400, 100 mM Tris, pH 8.0, 325 mM Sodium Acetate, 100 mM NaCl",277.15,"10.1038/nature19367","6AT, ATP","5SVM",84.13,"3.093","3.093","Crystal structure of the ATP-gated human P2X3 ion channel bound to agonist 2-methylthio-ATP in the desensitized state","GSRADFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNET","Homo sapiens","P2RX3","P2X purinoceptor 3","1","5SVM"
"5SVN",,"X-RAY DIFFRACTION",2.16,43.01,"VAPOR DIFFUSION",,"50mM Bis-Tris pH6.5, 45% PEG400",298,"10.1016/j.str.2016.12.017",,"5SVN",97.88,"2.1","2.1","Structure of IDH2 mutant R172K","ADKRIKVAKPVVEMDGDEMTRIIWQFIKEKLILPHVDIQLKYFDLGLPNRDQTDDQVTIDSALATQKYSVAVKCATITPDEARVEEFKLKKMWKSPNGTIRNILGGTVFREPIICKNIPRLVPGWTKPITIGKHAHGDQYKATDFVADRAGTFKMVFTPKDGSGVKEWEVYNFPAGGVGMGMYNTDESISGFAHSCFQYAIQKKWPLYMSTKNTILKAYDGRFKDIFQEIFDKHYKTDFDKNKIWYEHRLIDDMVAQVLKSSGGFVWACKNYDGDVQSDILAQGFGSLGLMTSVLVCPDGKTIEAEAAHGTVTRHYREHQKGRPTSTNPIASIFAWTRGLEHRGKLDGNQDLIRFAQMLEKVCVETVESGAMTKDLAGCIHGLSNVKLNEHFLNTTDFLDTIKSNLDRALGRQSLEHHHHHHHH","Homo sapiens","IDH2","Isocitrate dehydrogenase [NADP], mitochondrial","1","5SVN"
"5SVO",,"X-RAY DIFFRACTION",2.32,46.93,"VAPOR DIFFUSION",,"0.1M Hepes pH7.5, 0.2M NaCl, 25% (w/v) PEG3350",277,"10.1016/j.str.2016.12.017",,"5SVO",97.9,"1.87","1.87","Structure of IDH2 mutant R140Q","ADKRIKVAKPVVEMDGDEMTRIIWQFIKEKLILPHVDIQLKYFDLGLPNRDQTDDQVTIDSALATQKYSVAVKCATITPDEARVEEFKLKKMWKSPNGTIQNILGGTVFREPIICKNIPRLVPGWTKPITIGRHAHGDQYKATDFVADRAGTFKMVFTPKDGSGVKEWEVYNFPAGGVGMGMYNTDESISGFAHSCFQYAIQKKWPLYMSTKNTILKAYDGRFKDIFQEIFDKHYKTDFDKNKIWYEHRLIDDMVAQVLKSSGGFVWACKNYDGDVQSDILAQGFGSLGLMTSVLVCPDGKTIEAEAAHGTVTRHYREHQKGRPTSTNPIASIFAWTRGLEHRGKLDGNQDLIRFAQMLEKVCVETVESGAMTKDLAGCIHGLSNVKLNEHFLNTTDFLDTIKSNLDRALGRQSLEHHHHHHHH","Homo sapiens","IDH2","Isocitrate dehydrogenase [NADP], mitochondrial","1","5SVO"
"5SVP",,"X-RAY DIFFRACTION",5.34,76.97,"VAPOR DIFFUSION, HANGING DROP",,"21% PEG 400,
100 mM Tris, pH 8.0,
325 mM Sodium Acetate,
100 mM NaCl",277.15,"10.1038/nature19367","ATP, 6AT","5SVP",84.13,"3.298","3.298","Anomalous sulfur signal reveals the position of agonist 2-methylthio-ATP bound to the ATP-gated human P2X3 ion channel in the desensitized state","GSRADFFTYETTKSVVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNET","Homo sapiens","P2RX3","P2X purinoceptor 3","1","5SVP"
"5SVQ",,"X-RAY DIFFRACTION",4.02,69.38,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 400, 100 mM MES, pH 6.85, 50 mM MgCl2",277.15,"10.1038/nature19367",,"5SVQ",42.18,"3.25","3.25","Crystal structure of the ATP-gated human P2X3 ion channel bound to competitive antagonist TNP-ATP","GSRADFFTYETPKVIVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNET","Homo sapiens","P2RX3","P2X purinoceptor 3","1","5SVQ"
"5SVR",,"X-RAY DIFFRACTION",4.25,71.05,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 400, 100 mM Glycine, pH 8.5, 150 mM MgCl2",277.15,"10.1038/nature19367","71C","5SVR",41.8,"3.13","3.13","Crystal structure of the ATP-gated human P2X3 ion channel bound to competitive antagonist A-317491","GSRADFFTYETPKVIVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNET","Homo sapiens","P2RX3","P2X purinoceptor 3","1","5SVR"
"5SVS",,"X-RAY DIFFRACTION",4.01,69.29,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 400, 100 mM MES, pH 6.85, 50 mM MnCl2",277.15,"10.1038/nature19367",,"5SVS",41.71,"4.025","4.025","Anomalous Mn2+ signal reveals a divalent cation-binding site in the head domain of the ATP-gated human P2X3 ion channel","GSRADFFTYETPKVIVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNET","Homo sapiens","P2RX3","P2X purinoceptor 3","1","5SVS"
"5SVT",,"X-RAY DIFFRACTION",3.99,69.18,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 400, 100 mM MES, pH 6.85, 50 mM MgCl2, 100 mM CsCl",277.15,"10.1038/nature19367",,"5SVT",41.46,"3.794","3.794","Anomalous Cs+ signal reveals the site of Na+ ion entry to the channel pore of the human P2X3 ion channel through the extracellular fenestrations","GSRADFFTYETPKVIVVKSWTIGIINRVVQLLIISYFVGWVFLHEKAYQVRDTAIESSVVTKVKGSGLYANRVMDVSDYVTPPQGTSVFVIITKMIVTENQMQGFCPESEEKYRCVSDSQCGPERLPGGGILTGRCVNYSSVLRTCEIQGWCPTEVDTVETPIMMEAENFTIFIKNSIRFPLFNFEKGNLLPNLTARDMKTCRFHPDKDPFCPILRVGDVVKFAGQDFAKLARTGGVLGIKIGWVCDLDKAWDQCIPKYSFTRLDSVSEKSSVSPGYNFRFAKYYKMENGSEYRTLLKAFGIRFDVLVYGNAGKFNIIPTIISSVAAFTSVGVGTVLCDIILLNFLKGADQYKAKKFEEVNET","Homo sapiens","P2RX3","P2X purinoceptor 3","1","5SVT"
"5SXG",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350",293,"10.1038/s41598-017-17694-3",,"5SXG",44.3,"1.93","1.93","Crystal Structure of the Cancer Genomic DNA Mutator APOBEC3B","SEILRYLMDPDTFTSNFNNDPLVLRRRQTYLCYEVERLDNGTSVKMDQHMGFLCNESGRHAELRFLDLVPSLQLDPAQIYRVTWFISWSPCFSWGCAGEVRAFLQENTHVRLRIKAARIYDYDPLYKEALQMLRDAGAQVSIMTYDEFEYCWDTFVYRQGCPFQPWDGLEEHSQALSGRLRAILQ","Homo sapiens","APOBEC3B","DNA dC->dU-editing enzyme APOBEC-3B","1","5SXG"
"5SXH",,"X-RAY DIFFRACTION",2.06,40.25,"VAPOR DIFFUSION, SITTING DROP",,"PEG3350",283,"10.1038/s41598-017-17694-3",,"5SXH",43.96,"1.78","1.78","Crystal Structure of the Cancer Genomic DNA Mutator APOBEC3B","SEILRYLMDPDTFTSNFNNDPLVLRRRQTYLCYEVERLDNGTSVKMDQHMGFLCNESGRHAELRFLDLVPSLQLDPAQIYRVTWFISWSPCFSWGCAGEVRAFLQENTHVRLRIKAARIYDYDPLYKEALQMLRDAGAQVSIMTYDEFEYCWDTFVYRQGCPFQPWDGLEEHSQALSGRLRAILQ","Homo sapiens","APOBEC3B","DNA dC->dU-editing enzyme APOBEC-3B","1","5SXH"
"5SXN",,"X-RAY DIFFRACTION",3.08,60.12,"VAPOR DIFFUSION, SITTING DROP",7.9,"23% PEG600, 0.06M citrate, 0.04M citric acid",293,"10.1016/j.bmc.2016.09.030","74U","5SXN",75.62,"2.1","2.1","Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors","TLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","5SXN"
"5SY2",,"X-RAY DIFFRACTION",2.92,57.86,"VAPOR DIFFUSION, SITTING DROP",7.9,"23% PEG600, 0.06M citrate, 0.04M citric acid",293,"10.1016/j.bmc.2016.09.030","74V","5SY2",76.21,"2.25","2.25","Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors","LTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","5SY2"
"5SY3",,"X-RAY DIFFRACTION",3.02,59.33,"VAPOR DIFFUSION, SITTING DROP",7.9,"23% PEG600, 0.06M citrate, 0.04M citric acid",293,"10.1016/j.bmc.2016.09.030","74Z","5SY3",76.87,"2.3","2.3","Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors","TLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","5SY3"
"5SY6",,"X-RAY DIFFRACTION",3.06,59.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"23-27% PEG 3000, 100 mM HEPES, 200 mM NaCl, 10 mM dithiothreitol (DTT)",298,"10.1021/acs.biochem.6b00906",,"5SY6",20.35,"1.15","1.15","Atomic resolution structure of human DJ-1, DTT bound","GSHMASKRALVILAKGAEEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein deglycase DJ-1","1","5SY6"
"5SY9",,"X-RAY DIFFRACTION",2.83,56.52,"VAPOR DIFFUSION, SITTING DROP",8.5,"25-28% PEG 4000, 0.1 M Tris HCl, 0.1 M sodium citrate",298,"10.1021/acs.biochem.6b00906",,"5SY9",20.54,"1.1","1.1","Atomic resolution structure of E15Q mutant human DJ-1","GSHMASKRALVILAKGAQEMETVIPVDVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein deglycase DJ-1","1","5SY9"
"5SYA",,"X-RAY DIFFRACTION",3.02,59.28,"VAPOR DIFFUSION, SITTING DROP",8.5,"23-27% polyethylene glycol (PEG) 4000, 0.2 M Sodium Citrate, and 0.1 M Tris HCl",298,"10.1021/acs.biochem.6b00906",,"5SYA",20.35,"1.1","1.1","Atomic resolution structure of D24N mutant human DJ-1","GSHMASKRALVILAKGAEEMETVIPVNVMRRAGIKVTVAGLAGKDPVQCSRDVVICPDASLEDAKKEGPYDVVVLPGGNLGAQNLSESAAVKEILKEQENRKGLIAAICAGPTALLAHEIGFGSKVTTHPLAKDKMMNGGHYTYSENRVEKDGLILTSRGPGTSFEFALAIVEALNGKEVAAQVKAPLVLKD","Homo sapiens","PARK7","Protein deglycase DJ-1","1","5SYA"
"5SYB",,"X-RAY DIFFRACTION",1.83,32.77,"VAPOR DIFFUSION, HANGING DROP",,"100mM CHES pH9.5
0.8mM Sodium Citrate
0.5% beta-OG",298,"10.1038/ncomms15522",,"5SYB",25.97,"1.82","1.82","Crystal structure of human PHF5A","GGHMAKHHPDLIFCRKQAGVAIGRLCEKCDGKCVICDSYVRPSTLVRICDECNYGSYQGRCVICGGPGVSDAYYCKECTIQEKDRDGCPKIVNLGSSKTDLFYERKKYGFKKR","Homo sapiens","PHF5A","PHD finger-like domain-containing protein 5A","1","5SYB"
"5SYM",,"X-RAY DIFFRACTION",2.19,43.77,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1M sodium citrate, 22-24% PEG 3350, 200 mM MgCl2",293,"10.1021/acschembio.6b00720","71Q","5SYM",50.79,"1.55","1.55","Cocrystal structure of the human acyl protein thioesterase 1 with an isoform-selective inhibitor, ML348","MCGNNMSTPLPAIVPAARKATAAVIFLHGLGDTGHGWAEAFAGIRSSHIKYICPHAPVRPVTLNMNVAMPSWFDIIGLSPDSQEDESGIKQAAENIKALIDQEVKNGIPSNRIILGGFSQGGALSLYTALTTQQKLAGVTALSCWLPLRASFPQGPIGGANRDISILQCHGDCDPLVPLMFGSLTVEKLKTLVNPANVTFKTYEGMMHSSCQQEMMDVKQFIDKLLPPID","Homo sapiens","LYPLA1, APT1, LPL1","Acyl-protein thioesterase 1","1","5SYM"
"5SYN",,"X-RAY DIFFRACTION",2.18,43.56,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 mM sodium citrate pH 5.5, 20-24% PEG 3350.",293,"10.1021/acschembio.6b00720","71T","5SYN",101.25,"1.64","1.64","Cocrystal structure of the human acyl protein thioesterase 2 with an isoform-selective inhibitor, ML349","MCGNTMSVPLLTDAATVSGAERETAAVIFLHGLGDTGHSWADALSTIRLPHVKYICPHAPRIPVTLNMKMVMPSWFDLMGLSPDAPEDEAGIKKAAENIKALIEHEMKNGIPANRIVLGGFSQGGALSLYTALTCPHPLAGIVALSCWLPLHRAFPQAANGSAKDLAILQCHGELDPMVPVRFGALTAEKLRSVVTPARVQFKTYPGVMHSSCPQEMAAVKEFLEKLLPPV","Homo sapiens","LYPLA2, APT2","Acyl-protein thioesterase 2","1","5SYN"
"5SYT",,"X-RAY DIFFRACTION",3.83,67.87,"VAPOR DIFFUSION",7.5,"24% PEG3350, 170 mM ammonium sulfate, 15% glycerol, 50 mM HEPES, pH 7.5",286,"10.1002/pro.3074",,"5SYT",60.96,"2","2","Crystal Structure of ZMPSTE24","MGMWASLDALWEMPAEKRIFGAVLLFSWTVYLWETFLAQRQRRIYKTTTHVPPELGQIMDSETFEKSRLYQLDKSTFSFWSGLYSETEGTLILLFGGIPYLWRLSGRFCGYAGFGPEYEITQSLVFLLLATLFSALTGLPWSLYNTFVIEEKHGFNQQTLGFFMKDAIKKFVVTQCILLPVSSLLLYIIKIGGDYFFIYAWLFTLVVSLVLVTIYADYIAPLFDKFTPLPEGKLKEEIEVMAKSIDFPLTKVYVVEGSKRSSHSNAYFYGFFKNKRIVLFDTLLEEYSVLNKDIQEDSGMEPRNEEEGNSEEIKAKVKNKKQGCKNEEVLAVLGHELGHWKLGHTVKNIIISQMNSFLCFFLFAVLIGRKELFAAFGFYDSQPTLIGLLIIFQFIFSPYNEVLSFCLTVLSRRFEFQADAFAKKLGKAKDLYSALIKLNKDNLGFPVSDWLFSMWHYSHPPLLERLQALKTMKQSGLEVL","Homo sapiens","ZMPSTE24, FACE1, STE24","CAAX prenyl protease 1 homolog","1","5SYT"
"5SZ0",,"X-RAY DIFFRACTION",2.1,41.39,"VAPOR DIFFUSION, SITTING DROP",,"1.6M Sodium Citrate, 50mM Tris pH 7.8",296,"10.1002/cbic.201600513","72D","5SZ0",29.31,"1.63","1.63","Carbonic anhydrase II in complex with 4-(phenyl)-benzenesulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5SZ0"
"5SZ1",,"X-RAY DIFFRACTION",2.1,41.39,"VAPOR DIFFUSION, SITTING DROP",,"1.6M Sodium Citrate, 50mM Tris pH 7.8",296,"10.1002/cbic.201600513","72E","5SZ1",29.66,"1.55","1.55","Carbonic anhydrase II in complex with 4-(2-methylphenyl)-benzenesulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5SZ1"
"5SZ2",,"X-RAY DIFFRACTION",2.11,41.72,"VAPOR DIFFUSION, SITTING DROP",,"1.6M Sodium Citrate, 50mM Tris pH 7.8",296,"10.1002/cbic.201600513","72G","5SZ2",29.93,"1.63","1.63","Carbonic anhydrase II in complex with 4-(3-formylphenyl)-benzenesulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5SZ2"
"5SZ3",,"X-RAY DIFFRACTION",2.11,41.64,"VAPOR DIFFUSION, SITTING DROP",,"1.6M Sodium Citrate, 50mM Tris pH 7.8",296,"10.1002/cbic.201600513","72H","5SZ3",29.67,"1.689","1.689","Carbonic anhydrase II in complex with 4-(3-quinolinyl)-benzenesulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5SZ3"
"5SZ4",,"X-RAY DIFFRACTION",2.12,41.84,"VAPOR DIFFUSION, SITTING DROP",,"1.6M Sodium Citrate, 50mM Tris pH 7.8",296,"10.1002/cbic.201600513","72D","5SZ4",29.3,"1.6","1.6","Carbonic anhydrase IX-mimic in complex with 4-(phenyl)-benzenesulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5SZ4"
"5SZ5",,"X-RAY DIFFRACTION",2.11,41.81,"VAPOR DIFFUSION, SITTING DROP",,"1.6M Sodium Citrate, 50mM Tris pH 7.8",296,"10.1002/cbic.201600513","72E","5SZ5",29.24,"1.274","1.274","Carbonic anhydrase IX-mimic in complex with 4-(2-methylphenyl)-benzenesulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5SZ5"
"5SZ6",,"X-RAY DIFFRACTION",2.12,41.96,"VAPOR DIFFUSION, SITTING DROP",,"1.6M Sodium Citrate, 50mM Tris pH 7.8",296,"10.1002/cbic.201600513","72G","5SZ6",29.42,"1.15","1.15","Carbonic anhydrase IX-mimic in complex with 4-(3-formylphenyl)-benzenesulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5SZ6"
"5SZ7",,"X-RAY DIFFRACTION",2.11,41.66,"VAPOR DIFFUSION, SITTING DROP",,"1.6M Sodium Citrate, 50mM Tris pH 7.8",296,"10.1002/cbic.201600513","72H","5SZ7",29.51,"1.776","1.776","Carbonic anhydrase IX-mimic in complex with 4-(3-quinolinyl)-benzenesulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5SZ7"
"5SZ9",,"X-RAY DIFFRACTION",3.09,60.14,"VAPOR DIFFUSION, SITTING DROP",7.9,"23% PEG600, 0.06M citrate, 0.04M citric acid",293,"10.1016/j.bmc.2016.09.030","74Y","5SZ9",75.95,"2.85","2.85","Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors","TLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","5SZ9"
"5SZF",,"X-RAY DIFFRACTION",3.8,67.6,"VAPOR DIFFUSION, HANGING DROP",,"2M Ammonium sulfate
0.1 M trisodium citrate
pH 5.5",277.15,"10.1371/journal.ppat.1006469",,"5SZF",47.54,"2.52","2.52","2A10 FAB fragment 2.54 Angstoms","DIQMTQTTSSLSASLGDRVTISCSASQGISNYLNWYQQKPDGTVKLLIFYTSTLYSGVPSRFSGSGSGTDYSLTISNLEPEDIATYYCQQYSRFPYVFGGGTKLEIKRADAAPTVSIFPPSSEQLTSGGASVVCFLNNFYPKDINVKWKIDGSERQNGVLNSWTDQDSKDSTYSMSSTLTLTKDEYERHNSYTCEATHKTSTSPIVKSFNRN","Homo sapiens",,"2A10 antibody FAB fragment light chain","1","5SZF"
,,,,,,,,,,,,,,,,"QIQLVQSGPELKKPGETVKISCKASGYTFTNYGINWVKQAPGKGLKWMGWINTITEEPTFAEEFTGRFAFSLETSASTAYLQINNLKNEDTATYFCARGSEFGRLVYWGQGASVTVSSAKTTAPSVYPLAPVCGDTTGSSVTLGCLVKGYFPEPVTLTWNSGSLSSGVHTFPAVLQSDLYTLSSSVTVTSSTWPSQSITCNVAHPASSTKVDKKIEPRGPT","Homo sapiens",,"2A10 antibody FAB fragment heavy chain","2","5SZF"
"5SZG",,"X-RAY DIFFRACTION",2.63,53.32,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris pH 7.0 
50 % PEG 200",293,"10.7554/eLife.18675",,"5SZG",37.29,"2.7","2.7","Structure of the bMERB domain of Mical-3","GKQEELKRLHRAQIIQRQLQQVEERQRRLEERGVAVEKALRGEAGMGKKDDPKLMQEWFKLVQEKNAMVRYESELMIFARELELEDRQSRLQQELRERMAVEDHLKTEEELSEEKQILNEMLEVVEQRDSLVALLEEQRLREREEDKDLEA","Homo sapiens","MICAL3, KIAA0819, KIAA1364","Protein-methionine sulfoxide oxidase MICAL3","1","5SZG"
"5SZW",,"SOLUTION NMR",,,,,,,"10.1007/s10858-018-0217-y",,"5SZW",11.22,,,"NMR solution structure of the RRM1 domain of the post-transcriptional regulator HuR","GHMSNGYEDHMAEDCRGDIGRTNLIVNYLPQNMTQDELRSLFSSIGEVESAKLIRDKVAGHSLGYGFVNYVTAKDAERAINTLNGLRLQSKTIKVSYARPS","Homo sapiens","ELAVL1, HUR","ELAV-like protein 1","1","5SZW"
"5T0N",,"X-RAY DIFFRACTION",3.81,67.75,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M MES pH 6.0, 1.2 M sodium malonate, 1% (w/v) Jeffamine ED 2001",291.15,"10.1126/scisignal.aah4497",,"5T0N",273.46,"3.004","3.004","Pseudo-apo structure of Sestrin2 at 3.0 angstrom resolution","MIVADSECRAELKDYLRFAPGGVGDSGPGEEQRESRARRGPRGPSAFIPVEEVLREGAESLEQHLGLEALMSSGRVDNLAVVMGLHPDYFTSFWRLHYLLLHTDGPLASSWRHYIAIMAAARHQCSYLVGSHMAEFLQTGGDPEWLLGLHRAPEKLRKLSEINKLLAHRPWLITKEHIQALLKTGEHTWSLAELIQALVLLTHCHSLSSFVFGCGILPEGDADGSPAPQAPTPPSEQSSPPSRDPLNNSGGFESARDVEALMERMQQLQESLLRDEGTSQEEMESRFELEKSESLLVTPSADILEPSPHPDMLCFVEDPTFGYEDFTRRGAQAPPTFRAQDYTWEDHGYSLIQRLYPEGGQLLDEKFQAAYSLTYNTIAMHSGVDTSVLRRAIWNYIHCVFGIRYDDYDYGEVNQLLERNLKVYIKTVACYPEKTTRRMYNLFWRHFRHSEKVHVNLLLLEARMQAALLYALRAITRYMT","Homo sapiens","SESN2, Hi95, SEST2","Sestrin-2","1","5T0N"
"5T18",,"X-RAY DIFFRACTION",2.32,46.91,"VAPOR DIFFUSION",7,"25% PEG8K + 3% MEPEG5K + 0.2M TRIS-HCL, PH 7.0",298,"10.1021/acs.jmedchem.6b01088","73T","5T18",31.78,"1.5","1.5","Crystal structure of Bruton agammabulinemia tyrosine kinase complexed with BMS-986142 aka (2s)-6-fluoro-5-[3-(8-fluoro-1-methyl-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)-2-methylphenyl]-2-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1h-carbazole-8-carboxamide","GHMEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","5T18"
"5T19",,"X-RAY DIFFRACTION",3.11,60.4,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MgCl2, 0.1M Bis-Tris pH 6.3-6.5, 23-27% PEG 3350",278,"10.1021/acs.biochem.7b00151",,"5T19",38.02,"2.1001","2.1001","Structure of PTP1B complexed with N-(3'-(1,1-dioxido-4-oxo-1,2,5-thiadiazolidin-2-yl)-4'-methyl-[1,1'-biphenyl]-4-yl)acetamide","GHMEMEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDLEPPPEHIPPPPRPPKRILEPHN","Homo sapiens","PTPN1, PTP1B","Tyrosine-protein phosphatase non-receptor type 1","1","5T19"
"5T1H",,"X-RAY DIFFRACTION",3.16,61.05,"VAPOR DIFFUSION, HANGING DROP",6.5,"22-26% PEG 6K, 200 mM ammonium sulfate, 100 mM MES",293,,,"5T1H",83.37,"2.11","2.11","Crystal structure of CK2","MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQAR","Homo sapiens","CSNK2A1, CK2A1","Casein kinase II subunit alpha","1","5T1H"
"5T1S",,"X-RAY DIFFRACTION",2.81,56.22,"VAPOR DIFFUSION, HANGING DROP",6.4,".80 to 2.0 M Sodium Malonate 0.2 M Sodium Acetate 25 mM Hexamminecobalt(III)chloride 0.05%w/v Pluronic-F-68",289,"10.1016/j.bmcl.2017.04.050","76Q","5T1S",137.47,"2.3","2.3","Irak4 kinase - compound 1 co-structure","VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","5T1S"
"5T1T",,"X-RAY DIFFRACTION",2.78,55.74,"VAPOR DIFFUSION, HANGING DROP",6.4,"1.80 to 2.0 M Sodium Malonate 0.2 M Sodium Acetate 25 mM Hexamminecobalt(III)chloride 0.05%w/v Pluronic-F-68",289,"10.1016/j.bmcl.2017.04.050","76P","5T1T",137.09,"2.34","2.34","Irak4 kinase - compound 1 co-structure","VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","5T1T"
"5T1U",,"X-RAY DIFFRACTION",2.8,56.12,"VAPOR DIFFUSION, HANGING DROP",,"20 - 22.5% (w/v) PEG 5000 monomethylethyl (MME), 200 mM sodium citrate (pH 6.6), 200 mM ammonium iodide).",293,"10.1021/acs.jmedchem.6b01451","P6U","5T1U",47.33,"1.78","1.78","Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESTHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5T1U"
"5T1W",,"X-RAY DIFFRACTION",2.73,54.95,"VAPOR DIFFUSION, HANGING DROP",,"20-22.5% (w/v) PEG 5000 monomethylethyl (MME), 200 mM sodium citrate (pH 6.6), 200 mM ammonium iodide",293,"10.1021/acs.jmedchem.6b01451","74B","5T1W",47.72,"2.96","2.96","Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality","ETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDESTHHHHHH","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5T1W"
"5T21",,"X-RAY DIFFRACTION",3.24,62.04,"VAPOR DIFFUSION, HANGING DROP",,"1.0 to 1.4M Sodium Citrate",277,,"74E","5T21",23.71,"2.1","2.1","CRYSTAL STRUCTURE OF HSP90 IN COMPLEX WITH SAR148019.","HMETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","5T21"
"5T23",,"X-RAY DIFFRACTION",2.81,56.29,"VAPOR DIFFUSION, HANGING DROP",,"100mM Hepes pH 7.7-8.2, 18-19% PEG3350, 175mM (NH4)2SO4, 10mM DTT",293,"10.1016/j.bmcl.2016.11.004","74F","5T23",111.13,"2.78","2.78","PI3Kg IN COMPLEX WITH 5d","MSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSAHHHHHH","Homo sapiens","PIK3CG","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform","1","5T23"
"5T2Q",,"X-RAY DIFFRACTION",3.36,63.34,"VAPOR DIFFUSION, SITTING DROP",,"0.15 M CaCl2, 15% (w/v) PEG 3300, 30% (w/v) PEG 8K, 5% (v/v) Glycerol",277.15,,,"5T2Q",22.9,"1.9","1.9","Unliganded Human HVEM at 1.9A in P 1 21 1","GSHMLPSCKEDEYPVGSECCPKCSPGYRVKEACGELTGTVCEPCPPGTYIAHLNGLSKCLQCQMCDPAMGLRASRNCSRTENAVCGCSPGHFCIVQDGDHCAACRAYA","Homo sapiens","TNFRSF14, HVEA, HVEM, UNQ329/PRO509","Tumor necrosis factor receptor superfamily member 14","1","5T2Q"
"5T2R",,"X-RAY DIFFRACTION",3.33,63.08,"VAPOR DIFFUSION, SITTING DROP",,"0.15 M HEPES 7.5, 0.15 M NaCl, 0.05 M AS, 
30% (w/v) PEG 8K, 5% (v/v) Glycerol",296.15,,,"5T2R",22.9,"2.1","2.1","Unliganded Human HVEM at 2.1A in P 21 21 21","GSHMLPSCKEDEYPVGSECCPKCSPGYRVKEACGELTGTVCEPCPPGTYIAHLNGLSKCLQCQMCDPAMGLRASRNCSRTENAVCGCSPGHFCIVQDGDHCAACRAYA","Homo sapiens","TNFRSF14, HVEA, HVEM, UNQ329/PRO509","Tumor necrosis factor receptor superfamily member 14","1","5T2R"
"5T30",,"X-RAY DIFFRACTION",2.35,47.62,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.8M potassium phosphate, pH 7.8",296,"10.1016/j.jsb.2017.04.011",,"5T30",45.15,"1.77","1.77","Human MnSOD-azide complex","MKHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEKYQEALAKGDVTAQIALQPALKFNGGGHINHSIFWTNLSPNGGGEPKGELLEAIKRDFGSFDKFKEKLTAASVGVQGSGWGWLGFNKERGHLQIAACPNQDPLQGTTGLIPLLGIDVWEHAYYLQYKNVRPDYLKAIWNVINWENVTERYMACKK","Homo sapiens","SOD2","Superoxide dismutase [Mn], mitochondrial","1","5T30"
"5T31",,"X-RAY DIFFRACTION",2.76,55.36,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG MME 5,000 and 0.1 M Bis-Tris pH 6.5",293,"10.1126/scitranslmed.aam8460",,"5T31",94.43,"2.85","2.85","Exploiting an Asp-Glu switch in Glycogen Synthase Kinase 3 to design paralog selective inhibitors for use in acute myeloid leukemia","MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLEYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST","Homo sapiens","GSK3B","Glycogen synthase kinase-3 beta","1","5T31"
"5T36",,"X-RAY DIFFRACTION",4.06,69.73,"VAPOR DIFFUSION",,"0.1M TRIS pH 8.2
28% PEG 1K",294.15,"10.1016/j.bmcl.2016.11.011","755","5T36",18.75,"1.4","1.4","Crystal structure of mPGES-1 bound to inhibitor","MALPAHSLVMSSPALPAFLLCSTLLVIKMYVVAIITGQVRLRKKAFANPEDALRHGGPQYCRSDPDVERCLRAHRNDMETIYPFLFLGFVYSFLGPNPFVAWMHFLVFLVGRVAHTVAYLGKLRAPIRSVTYTLAQLPCASMALQILWEAARHL","Homo sapiens","PTGES, MGST1L1, MPGES1, PGES, PIG12","Prostaglandin E synthase","1","5T36"
"5T37",,"X-RAY DIFFRACTION",4.01,69.33,"VAPOR DIFFUSION",,"0.1M tris pH 8.2
28% PEG 1K",294.15,"10.1016/j.bmcl.2016.11.011","758","5T37",19.12,"1.761","1.761","crystal structure of mPGES-1 bound to inhibitor","MALPAHSLVMSSPALPAFLLCSTLLVIKMYVVAIITGQVRLRKKAFANPEDALRHGGPQYCRSDPDVERCLRAHRNDMETIYPFLFLGFVYSFLGPNPFVAWMHFLVFLVGRVAHTVAYLGKLRAPIRSVTYTLAQLPCASMALQILWEAARHL","Homo sapiens","PTGES, MGST1L1, MPGES1, PGES, PIG12","Prostaglandin E synthase","1","5T37"
"5T3P",,"X-RAY DIFFRACTION",2.68,54.18,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.8M Sodium phosphate monobasic, 0.8M pottassium phosphate dibasic, 0.1M HEPES pH 7.5",277,,,"5T3P",80.75,"2.03","2.03","Crystal structure of Human Peroxisomal coenzyme A diphosphatase NUDT7","SMSRLGLPEEPVRNSLLDDAKARLRKYDIGGKYSHLPYNKYSVLLPLVAKEGKLHLLFTVRSEKLRRAPGEVCFPGGKRDPTDMDDAATALREAQEEVGLRPHQVEVVCCLVPCLIDTDTLITPFVGLIDHNFQAQPNPAEVKDVFLVPLAYFLHPQVHDQHYVTRLGHRFINHIFEYTNPEDGVTYQIKGMTANLAVLVAFIILEKKPTFEVQFNLNDVLASSEELFLKVHKKAT","Homo sapiens","NUDT7","Peroxisomal coenzyme A diphosphatase NUDT7","1","5T3P"
"5T3Q",,"X-RAY DIFFRACTION",2.66,53.75,"VAPOR DIFFUSION, HANGING DROP",5,"12% PEG 6000, 1.0 M lithium chloride, 0.1 M sodium citrate (pH 5.0)",298,,"75H","5T3Q",35.77,"2","2","Crystal structure of the c-Met kinase domain in complex with a pyrazolone inhibitor","QNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHHHHHH","Homo sapiens","MET","Hepatocyte growth factor receptor","1","5T3Q"
"5T3V",,"X-RAY DIFFRACTION",3.06,59.81,"VAPOR DIFFUSION, SITTING DROP",,"2M (NH4)2SO4, 0.1M MgCl2, 0.1M Tris-HCl pH 8.5",290,"10.1038/ncomms14959",,"5T3V",72.99,"2.6","2.6","A Novel domain in human EXOG converts apoptotic endonuclease to DNA-repair enzyme","MKAVLEQFGFPLTGTEARCYTNHALSYDQAKRVPRWVLEHISKSKIMGDADRKHCKFKPDPNIPPTFSAFNEDYVGSGWSRGHMAPAGNNKFSSKAMAETFYLSNIVPQDFDNNSGYWNRIEMYCRELTERFEDVWVVSGPLTLPQTRGDGKKIVSYQVIGEDNVAVPSHLYKVILARRSSVSTEPLALGAFVVPNEAIGFQPQLTEFQVSLQDLEKLSGLVFFPHLDRTSDIRNICSVDTCKLLDFQEFTLYLSTRKIEGARSVLRLEKIMENLKNAEIEPDDYFMSRYEKKLEELKAKEQSGTQIRKPSHHHHHH","Homo sapiens","EXOG, ENDOGL1, ENDOGL2, ENGL","Nuclease EXOG, mitochondrial","1","5T3V"
"5T40",,"X-RAY DIFFRACTION",3.08,60.05,"VAPOR DIFFUSION, HANGING DROP",,"2.0M (NH4)2SO4, 0.1M Tris-HCl pH 8.5, 0.1M MgCl2",292,"10.1038/ncomms14959",,"5T40",73.12,"1.81","1.81","A Novel domain in human EXOG converts apoptotic endonuclease to DNA-repair enzyme","MKAVLEQFGFPLTGTEARCYTNHALSYDQAKRVPRWVLEHISKSKIMGDADRKHCKFKPDPNIPPTFSAFNEDYVGSGWSRGHMAPAGNNKFSSKAMAETFYLSNIVPQDFDNNSGYWNRIEMYCRELTERFEDVWVVSGPLTLPQTRGDGKKIVSYQVIGEDNVAVPSHLYKVILARRSSVSTEPLALGAFVVPNEAIGFQPQLTEFQVSLQDLEKLSGLVFFPHLDRTSDIRNICSVDTCKLLDFQEFTLYLSTRKIEGARSVLRLEKIMENLKNAEIEPDDYFMSRYEKKLEELKAKEQSGTQIRKPSHHHHHH","Homo sapiens","EXOG, ENDOGL1, ENDOGL2, ENGL","Nuclease EXOG, mitochondrial","1","5T40"
"5T43",,"SOLUTION NMR",,,,,,,,,"5T43",17.45,,,"NMR Structure of Apo-form Human Tear Lipocalin","HHLLASDEEIQDVSGTWYLKAMTVDREFPEMNLESVTPMTLTTLEGGNLEAKVTMLISGRCQEVKAVLEKTDEPGKYTADGGKHVAYIIRSHVKDHYIFYSEGELHGKPVRGVKLVGRDPKNNLEALEDFEKAAGARGLSTESILIPRQSETCSPGSD","Homo sapiens","LCN1, VEGP","Lipocalin-1","1","5T43"
"5T44",,"X-RAY DIFFRACTION",1.93,36.31,"VAPOR DIFFUSION, HANGING DROP",6.9,"0.1M MES at pH6.9, 12% 1-propanol, 10% PEG 500MME",277,"10.1073/pnas.1618293114",,"5T44",32.8,"1.9944","1.9944","Crystal structure of Frizzled 7 CRD","GSQPYHGEKGISVPDHGFCQPISIPLCTDIAYNQTILPNLLGHTNQEDAGLEVHQFYPLVKVQCSPELRFFLCSMYAPVCTVLDQAIPPCRSLCERARQGCEALMNKFGFQWPERLRCENFPVHGAGEICVGQNTSDGGNSHHHHHH","Homo sapiens","FZD7","Frizzled-7","1","5T44"
"5T4B",,"X-RAY DIFFRACTION",3,59,"VAPOR DIFFUSION, HANGING DROP",8,"0.27-0.30 M sodium acetate 17-18% polyethylene glycol 3350 0.1 M tris hydrochloride pH 8.0",291,"10.1016/j.bmc.2016.09.007","75N","5T4B",174.02,"1.76","1.76","Human DPP4 in complex with a ligand 34a","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","5T4B"
"5T4D","3","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2016.09.048",,"5T4D",240.37,"3",,"Cryo-EM structure of Polycystic Kidney Disease protein 2 (PKD2), residues 198-703","GAMGSRGLWGTRLMEESSTNREKYLKSVLRELVTYLLFLIVLCILTYGMMSSNVYYYTRMMSQLFLDTPVSKTEKTNFKTLSSMEDFWKFTEGSLLDGLYWKMQPSNQTEADNRSFIFYENLLLGVPRIRQLRVRNGSCSIPQDLRDEIKECYDVYSVSSEDRAPFGPRNGTAWIYTSEKDLNGSSHWGIIATYSGAGYYLDLSRTREETAAQVASLKKNVWLDRGTRATFIDFSVYNANINLFCVVRLLVEFPATGGVIPSWQFQPLKLIRYVTTFDFFLAACEIIFCFFIFYYVVEEILEIRIHKLHYFRSFWNCLDVVIVVLSVVAIGINIYRTSNVEVLLQFLEDQNTFPNFEHLAYWQIQFNNIAAVTVFFVWIKLFKFINFNRTMSQLSTTMSRCAKDLFGFAIMFFIIFLAYAQLAYLVFGTQVDDFSTFQECIFTQFRIILGDINFAEIEEANRVLGPIYFTTFVFFMFFILLNMFLAIINDTYSEVKSDLAQQKAEMELSD","Homo sapiens","PKD2, TRPP2","hPKD:198-703, Polycystin-2","1","5T4D"
"5T4E",,"X-RAY DIFFRACTION",3.02,59.32,"VAPOR DIFFUSION, HANGING DROP",8,"0.27-0.30 M sodium acetate 17-18% polyethylene glycol 3350 0.1 M tris hydrochloride pH 8.0",291,"10.1016/j.bmc.2016.09.007","75L","5T4E",174.05,"1.77","1.77","Human DPP4 in complex with ligand 19a","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","5T4E"
"5T4F",,"X-RAY DIFFRACTION",3.01,59.08,"VAPOR DIFFUSION, HANGING DROP",8,"0.27-0.30 M sodium acetate 17-18% polyethylene glycol 3350 0.1 M tris hydrochloride pH 8.0",291,"10.1016/j.bmc.2016.09.007","75M","5T4F",174.34,"1.9","1.9","Human DPP4 in complex with ligand 34p","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","5T4F"
"5T4H",,"X-RAY DIFFRACTION",3.03,59.4,"VAPOR DIFFUSION, HANGING DROP",8,"0.27-0.30 M sodium acetate 17-18% polyethylene glycol 3350 0.1 M tris hydrochloride pH 8.0",291,"10.1016/j.bmc.2016.09.007",,"5T4H",173.93,"2.61","2.61","Human DPP4 in complex with ligand 34n","TRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP","Homo sapiens","DPP4, ADCP2, CD26","Dipeptidyl peptidase 4","1","5T4H"
"5T4M",,"X-RAY DIFFRACTION",3.85,68.04,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M Sodium Cacodylate pH 6.0, 150 mM Calcium Chloride",277,"10.1016/j.str.2017.01.014",,"5T4M",82.2,"2.24","2.24","Crystal Structure of Human Protocadherin-15 EC3-5","MASPMFLPCVLVPNTRDCRPLTYQAAIPELRTPEELNPIIVTPPIQAIDQDRNIQPPSDRPGILYSILVGTPEDYPRFFHMHPRTAELSLLEPVNRDFHQKFDLVIKAEQDNGHPLPAFAGLHIEILDENNQSPYFTMPSYQGYILESAPVGATISDSLNLTSPLRIVALDKDIEDTKDPELHLFLNDYTSVFTVTQTGITRYLTLLQPVDREEQQTYTFSITAFDGVQESEPVIVNIQVMDANDNTPTFPEISYDVYVYTDMRPGDSVIQLTAVDADEGSNGEITYEILVGAQGDFIINKTTGLITIAPGVEMIVGRTYALTVQAADNAPPAERRNSICTVYIEVLPPNNQSPPRFLEHHHHHH","Homo sapiens","PCDH15, USH1F","Protocadherin-15","1","5T4M"
"5T4N",,"X-RAY DIFFRACTION",4.11,70.04,"VAPOR DIFFUSION, HANGING DROP",5.8,"0.1 M Sodium Cacodylate pH 5.8, 150 mM Calcium Chloride",277,"10.1016/j.str.2017.01.014",,"5T4N",82.11,"2.701","2.701","Crystal Structure of Human Protocadherin-15 EC3-5 D414A Variant","MASPMFLPCVLVPNTRDCRPLTYQAAIPELRTPEELNPIIVTPPIQAIDQDRNIQPPSDRPGILYSILVGTPEDYPRFFHMHPRTAELSLLEPVNRDFHQKFDLVIKAEQDNGHPLPAFAGLHIEILDENNQSPYFTMPSYQGYILESAPVGATISDSLNLTSPLRIVALDKDIEATKDPELHLFLNDYTSVFTVTQTGITRYLTLLQPVDREEQQTYTFSITAFDGVQESEPVIVNIQVMDANDNTPTFPEISYDVYVYTDMRPGDSVIQLTAVDADEGSNGEITYEILVGAQGDFIINKTTGLITIAPGVEMIVGRTYALTVQAADNAPPAERRNSICTVYIEVLPPNNQSPPRFLEHHHHHH","Homo sapiens","PCDH15, USH1F","Protocadherin-15","1","5T4N"
"5T4S",,"X-RAY DIFFRACTION",3.07,59.97,"VAPOR DIFFUSION, SITTING DROP",7.9,"26% PEG600, 0.06M citrate, 0.04M citric acid",293,"10.1016/j.bmc.2016.09.065",,"5T4S",75.53,"2.64","2.64","Novel Approach of Fragment-Based Lead Discovery applied to Renin Inhibitors","TLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","5T4S"
"5T4U",,"X-RAY DIFFRACTION",2.43,49.46,"VAPOR DIFFUSION, SITTING DROP",7.5,"20 % PEG3350, 0.2 M ammonium nitrate",277.15,"10.1021/acs.jmedchem.6b01583","12Q","5T4U",13.92,"1.5","1.5","Crystal structure of the bromodomain of human BRPF1 in complex with a quinolinone ligand","SMEMQLTPFLILLRKTLEQLQEKDTGNIFSEPVPLSEVPDYLDHIKKPMDFFTMKQNLEAYRYLNFDDFEEDFNLIVSNCLKYNAKDTIFYRAAVRLREQGGAVLRQARRQAEKMG","Homo sapiens","BRPF1, BR140","Peregrin","1","5T4U"
"5T4V",,"X-RAY DIFFRACTION",2.65,53.58,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 m bis-tris propane pH 8.5, 0.2 M sodium formate, 20% PEG 3350, 10% ethylene glycol",277.15,"10.1021/acs.jmedchem.6b01583","N48","5T4V",14.2,"1.65","1.65","Crystal structure of the bromodomain of human BRPF1 in complex with NI-48 ligand","SMEMQLTPFLILLRKTLEQLQEKDTGNIFSEPVPLSEVPDYLDHIKKPMDFFTMKQNLEAYRYLNFDDFEEDFNLIVSNCLKYNAKDTIFYRAAVRLREQGGAVLRQARRQAEKMG","Homo sapiens","BRPF1, BR140","Peregrin","1","5T4V"
"5T4W",,"X-RAY DIFFRACTION",2.24,45.09,"VAPOR DIFFUSION, HANGING DROP",,"60mM NaCaCo, 17mM MgCl2, 2mM Spermine, 50%MPD, 1.5 mM DAPI",293,"10.1107/S2053230X17011384",,"5T4W",7.6,"2.3","2.3","Crystal structure of a DNA sequence d (CGTGAATTCACG) with DAPI","CGTGAATTCACG","Homo sapiens",,"DNA (5'-D(*CP*GP*TP*GP*AP*AP*TP*TP*CP*AP*CP*G)-3')","1","5T4W"
"5T53",,"X-RAY DIFFRACTION",3.89,68.37,"VAPOR DIFFUSION, HANGING DROP",7.5,"8% PEG 8000, 0.1M HEPES, pH 7.5 and 10 % ethylene glycol",298.15,"10.1074/jbc.M116.752220",,"5T53",27.12,"2.699","2.699","MOLECULAR BASIS FOR COHESIN ACETYLATION BY ESTABLISHMENT OF SISTER CHROMATID COHESION N-ACETYLTRANSFERASE ESCO1","KTDEKQLIIDAGQKRFGAVSCNVCGMLYTASNPEDETQHLLFHNQFISAVKYVGWKKERILAEYPDGRIIMVLPEDPKYALKKVDEIREMVDNDLGFQQAPLMCYSRTKTLLFISNDKKVVGCLIAEHIQWGYRVIEEKLPVIRSEEEKVRFERQKAWCCSTLPEPAICGISRIWVFSMMRRKKIASRMIECLRSNFIYGSYLSKEEIAFSDPTPDGKLFATQYCGT","Homo sapiens","ESCO1, EFO1, KIAA1911","N-acetyltransferase ESCO1","1","5T53"
"5T5G",,"X-RAY DIFFRACTION",2.38,48.35,"VAPOR DIFFUSION",,"30% PEG-2000-MME, 0.1 M postassium thiocyanate, 0.1 M Bis-Tris",291,"10.1021/acs.jmedchem.6b01244",,"5T5G",17.22,"2.1","2.1","human SETD8 in complex with MS2177","GKSKAELQSEERKRIDELIESGKEEGMKIDLIDGKGRGVIATKQFSRGDFVVEYHGDLIEITDAKKREALYAQDPSTGCYMYYFQYLSKTYCVDATRETNRLGRLINHSKSGNCQTKLHDIDGVPHLILIASRDIAAGEELLYDYGDR","Homo sapiens","KMT5A, PRSET7, SET07, SET8, SETD8","N-lysine methyltransferase KMT5A","1","5T5G"
"5T5S",,"X-RAY DIFFRACTION",4.06,69.74,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M ammonium acetate, 0.1 M Tris, pH 8.5, 25% w/v PEG3350",290,"10.1073/pnas.1617316113",,"5T5S",23.47,"2.202","2.202","A fragment of a human tRNA synthetase","HHHHHHGAEAQKALRKAESLKKCLSVMEAKVKAQTAPNKDVQREIADLGEALATAVIPQWQKDELRETLKSLKKVMDDLDRASKADVQKRVLEKTKQFIDSNPNQPLVILEMESGATAKALNEALKLFKMHSPQTSAMLFTVDNEAGKITCLCQVPQNAANRGLKASEWVQQVSGLMDGKGGGKDVSAQATGKNVGCLQEALQLATSFAQLRLGD","Homo sapiens","AARS, AARS1","Alanine--tRNA ligase, cytoplasmic","1","5T5S"
"5T68",,"X-RAY DIFFRACTION",1.89,34.87,"VAPOR DIFFUSION, SITTING DROP",8.5,"14-18% PEG3350, 100 mM Tris pH 8.5 using a seed stock that was grown in PEG 3350 13-20% and 100 mM Tris pH 8.5",293,"10.1016/j.bmcl.2016.09.077","77V","5T68",68.41,"2.93","2.93","Crystal structure of Syk catalytic domain in complex with a furo[3,2-d]pyrimidine","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","5T68"
"5T71",,"X-RAY DIFFRACTION",2.11,41.67,"VAPOR DIFFUSION, HANGING DROP",,"3 M (NH4)2SO4, 50 mM Tris-HCl",293,"10.1021/acschembio.7b00862",,"5T71",30.06,"1.3","1.3","Human carboanhydrase F131C_C206S double mutant in complex with SA-2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDCGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLESVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5T71"
"5T72",,"X-RAY DIFFRACTION",2.09,41.16,"VAPOR DIFFUSION, HANGING DROP",8.5,"3 M (NH4)2SO4, 50 mM Tris-HCl",293,"10.1021/acschembio.7b00862","4WA","5T72",30.03,"1.3","1.3","Human carboanhydrase F131C_C206S double mutant in complex with 2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDCGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLESVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5T72"
"5T74",,"X-RAY DIFFRACTION",2.1,41.3,"VAPOR DIFFUSION, HANGING DROP",8.5,"3 M (NH4)2SO4, 50 mM Tris-HCl",293,"10.1021/acschembio.7b00862",,"5T74",30.06,"1.2","1.2","Human carboanhydrase F131C_C206S double mutant in complex with 14","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDCGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLESVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5T74"
"5T75",,"X-RAY DIFFRACTION",2.11,41.69,"VAPOR DIFFUSION, HANGING DROP",8.5,"3 M (NH4)2SO4, 50 mM Tris-HCl",293,"10.1021/acschembio.7b00862","4WA","5T75",29.94,"1.5","1.5","Human carbonic anhydrase II G132C_C206S double mutant in complex with SA-2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFCKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLESVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5T75"
"5T76",,"X-RAY DIFFRACTION",2.21,44.47,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris, pH 8.5, 25% w/v PEG3350",290,"10.1073/pnas.1617316113",,"5T76",23.75,"2","2","A fragment of a human tRNA synthetase","HHHHHHGAEAQKALRKAESLKKCLSVMEAKVKAQTAPNKDVQREIADLGEALATAVIPQWQKDELRETLKSLKKVMDDLDRASKADVQKRVLEKTKQFIDSNPNQPLVILEMESGATAKALNEALKLFKMHSPQTSAMLFTVDNEAGKITCLCQVPQNAANRGLKASEWVQQVSGLMDGKGGGKDVSAQATGKNVGCLQEALQLATSFAQLRLGD","Homo sapiens","AARS, AARS1","Alanine--tRNA ligase, cytoplasmic","1","5T76"
"5T7C",,"SOLUTION NMR",,,,,,,"10.1371/journal.pone.0165921",,"5T7C",22.42,,,"Solution structure of calcium free, myristoylated visinin-like protein 3","XGKQNSKLRPEVLQDLRENTEFTDHELQEWYKGFLKDCPTGHLTVDEFKKIYANFFPYGDASKFAEHVFRTFDTNGDGTIDFREFIIALSVTSRGKLEQKLKWAFSMYDLDGNGYISRSEMLEIVQAIYKMVSSVMKMPEDESTPEKRTDKIFRQMDTNNDGKLSLEEFIRGAKSDPSIVRLLQCDPSSASQF","Homo sapiens","HPCAL1, BDR1","Hippocalcin-like protein 1","1","5T7C"
"5T7I",,"X-RAY DIFFRACTION",2.35,47.63,"VAPOR DIFFUSION, HANGING DROP",,"10 mM sodium phosphate, 137 mM sodium chloride, 2.7 mM potassium chloride, 1.8 mM potassium phosphate",293,"10.1038/srep39556",,"5T7I",18.29,"2","2","Crystal structure of galectin-8N in complex with LNnT","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSVKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFSS","Homo sapiens","LGALS8","Galectin-8","1","5T7I"
"5T7Q",,"SOLUTION NMR",,,,,,,"10.1038/srep43043",,"5T7Q",2.55,,,"TIRAP phosphoinositide-binding motif","KKPLGKMADWFRQTLLKKPKK","Homo sapiens","TIRAP, MAL","Toll/interleukin-1 receptor domain-containing adapter protein","1","5T7Q"
"5T7R",,"X-RAY DIFFRACTION",3.33,63.02,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.9 M potassium sodium tartrate, 0.1 M Tris HCl pH 8.5, 0.5% PEG 5000 MME",300,"10.1038/s41598-017-16876-3",,"5T7R",11.56,"1.55","1.55","A6-A11 trans-dicarba human insulin","GIVEQACTSIASLYQLENYCN","Homo sapiens","INS","Insulin A chain","1","5T7R"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B chain","2","5T7R"
"5T7S",,"X-RAY DIFFRACTION",2.38,48.29,"VAPOR DIFFUSION, HANGING DROP",,"10 mM sodium phosphate, 137 mM sodium chloride, 2.7 mM potassium chloride, 1.8 mM potassium phosphate",293,"10.1038/srep39556",,"5T7S",18.02,"1.9","1.9","Crystal structure of galectin-8N in complex with Lactose","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSVKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFSS","Homo sapiens","LGALS8","Galectin-8","1","5T7S"
"5T7T",,"X-RAY DIFFRACTION",2.58,52.26,"VAPOR DIFFUSION, HANGING DROP",,"10 mM sodium phosphate, 137 mM sodium chloride, 2.7 mM potassium chloride, 1.8 mM potassium phosphate",293,"10.1038/srep39556",,"5T7T",18.01,"1.96","1.96","Galectin-8 N terminal domain in complex with LNT","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSVKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFSS","Homo sapiens","LGALS8","Galectin-8","1","5T7T"
"5T7U",,"X-RAY DIFFRACTION",2.35,47.7,"VAPOR DIFFUSION, HANGING DROP",,"10 mM sodium phosphate, 137 mM sodium chloride, 2.7 mM potassium chloride, 1.8 mM potassium phosphate",293,"10.1038/srep39556",,"5T7U",17.83,"1.58","1.58","Crystal structure of galectin-8N in complex with Glycerol","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSVKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFSS","Homo sapiens","LGALS8","Galectin-8","1","5T7U"
"5T8E",,"X-RAY DIFFRACTION",2.18,43.55,"VAPOR DIFFUSION, SITTING DROP",7.2,"Protein Storage Buffer: 25mM HEPES pH 7.2, 150mM LiSO4, 10mM DTT, 10% Glycerol, 0.1% bOG, 100uM inhibitor
Crystallization Buffer: ~1M ammonium phosphate dibasic",293,"10.1016/j.bmcl.2017.03.038","77U","5T8E",30.59,"2.71","2.71","Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives","MHHHHHHGSPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","5T8E"
"5T8J",,"X-RAY DIFFRACTION",2.1,41.33,"VAPOR DIFFUSION, SITTING DROP",7.2,"~1M ammonium phosphate dibasic",293,"10.1016/j.bmcl.2017.03.038","77T","5T8J",30.49,"2.7","2.7","Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives","MHHHHHHGSPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","5T8J"
"5T92",,"X-RAY DIFFRACTION",2.17,43.42,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M Magnesium Chloride hexahydrate, 0.1 M Tris-HCl pH 8.5, 21% PEG 3350",293,"10.1021/acs.jmedchem.6b01468","77W","5T92",58.6,"2.22","2.22","ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH (2E)-3-{4-[(1R)-2-(4-fluorophenyl)-6-hydroxy-1-methy l-1,2,3,4- tetrahydroisoquinolin-1-yl]phenyl}prop-2-enoic acid","GSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLYDLLLEMLDAHRLHAPT","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","5T92"
"5T93",,"X-RAY DIFFRACTION",2.02,39.01,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M sodium acetate
0.1 M sodium cacodylate
30% PEG 8000",298,"10.1021/acs.biochem.6b01043",,"5T93",46.95,"1.9","1.9","Immunoglobulin light chain variable domain AL-T05","QSVLTQPPSVSAAPGQTVTISCSGSSSNIGNNYVSWYQHLPGTAPKFLIYDNNKRPSGIPDRFSGFKSGTSATLGITGLQTGDEADYYCGTWDSSLSALVFGGGTKLTVL","Homo sapiens","IGLV","ALT-05 immunoglobulin light chain variable domain from light chain amyloidosis patient","1","5T93"
"5T97",,"X-RAY DIFFRACTION",2.08,40.78,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG 3350, 0.3 M Magnesium Chloride",298,"10.1021/acs.jmedchem.6b01468","782","5T97",58.65,"3","3","ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH (2E)-3-(4-{(1R)-6-hydroxy-1-methyl-2-[4-(propan-2 -yl)phenyl]-1,2,3,4- tetrahydroisoquinolin-1-yl}phenyl)prop-2-enoic acid","GSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPLYDLLLEMLDAHRLHAPT","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","5T97"
"5T9U",,"X-RAY DIFFRACTION",4.83,74.51,"VAPOR DIFFUSION",8.5,"0.1 M Tris-HCl, pH 8.5
0.1 M potassium chloride
2.2 M ammonium sulfate",293,"10.1021/acs.jmedchem.6b01329","7HG","5T9U",74.2,"2.301","2.301","Discovery of a Potent Cyclophilin Inhibitor (Compound 3) based on Structural Simplification of Sanglifehrin A","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQL","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","5T9U"
"5T9W",,"X-RAY DIFFRACTION",2.62,53.1,"VAPOR DIFFUSION",,"0.05 M monobasic potassium phosphate
20% (w/v) PEG 8000",293,"10.1021/acs.jmedchem.6b01329","78E","5T9W",18.46,"2","2","Discovery of a Potent Cyclophilin Inhibitor (Compound 5) based on Structural Simplification of Sanglifehrin A","VNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","5T9W"
"5T9Z",,"X-RAY DIFFRACTION",2.17,43.19,"VAPOR DIFFUSION",4.2,"sodium citrate, pH 4.2
25% (w/v) PEG 3350",293,"10.1021/acs.jmedchem.6b01329","78R","5T9Z",18.41,"1.4","1.4","Discovery of a Potent Cyclophilin Inhibitor (Compound 6) based on Structural Simplification of Sanglifehrin A","VNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQL","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","5T9Z"
"5TA2",,"X-RAY DIFFRACTION",2.18,43.65,"VAPOR DIFFUSION",,"sodium citrate, pH 4.2
25% (w/v) PEG 3350",293,"10.1021/acs.jmedchem.6b01329","78X","5TA2",18.42,"1.48","1.48","Discovery of a Potent Cyclophilin Inhibitor (Compound 7) based on Structural Simplification of Sanglifehrin A","VNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQL","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","5TA2"
"5TA4",,"X-RAY DIFFRACTION",2.06,40.22,"VAPOR DIFFUSION",8.5,"0.1 M Tris-HCl, pH 8.5
0.2 M potassium chloride
2.0 M ammonium sulfate",293,"10.1021/acs.jmedchem.6b01329","838","5TA4",18.56,"1.5","1.5","Discovery of a Potent Cyclophilin Inhibitor (Compound 8) based on Structural Simplification of Sanglifehrin A","VNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","5TA4"
"5TA6",,"X-RAY DIFFRACTION",2.39,48.62,"VAPOR DIFFUSION, SITTING DROP",,"0.95 mM succinic acid, 1.7% PEG2000 MME, 0.4 mM zinc acetate, 100 mM HEPES, pH 7.0,  temperature 277K",277,"10.1016/j.bmcl.2016.10.009","79D","5TA6",41.2,"2.5","2.5","Crystal structure of PLK1 in complex with a novel 5,6-dihydroimidazolo[1,5-f]pteridine inhibitor.","MSYYHHHHHHDYDIPTTENLYFQGAAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","5TA6"
"5TA8",,"X-RAY DIFFRACTION",2.45,49.83,"VAPOR DIFFUSION, SITTING DROP",,"0.95 mM succinic acid, 1.7% PEG2000 MME, 0.4 mM zinc acetate, 100 mM HEPES, pH 7.0, temperature 277K",277,"10.1016/j.bmcl.2016.10.009","79C","5TA8",41.19,"2.6","2.6","Crystal structure of PLK1 in complex with a novel 5,6-dihydroimidazolo[1,5-f]pteridine inhibitor","MSYYHHHHHHDYDIPTTENLYFQGAAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNK","Homo sapiens","PLK1, PLK","Serine/threonine-protein kinase PLK1","1","5TA8"
"5TAB",,"X-RAY DIFFRACTION",2.64,53.35,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M bis-tris propanol pH 6.5, 2.55 M ammonium sulfate titrated with 0.006 ml per 1 ml 1 N HCl",277.15,"10.1016/j.celrep.2016.09.056",,"5TAB",6.31,"1.25","1.25","Crystal Structure of the PHD Finger of PHF20","GPLGSEVVRCICEVQEENDFMIQCEECQSWQHGVCMGLLEENVPEKYTCYVCQ","Homo sapiens","PHF20, C20orf104, GLEA2, HCA58, NZF, TZP","PHD finger protein 20","1","5TAB"
"5TB6",,"X-RAY DIFFRACTION",2.04,39.67,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.15M KSCN
15% PEG 3350
5% EtGly",277,"10.1021/acsmedchemlett.6b00154","77X","5TB6",14.54,"1.79","1.79","Structure of bromodomain of CREBBP with a pyrazolo[4,3-c]pyridin fragment","SMRKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","5TB6"
"5TBE",,"X-RAY DIFFRACTION",1.95,36.93,"VAPOR DIFFUSION, HANGING DROP",,"100 mM MES, 21-29 % PEG4000, 25 mM BOG",293,"10.1002/anie.201701185","78L","5TBE",41.96,"2.44","2.44","Human p38alpha MAP Kinase in Complex with Dibenzosuberone Compound 2","MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","5TBE"
"5TBP",,"X-RAY DIFFRACTION",2.3,46.63,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.2 ul of 0.35 mM protein and 0.6 mM ligand in 100 mM NaCl, 20 mM Tris-Cl  were mixed with 0.2 ul of the well solution (20% PEG3330 and 0.2M Na Acetate)",293.15,"10.1038/ncomms16066","7A4","5TBP",111.77,"2.6","2.6","Crystal Structure of RXR-alpha ligand binding domain complexed with synthetic modulator K8003","GSHMTSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT","Homo sapiens","RXRA, NR2B1","Retinoic acid receptor RXR-alpha","1","5TBP"
"5TBX",,"X-RAY DIFFRACTION",2.07,40.66,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M sodium acetate trihydrate pH 8.0 in 20% w/v PEG 3350 from the PEG/Ion HT crystallization screen (Hampton Research, HR2-139).",298,"10.1107/S2053230X17003454",,"5TBX",20.46,"1.767","1.767","hnRNP A18 RNA Recognition Motif","GMASDEGKLFVGGLSFDTNEQSLEQVFSKYGQISEVVVVKDRETQRSRGFGFVTFENIDDAKDAMMAMNGKSVDGRQIRVDQAGKSSDNRSR","Homo sapiens","CIRBP, A18HNRNP, CIRP","Cold-inducible RNA-binding protein","1","5TBX"
"5TC0",,"X-RAY DIFFRACTION",2.2,44.03,"VAPOR DIFFUSION, HANGING DROP",8.5,"29% PEG 400, 0.2M MgCl2, 0,1M Tris pH 8.5",293,"10.1016/j.bmcl.2016.12.024","79Y","5TC0",72.42,"2.24","2.24","Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogate","MGSSHHHHHHSSGLVPRGSSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVMRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","5TC0"
"5TC4",,"X-RAY DIFFRACTION",1.98,38.02,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Phosphate/Citrate pH 4.1, 38 % v/v PEG300, in presence of 1:50 ratio each of trypsin, alpha-chymotrypsin, pepsin, papain, proteinase K and subtilisin to MTHFD2",293,"10.1158/0008-5472.CAN-16-1476","L34","5TC4",35.54,"1.89","1.89","Crystal structure of human mitochondrial methylenetetrahydrofolate dehydrogenase-cyclohydrolase (MTHFD2) in complex with LY345899 and cofactors","MEAVVISGRKLAQQIKQEVRQEVEEWVASGNKRPHLSVILVGENPASHSYVLNKTRAAAVVGINSETIMKPASISEEELLNLINKLNNDDNVDGLLVQLPLPEHIDERRICNAVSPDKDVDGFHVINVGRMCLDQYSMLPATPWGVWEIIKRTGIPTLGKNVVVAGRSKNVGMPIAMLLHTDGAHERPGGDATVTISHRYTPKEQLKKHTILADIVISAAGIPNLITADMIKEGAAVIDVGINRVHDPVTAKPKLVGDVDFEGVRQKAGYITPVPGGVGPMTVAMLMKNTIIAAKKVLRLEEREVLKSKELGVATN","Homo sapiens","MTHFD2, NMDMC","Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial","1","5TC4"
"5TC5",,"X-RAY DIFFRACTION",2.64,53.48,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein (15 mg/mL); Reservoir (3 M sodium chloride and 0.1 M sodium acetate (pH 4.5))",295,,,"5TC5",100.51,"1.96","1.96","Crystal structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase in complex with butylthio-DADMe-Immucillin-A and chloride","MHHHHHHENLYFQSMASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLARHGRQHTIMPSKVNYQANIWALKEEGCTHVIVTTACGSLREEIQPGDIVIIDQFIDRTTMRPQSFYDGSHSCARGVCHIPMAEPFCPKTREVLIETAKKLGLRCHSKGTMVTIEGPRFSSRAESFMFRTWGADVINMTTVPEVVLAKEAGICYASIAMATDYDCWKEHEEAVSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLKNMAQFSVLLPRH","Homo sapiens","MTAP, MSAP","S-methyl-5'-thioadenosine phosphorylase","1","5TC5"
"5TC6",,"X-RAY DIFFRACTION",2.92,57.9,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein (15 mg/mL); Reservoir (0.17 M sodium acetate, 85 mM Tris:HCl (pH 8.5), 25% (w/v) PEG 4000 and 15% (v/v) glycerol)",295,,"7A6","5TC6",33.69,"1.48","1.48","Crystal structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase in complex with propylthio-immucillin-A","MHHHHHHENLYFQSMASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLARHGRQHTIMPSKVNYQANIWALKEEGCTHVIVTTACGSLREEIQPGDIVIIDQFIDRTTMRPQSFYDGSHSCARGVCHIPMAEPFCPKTREVLIETAKKLGLRCHSKGTMVTIEGPRFSSRAESFMFRTWGADVINMTTVPEVVLAKEAGICYASIAMATDYDCWKEHEEAVSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLKNMAQFSVLLPRH","Homo sapiens","MTAP, MSAP","S-methyl-5'-thioadenosine phosphorylase","1","5TC6"
"5TC7",,"X-RAY DIFFRACTION",2.95,58.32,"VAPOR DIFFUSION, SITTING DROP",8.5,"Protein (15 mg/mL); Reservoir (0.2 M lithium sulfate, 0.1 M TRIS pH 8.5 and 20% (w/v) PEG 4000)",295,,,"5TC7",33.74,"1.75","1.75","Crystal structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase in complex with 5'-methylthiotubercidin at 1.75 angstrom","MHHHHHHENLYFQSMASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLARHGRQHTIMPSKVNYQANIWALKEEGCTHVIVTTACGSLREEIQPGDIVIIDQFIDRTTMRPQSFYDGSHSCARGVCHIPMAEPFCPKTREVLIETAKKLGLRCHSKGTMVTIEGPRFSSRAESFMFRTWGADVINMTTVPEVVLAKEAGICYASIAMATDYDCWKEHEEAVSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLKNMAQFSVLLPRH","Homo sapiens","MTAP, MSAP","S-methyl-5'-thioadenosine phosphorylase","1","5TC7"
"5TC8",,"X-RAY DIFFRACTION",2.95,58.36,"VAPOR DIFFUSION, SITTING DROP",5.5,"Protein (15 mg/mL); Reservoir (0.2 M magnesium chloride, 0.1 M sodium citrate:citric acid (pH 5.5) and 40% (v/v) PEG 400)",295,,"TDI","5TC8",34.22,"1.8","1.8","Crystal structure of human 5'-deoxy-5'-methylthioadenosine phosphorylase in complex with methylthio-DADMe-Immucillin-A","MHHHHHHENLYFQSMASGTTTTAVKIGIIGGTGLDDPEILEGRTEKYVDTPFGKPSDALILGKIKNVDCVLLARHGRQHTIMPSKVNYQANIWALKEEGCTHVIVTTACGSLREEIQPGDIVIIDQFIDRTTMRPQSFYDGSHSCARGVCHIPMAEPFCPKTREVLIETAKKLGLRCHSKGTMVTIEGPRFSSRAESFMFRTWGADVINMTTVPEVVLAKEAGICYASIAMATDYDCWKEHEEAVSVDRVLKTLKENANKAKSLLLTTIPQIGSTEWSETLHNLKNMAQFSVLLPRH","Homo sapiens","MTAP, MSAP","S-methyl-5'-thioadenosine phosphorylase","1","5TC8"
"5TCA",,"X-RAY DIFFRACTION",3.63,66.07,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris-HCl pH 8.5, 15% PEG 20000",293,"10.1021/acsmedchemlett.6b00299","J55","5TCA",175.48,"3.15","3.15","Complement Factor D inhibited with JH3","ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA","Homo sapiens","CFD, DF, PFD","Complement factor D","1","5TCA"
"5TCC",,"X-RAY DIFFRACTION",3.6,65.79,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES pH 6.5 and 25% PEG 8000",293,"10.1021/acsmedchemlett.6b00299","J56","5TCC",175.09,"3.37","3.37","Complement Factor D inhibited with JH4","ILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA","Homo sapiens","CFD, DF, PFD","Complement factor D","1","5TCC"
"5TCD",,"X-RAY DIFFRACTION",3.69,66.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"sodium iodide, PEG 3350",295,"10.1074/jbc.M116.769273",,"5TCD",55.64,"2.4","2.4","Human alkaline sphingomyelinase (ENPP7) in complex with phosphocholine","DRHHHHHHKLAPVQSQGSQNKLLLVSFDGFRWNYDQDVDTPNLDAMARDGVKARYMTPAFVTMTSPCHFTLVTGKYIENHGVVHNMYYNTTSKVKLPYHATLGIQRWWDNGSVPIWITAQRQGLRAGSFFYPGGNVTYQGVAVTRSRKEGIAHNYKNETEWRANIDTVMAWFTEEDLDLVTLYFGEPDSTGHRYGPESPERREMVRQVDRTVGYLRESIARNHLTDRLNLIITSDHGMTTVDKRAGDLVEFHKFPNFTFRDIEFELLDYGPNGMLLPKEGRLEKVYDALKDAHPKLHVYKKEAFPEAFHYANNPRVTPLLMYSDLGYVIHGRINVQFNNGEHGFDNKDMDMKTIFRAVGPSFRAGLEVEPFESVHVYELMCRLLGIVPEANDGHLATLLPMLHTESALPPDGRPTLLPKGRS","Homo sapiens","ENPP7, UNQ3077/PRO9912","Ectonucleotide pyrophosphatase/phosphodiesterase family member 7","1","5TCD"
"5TCE",,"SOLUTION NMR",,,,,,,"10.1021/acs.jpcb.5b01706",,"5TCE",3.83,,,"N-terminal microdomain of 34-mers from HsDHODH - N-t(DH)","GDERFYAEHLMPTLQGLLDPESAHRLAVRFTSLGX","Homo sapiens","DHODH","Dihydroorotate dehydrogenase (quinone), mitochondrial","1","5TCE"
"5TCO",,"X-RAY DIFFRACTION",2.29,46.3,"VAPOR DIFFUSION, HANGING DROP",6.2,"100 mM MES, 22% PEG4000, 50 mM n-BOG",293,"10.1002/anie.201701185","79Q","5TCO",42.45,"2.1","2.1","Human p38 MAP Kinase in Complex with Dibenzosuberone Compound 1","GSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","5TCO"
"5TCX",,"X-RAY DIFFRACTION",3.94,68.81,"LIPIDIC CUBIC PHASE",8,"25-35% PEG300, Ammonium citrate dibasic, Tris",291,"10.1016/j.cell.2016.09.056",,"5TCX",27.59,"2.955","2.955","Crystal structure of human tetraspanin CD81","RGVEGSTKSIKYLLFVFNFVFWLAGGVILGVALWLRHDPQTTNLLYLELGDKPAPNTFYVGIYILIAVGAVMMFVGFLGCYGAIQESQCLLGTFFTCLVILFACEVAAGIWGFVNKDQIAKDVKQFYDQALQQAVVDDDANNAKAVVKTFHETLDCCGSSTLTALTTSVLKNNLCPSGSNIISNLFKEDCHQKIDDLFSGKLYLIGIAAIVVAVIMIFEMILSMVLSSGIRNSSVYVPHHHHHHHH","Homo sapiens","CD81, TAPA1, TSPAN28","CD81 antigen","1","5TCX"
"5TD2",,"X-RAY DIFFRACTION",2.46,50.03,"VAPOR DIFFUSION, HANGING DROP",8.5,"29% PEG 400
0.2M MgCl2
0.1M Tris pH 8.5",293,"10.1016/j.bmcl.2016.12.024",,"5TD2",66.16,"2.68","2.68","Structure-based optimization of 1H-imidazole-2-carboxamides as Axl kinase inhibitors utilizing a Mer mutant surrogate","LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVMRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","5TD2"
"5TD4",,"X-RAY DIFFRACTION",2.32,47.07,"EVAPORATION",7.5,"MPD 50-58%, 0.1M sodium cacodylate. After crystal reached full size they were soaked in 200mM octaose for 24h prior to data collection, and then infused with a further aliquot of octaose just before freezing the complexed crystal in liquid nitrogen for use in X-ray diffraction analyses.",293,"10.1021/acs.biochem.6b00992",,"5TD4",59.66,"2.3","2.3","Starch binding sites on the Human pancreatic alpha amylase D300N variant complexed with an octaose substrate.","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHNNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","5TD4"
"5TD9",,"X-RAY DIFFRACTION",2.4,48.76,"VAPOR DIFFUSION",,"100 mM Bis-Tris, pH 6.5, 200 mM ammonium acetate, 20% w/v PEG3350, cryo-soak in solution containing 100 mM Bis-Tris, pH 6.5, 200 mM ammonium acetate, 35% w/v PEG3350",293,,,"5TD9",96.42,"2.318","2.318","Structure of Human Enolase 2","MSIEKIWAREILDSRGNPTVEVDLYTAKGLFRAAVPSGASTGIYEALELRDGDKQRYLGKGVLKAVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTENKSKFGANAILGVSLAVCKAGAAERELPLYRHIAQLAGNSDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGAESFRDAMRLGAEVYHTLKGVIKDKYGKDATNVGDEGGFAPNILENSEALELVKEAIDKAGYTEKIVIGMDVAASEFYRDGKYDLDFKSPTDPSRYITGDQLGALYQDFVRDYPVVSIEDPFDQDDWAAWSKFTANVGIQIVGDDLTVTNPKRIERAVEEKACNCLLLKVNQIGSVTEAIQACKLAQENGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEELGDEARFAGHNFRNPSVLHHHHHH","Homo sapiens","ENO2","Gamma-enolase","1","5TD9"
"5TDE",,"X-RAY DIFFRACTION",2.75,55.25,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5% P3350, 100 mM Tris-HCL pH 7.0, 125 mM ammonium phosphate pH 7.5",294,"10.1107/S2059798317009871",,"5TDE",84.07,"1.7","1.7","TEV Cleaved Human ATP Citrate Lyase Bound to Citrate","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPENLYFQ","Homo sapiens","ACLY","ATP-citrate synthase","1","5TDE"
,,,,,,,,,,,,,,,,"SKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVI","Homo sapiens","ACLY","ATP-citrate synthase","2","5TDE"
"5TDF",,"X-RAY DIFFRACTION",2.71,54.68,"VAPOR DIFFUSION, HANGING DROP",8.4,"15% P3350, 100 mM TrisHCl pH 8.4, 150 mM ammonium chloride",294,"10.1107/S2059798317009871","7A3, ADP","5TDF",84.63,"1.8","1.8","TEV Cleaved Human ATP Citrate Lyase Bound to 4S hydroxycitrate","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPENLYFQ","Homo sapiens","ACLY","ATP-citrate synthase","1","5TDF"
,,,,,,,,,,,,,,,,"SKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVI","Homo sapiens","ACLY","ATP-citrate synthase","2","5TDF"
"5TDI",,"X-RAY DIFFRACTION",2.11,41.68,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.05 M cadmium sulfate hydrate, 0.1 M HEPES pH 7.5, 1.0 M sodium acetate trihydrate",295,"10.1042/BCJ20160985",,"5TDI",24.04,"1.4","1.4","Crystal structure of Cathepsin K with a covalently-linked inhibitor at 1.4 Angstrom resolution.","APDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLAPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","5TDI"
"5TDM",,"X-RAY DIFFRACTION",2.73,55.02,"VAPOR DIFFUSION, HANGING DROP",,"13% P3350, 100 mM TrisHCl pH 8.7, 125 mM ammonium chloride",294,"10.1107/S2059798317009871","ADP","5TDM",84.39,"2.1","2.1","TEV Cleaved Human ATP Citrate Lyase Bound to 4R-Hydroxycitrate and ADP","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPENLYFQ","Homo sapiens","ACLY","ATP-citrate synthase","1","5TDM"
,,,,,,,,,,,,,,,,"SKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVI","Homo sapiens","ACLY","ATP-citrate synthase","2","5TDM"
"5TDN",,"X-RAY DIFFRACTION",2.48,50.47,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3,350, 0.04 M Citrate, 0.06 M BTP, pH6.4",292,,,"5TDN",94.78,"1.63","1.63","Crystal structure of the Fab fragment of anti-HER2 antibody 4D5 with redesigned heavy and light chain interfaces","DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQKKPGKAPKLLIYSASFLESGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVECLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"anti-HER2 Fab Light Chain","1","5TDN"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVREAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLKSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"anti-HER2 Fab Heavy Chain","2","5TDN"
"5TDO",,"X-RAY DIFFRACTION",2.51,50.9,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3,350, 0.04 M Citrate, 0.06 M BTP, pH6.4",292,,,"5TDO",94.78,"1.61","1.61","Crystal structure of the Fab fragment of anti-HER2 antibody 4D5 with redesigned heavy and light chain interfaces","DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQEKPGKAPKLLIYSASFLESGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVKCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"anti-HER2 Fab Light Chain","1","5TDO"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRKAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLESVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"anti-HER2 Fab Heavy Chain","2","5TDO"
"5TDP",,"X-RAY DIFFRACTION",2.5,50.81,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3,350, 0.04 M Citrate, 0.06 M BTP, pH6.4",292,,,"5TDP",94.32,"1.716","1.716","Crystal structure of the Fab fragment of anti-HER2 antibody 4D5 with redesigned heavy and light chain interfaces","DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQKKPGKAPKLLIYSASFLESGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIKRTVAAPSVAIFPPSDEQLKSGTASVVCVLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYALFSVLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"anti-HER2 Fab Light Chain","1","5TDP"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVREAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAILGCLVKDYFPEPVTVSWNSGALTSGVHTSPAVLQSSGLYMLASAVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"anti-HER2 Fab Heavy Chain","2","5TDP"
"5TDQ",,"X-RAY DIFFRACTION",3.24,62.08,"VAPOR DIFFUSION, HANGING DROP",7.5,"13% PEG 4000, 200 mM Ammonium Sulfate, 100 mM HEPES, 10% 2-propanol, 10% glycerol",289,"10.1016/j.str.2016.11.016",,"5TDQ",19.21,"2.493","2.493","Crystal Structure of the GOLD domain of ACBD3","GSHMPVIAAPSMWTRPQIKDFKEKIQQDADSVITVGRGEVVTVRVPTHEEGSYLFWEFATDNYDIGFGVYFEWTDSPNTAVSVHVSESSDDDEEEEENIGCEEKAKKNANKPLLDEIVPVYRRDCHEEVYAGSHQYPGRGVYLLKFDNSYSLWRSKSVYYRVYYTR","Homo sapiens","ACBD3, GCP60, GOCAP1, GOLPH1","Golgi resident protein GCP60","1","5TDQ"
"5TDZ",,"X-RAY DIFFRACTION",2.76,55.42,"VAPOR DIFFUSION, HANGING DROP",8.8,"13% P3350, 100 mM TrisHCl pH 8.8, 100 mM ammonium chloride",294,"10.1107/S2059798317009871","ADP","5TDZ",84.83,"2","2","TEV Cleaved Human ATP Citrate Lyase Bound to Tartrate and ADP","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPENLYFQ","Homo sapiens","ACLY","ATP-citrate synthase","1","5TDZ"
,,,,,,,,,,,,,,,,"SKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVI","Homo sapiens","ACLY","ATP-citrate synthase","2","5TDZ"
"5TE0",,"X-RAY DIFFRACTION",3.37,63.47,"VAPOR DIFFUSION, SITTING DROP",6.5,"25 % PEG 3350, 0.1M BIS-TRIS, 0.2M Lithium Sulfate",293,,"XIN","5TE0",40.47,"1.9","1.9","Crystal Structure of Adaptor Protein 2 Associated Kinase (AAK1) in complex with BIBF 1120","MTSGLGSGYIGRVFGIGRQQVTVDEVLAEGGFAIVFLVRTSNGMKCALKRMFVNNEHDLQVCKREIQIMRDLSGHKNIVGYIDSSINNVSSGDVWEVLILMDFCRGGQVVNLMNQRLQTGFTENEVLQIFCDTCEAVARLHQCKTPIIHRDLKVENILLHDRGHYVLCDFGSATNKFQNPQTEGVNAVEDEIKKYTTLSYRAPEMVNLYSGKIITTKADIWALGCLLYKLCYFTLPFGESQVAICDGNFTIPDNSRYSQDMHCLIRYMLEPDPDKRPDIYQVSYFSFKLLKKECPIPNVQNSPIPAKLPEPVKASEAAAKKTQPKARLTDPIPTTETSIAAENLYFQ","Homo sapiens","AAK1, KIAA1048","AP2-associated protein kinase 1","1","5TE0"
"5TE1",,"X-RAY DIFFRACTION",2.63,53.29,"VAPOR DIFFUSION, HANGING DROP",,"12.5% P3350, 200 mM MES pH 5.9, 125 mM ammonium acetate pH 5",294,"10.1107/S2059798317009871",,"5TE1",181.88,"2.25","2.25","C20S, C293G Mutant N-terminal Human ATP Citrate Lyase Bound to 4R-Hydroxycitrate","MSAKAISEQTGKELLYKFISTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTIGDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPNQPPTAAHTANFLLNASGSTSTPAPSRTASFSESRADEVAPAKKAKPAMPQDSVPSPRSLQGKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVIVPAQEVPAALEHHHHHHH","Homo sapiens","ACLY","ATP-citrate synthase","1","5TE1"
"5TE8",,"X-RAY DIFFRACTION",2.33,47.24,"VAPOR DIFFUSION, SITTING DROP",,"12% polyethilene glycol 3350, 0.1M sodium malonate pH 7.0",293,"10.1073/pnas.1616198114","08J","5TE8",170.1,"2.7","2.7","Crystal structure of the midazolam-bound human CYP3A4","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","5TE8"
"5TEE",,"X-RAY DIFFRACTION",2.6,53.1,"VAPOR DIFFUSION",5.5,"15% PEG4000, 0.2M ammonium acetate, 0.1M sodium citrate",291,"10.1101/gad.288340.116",,"5TEE",84.49,"1.65","1.65","Crystal structure of Gemin5 WD40 repeats in apo form","MGSSHHHHHHSSGLVPRGSMGQEPRTLPPSPNWYCARCSDAVPGGLFGFAARTSVFLVRVGPGAGESPGTPPFRVIGELVGHTERVSGFTFSHHPGQYNLCATSSDDGTVKIWDVETKTVVTEHALHQHTISTLHWSPRVKDLIVSGDEKGVVFCYWFNRNDSQHLFIEPRTIFCLTCSPHHEDLVAIGYKDGIVVIIDISKKGEVIHRLRGHDDEIHSIAWCPLPGEDCLSINQEETSEEAEITNGNAVAQAPVTKGCYLATGSKDQTIRIWSCSRGRGVMILKLPFLKRRGGGIDPTVKERLWLTLHWPSNQPTQLVSSCFGGELLQWDLTQSWRRKYTLFSASSEGQNHSRIVFNLCPLQTEDDKQLLLSTSMDRDVKCWDIATLECSWTLPSLGGFAYSLAFSSVDIGSLAIGVGDGMIRVWNTLSIKNNYDVKNFWQGVKSKVTALCWHPTKEGCLAFGTDDGKVGLYDTYSNKPPQISSTYHKKTVYTLAWGPPVPPMSLGGEGDRPSLALYSCGGEGIVLQHNPWKLSGEAFDINKLIRDTNSIKYKLPVHTEISWKADGKIMALGNEDGSIEIFQIPNLKLICTIQQHHKLVNTISWHHEHGSQPELSYLMASGSNNAVIYVHNLKTVIESSPESPVTITEPYRTLSGHTAKITSVAWSPHHDGRLVSASYDGTAQVWDALREEPLCNFRGHQGRLLCVAWSPLDPDCIYSGADDFCVHKWLTSMQDHSRPPQGKKSIELEKKRLSQPKA","Homo sapiens","GEMIN5","Gem-associated protein 5","1","5TEE"
"5TEF",,"X-RAY DIFFRACTION",2.35,47.69,"VAPOR DIFFUSION",5.5,"15% PEG4000, 0.2 M ammonium acetate, 0.1 sodium citrate, 0.0005-0.001 M m7GpppG",293,"10.1101/gad.288340.116","GTG","5TEF",85.25,"1.95","1.95","Crystal structure of Gemin5 WD40 repeats in complex with m7GpppG","MGSSHHHHHHSSGLVPRGSMGQEPRTLPPSPNWYCARCSDAVPGGLFGFAARTSVFLVRVGPGAGESPGTPPFRVIGELVGHTERVSGFTFSHHPGQYNLCATSSDDGTVKIWDVETKTVVTEHALHQHTISTLHWSPRVKDLIVSGDEKGVVFCYWFNRNDSQHLFIEPRTIFCLTCSPHHEDLVAIGYKDGIVVIIDISKKGEVIHRLRGHDDEIHSIAWCPLPGEDCLSINQEETSEEAEITNGNAVAQAPVTKGCYLATGSKDQTIRIWSCSRGRGVMILKLPFLKRRGGGIDPTVKERLWLTLHWPSNQPTQLVSSCFGGELLQWDLTQSWRRKYTLFSASSEGQNHSRIVFNLCPLQTEDDKQLLLSTSMDRDVKCWDIATLECSWTLPSLGGFAYSLAFSSVDIGSLAIGVGDGMIRVWNTLSIKNNYDVKNFWQGVKSKVTALCWHPTKEGCLAFGTDDGKVGLYDTYSNKPPQISSTYHKKTVYTLAWGPPVPPMSLGGEGDRPSLALYSCGGEGIVLQHNPWKLSGEAFDINKLIRDTNSIKYKLPVHTEISWKADGKIMALGNEDGSIEIFQIPNLKLICTIQQHHKLVNTISWHHEHGSQPELSYLMASGSNNAVIYVHNLKTVIESSPESPVTITEPYRTLSGHTAKITSVAWSPHHDGRLVSASYDGTAQVWDALREEPLCNFRGHQGRLLCVAWSPLDPDCIYSGADDFCVHKWLTSMQDHSRPPQGKKSIELEKKRLSQPKA","Homo sapiens","GEMIN5","Gem-associated protein 5","1","5TEF"
"5TEI",,"X-RAY DIFFRACTION",2.24,45.01,"EVAPORATION",7,"PEG3350, sodium chloride, 100mM Bis Tris Buffer, ytterbium chloride, sitting drop",298,,,"5TEI",56.31,"2.1","2.1","Structure of human ALDH1A1 with inhibitor CM039","MSSSGTPDLPVLLTDLKIQYTKIFINNEWHDSVSGKKFPVFNPATEEELCQVEEGDKEDVDKAVKAARQAFQIGSPWRTMDASERGRLLYKLADLIERDRLLLATMESMNGGKLYSNAYLSDLAGCIKTLRYCAGWADKIQGRTIPIDGNFFTYTRHEPIGVCGQIIPWNFPLVMLIWKIGPALSCGNTVVVKPAEQTPLTALHVASLIKEAGFPPGVVNIVPGYGPTAGAAISSHMDIDKVAFTGSTEVGKLIKEAAGKSNLKRVTLELGGKSPCIVLADADLDNAVEFAHHGVFYHQGQCCIAASRIFVEESIYDEFVRRSVERAKKYILGNPLTPGVTQGPQIDKEQYDKILDLIESGKKEGAKLECGGGPWGNKGYFVQPTVFSNVTDEMRIAKEEIFGPVQQIMKFKSLDDVIKRANNTFYGLSAGVFTKDIDKAITISSALQAGTVWVNCYGVVSAQCPFGGFKMSGNGRELGEYGFHEYTEVKTVTVKISQKNS","Homo sapiens","ALDH1A1, ALDC, ALDH1, PUMB1","Retinal dehydrogenase 1","1","5TEI"
"5TEL",,"X-RAY DIFFRACTION",3.51,64.91,"VAPOR DIFFUSION",,"imidazole 0,1M - NaAcetate 0,7M - pH6,5",277,"10.1016/j.bmcl.2017.08.069",,"5TEL",32.13,"2.214","2.214","Pim-1 kinase in complex with a 7-azaindole","PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHS","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","5TEL"
"5TEQ",,"X-RAY DIFFRACTION",2.52,51.16,"VAPOR DIFFUSION, HANGING DROP",7,"12.5% P3350, 100-200 mM MES pH 7, 125 mM ammonium citrate pH 4.5",294,"10.1107/S2059798317009871",,"5TEQ",181.84,"2.3","2.3","C20S C293G MUTANT N-TERMINAL HUMAN ATP CITRATE LYASE BOUND TO CITRATE","MSAKAISEQTGKELLYKFISTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTIGDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPNQPPTAAHTANFLLNASGSTSTPAPSRTASFSESRADEVAPAKKAKPAMPQDSVPSPRSLQGKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVIVPAQEVPAALEHHHHHHH","Homo sapiens","ACLY","ATP-citrate synthase","1","5TEQ"
"5TES",,"X-RAY DIFFRACTION",2.86,56.97,"VAPOR DIFFUSION, HANGING DROP",8.8,"12.5% P3350, 100 mM TrisHCl pH 8.8, 125 mM ammonium chloride",294,"10.1107/S2059798317009871","ADP","5TES",83.92,"2.4","2.4","TEV Cleaved Human ATP Citrate Lyase Bound to Citrate and ADP","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPENLYFQ","Homo sapiens","ACLY","ATP-citrate synthase","1","5TES"
,,,,,,,,,,,,,,,,"SKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVI","Homo sapiens","ACLY","ATP-citrate synthase","2","5TES"
"5TET",,"X-RAY DIFFRACTION",2.68,54.02,"VAPOR DIFFUSION, HANGING DROP",7,"12.5% of P3350, 100 mM TrisHCL pH 7.5, 125 mM ammonium phosphate pH 7.5",294,"10.1107/S2059798317009871","7A3","5TET",83.76,"2.2","2.2","TEV Cleaved Human ATP Citrate Lyase Bound to 4S Hydroxycitrate","MSAKAISEQTGKELLYKFICTTSAIQNRFKYARVTPDTDWARLLQDHPWLLSQNLVVKPDQLIKRRGKLGLVGVNLTLDGVKSWLKPRLGQEATVGKATGFLKNFLIEPFVPHSQAEEFYVCIYATREGDYVLFHHEGGVDVGDVDAKAQKLLVGVDEKLNPEDIKKHLLVHAPEDKKEILASFISGLFNFYEDLYFTYLEINPLVVTKDGVYVLDLAAKVDATADYICKVKWGDIEFPPPFGREAYPEEAYIADLDAKSGASLKLTLLNPKGRIWTMVAGGGASVVYSDTICDLGGVNELANYGEYSGAPSEQQTYDYAKTILSLMTREKHPDGKILIIGGSIANFTNVAATFKGIVRAIRDYQGPLKEHEVTIFVRRGGPNYQEGLRVMGEVGKTTGIPIHVFGTETHMTAIVGMALGHRPIPENLYFQ","Homo sapiens","ACLY","ATP-citrate synthase","1","5TET"
,,,,,,,,,,,,,,,,"SKSTTLFSRHTKAIVWGMQTRAVQGMLDFDYVCSRDEPSVAAMVYPFTGDHKQKFYWGHKEILIPVFKNMADAMRKHPEVDVLINFASLRSAYDSTMETMNYAQIRTIAIIAEGIPEALTRKLIKKADQKGVTIIGPATVGGIKPGCFKIGNTGGMLDNILASKLYRPGSVAYVSRSGGMSNELNNIISRTTDGVYEGVAIGGDRYPGSTFMDHVLRYQDTPGVKMIVVLGEIGGTEEYKICRGIKEGRLTKPIVCWCIGTCATMFSSEVQFGHAGACANQASETAVAKNQALKEAGVFVPRSFDELGEIIQSVYEDLVANGVI","Homo sapiens","ACLY","ATP-citrate synthase","2","5TET"
"5TEX",,"X-RAY DIFFRACTION",3.52,65.09,"VAPOR DIFFUSION",6.5,"imidazole 0,1M - NaAcetate 1M - pH6,5",277,"10.1016/j.bmcl.2017.08.069","7AU","5TEX",32.11,"2.149","2.149","Pim-1 kinase in complex with a 7-azaindole","PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHS","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","5TEX"
"5TF1",,"X-RAY DIFFRACTION",1.81,32.13,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.1 M Hepes pH 7.5",293,"10.1016/j.celrep.2016.10.017",,"5TF1",49.38,"1.858","1.858","Structure of chimeric 02-CC Fab, a VRC01-like germline antibody","MVQLVQSGTEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNGGDTNYAQKFQGRVTMTRDTSISTAYMELSSLRSEDMAVYYCAREYSSGWYFAYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTKLGGSGGHHHHHHGGSGHG","Homo sapiens",,"02-CC Fab Heavy chain","1","5TF1"
,,,,,,,,,,,,,,,,"EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYEFFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"O2-CC Fab Light Chain","2","5TF1"
"5TF2",,"X-RAY DIFFRACTION",3.4,63.81,"VAPOR DIFFUSION, SITTING DROP",7,"PREB protein was mixed with elastase at 1:1000 (w/w) ratio before setting up
crystallization.  Crystals were grown at 293 K using the sitting drop method by mixing 0.5 uL protein
with 0.5 uL well solution consisting of 1.4M Malonate, pH 7.0.
The crystals were cryoprotected by immersion in Paratone.",293,,,"5TF2",44.68,"2.8","2.8","CRYSTAL STRUCTURE OF THE WD40 DOMAIN OF THE HUMAN PROLACTIN REGULATORY ELEMENT-BINDING PROTEIN","MHHHHHHSSGRENLYFQGMGRRRAPELYRAPFPLYALQVDPSTGLLIAAGGGGAAKTGIKNGVHFLQLELINGRLSASLLHSHDTETRATMNLALAGDILAAGQDAHCQLLRFQAHQQQGNKAEKAGSKEQGPRQRKGAAPAEKKCGAETQHEGLELRVENLQAVQTDFSSDPLQKVVCFNHDNTLLATGGTDGYVRVWKVPSLEKVLEFKAHEGEIEDLALGPDGKLVTVGRDLKASVWQKDQLVTQLHWQENGPTFSSTPYRYQACRFGQVPDQPAGLRLFTVQIPHKRLRQPPPCYLTAWDGSNFLPLRTKSCGHEVVSCLDVSESGTFLGLGTVTGSVAIYIAFSLQCLYYVREAHGIVVTDVAFLPEKGRGPELLGSHETALFSVAVDSRCQLHLLPSRRSV","Homo sapiens","PREB, SEC12","Prolactin regulatory element-binding protein","1","5TF2"
"5TF5",,"X-RAY DIFFRACTION",2.49,50.6,"VAPOR DIFFUSION, HANGING DROP",,"Protein (1 uL) at a concentration of 7 mg/mL were mixed with an equal volume of a reservoir solution containing 200 mM NaCl, 0.1M NaCitrate pH 5.6, 24% PEG4K, 1.5mM DDT and equilibrated against 1 mL of a reservoir solution at 293 K.",293,,,"5TF5",95.62,"1.807","1.807","CRYSTAL STRUCTURE OF HUMAN KAT-2 IN COMPLEX WITH A REVERSIBLE INHIBITOR","MNYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKTIQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQGLCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKPEDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNKFRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQLMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKVKGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQLIKESL","Homo sapiens","AADAT, KAT2, KYAT2","Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial","1","5TF5"
"5TF7",,"X-RAY DIFFRACTION",2.38,48.3,"MICROBATCH",7.5,"40% (v/v) PEG 400, 100 mM NH4Cl, and 100 mM MES, pH 6",279,,,"5TF7",26.06,"1.931","1.931","Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR) with ATP","SLTTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","5TF7"
"5TF8",,"X-RAY DIFFRACTION",2.35,47.66,"MICROBATCH",7.5,"Protein buffer:containing 150 mM NaCl, 30% (v/v) glycerol, 1 mM TCEP, and 20 mM Na-HEPES, pH 7.5, Precipitant buffer: 40% (v/v) PEG 400, 100 mM NH4Cl, and 100 mM MES, pH 6",279,,,"5TF8",26.03,"1.861","1.861","Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR) with dTTP","SLTTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","5TF8"
"5TF9",,"X-RAY DIFFRACTION",2.12,41.95,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES, pH 7.5, 200 mM calcium acetate, 22% PEG3350",298,"10.1021/acschembio.6b00511","7AV","5TF9",65.9,"2.5","2.5","Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476","GELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRADFAKSVIGTPEFMAPEMYAAAYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEET","Homo sapiens","WNK1, HSN2, KDP, KIAA0344, PRKWNK1","Serine/threonine-protein kinase WNK1","1","5TF9"
"5TFA",,"X-RAY DIFFRACTION",2.36,47.83,"MICROBATCH",7.5,"Protein buffer: 150 mM NaCl, 30% (v/v) glycerol, 1 mM TCEP, and 20 mM Na-HEPES, pH 7.5;
Precipitant buffer: 40% (v/v) PEG 400, 100 mM NH4Cl, and 100 mM MES, pH 6",279,,,"5TFA",26.02,"1.87","1.87","Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR) with dUTP","SLTTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","5TFA"
"5TFB",,"X-RAY DIFFRACTION",2.39,48.58,"MICROBATCH",7.5,"Protein buffer: 150 mM NaCl, 30% (v/v) glycerol, 1 mM TCEP, and 20 mM Na-HEPES, pH 7.5
Precipitant buffer: 40% (v/v) PEG 400, 100 mM NH4Cl, and 100 mM MES, pH 6",279,,,"5TFB",26.09,"1.87","1.87","Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR) with 7-methyl-GTP","SLTTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","5TFB"
"5TFC",,"X-RAY DIFFRACTION",2.34,47.48,"MICROBATCH",7.5,"Protein buffer: 150 mM NaCl, 30% (v/v) glycerol, 1 mM TCEP, and 20 mM Na-HEPES, pH 7.5;
Precipitant buffer: 40% (v/v) PEG 400, 100 mM NH4Cl, and 100 mM MES, pH 6",279,,,"5TFC",26.07,"1.92","1.92","Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR) with GTP","SLTTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","5TFC"
"5TFD",,"X-RAY DIFFRACTION",2.38,48.33,"MICROBATCH",,"Protein buffer: 150 mM NaCl, 30% (v/v) glycerol, 1 mM TCEP, and 20 mM Na-HEPES, pH 7.5;
Precipitant buffer: 40% (v/v) PEG 400, 100 mM NH4Cl, and 100 mM MES, pH 6",279,,,"5TFD",26.03,"1.891","1.891","Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR) with CTP","SLTTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","5TFD"
"5TFF",,"X-RAY DIFFRACTION",2.38,48.36,"MICROBATCH",7.5,"Protein buffer: 150 mM NaCl, 30% (v/v) glycerol, 1 mM TCEP, and 20 mM Na-HEPES, pH 7.5;
Precipitant buffer: 40% (v/v) PEG 400, 100 mM NH4Cl, and 100 mM MES, pH 6",279,,,"5TFF",26.03,"1.891","1.891","Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR) with UTP","SLTTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","5TFF"
"5TFG",,"X-RAY DIFFRACTION",2.38,48.26,"MICROBATCH",,"Protein buffer: 150 mM NaCl, 30% (v/v) glycerol, 1 mM TCEP, and 20 mM Na-HEPES, pH 7.5;
Precipitant buffer: 40% (v/v) PEG 400, 100 mM NH4Cl, and 100 mM MES, pH 6",279,,,"5TFG",26.05,"1.91","1.91","Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR) with 5-methyl-UTP","SLTTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","5TFG"
"5TFI",,"X-RAY DIFFRACTION",2.36,47.82,"MICROBATCH",7.5,"Protein buffer: 150 mM NaCl, 10% (v/v) glycerol,10% (v/v) Ethylene glycol, 10mM MgCl2, 1 mM TCEP, and 20 mM Na-HEPES, pH 7.5. Precipitant buffer: 40% (v/v) PEG 400, 100 mM NH4Cl, and 100 mM MES, pH 6",279,,,"5TFI",26.06,"1.891","1.891","Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR) with dGTP","SLTTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","5TFI"
"5TFJ",,"X-RAY DIFFRACTION",2.38,48.24,"MICROBATCH",7.5,"Protein buffer: 150 mM NaCl, 10% (v/v) glycerol,10% (v/v) Ethylene glycol, 10mM MgCl2, 1 mM TCEP, and 20 mM Na-HEPES, pH 7.5. Precipitant buffer: 40% (v/v) PEG 400, 100 mM NH4Cl, and 100 mM MES, pH 6",279,,,"5TFJ",26.02,"1.85","1.85","Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR) with dCTP","SLTTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","5TFJ"
"5TFM",,"X-RAY DIFFRACTION",4.12,70.11,"VAPOR DIFFUSION, SITTING DROP",6.8,"0.1 M MES pH 6.8, 1.2 M NaCl",277,"10.1016/j.str.2018.06.003",,"5TFM",37.71,"2.92","2.92","Crystal Structure of Human Cadherin-23 EC6-8","MNVPTFQKDAYVGALRENEPSVTQLVRLRATDEDSPPNNQITYSIVSASAFGSYFDISLYEGYGVISVSRPLDYEQISNGLIYLTVMAMDAGNPPLNSTVPVTIEVFDENDNPPTFSKPAYFVSVVENIMAGATVLFLNATDLDRSREYGQESIIYSLEGSTQFRINARSGEITTTSLLDRETKSEYILIVRAVDGGVGHNQKTGIATVNITLLDINDNHPTWKDAPYYINLVEMTPPDSDVTTVVAVDPDLGENGTLVYSIQPPNKFYSLNSTTGKIRTTHAMLDRENPDPHEAELMRKIVVSVTDCGRPPLKATSSATVFVNLLDLNDNLEHHHHHH","Homo sapiens","CDH23, KIAA1774, KIAA1812, UNQ1894/PRO4340","Cadherin-23","1","5TFM"
"5TFP",,"X-RAY DIFFRACTION",3.08,60.07,"VAPOR DIFFUSION, HANGING DROP",7,"0.2 M ammonium tartrate (pH 6.0) and 20% PEG3350",277,,,"5TFP",15.81,"2","2","Crystal Structure of the SETDB2 Amino Terminal Domain","MGEKNGDAKTFWMELEDDGKVDFIFEQVQNVLQSLKQKIKDGSATNKEYIQAMILVNEATIINS","Homo sapiens","SETDB2, C13orf4, CLLD8, KMT1F","Histone-lysine N-methyltransferase SETDB2","1","5TFP"
"5TFS",,"X-RAY DIFFRACTION",2.53,51.39,"VAPOR DIFFUSION, HANGING DROP",,"30 % PEG 8000, 15 % isopropanol, 0.1 M Hepes pH 7.5, 0.2 M Ammonium Sulfate",293,"10.1016/j.celrep.2016.10.017",,"5TFS",46.85,"2.319","2.319","Structure of chimeric 02-K Fab, a VRC01-like germline antibody","QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELRSLRSDDTAVYYCARGWGWYFDLWGRGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP","Homo sapiens",,"02-K Fab Heavy chain","1","5TFS"
,,,,,,,,,,,,,,,,"EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYEFFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"02-K Fab Light chain","2","5TFS"
"5TFT",,"X-RAY DIFFRACTION",3.19,61.46,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, SODIUM ACETATE, SODIUM    CACODYLATE, POTASSIUM PHOSPHATE, SODIUM CHLORIDE, ZINC CHLORIDE, GLYCEROL, BETA-MERCAPTOETHANOL, THIORIDAZINE, HEGA-10, FACIAL AMPHIPHILE 231_CHOL. BETA-SECRETASE INHIBITOR WAS ADDED TO THE MOTHER LIQUOR AFTER CRYSTALLIZATION OF THE P450 2D6 THIORDIDAZINE TERNARY COMPLEX.",298,"10.1021/acs.jmedchem.6b01451","P6U","5TFT",219.23,"2.71","2.71","Structure of cytochrome P450 2D6 (CYP2D6) BACE1 inhibitor complex","MAKKTSSKGKLPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPRHHHH","Homo sapiens","CYP2D6, CYP2DL1","Cytochrome P450 2D6","1","5TFT"
"5TFU",,"X-RAY DIFFRACTION",3.14,60.88,"VAPOR DIFFUSION, HANGING DROP",,"PEG3350, SODIUM ACETATE, SODIUM CACODYLATE, POTASSIUM PHOSPHATE, SODIUM CHLORIDE, ZINC CHLORIDE, GLYCEROL, BETA-MERCAPTOETHANOL, THIORIDAZINE, HEGA-10, FACIAL AMPHIPHILE 231_CHOL. BETA-SECRETASE INHIBITOR WAS ADDED TO THE MOTHER LIQUOR AFTER CRYSTALLIZATION OF THE P450 2D6 THIORDIDAZINE TERNARY COMPLEX.",298,"10.1021/acs.jmedchem.6b01451","P6M","5TFU",219.29,"2.75","2.75","Structure of cytochrome P450 2D6 (CYP2D6) BACE1 inhibitor complex","MAKKTSSKGKLPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPRHHHH","Homo sapiens","CYP2D6, CYP2DL1","Cytochrome P450 2D6","1","5TFU"
"5TFX",,"X-RAY DIFFRACTION",2.11,41.8,"VAPOR DIFFUSION, SITTING DROP",8.3,"2.7 M ammonium sulfate, 100 mM Tris pH 8.3 with protein at 7 mg/mL",281,"10.1039/c6ob02299e","7B1","5TFX",29.76,"1.5","1.5","New method for synthesis of benzoxazole amide inhibitors of carbonic anhydrase","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5TFX"
"5TGB",,"X-RAY DIFFRACTION",2.74,55.05,"VAPOR DIFFUSION, HANGING DROP",,"20% isopropanol, 20% PEG 4000, 0.1 M Sodium citrate pH 5.6",293,"10.1016/j.celrep.2016.10.017",,"5TGB",93.98,"2.741","2.741","Structure of chimeric 02-CB Fab, a VRC01-like germline antibody","QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARDGWYSSGWYFDSWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKS","Homo sapiens",,"02-CB Fab Heavy Chain","1","5TGB"
,,,,,,,,,,,,,,,,"EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQYEFFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"02-CB Fab Light Chain","2","5TGB"
"5TGK",,"X-RAY DIFFRACTION",2.37,48.02,"MICROBATCH",7.5,"Protein buffer: 150 mM NaCl, 10% (v/v) glycerol,10% (v/v) Ethylene glycol, 10mM MgCl2, 1 mM TCEP, and 20 mM Na-HEPES, pH 7.5. Precipitant buffer: 40% (v/v) PEG 400, 100 mM NH4Cl, and 100 mM MES, pH 6",279,"10.1074/jbc.RA117.000819",,"5TGK",26.04,"1.912","1.912","Nucleotide-binding domain 1 of the human cystic fibrosis transmembrane conductance regulator (CFTR) with dATP","SLTTTEVVMENVTAFWEEGGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMMIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMG","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","5TGK"
"5TH4",,"X-RAY DIFFRACTION",2.11,41.66,"VAPOR DIFFUSION, SITTING DROP",8,"Ammonium Sulfate, Tris, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1007/s00775-017-1454-3",,"5TH4",29.6,"1.47","1.47","Crystal Structure of 1-hydroxypyridine-2(1H)-thione bound to human carbonic anhydrase 2 L198G","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSGTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5TH4"
"5TH6",,"X-RAY DIFFRACTION",2.1,41.44,"VAPOR DIFFUSION, SITTING DROP",5,"12% (v/v) PEG 8000
0.3 M lithium sulfate
0.1 M sodium acetate, pH 5.0",293,"10.1074/jbc.M116.760579",,"5TH6",104.85,"1.7","1.7","Structure determination of a potent, selective antibody inhibitor of human MMP9 (apo MMP9)","MATDRQLAEEYLYRYGYTRVAEMRGESKSLGPALLLLQKQLSLPETGELDSATLKAMRTPRCGVPDLGRFQTFEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGQGYSLFLVAAHEFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLY","Homo sapiens","MMP9, CLG4B","Matrix metalloproteinase-9,Matrix metalloproteinase-9","1","5TH6"
,,,,,,,,,,,,,,,,,"Homo sapiens","MMP9, CLG4B"
"5TH7",,"X-RAY DIFFRACTION",2.17,43.38,"VAPOR DIFFUSION, SITTING DROP",5.2,"20% PEG-3350, 0.2 M ammonium fluoride, 0.1 M sodium cacodylate",291,"10.1021/acs.jmedchem.6b01244",,"5TH7",34.4,"1.95","1.95","Complex of SETD8 with MS453","GKSKAELQSEERKRIDELIESGKEEGMKIDLIDGKGRGVIATKQFSRGDFVVEYHGDLIEITDAKKREALYAQDPSTGCYMYYFQYLSKTYCVDATRETNRLGRLINHSKSGNCQTKLHDIDGVPHLILIASRDIAAGEELLYDYGDR","Homo sapiens","KMT5A, PRSET7, SET07, SET8, SETD8","N-lysine methyltransferase KMT5A","1","5TH7"
"5THA",,"X-RAY DIFFRACTION",2.35,47.6,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Na-Citrate, pH 5.5, 0.2 M Ammonium Acetate, and 18% PEG4K with 1 mM GpppG",291,"10.1101/gad.288340.116","GP3","5THA",84.96,"1.8","1.8","Gemin5 WD40 repeats in complex with a guanosyl moiety","MGSSHHHHHHSSGLVPRGSMGQEPRTLPPSPNWYCARCSDAVPGGLFGFAARTSVFLVRVGPGAGESPGTPPFRVIGELVGHTERVSGFTFSHHPGQYNLCATSSDDGTVKIWDVETKTVVTEHALHQHTISTLHWSPRVKDLIVSGDEKGVVFCYWFNRNDSQHLFIEPRTIFCLTCSPHHEDLVAIGYKDGIVVIIDISKKGEVIHRLRGHDDEIHSIAWCPLPGEDCLSINQEETSEEAEITNGNAVAQAPVTKGCYLATGSKDQTIRIWSCSRGRGVMILKLPFLKRRGGGIDPTVKERLWLTLHWPSNQPTQLVSSCFGGELLQWDLTQSWRRKYTLFSASSEGQNHSRIVFNLCPLQTEDDKQLLLSTSMDRDVKCWDIATLECSWTLPSLGGFAYSLAFSSVDIGSLAIGVGDGMIRVWNTLSIKNNYDVKNFWQGVKSKVTALCWHPTKEGCLAFGTDDGKVGLYDTYSNKPPQISSTYHKKTVYTLAWGPPVPPMSLGGEGDRPSLALYSCGGEGIVLQHNPWKLSGEAFDINKLIRDTNSIKYKLPVHTEISWKADGKIMALGNEDGSIEIFQIPNLKLICTIQQHHKLVNTISWHHEHGSQPELSYLMASGSNNAVIYVHNLKTVIESSPESPVTITEPYRTLSGHTAKITSVAWSPHHDGRLVSASYDGTAQVWDALREEPLCNFRGHQGRLLCVAWSPLDPDCIYSGADDFCVHKWLTSMQDHSRPPQGKKSIELEKKRLSQPKA","Homo sapiens","GEMIN5","Gem-associated protein 5","1","5THA"
"5THH",,"X-RAY DIFFRACTION",2.84,56.7,"VAPOR DIFFUSION",,"Ammonium sulfate, acetone, Sodium phosphate",289,"10.1093/nar/gkx455",,"5THH",38.57,"1.959","1.959","Crystal structure of a human tyrosyl-tRNA synthetase mutant","APSPEEKLHLITRNLQEVLGEEKLKEILKERELKIYWGTATTGKPHVAYFVPMSKIADFLKAGCEVTILFADLHAYLDNMKAPWELLELRVSYYENVIKAMLESIGVPLEKLKFIKGTDYQLSKEYTLDVYRLSSVVTQHDSKKAGAEVVKQVEHPLLSGLLYPGLQALDEEYLKVDAQFGGIDQRKIFTFAKKYLPALGYSKRVHLMNPMVPGLTGSKMSSSEEESKIDLLDRKEDVKKKLKKAFCEPGNVENNGVLSFIKHVLFPLKSEFVILRDEKWGGNKTYTAYVDLEKDFAAEVVHPGDLKNSVEVALNKLLDPIREKFNTPALKKLASAAYP","Homo sapiens","YARS, YARS1","Tyrosine--tRNA ligase, cytoplasmic","1","5THH"
"5THI",,"X-RAY DIFFRACTION",2.1,41.46,"VAPOR DIFFUSION",8,"Ammonium Sulfate, Tris, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1007/s00775-017-1454-3","0TR","5THI",30.12,"1.5","1.5","Crystal Structure of 2-hydroxycyclohepta-2,4,6-trien-1-one bound to human carbonic anhydrase 2 L198G","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSGTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5THI"
"5THJ",,"X-RAY DIFFRACTION",2.08,40.87,"VAPOR DIFFUSION, SITTING DROP",8,"Ammonium Sulfate, Tris, pH 8.0, VAPOR DIFFUSION, temperature 291K",291,"10.1007/s00775-017-1454-3","0TR","5THJ",30.55,"1.5","1.5","Crystal Structure of 2-hydroxycyclohepta-2,4,6-trien-1-one bound to human carbonic anhydrase 2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5THJ"
"5THL",,"X-RAY DIFFRACTION",2.53,51.35,"VAPOR DIFFUSION",,"ammonium sulfate, acetone, sodium phosphate",289,"10.1093/nar/gkx455",,"5THL",42.23,"1.6","1.6","Crystal structure of the human tyrosyl-tRNA synthetase mutant G41R","MGDAPSPEEKLHLITRNLQEVLGEEKLKEILKERELKIYWRTATTGKPHVAYFVPMSKIADFLKAGCEVTILFADLHAYLDNMKAPWELLELRVSYYENVIKAMLESIGVPLEKLKFIKGTDYQLSKEYTLDVYRLSSVVTQHDSKKAGAEVVKQVEHPLLSGLLYPGLQALDEEYLKVDAQFGGIDQRKIFTFAEKYLPALGYSKRVHLMNPMVPGLTGSKMSSSEEESKIDLLDRKEDVKKKLKKAFCEPGNVENNGVLSFIKHVLFPLKSEFVILRDEKWGGNKTYTAYVDLEKDFAAEVVHPGDLKNSVEVALNKLLDPIREKFNTPALKKLASAAYPDPSKQKPMAKGPAKNSEPEEVILEHHHHHH","Homo sapiens","YARS, YARS1","Tyrosine--tRNA ligase, cytoplasmic","1","5THL"
"5THN",,"X-RAY DIFFRACTION",2.05,39.9,"VAPOR DIFFUSION, SITTING DROP",8,"Ammonium Sulfate, Tris, pH 8.0 VAPOR DIFFUSION, temperature 291K",291,"10.1007/s00775-017-1454-3","7CZ","5THN",30.1,"1.33","1.33","Crystal Structure of 2-Hydroxycyclohepta-2,4,6-triene-1-thione bound to human carbonic anhydrase 2","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5THN"
"5THS",,"X-RAY DIFFRACTION",2.43,49.31,"VAPOR DIFFUSION, SITTING DROP",,"100 mM imidazole (pH 7.0), 15% w/v PEG 35000, 4 mM TCEP",294,"10.1021/acs.biochem.6b01014",,"5THS",88.2,"1.9","1.9","Crystal Structure of G302A HDAC8 in complex with M344","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILAGGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","5THS"
"5THT",,"X-RAY DIFFRACTION",2.36,47.89,"VAPOR DIFFUSION, SITTING DROP",,"100 mM HEPES (pH 7.5), 22% w/v PEG 6000, 4 mM TCEP",294,"10.1021/acs.biochem.6b01014",,"5THT",176.46,"2.407","2.407","Crystal Structure of G303A HDAC8 in complex with M344","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGAGGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","5THT"
"5THU",,"X-RAY DIFFRACTION",2.5,50.81,"VAPOR DIFFUSION, SITTING DROP",,"100 mM BisTris (pH 6.5), 10% w/v PEG 35000, 4 mM TCEP",277,"10.1021/acs.biochem.6b01014",,"5THU",87.58,"1.95","1.95","Crystal Structure of G304A HDAC8 in complex with M344","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGAGYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","5THU"
"5THV",,"X-RAY DIFFRACTION",2.37,48.2,"VAPOR DIFFUSION, SITTING DROP",,"200 mM BisTris (pH 6.5), 13% w/v PEG 4000, 4 mM TCEP",294,"10.1021/acs.biochem.6b01014",,"5THV",89.01,"1.868","1.868","Crystal Structure of G305A HDAC8 in complex with M344","MEEPEEPADSGQSLVPVYIYSPEYVSMCDSLAKIPKRASMVHSLIEAYALHKQMRIVKPKVASMEEMATFHTDAYLQHLQKVSQEGDDDHPDSIEYGLGYDCPATEGIFDYAAAIGGATITAAQCLIDGMCKVAINWSGGWHHAKKDEASGFCYLNDAVLGILRLRRKFERILYVDLDLHHGDGVEDAFSFTSKVMTVSLHKFSPGFFPGTGDVSDVGLGKGRYYSVNVPIQDGIQDEKYYQICESVLKEVYQAFNPKAVVLQLGADTIAGDPMCSFNMTPVGIGKCLKYILQWQLATLILGGGAYNLANTARCWTYLTGVILGKTLSSEIPDHEFFTAYGPDYVLEITPSCRPDRNEPHRIQQILNYIKGNLKHVVIEGRGSHHHHHH","Homo sapiens","HDAC8, HDACL1, CDA07","Histone deacetylase 8","1","5THV"
"5TI0",,"X-RAY DIFFRACTION",2.06,40.25,"VAPOR DIFFUSION, SITTING DROP",8,"Ammonium Sulfate, Tris, pH 8.0 VAPOR DIFFUSION, temperature 291K",291,"10.1007/s00775-017-1454-3","7CZ","5TI0",29.59,"1.42","1.42","Crystal Structure of 2-Hydroxycyclohepta-2,4,6-triene-1-thione bound to human carbonic anhydrase 2 L198G","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSGTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5TI0"
"5TI2",,"X-RAY DIFFRACTION",2.13,42.16,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES PH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM, SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM 7635936",291,"10.1021/acsomega.7b00553","7CJ","5TI2",15.62,"1.65","1.65","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH INHIBITOR 7635936","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5TI2"
"5TI3",,"X-RAY DIFFRACTION",2.12,41.95,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES PH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM, SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM 17503468",291,"10.1021/acsomega.7b00553","7CG","5TI3",15.82,"1.703","1.703","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH INHIBITOR 17503468","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5TI3"
"5TI4",,"X-RAY DIFFRACTION",2.12,42.01,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES PH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM, SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM 8841871",291,"10.1021/acsomega.7b00553","7CM","5TI4",15.72,"1.62","1.62","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH INHIBITOR 8841871","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5TI4"
"5TI5",,"X-RAY DIFFRACTION",2.1,41.56,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES PH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM, SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM 8841880",291,"10.1021/acsomega.7b00553","7CN","5TI5",15.74,"1.83","1.83","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH INHIBITOR 8841880","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5TI5"
"5TI6",,"X-RAY DIFFRACTION",2.13,42.24,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES PH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM, SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM 8841881",291,"10.1021/acsomega.7b00553","7CO","5TI6",15.64,"1.704","1.704","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH INHIBITOR 8841881","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5TI6"
"5TI7",,"X-RAY DIFFRACTION",2.14,42.57,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES PH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM, SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM 17528462",291,"10.1021/acsomega.7b00553","7CQ","5TI7",15.77,"1.65","1.65","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH INHIBITOR 17528462","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5TI7"
"5TI9",,"X-RAY DIFFRACTION",2.7,54,"MICROBATCH",5.6,"50 mM sodium citrate (pH 5.6), 5% (w/v) PEG 3350 and 2% (w/v) Tacsimate (pH 5)",291,"10.1038/srep35169",,"5TI9",185.15,"2.5","2.5","Crystal structure of human TDO in complex with Trp and dioxygen, Northeast Structural Genomics Consortium Target HR6161","MLPVEGSEEDKSQTGVNRASKGGLIYGNYLHLEKVLNAQELQSETKGNKIHDEHLFIITHQAYELWFKQILWELDSVREIFQNGHVRDERNMLKVVSRMHRVSVILKLLVQQFSILETMTALDFNDFREYLSPASGFQSLQFRLLENKIGVLQNMRVPYNRRHYRDNFKGEENELLLKSEQEKTLLELVEAWLERTPGLEPHGFNFWGKLEKNITRGLEEEFIRIQAKEESEEKEEQVAEFQKQKEVLLSLFDEKRHEHLLSKGERRLSYRALQGALMIYFYREEPRFQVPFQLLTSLMDIDSLMTKWRYNHVCMVHRMLGSKAGTGGSSGYHYLRSTVSDRYKVFVDLFNLSTYLIPRHWIPKMNPTIHKFLEHHHHHH","Homo sapiens","TDO2, TDO","Tryptophan 2,3-dioxygenase","1","5TI9"
"5TIA",,"X-RAY DIFFRACTION",3.05,59.68,"MICROBATCH",5.6,"50 mM sodium citrate (pH 5.6), 5% (w/v) PEG 3350, and 2% (w/v) Tacsimate (pH 5)",291,"10.1038/srep35169",,"5TIA",184.83,"2.441","2.441","Crystal structure of human TDO in complex with Trp, Northeast Structural Genomics Consortium Target HR6161","MLPVEGSEEDKSQTGVNRASKGGLIYGNYLHLEKVLNAQELQSETKGNKIHDEHLFIITHQAYELWFKQILWELDSVREIFQNGHVRDERNMLKVVSRMHRVSVILKLLVQQFSILETMTALDFNDFREYLSPASGFQSLQFRLLENKIGVLQNMRVPYNRRHYRDNFKGEENELLLKSEQEKTLLELVEAWLERTPGLEPHGFNFWGKLEKNITRGLEEEFIRIQAKEESEEKEEQVAEFQKQKEVLLSLFDEKRHEHLLSKGERRLSYRALQGALMIYFYREEPRFQVPFQLLTSLMDIDSLMTKWRYNHVCMVHRMLGSKAGTGGSSGYHYLRSTVSDRYKVFVDLFNLSTYLIPRHWIPKMNPTIHKFLEHHHHHH","Homo sapiens","TDO2, TDO","Tryptophan 2,3-dioxygenase","1","5TIA"
"5TIJ",,"X-RAY DIFFRACTION",2.26,45.48,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM Bis-Tris, pH 6.5, 200 mM ammonium acetate, 20% w/v PEG3350, soak in solution containing 100 mM Bis-Tris, pH 6.5, 200 mM ammonium acetate, 35% w/v PEG3350, 2 mM compound",293,,,"5TIJ",96.77,"2.634","2.634","Structure of Human Enolase 2 with ((3S,5S)-1,5-dihydroxy-3-methyl-2-oxopyrrolidin-3-yl)phosphonate (purified enantiomer)","MSIEKIWAREILDSRGNPTVEVDLYTAKGLFRAAVPSGASTGIYEALELRDGDKQRYLGKGVLKAVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTENKSKFGANAILGVSLAVCKAGAAERELPLYRHIAQLAGNSDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGAESFRDAMRLGAEVYHTLKGVIKDKYGKDATNVGDEGGFAPNILENSEALELVKEAIDKAGYTEKIVIGMDVAASEFYRDGKYDLDFKSPTDPSRYITGDQLGALYQDFVRDYPVVSIEDPFDQDDWAAWSKFTANVGIQIVGDDLTVTNPKRIERAVEEKACNCLLLKVNQIGSVTEAIQACKLAQENGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEELGDEARFAGHNFRNPSVLHHHHHH","Homo sapiens","ENO2","Gamma-enolase","1","5TIJ"
"5TIN",,"X-RAY DIFFRACTION",4.53,72.84,"VAPOR DIFFUSION, HANGING DROP",6.5,"200 mM Calcium Chloride, 22.5-27.5% PEG-350MME, 100 mM MES",277,,"7C6","5TIN",212.1,"2.61","2.61","Crystal Structure of Human Glycine Receptor alpha-3 Mutant N38Q Bound to AM-3607","ARSRSAPMSPSDFLDKLMGRTSGYDARIRPNFKGPPVQVTCNIFINSFGSIAETTMDYRVNIFLRQKWNDPRLAYSEYPDDSLDLDPSMLDSIWKPDLFFANEKGANFHEVTTDNKLLRIFKNGNVLYSIRLTLTLSCPMDLKNFPMDVQTCIMQLESFGYTMNDLIFEWQDEAPVQVAEGLTLPQFLLKEEKDLRYCTKHYNTGKFTCIEVRFHLERQMGYYLIQMYIPSLLIVILSWVSFWINMDAAPARVALGITTVLTMTTQSSGSRASLPKVSYVKAIDIWMAVCLLFVFSALLEYAAVNFVSRAGTKVFIDRAKKIDTISRACFPLAFLIFNIFYWVIYKILRHEDIHWSHPQFEK","Homo sapiens","GLRA3","Glycine receptor subunit alpha-3","1","5TIN"
,,,,,,,,,,,,,,,,,"Homo sapiens","GLRA3"
"5TIO",,"X-RAY DIFFRACTION",3.87,68.18,"VAPOR DIFFUSION, HANGING DROP",6.5,"200 mM Calcium Chloride, 22.5-27.5% PEG-350MME, 100 mM MES",277,,"7C6","5TIO",212.22,"3.25","3.25","Crystal Structure of Human Glycine Receptor alpha-3 Bound to AM-3607","ARSRSAPMSPSDFLDKLMGRTSGYDARIRPNFKGPPVNVTCNIFINSFGSIAETTMDYRVNIFLRQKWNDPRLAYSEYPDDSLDLDPSMLDSIWKPDLFFANEKGANFHEVTTDNKLLRIFKNGNVLYSIRLTLTLSCPMDLKNFPMDVQTCIMQLESFGYTMNDLIFEWQDEAPVQVAEGLTLPQFLLKEEKDLRYCTKHYNTGKFTCIEVRFHLERQMGYYLIQMYIPSLLIVILSWVSFWINMDAAPARVALGITTVLTMTTQSSGSRASLPKVSYVKAIDIWMAVCLLFVFSALLEYAAVNFVSRAGTKVFIDRAKKIDTISRACFPLAFLIFNIFYWVIYKILRHEDIHWSHPQFEK","Homo sapiens","GLRA3","Glycine receptor subunit alpha-3","1","5TIO"
,,,,,,,,,,,,,,,,,"Homo sapiens","GLRA3"
"5TIU",,"X-RAY DIFFRACTION",2.24,45.16,"VAPOR DIFFUSION, SITTING DROP",,"16% PEG3350, 0.1M Tris pH 7.1-7.4",277.15,"10.1021/acsmedchemlett.6b00353","7CU","5TIU",34.19,"1.49","1.49","Crystal structure of SYK kinase domain with inhibitor","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","5TIU"
"5TJ7",,"X-RAY DIFFRACTION",2.05,40.02,"VAPOR DIFFUSION",,"0.1 M potassium thiocyanate, 30% PEG monomethyl ether 2000",291,"10.1016/j.molcel.2017.03.020",,"5TJ7",213.93,"2.6","2.6","Structure of WWP2 WW2-2,3-linker-HECT aa 334-398 linked to 485-865","GPGWEKRTDPRGRFYYVDHNTRTTTWQRPTAEYVRNYEQWQSQRNQLQGAMQHFSQRFLYQSSSASQGSPGAYDRSFRWKYHQFRFLCHSNALPSHVKISVSRQTLFEDSFQQIMNMKPYDLRRRLYIIMRGEEGLDYGGIAREWFFLLSHEVLNPMYCLFEYAGKNNYCLQINPASSINPDHLTYFRFIGRFIAMALYHGKFIDTGFTLPFYKRMLNKRPTLKDLESIDPEFYNSIVWIKENNLEECGLELYFIQDMEILGKVTTHELKEGGESIRVTEENKEEYIMLLTDWRFTRGVEEQTKAFLDGFNEVAPLEWLRYFDEKELELMLCGMQEIDMSDWQKSTIYRHYTKNSKQIQWFWQVVKEMDNEKRIRLLQFVTGTCRLPVGGFAELIGSNGPQKFCIDKVGKETWLPRSHTCFNRLDLPPYKSYEQLREKLLYAIEETE","Homo sapiens","WWP2","NEDD4-like E3 ubiquitin-protein ligase WWP2","1","5TJ7"
,,,,,,,,,,,,,,,,,"Homo sapiens","WWP2"
"5TJ8",,"X-RAY DIFFRACTION",2.06,40.26,"VAPOR DIFFUSION",6,"0.1 M MMT (DL-malic acid, MES, Tris-base in molar ratio of 1:2:2) pH 6.0, 25% PEG1500",298,"10.1016/j.molcel.2017.03.020",,"5TJ8",53.46,"2.3","2.3","Structure of WWP2 WW2-2,3-linker-HECT (no WW2 observed)","GPGWEKRTDPRGRFYYVDHNTRTTTWQRPTAEYVRNYEQWQSQRNQLQGAMQHFSQRFLYQSSSASQGSPGAYDRSFRWKYHQFRFLCHSNALPSHVKISVSRQTLFEDSFQQIMNMKPYDLRRRLYIIMRGEEGLDYGGIAREWFFLLSHEVLNPMYCLFEYAGKNNYCLQINPASSINPDHLTYFRFIGRFIAMALYHGKFIDTGFTLPFYKRMLNKRPTLKDLESIDPEFYNSIVWIKENNLEECGLELYFIQDMEILGKVTTHELKEGGESIRVTEENKEEYIMLLTDWRFTRGVEEQTKAFLDGFNEVAPLEWLRYFDEKELELMLCGMQEIDMSDWQKSTIYRHYTKNSKQIQWFWQVVKEMDNEKRIRLLQFVTGTCRLPVGGFAELIGSNGPQKFCIDKVGKETWLPRSHTCFNRLDLPPYKSYEQLREKLLYAIEETE","Homo sapiens","WWP2","NEDD4-like E3 ubiquitin-protein ligase WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2","1","5TJ8"
,,,,,,,,,,,,,,,,,"Homo sapiens","WWP2"
"5TJA",,"X-RAY DIFFRACTION",3.12,60.58,"VAPOR DIFFUSION, HANGING DROP",6,"1.38 M sodium phosphate monobasic monohydrate, 0.42 M potassium phosphate dibasic, pH 6.0, and 5% pentaerythritol ethoxylate (3/4 EO/OH)",289,"10.1038/nsmb.3362",,"5TJA",25.2,"2.3","2.3","I-II linker of TRPML1 channel at pH 6","GSGLSNQLAVTFREENTIAFRHLFLLGYSDGADDTFAAYTREQLYQAIFHAVDQYLALPDVSLGRYAYVRGGGDPWTNGSGLALCQRYYHRGHVDPANDTFDIDPMVVTDCIQVDPPERPPPPPSDDLTLLESSSSYKNLTLKFHKLVNVTIHFRLKTINLQSLINNEIPDCYTFSVLITFDNKAHSGRIPISLETQAHIQECKHPSVFQHGDNSLEHHHHHH","Homo sapiens","MCOLN1, ML4, MSTP080, TRPML1","Mucolipin-1","1","5TJA"
"5TJB",,"X-RAY DIFFRACTION",2.24,45.09,"VAPOR DIFFUSION, HANGING DROP",4.5,"200 mM magnesium sulfate, 5.3% PEG 3350, and 100 mM acetate pH 4.5",293,"10.1038/nsmb.3362",,"5TJB",25.2,"2.4","2.4","I-II linker of TRPML1 channel at pH 4.5","GSGLSNQLAVTFREENTIAFRHLFLLGYSDGADDTFAAYTREQLYQAIFHAVDQYLALPDVSLGRYAYVRGGGDPWTNGSGLALCQRYYHRGHVDPANDTFDIDPMVVTDCIQVDPPERPPPPPSDDLTLLESSSSYKNLTLKFHKLVNVTIHFRLKTINLQSLINNEIPDCYTFSVLITFDNKAHSGRIPISLETQAHIQECKHPSVFQHGDNSLEHHHHHH","Homo sapiens","MCOLN1, ML4, MSTP080, TRPML1","Mucolipin-1","1","5TJB"
"5TJC",,"X-RAY DIFFRACTION",2.53,51.3,"VAPOR DIFFUSION, HANGING DROP",,"100 mM magnesium sulfate, 4% PEG 3350, 100 mM HEPES at pH 7.5, macroseeding",293,"10.1038/nsmb.3362",,"5TJC",25.2,"2.4","2.4","I-II linker of TRPML1 channel at pH 7.5","GSGLSNQLAVTFREENTIAFRHLFLLGYSDGADDTFAAYTREQLYQAIFHAVDQYLALPDVSLGRYAYVRGGGDPWTNGSGLALCQRYYHRGHVDPANDTFDIDPMVVTDCIQVDPPERPPPPPSDDLTLLESSSSYKNLTLKFHKLVNVTIHFRLKTINLQSLINNEIPDCYTFSVLITFDNKAHSGRIPISLETQAHIQECKHPSVFQHGDNSLEHHHHHH","Homo sapiens","MCOLN1, ML4, MSTP080, TRPML1","Mucolipin-1","1","5TJC"
"5TJD",,"X-RAY DIFFRACTION",2.12,41.86,"VAPOR DIFFUSION, HANGING DROP",8,"0.1 M ADA pH 7.5
0.17 M MgCl2
20% (w/v) PEG-6000",292,"10.1073/pnas.2010317117",,"5TJD",51.37,"2.1","2.1","Computer-based rational design of improved functionality for antibody catalysts toward organophosphorus compounds","QVQLQESGPGLVKPSETLSLTCAVSGYSISSGYYWGWIRQPPGKGLEWIGSIYHSGSTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYYCAGLTQSSHNDANWGQGTLTTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCLEHVDHHHHHH","Homo sapiens",,"FAB A.17 L47K mutant HEAVY CHAIN","1","5TJD"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKKLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLNPVFGGGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECIDAAAAASFLEQKLISEEDLNSAVDHHHHHH","Homo sapiens",,"FAB A.17 L47K mutant Light Chain","2","5TJD"
"5TJH",,"X-RAY DIFFRACTION",2.79,55.98,"VAPOR DIFFUSION, HANGING DROP",,"12% PEG 3350,0.2M NaCl, 0.1M Tris buffer pH 7.6",293,"10.1021/acs.biochem.6b01044",,"5TJH",332.44,"2.05","2.05","hUGDH A136M Substitution","MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRAADLKYIEACARRIVQNSNGYKIVTEKSTVPVRMAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKVSSKRIPYAPSGEIPKFSLQDPPNKKPKV","Homo sapiens","UGDH","UDP-glucose 6-dehydrogenase","1","5TJH"
"5TJK",,"X-RAY DIFFRACTION",2.25,45.23,"VAPOR DIFFUSION, HANGING DROP",,"Native crystals of GTA/GTB lacking any heavy metals were grown at 4 degrees Celsius from much higher concentrations of protein (30-40 mg/mL for GTB and 16-20 mg/mL for GTA) along with 1% PEG 4000, 4.5-5% 2-methyl-2,4-pentanediol (MPD), 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA buffer pH 7.5, 30 mM sodium acetate buffer pH 4.6 and 5 mM MnCl2 for GTB crystallization and 5-8 mM CoCl2 for GTA crystallization.  10-15 microlitre drops were placed against a reservoir containing 3.7% PEG 4000, 7% MPD, 0.3 M ammonium sulfate, 0.25 M sodium chloride, 0.2 M ADA buffer and 0.1 M sodium acetate.  The crystals were usually grown for 5-10 days. Before making complexes, crystals of GTA/GTB were washed with modified mother liquor ML-2 consisting of 3.5% PEG 4000, 50 mM ammonium sulfate, 40 mM sodium chloride, 35 mM ADA buffer and 15% MPD or glycerol. Crystals of native GTA/GTB in complex with the respective A or B trisaccharide were obtained by soaking them in mother liquor ML-2 with 15% glycerol or MPD and 45-50 mM of each substrate for 2-5 days at 4 degrees Celsius.  Before freezing the crystals for data collection, the concentration of the cryoprotectant was made 30% glycerol or 20% MPD respectively",277,"10.1093/glycob/cwx053",,"5TJK",35.3,"1.45","1.45","Crystal structure of GTA + A trisaccharide (native)","AIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYLGGFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","5TJK"
"5TJL",,"X-RAY DIFFRACTION",2.26,45.66,"VAPOR DIFFUSION",,"The first crystals of GTA/GTB were grown as mercury derivatives (Patenaude, S.I., et al. 2002): 10 ul drops with 6-8 mg/ml protein, 70 mM N-(2-acetamido)-2-iminodiacetic acid (ADA) pH 7.5, 50 mM, sodium acetate pH 4.6, 40 mM NaCl, 5-8 mM MnCl2, 2.5% (v/v) 2-methyl-2,4-pentanediol (MPD), 5%(v/v) glycerol, 2%(w/v) PEG 4000, and 0.3-0.5 mM 3-chloromercuri-2-methoxypropylurea suspended over 1 ml of a resevoir solution: 50 mM ADA pH 7.5, 10 mM MnCl2, 100 mM ammonium sulfate, 5%(v/v) MPD, 10%(v/v) glycerol, and 8-10%(w/v) PEG 4000. Crystals were washed with artificial mother liquor ML-1 consisting of 10% polyethylene glycol (PEG) 4000, 30 mM N-(2-acetamido)-2-iminodiacetic acid (ADA) buffer pH 7.5, 30 mM sodium acetate buffer pH 4.6, 100 mM ammonium sulfate, 10 mM MnCl2 and 30% glycerol as the cryoprotectant. Crystals of GTA/GTB in complex with the A and B trisaccharides were obtained by soaking them in mother liquor ML-1 with 30% glycerol and 45-50 mM substrates for 2-5 days at 18 degrees Celsius",277,"10.1093/glycob/cwx053",,"5TJL",36.01,"1.89","1.89","Crystal structure of GTA + A trisaccharide (mercury derivative)","AIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVRAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPGFYGSSREAFTYERRPQSQAYIPKDEGDFYYLGGFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","5TJL"
"5TJN",,"X-RAY DIFFRACTION",2.26,45.55,"VAPOR DIFFUSION",,"Native crystals of GTA/GTB lacking any heavy metals were grown at 4 degrees Celsius from much higher concentrations of protein (30-40 mg/mL for GTB and 16-20 mg/mL for GTA) along with 1% PEG 4000, 4.5-5% 2-methyl-2,4-pentanediol (MPD), 100 mM ammonium sulfate, 70 mM sodium chloride, 50 mM ADA buffer pH 7.5, 30 mM sodium acetate buffer pH 4.6 and 5 mM MnCl2 for GTB crystallization and 5-8 mM CoCl2 for GTA crystallization.  10-15 microlitre drops were placed against a reservoir containing 3.7% PEG 4000, 7% MPD, 0.3 M ammonium sulfate, 0.25 M sodium chloride, 0.2 M ADA buffer and 0.1 M sodium acetate.  The crystals were usually grown for 5-10 days. Before making complexes, crystals of GTA/GTB were washed with modified mother liquor ML-2 consisting of 3.5% PEG 4000, 50 mM ammonium sulfate, 40 mM sodium chloride, 35 mM ADA buffer and 15% MPD or glycerol. Crystals of native GTA/GTB in complex with the respective A or B trisaccharide were obtained by soaking them in mother liquor ML-2 with 15% glycerol or MPD and 45-50 mM of each substrate for 2-5 days at 4 degrees Celsius.  Before freezing the crystals for data collection, the concentration of the cryoprotectant was made 30% glycerol or 20% MPD respectively",277,"10.1093/glycob/cwx053",,"5TJN",35.25,"1.47","1.47","Crystal structure of GTB + B trisaccharide (native)","AIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","5TJN"
"5TJO",,"X-RAY DIFFRACTION",2.27,45.76,"VAPOR DIFFUSION",,"The first crystals of GTA/GTB were grown as mercury derivatives (Patenaude, S.I., et al. 2002): 10 ul drops with 6-8 mg/ml protein, 70 mM N-(2-acetamido)-2-iminodiacetic acid (ADA) pH 7.5, 50 mM, sodium acetate pH 4.6, 40 mM NaCl, 5-8 mM MnCl2, 2.5% (v/v) 2-methyl-2,4-pentanediol (MPD), 5%(v/v) glycerol, 2%(w/v) PEG 4000, and 0.3-0.5 mM 3-chloromercuri-2-methoxypropylurea suspended over 1 ml of a resevoir solution: 50 mM ADA pH 7.5, 10 mM MnCl2, 100 mM ammonium sulfate, 5%(v/v) MPD, 10%(v/v) glycerol, and 8-10%(w/v) PEG 4000. Crystals were washed with artificial mother liquor ML-1 consisting of 10% polyethylene glycol (PEG) 4000, 30 mM N-(2-acetamido)-2-iminodiacetic acid (ADA) buffer pH 7.5, 30 mM sodium acetate buffer pH 4.6, 100 mM ammonium sulfate, 10 mM MnCl2 and 30% glycerol as the cryoprotectant. Crystals of GTA/GTB in complex with the A and B trisaccharides were obtained by soaking them in mother liquor ML-1 with 30% glycerol and 45-50 mM substrates for 2-5 days at 18 degrees Celsius",277,"10.1093/glycob/cwx053",,"5TJO",36.33,"1.57","1.57","Crystal structure of GTB + B trisaccharide (mercury derivative)","AIGEFMVSLPRMVYPQPKVLTPCRKDVLVVTPWLAPIVWEGTFNIDILNEQFRLQNTTIGLTVFAIKKYVAFLKLFLETAEKHFMVGHRVHYYVFTDQPAAVPRVTLGTGRQLSVLEVGAYKRWQDVSMRRMEMISDFCERRFLSEVDYLVCVDVDMEFRDHVGVEILTPLFGTLHPSFYGSSREAFTYERRPQSQAYIPKDEGDFYYMGAFFGGSVQEVQRLTRACHQAMMVDQANGIEAVWHDESHLNKYLLRHKPTKVLSPEYLWDQQLLGWPAVLRKLRFTAVPKNHQAVRNP","Homo sapiens","ABO","Histo-blood group ABO system transferase","1","5TJO"
"5TJQ",,"X-RAY DIFFRACTION",1.83,32.76,"VAPOR DIFFUSION",6,"0.1 M MMT (DL-malic acid, MES, Tris-base in molar ratio of 1:2:2) pH 6.0, 25% PEG1500",298,"10.1016/j.molcel.2017.03.020",,"5TJQ",53.44,"2.75","2.75","Structure of WWP2 2,3-linker-HECT","GPGWEKRTDPRGRFYYVDHNTRTTTWQRPTAEYVRNYEQWQSQRNQLQGAMQHFSQRFLYQSSSASQGSPGAYDRSFRWKYHQFRFLCHSNALPSHVKISVSRQTLFEDSFQQIMNMKPYDLRRRLYIIMRGEEGLDYGGIAREWFFLLSHEVLNPMYCLFEYAGKNNYCLQINPASSINPDHLTYFRFIGRFIAMALYHGKFIDTGFTLPFYKRMLNKRPTLKDLESIDPEFYNSIVWIKENNLEECGLELYFIQDMEILGKVTTHELKEGGESIRVTEENKEEYIMLLTDWRFTRGVEEQTKAFLDGFNEVAPLEWLRYFDEKELELMLCGMQEIDMSDWQKSTIYRHYTKNSKQIQWFWQVVKEMDNEKRIRLLQFVTGTCRLPVGGFAELIGSNGPQKFCIDKVGKETWLPRSHTCFNRLDLPPYKSYEQLREKLLYAIEETE","Homo sapiens","WWP2","NEDD4-like E3 ubiquitin-protein ligase WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2","1","5TJQ"
,,,,,,,,,,,,,,,,,"Homo sapiens","WWP2"
"5TJX",,"X-RAY DIFFRACTION",2.17,43.42,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M potassium di-hydrogen phosphate, 21 % PEG 3350",296,"10.1021/acsmedchemlett.6b00384","GBT","5TJX",30.14,"1.408","1.408","Structure of human plasma kallikrein","NTGDNSVCTTKTSTRIVGGTESSWGEWPWQVSLQVKLTAQRHLCGGSLIGHQWVLTAAHCFDGLPLQDVWRIYSGILELSDITKDTPFSQIKEIIIHQNYKVSEGNHDIALIKLQAPLEYTEFQKPISLPSKGDTSTIYTNCWVTGWGFSKEKGEIQNILQKVNIPLVTNEECQKRYQDYKITQRMVCAGYKEGGKDACKGDSGGPLVCKHNGMWRLVGITSWGEGCARREQPGVYTKVAEYMDWILEKTQSSDGKAQMQSPA","Homo sapiens","KLKB1, KLK3","Plasma kallikrein","1","5TJX"
"5TK5",,"X-RAY DIFFRACTION",2.97,58.62,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5, 2% PEG 400, and 2.0 M ammonium sulfate",277,"10.1107/S2059798317002029",,"5TK5",33.24,"1.88","1.88","Crystal structure of human 3HAO with iron bound in the active site","GPGSMERRLGVRAWVKENRGSFQPPVCNKLMHQEQLKVMFIGGPNTRKDYHIEEGEEVFYQLEGDMVLRVLEQGKHRDVVIRQGEIFLLPARVPHSPQRFANTVGLVVERRRLETELDGLRYYVGDTMDVLFEKWFYCKDLGTQLAPIIQEFFSSEQYRTGKPIPDQLLKEPPFPLSTRSIMEPMSLDAWLDSHHRELQAGTPLSLFGDTYETQVIAYGQGSSEGLRQNVDVWLWQLEGSSVVTMGGRRLSLAPDDSLLVLAGTSYAWERTQGSVALSVTQDPACKKPLG","Homo sapiens","HAAO","3-hydroxyanthranilate 3,4-dioxygenase","1","5TK5"
"5TKB",,"X-RAY DIFFRACTION",2.55,51.69,"VAPOR DIFFUSION, SITTING DROP",,"100mM HEPES, pH 7.5, 35% Ethylene Glycol, 5% Glycerol, 22% PEG3350",293,"10.1039/c6md00560h",,"5TKB",177.95,"2.16","2.16","CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH A TETRAFLUORANLINE COMPOUND","MSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQAPAPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGHHHHHH","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","5TKB"
"5TKD",,"X-RAY DIFFRACTION",2.37,48.09,"VAPOR DIFFUSION",6.5,,298,"10.1039/c6md00560h",,"5TKD",67.54,"1.92","1.92","CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH 6-[(3,5-DIMETHYLPHE NYL)AMINO]-8- (METHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBO XAMIDE","GHMNLSQLSFHRVDQKEITQLSHLGQGTRTNVYEGRLRVEGSGDPEEGKMDDEDPLVPGRDRGQELRVVLKVLDPSHHDIALAFYETASLMSQVSHTHLAFVHGVCVRGPENIMVTEYVEHGPLDVWLRRERGHVPMAWKMVVAQQLASALSYLENKNLVHGNVCGRNILLARLGLAEGTSPFIKLSDPGVGLGALSREERVERIPWLAPECLPGGANSLSTAMDKWGFGATLLEICFDGEAPLQSRSPSEKEHFYQRQHRLPEPSCPQLATLTSQCLTYEPTQRPSFRTILRDLTRL","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","5TKD"
"5TKE",,"X-RAY DIFFRACTION",2.78,55.71,"EVAPORATION",7,"0.032 M ammonium citrate tribasic (pH 7.0), 0.02 M MES monohydrate, 0.016 M imidazole, 0.002 M zinc sulfate heptahydrate, 0.128 M potassium thiocyanate, 12.8% w/v polyethylene glycol 3,350, 3.2% w/v polyethylene glycol monomethyl ether 2,000, and 5% w/v polyethylene glycol monomethyl ether 550",293,"10.1038/nsmb.3390",,"5TKE",115.65,"2.481","2.481","Crystal Structure of Eukaryotic Hydrolase","HFLCGVVEGFYGRPWVMEQRKELFRRLQKWELNTYLYAPKDDYKHRMFWREMYSVEEAEQLMTLISAAREYEIEFIYAISPGLDITFSNPKEVSTLKRKLDQVSQFGCRSFALLFDDIDHNMCAADKEVFSSFAHAQVSITNEIYQYLGEPETFLFCPTEYCGTFCYPNVSQSPYLRTVGEKLLPGIEVLWTGPKVVSKEIPVESIEEVSKIIKRAPVIWDNIHANDYDQKRLFLGPYKGRSTELIPRLKGVLTNPNCEFEANYVAIHTLATWYKSNMNGVRKDVVMTDSEDSTVSIQIKLENEGSDEDIETDVLYSPQMALKLALTEWLQEFGVPHQYSSRGGGGSGGGGSVTLEDLQLLADLFYLPYEHGPKGAQMLREFQWLRANSSVVSVNCKGKDSEKIEEWRSRAAKFEEMCGLVMGMFTRLSNCANRTILYDMYSYVWDIKSIMSMVKSFVQWLGCRSHSSAQFLIGDQEPWAFRGGLAGEFQRLLPIDGANDLFFQ","Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5","O-GlcNAcase: chimera construct","1","5TKE"
,,,,,,,,,,,,,,,,,"Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5"
"5TKM",,"X-RAY DIFFRACTION",2.23,44.77,"VAPOR DIFFUSION, SITTING DROP",5.6,"0.01 M Iron (III) chloride hexahydrate, 0.1 M sodium citrate dehydrate pH 5.6, 10% v/v Jeffamine M-600",291,"10.1093/nar/gkx362",,"5TKM",47.3,"1.9","1.9","Crystal structure of human APOBEC3B N-terminal Domain","GPGGSGGMNPQIRNPMERMDRDTFYDNFENEPILSGRSYTWLCYEVKIKRGRSNLLWDTGVFRGQVYFKPQYHAEMCFLSWFCGNQLPADKCFQITWFVSWTPCPDCVAKLAEFLSEHPNVTLTISAARLYYYSERDYRRALCRLSQAGARVKIMDYEEFAYCWENFVDNEGQQFMPWYKFDENYAFLHRTLKEILRH","Homo sapiens","APOBEC3B","DNA dC->dU-editing enzyme APOBEC-3B","1","5TKM"
"5TKQ",,"X-RAY DIFFRACTION",3.01,59.12,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES pH 7.5, 2% PEG 400, and 2.0 M ammonium sulfate",277,"10.1107/S2059798317002029",,"5TKQ",33.44,"1.75","1.75","Crystal structure of human 3HAO with zinc bound in the active site","GPGSMERRLGVRAWVKENRGSFQPPVCNKLMHQEQLKVMFIGGPNTRKDYHIEEGEEVFYQLEGDMVLRVLEQGKHRDVVIRQGEIFLLPARVPHSPQRFANTVGLVVERRRLETELDGLRYYVGDTMDVLFEKWFYCKDLGTQLAPIIQEFFSSEQYRTGKPIPDQLLKEPPFPLSTRSIMEPMSLDAWLDSHHRELQAGTPLSLFGDTYETQVIAYGQGSSEGLRQNVDVWLWQLEGSSVVTMGGRRLSLAPDDSLLVLAGTSYAWERTQGSVALSVTQDPACKKPLG","Homo sapiens","HAAO","3-hydroxyanthranilate 3,4-dioxygenase","1","5TKQ"
"5TKS",,"X-RAY DIFFRACTION",3.44,64.27,"VAPOR DIFFUSION, HANGING DROP",7,"100 MM SODIUM ACETATE, PH 4.6, 25%(w/v) MEPEG2000, 200 MM AMMONIUM SULFATE, then transferred to 100 MM TRIS-HCL, pH 7.0, 25%(w/v) MEPEG2000, 200 MM AMMONIUM SULFATE",277,"10.1021/acs.jmedchem.6b01460","7DL","5TKS",29.24,"1.55","1.55","FACTOR XIA IN COMPLEX WITH THE INHIBITOR ((15S)-18-CHLORO- 15-(((2E)-3-(5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL)-2- PROPENOYL)AMINO)-17,19-DIAZATRICYCLO[14.2.1.0~2,7~]NONADECA-1(18),2,4,6,16(19)-PENTAEN-5-YL)CARBAMATE","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","5TKS"
"5TKT",,"X-RAY DIFFRACTION",3.43,64.18,"VAPOR DIFFUSION, HANGING DROP",7,"100 MM SODIUM ACETATE, PH 4.6, 25%(w/v) MEPEG2000, 200 MM AMMONIUM SULFATE, then transferred to 100 MM TRIS-HCL, pH 7.0, 25%(w/v) MEPEG2000, 200 MM AMMONIUM SULFATE",277,"10.1021/acs.jmedchem.6b01460","7DS","5TKT",29.06,"2.12","2.12","FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL ((12E,15S)-15-(((2E)-3-(5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL)-2-PROPENOYL)AMINO)-9-OXO-8,17,19-TRIAZATRICYCLO[14.2.1.0~2,7~]NONADECA-1(18),2,4,6,12,16(19)-HEXAEN-5-YL)CARBAMATE","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Factor XIa (Light Chain)","1","5TKT"
"5TKU",,"X-RAY DIFFRACTION",3.43,64.11,"VAPOR DIFFUSION, HANGING DROP",7,"100 MM SODIUM ACETATE, PH 4.6, 25%(w/v) MEPEG2000, 200 MM AMMONIUM SULFATE, then transferred to 100 MM TRIS-HCL, pH 7.0, 25%(w/v) MEPEG2000, 200 MM AMMONIUM SULFATE",277,"10.1021/acs.jmedchem.6b01460","7DK","5TKU",29,"2.12","2.12","FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL ((15S)-15-(((2E)-3-(5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL)-2-PROPENOYL)AMINO)-9-OXO-8,17,19-TRIAZATRICYCLO[14.2.1.0~2,7~]NONADECA-1(18),2,4,6,16(19)-PENTAEN-5-YL)CARBAMATE","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Factor XIa (Light Chain)","1","5TKU"
"5TL9",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION",,"0.1M TRIS pH 8.9
28% PEG 1K",294.15,"10.1016/j.bmcl.2016.11.011","7DN","5TL9",19.17,"1.2","1.2","crystal structure of mPGES-1 bound to inhibitor","MALPAHSLVMSSPALPAFLLCSTLLVIKMYVVAIITGQVRLRKKAFANPEDALRHGGPQYCRSDPDVERCLRAHRNDMETIYPFLFLGFVYSFLGPNPFVAWMHFLVFLVGRVAHTVAYLGKLRAPIRSVTYTLAQLPCASMALQILWEAARHL","Homo sapiens","PTGES, MGST1L1, MPGES1, PGES, PIG12","Prostaglandin E synthase","1","5TL9"
"5TMG",,"X-RAY DIFFRACTION",3.1,60.26,"VAPOR DIFFUSION, SITTING DROP",7.9,"23% PEG600, 0.06M citrate, 0.04M citric acid",293,,"7EK","5TMG",76.02,"2.2","2.2","Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor","GNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","5TMG"
"5TMK",,"X-RAY DIFFRACTION",3.08,60.02,"VAPOR DIFFUSION, SITTING DROP",7.9,"23% PEG600, 0.06M citrate, 0.04M citric acid",293,,"7EJ","5TMK",75.49,"2.65","2.65","Optimization of 3,5-Disubstitued Piperidine: Discovery of Non-Peptide mimetics as an Orally Active Renin Inhibitor","GNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","5TMK"
"5TN9",,"X-RAY DIFFRACTION",2.15,42.69,"VAPOR DIFFUSION, HANGING DROP",8,"pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/acschembio.6b00918",,"5TN9",119.8,"2.253","2.253","Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate","IKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTSHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","5TN9"
"5TNB",,"X-RAY DIFFRACTION",2.16,43.17,"VAPOR DIFFUSION, HANGING DROP",8,"pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1021/acschembio.6b00918",,"5TNB",119.64,"2.08","2.08","Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate","IKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTSHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","5TNB"
"5TNO",,"X-RAY DIFFRACTION",2.77,55.56,"VAPOR DIFFUSION, HANGING DROP",9,"50 MM CHES, PH 9.0, 1.3 M TRI-SODIUM CITRATE AND 3 MM COMPOUND (CROSS SEEDED WITH CRYSTALS GROWN FROM REMARK 280 50 MM TRIS, PH 7.2, 1.45 M AMMONIUM SULFATE, 2.0 M SODIUM REMARK 280 CHLORIDE AND 3 MM COMPOUND)",295,"10.1016/j.bmcl.2017.03.002",,"5TNO",33.38,"1.54","1.54","Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors","VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGASALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTKLT","Homo sapiens","F9","Coagulation factor IX","1","5TNO"
,,,,,,,,,,,,,,,,"MDVTCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSVSQTSKLTR","Homo sapiens","F9","Coagulation factor IX","2","5TNO"
"5TNT",,"X-RAY DIFFRACTION",2.78,55.82,"VAPOR DIFFUSION, HANGING DROP",9,"50 MM CHES, PH 9.0, 1.3 M TRI-SODIUM CITRATE AND 3 MM COMPOUND (CROSS SEEDED WITH CRYSTALS GROWN FROM REMARK 280 50 MM TRIS, PH 7.2, 1.45 M AMMONIUM SULFATE, 2.0 M SODIUM CHLORIDE AND 3 MM COMPOUND)",295,"10.1016/j.bmcl.2017.03.002","7GQ","5TNT",33.68,"1.4","1.4","Discovery of novel aminobenzisoxazole derivatives as orally available factor IXa inhibitors","VVGGEDAKPGQFPWQVVLNGKVDAFCGGSIVNEKWIVTAAHCVETGVKITVVAGEHNIEETEHTEQKRNVIRIIPHHNYNAAINKYNHDIALLELDEPLVLNSYVTPICIADKEYTNIFLKFGSGYVSGWGRVFHKGASALVLQYLRVPLVDRATCLRSTKFTIYNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISWGEECAMKGKYGIYTKVSRYVNWIKEKTKLT","Homo sapiens","F9","Coagulation factor IX","1","5TNT"
,,,,,,,,,,,,,,,,"MDVTCNIKNGRCEQFCKNSADNKVVCSCTEGYRLAENQKSCEPAVPFPCGRVSVSQTSKLTR","Homo sapiens","F9","Coagulation factor IX","2","5TNT"
"5TNY",,"X-RAY DIFFRACTION",2.41,48.87,"VAPOR DIFFUSION, HANGING DROP",6,"0.1 M MES pH 6.0, 1 M LiCl, and 15-20% (w/v) PEG-6000",293,"10.1038/cddis.2017.487",,"5TNY",36.2,"1.7","1.7","HTRA2 G399S mutant","MAVPSPPPASPRSQYNFIADVVEKTAPAVVYIEILDRHPFLGREVPISNGSGFVVAADGLIVTNAHVVADRRRVRVRLLSGDTYEAVVTAVDPVADIATLRIQTKEPLPTLPLGRSADVRQGEFVVAMGSPFALQNTITSGIVSSAQRPARDLGLPQTNVEYIQTDAAIDFGNSGGPLVNLDGEVIGVNTMKVTAGISFAIPSDRLREFLHRGEKKNSSSGISGSQRRYIGVMMLTLSPSILAELQLREPSFPDVQHGVLIHKVILSSPAHRAGLRPGDVILAIGEQMVQNAEDVYEAVRTQSQLAVQIRRGRETLTLYVTPEVTEHHHHHH","Homo sapiens","HTRA2, OMI, PRSS25","Serine protease HTRA2, mitochondrial","1","5TNY"
"5TNZ",,"X-RAY DIFFRACTION",2.36,47.9,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M MES pH 6.0, 1 M LiCl, and 15-20% (w/v) PEG-6000",293,"10.1038/cddis.2017.487",,"5TNZ",36.22,"1.75","1.75","HtrA2 S142D mutant","MAVPSPPPADPRSQYNFIADVVEKTAPAVVYIEILDRHPFLGREVPISNGSGFVVAADGLIVTNAHVVADRRRVRVRLLSGDTYEAVVTAVDPVADIATLRIQTKEPLPTLPLGRSADVRQGEFVVAMGSPFALQNTITSGIVSSAQRPARDLGLPQTNVEYIQTDAAIDFGNSGGPLVNLDGEVIGVNTMKVTAGISFAIPSDRLREFLHRGEKKNSSSGISGSQRRYIGVMMLTLSPSILAELQLREPSFPDVQHGVLIHKVILGSPAHRAGLRPGDVILAIGEQMVQNAEDVYEAVRTQSQLAVQIRRGRETLTLYVTPEVTEHHHHHH","Homo sapiens","HTRA2, OMI, PRSS25","Serine protease HTRA2, mitochondrial","1","5TNZ"
"5TO0",,"X-RAY DIFFRACTION",2.38,48.28,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M MES pH 6.0, 1 M LiCl, and 15-20% (w/v) PEG-6000",293,"10.1038/cddis.2017.487",,"5TO0",36.19,"1.9","1.9","HTRA2 S276C mutant","MAVPSPPPASPRSQYNFIADVVEKTAPAVVYIEILDRHPFLGREVPISNGSGFVVAADGLIVTNAHVVADRRRVRVRLLSGDTYEAVVTAVDPVADIATLRIQTKEPLPTLPLGRSADVRQGEFVVAMGSPFALQNTITSGIVCSAQRPARDLGLPQTNVEYIQTDAAIDFGNSGGPLVNLDGEVIGVNTMKVTAGISFAIPSDRLREFLHRGEKKNSSSGISGSQRRYIGVMMLTLSPSILAELQLREPSFPDVQHGVLIHKVILGSPAHRAGLRPGDVILAIGEQMVQNAEDVYEAVRTQSQLAVQIRRGRETLTLYVTPEVTEHHHHHH","Homo sapiens","HTRA2, OMI, PRSS25","Serine protease HTRA2, mitochondrial","1","5TO0"
"5TO1",,"X-RAY DIFFRACTION",2.39,48.51,"VAPOR DIFFUSION, SITTING DROP",6,"0.1 M MES pH 6.0, 1 M LiCl, and 15-20% (w/v) PEG-6000",293,"10.1038/cddis.2017.487",,"5TO1",36.45,"1.69","1.69","HtrA2 exposed (L266R, F303A) mutant","MAVPSPPPASPRSQYNFIADVVEKTAPAVVYIEILDRHPFLGREVPISNGSGFVVAADGLIVTNAHVVADRRRVRVRLLSGDTYEAVVTAVDPVADIATLRIQTKEPLPTLPLGRSADVRQGEFVVAMGSPFARQNTITSGIVSSAQRPARDLGLPQTNVEYIQTDAAIDAGNSGGPLVNLDGEVIGVNTMKVTAGISFAIPSDRLREFLHRGEKKNSSSGISGSQRRYIGVMMLTLSPSILAELQLREPSFPDVQHGVLIHKVILGSPAHRAGLRPGDVILAIGEQMVQNAEDVYEAVRTQSQLAVQIRRGRETLTLYVTPEVTELEHHHHHH","Homo sapiens","HTRA2, OMI, PRSS25","Serine protease HTRA2, mitochondrial","1","5TO1"
"5TO5",,"X-RAY DIFFRACTION",2.57,52.07,"EVAPORATION",6.25,"16% PEG1.5K, 0.1M Bistris (6.25)",295,"10.1016/j.str.2017.04.015",,"5TO5",33.5,"2.5","2.5","Structure of the TPR oligomerization domain","AAVLQQVLERTELNKLPKSVQNKLEKFLADQQSEIDGLKGRHEKFKVESEQQYMEIEKRLSHSQERLVNETRECQSLRLELEKLNNQLKALTEKNKELEIAQDRNIAIQSQMTRTKEELEAEKRDLIRTNERLSQELEYLT","Homo sapiens","TPR","Nucleoprotein TPR","1","5TO5"
"5TO6",,"X-RAY DIFFRACTION",2.26,45.61,"VAPOR DIFFUSION",8,"0.1M Tris (8.0), 150mM Sodium malonate, 29% PEG1000",299,"10.1016/j.str.2017.04.015",,"5TO6",67.12,"2.7","2.7","Structure of the TPR oligomerization domain","AAVLQQVLERTELNKLPKSVQNKLEKFLADQQSEIDGLKGRHEKFKVESEQQYFEIEKRLSHSQERLVNETRECQSLRLELEKLNNQLKALTEKNKELEIAQDRNIAIQSQFTRTKEELEAEKRDLIRTNERLSQELEYLT","Homo sapiens","TPR","Nucleoprotein TPR","1","5TO6"
"5TO7",,"X-RAY DIFFRACTION",2.76,55.5,"EVAPORATION",7.25,"28% PEG1K, 0.1M HEPES (7.25)",295,"10.1016/j.str.2017.04.015",,"5TO7",67.06,"2.6","2.6","Structure of the TPR oligomerization domain","AAVLQQVLERTELNKLPKSVQNKLEKFLADQQSEIDGLKGRHEKFKVESEQQYFEIEKRLSHSQERLVNETRECQSLRLELEKLNNQLKALTEKNKELEIAQDRNIAIQSQMTRTKEELEAEKRDLIRTNERLSQELEYLT","Homo sapiens","TPR","Nucleoprotein TPR","1","5TO7"
"5TO8",,"X-RAY DIFFRACTION",2.33,47.2,"VAPOR DIFFUSION, SITTING DROP",,"19% PEG1000, 100 mM LiSulfate, 50 mM Disodium hydrogen phosphate, 50 mM Citric Acid",293,"10.1016/j.bmcl.2016.10.092","7FM","5TO8",33.14,"1.9849","1.9849","Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency","GSMGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME","Homo sapiens","PTK2B, FAK2, PYK2, RAFTK","Protein-tyrosine kinase 2-beta","1","5TO8"
"5TOA",,"X-RAY DIFFRACTION",3.05,59.64,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M Na-citrate, 10% [w/v] PEG-4000, 10% [v/v] isopropanol",292,"10.1038/s41598-017-03774-x","EST","5TOA",56.6,"2.5","2.5","Crystal Structure of ER beta bound to Estradiol","MALSPEQLVLTLLEAEPPHVLISRPSAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPVYDLLLEMLNAHVLRGDKSSITG","Homo sapiens","ESR2, ESTRB, NR3A2","Estrogen receptor beta","1","5TOA"
"5TOB",,"X-RAY DIFFRACTION",2.3,46.48,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG3350, 100 mM Bis-Tris pH 5.5, 100 mM MgCl2",298,"10.1016/j.bmcl.2016.10.092","YAM","5TOB",33.09,"2.117","2.117","Selectivity switch between FAK and Pyk2: Macrocyclization of FAK inhibitors improves Pyk2 potency","GSMGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDIAME","Homo sapiens","PTK2B, FAK2, PYK2, RAFTK","Protein-tyrosine kinase 2-beta","1","5TOB"
"5TOD",,"X-RAY DIFFRACTION",2.86,57.02,"VAPOR DIFFUSION, SITTING DROP",,"100-200 mM MgCl2, 100 mM bis-tris propane pH 6.5-8.0, 45% PEG 200",293,"10.1126/science.aah6171",,"5TOD",126.36,"2.96","2.96","Transmembrane protein 24 SMP domain","GPGSRAGAAEEPGVRGLLASLFAFKSFRENWQRAWVRALNEQACRNGSSIQIAFEEVPQLPPRASISHVTCVDQSEHTMVLRCQLSAEEVRFPVSVTQQSPAAVSMETYHVTLTLPPTQLEVNLEEIPGEGLLISWAFTDRPDLSLTVLPKLQARERGEEQVELSTIEELIKDAIVSTQPAMMVNLRAC","Homo sapiens","C2CD2L, KIAA0285, TMEM24, DLNB23","Transmembrane protein 24","1","5TOD"
"5TOE",,"X-RAY DIFFRACTION",3.52,65.05,"VAPOR DIFFUSION",,"0.1M imidazole, 1M NaAcetate, 20% glycerol pH 6.5",277,"10.1016/j.bmcl.2017.08.069","7GK","5TOE",31.81,"2.301","2.301","Pim-1 kinase in complex with a 7-azaindole","LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHS","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","5TOE"
"5TOF",,"X-RAY DIFFRACTION",1.74,24.84,"VAPOR DIFFUSION, HANGING DROP",4.6,"1ul protein solution at 20 mg/ml (20 mM Tris pH 8.0, 150 mM NaCl), 1ul crystallization solution (0.1 M citric acid pH 4.6, 2.6 M ammonium sulfate)",293,"10.1016/j.str.2017.03.009",,"5TOF",8.93,"1.12","1.12","Room temperature structure of ubiquitin variant u7ub25","GSMQIFVKFRTGKTYTLEVEPSDTIENVKAKIQDKLGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHGVRRLRGG","Homo sapiens","UBB","Polyubiquitin-B","1","5TOF"
"5TOG",,"X-RAY DIFFRACTION",1.79,31.16,"VAPOR DIFFUSION, HANGING DROP",,"1ul protein solution at 10 mg/ml (20 mM Tris pH 8.0, 150 mM NaCl), 1ul crystallization solution (0.1 M citric acid pH 4.2, 2.2 M ammonium sulfate)",293,"10.1016/j.str.2017.03.009",,"5TOG",9.1,"1.08","1.08","Room temperature structure of ubiquitin variant u7ub25.2540","GSMQIFVKFRTGKTYTLEVEPSDTIENVKAKIQDKLGIPPDQQWLIFAGKRLEDGRTLSDYNIQKESTLRGVRRLRGG","Homo sapiens","UBB","Polyubiquitin-B","1","5TOG"
"5TOL",,"X-RAY DIFFRACTION",2.77,55.62,"VAPOR DIFFUSION",6.4,,298,"10.1016/j.bmcl.2016.10.055","7H3","5TOL",46.37,"2.51","2.51","CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 COMPLEXED WITH N-(3-((4AS,7AS)-2-AMINO-4,4A,5,6-TETRAHYDRO-7AH-FURO[2,3-D][1,3]THIAZIN-7A-YL)-4-FLUOROPHENYL)-5-BROMO-2-PYRIDINECARBOXAMIDE","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5TOL"
"5TOZ",,"X-RAY DIFFRACTION",2.22,44.71,"VAPOR DIFFUSION, HANGING DROP",8,"20% PEG-3350, 0.2 M ammonium sulfate",298,"10.1021/acschembio.6b00677",,"5TOZ",36.93,"1.98","1.98","JAK3 with covalent inhibitor PF-06651600","MGHHHHHHQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","5TOZ"
"5TP0",,"X-RAY DIFFRACTION",2.19,43.86,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES
2 M Ammonium Sulfate
2 % PEG-400",298,"10.1371/journal.pone.0176694","BRN","5TP0",24.98,"1.25","1.25","Human mesotrypsin in complex with diminazene","IVGGYTCEENSLPYQVSLNSGSHFCGGSLISEQWVVSAAHCYKTRIQVRLGEHNIKVLEGNEQFINAAKIIRHPKYNRDTLDNDIMLIKLSSPAVINARVSTISLPTAPPAAGTECLISGWGNTLSFGADYPDELKCLDAPVLTQAECKASYPGKITNSMFCVGFLEGGKDSCQRDSGGPVVCNGQLQGVVSWGHGCAWKNRPGVYTKVYNYVDWIKDTIAANS","Homo sapiens","PRSS3, PRSS4, TRY3, TRY4","Trypsin-3","1","5TP0"
"5TP5",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.6b01296",,"5TP5",16.55,,,"Solution structure of the calcium deficient mutant calmodulin CaM1234","ADQLTEEQIAEFKEAFSLFAKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVAADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFAKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREAAIDGDGQVNYEEFVQMMTAK","Homo sapiens","CALM1, CALM, CAM, CAM1, CALM2, CAM2, CAMB, CALM3, CALML2, CAM3, CAMC, CAMIII","Calmodulin","1","5TP5"
"5TPG",,"X-RAY DIFFRACTION",1.99,38.19,"VAPOR DIFFUSION, SITTING DROP",5.5,"20% PEG 3350, 0.1 Na Citrate, pH 5.5, 4% Acetonitrile",293,"10.1016/j.bmcl.2016.12.053","7H5","5TPG",36.37,"1.5","1.5","Optimization of spirocyclic proline tryptophanhydroxylase-1 inhibitors","TVPWFPKKISDLDHCANRVLMYGSELDADHPGFKDNVYRKRRKYFADLAMNYKHGDPIPKVEFTEEEIKTWGTVFQELNKLYPTHACREYLKNLPLLSKYCGYREDNIPQLEDVSNFLKERTGFSIRPVAGYLSPRDFLSGLAFRVFHCTQYVRHSSDPFYTPEPDTCHELLGHVPLLAEPSFAQFSQEIGLASLGASEEAVQKLATCYFFTVEFGLCKQDGQLRVFGAGLLSSISELKHALSGHAKVKPFDPKITCKQECLITTFQDVYFVSESFEDAKEKMREFTKTIKRPFGVKYNHHHHHHHH","Homo sapiens","TPH1, TPH, TPRH, TRPH","Tryptophan 5-hydroxylase 1","1","5TPG"
"5TPL",,"X-RAY DIFFRACTION",2.6,52.67,"VAPOR DIFFUSION, HANGING DROP",4.5,"100 mM sodium acetate, pH 4.5 and 1.4 M LiSO4",293,"10.1126/scitranslmed.aai7514",,"5TPL",48.55,"2.5","2.5","Crystal Structure of DH270.3 (unliganded) from the DH270 Broadly Neutralizing N332-glycan Dependent Lineage","QPVLTQPASVSGSPGQSITISCTGSSSDVGSYNLVSWYQQHPGKAPKLMIYEVNKWASGVSDRFAGSKSGNTASLTISRLQAEDEANYFCSSSTNSATVIFGGGTKLTVLGQPKGAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"DH270.3 Fab light chain","1","5TPL"
,,,,,,,,,,,,,,,,"QVQLVQSGAELKKPGASVKVSCKASGYTLSDYYVHWLRQAPGQGLEWVAWINPTSGRTISPRKFQGRVTMTTDTSMNVAYMELRGLRSDDTAVYFCARGGWISLYVDYSYYPNFDSWGQGTLVSVSGASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"DH270.3 Fab heavy chain","2","5TPL"
"5TPP",,"X-RAY DIFFRACTION",2.61,52.92,"VAPOR DIFFUSION, HANGING DROP",4,"100 mM sodium citrate, pH 4.0 and 40% PEG 400",293,"10.1126/scitranslmed.aai7514",,"5TPP",48.87,"1.85","1.85","Crystal Structure of DH270.5 (unliganded) from the DH270 Broadly Neutralizing N332-glycan Dependent Lineage","LPVLTQPASVSGSPGQSITISCTGTIYDVGKFDLVSWYQHHPGKAPKYLIYEVKKWPSGVSHRFSGSKSGNTASLTISGLQVEDEADYYCCSFGGSAAVVCGGGTKVTVLGQPKGAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"DH270.5 Fab heavy chain","1","5TPP"
,,,,,,,,,,,,,,,,"QVQLVQSGAEVKNPGASVKVSCAPSGYTFTDFYIHWVRLAPGQGLEWLGWMNPKTGRTNQGQNFQGRVTMTRDTSIGTAYMELRSLTSDDTAVYYCVTGAWISDYYDSSYYPNFDHWGQGTLVTVSGASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"DH270.5 Fab light chain","2","5TPP"
"5TPS",,"X-RAY DIFFRACTION",2.55,51.81,"VAPOR DIFFUSION, SITTING DROP",6,"15% PEG 3350, 1M LiCl, 0.1M MES pH6.0",295,,,"5TPS",55.85,"2.7","2.7","Structure of a Fc heterodimer","GSGGGDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVCTLPPSRDELTKNQVSLSCAVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFKLVSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGKGGSHHHHHHHH","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","5TPS"
,,,,,,,,,,,,,,,,"GSGGGDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPCRDELTKNQVSLWCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSALTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens","IGHG1","Ig gamma-1 chain C region","2","5TPS"
"5TPT",,"X-RAY DIFFRACTION",2.1,41.41,"VAPOR DIFFUSION, SITTING DROP",4.4,"0.1 M phosphate-citrate, 40% PEG400",298.15,"10.1096/fj.201802315R",,"5TPT",47.06,"2.422","2.422","The Crystal Structure of Amyloid Precursor-Like Protein 2 (APLP2) E2 Domain","DVDVYFETSADDNEHARFQKAKEQLEIRHRNRMDRVKKEWEEAELQAKNLPKAERQTLIQHFQAMVKALEKEAASEKQQLVETHLARVEAMLNDRRRMALENYLAALQSDPPRPHRILQALRRYVRAENKDRLHTIRHYQHVLAVDPEKAAQMKSQVMTHLHVIEERRNQSLSLLYKVPYVAQEIQEEIDELLQEQR","Homo sapiens","APLP2, APPL2","Amyloid-like protein 2","1","5TPT"
"5TQ3",,"X-RAY DIFFRACTION",2.32,46.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Hepes, pH 7.5, 0.1 M Sodium acetate, 30% PEG3350",293,"10.1021/acs.jmedchem.6b01634","7GZ","5TQ3",72.49,"2.69","2.69","Design and Synthesis of a pan-JAK kinase inhibitor clinical candidate (PF-06263276) suitable for the treatment of inflammatory diseases of the lungs and skin","MGHHHHHHEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQSIVTHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQVRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5TQ3"
"5TQ4",,"X-RAY DIFFRACTION",2.75,55.35,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Hepes, pH 7.5, 0.1 M sodium acetate, 30% PEG-3350",293,"10.1021/acs.jmedchem.6b01634","7GY","5TQ4",35.31,"2.3","2.3","Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin","GSEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQSIVTHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5TQ4"
"5TQ5",,"X-RAY DIFFRACTION",2.26,45.65,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Hepes, pH 7.5, 0.1 M sodium acetate, 30% PEG-3350",293,"10.1021/acs.jmedchem.6b01634","7GX","5TQ5",35.25,"2.3","2.3","Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin","GSEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQSIVTHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5TQ5"
"5TQ6",,"X-RAY DIFFRACTION",2.32,47.08,"VAPOR DIFFUSION",,"0.1 M Hepes, pH 7.5, 0.1 M sodium acetate, 30% PEG3350",293,"10.1021/acs.jmedchem.6b01634","7GV","5TQ6",72.5,"2.06","2.06","Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin","MGHHHHHHEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQSIVTHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5TQ6"
"5TQ7",,"X-RAY DIFFRACTION",2.35,47.6,"VAPOR DIFFUSION",7.5,"0.1 M Hepes, pH 7.5, 100 mM sodium acetate, 30% PEG3350",293,"10.1021/acs.jmedchem.6b01634",,"5TQ7",72.75,"2.1","2.1","Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin","MGHHHHHHEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQSIVTHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQVRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5TQ7"
"5TQ8",,"X-RAY DIFFRACTION",2.22,44.7,"VAPOR DIFFUSION",7.5,"0.1 M Hepes, pH 7.5, 100 mM sodium acetate, 30% PEG-3350",293,"10.1021/acs.jmedchem.6b01634","7GS","5TQ8",35.44,"1.59","1.59","Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin","GSEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQSIVTHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5TQ8"
"5TQA",,"X-RAY DIFFRACTION",2.73,55.01,"VAPOR DIFFUSION, HANGING DROP",6,"30% PEG 4000, 100 mM PIPES pH 6, and 1M NaCl",293,"10.1126/scitranslmed.aai7514",,"5TQA",97.36,"2.723","2.723","Crystal Structure of DH270.6 (unliganded) from the DH270 Broadly Neutralizing N332-Glycan Dependent Lineage","QVQLVQSGAQMKNPGASVKVSCAPSGYTFTDFYIHWLRQAPGQGLQWMGWMNPQTGRTNTARNFQGRVTMTRDTSIGTAYMELRSLTSDDTAIYYCTTGGWISLYYDSSYYPNFDHWGQGTLLTVSGASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"DH270.6 Fab heavy chain","1","5TQA"
,,,,,,,,,,,,,,,,"QSALTQPASVSGSPGQSITISCTGTKYDVGSHDLVSWYQQYPGKVPKYMIYEVNKRPSGVSNRFSGSKSGNTASLTISGLRAEDEADYYCCSFGGSATVVCGGGTKVTVLGQPKGAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"DH270.6 Fab light chain","2","5TQA"
"5TQE",,"X-RAY DIFFRACTION",3.91,68.52,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000",277,"10.1021/acsmedchemlett.6b00375","7KQ","5TQE",35.42,"1.9","1.9","Factor VIIa in complex with the inhibitor (5R)-5-[(1-aminoisoquinolin-6-yl)amino]-19-(cyclopropylsulfonyl)-3-methyl-13-oxa-3,15-diazatricyclo[14.3.1.1~6,10~]henicosa-1(20),6(21),7,9,16,18-hexaene-4,14-dione","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VIIa (Heavy Chain)","1","5TQE"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VIIa (Light Chain)","2","5TQE"
"5TQF",,"X-RAY DIFFRACTION",3.88,68.28,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000",277,"10.1021/acsmedchemlett.6b00375","7KR","5TQF",35.4,"1.85","1.85","Factor VIIa in complex with the inhibitor (11R)-11-[(1-aminoisoquinolin-6-yl)amino]-16-(cyclopropylsulfonyl)-13-methyl-2,13-diazatricyclo[13.3.1.1~6,10~]icosa-1(19),6(20),7,9,15,17-hexaene-3,12-dione","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VIIa (Heavy Chain)","1","5TQF"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VIIa (Light Chain)","2","5TQF"
"5TQG",,"X-RAY DIFFRACTION",3.94,68.75,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000",277,"10.1021/acsmedchemlett.6b00375","7KS","5TQG",35.61,"1.9","1.9","Factor VIIa in complex with the inhibitor (5R,11R)-11-[(1-amino-4-fluoroisoquinolin-6-yl)amino]-16-(cyclopropylsulfonyl)-7-(2,2-difluoroethoxy)-5,13-dimethyl-2,13-diazatricyclo[13.3.1.1~6,10~]icosa-1(19),6(20),7,9,15,17-hexaene-3,12-dione","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Factor VIIa (Heavy Chain)","1","5TQG"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Factor VIIa (Light Chain)","2","5TQG"
"5TQH",,"X-RAY DIFFRACTION",2.77,37.19,"VAPOR DIFFUSION, HANGING DROP",,"co-crystallization with protein concentration at 10mG/mL and compound at 250uM; reservoir solution contains 1.6M tri-ammonium citrate and 0.1M Bis-Tris (pH5.5)",294,"10.1021/acsmedchemlett.6b00334","7J2","5TQH",193.13,"2.2","2.2","IDH1 R132H mutant in complex with IDH889","GPGMSKKISGGSVVEMQGDEMTRIIWELIKEKLIFPYVELDLHSYDLGIENRDATNDQVTKDAAEAIKKHNVGVKCATITPDEKRVEEFKLKQMWKSPNGTIRNILGGTVFREAIICKNIPRLVSGWVKPIIIGHHAYGDQYRATDFVVPGPGKVEITYTPSDGTQKVTYLVHNFEEGGGVAMGMYNQDKSIEDFAHSSFQMALSKGWPLYLSTKNTILKKYDGRFKDIFQEIYDKQYKSQFEAQKIWYEHRLIDDMVAQAMKSEGGFIWACKNYDGDVQSDSVAQGYGSLGMMTSVLVCPDGKTVEAEAAHGTVTRHYRMYQKGQETSTNPIASIFAWTRGLAHRAKLDNNKELAFFANALEEVSIETIEAGFMTKDLAACIKGLPNVQRSDYLNTFEFMDKLGENLKIKLAQAKL","Homo sapiens","IDH1, PICD","Isocitrate dehydrogenase [NADP] cytoplasmic","1","5TQH"
"5TQW","5.6","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.celrep.2016.10.067",,"5TQW",150.29,"5.6",,"CryoEM reconstruction of human IKK1, open conformation 1","DPEFGAGGPWEMRERLGTGGFGNVCLYQHRELDLKIAIKSCRLELSTKNRERWCHEIQIMKKLNHANVVKACDVPEELNILIHDVPLLAMEYCSGGDLRKLLNKPENCCGLKESQILSLLSDIGSGIRYLHENKIIHRDLKPENIVLQDVGGKIIHKIIDLGYAKDVDQGELCTEFVGTLQYLAPELFENKPYTATVDYWSFGTMVFECIAGYRPFLHHLQPFTWHEKIKKKDPKCIFACEEMSGEVRFSSHLPQPNSLCSLIVEPMENWLQLMLNWDPQQRGGPVDLTLKQPRCFVLMDHILNLKIVHILNMTSAKIISFLLPPDESLHSLQSRIERETGINTGSQELLSETGISLDPRKPASQCVLDGVRGCDSYMVYLFDKSKTVYEGPFASRSLSDCVNYIVQDSKIQLPIIQLRKVWAEAVHYVSGLKEDYSRLFQGQRAAMLSLLRYNANLTKMKNTLISASQQLKAKLEFFHKSIQLDLERYSEQMTYGISSEKMLKAWKEMEEKAIHYAEVGVIGYLEDQIMSLHAEIMELQKSPYGRRQGDLMESLEQRAIDLYKQLKHRPSDHSYSDSTEMVKIIVHTVQSQDRVLKELFGHLSKLLGCKQKIIDLLPKVEVALSNIKEADNTVMFMQGKRQKEIWHLLKIACTQ","Homo sapiens","CHUK, IKKA, TCF16","Inhibitor of nuclear factor kappa-B kinase subunit alpha","1","5TQW"
"5TQX","5.4","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.celrep.2016.10.067",,"5TQX",150.29,"5.4",,"CryoEM reconstruction of human IKK1, intermediate conformation 2","DPEFGAGGPWEMRERLGTGGFGNVCLYQHRELDLKIAIKSCRLELSTKNRERWCHEIQIMKKLNHANVVKACDVPEELNILIHDVPLLAMEYCSGGDLRKLLNKPENCCGLKESQILSLLSDIGSGIRYLHENKIIHRDLKPENIVLQDVGGKIIHKIIDLGYAKDVDQGELCTEFVGTLQYLAPELFENKPYTATVDYWSFGTMVFECIAGYRPFLHHLQPFTWHEKIKKKDPKCIFACEEMSGEVRFSSHLPQPNSLCSLIVEPMENWLQLMLNWDPQQRGGPVDLTLKQPRCFVLMDHILNLKIVHILNMTSAKIISFLLPPDESLHSLQSRIERETGINTGSQELLSETGISLDPRKPASQCVLDGVRGCDSYMVYLFDKSKTVYEGPFASRSLSDCVNYIVQDSKIQLPIIQLRKVWAEAVHYVSGLKEDYSRLFQGQRAAMLSLLRYNANLTKMKNTLISASQQLKAKLEFFHKSIQLDLERYSEQMTYGISSEKMLKAWKEMEEKAIHYAEVGVIGYLEDQIMSLHAEIMELQKSPYGRRQGDLMESLEQRAIDLYKQLKHRPSDHSYSDSTEMVKIIVHTVQSQDRVLKELFGHLSKLLGCKQKIIDLLPKVEVALSNIKEADNTVMFMQGKRQKEIWHLLKIACTQ","Homo sapiens","CHUK, IKKA, TCF16","Inhibitor of nuclear factor kappa-B kinase subunit alpha","1","5TQX"
"5TQY","5.2","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.celrep.2016.10.067",,"5TQY",150.29,"5.2",,"CryoEM reconstruction of human IKK1, closed conformation 3","DPEFGAGGPWEMRERLGTGGFGNVCLYQHRELDLKIAIKSCRLELSTKNRERWCHEIQIMKKLNHANVVKACDVPEELNILIHDVPLLAMEYCSGGDLRKLLNKPENCCGLKESQILSLLSDIGSGIRYLHENKIIHRDLKPENIVLQDVGGKIIHKIIDLGYAKDVDQGELCTEFVGTLQYLAPELFENKPYTATVDYWSFGTMVFECIAGYRPFLHHLQPFTWHEKIKKKDPKCIFACEEMSGEVRFSSHLPQPNSLCSLIVEPMENWLQLMLNWDPQQRGGPVDLTLKQPRCFVLMDHILNLKIVHILNMTSAKIISFLLPPDESLHSLQSRIERETGINTGSQELLSETGISLDPRKPASQCVLDGVRGCDSYMVYLFDKSKTVYEGPFASRSLSDCVNYIVQDSKIQLPIIQLRKVWAEAVHYVSGLKEDYSRLFQGQRAAMLSLLRYNANLTKMKNTLISASQQLKAKLEFFHKSIQLDLERYSEQMTYGISSEKMLKAWKEMEEKAIHYAEVGVIGYLEDQIMSLHAEIMELQKSPYGRRQGDLMESLEQRAIDLYKQLKHRPSDHSYSDSTEMVKIIVHTVQSQDRVLKELFGHLSKLLGCKQKIIDLLPKVEVALSNIKEADNTVMFMQGKRQKEIWHLLKIACTQ","Homo sapiens","CHUK, IKKA, TCF16","Inhibitor of nuclear factor kappa-B kinase subunit alpha","1","5TQY"
"5TR2",,"X-RAY DIFFRACTION",2.85,60,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.6 M Ammonium Sulfate, 0.1 M NaCl, and 0.1 M HEPES pH 7.5",292,"10.1111/febs.14025",,"5TR2",128.98,"2.5","2.5","Crystal structure of the D263G missense variant of human PGM1","MHHHHHHSSGVDLGTENLYFQSNMVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPGPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT","Homo sapiens","PGM1","Phosphoglucomutase-1","1","5TR2"
"5TR5",,"SOLUTION NMR",,,,,,,"10.1073/pnas.1613040114",,"5TR5",8.92,,,"Solution structure of Serine 65 phosphorylated UBL domain from parkin","MIVFVRFNSSHGFPVEVDSDTSIFQLKEVVAKRQGVPADQLRVIFAGKELRNDWTVQNCDLDQQSIVHIVQRPWRK","Homo sapiens","PARK2, PRKN","E3 ubiquitin-protein ligase parkin","1","5TR5"
"5TR6",,"X-RAY DIFFRACTION",2.43,49.32,"VAPOR DIFFUSION, SITTING DROP",6.1,"0.7M Potassium Na Tartrate, 0.06M MES_Na, 0.04M MES",293,"10.1016/j.bmcl.2016.10.087","7KG","5TR6",34.1,"1.93","1.93","Discovery of TAK-659, an Orally Available Investigational Inhibitor of Spleen Tyrosine Kinase (SYK)","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","5TR6"
"5TRB",,"X-RAY DIFFRACTION",2.56,52.02,"VAPOR DIFFUSION, HANGING DROP",6.5,"8% (w/v) PEG 4000 (polyethylene glycol 4000), 16% (v/v) glycerol, 0.02 M of each carboxylic acid (sodium formate, ammonium acetate, trisodium citrate and sodium potassium L-tartrate) and 0.1 M MES/Imidazole pH 6.5",291,"10.1016/j.jmb.2016.07.025",,"5TRB",8.85,"1.8","1.8","Crystal structure of the RNF20 RING domain","GPLGSDEILMEEIKDYKARLTCPCCNMRKKDAVLTKCFHVFCFECVKTRYDTRQRKCPKCNAAFGANDFHRIYIG","Homo sapiens","RNF20, BRE1A","E3 ubiquitin-protein ligase BRE1A","1","5TRB"
"5TRF",,"X-RAY DIFFRACTION",3.47,64.52,"VAPOR DIFFUSION, SITTING DROP",,"2m2M Ammonium Sulfate and 0.2M Lithium Nitrate",293,"10.1158/0008-5472.CAN-14-0799","7HC","5TRF",66.28,"2.1","2.1","MDM2 in complex with SAR405838","TDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDS","Homo sapiens","MDM2","E3 ubiquitin-protein ligase Mdm2","1","5TRF"
"5TRL",,"X-RAY DIFFRACTION",2.91,57.77,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.4M Ammonium sulfate, 0.4M Lithium chloride",293,"10.1038/nature25003",,"5TRL",162.19,"2.299","2.299","Crystal structure of human GCN5 histone acetyltransferase domain","GSGIIEFHVIGNSLTPKANRRVLLWLVGLQNVFSHQLPRMPKEYIARLVFDPKHKTLALIKDGRVIGGICFRMFPTQGFTEIVFCAVTSNEQVKGYGTHLMNHLKEYHIKHNILYFLTYADEYAIGYFKKQGFSKDIKVPKSRYLGYIKDYEGATLMECELNPRIPYT","Homo sapiens","KAT2A, GCN5, GCN5L2, HGCN5","Histone acetyltransferase KAT2A","1","5TRL"
"5TRM",,"X-RAY DIFFRACTION",2.81,56.19,"VAPOR DIFFUSION, HANGING DROP",4.6,"1.8M Sodium formate, 0.1M Sodium acetate pH 4.6",293,"10.1038/nature25003",,"5TRM",465.76,"2.9","2.9","Crystal structure of human GCN5 histone acetyltransferase domain","GSGIIEFHVIGNSLTPKANRRVLLWLVGLQNVFSHQLPRMPKEYIARLVFDPKHKTLALIKDGRVIGGICFRMFPTQGFTEIVFCAVTSNEQVKGYGTHLMNHLKEYHIKHNILYFLTYADEYAIGYFKKQGFSKDIKVPKSRYLGYIKDYEGATLMECELNPRIPYT","Homo sapiens","KAT2A, GCN5, GCN5L2, HGCN5","Histone acetyltransferase KAT2A","1","5TRM"
"5TRP",,"X-RAY DIFFRACTION",2.79,55.96,"VAPOR DIFFUSION, HANGING DROP",5,"2.5 M AmSO4, 100 mM Na Acetate, pH 5.0",293,"10.1126/scitranslmed.aai7514",,"5TRP",49.89,"2.692","2.692","Crystal Structure of the Unliganded DH270 Cooperating Lineage Member DH272","QVQLVQSGAEVKKPGASVKVSCHASGFRFTDHYINWLRQAPGQEFEWIGWINPGNSVTHYAQKFQARVTMTRFGSTIYMELNRLRSDDTAVYYCAREPYDFHSGLEGSLDYWGQGTLVTVSGASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"DH272 Fab heavy chain","1","5TRP"
,,,,,,,,,,,,,,,,"DIVMTQSPLSLPVTLGQPASISCRSSQSLVHNYGNTYLNWFQQRPGQSPRRLIYKVSGRDSGVPDRFSGGGSGTDFTLKISSVEAEDVGVYYCMQGTHWPRTFGQGTKLEINRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"DH272 Fab light chain","2","5TRP"
"5TSU",,"X-RAY DIFFRACTION",2.24,45.07,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mM Sodium Cocadylate PH6.5
150mM Sodium Cirtate
305 Isopropanol",277,"10.1021/acs.biochem.6b01172",,"5TSU",373.78,"2.2","2.2","Active conformation for Engineered human cystathionine gamma lyase (E59N, R119L, E339V) to depleting methionine","MGGHHHHHHGLEVLFQGPQEKDASSQGFLPHFQHFATQAIHVGQDPEQWTSRAVVPPISLSTTFKQGAPGQHSGFNYSRSGNPTRNCLEKAVAALDGAKYCLAFASGLAATVTITHLLKAGDQIICMDDVYGGTNLYFRQVASEFGLKISFVDCSKIKLLEAAITPETKLVWIETPTNPTQKVIDIEGCAHIVHKHGDIILVVDNTFMSPYFQRPLALGADISMYSATKYMNGHSDVVMGLVSVNCESLHNRLRFLQNSLGAVPSPIDCYLCNRGLKTLHVRMEKHFKNGMAVAQFLESNPWVEKVIYPGLPSHPQHELVKRQCTGCTGMVTFYIKGTLQHAEIFLKNLKLFTLAVSLGGFESLAELPAIMTHASVLKNDRDVLGISDTLIRLSVGLEDEEDLLEDLDQALKAAHPPSGSHS","Homo sapiens","CTH","Cystathionine gamma-lyase","1","5TSU"
,,,,,,,,,,,,,,,,"MGGHHHHHHGLEVLFQGPQEKDASSQGFLPHFQHFATQAIHVGQDPEQWTSRAVVPPISLSTTFKQGAPGQHSGFNYSRSGNPTRNCLEKAVAALDGAKYCLAFASGLAATVTITHLLKAGDQIICMDDVYGGTNLYFRQVASEFGLKISFVDCSKIKLLEAAITPETKLVWIETPTNPTQKVIDIEGCAHIVHKHGDIILVVDNTFMSPYFQRPLALGADISMYSATKYMNGHSDVVMGLVSVNCESLHNRLRFLQNSLGAVPSPIDCYLCNRGLKTLHVRMEKHFKNGMAVAQFLESNPWVEKVIYPGLPSHPQHELVKRQCTGCTGMVTFYIKGTLQHAEIFLKNLKLFTLAVSLGGFESLAELPAIMTHASVLKNDRDVLGISDTLIRLSVGLEDEEDLLEDLDQALKAAHPPSGSHS","Homo sapiens","CTH","Cystathionine gamma-lyase","2","5TSU"
"5TSW",,"X-RAY DIFFRACTION",2.14,42.65,,6.8,"20% POLYETHYLENEGLYCOL 4000, 0.1 M SODIUM CITRATE PH 5.6, pH 6.8",,"10.1074/jbc.273.4.2153",,"5TSW",99.47,"2.5","2.5","HIGH RESOLUTION CRYSTAL STRUCTURE OF A HUMAN TNF-ALPHA MUTANT","PSDKPVAHVVANPQAEGQLQWSNRRANALLANGVELRDNQLVVPIEGLFLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","PROTEIN (TUMOR NECROSIS FACTOR-ALPHA)","1","5TSW"
"5TT2",,"X-RAY DIFFRACTION",2.44,49.63,"VAPOR DIFFUSION, SITTING DROP",6.5,"100mM MES pH6.5
20% PEG3350
200mM Na/K tartrate
200mM lithium sulfate",277,"10.1021/acs.biochem.6b01172",,"5TT2",93.6,"2.949","2.949","Inactive conformation of engineered human cystathionine gamma lyase (E59N, R119L, E339V) to depleting methionine","MGGHHHHHHGLEVLFQGPQEKDASSQGFLPHFQHFATQAIHVGQDPEQWTSRAVVPPISLSTTFKQGAPGQHSGFNYSRSGNPTRNCLEKAVAALDGAKYCLAFASGLAATVTITHLLKAGDQIICMDDVYGGTNLYFRQVASEFGLKISFVDCSKIKLLEAAITPETKLVWIETPTNPTQKVIDIEGCAHIVHKHGDIILVVDNTFMSPYFQRPLALGADISMYSATKYMNGHSDVVMGLVSVNCESLHNRLRFLQNSLGAVPSPIDCYLCNRGLKTLHVRMEKHFKNGMAVAQFLESNPWVEKVIYPGLPSHPQHELVKRQCTGCTGMVTFYIKGTLQHAEIFLKNLKLFTLAVSLGGFESLAELPAIMTHASVLKNDRDVLGISDTLIRLSVGLEDEEDLLEDLDQALKAAHPPSGIHS","Homo sapiens","CTH","Cystathionine gamma-lyase","1","5TT2"
"5TT7",,"X-RAY DIFFRACTION",2.36,47.83,"VAPOR DIFFUSION, SITTING DROP",8.7,"1.2M Potassium Na Tartrate, 0.1M Tris pH 8.7",293,"10.1016/j.bmcl.2016.10.087","7KF","5TT7",34.05,"1.77","1.77","Discovery of TAK-659, an Orally Available Investigational Inhibitor of Spleen Tyrosine Kinase (SYK)","MALEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNHHHHHH","Homo sapiens","SYK","Tyrosine-protein kinase SYK","1","5TT7"
"5TTF",,"X-RAY DIFFRACTION",2.3,46.43,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG 3350, 0.2 M NaCl, 0.1 M Bis-Tris pH6.5",291,"10.1021/acs.jmedchem.6b01645","7KZ","5TTF",134.88,"1.72","1.72","Crystal structure of catalytic domain of G9a with MS012","GSNRAIRTEKIICRDVARGYENVPIPCVNGVDGEPCPEDYKYISENCETSTMNIDRNITHLQHCTCVDDCSSSNCLCGQLSIRCWYDKDGRLLQEFNKIEPPLIFECNQACSCWRNCKNRVVQSGIKVRLQLYRTAKMGWGVRALQTIPQGTFICEYVGELISDAEADVREDDSYLFDLDNKDGEVYCIDARYYGNISRFINHLCDPNIIPVRVFMLHQDLRFPRIAFFSSRDIRTGEELGFDYGDRFWDIKSKYFTCQCGSEKCKHSAEAIALEQSRLARLD","Homo sapiens","EHMT2, BAT8, C6orf30, G9A, KMT1C, NG36","Histone-lysine N-methyltransferase EHMT2","1","5TTF"
"5TTG",,"X-RAY DIFFRACTION",2.76,55.48,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 4000, 20% IProp, 0.1 M NaCitrate pH5.6",293,"10.1021/acs.jmedchem.6b01645","7KZ","5TTG",68.28,"1.66","1.66","Crystal structure of catalytic domain of GLP with MS012","GSNSQVWSALQMSKALQDSAPDRPSPVERIVSRDIARGYERIPIPCVNAVDSEPCPSNYKYVSQNCVTSPMNIDRNITHLQYCVCIDDCSSSNCMCGQLSMRCWYDKDGRLLPEFNMAEPPLIFECNHACSCWRNCRNRVVQNGLRARLQLYRTRDMGWGVRSLQDIPPGTFVCEYVGELISDSEADVREEDSYLFDLDNKDGEVYCIDARFYGNVSRFINHHCEPNLVPVRVFMAHQDLRFPRIAFFSTRLIEAGEQLGFDYGERFWDIKGKLFSCRCGSPKCRHS","Homo sapiens","EHMT1, EUHMTASE1, GLP, KIAA1876, KMT1D","Histone-lysine N-methyltransferase EHMT1","1","5TTG"
"5TTO",,"X-RAY DIFFRACTION",2.7,54.4,"VAPOR DIFFUSION, HANGING DROP",8,"2M ammonium sulfate",289,"10.1021/acs.jmedchem.6b01727","7KK","5TTO",63.54,"2.246","2.246","X-ray crystal structure of PPARgamma in complex with SR1643","NPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","5TTO"
"5TTR",,"X-RAY DIFFRACTION",2.6,53,,7.5,"pH 7.5",,"10.1074/jbc.273.38.24715",,"5TTR",110.09,"2.7","2.7","LEU 55 PRO TRANSTHYRETIN CRYSTAL STRUCTURE","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGEPHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","TRANSTHYRETIN","1","5TTR"
"5TTS",,"X-RAY DIFFRACTION",2.2,44.05,"VAPOR DIFFUSION, SITTING DROP",8,"20% PEG 3350, 0.2M (NH4)2SO4, 2% phenylurea",298,"10.1021/acs.jmedchem.6b01694",,"5TTS",36.82,"2.34","2.34","Jak3 with covalent inhibitor 4","MGHHHHHHQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","5TTS"
"5TTU",,"X-RAY DIFFRACTION",2.2,44.19,"VAPOR DIFFUSION, SITTING DROP",8,"20% PEG 3350, 0.2M (NH4)2SO4, 2% phenylurea",298,"10.1021/acs.jmedchem.6b01694",,"5TTU",37.04,"1.72","1.72","Jak3 with covalent inhibitor 7","MGHHHHHHQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","5TTU"
"5TTV",,"X-RAY DIFFRACTION",2.14,42.57,"VAPOR DIFFUSION, SITTING DROP",8,"20% PEG 3350, 0.2M (NH4)2SO4, 2% phenylurea",298,"10.1021/acs.jmedchem.6b01694",,"5TTV",36.81,"1.93","1.93","Jak3 with covalent inhibitor 6","MGHHHHHHQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFTAHPEGKHHSLSFS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","5TTV"
"5TUN",,"X-RAY DIFFRACTION",2.12,42.02,"VAPOR DIFFUSION, SITTING DROP",4.2,"20% polyethylene glycol (PEG) 8000, 0.1 M phosphate/citrate pH 4.2 and 0.2 M sodium chloride",294.15,"10.1042/BCJ20160985",,"5TUN",23.52,"1.62","1.62","Crystal structure of uninhibited human Cathepsin K at 1.62 Angstrom resolution","APDSVDYRKKGYVTPVKNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFYSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM","Homo sapiens","CTSK, CTSO, CTSO2","Cathepsin K","1","5TUN"
"5TUR",,"X-RAY DIFFRACTION",2.45,49.79,"VAPOR DIFFUSION",,"0.1M imidazole, 1M NaAcetate, 20% glycerol pH 6.5",277,"10.1016/j.bmcl.2017.08.069","7LK","5TUR",45.8,"2.948","2.948","Pim-1 kinase in complex with a 7-azaindole","MPHEPHEPLTPPFSALPDPAGAPSRRQSRQRPQLSSDSPSAFRASRSHSRNATRSHSHSHSPRHSLRHSPGSGSCGSSSGHRPCADILEVGMLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","5TUR"
"5TUS",,"X-RAY DIFFRACTION",2.43,49.31,"VAPOR DIFFUSION, HANGING DROP",7.9,"0.1 M Tris-HCl pH 7.9, 0.2 M LiSO4, 19% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 298K",298,"10.1073/pnas.1620220114",,"5TUS",181.68,"2.66","2.66","Potent competitive inhibition of human ribonucleotide reductase by a novel non-nucleoside small molecule","MHVIKRDGRQERVMFDKITSRIQKLCYGLNMDFVDPAQITMKVIQGLYSGVTTVELDTLAAETAATLTTKHPDYAILAARIAVSNLHKETKKVFSDVMEDLYNYINPHNGKHSPMVAKSTLDIVLANKDRLNSAIIYDRDFSYNYFGFKTLERSYLLKINGKVAERPQHMLMRVSVGIHKEDIDAAIETYNLLSERWFTHASPTLFNAGTNRPQLSSCFLLSMKDDSIEGIYDTLKQCALISKSAGGIGVAVSCIRATGSYIAGTNGNSNGLVPMLRVYNNTARYVDQGGNKRPGAFAIYLEPWHLDIFEFLDLKKNTGKEEQRARDLFFALWIPDLFMKRVETNQDWSLMCPNECPGLDEVWGEEFEKLYASYEKQGRVRKVVKAQQLWYAIIESQTETGTPYMLYKDSCNRKSNQQNLGTIKCSNLCTEIVEYTSKDEVAVCNLASLALNMYVTSEHTYDFKKLAEVTKVVVRNLNKIIDINYYPVPEACLSNKRHRPIGIGVQGLADAFILMRYPFESAEAQLLNKQIFETIYYGALEASCDLAKEQGPYETYEGSPVSKGILQYDMWNVTPTDLWDWKVLKEKIAKYGIRNSLLIAPMPTASTAQILGNNESIEPYTSNIYTRRVLSGEFQIVNPHLLKDLTERGLWHEEMKNQIIACNGSIQSIPEIPDDLKQLYKTVWEISQKTVLKMAAERGAFIDQSQSLNIHIAEPNYGKLTSMHFYGWKQGLKTGMYYLRTRPAANPIQFTLNKEKLKDKEKVSKEEEEKERNTAAMVCSLENRDECLMCGS","Homo sapiens","RRM1, RR1","Ribonucleoside-diphosphate reductase large subunit","1","5TUS"
"5TUY",,"X-RAY DIFFRACTION",2.81,56.24,"VAPOR DIFFUSION",6.5,"20% (w/v) PEG 3,350, 0.2 M NaF, 0.1 M Bis-Tris propane (pH 6.5)",290,"10.1021/acs.jmedchem.6b01645","7L6","5TUY",63.88,"2.6","2.6","Structure of human G9a SET-domain (EHMT2) in complex with inhibitor MS0124","IICRDVARGYENVPIPCVNGVDGEPCPEDYKYISENCETSTMNIDRNITHLQHCTCVDDCSSSNCLCGQLSIRCWYDKDGRLLQEFNKIEPPLIFECNQACSCWRNCKNRVVQSGIKVRLQLYRTAKMGWGVRALQTIPQGTFICEYVGELISDAEADVREDDSYLFDLDNKDGEVYCIDARYYGNISRFINHLCDPNIIPVRVFMLHQDLRFPRIAFFSSRDIRTGEELGFDYGDRFWDIKSKYFTCQCGSEKCKHSAEAIALEQSK","Homo sapiens","EHMT2, BAT8, C6orf30, G9A, KMT1C, NG36","Histone-lysine N-methyltransferase EHMT2","1","5TUY"
"5TUZ",,"X-RAY DIFFRACTION",3.04,59.51,"VAPOR DIFFUSION",9,"20% PEG 20,000, 2% (v/v) 1,4-Dioxane, 0.1 M Bicine (pH 9.0)",290,"10.1021/acs.jmedchem.6b01645","7L6","5TUZ",62.68,"1.95","1.95","Structure of human GLP SET-domain (EHMT1) in complex with inhibitor MS0124","VERIVSRDIARGYERIPIPCVNAVDSEPCPSNYKYVSQNCVTSPMNIDRNITHLQYCVCIDDCSSSNCMCGQLSMRCWYDKDGRLLPEFNMAEPPLIFECNHACSCWRNCRNRVVQNGLRARLQLYRTRDMGWGVRSLQDIPPGTFVCEYVGELISDSEADVREEDSYLFDLDNKDGEVYCIDARFYGNVSRFINHHCEPNLVPVRVFMAHQDLRFPRIAFFSTRLIEAGEQLGFDYGERFWDIKGKLFSCRCGSPKCRHS","Homo sapiens","EHMT1, EUHMTASE1, GLP, KIAA1876, KMT1D","Histone-lysine N-methyltransferase EHMT1","1","5TUZ"
"5TVB",,"X-RAY DIFFRACTION",2.52,51.15,"EVAPORATION",7.5,"0.1M HEPES 7.5,
30%  PEG1000",299,"10.1016/j.str.2017.04.015",,"5TVB",33.81,"2.75","2.75","Structure of the TPR oligomerization domain","AAVLQQVLERTELNKLPKSVQNKLEKFLADQQSEIDGLKGRHEKFKVESEQQYMEIEKRLSHSQERLVNETRECQSLRLELEKLNNQLKALTEKNKELEMAQDRNIAIQSQMTRTKEELEAEKRDLIRTNERLSQELEYLT","Homo sapiens","TPR","Nucleoprotein TPR","1","5TVB"
"5TVR",,"X-RAY DIFFRACTION",2.66,53.85,"VAPOR DIFFUSION, HANGING DROP",6,"17.5% PEG-3350 and 0.1 M citrate pH 6.0",277,"10.1039/c6cc09882g",,"5TVR",84.08,"2.093","2.093","JMJD2A in complex with Ni(II) and alpha-Ketoglutarate","MASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","5TVR"
"5TVS",,"X-RAY DIFFRACTION",2.61,52.82,"VAPOR DIFFUSION, HANGING DROP",6,"17.5% PEG-3350 and 0.1 M citrate pH 6.0",277,"10.1039/c6cc09882g",,"5TVS",83.78,"2.745","2.745","JMJD2A in complex with Ni(II)","MASESETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFLKESEL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","5TVS"
"5TVT",,"X-RAY DIFFRACTION",2.58,52.27,"VAPOR DIFFUSION, SITTING DROP",,"24% PEG3350, 0.1 M MgCl, 0.1M HEPES pH 7.0",298,,,"5TVT",39.21,"2.28","2.28","Structure of Maternal Embryonic Leucine Zipper Kinase","GSKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLR","Homo sapiens","MELK, KIAA0175","Maternal embryonic leucine zipper kinase","1","5TVT"
"5TWF",,"X-RAY DIFFRACTION",2.56,52.02,"VAPOR DIFFUSION",5.5,"0.1 M MES pH 5.5, 0.2 M NH4Cl, and 20% PEG 6000",298,"10.1074/mcp.M117.068130",,"5TWF",50.36,"3.136","3.136","Regulation of protein interactions by MOB1 phosphorylation","MSFLFSSRSSKTFKPKKNIPEGSHQYELLKHAEATLGSGNLRQAVMLPEGEDLNEWIAVNTVDFFNQINMLYGTITEFCTEASCPVMSAGPRYEYHWADGTNIKKPIKCSAPKYIDYLMTWVQDQLDDETLFPSKIGVPFPKNFMSVAKTILKRLFRVYAHIYHQHFDSVMQLEEEAHLNTSFKHFIFFVQEFNLIDRRELAPLQELIEKLGSKDR","Homo sapiens","MOB1A, C2orf6, MOB4B, MOBK1B, MOBKL1B","MOB kinase activator 1A","1","5TWF"
"5TWL",,"X-RAY DIFFRACTION",2.79,55.84,"VAPOR DIFFUSION, SITTING DROP",,"magnesium chloride, PEG 3350, BIS-TRIS",293,"10.7554/eLife.26693","H91","5TWL",39.88,"2.42","2.42","Structure of Maternal Embryonic Leucine Zipper Kinase","GSKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSSFSCG","Homo sapiens","MELK, KIAA0175","Maternal embryonic leucine zipper kinase","1","5TWL"
"5TWU",,"X-RAY DIFFRACTION",2.57,52.08,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000",293,"10.7554/eLife.26693",,"5TWU",79.31,"2.603","2.603","Structure of Maternal Embryonic Leucine Zipper Kinase","GSGSMKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSSFSCG","Homo sapiens","MELK, KIAA0175","Maternal embryonic leucine zipper kinase","1","5TWU"
"5TWW",,"SOLUTION NMR",,,,,,,,,"5TWW",1.27,,,"Alpha Helix Nucleation by a Simple Cyclic Tetrapeptide","AAAXARAARAARAX","Homo sapiens",,"Cyclic peptide ALA-ALA-ALA-UN1-ALA-ARG-ALA-ALA-ARG-ALA-ALA-ARG-ALA","1","5TWW"
"5TWX",,"X-RAY DIFFRACTION",2.55,51.75,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000",293,"10.1002/anie.201611281",,"5TWX",58.73,"2.55","2.55","Crystal Structure of BRD9 bromodomain","GPHMAENESTPIQQLLEHFLRQLQRKDPHGFFAFPVTDAIAPGYSMIIKHPMDFGTMKDKIVANEYKSVTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKQAALLGNEDTA","Homo sapiens","BRD9, UNQ3040/PRO9856","Bromodomain-containing protein 9","1","5TWX"
"5TWY",,"X-RAY DIFFRACTION",2.4,48.72,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000",293,"10.7554/eLife.26693",,"5TWY",79.64,"2.91","2.91","Structure of Maternal Embryonic Leucine Zipper Kinase","GSKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSSFSCG","Homo sapiens","MELK, KIAA0175","Maternal embryonic leucine zipper kinase","1","5TWY"
"5TWZ",,"X-RAY DIFFRACTION",2.43,49.32,"VAPOR DIFFUSION, SITTING DROP",,"PEG 4000",293,"10.7554/eLife.26693",,"5TWZ",39.75,"2.631","2.631","Structure of Maternal Embryonic Leucine Zipper Kinase","GSKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSSFSCG","Homo sapiens","MELK, KIAA0175","Maternal embryonic leucine zipper kinase","1","5TWZ"
"5TX3",,"X-RAY DIFFRACTION",2.36,47.98,"VAPOR DIFFUSION, HANGING DROP",,"PEG 4000",293,"10.7554/eLife.26693",,"5TX3",80.25,"2.9","2.9","Structure of Maternal Embryonic Leucine Zipper Kinase","GSGSMKDYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIVSAVAYVHSQGYAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYAAPELIQGKSYLGSEADVWSMGILLYVLMCGFLPFDDDNVMALYKKIMRGKYDVPKWLSPSSILLLQQMLQVDPKKRISMKNLLNHPWIMQDYNYPVEWQSKNPFIHLDDDCVTELSVHHRNNRQTMEDLISLWQYDHLTATYLLLLAKKARGKPVRLRLSSFSCG","Homo sapiens","MELK, KIAA0175","Maternal embryonic leucine zipper kinase","1","5TX3"
"5TX5",,"X-RAY DIFFRACTION",2.03,39.42,"VAPOR DIFFUSION",,"23 % PEG 4000, 0.1 M ammonium acetate and 0.1 M HEPES pH 7.5.",277,"10.1021/acs.jmedchem.6b01751",,"5TX5",69.95,"2.56","2.56","Rip1 Kinase ( flag 1-294, C34A, C127A, C233A, C240A) with GSK772","MDYKDDDDKMQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLAFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMAYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAIAEQQLIMAIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLE","Homo sapiens","RIPK1, RIP, RIP1","Receptor-interacting serine/threonine-protein kinase 1","1","5TX5"
"5TXD",,"X-RAY DIFFRACTION",1.42,13.45,"VAPOR DIFFUSION, HANGING DROP",5,"reservoir contained 20% PEG 3350, 0.2M Potassium Phosphate dibasic",298,"10.1002/pro.3375",,"5TXD",0.74,"1.452","1.452","Structure of amyloid-beta derived peptide - NKGAIF","NKGAIF","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","5TXD"
"5TXF",,"X-RAY DIFFRACTION",3.52,65.09,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M ammonium formate, 20% PEG 3350",277,"10.1074/jbc.M117.802736",,"5TXF",195.47,"3.1","3.1","Crystal structure of Lecithin:cholesterol acyltransferase (LCAT) in a closed conformation","FWLLNVLFPPHTTPKAELSNHTRPVILVPGCLGNQLEAKLDKPDVVNWMCYRKTEDFFTIWLDLNMFLPLGVDCWIDNTRVVYNRSSGLVSNAPGVQIRVPGFGKTYSVEYLDSSKLAGYLHTLVQNLVNNGYVRDETVRAAPYDWRLEPGQQEEYYRKLAGLVEEMHAAYGKPVFLIGHSLGCLHLLYFLLRQPQAWKDRFIDGFISLGAPWGGSIKPMLVLASGDNQGIPIMSSIKLKEEQRITTTSPWMFPSRMAWPEDHVFISTPSFNYTGRDFQRFFADLHFEEGWYMWLQSRDLLAGLPAPGVEVYCLYGVGLPTPRTYIYDHGFPYTDPVGVLYEDGDDTVATRSTELCGLWQGRQPQPVHLLPLHGIQHLNMVFSNLTLEHINAILLGAYRQGPPASPTASPEPPPPEHHHHHH","Homo sapiens","LCAT","Phosphatidylcholine-sterol acyltransferase","1","5TXF"
"5TXH",,"X-RAY DIFFRACTION",1.48,16.77,"VAPOR DIFFUSION, HANGING DROP",5,"Reservoir contained 20% PEG 4000, 0.1M Sodium Citrate pH 5.6 and 20% Isopropanol",298,"10.1002/pro.3375",,"5TXH",2.83,"1.45","1.45","Polymorphic form 2 of amyloid-beta derived peptide - IFAEDV","IFAEDV","Homo sapiens",,"IFAEDV","1","5TXH"
"5TXJ",,"X-RAY DIFFRACTION",1.39,11.7,"VAPOR DIFFUSION, HANGING DROP",5,"reservoir contained 20% PEG 3350, 0.2M Ammonium Nitrate",298,"10.1002/pro.3375",,"5TXJ",1.39,"1.13","1.13","Polymorphic form 1 of amyloid-beta derived peptide - IFAEDV","IFAEDV","Homo sapiens",,"amyloid-beta derived peptide","1","5TXJ"
"5TXY",,"X-RAY DIFFRACTION",2.08,40.93,"VAPOR DIFFUSION, SITTING DROP",,"2.58 M ammonium sulfate, 
0.1 M tris-chloride (pH 8.9)",280,"10.1021/acs.jmedchem.7b00606","7Q1","5TXY",29.58,"1.206","1.206","Identification of a New Zinc Binding Chemotype of by Fragment Screening on human carbonic anhydrase","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5TXY"
"5TY1",,"X-RAY DIFFRACTION",2.1,41.47,"VAPOR DIFFUSION, SITTING DROP",8.3,"the reservoir condition consisted of 2.9 M ammonium sulfate with 0.1 M Tris buffer at pH 8.3; concentrated CA II at ~10 mg mL-1 was set up with seeding; dry compound was added to crystals several days before harvesting and data collection",281,"10.1021/acs.jmedchem.7b00606","7QV","5TY1",29.61,"1.6","1.6","Identification of a New Zinc Binding Chemotype by Fragment Screening","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5TY1"
"5TY3",,"X-RAY DIFFRACTION",2.26,50.78,"VAPOR DIFFUSION, HANGING DROP",8,"25% PEG 6000, 0.1 M TRIS PH 8, VAPOR
 DIFFUSION, HANGING DROP, TEMPERATURE 293K",293,"10.1021/acs.biochem.7b00342",,"5TY3",24.59,"1.25","1.25","Crystal structure of K72A variant of Human Cytochrome c","GDVEKGKKIFIMKCSQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGYSYTAANKNKGIIWGEDTLMEYLENPAKYIPGTKMIFVGIKKKEERADLIAYLKKATNE","Homo sapiens","CYCS, CYC","Cytochrome c","1","5TY3"
"5TY6",,"X-RAY DIFFRACTION",2.89,57.49,"VAPOR DIFFUSION, HANGING DROP",7.4,"0.5 M Lithium sulfate, 20% PEG 8000",293,"10.1126/sciimmunol.aan2676",,"5TY6",48.06,"1.361","1.361","Crystal structure of the broadly neutralizing Influenza A antibody VRC 315 13-1b02 Fab.","EVQLVESGGGLVQPGGSLRLSCIGSEFTFSNYGMNWVRQAPGKGLEWISYITGASATVYYAASVRGRFTISRDNARNSLFLEMNGLRAEDTAVYYCARDRGCNSPTCFVIGYYYYGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"VRC 315 13-1b02 Fab Heavy chain","1","5TY6"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRASQTISRYLNWYQQKAGKAPTLLIYDASRLQSGVPSRFSGSGSGTEFTLTISSLQREDFATYYCQQSDSIPALTFGGGTRVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAVVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNR","Homo sapiens",,"VRC 315 13-1b02 Fab Light chain","2","5TY6"
"5TY8",,"X-RAY DIFFRACTION",2.1,41.44,"VAPOR DIFFUSION, SITTING DROP",8.3,"the reservoir condition consisted of 2.9 M ammonium sulfate with 0.1 M Tris buffer at pH 8.3; concentrated CA II at ~10 mg mL-1 was set up with seeding; dry compound was added to crystals several days before harvesting and data collection",281,"10.1021/acs.jmedchem.7b00606","7Q1","5TY8",29.53,"1.45","1.45","Identification of a New Zinc Binding Chemotype by Fragment Screening","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5TY8"
"5TY9",,"X-RAY DIFFRACTION",2.11,41.57,"VAPOR DIFFUSION, SITTING DROP",8.3,"the reservoir condition consisted of 2.9 M ammonium sulfate with 0.1 M Tris buffer at pH 8.3; concentrated CA II at ~10 mg mL-1 was set up with seeding; dry compound was added to crystals several days before harvesting and data collection",281,"10.1021/acs.jmedchem.7b00606","7QV","5TY9",29.59,"1.53","1.53","Identification of a New Zinc Binding Chemotype by Fragment Screening","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5TY9"
"5TYA",,"X-RAY DIFFRACTION",2.09,41.29,"VAPOR DIFFUSION, SITTING DROP",8.3,"the reservoir condition consisted of 2.9 M ammonium sulfate with 0.1 M Tris buffer at pH 8.3; concentrated CA II at ~10 mg mL-1 was set up with seeding; dry compound was added to crystals several days before harvesting and data collection",281,"10.1021/acs.jmedchem.7b00606","7QS","5TYA",29.55,"1.5","1.5","Identification of a New Zinc Binding Chemotype by Fragment Screening","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5TYA"
"5TZ3",,"X-RAY DIFFRACTION",2.18,43.52,"VAPOR DIFFUSION, HANGING DROP",8.4,"17-19% PEG3350, 0.2M MgCl2, 0.1M Tris, pH 8.4",293,"10.1021/acs.jmedchem.6b01793","7OM","5TZ3",162.58,"1.72","1.72","CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX with [1,2,4]triazolo[1,5-a]pyrimidin-7-yl}-N-(naphthalene-2-yl)piperidine-3-carboxamide","SAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5TZ3"
"5TZA",,"X-RAY DIFFRACTION",2.2,44.2,"VAPOR DIFFUSION, HANGING DROP",8.4,"17-19% PEG3350, 0.2M MgCl2, 0.1M Tris, pH 8.4",293,"10.1021/acs.jmedchem.6b01793","7OG","5TZA",162.52,"1.7","1.7","CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A WITH 3-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl-1-[(naphthalene-2-yl)carbonyl]piperidine","SAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5TZA"
"5TZC",,"X-RAY DIFFRACTION",2.2,44.01,"VAPOR DIFFUSION, HANGING DROP",8.4,"17-19% PEG3350, 0.2M MgCl2, 0.1M Tris, pH 8.4",293,"10.1021/acs.jmedchem.6b01793","7OJ","5TZC",162.85,"2.36","2.36","Crystal Structure of human PDE2a in complex with (5S)-1-[(3-bromo-4-fluorophenyl)carbonyl]-3,3-difluoro-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine","SAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5TZC"
"5TZH",,"X-RAY DIFFRACTION",2.19,43.82,"VAPOR DIFFUSION, HANGING DROP",8.4,"17-19% PEG3350, 0.2M MgCl2, 0.1M Tris, pH 8.4",293,"10.1021/acs.jmedchem.6b01793","7OP","5TZH",162.53,"1.6","1.6","CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 3,3-difluoro-1-[(4-fluorophenyl)carbonyl]-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine","SAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5TZH"
"5TZL",,"X-RAY DIFFRACTION",2.15,42.77,"VAPOR DIFFUSION, SITTING DROP",5.5,"WT-TTR at 4 mg/mL and five-fold molar excess compound 201 crystallized from solution containing 1.395 M sodium citrate, 3.5% v/v glycerol at pH 5.5. Crystals cryoprotected by addition of 10% (v/v) glycerol.",298,"10.1016/j.bmcl.2017.05.080",,"5TZL",28.65,"1.4","1.4","Structure of transthyretin in complex with the kinetic stabilizer 201","GPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","5TZL"
"5TZM",,"X-RAY DIFFRACTION",2.38,48.4,"VAPOR DIFFUSION, HANGING DROP",7.5,"17% tacsimate, 0.1M HEPES pH 7.5, 4% PEG3350, 10 mg/mL C-terminal his-tagged Ig59",293,"10.1371/journal.pone.0186642",,"5TZM",10.71,"1.177","1.177","59th Ig domain of human obscurin (OBSCN Ig59)","RLEILELLKNAAVRAGAQACFTCTLSEAVPVGEASWYINGAAVQPDDSDWTVTADGSHHALLLRSAQPHHAGEVTFACRDAVASARLTVLGGLEHHHHHH","Homo sapiens","OBSCN, KIAA1556, KIAA1639","Obscurin","1","5TZM"
"5TZW",,"X-RAY DIFFRACTION",2.19,43.9,"VAPOR DIFFUSION, HANGING DROP",8.4,"17-19% PEG3350, 0.2M MgCl2, 0.1M Tris, pH 8.4",293,"10.1021/acs.jmedchem.6b01793","7P4","5TZW",162.6,"1.59","1.59","CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3,4-difluorophenyl)carbonyl]-3,3-difluoro-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine","SAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5TZW"
"5TZX",,"X-RAY DIFFRACTION",2.16,43.11,"VAPOR DIFFUSION, HANGING DROP",8.4,"17-19% PEG3350, 0.2M MgCl2, 0.1M Tris, pH 8.4",293,"10.1021/acs.jmedchem.6b01793","7OY","5TZX",162.67,"1.9","1.9","CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3-chloro-4-fluorophenyl)carbonyl]-3,3-difluoro-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine","SAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5TZX"
"5TZZ",,"X-RAY DIFFRACTION",2.18,43.58,"VAPOR DIFFUSION, HANGING DROP",8.4,"17-19% PEG3350, 0.2M MgCl2, 0.1M Tris, pH 8.4",293,"10.1021/acs.jmedchem.6b01793","7OJ","5TZZ",162.85,"1.6","1.6","CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 1-[(3-bromo-4-fluorophenyl)carbonyl]-3,3-difluoro-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine","SAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5TZZ"
"5U00",,"X-RAY DIFFRACTION",2.22,44.52,"VAPOR DIFFUSION, HANGING DROP",8.4,"17-19% PEG3350, 0.2M MgCl2, 0.1M Tris, pH 8.4",293,"10.1021/acs.jmedchem.6b01793","7OV","5U00",163.04,"1.41","1.41","CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 2A IN COMPLEX WITH 3,3-difluoro-1-[(4-fluoro-3-iodophenyl)carbonyl]-5-{5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl}piperidine","SAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5U00"
"5U03","6.1","ELECTRON MICROSCOPY",,,,,,,"10.1038/nsmb.3407",,"5U03",271.07,"6.1",,"Cryo-EM structure of the human CTP synthase filament","MKYILVTGGVISGIGKGIIASSVGTILKSCGLHVTSIKIDPYINIDAGTFSPYEHGEVFVLDDGGEVDLDLGNYERFLDIRLTKDNNLTTGKIYQYVINKERKGDYLGKTVQVVPHITDAIQEWVMRQALIPVDEDGLEPQVCVIELGGTVGDIESMPFIEAFRQFQFKVKRENFCNIHVSLVPQPSSTGEQKTKPTQNSVRELRGLGLSPDLVVCRCSNPLDTSVKEKISMFCHVEPEQVICVHDVSSIYRVPLLLEEQGVVDYFLRRLDLPIERQPRKMLMKWKEMADRYDRLLETCSIALVGKYTKFSDSYASVIKALEHSALAINHKLEIKYIDSADLEPITSQEEPVRYHEAWQKLCSAHGVLVPGGFGVRGTEGKIQAIAWARNQKKPFLGVCLGMQLAVVEFSRNVLGWQDANSTEFDPTTSHPVVVDMPEHNPGQMGGTMRLGKRRTLFQTKNSVMRKLYGDADYLEERHRHRFEVNPVWKKCLEEQGLKFVGQDVEGERMEIVELEDHPFFVGVQYHPEFLSRPIKPSPPYFGLLLASVGRLSHYLQKGCRLSPRDTYSDRSGSSSPDSEITELKFPSINHD","Homo sapiens","CTPS1, CTPS","CTP synthase 1","1","5U03"
"5U0D",,"X-RAY DIFFRACTION",2.1,41.35,"VAPOR DIFFUSION, SITTING DROP",,"the reservoir condition consisted of 2.9 M ammonium sulfate with 0.1 M Tris buffer at pH 8.3; concentrated CA II at ~10 mg mL-1 was set up with seeding; dry compound was added to crystals several days before harvesting and data collection",281,"10.1021/acs.jmedchem.7b00606","7R7","5U0D",29.7,"1.59","1.59","Identification of a New Zinc Binding Chemotype by Fragment Screening","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5U0D"
"5U0E",,"X-RAY DIFFRACTION",2.11,41.58,"VAPOR DIFFUSION, SITTING DROP",,"the reservoir condition consisted of 2.9 M ammonium sulfate with 0.1 M Tris buffer at pH 8.3; concentrated CA II at ~10 mg mL-1 was set up with seeding; dry compound was added to crystals several days before harvesting and data collection",281,"10.1021/acs.jmedchem.7b00606","7R4","5U0E",29.73,"1.27","1.27","Identification of a New Zinc Binding Chemotype by Fragment Screening","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5U0E"
"5U0F",,"X-RAY DIFFRACTION",2.1,41.38,"VAPOR DIFFUSION, SITTING DROP",,"the reservoir condition consisted of 2.9 M ammonium sulfate with 0.1 M Tris buffer at pH 8.3; concentrated CA II at ~10 mg mL-1 was set up with seeding; dry compound was added to crystals several days before harvesting and data collection",281,"10.1021/acs.jmedchem.7b00606","7R1","5U0F",29.64,"1.21","1.21","Identification of a New Zinc Binding Chemotype by Fragment Screening","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5U0F"
"5U0G",,"X-RAY DIFFRACTION",2.1,41.55,"VAPOR DIFFUSION, SITTING DROP",,"the reservoir condition consisted of 2.9 M ammonium sulfate with 0.1 M Tris buffer at pH 8.3; concentrated CA II at ~10 mg mL-1 was set up with seeding; dry compound was added to crystals several days before harvesting and data collection",281,"10.1021/acs.jmedchem.7b00606","7QY","5U0G",29.78,"1.54","1.54","Identification of a New Zinc Binding Chemotype by Fragment Screening","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5U0G"
"5U0I",,"X-RAY DIFFRACTION",1.98,37.85,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M TRIS, 3.2 M sodium chloride",277,"10.1074/jbc.M117.787291",,"5U0I",31.72,"1.423","1.423","C-terminal ankyrin repeats from human kidney-type glutaminase (KGA) - tetragonal crystal form","MGSSHHHHHHSSGLVPRGSHMVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","5U0I"
"5U0J",,"X-RAY DIFFRACTION",3.3,62.74,"VAPOR DIFFUSION, SITTING DROP",7,"3.8 M NH4Cl, 0.1 M Bis-TRIS Propane",291,"10.1074/jbc.M117.787291",,"5U0J",63.37,"1.72","1.72","C-terminal ankyrin repeats from human kidney-type glutaminase (KGA) - monoclinic crystal form","MGSSHHHHHHSSGLVPRGSHMVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQTVHKNLDGLL","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","5U0J"
"5U0K",,"X-RAY DIFFRACTION",2.23,44.86,"VAPOR DIFFUSION, SITTING DROP",8,"1.1 M tri-sodium citrate, 0.1 M imidazole, 20 mM glutamine",277,"10.1074/jbc.M117.787291",,"5U0K",158.41,"2.548","2.548","C-terminal ankyrin repeats from human liver-type glutaminase (GAB/LGA)","MHHHHHHSSGVDLGTENLYFQSMKTVVNLLFAAYSGDVSALRRFALSAMDMEQKDYDSRTALHVAAAEGHIEVVKFLIEACKVNPFAKDRWGNIPLDDAVQFNHLEVVKLLQDYQDSYTLSETQAEAAAEALSKENLESMV","Homo sapiens","GLS2, GA","Glutaminase liver isoform, mitochondrial","1","5U0K"
"5U0R",,"X-RAY DIFFRACTION",3.63,66.13,"VAPOR DIFFUSION, HANGING DROP",4,"1.5M ammonium sulfate and 100mM sodium acetate, pH 4.0",293,"10.1126/scitranslmed.aai7514",,"5U0R",48.56,"3.295","3.295","Crystal Structure of DH270.UCA1 (unliganded) from the DH270 Broadly Neutralizing N332-glycan Dependent Lineage","QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCATGGWIGLYYDSSGYPNFDYWGQGTLVTVSGASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"DH270.UCA1 heavy chain","1","5U0R"
,,,,,,,,,,,,,,,,"QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSIILFGGGTKLTVLGQPKGAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"DH270.UCA1 light chain","2","5U0R"
"5U0U",,"X-RAY DIFFRACTION",3.07,59.94,"VAPOR DIFFUSION, HANGING DROP",4.5,"2.5 M sodium chloride, 100 mM sodium acetate, pH 4.5 and 200 mM LiSO4",293,"10.1126/scitranslmed.aai7514",,"5U0U",109.2,"3.428","3.428","Crystal Structure of DH270.1 (unliganded, single-chain Fv) from the DH270 Broadly Neutralizing N332-glycan Dependent Lineage","QVQLVQSGAEMKKPGASVRVSCKASGYTFTDYYIHWVRQAPGQGPEWMGWINPSTGRTNSPQKFQGRVTMTRDTSISTAYMDLNRLTSDDTAMYYCTTGGWIGLYSDTSGYPNFDYWGQGTLVTVSGGSGGGGSGGGGSGGQSALTQPASVSGSPGQSITISCTGTNYDVGSYNLVSWYQQHPGKVPKYIIYEVNKRPSGVSNRFSGSKSGNTASLTISGLQAEDEATYYCCSYAGSSIIFFGGGTKLTVHHHHHH","Homo sapiens",,"DH270.1 single-chain variable fragment","1","5U0U"
"5U15",,"X-RAY DIFFRACTION",2.62,53.07,"VAPOR DIFFUSION, HANGING DROP",5,"20% PEG 4000, 100 mM Na acetate pH 5.0, 100 mM MgSO4",293,"10.1126/scitranslmed.aai7514",,"5U15",96.86,"2.26","2.26","Crystal Structure of DH270.UCA3 (unliganded) from the DH270 Broadly Neutralizing N332-glycan Dependent Lineage","QVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPNSGGTNYAQKFQGRVTMTRDTSISTAYMELSRLRSDDTAVYYCARGGWISLYYDSSGYPNFDYWGQGTLVTVSGASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"DH270.UCA3 heavy chain","1","5U15"
,,,,,,,,,,,,,,,,"QSALTQPASVSGSPGQSITISCTGTSSDVGSYNLVSWYQQHPGKAPKLMIYEVSKRPSGVSNRFSGSKSGNTASLTISGLQAEDEADYYCCSYAGSSTVIFGGGTKLTVLGQPKGAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"DH270.UCA3 light chain","2","5U15"
"5U28",,"X-RAY DIFFRACTION",2.55,51.76,"VAPOR DIFFUSION, HANGING DROP",,"40% PEG3350 (w/v) and 0.2 M potassium thiocyanate (pH 7.5)",298,"10.1073/pnas.1613091114","82V","5U28",16.77,"1.798","1.798","BRD4 first bromodomain (BD1) in complex with dual PI3 kinase inhibitor SF2523","ANPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETEIMIVQAKGRG","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5U28"
"5U2B",,"X-RAY DIFFRACTION",2.57,52.08,"VAPOR DIFFUSION, HANGING DROP",8.3,"15% PEG 3350, 0.05M MgCl2, 0.067M NaCl, 0.1M Tris",294,"10.1016/j.molcel.2017.02.008",,"5U2B",177.88,"2.22","2.22","Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol, without a coactivator peptide","IKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLSDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","5U2B"
"5U2C",,"X-RAY DIFFRACTION",3.89,68.42,"VAPOR DIFFUSION, SITTING DROP",7.5,"2.5 M ammonium sulfate in 100 mM TRIS (pH 7.5)",298,"10.1073/pnas.1613091114","82Y","5U2C",29.15,"3.3","3.3","BRD4 second bromodomain (BD2) in complex with dual PI3 kinase (PI3K) inhibitor SF2558HA","GGGILPAPEKSSKVSEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMPDE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5U2C"
"5U2E",,"X-RAY DIFFRACTION",2.3,46.6,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG3350 (w/v), 0.2 M ammonium chloride, 0.1 M TRIS",298,"10.1073/pnas.1613091114","837","5U2E",33.6,"1.991","1.991","BRD4 first bromodomain (BD1) in complex with dual PI3 kinase (PI3K) inhibitor SF2535","GSTNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETEIMIVQAKGRG","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5U2E"
"5U2F",,"X-RAY DIFFRACTION",2.31,46.76,"VAPOR DIFFUSION, HANGING DROP",8.5,"25% PEG3350 (w/v), 0.2 M ammonium chloride, 0.1 M TRIS",298,"10.1073/pnas.1613091114","82Y","5U2F",33.57,"2.525","2.525","BRD4 first bromodomain (BD1) in complex with dual PI3 kinase (PI3K) inhibitor SF2558HA","GSTNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEETEIMIVQAKGRG","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5U2F"
"5U2M",,"X-RAY DIFFRACTION",2.49,50.51,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.2 M ammonium sulfate, and 0.1 M HEPES, pH 7.5",277,"10.1158/1535-7163.MCT-16-0819","7T7","5U2M",109.55,"1.89","1.89","Crystal structure of human NAMPT with A-1293201","FNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIE","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","5U2M"
"5U2N",,"X-RAY DIFFRACTION",2.49,50.62,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.2 M ammonium sulfate, and 0.1 M HEPES, pH 7.5",277,"10.1158/1535-7163.MCT-16-0819",,"5U2N",109.6,"1.73","1.73","Crystal structure of human NAMPT with A-1326133","FNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIE","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","5U2N"
"5U3A",,"X-RAY DIFFRACTION",2.06,40.3,"VAPOR DIFFUSION, SITTING DROP",7,"MPD 57%, 0.1 M sodium cacodylate",293,"10.1021/acschembio.9b00290",,"5U3A",56.23,"0.95","0.95","Ultra High Resolution Crystal Structure of Human Pancreatic Alpha Amylase","QYSPNTQQGRTSIVHLFEWRWVDIALECERYLAPKGFGGVQVSPPNENVAIYNPFRPWWERYQPVSYKLCTRSGNEDEFRNMVTRCNNVGVRIYVDAVINHMCGNAVSAGTSSTCGSYFNPGSRDFPAVPYSGWDFNDGKCKTGSGDIENYNDATQVRDCRLTGLLDLALEKDYVRSKIAEYMNHLIDIGVAGFRLDASKHMWPGDIKAILDKLHNLNSNWFPAGSKPFIYQEVIDLGGEPIKSSDYFGNGRVTEFKYGAKLGTVIRKWNGEKMSYLKNWGEGWGFVPSDRALVFVDNHDNQRGHGAGGASILTFWDARLYKMAVGFMLAHPYGFTRVMSSYRWPRQFQNGNDVNDWVGPPNNNGVIKEVTINPDTTCGNDWVCEHRWRQIRNMVIFRNVVDGQPFTNWYDNGSNQVAFGRGNRGFIVFNNDDWSFSLTLQTGLPAGTYCDVISGDKINGNCTGIKIYVSDDGKAHFSISNSAEDPFIAIHAESKL","Homo sapiens","AMY2A","Pancreatic alpha-amylase","1","5U3A"
"5U3P",,"X-RAY DIFFRACTION",2.37,48.08,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M di-sodium hydrogen phosphate, 20% PEG 3350",293,"10.1126/sciimmunol.aal2200",,"5U3P",48.4,"1.5","1.5","Crystal Structure of DH511.4 Fab","DIQLTQSPASLSASVGDTVTITCRASQSIKDYINWYQHKSGSAPRLLIYAASTLQSGISSRFTGSGSGTQFTLTINSLQPEDFATYYCQEAYNTNPTLSFGQGTRVDKKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG","Homo sapiens",,"DH511.4 Fab Light Chain","2","5U3P"
,,,,,,,,,,,,,,,,"EVQLVESGGGLIKPGQSLTLFCVGFGFNFANDWMGWVRQAPGKGLEWVGRIRRLKDGAKAEYGSSVKGRFTISRDDSKNTLYLHMSSLKVEDTAVYYCTRDEGAPVTRFLEWGSYYYYMAVWGKGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEP","Homo sapiens",,"DH511.4 Fab Heavy Chain","1","5U3P"
"5U3Q",,"X-RAY DIFFRACTION",2.86,57.04,"VAPOR DIFFUSION, HANGING DROP",,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114",,"5U3Q",65.2,"1.5","1.5","Human PPARdelta ligand-binding domain in complexed with specific agonist 1","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U3Q"
"5U3R",,"X-RAY DIFFRACTION",2.87,57.12,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114","7V1","5U3R",64.93,"1.95","1.95","Human PPARdelta ligand-binding domain in complexed with specific agonist 2","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U3R"
"5U3S",,"X-RAY DIFFRACTION",2.85,56.91,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114",,"5U3S",64.46,"2","2","Human PPARdelta ligand-binding domain in complexed with specific agonist 3","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U3S"
"5U3T",,"X-RAY DIFFRACTION",2.87,57.19,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114",,"5U3T",65.34,"1.7","1.7","Human PPARdelta ligand-binding domain in complexed with specific agonist 4","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U3T"
"5U3U",,"X-RAY DIFFRACTION",2.88,57.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114",,"5U3U",63.44,"2.1","2.1","Human PPARdelta ligand-binding domain in complexed with specific agonist 5","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U3U"
"5U3V",,"X-RAY DIFFRACTION",2.88,57.28,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114",,"5U3V",64.75,"1.84","1.84","Human PPARdelta ligand-binding domain in complexed with specific agonist 6","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U3V"
"5U3W",,"X-RAY DIFFRACTION",2.87,57.21,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114",,"5U3W",64.26,"1.8","1.8","Human PPARdelta ligand-binding domain in complexed with specific agonist 7","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U3W"
"5U3X",,"X-RAY DIFFRACTION",2.78,55.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114",,"5U3X",64.4,"2.1","2.1","Human PPARdelta ligand-binding domain in complexed with specific agonist 8","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U3X"
"5U3Y",,"X-RAY DIFFRACTION",2.86,57.05,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114","7U7","5U3Y",64.55,"1.9","1.9","Human PPARdelta ligand-binding domain in complexed with specific agonist 9","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U3Y"
"5U3Z",,"X-RAY DIFFRACTION",2.86,56.95,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114",,"5U3Z",64.87,"1.72","1.72","Human PPARdelta ligand-binding domain in complexed with specific agonist 10","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U3Z"
"5U40",,"X-RAY DIFFRACTION",2.85,56.79,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114",,"5U40",64.59,"2","2","Human PPARdelta ligand-binding domain in complexed with specific agonist 15","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U40"
"5U41",,"X-RAY DIFFRACTION",2.87,57.14,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114",,"5U41",64.69,"1.9","1.9","Human PPARdelta ligand-binding domain in complexed with specific agonist 16","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U41"
"5U42",,"X-RAY DIFFRACTION",2.9,57.55,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114",,"5U42",64.77,"1.7","1.7","Human PPARdelta ligand-binding domain in complexed with specific agonist 11","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U42"
"5U43",,"X-RAY DIFFRACTION",2.89,57.43,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114",,"5U43",64.59,"1.9","1.9","Human PPARdelta ligand-binding domain in complexed with specific agonist 12","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U43"
"5U44",,"X-RAY DIFFRACTION",2.89,57.46,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114",,"5U44",63.96,"2.15","2.15","Human PPARdelta ligand-binding domain in complexed with specific agonist 13","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U44"
"5U45",,"X-RAY DIFFRACTION",2.89,57.48,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114",,"5U45",64.59,"1.95","1.95","Human PPARdelta ligand-binding domain in complexed with specific agonist 14","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U45"
"5U46",,"X-RAY DIFFRACTION",2.89,57.41,"VAPOR DIFFUSION, HANGING DROP",7.5,"Bis-tris propane, potassium chloride, PEG 8000, 1,2-propandiol, EDTA, DTT",277.15,"10.1073/pnas.1621513114","7T1","5U46",64.06,"2","2","Human PPARdelta ligand-binding domain in complexed with GW501516","PQVADLKAFSKHIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKEISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNKDGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGDRPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRIKKTETETSLHPLLQEIYKDMY","Homo sapiens","PPARD, NR1C2, PPARB","Peroxisome proliferator-activated receptor delta","1","5U46"
"5U48",,"X-RAY DIFFRACTION",2.32,42.31,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.3 M Sodium Citrate, 3.0% glycerol",298,"10.1021/acs.jmedchem.7b00952","S4B","5U48",28.33,"1.5","1.5","Wild-type Transthyretin in complex with 5-[(1E)-2-(4-Boronic acid)ethenyl]-1,3-benzenediol","MGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","5U48"
"5U49",,"X-RAY DIFFRACTION",2.23,44.85,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.3 M Sodium Citrate, 3.0% Glycerol",298,"10.1021/acs.jmedchem.7b00952","S2L","5U49",14.17,"2.22","2.22","Wild-type Transthyretin in complex with 5-[(1E)-2-(2-Chloro-4-hydroxyphenyl)ethenyl]-1,3-benzenediol","MGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","5U49"
"5U4A",,"X-RAY DIFFRACTION",2.1,41.37,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.3 M Sodium Citrate, 3.0% Glycerol",298,"10.1021/acs.jmedchem.7b00952","7VG","5U4A",28.4,"1.9","1.9","Wild-type Transthyretin in complex with 5-[(1E)-2-(2-Chloro-4-boronic acid)ethenyl]-1,3-benzenediol","MGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","5U4A"
"5U4B",,"X-RAY DIFFRACTION",2.12,41.97,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.3 M Sodium Citrate, 3.0% Glycerol",298,"10.1021/acs.jmedchem.7b00952","XOS","5U4B",28.3,"1.448","1.448","Wild-type Transthyretin in complex with 3-[(1E)-2-(4-Hydroxyphenyl)ethenyl]benzoic Acid","MGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","5U4B"
"5U4C",,"X-RAY DIFFRACTION",2.11,41.57,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.3 M Sodium Citrate, 3.0% Glycerol",298,"10.1021/acs.jmedchem.7b00952","XBS","5U4C",28.35,"1.7","1.7","Wild-type Transthyretin in complex with 3-[(1E)-2-(4-Boronic acid)ethenyl]benzoic Acid","MGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","5U4C"
"5U4D",,"X-RAY DIFFRACTION",2.13,42.2,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.3 M Sodium Citrate, 3.0% Glycerol",298,"10.1021/acs.jmedchem.7b00952","XLO","5U4D",28.37,"1.55","1.55","Wild-type Transthyretin in complex with 3-[(1E)-2-(2-Chloro-4-hydroxyphenyl)ethenyl]benzoic Acid","MGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","5U4D"
"5U4E",,"X-RAY DIFFRACTION",2.12,41.97,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.3 M Sodium Citrate, 3.0% Glycerol",298,"10.1021/acs.jmedchem.7b00952","XLB","5U4E",28.42,"1.45","1.45","Wild-type Transthyretin in complex with 3-[(1E)-2-(2-Chloro-4-boronic acid)ethenyl]benzoic Acid","MGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","5U4E"
"5U4F",,"X-RAY DIFFRACTION",2.1,41.48,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.3 M Sodium Citrate, 3.0% Glycerol",298,"10.1021/acs.jmedchem.7b00952","IWW","5U4F",28.49,"1.5","1.5","Wild-type Transthyretin in complex with 1,1'-(1E)-(1,2-Ethenediyl)bis[2-chloro-4-boronic acid]benzene","MGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","5U4F"
"5U4G",,"X-RAY DIFFRACTION",2.11,41.62,"VAPOR DIFFUSION, HANGING DROP",5.5,"1.3 M Sodium Citrate, 3.0% Glycerol",298,"10.1021/acs.jmedchem.7b00952",,"5U4G",28.39,"1.8","1.8","Wild-type Transthyretin in complex with 2-Boronic Acid-1-[(1E)-2-(3-boronic acid)ethenyl]-4-chlorobenzene","MGPTGTGESKCPLMVKVLDAVRGSPAINVAVHVFRKAADDTWEPFASGKTSESGELHGLTTEEEFVEGIYKVEIDTKSYWKALGISPFHEHAEVVFTANDSGPRRYTIAALLSPYSYSTTAVVTNPKE","Homo sapiens","TTR, PALB","Transthyretin","1","5U4G"
"5U4R",,"X-RAY DIFFRACTION",2.48,50.38,"VAPOR DIFFUSION, HANGING DROP",4.6,"0.1 M sodium acetate, pH 4.6, 0.24 M ammonium acetate
26% (w/v) PEG-4000",293,"10.1126/sciimmunol.aan2676",,"5U4R",97.07,"1.762","1.762","Crystal structure of the broadly neutralizing Influenza A antibody VRC 315 53-1A09 Fab.","EVQLVESGGGLVKPGGSLRLSCEVSGFTFSDYHATWLRQAPGKGLEWISYISGSGSTTYYADAVKGRFTISRDNAKNSVYLEMSSLRDEDTAVYYCARTRLGDIVQAPGVIGYYYGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"VRC 315 53-1A09 Fab Heavy chain","1","5U4R"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCRASQRIRNYLNWYQQKPGRAPKLLIYTASKLQGGVPSRFSGSGSGTDFTLTINSLQPEDFATYYCQQSHETPLTFGQGTKIEVRRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"VRC 315 53-1A09 Fab Light chain","2","5U4R"
"5U4V",,"X-RAY DIFFRACTION",1.99,38.29,"VAPOR DIFFUSION, HANGING DROP",4.7,"2.15 M sodium malonate pH 4.7",298,"10.1038/s41467-017-00483-x",,"5U4V",19.84,"2.6","2.6","pseudoGTPase domain (pG1) of p190RhoGAP-B","GSSTNIDKVNLFILGKDGLAQELANEIRTQSTDDEYALDGKIYELDLRPVDAKSPYFLSQLWTAAFKPHGCFCVFNSIESLSFIGEFIGKIRTEASQIRKDKYMANLPFTLILANQRDSISKNLPILRHQGQQLANKLQCPFVDVPAGTYPRKFNETQIKQALRGVLESVKHNLDV","Homo sapiens","ARHGAP5, RHOGAP5","Rho GTPase-activating protein 5","1","5U4V"
"5U4X",,"X-RAY DIFFRACTION",2.49,50.54,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG 3350, 0.2 M AmSO4, 0.1 M Tris pH8.5",291,"10.18632/oncotarget.24883","SAH","5U4X",158.36,"1.88","1.88","Coactivator-associated arginine methyltransferase 1 with TP-064","RTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSFFAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDEQLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIMTVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTT","Homo sapiens","CARM1, PRMT4","Histone-arginine methyltransferase CARM1","1","5U4X"
"5U5H",,"X-RAY DIFFRACTION",2.31,46.87,"EVAPORATION",,"Crystals grown in a precipitant composed of 3-3.5 M sodium formate using the vapor diffusion method. Crystals grew in 3-5 days at 18 degree Celsius and harvested and soaked in defined drops consisting of 30 uL of precipitant with 1-2 mM of compound (typically solubilized in DMSO) for 24-48 h. Crystals were cryopreserved for data collection using a cryosolution consisting of 3.5 M sodium formate, 1-2 mM of compound, and 30% (v/v) glycerol.",291,"10.1021/acs.jmedchem.6b01473","7VV","5U5H",42.77,"1.8","1.8","Crystal structure of EED in complex with 6-(2-fluoro-5-methoxybenzyl)-1-isopropyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-3-amine 6-(2-fluoro-5-methoxybenzyl)-1-isopropyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-3-amine","GKKCKYSFKCVNSLKEDHNQPLFGVQFNWHSKEGDPLVFATVGSNRVTLYECHSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLAVAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDTLVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIDKIKPSESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTTLTHHKCGAAIRQTSFSRDSSILIAVCDDASIWRWDRLR","Homo sapiens","EED","Polycomb protein EED","1","5U5H"
"5U5K",,"X-RAY DIFFRACTION",2.33,47.12,"EVAPORATION",,"Crystals grown in a precipitant composed of 3-3.5 M sodium formate using the vapor diffusion method. Crystals grew in 3-5 days at 18 Celsius and harvested and soaked in defined drops consisting of 30 uL of precipitant with 1-2 mM of compound (typically solubilized in DMSO) for 24-48 h. Crystals were cryopreserved for data collection using a cryosolution consisting of 3.5 M sodium formate, 1-2 mM of compound, and 30% (v/v) glycerol.",291,"10.1021/acs.jmedchem.6b01473","7VY","5U5K",42.61,"2.33","2.33","Crystal structure of EED in complex with 3-(3-methoxybenzyl)piperidine hydrochloride","GKKCKYSFKCVNSLKEDHNQPLFGVQFNWHSKEGDPLVFATVGSNRVTLYECHSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLAVAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDTLVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIDKIKPSESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTTLTHHKCGAAIRQTSFSRDSSILIAVCDDASIWRWDRLR","Homo sapiens","EED","Polycomb protein EED","1","5U5K"
"5U5L",,"X-RAY DIFFRACTION",2.69,54.27,"VAPOR DIFFUSION, HANGING DROP",8,"1M Na Citrate",289,"10.1016/j.bbagen.2017.05.008","7VA","5U5L",62.81,"2.55","2.55","X-ray Crystal Structure of the PPARgamma Ligand Binding Domain in Complex with Rivoglitazone","NPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","5U5L"
"5U69",,"X-RAY DIFFRACTION",2.62,53.06,"VAPOR DIFFUSION",8.5,"3.08M Sodium Formate, 20% Glycerol, 0.1M Tris pH8.5",290,"10.1016/j.bmcl.2017.02.030","LQD","5U69",42.95,"1.28","1.28","Polycomb protein EED in complex with inhibitor: (3R,4S)-1-[(2-methoxyphenyl)methyl]-N,N-dimethyl-4-(1-methylindol-3-yl)pyrrolidin-3-amine","GSHMKCKYSFKCVNSLKEDHNQPLFGVQFNWHSKEGDPLVFATVGSNRVTLYECHSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLAVAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDTLVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIDKIKPSESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTTLTHHKCGAAIRQTSFSRDSSILIAVCDDASIWRWDRLR","Homo sapiens","EED","Polycomb protein EED","1","5U69"
"5U6B",,"X-RAY DIFFRACTION",2.41,48.96,"VAPOR DIFFUSION, SITTING DROP",,"1.2 microL of the protein-ligand complex (1:3 ratio of protein:ligand) and 1.2 microL of the reservoir solution (0.1 M Tris, pH 8.5, 0.2 M MgCl2, 30 % (w/v) PEG-4000, 1-2 % (v/v) 1-butanol).",294,"10.1074/jbc.M116.771485",,"5U6B",141.32,"2.84","2.84","Structure of the Axl kinase domain in complex with a macrocyclic inhibitor","GSNSLGISEELKEKLRDVMVDRHKVALGKTLGEGEFGAVMEGQLNQDDSILKVAVKTMKIAICTRSELEDFLSEAVCMKEFDHPNVMRLIGVCFQGSERESFPAPVVILPFMKHGDLHSFLLYSRLGDQPVYLPTQMLVKFMADIASGMEYLSTKRFIHRDLAARNCMLNENMSVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPADCLDGLYALMSRCWELNPQDRPSFTELREDLENTLKALPPAQEPDE","Homo sapiens","AXL, UFO","Tyrosine-protein kinase receptor UFO","1","5U6B"
"5U6C",,"X-RAY DIFFRACTION",2.24,45.1,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Magnesium chloride, 28-35%  PEG 600,  0.1 M Tris (pH 8.7-9.0)",286,"10.1074/jbc.M116.771485","7YS","5U6C",73.39,"2.1","2.1","Crystal structure of the Mer kinase domain in complex with a macrocyclic inhibitor","MGSSHHHHHHSSGENLYFQGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVMRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLPDV","Homo sapiens","MERTK, MER","Tyrosine-protein kinase Mer","1","5U6C"
"5U6D",,"X-RAY DIFFRACTION",2.62,53.06,"VAPOR DIFFUSION",8.5,"3.08M Sodium Formate, 20% Glycerol, 0.1M Tris, pH8.5",290,"10.1016/j.bmcl.2017.02.030","7XG","5U6D",43.02,"1.64","1.64","Polycomb protein EED in complex with inhibitor: 2-[4-(4-{(3S,4R)-4-(dimethylamino)-1-[(2-fluoro-6-methylphenyl)methyl]pyrrolidin-3-yl}phenyl)-1H-pyrazol-1-yl]acetamide","GSHMKCKYSFKCVNSLKEDHNQPLFGVQFNWHSKEGDPLVFATVGSNRVTLYECHSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLAVAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDTLVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIDKIKPSESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTTLTHHKCGAAIRQTSFSRDSSILIAVCDDASIWRWDRLR","Homo sapiens","EED","Polycomb protein EED","1","5U6D"
"5U6G",,"X-RAY DIFFRACTION",2.26,45.68,"VAPOR DIFFUSION, HANGING DROP",4.5,"30% PEG 4000, 0.1 M sodium acetate, 0.1 M ammonium acetate, pH 4.6",298,,,"5U6G",190.17,"2.6","2.6","Crystal Structure of the holo Domain-Swapped Dimer mutant Q108K:K40D Human Cellular Retinol Binding Protein II bound with all trans retinal","TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTDVIDQDGDNFKTKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","1","5U6G"
,,,,,,,,,,,,,,,,"TRDQNGTWEMESNENFEGYMKALDIDFATRKIAVRLTQTKVIDQDGDNFKTKTTSTFRNYDVDFTVGVEFDEYTKSLDNRHVKALVTWEGDVLVCVQKGEKENRGWKKWIEGDKLYLELTCGDQVCRQVFKKK","Homo sapiens","RBP2, CRBP2","Retinol-binding protein 2","2","5U6G"
"5U6H",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.7b00484",,"5U6H",10.71,,,"Solution structure of the zinc fingers 1 and 2 of MBNL1","MAVSVTPIRDTKWLTLEVCREFQRGTCSRPDTECKFAHPSKSCQVENGRVIACFDSLKGRCSRENCKYLHPPPHLKTQLEINGRNNLIQQKN","Homo sapiens","MBNL1, EXP, KIAA0428, MBNL","Muscleblind-like protein 1","1","5U6H"
"5U6J",,"X-RAY DIFFRACTION",3.92,68.66,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES, pH 6.0, 20 mM CACL2, 17.5%(W/V) PEG 6000",277,"10.1016/j.bmcl.2017.04.008","82J","5U6J",35.34,"2.3","2.3","Factor VIIa in complex with the inhibitor 3-{[(2R)-17-ethyl-4-methyl-3,12-dioxo-7-[(propan-2-yl)sulfonyl]-13-oxa-4,11-diazatricyclo[14.2.2.1~6,10~]henicosa-1(18),6(21),7,9,16,19-hexaen-2-yl]amino}benzamide","IVGGKVCPKGECPWQVLLLVNGAQLCGGTLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVPLCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSCKGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP","Homo sapiens","F7","Coagulation factor VII Heavy Chain","1","5U6J"
,,,,,,,,,,,,,,,,"ICVNENGGCEQYCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKR","Homo sapiens","F7","Coagulation factor VII Light Chain","2","5U6J"
"5U6L",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.7b00484",,"5U6L",9.8,,,"Solution structure of the zinc fingers 3 and 4 of MBNL1","AQKLMRTDRLEVCREYQRGNCNRGENDCRFAHPADSTMIDTNDNTVTVCMDYIKGRCSREKCKYFHPPAHLQAKIKAAQYQVN","Homo sapiens","MBNL1, EXP, KIAA0428, MBNL","Muscleblind-like protein 1","1","5U6L"
"5U6O","3.5","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2016.12.023",,"5U6O",298.57,"3.5, 3.5",,"Structure of the human HCN1 hyperpolarization-activated cyclic nucleotide-gated ion channel","MEGGGKPNSSSNSRDDGNSVFPAKASATGAGPAAAEKRLGTPPGGGGAGAKEHGNSVCFKVDGGGGGGGGGGGGEEPAGGFEDAEGPRRQYGFMQRQFTSMLQPGVNKFSLRMFGSQKAVEKEQERVKTAGFWIIHPYSDFRFYWDLIMLIMMVGNLVIIPVGITFFTEQTTTPWIIFNVASDTVFLLDLIMNFRTGTVNEDSSEIILDPKVIKMNYLKSWFVVDFISSIPVDYIFLIVEKGMDSEVYKTARALRIVRFTKILSLLRLLRLSRLIRYIHQWEEIFHMTYDLASAVVRIFNLIGMMLLLCHWDGCLQFLVPLLQDFPPDCWVSLNEMVNDSWGKQYSYALFKAMSHMLCIGYGAQAPVSMSDLWITMLSMIVGATCYAMFVGHATALIQSLDSSRRQYQEKYKQVEQYMSFHKLPADMRQKIHDYYEHRYQGKIFDEENILNELNDPLREEIVNFNCRKLVATMPLFANADPNFVTAMLSKLRFEVFQPGDYIIREGAVGKKMYFIQHGVAGVITKSSKEMKLTDGSYFGEICLLTKGRRTASVRADTYCRLYSLSVDNFNEVLEEYPMMRRAFETVAIDRLDRIGKKNSILLQKFQKDLNTGVFNNQENEILKQIVKHDREMVQAALPRESSSVLNTDPDAEKPRFASNL","Homo sapiens","HCN1, BCNG1","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1","1","5U6O"
,,,,,,,,,,,,,,,,,"Homo sapiens","HCN1, BCNG1"
"5U6P","3.51","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2016.12.023",,"5U6P",306.43,"3.51",,"Structure of the human HCN1 hyperpolarization-activated cyclic nucleotide-gated ion channel in complex with cAMP","MEGGGKPNSSSNSRDDGNSVFPAKASATGAGPAAAEKRLGTPPGGGGAGAKEHGNSVCFKVDGGGGGGGGGGGGEEPAGGFEDAEGPRRQYGFMQRQFTSMLQPGVNKFSLRMFGSQKAVEKEQERVKTAGFWIIHPYSDFRFYWDLIMLIMMVGNLVIIPVGITFFTEQTTTPWIIFNVASDTVFLLDLIMNFRTGTVNEDSSEIILDPKVIKMNYLKSWFVVDFISSIPVDYIFLIVEKGMDSEVYKTARALRIVRFTKILSLLRLLRLSRLIRYIHQWEEIFHMTYDLASAVVRIFNLIGMMLLLCHWDGCLQFLVPLLQDFPPDCWVSLNEMVNDSWGKQYSYALFKAMSHMLCIGYGAQAPVSMSDLWITMLSMIVGATCYAMFVGHATALIQSLDSSRRQYQEKYKQVEQYMSFHKLPADMRQKIHDYYEHRYQGKIFDEENILNELNDPLREEIVNFNCRKLVATMPLFANADPNFVTAMLSKLRFEVFQPGDYIIREGAVGKKMYFIQHGVAGVITKSSKEMKLTDGSYFGEICLLTKGRRTASVRADTYCRLYSLSVDNFNEVLEEYPMMRRAFETVAIDRLDRIGKKNSILLQKFQKDLNTGVFNNQENEILKQIVKHDREMVQAALPRESSSVLNTDPDAEKPRFASNL","Homo sapiens","HCN1, BCNG1","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 11","1","5U6P"
,,,,,,,,,,,,,,,,,"Homo sapiens","HCN1, BCNG1"
,,,,,,,,,,,,,,,,"XXXXXXXXXXXXXXXXXXX","Homo sapiens","HCN1, BCNG1","Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 11","2","5U6P"
"5U6V",,"X-RAY DIFFRACTION",2.34,47.34,"VAPOR DIFFUSION, SITTING DROP",,"20w/v PEG 4000, 0.1M sodium HEPES pH7.5, 10 v/v2-propanol",293,"10.1021/acsmedchemlett.7b00389","7WY","5U6V",13.63,"1.775","1.775","X-ray crystal structure of 1,2,3-triazolobenzodiazepine in complex with BRD2(D2)","GSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMPD","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","5U6V"
"5U73",,"X-RAY DIFFRACTION",4.35,71.71,"EVAPORATION",5.5,"0.1 M sodium citrate pH 5.5 ,
0.1 M NaCl, 12% (vol/vol) PEG4000",293,"10.1073/pnas.1711716114",,"5U73",145.62,"3.348","3.348","Crystal structure of human Niemann-Pick C1 protein","MTARGLALGLLLLLLCPAQVFSQSCVWYGECGIAYGDKRYNCEYSGPPKPLPKDGYDLVQELCPGFFFGNVSLCCDVRQLQTLKDNLQLPLQFLSRCPSCFYNLLNLFCELTCSPRQSQFLNVTATEDYVDPVTNQTKTNVKELQYYVGQSFANAMYNACRDVEAPSSNDKALGLLCGKDADACNATNWIEYMFNKDNGQAPFTITPVFSDFPVHGMEPMNNATKGCDESVDEVTAPCSCQDCSIVCGPKPQPPPPPAPWTILGLDAMYVIMWITYMAFLLVFFGAFFAVWCYRKRYFVSEYTPIDSNIAFSVNASDKGEASCCDPVSAAFEGCLRRLFTRWGSFCVRNPGCVIFFSLVFITACSSGLVFVRVTTNPVDLWSAPSSQARLEKEYFDQHFGPFFRTEQLIIRAPLTDKHIYQPYPSGADVPFGPPLDIQILHQVLDLQIAIENITASYDNETVTLQDICLAPLSPYNTNCTILSVLNYFQNSHSVLDHKKGDDFFVYADYHTHFLYCVRAPASLNDTSLLHDPCLGTFGGPVFPWLVLGGYDDQNYNNATALVITFPVNNYYNDTEKLQRAQAWEKEFINFVKNYKNPNLTISFTAERSIEDELNRESDSDVFTVVISYAIMFLYISLALGHIKSCRRLLVDSKVSLGIAGILIVLSSVACSLGVFSYIGLPLTLIVIEVIPFLVLAVGVDNIFILVQAYQRDERLQGETLDQQLGRVLGEVAPSMFLSSFSETVAFFLGALSVMPAVHTFSLFAGLAVFIDFLLQITCFVSLLGLDIKRQEKNRLDIFCCVRGAEDGTSVQASESCLFRFFKNSYSPLLLKDWMRPIVIAIFVGVLSFSIAVLNKVDIGLDQSLSMPDDSYMVDYFKSISQYLHAGPPVYFVLEEGHDYTSSKGQNMVCGGMGCNNDSLVQQIFNAAQLDNYTRIGFAPSSWIDDYFDWVKPQSSCCRVDNITDQFCNASVVDPACVRCRPLTPEGKQRPQGGDFMRFLPMFLSDNPNPKCGKGGHAAYSSAVNILLGHGTRVGATYFMTYHTVLQTSADFIDALKKARLIASNVTETMGINGSAYRVFPYSVFYVFYEQYLTIIDDTIFNLGVSLGAIFLVTMVLLGCELWSAVIMCATIAMVLVNMFGVMWLWGISLNAVSLVNLVMSCGISVEFCSHITRAFTVSMKGSRVERAEEALAHMGSSVFSGITLTKFGGIVVLAFAKSQIFQIFYFRMYLAMVLLGATHGLIFLPVLLSYIGPSVNKAKSCATEERYKGTERERLLNF","Homo sapiens","NPC1","Niemann-Pick C1 protein","1","5U73"
"5U74",,"X-RAY DIFFRACTION",3.68,66.58,"EVAPORATION",5.5,"0.1 M sodium acetate pH 5.5, 0.1 M NaCl, 10% (vol/vol) PEG4000, 6% (vol/vol) Jeffamine M-600 pH 7.0, and 6% (vol/vol) PEG P400",293,"10.1073/pnas.1711716114",,"5U74",145.82,"3.335","3.335","Structure of human Niemann-Pick C1 protein","MTARGLALGLLLLLLCPAQVFSQSCVWYGECGIAYGDKRYNCEYSGPPKPLPKDGYDLVQELCPGFFFGNVSLCCDVRQLQTLKDNLQLPLQFLSRCPSCFYNLLNLFCELTCSPRQSQFLNVTATEDYVDPVTNQTKTNVKELQYYVGQSFANAMYNACRDVEAPSSNDKALGLLCGKDADACNATNWIEYMFNKDNGQAPFTITPVFSDFPVHGMEPMNNATKGCDESVDEVTAPCSCQDCSIVCGPKPQPPPPPAPWTILGLDAMYVIMWITYMAFLLVFFGAFFAVWCYRKRYFVSEYTPIDSNIAFSVNASDKGEASCCDPVSAAFEGCLRRLFTRWGSFCVRNPGCVIFFSLVFITACSSGLVFVRVTTNPVDLWSAPSSQARLEKEYFDQHFGPFFRTEQLIIRAPLTDKHIYQPYPSGADVPFGPPLDIQILHQVLDLQIAIENITASYDNETVTLQDICLAPLSPYNTNCTILSVLNYFQNSHSVLDHKKGDDFFVYADYHTHFLYCVRAPASLNDTSLLHDPCLGTFGGPVFPWLVLGGYDDQNYNNATALVITFPVNNYYNDTEKLQRAQAWEKEFINFVKNYKNPNLTISFTAERSIEDELNRESDSDVFTVVISYAIMFLYISLALGHIKSCRRLLVDSKVSLGIAGILIVLSSVACSLGVFSYIGLPLTLIVIEVIPFLVLAVGVDNIFILVQAYQRDERLQGETLDQQLGRVLGEVAPSMFLSSFSETVAFFLGALSVMPAVHTFSLFAGLAVFIDFLLQITCFVSLLGLDIKRQEKNRLDIFCCVRGAEDGTSVQASESCLFRFFKNSYSPLLLKDWMRPIVIAIFVGVLSFSIAVLNKVDIGLDQSLSMPDDSYMVDYFKSISQYLHAGPPVYFVLEEGHDYTSSKGQNMVCGGMGCNNDSLVQQIFNAAQLDNYTRIGFAPSSWIDDYFDWVKPQSSCCRVDNITDQFCNASVVDPACVRCRPLTPEGKQRPQGGDFMRFLPMFLSDNPNPKCGKGGHAAYSSAVNILLGHGTRVGATYFMTYHTVLQTSADFIDALKKARLIASNVTETMGINGSAYRVFPYSVFYVFYEQYLTIIDDTIFNLGVSLGAIFLVTMVLLGCELWSAVIMCATIAMVLVNMFGVMWLWGISLNAVSLVNLVMSCGISVEFCSHITRAFTVSMKGSRVERAEEALAHMGSSVFSGITLTKFGGIVVLAFAKSQIFQIFYFRMYLAMVLLGATHGLIFLPVLLSYIGPSVNKAKSCATEERYKGTERERLLNF","Homo sapiens","NPC1","Niemann-Pick C1 protein","1","5U74"
"5U77",,"X-RAY DIFFRACTION",2.68,54.05,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES, pH 7.5, 0.2 M Ammonium formate, 0.2 M NDSB-195, 27% PEG 3350",293,"10.1038/s41467-017-00861-5",,"5U77",13.87,"2.157","2.157","Crystal structure of ORP8 PH domain","GSSGIVMADWLKIRGTLKSWTKLWCVLKPGVLLIYKTQKNGQWVGTVLLNACEIIERPSKKDGFCFKLFHPLEQSIWAVKGPKGEAVGSITQPLPSSYLIIRATSESDGRCWMDALELALKSG","Homo sapiens","OSBPL8, KIAA1451, ORP8, OSBP10","Oxysterol-binding protein-related protein 8","1","5U77"
"5U78",,"X-RAY DIFFRACTION",2.52,51.2,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Bis-tris propane, pH 6.5, 0.2 M Potassium thiocyanate, 20% PEG3350",293,"10.1038/s41467-017-00861-5",,"5U78",54.44,"1.978","1.978","Crystal structure of ORP8 PH domain in P1211 space group","GSSGIVMADWLKIRGTLKSWTKLWCVLKPGVLLIYKTQKNGQWVGTVLLNACEIIERPSKKDGFCFKLFHPLEQSIWAVKGPKGEAVGSITQPLPSSYLIIRATSESDGRCWMDALELALKSG","Homo sapiens","OSBPL8, KIAA1451, ORP8, OSBP10","Oxysterol-binding protein-related protein 8","1","5U78"
"5U7D",,"X-RAY DIFFRACTION",2.21,44.45,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.1 M Tris, pH 8.5, and 0.2 M MgCl2",294,"10.1021/acs.jmedchem.7b00397","19F","5U7D",122.37,"1.75","1.75","PDE2 catalytic domain complexed with inhibitors","GSAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5U7D"
"5U7I",,"X-RAY DIFFRACTION",2.17,43.38,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.1 M Tris, pH 8.5, and 0.2 M MgCl2",294,"10.1021/acs.jmedchem.7b00397","7XS","5U7I",162.73,"2","2","PDE2 catalytic domain complexed with inhibitors","GSAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5U7I"
"5U7J",,"X-RAY DIFFRACTION",2.24,44.98,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.1 M Tris, pH 8.5, and 0.2 M MgCl2",294,"10.1021/acs.jmedchem.7b00397","7XV","5U7J",162.56,"1.9","1.9","PDE2 catalytic domain complexed with inhibitors","GSAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5U7J"
"5U7K",,"X-RAY DIFFRACTION",2.2,44.14,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.1 M Tris, pH 8.5, and 0.2 M MgCl2",294,"10.1021/acs.jmedchem.7b00397","7Y1","5U7K",162.74,"2.06","2.06","PDE2 catalytic domain complexed with inhibitors","GSAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5U7K"
"5U7L",,"X-RAY DIFFRACTION",2.23,44.96,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.1 M Tris, pH 8.5, and 0.2 M MgCl2",294,"10.1021/acs.jmedchem.7b00397","7Y4","5U7L",122.24,"2.38","2.38","PDE2 catalytic domain complexed with inhibitors","GSAMDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5U7L"
"5U7Q",,"X-RAY DIFFRACTION",4.16,70.41,"VAPOR DIFFUSION, SITTING DROP",7,"1.1 M Sodium malonate pH 7.0, 0.1 M HEPES pH 7.0, 0.5% v/v Jeffamine ED-2001 pH 7.0",293,"10.1016/j.bmc.2017.02.021",,"5U7Q",181.6,"3.15","3.15","Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones","GASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGFYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYR","Homo sapiens","ROCK2, KIAA0619","Rho-associated protein kinase 2","1","5U7Q"
"5U7R",,"X-RAY DIFFRACTION",4.07,69.77,"VAPOR DIFFUSION",,"0.8M Citrate, 0.1M Citrate pH 5.1 in hanging drops at 293K",293,"10.1016/j.bmc.2017.02.021",,"5U7R",183.32,"3.33","3.33","Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones","GASRQRKLEALIRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLICAFLTDREVRLGRNGVEEIRQHPFFKNDQWHWDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDVETFPIPKAFVGNQLPFIGFTYYR","Homo sapiens","ROCK2, KIAA0619","Rho-associated protein kinase 2","1","5U7R"
"5U7Z",,"X-RAY DIFFRACTION",2.5,50.89,"VAPOR DIFFUSION, HANGING DROP",,"PEG 1000
sodium phosphate-citrate
lithium sulfate",298,"10.1038/s41467-018-03844-2",,"5U7Z",91.67,"2.5","2.5","Human acid ceramidase (ASAH1, aCDase) self-activated","DRHHHHHHKLQHAPPWTEDCRKSTYPPSGPTYRGAVPWYTINLDLPPYKRWHELMLDKAPMLKVIVNSLKNMINTFVPSGKVMQVVDEKLPGLLGNFPGPFEEEMKGIAAVTDIPLGEIISFNIFYELF","Homo sapiens","ASAH1, ASAH, HSD-33, HSD33","Acid ceramidase","1","5U7Z"
,,,,,,,,,,,,,,,,"TICTSIVAEDKKGHLIHGRNMDFGVFLGWNINNDTWVITEQLKPLTVNLDFQRNNKTVFKASSFAGYVGMLTGFKPGLFSLTLNERFSINGGYLGILEWILGKKDAMWIGFLTRTVLENSTSYEEAKNLLTKTKILAPAYFILGGNQSGEGCVITRDRKESLDVYELDAKQGRWYVVQTNYDRWKHPFFLDDRRTPAKMCLNRTSQENISFETMYDVLSTKPVLNKLTVYTTLIDVTKGQFETYLRDCPDPCIGW","Homo sapiens","ASAH1, ASAH, HSD-33, HSD33","Acid ceramidase","2","5U7Z"
"5U8A",,"X-RAY DIFFRACTION",2.62,53.06,"VAPOR DIFFUSION",8.5,"3.08M Sodium Formate, 20% Glycerol, 0.1M Tris pH8.5",290,"10.1016/j.bmcl.2017.02.030","82D","5U8A",43.01,"1.45","1.45","Polycomb protein EED in complex with inhibitor: (3R,4S)-1-[(2-bromo-6-fluorophenyl)methyl]-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine","GSHMKCKYSFKCVNSLKEDHNQPLFGVQFNWHSKEGDPLVFATVGSNRVTLYECHSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLAVAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDTLVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIDKIKPSESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTTLTHHKCGAAIRQTSFSRDSSILIAVCDDASIWRWDRLR","Homo sapiens","EED","Polycomb protein EED","1","5U8A"
"5U8F",,"X-RAY DIFFRACTION",2.62,53.06,"VAPOR DIFFUSION",8.5,"3.08M Sodium Formate, 20% Glycerol, 0.1M Tris pH8.5",290,"10.1016/j.bmcl.2017.02.030","82G","5U8F",42.96,"1.343","1.343","Polycomb protein EED in complex with inhibitor: (3R,4S)-1-[(1S)-7-fluoro-2,3-dihydro-1H-inden-1-yl]-N,N-dimethyl-4-(1-methyl-1H-indol-3-yl)pyrrolidin-3-amine","GSHMKCKYSFKCVNSLKEDHNQPLFGVQFNWHSKEGDPLVFATVGSNRVTLYECHSQGEIRLLQSYVDADADENFYTCAWTYDSNTSHPLLAVAGSRGIIRIINPITMQCIKHYVGHGNAINELKFHPRDPNLLLSVSKDHALRLWNIQTDTLVAIFGGVEGHRDEVLSADYDLLGEKIMSCGMDHSLKLWRINSKRMMNAIKESYDYNPNKTNRPFISQKIHFPDFSTRDIHRNYVDCVRWLGDLILSKSCENAIVCWKPGKMEDDIDKIKPSESNVTILGRFDYSQCDIWYMRFSMDFWQKMLALGNQVGKLYVWDLEVEDPHKAKCTTLTHHKCGAAIRQTSFSRDSSILIAVCDDASIWRWDRLR","Homo sapiens","EED","Polycomb protein EED","1","5U8F"
"5U8L",,"X-RAY DIFFRACTION",2.07,40.71,"VAPOR DIFFUSION, SITTING DROP",,"Salt: 0.2 M Ammonium sulfate
Buffer: 0.1 M HEPES (pH 7.50)
Precipitant: 20.0 %w/v PEG 8000
Precipitant: 5.7 %v/v  iso-propanol",277,"10.1021/jacs.6b08536",,"5U8L",38.31,"1.6","1.6","Crystal structure of EGFR kinase domain in complex with a sulfonyl fluoride probe XO44","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5U8L"
"5U9A",,"X-RAY DIFFRACTION",2.37,48.13,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Na-Citrate
20% (W/V) PEG 4000
20 % (V/V) 2-Propanol",291,"10.1073/pnas.1704782114",,"5U9A",19.33,"2.7","2.7","Crystal structure of the FKBP domain of human aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1)","MGHHHHHHGDAALLLNVEGVKKTILHGGTGELPNFITGSRVIFHFRTMKCDEERTVIDDSRQVGQPMHIIIGNMFKLEVWEILLTSMRVHEVAEFWCDTIHTGVYPILSRSLRQMAQGKDPTEWHVHTCGLANMFAYHTLGYEDLDELQKEPQPLVFVIELLQVDAPSD","Homo sapiens","AIPL1, AIPL2","Aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1)","1","5U9A"
"5U9D",,"X-RAY DIFFRACTION",2.3,46.5,"VAPOR DIFFUSION, SITTING DROP",,"Polyethylene glycols (PEG3350 / PEG5000MME), (NH4)2SO4 and MES buffer at pH6.0-6.7",298,"10.1002/cbic.201600573","83P","5U9D",32.48,"1.33","1.33","Discovery of a potent BTK inhibitor with a novel binding mode using parallel selections with a DNA-encoded chemical library","GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","5U9D"
"5U9I",,"X-RAY DIFFRACTION",2.52,51.12,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Na-Citrate
20% (W/V) PEG 4000
20% (V/V) 2-Propanol",291,"10.1073/pnas.1704782114",,"5U9I",19.53,"2.3","2.3","Crystal structure of the FKBP domain of human aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) complexed with S-farnesyl-L-cysteine methyl ester","MGHHHHHHGDAALLLNVEGVKKTILHGGTGELPNFITGSRVIFHFRTMKCDEERTVIDDSRQVGQPMHIIIGNMFKLEVWEILLTSMRVHEVAEFWCDTIHTGVYPILSRSLRQMAQGKDPTEWHVHTCGLANMFAYHTLGYEDLDELQKEPQPLVFVIELLQVDAPSD","Homo sapiens","AIPL1, AIPL2","Aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1)","1","5U9I"
"5U9J",,"X-RAY DIFFRACTION",2.45,49.82,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Na-Citrate
20%(W/V) PEG 4000
20% (V/V) 2-Propanol",291,"10.1073/pnas.1704782114",,"5U9J",39.29,"2.1","2.1","Crystal structure of the FKBP domain of human aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) complexed with geranyl geranyl pyrophoshate","MGHHHHHHGDAALLLNVEGVKKTILHGGTGELPNFITGSRVIFHFRTMKCDEERTVIDDSRQVGQPMHIIIGNMFKLEVWEILLTSMRVHEVAEFWCDTIHTGVYPILSRSLRQMAQGKDPTEWHVHTCGLANMFAYHTLGYEDLDELQKEPQPLVFVIELLQVDAPSD","Homo sapiens","AIPL1, AIPL2","Aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1)","1","5U9J"
"5U9K",,"X-RAY DIFFRACTION",2.31,46.72,"VAPOR DIFFUSION, HANGING DROP",,"100 mM Na-Citrate
20% (W/V) PEG 4000
20% (V/V) 2-Propanol",291,"10.1073/pnas.1704782114",,"5U9K",19.38,"2.7","2.7","Crystal structure of V71F mutant of the FKBP domain of human aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1)","MGHHHHHHGDAALLLNVEGVKKTILHGGTGELPNFITGSRVIFHFRTMKCDEERTVIDDSRQVGQPMHIIIGNMFKLEFWEILLTSMRVHEVAEFWCDTIHTGVYPILSRSLRQMAQGKDPTEWHVHTCGLANMFAYHTLGYEDLDELQKEPQPLVFVIELLQVDAPSD","Homo sapiens","AIPL1, AIPL2","Aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1)","1","5U9K"
"5UA3",,"X-RAY DIFFRACTION",2.33,47.11,"VAPOR DIFFUSION, HANGING DROP",6.5,"2.5 M NaCl, 10% v/v ethanol, 0.1 M sodium cacodylate, G4R1 53-105 peptide (UniProtKB Q9H2U1/DHX36_HUMAN, amino acid residues 53-105)",293.15,"10.1093/nar/gky307",,"5UA3",12.8,"1.8802","1.8802","Crystal Structure of a DNA G-Quadruplex with a Cytosine Bulge","GGGTTGCGGAGGGTGGGCCT","Homo sapiens",,"DNA (5'-D(*GP*GP*GP*TP*TP*GP*CP*GP*GP*AP*GP*GP*GP*TP*GP*GP*GP*CP*CP*T)-3')","1","5UA3"
"5UAB",,"X-RAY DIFFRACTION",2.07,40.52,"VAPOR DIFFUSION, SITTING DROP",7.8,"16.% PEG MME 5000, 15.% Isopropanol, 0.1M HEPES pH 7.8",293,"10.1158/1535-7163.MCT-16-0771",,"5UAB",39.06,"1.9","1.9","MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody","GAMGSQVQYPLTDMSPILTSGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVK","Homo sapiens","MET","Hepatocyte growth factor receptor","1","5UAB"
"5UAD",,"X-RAY DIFFRACTION",2.11,44.77,"VAPOR DIFFUSION, SITTING DROP",7.2,"19.% PEG 3350, 12.% Isopropanol, 0.1M HEPES pH 7.2",273,"10.1158/1535-7163.MCT-16-0771",,"5UAD",39.03,"2.25","2.25","MET Tyrosine Kinase Inhibition Enhances the Antitumor Efficacy of an HGF Antibody","GAMGSQVQYPLTDMSPILTSGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVK","Homo sapiens","MET","Hepatocyte growth factor receptor","1","5UAD"
"5UAK","3.87","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2017.02.024",,"5UAK",170.99,"3.87",,"Dephosphorylated, ATP-free human cystic fibrosis transmembrane conductance regulator (CFTR)","MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRLSNSLEVLFQ","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","1","5UAK"
,,,,,,,,,,,,,,,,"XXXXXXXXXXXXXXXXXXX","Homo sapiens","CFTR, ABCC7","Cystic fibrosis transmembrane conductance regulator","2","5UAK"
"5UAP",,"X-RAY DIFFRACTION",3.2,61.62,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Bis-Tris pH 6.5
16% w/v PEG10000",291,"10.1021/acschembio.7b00056",,"5UAP",113.93,"2.03","2.03","Crystal Structure of CYP2B6 (Y226H/K262R) in complex with Bornyl Bromide","MAKKTSSKGKLPPGPRPLPLLGNLLQMDRRGLLKSFLRFREKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNRWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIICSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKHFPGAHRQVYKNLQEINAYIGHSVEKHRETLDPSAPRDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGTETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFSDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGALKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKIPPTYQIRFLPRHHHH","Homo sapiens","CYP2B6","Cytochrome P450 2B6","1","5UAP"
"5UAT",,"X-RAY DIFFRACTION",2.42,49.2,"VAPOR DIFFUSION, SITTING DROP",7.5,"300 mM Na2SO4, 16-18% (w/v) polyethylene glycol (PEG) 3350, and 0.1 M HEPES at pH 7.5. The crystal was soaked in the cryobuffer containing 100 mM NADPH",295,"10.1074/jbc.M117.780288",,"5UAT",172.2,"1.92","1.92","Structure of human PYCR-1 complexed with NADPH","MHHHHHHSSGVDLGTENLYFQSMSVGFIGAGQLAFALAKGFTAAGVLAAHKIMASSPDMDLATVSALRKMGVKLTPHNKETVQHSDVLFLAVKPHIIPFILDEIGADIEDRHIVVSCAAGVTISSIEKKLSAFRPAPRVIRCMTNTPVVVREGATVYATGTHAQVEDGRLMEQLLSSVGFCTEVEEDLIDAVTGLSGSGPAYAFTALDALADGGVKMGLPRRLAVRLGAQALLGAAKMLLHSEQHPGQLKDNVSSPGGATIHALHVLESGGFRSLLINAVEASCIRTRELQSMADQEQVSPAAIKKTILDKVKLDSPAGTAL","Homo sapiens","PYCR1","Pyrroline-5-carboxylate reductase 1, mitochondrial","1","5UAT"
"5UAU",,"X-RAY DIFFRACTION",2.49,50.66,"VAPOR DIFFUSION, SITTING DROP",7.5,"300 mM Na2SO4, 16-18% (w/v) polyethylene glycol (PEG) 3350, and 0.1 M HEPES at pH 7.5. The crystal was soaked in 1.8 M L-proline",295,"10.1074/jbc.M117.780288",,"5UAU",171.75,"1.9","1.9","Structure of human PYCR-1 complexed with proline","MHHHHHHSSGVDLGTENLYFQSMSVGFIGAGQLAFALAKGFTAAGVLAAHKIMASSPDMDLATVSALRKMGVKLTPHNKETVQHSDVLFLAVKPHIIPFILDEIGADIEDRHIVVSCAAGVTISSIEKKLSAFRPAPRVIRCMTNTPVVVREGATVYATGTHAQVEDGRLMEQLLSSVGFCTEVEEDLIDAVTGLSGSGPAYAFTALDALADGGVKMGLPRRLAVRLGAQALLGAAKMLLHSEQHPGQLKDNVSSPGGATIHALHVLESGGFRSLLINAVEASCIRTRELQSMADQEQVSPAAIKKTILDKVKLDSPAGTAL","Homo sapiens","PYCR1","Pyrroline-5-carboxylate reductase 1, mitochondrial","1","5UAU"
"5UAV",,"X-RAY DIFFRACTION",2.4,48.8,"VAPOR DIFFUSION, SITTING DROP",7.5,"300 mM Na2SO4, 16-18% (w/v) polyethylene glycol (PEG) 3350, and 0.1 M HEPES at pH 7.5.  The crystal was soaked in the cryobuffer containing 100 mM NADPH followed by 50 mM L-tetrahydrofuroic acid",295,"10.1074/jbc.M117.780288",,"5UAV",174.63,"1.85","1.85","Structure of human PYCR-1 complexed with NADPH and L-tetrahydrofuroic acid","MHHHHHHSSGVDLGTENLYFQSMSVGFIGAGQLAFALAKGFTAAGVLAAHKIMASSPDMDLATVSALRKMGVKLTPHNKETVQHSDVLFLAVKPHIIPFILDEIGADIEDRHIVVSCAAGVTISSIEKKLSAFRPAPRVIRCMTNTPVVVREGATVYATGTHAQVEDGRLMEQLLSSVGFCTEVEEDLIDAVTGLSGSGPAYAFTALDALADGGVKMGLPRRLAVRLGAQALLGAAKMLLHSEQHPGQLKDNVSSPGGATIHALHVLESGGFRSLLINAVEASCIRTRELQSMADQEQVSPAAIKKTILDKVKLDSPAGTAL","Homo sapiens","PYCR1","Pyrroline-5-carboxylate reductase 1, mitochondrial","1","5UAV"
"5UAW",,"X-RAY DIFFRACTION",2.48,50.32,"VAPOR DIFFUSION, SITTING DROP",7.5,"300 mM Na2SO4, 16-18% (w/v) polyethylene glycol (PEG) 3350, and 0.1 M HEPES at pH 7.5",295,"10.1074/jbc.M117.780288",,"5UAW",170.7,"1.85","1.85","Structure of apo human PYCR-1 crystallized in space group P21212","MHHHHHHSSGVDLGTENLYFQSMSVGFIGAGQLAFALAKGFTAAGVLAAHKIMASSPDMDLATVSALRKMGVKLTPHNKETVQHSDVLFLAVKPHIIPFILDEIGADIEDRHIVVSCAAGVTISSIEKKLSAFRPAPRVIRCMTNTPVVVREGATVYATGTHAQVEDGRLMEQLLSSVGFCTEVEEDLIDAVTGLSGSGPAYAFTALDALADGGVKMGLPRRLAVRLGAQALLGAAKMLLHSEQHPGQLKDNVSSPGGATIHALHVLESGGFRSLLINAVEASCIRTRELQSMADQEQVSPAAIKKTILDKVKLDSPAGTAL","Homo sapiens","PYCR1","Pyrroline-5-carboxylate reductase 1, mitochondrial","1","5UAW"
"5UAX",,"X-RAY DIFFRACTION",2.71,54.64,"VAPOR DIFFUSION, SITTING DROP",,"3 M NaCl and 0.1 M HEPES at pH 7.5-8.0",295,"10.1074/jbc.M117.780288",,"5UAX",170.39,"1.85","1.85","Structure of apo human PYCR-1 crystallized in space group C2","MHHHHHHSSGVDLGTENLYFQSMSVGFIGAGQLAFALAKGFTAAGVLAAHKIMASSPDMDLATVSALRKMGVKLTPHNKETVQHSDVLFLAVKPHIIPFILDEIGADIEDRHIVVSCAAGVTISSIEKKLSAFRPAPRVIRCMTNTPVVVREGATVYATGTHAQVEDGRLMEQLLSSVGFCTEVEEDLIDAVTGLSGSGPAYAFTALDALADGGVKMGLPRRLAVRLGAQALLGAAKMLLHSEQHPGQLKDNVSSPGGATIHALHVLESGGFRSLLINAVEASCIRTRELQSMADQEQVSPAAIKKTILDKVKLDSPAGTAL","Homo sapiens","PYCR1","Pyrroline-5-carboxylate reductase 1, mitochondrial","1","5UAX"
"5UBA",,"X-RAY DIFFRACTION",2.31,46.76,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.2 M CaCl2",291,,,"5UBA",33.62,"1.54","1.54","Human RNA Pseudouridylate Synthase Domain Containing 4","MHHHHHHSSGRENLYFQGNVLAKALTRGILHQDKNLVVINKPYGLPVHGGPGVQLCITDVLPILAKMLHGHKAEPLHLCHRLDKETTGVMVLAWDKDMAHQVQELFRTRQVVKKYWAITVHVPMPSAGVVDIPIVEKEAQGQQQHHKMTLSPSYRMDDGKMVKVRRSRNAQVAVTQYQVLSSTLSSALVELQPITGIKHQLRVHLSFGLDCPILGDHKYSDWNRLAPQKLSVGTLKKLGLEQSKARYIPLHLHARQLILPALGSGKEELNLVCKLPRFFVHSLHRLRLEMPNEDQ","Homo sapiens","RPUSD4","RNA pseudouridylate synthase domain-containing protein 4","1","5UBA"
"5UBB",,"X-RAY DIFFRACTION",2.56,52.02,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG3350, 0.2 M sodium acetate",291,"10.1038/s42003-018-0196-2",,"5UBB",25.4,"2","2","Crystal structure of human alpha N-terminal protein methyltransferase 1B","GTSQVINGEMQFYARAKLFYQEVPATEEGMMGNFIELSSPDIQASQKFLRKFVGGPGRAGTDCALDCGSGIGRVSKHVLLPVFNSVELVDMMESFLLEAQNYLQVKGDKVESYHCYSLQEFTPPFRRYDVIWIQWVSGHLTDKDLLAFLSRCRDGLKENGIIILKDNVAREGCILDLSDSSVTRDMDILRSLIRKSGLVVLGQEKQDGFPEQCIPVWMFALH","Homo sapiens","METTL11B, C1orf184, NRMT2, NTMT2","Alpha N-terminal protein methyltransferase 1B","1","5UBB"
"5UBR",,"X-RAY DIFFRACTION",2.65,53.6,"VAPOR DIFFUSION",,"NULL",293,"10.1016/j.bmcl.2017.01.016",,"5UBR",110.28,"2.4","2.4","CRYSTAL STRUCTURE OF PI3K ALPHA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1-YL)PHENYL)PYRROLO[2,1-F][1,2,4] TRIAZIN-4-AMINE DERIVIATINE","NREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKHIYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGG","Homo sapiens","PIK3CA","Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform","1","5UBR"
"5UBY",,"X-RAY DIFFRACTION",2.24,45.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"18% (w/v) polyethylene glycol (PEG) 8000, 0.1 M HEPES pH 7.5",291.15,,,"5UBY",46.71,"2.6","2.6","Fab structure of anti-HIV-1 gp120 mAb 1A8","QVQLQESGPGLVKPSETLSLTCTVSGGSISSSDYYWGWIRQPPGKGLEWIGSMSYSGRTYYNPSLKSRVTISVDTSKNQFSLKLSSVTAADTAVYFCASHWRYSGGLFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKTH","Homo sapiens",,"Heavy chain of Fab fragment of anti-HIV1 gp120 mAb 1A8","1","5UBY"
,,,,,,,,,,,,,,,,"SYELTQPPSVSVAPGKTARITCGGNNIGSKNVHWYQQKAGQAPVVVVYDYTDRPSGSPERFSGSKSGSTATLTISRVEAGDEADYYCQVWDSSGDHVVFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPT","Homo sapiens",,"Light chain of Fab fragment of anti-HIV1 gp120 mAb 1A8","2","5UBY"
"5UBZ",,"X-RAY DIFFRACTION",2.08,41,"VAPOR DIFFUSION, HANGING DROP",4.6,"28% (w/v) PEG 4000, 0.085 M sodium Acetate pH 4.6, and 15% glycerol",291.15,,,"5UBZ",46.75,"2.75","2.75","Fab structure of HIV gp120 specific mAb 1E12","QVQLQESGPRLVKPSDTLSLTCTVSGGSITSDSHYWGWVRQSPGKGLEWIASTSDSGSTYHNRPIYYNPSLKSRVTISVATSKNQFSLKLRSVTAADTAMYYCVRQWRYSSGSLDCWGQGILVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPK","Homo sapiens",,"Anti-HIV1 gp120 mAb 1E12 Fab heavy chain","1","5UBZ"
,,,,,,,,,,,,,,,,"QAVVTQPPSASGTPGQRVTISCSGSSSNIGSNTVNWYQQLPGLAPKLLIYSSNQRPSGVPDRFSGSKSGTSASLAISGLQSEDEAHYYCATWDDSLNGVIFGGGTKLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPT","Homo sapiens",,"Anti-HIV1 gp120 mAb 1E12 Fab light chain","2","5UBZ"
"5UC3",,"X-RAY DIFFRACTION",3.06,59.75,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES, 0.1 M sodium citrate, 15 % MPD (v/v)",293,,"486","5UC3",61.73,"2.009","2.009","Structure of the dominant negative mutant Glucocorticoid Receptor alpha (L733K/N734P) complexed with RU-486","SPATLPQLTPTLVSLLEVIEPEVLYAGYDSSVPDSTWRIMTTLNMLGGRQVIAAVKWAKAIPGFRNLHLDDQMTLLQYSWMFLMAFALGWRSYRQSSANLLCFAPDLIINEQRMTLPCMYDQCKHMLYVSSELHRLQVSYEEYLCMKTLLLLSSVPKDGLKSQELFDEIRMTYIKELGKAIVKREGNSSQNWQRFYQLTKLLDSMHEVVENLKPYCFQTFLDKTMSIEFPEMLAEIITNQIPKYSNGNIKKLLFHQK","Homo sapiens","NR3C1, GRL","Glucocorticoid receptor","1","5UC3"
"5UC4",,"X-RAY DIFFRACTION",2.62,52.99,"EVAPORATION",,"30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5",293,"10.1038/s41467-017-02013-1","83S","5UC4",100.07,"2.05","2.05","Hsp90b N-terminal domain with inhibitors","GHMPEEVHHGEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLTDPSKLDSGKELKIDIIPNPQERTLTLVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVVVITKHNDDEQYAWESSAGGSFTVRADHGEPIGRGTKVILHLKEDQTEYLEERRVKEVVKKHSQFIGYPITLYLE","Homo sapiens","HSP90AB1, HSP90B, HSPC2, HSPCB","Heat shock protein HSP 90-beta","1","5UC4"
"5UC8",,"X-RAY DIFFRACTION",2.17,43.44,"VAPOR DIFFUSION",,"0.1 M Bis-Tris (pH 6.5) and 24% (w/v) PEG 2,000 monomethyl ether",293,"10.1016/j.chom.2017.01.002",,"5UC8",105.15,"2","2","Crystal structure of human Heme Oxygenase-2","MGSSHHHHHHSSGMADLSELLKEGTKEAHDRAENTQFVKDFLKGNIKKELFKLATTALYFTYSALEEEMERNKDHPAFAPLYFPMELHRKEALTKDMEYFFGENWEEQVQCPKAAQKYVERIHYIGQNEPELLVAHAYTRYMGDLSGGQVLKKVAQRALKLPSTGEGTQFYLFENVDNAQQFKQLYRARMNALDLNMKTKERIVEEANKAFEYNMQIFNELDQAGS","Homo sapiens","HMOX2, HO2","Heme oxygenase 2","1","5UC8"
"5UC9",,"X-RAY DIFFRACTION",2.1,41.44,"VAPOR DIFFUSION",,"0.1 M Bis-Tris (pH 6.5) and 24% (w/v) PEG 2,000 monomethyl ether",293,"10.1016/j.chom.2017.01.002",,"5UC9",106.06,"1.903","1.903","Crystal structure of human Heme Oxygenase-2 in complex with Myristate","MGSSHHHHHHSSGMADLSELLKEGTKEAHDRAENTQFVKDFLKGNIKKELFKLATTALYFTYSALEEEMERNKDHPAFAPLYFPMELHRKEALTKDMEYFFGENWEEQVQCPKAAQKYVERIHYIGQNEPELLVAHAYTRYMGDLSGGQVLKKVAQRALKLPSTGEGTQFYLFENVDNAQQFKQLYRARMNALDLNMKTKERIVEEANKAFEYNMQIFNELDQAGS","Homo sapiens","HMOX2, HO2","Heme oxygenase 2","1","5UC9"
"5UCA",,"X-RAY DIFFRACTION",2.13,42.38,"VAPOR DIFFUSION",,"0.1 M Bis-Tris (pH 6.5) and 24% (w/v) PEG 2000 monomethyl ether",293,"10.1016/j.chom.2017.01.002",,"5UCA",105.75,"2.117","2.117","Crystal structure of human Heme Oxygenase-2 in complex with Laurate","MGSSHHHHHHSSGMADLSELLKEGTKEAHDRAENTQFVKDFLKGNIKKELFKLATTALYFTYSALEEEMERNKDHPAFAPLYFPMELHRKEALTKDMEYFFGENWEEQVQCPKAAQKYVERIHYIGQNEPELLVAHAYTRYMGDLSGGQVLKKVAQRALKLPSTGEGTQFYLFENVDNAQQFKQLYRARMNALDLNMKTKERIVEEANKAFEYNMQIFNELDQAGS","Homo sapiens","HMOX2, HO2","Heme oxygenase 2","1","5UCA"
"5UCH",,"X-RAY DIFFRACTION",2.6,52.77,"EVAPORATION",,"30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5",293,"10.1038/s41467-017-02013-1",,"5UCH",100.11,"2.654","2.654","Hsp90b N-terminal domain with inhibitors","GHMPEEVHHGEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLTDPSKLDSGKELKIDIIPNPQERTLTLVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVVVITKHNDDEQYAWESSAGGSFTVRADHGEPIGRGTKVILHLKEDQTEYLEERRVKEVVKKHSQFIGYPITLYLE","Homo sapiens","HSP90AB1, HSP90B, HSPC2, HSPCB","Heat shock protein HSP 90-beta","1","5UCH"
"5UCI",,"X-RAY DIFFRACTION",2.63,53.28,"EVAPORATION",,"30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5",293,"10.1038/s41467-017-02013-1",,"5UCI",100.14,"2.7","2.7","Hsp90b N-terminal domain with inhibitors","GHMPEEVHHGEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLTDPSKLDSGKELKIDIIPNPQERTLTLVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVVVITKHNDDEQYAWESSAGGSFTVRADHGEPIGRGTKVILHLKEDQTEYLEERRVKEVVKKHSQFIGYPITLYLE","Homo sapiens","HSP90AB1, HSP90B, HSPC2, HSPCB","Heat shock protein HSP 90-beta","1","5UCI"
"5UCJ",,"X-RAY DIFFRACTION",2.62,52.99,"EVAPORATION",,"30% PEG 8,000, 0.2 M sodium acetate, 0.1 sodium cacodylate pH 6.5",293,"10.1038/s41467-017-02013-1","KU3","5UCJ",100.16,"1.693","1.693","Hsp90b N-terminal domain with inhibitors","GHMPEEVHHGEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLTDPSKLDSGKELKIDIIPNPQERTLTLVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVVVITKHNDDEQYAWESSAGGSFTVRADHGEPIGRGTKVILHLKEDQTEYLEERRVKEVVKKHSQFIGYPITLYLE","Homo sapiens","HSP90AB1, HSP90B, HSPC2, HSPCB","Heat shock protein HSP 90-beta","1","5UCJ"
"5UCX",,"X-RAY DIFFRACTION",3.1,60.3,"VAPOR DIFFUSION, SITTING DROP",8.7,"12.5% PEG1000, 12.5% PEG3350. 12.5% MPD, 0.02 M alcohol additives at pH 8.7 (Fine screen derived from Gorrec, 2009)",293,"10.1016/j.bbrc.2018.02.093",,"5UCX",199.89,"2.4","2.4","Structure of S78C Human Peroxiredoxin 3 as three stacked rings","GIDPFTAPAVTQHAPYFKGTAVVNGEFKDLSLDDFKGKYLVLFFYPLDFTFVCPTEIVAFSDKANEFHDVNCEVVAVSVDSHFCHLAWINTPRKNGGLGHMNIALLSDLTKQISRDYGVLLEGSGLALRGLFIIDPNGVIKHLSVNDLPVGRSVEETLRLVKAFQYVETHGEVCPANWTPDSPTIKPSPAASKEYFQKVNQ","Homo sapiens","PRDX3, AOP1","Thioredoxin-dependent peroxide reductase, mitochondrial","1","5UCX"
"5UD7",,"X-RAY DIFFRACTION",2.43,49.44,"EVAPORATION",7.9,"0.2 M sodium iodide, 1.6 M ammonium sulfate, 0.1 M Tris 7.9",293,"10.1074/jbc.RA118.002352",,"5UD7",116.89,"2.20002253654","2.20002253654","Crystal Structure of Wild-Type Ig-like Domain","HDTTVFQGVAGQSLQVSCPYDSMKHWGRRKAWCRQLGEKGPCQRVVSTHNLWLLSFLRRWNGSTAITDDTLGGTLTITLRNLQPHDAGLYQCQSLHGSEADTLRKVLVEVLADPLDHRDAGDLWFPGESESFEDAHVEHSISRSLLEGEIPFPPTSENLYFQGHHHHHH","Homo sapiens","TREM2","Triggering receptor expressed on myeloid cells 2","1","5UD7"
"5UD8",,"X-RAY DIFFRACTION",1.86,33.84,"EVAPORATION",8,"30% PEG 6000, 0.1 M Tris 8.0",293,"10.1074/jbc.RA118.002352",,"5UD8",25.06,"1.8","1.8","Crystal Structure of Mutant Ig-like Domain","HNTTVFQGVAGQSLQVSCPYDSMKHWGRHKAWCRQLGEKGPCQRVVSTHNLWLLSFLRRWNGSTAITDDTLGGTLTITLRNLQPHDAGLYQCQSLHGSEADTLRKVLVEVLA","Homo sapiens","TREM2","Triggering receptor expressed on myeloid cells 2","1","5UD8"
"5UD9",,"X-RAY DIFFRACTION",2.29,46.27,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1M sodium acetate pH4.5, 26.8% (v/v) PEG 400, 13.4% (w/v) PEG 800",298,"10.1126/scitranslmed.aal2144",,"5UD9",49.18,"1.3","1.3","Crystal structure of 354BG18 Fab","QVQLRESGPGLVKPSETLSLSCTVSQDSRPSDHSWTWVRQSPGKALEWIGDIHYNGATTYNPSLRSRVRIELDQSIPRFSLKMTSMTAADTGMYYCARNAIRIYGVVALGEWFHYGMDVWGQGTAVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKHHHHHH","Homo sapiens",,"Fab heavy chain","1","5UD9"
,,,,,,,,,,,,,,,,"WASSELTQPPSVSVSPGQTARITCSGAPLTSRFTYWYRQKPGQAPVLIISRSSQRSSGWSGRFSASWSGTTVTLTIRGVQADDEADYYCQSSDTSDSYKMFGGGTKLTVLGQPAAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHKSYSCQVTHEGSTVEKTVAPTEC","Homo sapiens",,"Light chain","2","5UD9"
"5UDA",,"X-RAY DIFFRACTION",3.24,62.02,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.2 M Sodium Chloride
0.1 M HEPES
25% w/v Polyethylene glycol 3350",291,"10.1021/acschembio.7b00056",,"5UDA",113.77,"1.93","1.93","Crystal structure of CYP2B6 (Y226H/K262R) in complex with a monoterpene bornane","MAKKTSSKGKLPPGPRPLPLLGNLLQMDRRGLLKSFLRFREKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNRWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIICSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKHFPGAHRQVYKNLQEINAYIGHSVEKHRETLDPSAPRDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGTETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFSDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGALKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKIPPTYQIRFLPRHHHH","Homo sapiens","CYP2B6","Cytochrome P450 2B6","1","5UDA"
"5UDP",,"X-RAY DIFFRACTION",2.31,46.85,"VAPOR DIFFUSION, HANGING DROP",8.2,"0.3 M TRIS, 0.5 M sodium sulfate, 0.6 mM Zinc acetate, 0.06% phenol",292,"10.1002/chem.201605578",,"5UDP",35.7,"1.348","1.348","High resolution x-ray crystal structure of synthetic insulin lispro","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin Lispro A chain","1","5UDP"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTKPT","Homo sapiens","INS","Insulin Lispro B chain","2","5UDP"
"5UDY",,"X-RAY DIFFRACTION",3.61,65.94,"VAPOR DIFFUSION",,"sodium iodide, PEG 3350",293,"10.1074/jbc.M116.769273",,"5UDY",53.35,"2.6","2.6","Human alkaline sphingomyelinase (alk-SMase, ENPP7, NPP7)","DRHHHHHHKLAPVQSQGSQNKLLLVSFDGFRWNYDQDVDTPNLDAMARDGVKARYMTPAFVTMTSPCHFTLVTGKYIENHGVVHNMYYNTTSKVKLPYHATLGIQRWWDNGSVPIWITAQRQGLRAGSFFYPGGNVTYQGVAVTRSRKEGIAHNYKNETEWRANIDTVMAWFTEEDLDLVTLYFGEPDSTGHRYGPESPERREMVRQVDRTVGYLRESIARNHLTDRLNLIITSDHGMTTVDKRAGDLVEFHKFPNFTFRDIEFELLDYGPNGMLLPKEGRLEKVYDALKDAHPKLHVYKKEAFPEAFHYANNPRVTPLLMYSDLGYVIHGRINVQFNNGEHGFDNKDMDMKTIFRAVGPSFRAGLEVEPFESVHVYELMCRLLGIVPEANDGHLATLLPMLHTESALPPDGRPTLLPKGRS","Homo sapiens","ENPP7, UNQ3077/PRO9912","Ectonucleotide pyrophosphatase/phosphodiesterase family member 7","1","5UDY"
"5UE2",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2017.05.019",,"5UE2",30.13,,,"proMMP-7 with heparin octasaccharide bridging between domains","PQEAGGMSELQWEQAQDYLKRFYLYDSETKNANSLEAKLKEMQKFFGLPITGMLNSRVIEIMQKPRCGVPDVAEYSLFPNSPKWTSKVVTYRIVSYTRDLPHITVDRLVSKALNMWGKEIPLHFRKVVWGTADIMIGFARGAHGDSYPFDGPGNTLAHAFAPGTGLGGDAHFDEDERWTDGSSLGINFLYAATHALGHSLGMGHSSDPNAVMYPTYGNGDPQNFKLSQDDIKGIQKLYGKRSNSRKK","Homo sapiens","MMP7, MPSL1, PUMP1","Matrilysin","1","5UE2"
"5UE3",,"X-RAY DIFFRACTION",2.3,46.58,"VAPOR DIFFUSION",5.5,"25% PEG 8K 1% glycerol 0.2 M ammonium sulfate 100 mM NaCacodylate",293,"10.1074/jbc.M117.806075",,"5UE3",54.19,"1.599","1.599","proMMP-9desFnII","LRTNLTDRQLAEEYLYRYGYTRVAEMRGESKSLGPALLLLQKQLSLPETGELDSATLKAMRTPRCGVPDLGRFQTFEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGQGYSLFLVAAHEFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYGP","Homo sapiens","MMP9, CLG4B","Matrix metalloproteinase-9","1","5UE3"
,,,,,,,,,,,,,,,,,"Homo sapiens","MMP9, CLG4B"
"5UE4",,"X-RAY DIFFRACTION",2.28,45.99,"VAPOR DIFFUSION",5.5,"25% PEG 8K 1% glycerol 0.2 M ammonium sulfate 100 mM NaCacodylate",293,"10.1074/jbc.M117.806075","5XQ","5UE4",54.14,"1.8","1.8","proMMP-9desFnII complexed to JNJ0966 INHIBITOR","LRTNLTDRQLAEEYLYRYGYTRVAEMRGESKSLGPALLLLQKQLSLPETGELDSATLKAMRTPRCGVPDLGRFQTFEGDLKWHHHNITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYPFDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGQGYSLFLVAAHEFGHALGLDHSSVPEALMYPMYRFTEGPPLHKDDVNGIRHLYGP","Homo sapiens","MMP9, CLG4B","Matrix metalloproteinase-9","1","5UE4"
,,,,,,,,,,,,,,,,,"Homo sapiens","MMP9, CLG4B"
"5UE5",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2017.05.019",,"5UE5",30.13,,,"proMMP-7 with heparin octasaccharide bound to the catalytic domain","PQEAGGMSELQWEQAQDYLKRFYLYDSETKNANSLEAKLKEMQKFFGLPITGMLNSRVIEIMQKPRCGVPDVAEYSLFPNSPKWTSKVVTYRIVSYTRDLPHITVDRLVSKALNMWGKEIPLHFRKVVWGTADIMIGFARGAHGDSYPFDGPGNTLAHAFAPGTGLGGDAHFDEDERWTDGSSLGINFLYAATHALGHSLGMGHSSDPNAVMYPTYGNGDPQNFKLSQDDIKGIQKLYGKRSNSRKK","Homo sapiens","MMP7, MPSL1, PUMP1","Matrilysin","1","5UE5"
"5UEC",,"X-RAY DIFFRACTION",3.2,61.52,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.2 M Magnesium acetate tetrahydrate
25%w/v PEG3350",291,"10.1021/acschembio.7b00056",,"5UEC",56.96,"2.27","2.27","Crystal Structure of CYP2B6 (Y226H/K262R) in complex with myrtenyl bromide.","MAKKTSSKGKLPPGPRPLPLLGNLLQMDRRGLLKSFLRFREKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNRWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIICSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKHFPGAHRQVYKNLQEINAYIGHSVEKHRETLDPSAPRDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGTETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFSDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGALKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKIPPTYQIRFLPRHHHH","Homo sapiens","CYP2B6","Cytochrome P450 2B6","1","5UEC"
"5UEH",,"X-RAY DIFFRACTION",2.39,48.51,"VAPOR DIFFUSION, SITTING DROP",5,"5 mg/mL solution of protein crystallized from precipitant solution containing 2.4 M ammonium sulfate and 0.1 M MES solution pH 5. Crystals cryoprotected by brief immersion in solution containing 1.5 M ammonium sulfate, 25% (v/v) glycerol",298,"10.1021/jacs.7b08366",,"5UEH",28.64,"2","2","Structure of GSTO1 covalently conjugated to quinolinic acid fluorosulfate","SMSGESARSLGKGSAPPGPVPEGSIRIYSMRFCPFAERTRLVLKAKGIRHEVININLKNKPEWFFKKNPFGLVPVLENSQGQLIYESAITCEYLDEAYPGKKLLPDDPYEKACQKMILELFSKVPSLVGSFIRSQNKEDYAGLKEEFRKEFTKLEEVLTNKKTTFFGGNSISMIDYLIWPWFERLEAMKLNECVDHTPKLKLWMAAMKEDPTVSALLTSEKDWQGFLELYLQNSPEACDYGL","Homo sapiens","GSTO1, GSTTLP28","Glutathione S-transferase omega-1","1","5UEH"
"5UEL",,"X-RAY DIFFRACTION",3.02,59.22,"VAPOR DIFFUSION, SITTING DROP",4.6,"0.1 M sodium acetate trihydrate pH 4.6,
2.0 M ammonium sulfate",293,"10.1126/scitranslmed.aal2144",,"5UEL",48.75,"1.6","1.6","Crystal structure of 354NC102 Fab","QVRLVQSGGQVKKPGASVTVSCEADGYDFPDYYIHWVRQAPGRGPEWLGLIKVGHGGAAIYAPNLRGRVSMTRDIHTTTAYMTLQRLTLDDTATYYCSRDNFGTRPVPGRGYYYGMDVWGQGTTIIVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"354NC102 Fab Heavy Chain","1","5UEL"
,,,,,,,,,,,,,,,,"EIVLTQSPGVLSLSPGERASLSCRASHGLDTSHLAWFQHKPGQPPRLLIYGTSSRPPGIPDRFRGSGSGTDFTLTITKLEPEDFAVYYCQNSGGGTPLIFGPGTKVNIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"354NC102 Fab Light Chain","2","5UEL"
"5UEO",,"X-RAY DIFFRACTION",2.64,53.41,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl   5 mM DTT
Crystallization :
15 % (v/v) Ethanol   Tris PH 7.0",277,,"87G","5UEO",26.53,"1.85","1.85","BRD4_BD2_A-1395017","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UEO"
"5UEP",,"X-RAY DIFFRACTION",2.74,55.06,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl   5 mM DTT
Crystallization :
15 % (v/v) Ethanol   Tris 7.0",277,,"88P","5UEP",13.03,"1.77","1.77","BRD4_BD2_A-581577","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UEP"
"5UEQ",,"X-RAY DIFFRACTION",2.99,58.82,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl   5 mM DTT
Crystallization :
15 % (v/v) Ethanol  Tris PH 7.0",277,,"87M","5UEQ",13.23,"1.7","1.7","BRD4_BD2_A-1390146","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UEQ"
"5UER",,"X-RAY DIFFRACTION",2.7,54.42,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl   5 mM DTT
Crystallization :
15 % (v/v) Ethanol   Tris PH 7.0",277,,"87P","5UER",13.22,"1.87","1.87","BRD4_BD2_A-1359930","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UER"
"5UES",,"X-RAY DIFFRACTION",2.75,55.19,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl   5 mM DTT
Crystallization :
15 % (v/v) Ethanol  Tris PH 7.0",277,,"87S","5UES",13.13,"1.62","1.62","BRD4_BD2_A-1344772","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UES"
"5UET",,"X-RAY DIFFRACTION",2.83,56.56,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl   5 mM DTT
Crystallization :
15 % (v/v) Ethanol  Tris PH 7.0",277,,"87V","5UET",13.01,"2.29","2.29","BRD4_BD2_A-1308586","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UET"
"5UEU",,"X-RAY DIFFRACTION",2.65,53.55,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl   5 mM DTT
Crystallization :
15 % (v/v) Ethanol   Tris PH 7.0",277,"10.1021/acs.jmedchem.7b00017","0S6","5UEU",26.44,"2.26","2.26","BRD4_BD2_A-1107604","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UEU"
"5UEV",,"X-RAY DIFFRACTION",2.75,55.21,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl   5 mM DTT
Crystallization :
15 % (v/v) Ethanol   Tris PH 7.0",277,,"88Y","5UEV",13.02,"1.94","1.94","BRD4_BD2_A-556343","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UEV"
"5UEW",,"X-RAY DIFFRACTION",2.21,44.46,"VAPOR DIFFUSION",,"Protein buffer : 10 mM HEPES PH 7.5
100 mM NaCl  5 mM DTT
Crystallization :
15 % (v/v) Ethanol Tris PH 7.0",277,"10.1021/acs.jmedchem.7b00017",,"5UEW",26.85,"1.83","1.83","BRD2 Bromodomain2 with A-1360579","GSHSEQLKHCNGILKELLSKKHAAYAWPFYKPVDASALGLHDYHDIIKHPMDLSTVKRKMENRDYRDAQEFAADVRLMFSNCYKYNPPDHDVVAMARKLQDVFEFRYAKMP","Homo sapiens","BRD2, KIAA9001, RING3","Bromodomain-containing protein 2","1","5UEW"
"5UEX",,"X-RAY DIFFRACTION",2.53,51.38,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100mM NaCl,   5 mM DTT
Crystallization :
15 % (v/v) Ethanol,  Tris PH 7.0",277,"10.1021/acs.jmedchem.7b00017","89D","5UEX",13.3,"2.29","2.29","BRD4_BD2_A-1497627","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UEX"
"5UEY",,"X-RAY DIFFRACTION",2.65,53.63,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl    5mM DTT
Crystallization :
15 % (v/v) Ethanol  Tris PH 7.0",277,"10.1021/acs.jmedchem.7b00017","88M","5UEY",13.27,"2.41","2.41","BRD4_BD2_A-1412838","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UEY"
"5UEZ",,"X-RAY DIFFRACTION",2.77,55.63,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl  5mM DTT
Crystallization :
15 %(v/v) Ethanol Tris PH 7.0",277,"10.1021/acs.jmedchem.7b00017","89G","5UEZ",13.12,"1.51","1.51","BRD4_BD2_A-1342843","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UEZ"
"5UF0",,"X-RAY DIFFRACTION",2.75,55.29,"VAPOR DIFFUSION",7,"Protein buffer : PH 7.5 10 mM HEPES
100 mM NaCl   5mM DTT
Crystallization : 15 %(V/V) Ethanol Tris PH 7.0",277,"10.1021/acs.jmedchem.7b00017","89J","5UF0",13.02,"1.35","1.35","BRD4_BD2-A-35165","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UF0"
"5UFG",,"X-RAY DIFFRACTION",3.18,61.29,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5
20%w/v Polyethylene glycol 10K",291,"10.1021/acschembio.7b00056",,"5UFG",56.95,"1.76","1.76","Crystal Structure of CYP2B6 (Y226H/K262R/I114V) in complex with myrtenyl bromide","MAKKTSSKGKLPPGPRPLPLLGNLLQMDRRGLLKSFLRFREKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVVFANGNRWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIICSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKHFPGAHRQVYKNLQEINAYIGHSVEKHRETLDPSAPRDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGTETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFSDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGALKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKIPPTYQIRFLPRHHHH","Homo sapiens","CYP2B6","Cytochrome P450 2B6","1","5UFG"
"5UFI",,"X-RAY DIFFRACTION",2.61,52.86,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 4000 and 100 mM potassium phosphate (monobasic)",293,"10.1038/s41467-017-01243-7",,"5UFI",107.35,"2.58","2.58","DCN1 bound to DI-591","MSYYHHHHHHLESTSLYKKAGTMGSLDRKKLEQLYNRYKDPQDENKIGIDGIQQFCDDLALDPASISVLIIAWKFRAATQCEFSKQEFMDGMTELGCDSIEKLKAQIPKMEQELKEPGRFKDFYQFTFNFAKNPGQKGLDLEMAIAYWNLVLNGRFKFLDLWNKFLLEHHKRSIPKDTWNLLLDFSTMIADDMSNYDEEGAWPVLIDDFVEFARPQIAGTKSTTV","Homo sapiens","DCUN1D1, DCUN1L1, RP42, SCCRO, DCN1","DCN1-like protein 1","1","5UFI"
"5UFL",,"X-RAY DIFFRACTION",2.87,57.12,"VAPOR DIFFUSION, HANGING DROP",,"0.1M Sodium malonate pH6.0, 7% PEG 4000, 1% PEG8000",298,"10.15252/embr.201642788",,"5UFL",124.72,"3","3","Crystal structure of a CIP2A core domain","GMDSTACLKSLLLTVSQYKAVKSEANATQLLRHLEVISGQKLTRLFTSNQILTSECLSCLVELLEDPNISASLILSIIGLLSQLAVDIETRDCLQNTYNLNSVLAGVVCRSSHTDSVFLQCIQLLQKLTYNVKIFYSGANIDELITFLIDHIQSSEDELKMPCLGLLANLCRHNLSVQTHIKTLSNVKSFYRTLITLLAHSSLTVVVFALSILSSLTLNEEVGEKLFHARNIHQTFQLIFNILINGDGTLTRKYSVDLLMDLLKNPKIADYLTRYEHFSSCLHQVLGLLNGKDPDSSSKVLELLLAFCSVTQLRHMLTQMMFEQSPPGSATLGSHTKCLEPTVALLRWLSQPLDGSENCSVLALELFKEIFEDVIDAANCSSADRFVTLLLPTILDQLQFTEQNLDEALTRKKCERIAKAIEVLLTLCGDDTLKMHIAKILTTVKCTTLIEQQFTYGKIDLGFGTKVADSELCKLAADVILKTLDLINKLKPLVPGMEVSFYKILQDPRLITPLAFALTSDNREQVQSGLRILLEAAPLPDFPALVLGESIAANNAYRQQE","Homo sapiens","KIAA1524, CIP2A","Protein CIP2A","1","5UFL"
"5UFO",,"X-RAY DIFFRACTION",2.73,54.91,"VAPOR DIFFUSION",,"1.35M NaFormate, 0.1M Hepes pH7, 3%MPD",293,"10.1016/j.bmcl.2017.02.044","87J","5UFO",30.71,"2.802","2.802","Structure of RORgt bound to","GHHHHHHGENLYFQGASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","5UFO"
"5UFR",,"X-RAY DIFFRACTION",2.87,57.17,"VAPOR DIFFUSION",,"1.4M NaAcetate, 100mM MES pH 6.5",293,"10.1016/j.bmcl.2017.02.044","88J","5UFR",61.15,"2.068","2.068","Structure of RORgt bound to","GHHHHHHGENLYFQGASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","5UFR"
"5UFW",,"X-RAY DIFFRACTION",2.24,45.13,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG 3,350, Tris pH 7.5, and 200 mM MgCl2",298.15,"10.1038/s41467-018-04413-3",,"5UFW",57.63,"1.583","1.583","Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1154","LALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","5UFW"
"5UFX",,"X-RAY DIFFRACTION",2.25,45.43,"VAPOR DIFFUSION, HANGING DROP",,"10% PEG 3,350, Bis-Tris pH 6.2, 200 mM MgCl2",298.15,"10.1038/s41467-018-04413-3",,"5UFX",57.63,"1.5503","1.5503","Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1074","LALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","5UFX"
"5UG8",,"X-RAY DIFFRACTION",1.84,33.11,"VAPOR DIFFUSION, SITTING DROP",,"Salt: 0.2 M Ammonium sulfate
Precipitant: 11.4 %w/v PEG 8000
Buffer: 0.1 M HEPES (pH 7.50)
Precipitant: 10.0 %v/v iso-propanol",286,"10.1021/acs.jmedchem.6b01894",,"5UG8",38.56,"1.46","1.46","Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with a covalent inhibitor N-[(3R,4R)-4-fluoro-1-{6-[(1-methyl-1H-pyrazol-4-yl)amino]-9-(propan-2-yl)-9H-purin-2-yl}pyrrolidin-3-yl]propanamide","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5UG8"
"5UG9",,"X-RAY DIFFRACTION",1.84,33.05,"VAPOR DIFFUSION, SITTING DROP",,"Salt: 0.2 M Ammonium sulfate
Precipitant: 14.1 %w/v PEG 8000
Buffer: 0.1 M HEPES (pH 7.50)
Precipitant: 10.0 %v/v iso-propanol",294,"10.1021/acs.jmedchem.6b01894",,"5UG9",38.51,"1.33","1.33","Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with a covalent inhibitor N-[(3R,4R)-4-fluoro-1-{6-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]-9-(propan-2-yl)-9H-purin-2-yl}pyrrolidin-3-yl]propanamide","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5UG9"
"5UGA",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",,"Salt: 0.2 M Ammonium sulfate
Precipitant: 20.0 %w/v PEG 8000
Buffer: 0.1 M HEPES (pH 7.50)
Precipitant: 13.6 %v/v iso-propanol",296,"10.1021/acs.jmedchem.6b01894","8BM","5UGA",38.53,"1.82","1.82","Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with 4-(4-{[2-{[(3S)-1-acetylpyrrolidin-3-yl]amino}-9-(propan-2-yl)-9H-purin-6-yl]amino}phenyl)-1-methylpiperazin-1-ium","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5UGA"
"5UGB",,"X-RAY DIFFRACTION",3.51,64.99,"VAPOR DIFFUSION, SITTING DROP",,"Buffer: 0.1 M MES (pH 6.90)
Salt: 1.2 M Potassium sodium tartrate tetrahydrate",294,"10.1021/acs.jmedchem.6b01894","8BM","5UGB",37.93,"2.53","2.53","Crystal structure of the EGFR kinase domain in complex with 4-(4-{[2-{[(3S)-1-acetylpyrrolidin-3-yl]amino}-9-(propan-2-yl)-9H-purin-6-yl]amino}phenyl)-1-methylpiperazin-1-ium","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5UGB"
"5UGC",,"X-RAY DIFFRACTION",1.8,31.73,"VAPOR DIFFUSION, SITTING DROP",,"Salt: 0.2 M Ammonium sulfate
Precipitant: 19.5 %w/v PEG 8000
Buffer: 0.1 M HEPES (pH 7.50)
Precipitant: 10.0 %v/v iso-propanol",294,"10.1021/acs.jmedchem.6b01894",,"5UGC",38.53,"1.58","1.58","Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with a covalent inhibitor N-[(3R,4R)-4-fluoro-1-{6-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]-9-methyl-9H-purin-2-yl}pyrrolidin-3-yl]propanamide","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5UGC"
"5UGD",,"X-RAY DIFFRACTION",2.05,40.14,"VAPOR DIFFUSION, HANGING DROP",5,"10 % (w/v) polyethylene glycol 6,000, 
4 % (v/v) 2-methyl-2,4-pentanediol, 
0.1M (2-(N-morpholino)ethanesulfonic acid)",293,"10.1182/bloodadvances.2016004150","89S","5UGD",28.06,"1.38","1.38","Protease Inhibitor","EFAPSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN","Homo sapiens","PLG","Plasminogen","1","5UGD"
"5UGF",,"X-RAY DIFFRACTION",2.08,40.88,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM HEPES, pH 7.5, 0.2 M lithium sulfate, 25% w/v PEG3350",295,"10.1073/pnas.1704786114","IM5","5UGF",218.82,"2.2","2.2","Crystal structure of human purine nucleoside phosphorylase (F159Y) mutant complexed with DADMe-ImmG and phosphate","HHHHHHGMASMTGGQQMGRDLYDDDDKDPTLMENGYTYEDYKNTAEWLLSHTKHRPQVAIICGSGLGGLTDKLTQAQIFDYSEIPNFPRSTVPGHAGRLVFGFLNGRACVMMQGRFHMYEGYPLWKVTFPVRVFHLLGVDTLVVTNAAGGLNPKFEVGDIMLIRDHINLPGFSGQNPLRGPNDERFGDRYPAMSDAYDRTMRQRALSTWKQMGEQRELQEGTYVMVAGPSFETVAECRVLQKLGADAVGMSTVPEVIVARHCGLRVFGFSLITNKVIMDYESLEKANHEEVLAAGKQAAQKLEQFVSILMASIPLPDKAS","Homo sapiens","PNP, NP","Purine nucleoside phosphorylase","1","5UGF"
"5UGG",,"X-RAY DIFFRACTION",2.05,39.93,"VAPOR DIFFUSION, HANGING DROP",5,"10 % (w/v) polyethylene glycol 6,000, 
4 % (v/v) 2-methyl-2,4-pentanediol,
0.1M (2-(N-morpholino)ethanesulfonic acid)",293,"10.1182/bloodadvances.2016004150","89M","5UGG",28.11,"1.2","1.2","Protease Inhibitor","EFAPSFDCGKPQVEPKKCPGRVVGGCVAHPHSWPWQVSLRTRFGMHFCGGTLISPEWVLTAAHCLEKSPRPSSYKVILGAHQEVNLEPHVQEIEVSRLFLEPTRKDIALLKLSSPAVITDKVIPACLPSPNYVVADRTECFITGWGETQGTFGAGLLKEAQLPVIENKVCNRYEFLNGRVQSTELCAGHLAGGTDSCQGDSGGPLVCFEKDKYILQGVTSWGLGCARPNKPGVYVRVSRFVTWIEGVMRNN","Homo sapiens","PLG","Plasminogen","1","5UGG"
"5UGH",,"X-RAY DIFFRACTION",2.27,45.93,"VAPOR DIFFUSION, SITTING DROP",,"4% v/v Tacsimate pH 6.0, 12% w/v Polyethylene glycol 3,350",294,"10.1038/nchembio.2384","8AJ","5UGH",176.86,"2.062","2.062","Crystal structure of Mat2a bound to the allosteric inhibitor PF-02929366","GSMNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVAKTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQGVHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDSKTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDTIYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARWVAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVIVRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY","Homo sapiens","MAT2A, AMS2, MATA2","S-adenosylmethionine synthase isoform type-2","1","5UGH"
"5UGL",,"X-RAY DIFFRACTION",2.08,40.86,"VAPOR DIFFUSION, HANGING DROP",,"25 mM HEPES pH7.5, 15%-25% w/v PEG4000, 0.2-0.3 M NH4SO3",293,"10.7554/eLife.21137",,"5UGL",75.39,"1.861","1.861","Crystal Structure of FGF Receptor 2 Tyrosine Kinase Domain Harboring the D650V Activating Mutation","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARVINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KGFR, KSAM","Fibroblast growth factor receptor 2","1","5UGL"
"5UGM",,"X-RAY DIFFRACTION",3.13,60.71,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.8M SODIUM CITRATE, 100mM MOPS, PH 7.6",293,"10.7554/eLife.43320",,"5UGM",64.17,"2.1","2.1","Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Edaglitazone","ESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY","Homo sapiens","PPARG, NR1C3","Peroxisome proliferator-activated receptor gamma","1","5UGM"
"5UGW",,"X-RAY DIFFRACTION",3.22,61.79,"VAPOR DIFFUSION, SITTING DROP",,"50 mM Tris 8.5
0.8 M LiSo4
10 mM GSH/GSSG
3% 1,6-hexanediol",283,"10.1074/jbc.M116.771204",,"5UGW",20.11,"2.31","2.31","STRUCTURE OF THE HUMAN TELOMERASE THUMB DOMAIN","SNANRGFKAGRNMRRKLFGVLRLKCHSLFLDLQVNSLQTVCTNIYKILLLQAYRFHACVLQLPFHQQVWKNPTFFLRVISDTASLCYSILKAKNAGMSLGAKGAAGPLPSEAVQWLCHQAFLLKLTRHRVTYVPLLGSLRTAQTQLSRKLPGTTLTALEAAANPALPSDFKTILD","Homo sapiens","TERT, EST2, TCS1, TRT","Telomerase reverse transcriptase","1","5UGW"
"5UGX",,"X-RAY DIFFRACTION",2.04,39.65,"VAPOR DIFFUSION, HANGING DROP",,"25 mM HEPES (pH 7.5), 15%-25% w/v PEG 4000, 0.2-0.3 M Ammonium sulfate",293,"10.7554/eLife.21137",,"5UGX",75.52,"2.349","2.349","Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 Harboring a E565A/D650V double Gain-of-Function Mutation","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARVINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KGFR, KSAM","Fibroblast growth factor receptor 2","1","5UGX"
"5UHI",,"X-RAY DIFFRACTION",2.79,55.96,"VAPOR DIFFUSION",,"12% 8K PEG, 100mM HEPES pH7.5",293,"10.1016/j.bmcl.2017.02.044","8A4","5UHI",61.35,"3.198","3.198","Structure of RORgt bound to","GHHHHHHGENLYFQGASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","5UHI"
"5UHK",,"X-RAY DIFFRACTION",2.56,51.96,"VAPOR DIFFUSION, HANGING DROP",,"14-17% PEG 3350, 0.2 M Mg Formate",293,,,"5UHK",117.82,"2.97","2.97","Crystal structure of the core catalytic domain of Human O-GlcNAcase","GARRFLCGVVEGFYGRPWVMEQRKELFRRLQKWELNTYLYAPKDDYKHRMFWREMYSVEEAEQLMTLISAAREYEIEFIYAISPGLDITFSNPKEVSTLKRKLDQVSQFGCRSFALLFDDIDHNMCAADKEVFSSFAHAQVSITNEIYQYLGEPETFLFCPTEYCGTFCYPNVSQSPYLRTVGEKLLPGIEVLWTGPKVVSKEIPVESIEEVSKIIKRAPVIWDNIHANDYDQKRLFLGPYKGRSTELIPRLKGVLTNPNCEFEANYVAIHTLATWYKSNMNGVRKDVVMTDSEDSTVSIQIKLENEGSDEDIETDVLYSPQMALKLALTEWLQEFGVPHQYSSR","Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5, OGA","O-GlcNAcase TIM-barrel domain","1","5UHK"
,,,,,,,,,,,,,,,,"MEKPLYTAEPVTLEDLQLLADLFYLPYEHGPKGAQMLREFQWLRANSSVVSVNCKGKDSEKIEEWRSRAAKFEEMCGLVMGMFTRLSNCANRTILYDMYSYVWDIKSIMSMVKSFVQWLGCRSHSSAQFLIGDQEPWAFRGGLAGEFQRLLPIDGANDLFFQP","Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5, OGA","O-GlcNAcase stalk domain","2","5UHK"
"5UHL",,"X-RAY DIFFRACTION",2.68,54.12,"VAPOR DIFFUSION, HANGING DROP",,"14-17% PEG 3350, 0.2 M Mg Formate",293,,,"5UHL",118.04,"3.14","3.14","Crystal structure of the core catalytic domain of human O-GlcNAcase complexed with Thiamet G","GARRFLCGVVEGFYGRPWVMEQRKELFRRLQKWELNTYLYAPKDDYKHRMFWREMYSVEEAEQLMTLISAAREYEIEFIYAISPGLDITFSNPKEVSTLKRKLDQVSQFGCRSFALLFDDIDHNMCAADKEVFSSFAHAQVSITNEIYQYLGEPETFLFCPTEYCGTFCYPNVSQSPYLRTVGEKLLPGIEVLWTGPKVVSKEIPVESIEEVSKIIKRAPVIWDNIHANDYDQKRLFLGPYKGRSTELIPRLKGVLTNPNCEFEANYVAIHTLATWYKSNMNGVRKDVVMTDSEDSTVSIQIKLENEGSDEDIETDVLYSPQMALKLALTEWLQEFGVPHQYSSR","Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5, OGA","O-GlcNAcase TIM-barrel domain","1","5UHL"
,,,,,,,,,,,,,,,,"MEKPLYTAEPVTLEDLQLLADLFYLPYEHGPKGAQMLREFQWLRANSSVVSVNCKGKDSEKIEEWRSRAAKFEEMCGLVMGMFTRLSNCANRTILYDMYSYVWDIKSIMSMVKSFVQWLGCRSHSSAQFLIGDQEPWAFRGGLAGEFQRLLPIDGANDLFFQP","Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5, OGA","O-GlcNAcase stalk domain","2","5UHL"
"5UHM",,"X-RAY DIFFRACTION",2.5,50.89,"VAPOR DIFFUSION, HANGING DROP",3.75,"5mM Calcium Chloride
0.1M Sodium Acetate
33% MPD",298.15,"10.1186/s12915-017-0350-1",,"5UHM",24.94,"1.9","1.9","Apo-Structure of Mature Growth Differentiation Factor 11","NLGLDCDEHSSESRCCRYPLTVDFEAFGWDWIIAPKRYKANYCSGQCEYMFMQKYPHTHLVQQANPRGSAGPCCTPTKMSPINMLYFNDKQQIIYGKIPGMVVDRCGCS","Homo sapiens","GDF11, BMP11","Growth/differentiation factor 11","1","5UHM"
"5UHN",,"X-RAY DIFFRACTION",2.08,40.82,"VAPOR DIFFUSION, HANGING DROP",,"25 mM HEPES (pH 7.5), 15-25% w/v PEG 4000, 0.2-0.3 M Ammonium Sulfate",293,"10.7554/eLife.21137",,"5UHN",75.4,"2.909","2.909","Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring a N549H/E565A Double Gain-of-Function Mutation","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KGFR, KSAM","Fibroblast growth factor receptor 2","1","5UHN"
"5UHO",,"X-RAY DIFFRACTION",2.62,53.13,"VAPOR DIFFUSION, HANGING DROP",,"14-17% PEG 3350, 0.2 M Mg Formate",293,,,"5UHO",118.25,"3.21","3.21","Crystal structure of the core catalytic domain of human O-GlcNAcase complexed with PUGNAc","GARRFLCGVVEGFYGRPWVMEQRKELFRRLQKWELNTYLYAPKDDYKHRMFWREMYSVEEAEQLMTLISAAREYEIEFIYAISPGLDITFSNPKEVSTLKRKLDQVSQFGCRSFALLFDDIDHNMCAADKEVFSSFAHAQVSITNEIYQYLGEPETFLFCPTEYCGTFCYPNVSQSPYLRTVGEKLLPGIEVLWTGPKVVSKEIPVESIEEVSKIIKRAPVIWDNIHANDYDQKRLFLGPYKGRSTELIPRLKGVLTNPNCEFEANYVAIHTLATWYKSNMNGVRKDVVMTDSEDSTVSIQIKLENEGSDEDIETDVLYSPQMALKLALTEWLQEFGVPHQYSSR","Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5, OGA","O-GlcNAcase TIM-barrel domain","1","5UHO"
,,,,,,,,,,,,,,,,"MEKPLYTAEPVTLEDLQLLADLFYLPYEHGPKGAQMLREFQWLRANSSVVSVNCKGKDSEKIEEWRSRAAKFEEMCGLVMGMFTRLSNCANRTILYDMYSYVWDIKSIMSMVKSFVQWLGCRSHSSAQFLIGDQEPWAFRGGLAGEFQRLLPIDGANDLFFQP","Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5, OGA","O-GlcNAcase stalk domain","2","5UHO"
"5UHP",,"X-RAY DIFFRACTION",2.46,50.1,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M K Na tartrate tetrahydrate, 20% PEG 3350",293,,,"5UHP",249.99,"2.79","2.79","Crystal structure of the core catalytic domain of human O-GlcNAcase","GESELSSNPAASAGASLEPPAAPAPGEDNPAGAGGAAVAGAAGGARRFLCGVVEGFYGRPWVMEQRKELFRRLQKWELNTYLYAPKDDYKHRMFWREMYSVEEAEQLMTLISAAREYEIEFIYAISPGLDITFSNPKEVSTLKRKLDQVSQFGCRSFALLFDDIDHNMCAADKEVFSSFAHAQVSITNEIYQYLGEPETFLFCPTEYCGTFCYPNVSQSPYLRTVGEKLLPGIEVLWTGPKVVSKEIPVESIEEVSKIIKRAPVIWDNIHANDYDQKRLFLGPYKGRSTELIPRLKGVLTNPNCEFEANYVAIHTLATWYKSNMNGVRKDVVMTDSEDSTVSIQIKLENEGSDEDIETDVLYSPQMALKLALTEWLQEFGVPHQYSSR","Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5, OGA","O-GlcNAcase TIM-barrel domain","1","5UHP"
,,,,,,,,,,,,,,,,"MTLEDLQLLADLFYLPYEHGPKGAQMLREFQWLRANSSVVSVNCKGKDSEKIEEWRSRAAKFEEMCGLVMGMFTRLSNCANRTILYDMYSYVWDIKSIMSMVKSFVQWLGCRSHSSAQFLIGDQEPWAFRGGLAGEFQRLLPIDGANDLFFQPHHHHHHHH","Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5, OGA","O-GlcNAcase stalk domain","2","5UHP"
"5UHR",,"X-RAY DIFFRACTION",1.93,36.15,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Sodium citrate at pH 4.9, 20% (v/v) isopropanol, 18% PEG 4000",296.15,"10.1021/acs.joc.7b01116",,"5UHR",7.41,"1.798","1.798","Crystal structure of (Cit)LANFLV heptapeptide segment from islet amyloid polypeptide (IAPP) incorporated into a macrocyclic beta-sheet template","ARLANFLVAIKXKX","Homo sapiens",,"ORN-CIR-LEU-ALA-ASN-PHE-LEU-VAL-ORN-ILE-LYS-HAO-LYS-A8E","1","5UHR"
"5UHV",,"X-RAY DIFFRACTION",1.86,33.86,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.2 M magnesium acetate tetrahydrate, 0.1 M sodium cacodylate trihydrate pH 6.5, 20% w/v PEG 8000 (Hampton Research Crystal Screen number 18)",291.15,"10.1074/jbc.M117.778886",,"5UHV",19.44,"1.672","1.672","wild-type NRas bound to GppNHp","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNSKSFADINLYREQIKRVKDSDDVPMVLVGNKCDLPTRTVDTKQAHELAKSYGIPFIETSAKTRQGVEDAFYTLVREIRQY","Homo sapiens","NRAS, HRAS1","GTPase NRas","1","5UHV"
"5UI0",,"X-RAY DIFFRACTION",2.87,57.16,"VAPOR DIFFUSION, HANGING DROP",,"25 mM HEPES pH 7.5, 15%-25% w/v PEG 4000, 0.2-0.3 M Ammonium Sulfate",293,"10.7554/eLife.21137",,"5UI0",75.09,"2.05","2.05","Crystal Structure of the Tyrosine Kinase Domain of FGF Receptor 2 harboring an E565A/K659M Double Gain-of-Function Mutation","MGSSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKMTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNEE","Homo sapiens","FGFR2, BEK, KGFR, KSAM","Fibroblast growth factor receptor 2","1","5UI0"
"5UI1",,"X-RAY DIFFRACTION",1.98,37.82,"VAPOR DIFFUSION, SITTING DROP",8,"20-26% MPD, 4-8% PEG5000MME, 1 mM Manganese chloride, 10 mM Tris",289,,,"5UI1",152.74,"1.96","1.96","Crystal Structure of Human Protein Phosphatase 5C (PP5C) in complex with a triazole inhibitor","GASMTIEDEYSGPKLEDGKVTISFMKELMQWYKDQKKLHRKCAYQILVQVKEVLSKLSTLVETTLKETEKITVCGDTHGQFYDLLNIFELNGLPSETNPYIFNGDFVDRGSFSVEVILTLFGFKLLYPDHFHLLRGNHETDNMNQIYGFEGEVKAKYTAQMYELFSEVFEWLPLAQCINGKVLIMHGGLFSEDGVTLDDIRKIERNRQPPDSGPMCDLLWSDPQPQNGRSISKRGVSCQFGPDVTKAFLEENNLDYIIRSHEVKAEGYEVAHGGRCVTVFSAPNYCDQMGNKASYIHLQGSDLRPQFHQFTAVPHPNVKPMAYANTLLQLGMM","Homo sapiens","PPP5C, PPP5","Serine/threonine-protein phosphatase 5","1","5UI1"
"5UI4",,"X-RAY DIFFRACTION",2.11,41.72,"VAPOR DIFFUSION, SITTING DROP",,"4.7 mg/mL solution protein-fluorosulfate conjugate combined with solution containing 0.2 M NaCl, 0.1 M HEPES pH 7.5 and 30% (v/v) PEG400 in sitting drops. Crystals frozen in LN2 stream without additional cryoprotectant",298,"10.1021/jacs.7b08366",,"5UI4",111.1,"2.75","2.75","Structure of NME1 covalently conjugated to imidazole fluorosulfate","MHHHHHHMANCERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVGLKFMQASEDLLKEHYVDLKDRPFFAGLVKYMHSGPVVAMVWEGLNVVKTGRVMLGETNPADSKPGTIRGDFCIQVGRNIIHGSDSVESAEKEIGLWFHPEELVDYTSCAQNWIYE","Homo sapiens","NME1, NDPKA, NM23","Nucleoside diphosphate kinase A","1","5UI4"
"5UIQ",,"X-RAY DIFFRACTION",2.5,50.81,"VAPOR DIFFUSION, HANGING DROP",,"1.6-1.8 M Ammonium Citrate, pH 7.0",295,"10.1021/acs.jmedchem.7b00231","8BV","5UIQ",147.05,"2.64","2.64","Crystal structure of IRAK4 in complex with compound 9","MHHHHHHGGENLYFQGENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","5UIQ"
"5UIR",,"X-RAY DIFFRACTION",2.33,47.29,"VAPOR DIFFUSION, HANGING DROP",,"1.6-1.8M Ammonium Citrate, pH 7.0",295,"10.1021/acs.jmedchem.7b00231","8BY","5UIR",73.83,"2.64","2.64","Crystal structure of IRAK4 in complex with compound 11","MHHHHHHGGENLYFQGENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","5UIR"
"5UIS",,"X-RAY DIFFRACTION",2.49,50.52,"VAPOR DIFFUSION, HANGING DROP",,"1.6-1.6M Ammonium Citrate, pH 7.0",295,"10.1021/acs.jmedchem.7b00231","8C1","5UIS",147.33,"2.5","2.5","Crystal structure of IRAK4 in complex with compound 12","MHHHHHHGGENLYFQGENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","5UIS"
"5UIT",,"X-RAY DIFFRACTION",2.58,52.39,"VAPOR DIFFUSION, HANGING DROP",,"1.6-1.8 M Ammonium Citrate, pH7.0",295,"10.1021/acs.jmedchem.7b00231","8CD","5UIT",73.69,"1.84","1.84","Crystal structure of IRAK4 in complex with compound 14","MHHHHHHGGENLYFQGENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","5UIT"
"5UIU",,"X-RAY DIFFRACTION",2.53,51.33,"VAPOR DIFFUSION, HANGING DROP",,"1.6-1.8M Ammonium Citrate, pH7.0",295,"10.1021/acs.jmedchem.7b00231","8CG","5UIU",73.89,"2.02","2.02","Crystal structure of IRAK4 in complex with compound 30","MHHHHHHGGENLYFQGENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","5UIU"
"5UIX",,"X-RAY DIFFRACTION",2.45,49.7,"VAPOR DIFFUSION, HANGING DROP",7,"20% PEG 4000, 100mM Hepes, pH 7.0, 1M NaCl",293,"10.1371/journal.ppat.1006182",,"5UIX",48.32,"2.501","2.501","Crystal Structure of the DH576 CD4bs Fab (unliganded) from the RV305 HIV Vaccine Trial","EVQLVESGGGVVQPGRSLRLSCGVSGFTFSNYAIHWVRQAPGKRLEWVALISYDGKKQYYLDSVKGRFTISRDNSKDMVYLQMNSLKAEDTAIYYCARDRARSTGYFGGIYYYYYGMDVWGQGTTVTVSGASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEP","Homo sapiens",,"DH576 Fab heavy chain","1","5UIX"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCQASQDIDNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTSFTLTISSLQPEDIGTYYCQKYGSVPFPFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"DH576 Fab light chain","2","5UIX"
"5UIY",,"X-RAY DIFFRACTION",2.37,48.11,"VAPOR DIFFUSION, HANGING DROP",,"100 mM HEPES pH 7.2 and 25% PEG 3350",298,"10.1038/s41467-017-00866-0",,"5UIY",53.63,"1.687","1.687","Structure of Bromodomain from human BAZ1A","GSSSGRQGGVHELSAFEQLVVELVRHDDSWPFLKLVSKIQVPDYYDIIKKPIALNIIREKVNKCEYKLASEFIDDIELMFSNCFEYNPRNTSEAKAGTRLQAFFHIQAQKLGLHVT","Homo sapiens","BAZ1A, ACF1, WCRF180, HSPC317","Bromodomain adjacent to zinc finger domain protein 1A","1","5UIY"
"5UJB",,"X-RAY DIFFRACTION",2.2,43.99,"EVAPORATION",7,"25-30% PEG3350, 50 mM K2PO4",293,"10.1016/j.bmc.2017.03.060",,"5UJB",140.55,"2.7","2.7","Structure of a Mcl-1 Inhibitor Binding to Site 3 of Human Serum Albumin","MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPFEDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEPERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLFFAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAVARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLKECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYARRHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFEQLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVVLNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTLSEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLVAASQAALGL","Homo sapiens","ALB, GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675, UNQ696/PRO1341","Serum albumin","1","5UJB"
"5UJI",,"X-RAY DIFFRACTION",2.42,49.27,"VAPOR DIFFUSION, HANGING DROP",5,"20 % PEG4000, 0.1 M Na Citrate pH5.0, 0.1 M MgCl2",277,"10.1080/15476286.2017.1377868",,"5UJI",89.29,"2.79","2.79","Crystal structure of human T2-Tryptophanyl-tRNA synthetase with H130R mutation","GIDYDKLIVRFGSSKIDKELINRIERATGQRPHRFLRRGIFFSHRDMNQVLDAYENKKPFYLYTGRGPSSEAMHVGHLIPFIFTKWLQDVFNVPLVIQMTDDEKYLWKDLTLDQAYSYAVENAKDIIACGFDINKTFIFSDLDYMGMSSGFYKNVVKIQKHVTFNQVKGIFGFTDSDCIGKISFPAIQAAPSFSNSFPQIFRDRTDIQCLIPCAIDQDPYFRMTRDVAPRIGYPKPALLHSTFFPALQGAQTKMSASDPNSSIFLTDTAKQIKTKVNKHAFSGGRDTIEEHRQFGGNCDVDVSFMYLTFFLEDDDKLEQIRKDYTSGAMLTGELKKALIEVLQPLIAEHQARRKEVTDEIVKEFMTPRKLSFDFQKLAAALEHHHHHH","Homo sapiens","WARS, IFI53, WRS, WARS1","Tryptophan--tRNA ligase, cytoplasmic","1","5UJI"
"5UJJ",,"X-RAY DIFFRACTION",2.31,46.79,"VAPOR DIFFUSION, HANGING DROP",6.5,"18% PEG1500, 0.1mol/L Bis-Tris pH6.5",277,"10.1080/15476286.2017.1377868",,"5UJJ",110.69,"2.1","2.1","Crystal structure of human H130R tryptophanyl-tRNA synthetase in complex with TrpAMP","MPNSEPASLLELFNSIATQGELVRSLKAGNASKDEIDSAVKMLVSLKMSYKAAAGEDYKADCPPGNPAPTSNHGPDATEAEEDFVDPWTVQTSSAKGIDYDKLIVRFGSSKIDKELINRIERATGQRPHRFLRRGIFFSHRDMNQVLDAYENKKPFYLYTGRGPSSEAMHVGHLIPFIFTKWLQDVFNVPLVIQMTDDEKYLWKDLTLDQAYSYAVENAKDIIACGFDINKTFIFSDLDYMGMSSGFYKNVVKIQKHVTFNQVKGIFGFTDSDCIGKISFPAIQAAPSFSNSFPQIFRDRTDIQCLIPCAIDQDPYFRMTRDVAPRIGYPKPALLHSTFFPALQGAQTKMSASDPNSSIFLTDTAKQIKTKVNKHAFSGGRDTIEEHRQFGGNCDVDVSFMYLTFFLEDDDKLEQIRKDYTSGAMLTGELKKALIEVLQPLIAEHQARRKEVTDEIVKEFMTPRKLSFDFQKLAAALEHHHHHH","Homo sapiens","WARS, IFI53, WRS, WARS1","Tryptophan--tRNA ligase, cytoplasmic","1","5UJJ"
"5UJL",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2016.01.007",,"5UJL",17.15,,,"Representative 1-conformer ensembles of K27-linked Ub2 from RDC data","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBB","Ubiquitin","1","5UJL"
"5UJN",,"SOLUTION NMR",,,,,,,"10.1016/j.str.2016.01.007",,"5UJN",17.15,,,"Representative 2-conformer ensembles of K27-linked Ub2 from RDC data","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG","Homo sapiens","UBB","Ubiquitin","1","5UJN"
"5UK9",,"X-RAY DIFFRACTION",2.12,42.07,"VAPOR DIFFUSION, HANGING DROP",6.5,"ammonium sulfate, sodium cacodylate, PEG 8000",291,"10.1016/j.str.2018.03.018",,"5UK9",39.06,"1.887","1.887","Wild-type K-Ras(GCP) pH 6.5","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKH","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5UK9"
"5UKE",,"SOLUTION NMR",,,,,,,"10.1038/s41467-018-03886-6",,"5UKE",13.47,,,"NMR structure of monomeric human IRAK-M Death Domain R56D, Y61E mutant","SEFGSMAGNCGARGALSAHTLLFDLPPALLGELCAVLDSCDGALGWRGLAERLSSSWLDVDHIEKEVDQGKSGTRELLWSWAQKNKTIGDLLQVLQEMGHRRAIHLITNYGAVLSPSEKSYQEG","Homo sapiens","IRAK3","Interleukin-1 receptor-associated kinase 3","1","5UKE"
"5UKF",,"X-RAY DIFFRACTION",2.59,52.52,"VAPOR DIFFUSION, SITTING DROP",7,"27.5% PEG 3350; 0.3M AmSO4; 0.1M HEPES pH 7.0",293,"10.1038/s41598-017-07755-y",,"5UKF",166.71,"2.4","2.4","Crystal Structure of the Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor","MRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","5UKF"
"5UKW",,"X-RAY DIFFRACTION",2.53,51.38,"VAPOR DIFFUSION, HANGING DROP",9,"100 mM Tris-HCl pH 9, 200 mM MgCl2, 13% PEG 4000 and 20% glycerol",291,"10.1002/1873-3468.12638",,"5UKW",56.55,"2.65","2.65","Crystal structure of human Glucose 6-phosphate Dehydrogenase mutant (A277C) complexed with G6P","GGSEFSDTHIFIIMGASGDLAKKKIYPTIWWLFRDGLLPENTFIVGYARSRLTVADIRKQSEPFFKATPEEKLKLEDFFARNSYVAGQYDDAASYQRLNSHMNALHLGSQANRLFYLALPPTVYEAVTKNIHESCMSQIGWNRIIVEKPFGRDLQSSDRLSNHISSLFREDQIYRIDHYLGKEMVQNLMVLRFANRIFGPIWNRDNIACVILTFKEPFGTEGRGGYFDEFGIIRDVMQNHLLQMLCLVAMEKPCSTNSDDVRDEKVKVLKCISEVQANNVVLGQYVGNPDGEGEATKGYLDDPTVPRGSTTATFAAVVLYVENERWDGVPFILRCGKALNERKAEVRLQFHDVAGDIFHQQCKRNELVIRVQPNEAVYTKMMTKKPGMFFNPEESELDLTYGNRYKNVKLPDAYERLILDVFCGSQMHFVRSDELREAWRIFTPLLHQIELEKPKPIPYIYGSRGPTEADELMKRVGFQYEGTYKWVN","Homo sapiens","G6PD","Glucose-6-phosphate 1-dehydrogenase","1","5UKW"
"5ULA",,"X-RAY DIFFRACTION",2.7,54.39,"VAPOR DIFFUSION, SITTING DROP",,"4.3 M SODIUM CHLORIDE, 0.1 M HEPES PH
 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K",293,"10.1073/pnas.1615601114","5MJ","5ULA",30.94,"1.5","1.5","Crystal Structure of the First Bromodomain of Human BRD4 in Complex With Cyclic Vinylogous Amide Inhibitor MS402","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5ULA"
"5ULM",,"X-RAY DIFFRACTION",2.34,47.46,"VAPOR DIFFUSION, SITTING DROP",7.6,"0.1 M Sodium Fluoride, 10 % PEG 3350,",290,"10.1073/pnas.1620813114",,"5ULM",90.74,"2.1","2.1","Structure of the ASK1 central regulatory region","GPGSQYFRESILNDIRKARNLYTGKELAAELARIRQRVDNIEVLTADIVINLLLSYRDIQDYDSIVKLVETLEKLPTFDLASHHHVKFHYAFALNRRNLPGDRAKALDIMIPMVQSEGQVASDMYCLVGRIYKDMFLDSNFTDTESRDHGASWFKKAFESEPTLQSGINYAVLLLAAGHQFESSFELRKVGVKLSSLLGKKGNLEKLQSYWEVGFFLGASVLANDHMRVIQASEKLFKLKTPAWYLKSIVETILIYKHFVKLTTEQPVAKQELVDFWMDFLVEATKTDVTVVRFPVLILEPTKIYQPSYLSINNEVEEKTISIWHVLPDDKKGIHEWNFSASSVRGVSISKFEERCCFLYVLHNSDDFQIYFCTELHCKKFFEMVNTITEEKG","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","5ULM"
"5ULN",,"X-RAY DIFFRACTION",2.11,41.64,"VAPOR DIFFUSION, SITTING DROP",8.3,"concentrated CA II at ~10 mg/mL was set up in SD-2 plates (Molecular Dimensions) with the following ratio of protein plus reservoir plus
 seeds: 250 nL + 225 nL + 25 nL. The plate was incubated at 8 C and the reservoir condition consisted of 2.9 M ammonium sulfate with 0.1 
M Tris buffer at pH 8.3.  Dry compound was added to the crystallization drop after crystals had formed and several days before data were c
ollected.",281,"10.1021/acsmedchemlett.7b00280","8JS","5ULN",29.82,"1.35","1.35","Synthesis of novel seleno ureido containing compounds as SLC-0111 analogs. Investigations on carbonic anhydrases activity, glutathione peroxidase and X-ray crystallography","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5ULN"
"5ULY",,"X-RAY DIFFRACTION",3.13,60.64,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES (pH 7.5), 0.1 M KCl, 15% PEG 6000",277.15,"10.1073/pnas.1920444117",,"5ULY",117.82,"2.64","2.64","Crystal Structure of Human Protocadherin-15 EC2-3","MASNSPTFKHESYYATVNELTPVGTTIFTGFSGDNGATDIDDGPNGQIEYVIQYNPDDPTSNDTFEIPLMLTGNIVLRKRLNYEDKTRYFVIIQANDRAQNLNERRTTTTTLTVDVLDGDDLGPMFLPCVLVPNTRDCRPLTYQAAIPELRTPEELNPIIVTPPIQAIDQDRNIQPPSDRPGILYSILVGTPEDYPRFFHMHPRTAELSLLEPVNRDFHQKFDLVIKAEQDNGHPLPAFAGLHIEILDENNLEHHHHHH","Homo sapiens","PCDH15, USH1F","Protocadherin-15","1","5ULY"
"5UM3",,"X-RAY DIFFRACTION",1.72,28.29,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES pH 7.5
25% PEG 4000",295,"10.1016/j.str.2017.03.004",,"5UM3",8.45,"1.198","1.198","Crystal structure of the V122L mutant of human UBR-box domain from UBR2","GPLGSLCGRVFKVGEPTYSCRDCAVDPTCLLCMECFLGSIHRDHRYRMTTSGGGGFCDCGDTEAWKEGPYCQKHE","Homo sapiens","UBR2, C6orf133, KIAA0349","E3 ubiquitin-protein ligase UBR2","1","5UM3"
"5UMC",,"X-RAY DIFFRACTION",2.11,41.62,"VAPOR DIFFUSION, SITTING DROP",,"concentrated CA II at ~10 mg/mL was set up in SD-2 plates (Molecular Dimensions) with the following ratio of protein plus reservoir plus
 seeds: 250 nL + 225 nL + 25 nL. The plate was incubated at 8 C and the reservoir condition consisted of 2.9 M ammonium sulfate with 0.1 
M Tris buffer at pH 8.3.  Dry compound was added to the crystallization drop after crystals had formed and several days before data were 
collected.",281,"10.1021/acsmedchemlett.7b00280",,"5UMC",29.54,"2.15","2.15","Synthesis of novel seleno ureido containing compounds as SLC-0111 analogs. Investigations on carbonic anhydrases activity, glutathione peroxidase and X-ray crystallography","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5UMC"
"5UMJ",,"X-RAY DIFFRACTION",2.72,54.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium sulfate, 3 % 2-propanol, 0.1 M Tris-HCl, pH 7.5",293,"10.1016/j.chembiol.2020.05.001",,"5UMJ",37.45,"1.61","1.61","Crystal structure of H62A mutant of human macrophage migration inhibitory factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLASIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","5UMJ"
"5UMK",,"X-RAY DIFFRACTION",2.71,54.66,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5",293,"10.1016/j.chembiol.2020.05.001",,"5UMK",37.76,"1.73","1.73","Crystal structure of H62Y mutant of human macrophage migration inhibitory factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLYSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","5UMK"
"5UMR",,"X-RAY DIFFRACTION",2.02,39.03,"VAPOR DIFFUSION, HANGING DROP",7,"2.2 M DL-Malic acid, 100 mM Bis-Tris propane, pH 7.0.",288,,,"5UMR",12.02,"1.501","1.501","Crystal structure of N-terminal domain of human FACT complex subunit SSRP1","GHMAETLEFNDVYQEVKGSMNDGRLRLSRQGIIFKNSKTGKVDNIQAGELTEGIWRRVALGHGLKLLTKNGHVYKYDGFRESEFEKLSDFFKTHYRLELMEK","Homo sapiens","SSRP1, FACT80","FACT complex subunit SSRP1","1","5UMR"
"5UMS",,"X-RAY DIFFRACTION",2.09,41.16,"VAPOR DIFFUSION, HANGING DROP",6.5,"100 mM Bis-Tris, pH 6.5, 28% polyethylene glycol monomethyl ether 2000",277,,,"5UMS",30.46,"1.569","1.569","Crystal structure of middle double PH domain of human FACT complex subunit SSRP1","GVDPVEAFAQNVLSKADVIQATGDAICIFRELQCLTPRGRYDIRIYPTFLHLHGKTFDYKIPYTTVLRLFLLPHKDQRQMFFVISLDPPIKQGQTRYHFLILLFSKDEDISLTLNMNEEEVEKRFEGRLTKNMSGSLYEMVSRVMKALVNRKITVPGNFQGHSGAQCITCSYKASSGLLYPLERGFIYVHKPPVHIRFDEISFVNFARGTTTTRSFDFEIETKQGTQYTFSSIEREEYGKLFDFVNAKKLNIKNRGLKEGMNPS","Homo sapiens","SSRP1, FACT80","FACT complex subunit SSRP1","1","5UMS"
"5UMT",,"X-RAY DIFFRACTION",2.75,55.29,"VAPOR DIFFUSION, HANGING DROP",,"10mM HEPES, 150mM NaCl, 5% glycerol, 20% ethylene glycol",277,,,"5UMT",49.75,"2.092","2.092","Crystal structure of N-terminal domain of human FACT complex subunit SPT16","MAVTLDKDAYYRRVKRLYSNWRKGEDEYANVDAIVVSVGVDEEIVYAKSTALQTWLFGYELTDTIMVFCDDKIIFMASKKKVEFLKQIANTKGNENANGAPAITLLIREKNESNKSSFDKMIEAIKESKNGKKIGVFSKDKFPGEFMKSWNDCLNKEGFDKIDISAVVAYTIAVKEDGELNLMKKAASITSEVFNKFFKERVMEIVDADEKVRHSKLAESVEKAIEEKKYLAGADPSTVEMCYPPIIQSGGNYNLKFSVVSDKNHMHFGAITCAMGIRFKSYCSNLVRTLMVDPSQEVQENYNFLLQLQEELLKELRHGVKICDVYNAVMDVVKKQKPELLNKITKNLGFGMGIEFREGSLVINSKNQYKLKKGMVFSINLGFSDLTNKEGKKPEEKTYALFIGDTVLVDEDGPATVLTSVKKKVKNVGIFLKN","Homo sapiens","SUPT16H, FACT140, FACTP140","FACT complex subunit SPT16","1","5UMT"
"5UMU",,"X-RAY DIFFRACTION",2.27,45.82,"VAPOR DIFFUSION, HANGING DROP",5.6,"2% Tacsimate pH 5.0, 100 mM Sodium citrate tribasic dihydrate pH 5.6, 10-20% Polyethylene glycol 3350",277,,,"5UMU",68.06,"1.903","1.903","Crystal structure of the middle double PH domain of human FACT complex subunit SPT16","GAMGSDSLVINLNRSNPKLKDLYIRPNIAQKRMQGSLEAHVNGFRFTSVRGDKVDILYNNIKHALFQPCDGEMIIVLHFHLKNAIMFGKKRHTDVQFYTEVGEITTDLGKHQHMHDRDDLYAEQMEREMRHKLKTAFKNFIEKVEALTKEELEFEVPFRDLGFNGAPYRSTCLLQPTSSALVNATEWPPFVVTLDEVELIHFERVQFHLKNFDMVIVYKDYSKKVTMINAIPVASLDPIKEWLNSCDLKYTEGVQSLNWTKIMKTIVDDPEGFFEQGGWSFLE","Homo sapiens","SUPT16H, FACT140, FACTP140","FACT complex subunit SPT16","1","5UMU"
"5UN9",,"X-RAY DIFFRACTION",2.93,58,"EVAPORATION",,"0.128 M potassium thiocyanate, 0.032 M ammonium citrate tribasic (pH 7.0), 0.016 M imidazole (pH 7.0), 0.002 M zinc sulfate heptahydrate, 0.02 M MES monohydrate (pH 6.5), 12.8% w/v polyethylene glycol 3,350, 3.2% w/v polyethylene glycol monomethyl ether 2,000, 5% v/v polyethylene glycol monomethyl ether 550",293,"10.1038/nsmb.3390","NHT","5UN9",116.14,"2.5","2.5","The crystal structure of human O-GlcNAcase in complex with Thiamet-G","HFLCGVVEGFYGRPWVMEQRKELFRRLQKWELNTYLYAPKDDYKHRMFWREMYSVEEAEQLMTLISAAREYEIEFIYAISPGLDITFSNPKEVSTLKRKLDQVSQFGCRSFALLFDDIDHNMCAADKEVFSSFAHAQVSITNEIYQYLGEPETFLFCPTEYCGTFCYPNVSQSPYLRTVGEKLLPGIEVLWTGPKVVSKEIPVESIEEVSKIIKRAPVIWDNIHANDYDQKRLFLGPYKGRSTELIPRLKGVLTNPNCEFEANYVAIHTLATWYKSNMNGVRKDVVMTDSEDSTVSIQIKLENEGSDEDIETDVLYSPQMALKLALTEWLQEFGVPHQYSSRGGGGSGGGGSVTLEDLQLLADLFYLPYEHGPKGAQMLREFQWLRANSSVVSVNCKGKDSEKIEEWRSRAAKFEEMCGLVMGMFTRLSNCANRTILYDMYSYVWDIKSIMSMVKSFVQWLGCRSHSSAQFLIGDQEPWAFRGGLAGEFQRLLPIDGANDLFFQ","Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5, OGA","Protein O-GlcNAcase","1","5UN9"
"5UNE",,"X-RAY DIFFRACTION",3.01,59.18,"VAPOR DIFFUSION, HANGING DROP",7.5,"500mM Tris-HCl, 1MKCl, 50mM MgCl2",295,,,"5UNE",30.63,"2.90009915777","2.90009915777","Dimerized Structure Gives Further Insight Into the Function of the Novel RNA Gene: HAR1","GGGAAAUGAUGGGCGUAGACGCACGUCAGCGGCGGAAAUGGUUUCCC","Homo sapiens",,"RNA (47-MER)","1","5UNE"
"5UNP",,"X-RAY DIFFRACTION",3.58,65.6,"VAPOR DIFFUSION, HANGING DROP",7,"0.1M Hepes (pH 7.0), 0.2M KBr, 0.2M KSCN, 0.4-1.8% PGA (poly-gama-glutamic acid) and 1-4% PEG MME M.W. 2,000",277,,,"5UNP",87.51,"2.92","2.92","Structure of CDC2-Like Kinase 2 (CLK2) in Complex with Compound T-025 [N2-methyl-N4-(pyrimidin-2-ylmethyl)-5-(quinolin-6-yl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine]","GGSRSSSHSSRRAKSVEDDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESMLEYEPAKRLTLGEALQHPFFARLRAEPPNKLWDSSRD","Homo sapiens","CLK2","Dual specificity protein kinase CLK2","1","5UNP"
"5UO1",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.7b00259","8EV","5UO1",100.08,"1.9","1.9","Structure of human neuronal nitric oxide synthase heme domain in complex with 3-[(2-aminoquinolin-7-yl)methoxy]-5-((methylamino)methyl)benzonitrile","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5UO1"
"5UO2",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350,35mM citric acid,65mM Bis-Tris-Propane,10% glycerol,5mM TCEP",277,"10.1021/acs.jmedchem.7b00259","8J4","5UO2",100.27,"1.947","1.947","Structure of human neuronal nitric oxide synthase heme domain in complex with 7-[(3-Ethyl-5-((methylamino)methyl)phenoxy)methyl]quinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5UO2"
"5UO3",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",,"10.1021/acs.jmedchem.7b00259","8EY","5UO3",100.35,"2.2","2.2","Structure of human neuronal nitric oxide synthase heme domain in complex with 3-[(2-amino-4-methylquinolin-7-yl)methoxy]-5-((methylamino)methyl)benzonitrile","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5UO3"
"5UO4",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.7b00259","8F1","5UO4",100.5,"2","2","Structure of human neuronal nitric oxide synthase heme domain in complex with 3-[(2-amino-4-methylquinolin-7-yl)methoxy]-5-(2-(methylamino)ethyl)benzonitrile","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5UO4"
"5UO5",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",,"10.1021/acs.jmedchem.7b00259","8FD, M4R","5UO5",100.79,"2","2","Structure of human neuronal nitric oxide synthase heme domain in complex with (RS)-3-[(2-amino-4-methylquinolin-7-yl)methoxy]-5-(2-(methylamino)propyl)benzonitrile","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5UO5"
"5UO6",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.7b00259","M4R","5UO6",100.44,"1.96","1.96","Structure of human neuronal nitric oxide synthase heme domain in complex with (R)-3-[(2-amino-4-methylquinolin-7-yl)methoxy]-5-(2-(methylamino)propyl)benzonitrile","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5UO6"
"5UO7",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350, 35 mM citric acid, 65 mM Bis-Tris propane, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.7b00259","8FD","5UO7",100.07,"2.06","2.06","Structure of human neuronal nitric oxide synthase heme domain in complex with (S)-3-[(2-amino-4-methylquinolin-7-yl)methoxy]-5-(2-(methylamino)propyl)benzonitrile","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5UO7"
"5UO8",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1 M Bis-Tris, 0.2-0.3 M magnesium acetate, 0.1 M gadolinium chloride, 10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.7b00259","8EV","5UO8",204.71,"2.18","2.18","Structure of human endothelial nitric oxide synthase heme domain in complex with 3-[(2-aminoquinolin-7-yl)methoxy]-5-((methylamino)methyl)benzonitrile","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","5UO8"
"5UO9",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS,0.2-0.3M MG ACETATE, 0.1M GdCl3,10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.7b00259","8J4","5UO9",205.8,"2.19","2.19","Structure of human endothelial nitric oxide synthase heme domain in complex with 7-[(3-Ethyl-5-((methylamino)methyl)phenoxy)methyl]quinolin-2-amine","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","5UO9"
"5UOA",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS,0.2-0.3M MG ACETATE, 0.1M GdCl3,10% glycerol, 5 MM TCEP",277,"10.1021/acs.jmedchem.7b00259","8EY","5UOA",103.6,"2.2","2.2","Structure of human endothelial nitric oxide synthase heme domain in complex with 3-[(2-Amino-4-methylquinolin-7-yl)methoxy]-5-((methylamino)methyl)benzonitrile","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","5UOA"
"5UOB",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS,0.2-0.3M MG ACETATE, 0.1M GdCl3,10% glycerol, 5 MM TCEP",277,"10.1021/acs.jmedchem.7b00259","M4R","5UOB",206.38,"2.292","2.292","Structure of human endothelial nitric oxide synthase heme domain in complex with (R)-3-[(2-amino-4-methylquinolin-7-yl)methoxy]-5-(2-(methylamino)propyl)benzonitrile","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","5UOB"
"5UOC",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS,0.2-0.3M MG ACETATE, 0.1M GdCl3,10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.7b00259","8FD","5UOC",205.77,"2.2","2.2","Structure of human endothelial nitric oxide synthase heme domain in complex with (S)-3-[(2-amino-4-methylquinolin-7-yl)methoxy]-5-(2-(methylamino)propyl)benzonitrile","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","5UOC"
"5UOO",,"X-RAY DIFFRACTION",2,38.44,"VAPOR DIFFUSION, SITTING DROP",8,"60% peg 400, 0.1M Imidizole, 5mM ATP",293.15,"10.1021/acs.jmedchem.7b00193","8FV","5UOO",15.7,"1.69","1.69","BRD4 bromodomain 2 in complex with CD161","SNAKDVPDSQQHPAPEKSSKVSEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKMPDE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UOO"
"5UOR",,"X-RAY DIFFRACTION",3.16,61.01,"VAPOR DIFFUSION, SITTING DROP",6,"6% polyethylene glycol 2000 MME , 0.1M MES, pH 6.0",277,"10.1021/acsmedchemlett.6b00481","8GV","5UOR",61.91,"2.75","2.75","Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure","LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","5UOR"
"5UOS",,"X-RAY DIFFRACTION",5.25,76.6,"VAPOR DIFFUSION, SITTING DROP",9.5,"0.2 M NaCl, 0.1 M CHES:NaOH pH 9.5, 1.26 M (NH4)2SO4",277,"10.1002/anie.201701583",,"5UOS",29.68,"2.51","2.51","Crystal Structure of CblC (MMACHC) (1-238), a human B12 processing enzyme, complexed with an Antivitamin B12","SNAMEPKVAELKQKIEDTLCPFGFEVYPFQVAWYNELLPPAFHLPLPGPTLAFLVLSTPAMFDRALKPFLQSCHLRMLTDPVDQCVAYHLGRVRESLPELQIEIIADYEVHPNRRPKILAQTAAHVAGAAYYYQRQDVEADPWGNQRISGVCIHPRFGGWFAIRGVVLLPGIEVPDLPPRKPHDCVPTRADRIALLEGFNFHWRDWTYRDAVTPQERYSEEQKAYFSTPPAQRLALLGLAQ","Homo sapiens","MMACHC","Methylmalonic aciduria and homocystinuria type C protein","1","5UOS"
"5UOT","4.6","ELECTRON MICROSCOPY",,,,,,,"10.1126/sciadv.1701264",,"5UOT",4400.74,"4.6",,"CryoEM structure of the helical assembly of full length MxB","YEQKVRPCIDLIDSLRALGVEQDLALPAIAVIGDQSSGKSSVLEALSGVALPRGSGIVTRCPLVLKLKKQPCEAWAGRISYRNTELELQDPGQVEKEIHKAQNVMAGNGRGISHELISLEITSPEVPDLTIIDLPGITRVAVDNQPRDIGLQIKALIKKYIQRQQTINLVVVPCNVDIATTEALSMAHEVDPEGDRTIGILTKPDLMDRGTEKSVMNVVRNLTYPLKKGYMIVKCRGQQEITNRLSLAEATKKEITFFQTHPYFRVLLEEGSATVPRLAERLTTELIMHIQKSLPLLEGQIRESHQKATEELRRCGADIPSQEADKMFFLIEKIKMFNQDIEKLVEGEEVVRENETRLYNKIREDFKNWVGILATNTQKVKNIIHEEVEKYEKQYRGKELLGFVNYKTFEIIVHQYIQQLVEPALSMLQKAMEIIQQAFINVAKKHFGEFFNLNQTVQSTIEDIKVKHTAKAENMIQLQFRMEQMVFCQDQIYSVVLKKVREEIFNPLGTPSQNMKLNSHFPSNESSVSSFTEIGIHLNAYFLETSKRLANQIPFIIQYFMLRENGDSLQKAMMQILQEKNRYSWLLQEQSETATKRRILKERIYRLTQARHALCQFSS","Homo sapiens","MX2","Interferon-induced GTP-binding protein Mx2","1","5UOT"
"5UOX",,"X-RAY DIFFRACTION",3.17,61.16,"VAPOR DIFFUSION, SITTING DROP",6,"6% polyethylene glycol 2000 MME ,0.05M Ammonium Sulphate, 0.1M MES, pH 6.0",277,"10.1021/acsmedchemlett.6b00481","8GY","5UOX",61.81,"2.5","2.5","Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure","LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","5UOX"
"5UOY",,"X-RAY DIFFRACTION",3.12,60.56,"VAPOR DIFFUSION, HANGING DROP",6.9,"3.1 M NaCl, 0.1 M HEPES pH 6.9",293,"10.1021/acs.jmedchem.7b00302","8HM","5UOY",42.3,"1.82","1.82","Crystal structure of human PDE1B catalytic domain in complex with inhibitor 16j (6-(4-Methoxybenzyl)-9-((tetrahydro-2H-pyran-4-yl)methyl)-8,9,10,11-tetrahydropyrido[4',3':4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one)","VGPTYSTAVLNCLKNLDLWCFDVFSLNQAADDHALRTIVFELLTRHNLISRFKIPTVFLMSFLDALETGYGKYKNPYHNQIHAADVTQTVHCFLLRTGMVHCLSEIELLAIIFAAAIHDYEHTGTTNSFHIQTKSECAIVYNDRSVLENHHISSVFRLMQDDEMNIFINLTKDEFVELRALVIEMVLATDMSCHFQQVKTMKTALQQLERIDKPKALSLLLHAADISHPTKQWLVHSRWTKALMEEFFRQGDKEAELGLPFSPLCDRTSTLVAQSQIGFIDFIVEPTFSVLTDVAEKSVQPLADEDSKSKNQPSFQWRQPSLDVEVGDPNPDVVSFRSTWVKRIQENKQKWKERAASGITN","Homo sapiens","PDE1B, PDE1B1, PDES1B","Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B","1","5UOY"
"5UOZ",,"X-RAY DIFFRACTION",3.46,64.46,"VAPOR DIFFUSION",8,"0.3M Tris, 0.5mM Zinc Acetate, 425mM Sodium Citrate",293,,,"5UOZ",5.84,"1.17463871031","1.17463871031","Insulin with proline analog FyP at position B28 in the T2 state","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin Chain A","1","5UOZ"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin Chain B","2","5UOZ"
"5UP0",,"X-RAY DIFFRACTION",3.12,60.55,"VAPOR DIFFUSION, HANGING DROP",6.9,"3.1 M NaCl, 0.1 M HEPES pH 6.9",293,"10.1021/acs.jmedchem.7b00302","8HP","5UP0",41.74,"2.04","2.04","Crystal structure of human PDE1B catalytic domain in complex with inhibitor 3 (6-(4-chlorobenzyl)-8,9,10,11-tetrahydrobenzo[4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one)","VGPTYSTAVLNCLKNLDLWCFDVFSLNQAADDHALRTIVFELLTRHNLISRFKIPTVFLMSFLDALETGYGKYKNPYHNQIHAADVTQTVHCFLLRTGMVHCLSEIELLAIIFAAAIHDYEHTGTTNSFHIQTKSECAIVYNDRSVLENHHISSVFRLMQDDEMNIFINLTKDEFVELRALVIEMVLATDMSCHFQQVKTMKTALQQLERIDKPKALSLLLHAADISHPTKQWLVHSRWTKALMEEFFRQGDKEAELGLPFSPLCDRTSTLVAQSQIGFIDFIVEPTFSVLTDVAEKSVQPLADEDSKSKNQPSFQWRQPSLDVEVGDPNPDVVSFRSTWVKRIQENKQKWKERAASGITN","Homo sapiens","PDE1B, PDE1B1, PDES1B","Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B","1","5UP0"
"5UP3",,"X-RAY DIFFRACTION",3.17,61.17,"VAPOR DIFFUSION, SITTING DROP",6,"7% polyethylene glycol 2000 MME , 0.05M Ammonium Sulphate, 0.05M MES, pH 6.0",277,"10.1021/acsmedchemlett.6b00481","8GS","5UP3",61.66,"2.95","2.95","Structure-Based Design of ASK1 Inhibitors as Potential First-in-Class Agents for Heart Failure","LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","5UP3"
"5UP7",,"X-RAY DIFFRACTION",2.88,57.34,"VAPOR DIFFUSION, SITTING DROP",8,"Reservoir: 500 uL total volume: 25 mM Tris (pH 8), 10 mM CaCl2, 1 mM NiCl2, 1% PEG 6000

Sitting Drop: 2 uL reservoir, 2 uL of 
12.5 uM ferritin",293,"10.1021/jacs.7b01202",,"5UP7",21.59,"1.79","1.79","Crystal Structure of the Ni-bound Human Heavy-Chain Ferritin 122H-delta C-star variant","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDEDDWESGLNAMEAALHLEKNVNQSLLELHKLAHDKNDPHLADFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","5UP7"
"5UP8",,"X-RAY DIFFRACTION",3.73,67.03,"VAPOR DIFFUSION, SITTING DROP",,"Reservoir: 500 uL total volume: 50 mM CHES (pH 8.5), 150 mM NaCl,
 0.14 mM ZnCl2

Sitting Drop: 8.6 uL reservoir, 1 uL of 12.5 uM ferritin, 2.4 uL of 5 mM 
p-H2bdh in 50 mM CHES (pH 9.5) with 150 mM NaCl",295,"10.1021/jacs.7b01202",,"5UP8",21.54,"2.631","2.631","Crystal Structure of the Zn-bound Human Heavy-Chain variant 122H-delta C-star with para-benzenedihydroxamate","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDEDDWESGLNAMEAALHLEKNVNQSLLELHKLAHDKNDPHLADFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","5UP8"
"5UP9",,"X-RAY DIFFRACTION",3.59,65.78,"VAPOR DIFFUSION, SITTING DROP",,"Reservoir: 500 uL total volume: 50 mM CHES (pH 8.5), 150 mM NaCl, 
0.474 mM ZnCl2, 3% PEG 300

Sitting Drop: 7.6 uL reservoir, 2 uL of 12.5 uM ferritin, 2.4 uL of 5 mM 
p-H2xdh in 50 mM CHES (pH 9.5) with 150 mM NaCl",293,"10.1021/jacs.7b01202",,"5UP9",130.97,"2.45","2.45","Crystal Structure of Zn-bound Human Heavy-Chain ferritin variant 122H-delta C-star with para-xylenedihydroxamate","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDEDDWESGLNAMEAALHLEKNVNQSLLELHKLAHDKNDPHLADFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","5UP9"
"5UPD",,"X-RAY DIFFRACTION",2.41,48.87,"VAPOR DIFFUSION, SITTING DROP",6.5,"20% PEG-5000-MME, 0.1 M bis-tris, 0.02 M sarcosine",293,,,"5UPD",27.09,"1.8","1.8","Methyltransferase domain of human Wolf-Hirschhorn Syndrome Candidate 1-Like protein 1 (WHSC1L1)","GQRESKEALEIEKNSRKPPPYKHIKANKVIGKVQIQVADLSEIPRCNCKPADENPCGLESECLNRMLQYECHPQVCPAGDRCQNQCFTKRLYPDAEIIKTERRGWGLRTKRSIKKGEFVNEYVGELIDEEECRLRIKRAHENSVTNFYMLTVTKDRIIDAGPKGNYSRFMNHSCNPNCETQKWTVNGDVRVGLFALCDIPAGMELTFNYNLDCLGNGRTECHCGADNCSGFLG","Homo sapiens","WHSC1L1, NSD3, DC28","Histone-lysine N-methyltransferase NSD3","1","5UPD"
"5UPE",,"X-RAY DIFFRACTION",2.37,48.12,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.2 M ammonium sulfate, and 0.1 M HEPES, pH 7.5",277,"10.1016/j.bmcl.2017.06.018","8HY","5UPE",113.98,"1.93","1.93","Crystal structure of human NAMPT with isoindoline urea inhibitor compound 5","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHDYKDDDDK","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","5UPE"
"5UPF",,"X-RAY DIFFRACTION",2.38,48.33,"VAPOR DIFFUSION, HANGING DROP",,"25% PEG 3350, 0.2 M ammonium sulfate, and 0.1 M HEPES, pH 7.5",277,"10.1016/j.bmcl.2017.06.018","8HV","5UPF",114.03,"1.69","1.69","Crystal structure of human NAMPT with isoindoline urea inhibitor compound 53","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHHDYKDDDDK","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","5UPF"
"5UPH",,"X-RAY DIFFRACTION",4.36,71.8,"VAPOR DIFFUSION, HANGING DROP",7.5,"protein in 10 mM HEPES, pH 7.5 200 mM NaCl mixed with equal amount of 0.22 M NaCl, 29% PPG 400",295,"10.1038/s41467-017-02044-8",,"5UPH",103.83,"3","3","Lipids bound lysosomal integral membrane protein 2","VFQKAVDQSIEKKIVLRNGTEAFDSWEKPPLPVYTQFYFFNVTNPEEILRGETPRVEEVGPYTYRELRNKANIQFGDNGTTISAVSNKAYVFERDQSVGDPKIDLIRTLNIPVLTVIEWSQVHFLREIIEAMLKAYQQKLFVTHTVDELLWGYKDEILSLIHVFRPDISPYFGLFYEKNGTNDGDYVFLTGEDSYLNFTKIVEWNGKTSLDWWITDKCNMINGTDGDSFHPLITKDEVLYVFPSDFCRSVYITFSDYESVQGLPAFRYKVPAEILANTSDNAGFCIPEGNCLGSGVLNVSICKNGAPIIMSFPHFYQADERFVSAIEGMHPNQEDHETFVDINPLTGIILKAAKRFQINIYVKKLDDFVETGDIRTMVFPVMYLNESVHIDKETASRLKSMINTHHHHHH","Homo sapiens","SCARB2, CD36L2, LIMP2, LIMPII","Lysosome membrane protein 2","1","5UPH"
"5UPP",,"X-RAY DIFFRACTION",3.03,59.37,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES pH 7.5
1% (v/v) MPD
4% (w/v) PEG 10000",294,"10.1111/febs.14782",,"5UPP",100.76,"1.8","1.8","Crystal structure of human fumarate hydratase","ASQNSFRIEYDTFGELKVPNDKYYGAQTVRSTMNFKIGGVTERMPTPVIKAFGILKRAAAEVNQDYGLDPKIANAIMKAADEVAEGKLNDHFPLVVWQTGSGTQTNMNVNEVISNRAIEMLGGELGSKIPVHPNDHVNKSQSSNDTFPTAMHIAAAIEVHEVLLPGLQKLHDALDAKSKEFAQIIKIGRTHTQDAVPLTLGQEFSGYVQQVKYAMTRIKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTACSLMKIANDIRFLGSGPRSGLGELILPENEPGSSIMPGKVNPTQCEAMTMVAAQVMGNHVAVTVGGSNGHFELNVFKPMMIKNVLHSARLLGDASVSFTENCVVGIQANTERINKLMNESLMLVTALNPHIGYDKAAKIAKTAHKNGSTLKETAIELGYLTAEQFDEWVKPKDMLGPK","Homo sapiens","FH","Fumarate hydratase, mitochondrial","1","5UPP"
"5UQ0",,"X-RAY DIFFRACTION",2.4,48.83,"VAPOR DIFFUSION, HANGING DROP",,"20% MPEG 5000, 0.1 M sodium cacodylate pH 7.5, 0.2 M ammonium sulfate",291,,,"5UQ0",71.09,"2.3","2.3","FGFR1 kinase domain complex with fragment 2,2-dimethyl-2,3-dihydrobenzofuran-7-carboxamide","GAMSGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","5UQ0"
"5UQ9",,"X-RAY DIFFRACTION",2.23,44.82,"VAPOR DIFFUSION, HANGING DROP",,"13% (w/v) PEG 3350, 10.0% (v/v) ethylene glycol",293,"10.1016/j.celrep.2018.12.043","8HS","5UQ9",430.38,"3","3","Crystal structure of 6-phosphogluconate dehydrogenase with ((4R,5R)-5-(hydroxycarbamoyl)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl dihydrogen phosphate","GAMADIMAQADIALIGLAVMGQNLILNMNDHGFVVCAFNRTVSKVDDFLANEAKGTKVVGAQSLKEMVSKLKKPRRIILLVKAGQAVDDFIEKLVPLLDTGDIIIDGGNSEYRDTTRRCRDLKAKGILFVGSGVSGGEEGARYGPSLMPGGNKEAWPHIKTIFQGIAAKVGTGEPCCDWVGDEGAGHFVKMVHNGIEYGDMQLICEAYHLMKDVLGMAQDEMAQAFEDWNKTELDSFLIEITANILKFQDTDGKHLLPKIRDSAGQKGTGKWTAISALEYGVPVTLIGEAVFARCLSSLKDERIQASKKLKGPQKFQFDGDKKSFLEDIRKALYASKIISYAQGFMLLRQAATEFGWTLNYGGIALMWRGGCIIRSVFLGKIKDAFDRNPELQNLLLDDFFKSAVENCQDSWRRAVSTGVQAGIPMPCFTTALSFYDGYRHEMLPASLIQAQRDYFGAHTYELLAKPGQFIHTNWTGHGGTVSSSSYNA","Homo sapiens","PGD, PGDH","6-phosphogluconate dehydrogenase, decarboxylating","1","5UQ9"
"5UQA",,"X-RAY DIFFRACTION",2.34,47.45,"VAPOR DIFFUSION, HANGING DROP",8,"0.3M Tris pH8, 17mM Zinc Acetate, 1% Phenol, 0.3875M Sodium Citrate, 2.1% Acetone",293,,,"5UQA",36.07,"1.31000248093","1.31000248093","Insulin with proline analog FzP at position B28 in the R6 state","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin, chain A","1","5UQA"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin, chain B","2","5UQA"
"5UQE",,"X-RAY DIFFRACTION",5.76,78.65,"VAPOR DIFFUSION, SITTING DROP",6.8,"BIS-TRIS propane 0.1 M pH 6,8; Sodium Formate 1.8 M; Sodium Chloride 0.5 M; BPTES 1.2 mM",277,"10.1074/jbc.M117.787291","04A","5UQE",292.3,"3.6","3.6","Multidomain structure of human kidney-type glutaminase(KGA/GLS)","PSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKLVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVEVVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGK","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","5UQE"
"5UQV",,"X-RAY DIFFRACTION",2.61,52.78,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 1000, 0.1M Tris-HCl 7.0",289,"10.1038/nature24006","8JM","5UQV",85.61,"2.84","2.84","USP7 in complex with GNE6640 (4-(2-amino-4-ethyl-5-(1H-indazol-5-yl)pyridin-3-yl)phenol)","MGSSHHHHHHSSGLVPRGSHMKKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQK","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","5UQV"
"5UQW",,"X-RAY DIFFRACTION",2,38.44,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Bis-Tris, 25% w/v PEG3350, pH 6.5",293,"10.1016/j.cell.2017.02.006",,"5UQW",43.91,"1.5","1.5","Crystal structure of human KRAS G12V mutant in complex with GDP","MGSSHHHHHHSSGLVPRGSHMTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5UQW"
"5UQX",,"X-RAY DIFFRACTION",2.46,49.94,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 1000, 0.1M Tris-HCl 7.0",289,"10.1038/nature24006","8JP","5UQX",85.97,"2.23","2.23","USP7 in complex with GNE6776 (6'-amino-4'-ethyl-5'-(4-hydroxyphenyl)-N-methyl-[3,3'-bipyridine]-6-carboxamide)","MGSSHHHHHHSSGLVPRGSHMKKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQKR","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","5UQX"
"5UR1",,"X-RAY DIFFRACTION",2.47,50.13,"VAPOR DIFFUSION, HANGING DROP",,"20% MPEG 5000, 0.1 M sodium cacodylate pH 7.5, 0.2 M ammonium sulfate",291,"10.1016/j.ejmech.2017.04.049","YY9","5UR1",71.99,"2.2","2.2","FGFR1 kinase domain complex with SN37333 in reversible binding mode","GAMSGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","5UR1"
"5UR7",,"X-RAY DIFFRACTION",3.29,62.64,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M ammonium acetate, 0.1 M sodium HEPES, 25% v/v 2-propanol",302,"10.1073/pnas.1704958114",,"5UR7",16.47,"2.0004","2.0004","Crystal structure of engineered CCL20 disulfide locked dimer","ASNFDCCLGYTDRILHPKFIVGFTRQLANEGCDINAIIFHTKKKLSVCANPKQTWVKYIVRLLCKKVKNM","Homo sapiens","CCL20, LARC, MIP3A, SCYA20","C-C motif chemokine 20","1","5UR7"
"5UR8",,"X-RAY DIFFRACTION",4.7,72.9,"VAPOR DIFFUSION, HANGING DROP",6,"57.5% Tacsimate",293,"10.1038/s41467-018-02827-7",,"5UR8",49.13,"1.75500231418","1.75500231418","Human antibody fragment (Fab) to meningococcal Factor H binding protein","EVQLVQSGAELKKPGESLKISCKASGYTFTNYWVVWVRQMPGEGLEWMGSIHPRDSDARYSLSFEGRVTFSVDKSTTTAYLQWSSLKVSDSAIYYCARLSQVSGWSPWVGPWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKLEHHHHHH","Homo sapiens",,"human immunoglobulin gamma, heavy chain Fd fragment","1","5UR8"
,,,,,,,,,,,,,,,,"ADIVMTQSPSSLSASVGDRVTITCRASQSISVSLNWYQQKPGKAPKVLIYAASRLQSGIPSRFSGSGSGSHFTLTISSLQPEDFATYYCQETYSDLMYTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGECS","Homo sapiens",,"human immunoglobulin gamma, kappa light chain","2","5UR8"
"5UR9",,"X-RAY DIFFRACTION",2.87,57.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES, pH 7.5, 2% polyethylene glycol 400, and 2.1 M ammonium sulfate 15",293,"10.1021/acs.biochem.7b00194","8KS","5UR9",129.95,"2.19800343737","2.19800343737","Enantiomer-Specific Binding of the Potent Antinociceptive Agent SBFI-26 to Anandamide transporters FABP5","GSHMATVQQLEGRWRLVDSKGFDEYMKELGVGIALRKMGAMAKPDCIITCDGKNLTIKTESTLKTTQFSCTLGEKFEETTADGRKTQTVCNFTDGALVQHQEWDGKESTITRKLKDGKLVVECVMNNVTCTRIYEKVE","Homo sapiens","FABP5","Fatty acid-binding protein, epidermal","1","5UR9"
"5URA",,"X-RAY DIFFRACTION",2.29,46.4,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris, pH8.5, 0.1 M lithium sulfate, and 33% polyethylene glycol 4000",293,"10.1021/acs.biochem.7b00194","8KS","5URA",63.22,"1.85002167328","1.85002167328","Enantiomer-Specific Binding of the Potent Antinociceptive Agent SBFI-26 to Anandamide transporters FABP7","GSHMVEAFCATWKLTNSQNFDEYMKALGVGFATRQVGNVTKPTVIISQEGDKVVIRTLSTFKNTEISFQLGEEFDETTADDRNCKSVVSLDGDKLVHIQKWDGKETNFVREIKDGKMVMTLTFGDVVAVRHYEKA","Homo sapiens","FABP7, BLBP, FABPB, MRG","Fatty acid-binding protein, brain","1","5URA"
"5URJ",,"X-RAY DIFFRACTION",3.45,64.33,"VAPOR DIFFUSION, HANGING DROP",,"1.25-1.5M sodium malonate, 100mM sodium citrate pH 5.0-5.3, 10mg/ml BRR2",293,"10.1021/acs.jmedchem.7b00461",,"5URJ",199.17,"2.75","2.75","Crystal structure of human BRR2 in complex with T-3905516","GGSDLDQGGEALAPRQVLDLEDLVFTQGSHFMANKRCQLPDGSFRRQRKGYEEVHVPALKPKPFGSEEQLLPVEKLPKYAQAGFEGFKTLNRIQSKLYRAALETDENLLLCAPTGAGKTNVALMCMLREIGKHINMDGTINVDDFKIIYIAPMRSLVQEMVGSFGKRLATYGITVAELTGDHQLCKEEISATQIIVCTPEKWDIITRKGGERTYTQLVRLIILDEIHLLHDDRGPVLEALVARAIRNIEMTQEDVRLIGLSATLPNYEDVATFLRVDPAKGLFYFDNSFRPVPLEQTYVGITEKKAIKRFQIMNEIVYEKIMEHAGKNQVLVFVHSRKETGKTARAIRDMCLEKDTLGLFLREGSASTEVLRTEAEQCKNLELKDLLPYGFAIHHAGMTRVDRTLVEDLFADKHIQVLVSTATLAWGVNLPAHTVIIKGTQVYSPEKGRWTELGALDILQMLGRAGRPQYDTKGEGILITSHGELQYYLSLLNQQLPIESQMVSKLPDMLNAEIVLGNVQNAKDAVNWLGYAYLYIRMLRSPTLYGISHDDLKGDPLLDQRRLDLVHTAALMLDKNNLVKYDKKTGNFQVTELGRIASHYYITNDTVQTYNQLLKPTLSEIELFRVFSLSSEFKNITVREEEKLELQKLLERVPIPVKESIEEPSAKINVLLQAFISQLKLEGFALMADMVYVTQSAGRLMRAIFEIVLNRGWAQLTDKTLNLCKMIDKRMWQSMCPLRQFRKLPEEVVKKIEKKNFPFERLYDLNHNEIGELIRMPKMGKTIHKYVHLFPKLELSVHLQPITRSTLKVELTITPDFQWDEKVHGSSEAFWILVEDVDSEVILHHEYFLLKAKYAQDEHLITFFVPVFEPLPPQYFIRVVSDRWLSCETQLPVSFRHLILPEKYPPPTELLDLQPLPVSALRNSAFESLYQDKFPFFNPIQTQVFNTVYNSDDNVFVGAPTGSGKTICAEFAILRMLLQSSEGRCVYITPMEALAEQVYMDWYEKFQDRLNKKVVLLTGETSTDLKLLGKGNIIISTPEKWDILSRRWKQRKNVQNINLFVVDEVHLIGGENGPVLEVICSRMRYISSQIERPIRIVALSSSLSNAKDVAHWLGCSATSTFNFHPNVRPVPLELHIQGFNISHTQTRLLSMAKPVYHAITKHSPKKPVIVFVPSRKQTRLTAIDILTTCAADIQRQRFLHCTEKDLIPYLEKLSDSTLKETLLNGVGYLHEGLSPMERRLVEQLFSSGAIQVVVASRSLCWGMNVAAHLVIIMDTQYYNGKIHAYVDYPIYDVLQMVGHANRPLQDDEGRCVIMCQGSKKDFFKKFLYEPLPVESHLDHCMHDHFNAEIVTKTIENKQDAVDYLTWTFLYRRMTQNPNYYNLQGISHRHLSDHLSELVEQTLSDLEQSKCISIEDEMDVAPLNLGMIAAYYYINYTTIELFSMSLNAKTKVRGLIEIISNAAEYENIPIRHHEDNLLRQLAQKVPHKLNNPKFNDPHVKTNLLLQAHLSRMQLSAELQSDTEEILSKAIRLIQACVDVLSSNGWLSPALAAMELAQMVTQAMWSKDSYLKQLPHFTSEHIKRCTDKGVESVFDIMEMEDEERNALLQLTDSQIADVARFCNRYPNIELSYEVVDKDSIRSGGPVVVLVQLEREEEVTGPVIAPLFPQKREEGWWVVIGDAKSNSLISIKRLTLQQKAKVKLDFVAPATGAHNYTLYFMSDAYMGCDQEYKFSVDVKEA","Homo sapiens","SNRNP200, ASCC3L1, HELIC2, KIAA0788","U5 small nuclear ribonucleoprotein 200 kDa helicase","1","5URJ"
"5URK",,"X-RAY DIFFRACTION",3.48,64.66,"VAPOR DIFFUSION, HANGING DROP",,"1.25-1.5 M sodium malonate, 100 mM sodium citrate pH 5.0-5.3, 10mg/ml BRR2",293,"10.1021/acs.jmedchem.7b00461","8LP","5URK",199.11,"2.95","2.95","Crystal structure of human BRR2 in complex with T-3935799","GGSDLDQGGEALAPRQVLDLEDLVFTQGSHFMANKRCQLPDGSFRRQRKGYEEVHVPALKPKPFGSEEQLLPVEKLPKYAQAGFEGFKTLNRIQSKLYRAALETDENLLLCAPTGAGKTNVALMCMLREIGKHINMDGTINVDDFKIIYIAPMRSLVQEMVGSFGKRLATYGITVAELTGDHQLCKEEISATQIIVCTPEKWDIITRKGGERTYTQLVRLIILDEIHLLHDDRGPVLEALVARAIRNIEMTQEDVRLIGLSATLPNYEDVATFLRVDPAKGLFYFDNSFRPVPLEQTYVGITEKKAIKRFQIMNEIVYEKIMEHAGKNQVLVFVHSRKETGKTARAIRDMCLEKDTLGLFLREGSASTEVLRTEAEQCKNLELKDLLPYGFAIHHAGMTRVDRTLVEDLFADKHIQVLVSTATLAWGVNLPAHTVIIKGTQVYSPEKGRWTELGALDILQMLGRAGRPQYDTKGEGILITSHGELQYYLSLLNQQLPIESQMVSKLPDMLNAEIVLGNVQNAKDAVNWLGYAYLYIRMLRSPTLYGISHDDLKGDPLLDQRRLDLVHTAALMLDKNNLVKYDKKTGNFQVTELGRIASHYYITNDTVQTYNQLLKPTLSEIELFRVFSLSSEFKNITVREEEKLELQKLLERVPIPVKESIEEPSAKINVLLQAFISQLKLEGFALMADMVYVTQSAGRLMRAIFEIVLNRGWAQLTDKTLNLCKMIDKRMWQSMCPLRQFRKLPEEVVKKIEKKNFPFERLYDLNHNEIGELIRMPKMGKTIHKYVHLFPKLELSVHLQPITRSTLKVELTITPDFQWDEKVHGSSEAFWILVEDVDSEVILHHEYFLLKAKYAQDEHLITFFVPVFEPLPPQYFIRVVSDRWLSCETQLPVSFRHLILPEKYPPPTELLDLQPLPVSALRNSAFESLYQDKFPFFNPIQTQVFNTVYNSDDNVFVGAPTGSGKTICAEFAILRMLLQSSEGRCVYITPMEALAEQVYMDWYEKFQDRLNKKVVLLTGETSTDLKLLGKGNIIISTPEKWDILSRRWKQRKNVQNINLFVVDEVHLIGGENGPVLEVICSRMRYISSQIERPIRIVALSSSLSNAKDVAHWLGCSATSTFNFHPNVRPVPLELHIQGFNISHTQTRLLSMAKPVYHAITKHSPKKPVIVFVPSRKQTRLTAIDILTTCAADIQRQRFLHCTEKDLIPYLEKLSDSTLKETLLNGVGYLHEGLSPMERRLVEQLFSSGAIQVVVASRSLCWGMNVAAHLVIIMDTQYYNGKIHAYVDYPIYDVLQMVGHANRPLQDDEGRCVIMCQGSKKDFFKKFLYEPLPVESHLDHCMHDHFNAEIVTKTIENKQDAVDYLTWTFLYRRMTQNPNYYNLQGISHRHLSDHLSELVEQTLSDLEQSKCISIEDEMDVAPLNLGMIAAYYYINYTTIELFSMSLNAKTKVRGLIEIISNAAEYENIPIRHHEDNLLRQLAQKVPHKLNNPKFNDPHVKTNLLLQAHLSRMQLSAELQSDTEEILSKAIRLIQACVDVLSSNGWLSPALAAMELAQMVTQAMWSKDSYLKQLPHFTSEHIKRCTDKGVESVFDIMEMEDEERNALLQLTDSQIADVARFCNRYPNIELSYEVVDKDSIRSGGPVVVLVQLEREEEVTGPVIAPLFPQKREEGWWVVIGDAKSNSLISIKRLTLQQKAKVKLDFVAPATGAHNYTLYFMSDAYMGCDQEYKFSVDVKEA","Homo sapiens","SNRNP200, ASCC3L1, HELIC2, KIAA0788","U5 small nuclear ribonucleoprotein 200 kDa helicase","1","5URK"
"5URM",,"X-RAY DIFFRACTION",3.32,62.92,"VAPOR DIFFUSION, HANGING DROP",,"1.25-1.5M sodium malonate, 100mM sodium citrate pH 5.0-5.3, 10mg/ml BRR2",293,"10.1021/acs.jmedchem.7b00461",,"5URM",398.07,"2.8","2.8","Crystal structure of human BRR2 in complex with T-1206548","GGSDLDQGGEALAPRQVLDLEDLVFTQGSHFMANKRCQLPDGSFRRQRKGYEEVHVPALKPKPFGSEEQLLPVEKLPKYAQAGFEGFKTLNRIQSKLYRAALETDENLLLCAPTGAGKTNVALMCMLREIGKHINMDGTINVDDFKIIYIAPMRSLVQEMVGSFGKRLATYGITVAELTGDHQLCKEEISATQIIVCTPEKWDIITRKGGERTYTQLVRLIILDEIHLLHDDRGPVLEALVARAIRNIEMTQEDVRLIGLSATLPNYEDVATFLRVDPAKGLFYFDNSFRPVPLEQTYVGITEKKAIKRFQIMNEIVYEKIMEHAGKNQVLVFVHSRKETGKTARAIRDMCLEKDTLGLFLREGSASTEVLRTEAEQCKNLELKDLLPYGFAIHHAGMTRVDRTLVEDLFADKHIQVLVSTATLAWGVNLPAHTVIIKGTQVYSPEKGRWTELGALDILQMLGRAGRPQYDTKGEGILITSHGELQYYLSLLNQQLPIESQMVSKLPDMLNAEIVLGNVQNAKDAVNWLGYAYLYIRMLRSPTLYGISHDDLKGDPLLDQRRLDLVHTAALMLDKNNLVKYDKKTGNFQVTELGRIASHYYITNDTVQTYNQLLKPTLSEIELFRVFSLSSEFKNITVREEEKLELQKLLERVPIPVKESIEEPSAKINVLLQAFISQLKLEGFALMADMVYVTQSAGRLMRAIFEIVLNRGWAQLTDKTLNLCKMIDKRMWQSMCPLRQFRKLPEEVVKKIEKKNFPFERLYDLNHNEIGELIRMPKMGKTIHKYVHLFPKLELSVHLQPITRSTLKVELTITPDFQWDEKVHGSSEAFWILVEDVDSEVILHHEYFLLKAKYAQDEHLITFFVPVFEPLPPQYFIRVVSDRWLSCETQLPVSFRHLILPEKYPPPTELLDLQPLPVSALRNSAFESLYQDKFPFFNPIQTQVFNTVYNSDDNVFVGAPTGSGKTICAEFAILRMLLQSSEGRCVYITPMEALAEQVYMDWYEKFQDRLNKKVVLLTGETSTDLKLLGKGNIIISTPEKWDILSRRWKQRKNVQNINLFVVDEVHLIGGENGPVLEVICSRMRYISSQIERPIRIVALSSSLSNAKDVAHWLGCSATSTFNFHPNVRPVPLELHIQGFNISHTQTRLLSMAKPVYHAITKHSPKKPVIVFVPSRKQTRLTAIDILTTCAADIQRQRFLHCTEKDLIPYLEKLSDSTLKETLLNGVGYLHEGLSPMERRLVEQLFSSGAIQVVVASRSLCWGMNVAAHLVIIMDTQYYNGKIHAYVDYPIYDVLQMVGHANRPLQDDEGRCVIMCQGSKKDFFKKFLYEPLPVESHLDHCMHDHFNAEIVTKTIENKQDAVDYLTWTFLYRRMTQNPNYYNLQGISHRHLSDHLSELVEQTLSDLEQSKCISIEDEMDVAPLNLGMIAAYYYINYTTIELFSMSLNAKTKVRGLIEIISNAAEYENIPIRHHEDNLLRQLAQKVPHKLNNPKFNDPHVKTNLLLQAHLSRMQLSAELQSDTEEILSKAIRLIQACVDVLSSNGWLSPALAAMELAQMVTQAMWSKDSYLKQLPHFTSEHIKRCTDKGVESVFDIMEMEDEERNALLQLTDSQIADVARFCNRYPNIELSYEVVDKDSIRSGGPVVVLVQLEREEEVTGPVIAPLFPQKREEGWWVVIGDAKSNSLISIKRLTLQQKAKVKLDFVAPATGAHNYTLYFMSDAYMGCDQEYKFSVDVKEA","Homo sapiens","SNRNP200, ASCC3L1, HELIC2, KIAA0788","U5 small nuclear ribonucleoprotein 200 kDa helicase","1","5URM"
"5URT",,"X-RAY DIFFRACTION",3.31,62.86,"VAPOR DIFFUSION, SITTING DROP",7.75,"200mM Sodium Citrate, 100mM Hepes pH 7.75",293,,,"5URT",5.84,"1.18","1.18","Insulin with proline analog DhP at position B28 in the T2 state","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin Chain A","1","5URT"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTXKT","Homo sapiens","INS","Insulin Chain B","2","5URT"
"5URU",,"X-RAY DIFFRACTION",2.03,39.27,"VAPOR DIFFUSION, SITTING DROP",8,"300mM Tris pH 8, 17mM Zinc Acetate, 1% Phenol, 313mM Sodium Citrate, 11.25% Acetone",293,,,"5URU",24.04,"2.41","2.41","Insulin with proline analog DhP at position B28 in the R6 state","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin Chain A","1","5URU"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTXKT","Homo sapiens","INS","Insulin Chain B","2","5URU"
"5URV",,"X-RAY DIFFRACTION",3.21,61.71,"VAPOR DIFFUSION, SITTING DROP",,"0.1M MES sodium salt pH 6.5, 2.0M Ammonium sulfate, 5%(w/v) PEG 400",292,"10.1073/pnas.1618293114",,"5URV",35.27,"2.2","2.2","Crystal structure of Frizzled 7 CRD in complex with C24 fatty acid","AGSQPYHGEKGISVPDHGFCQPISIPLCTDIAYNQTILPNLLGHTNQEDAGLEVHQFYPLVKVQCSPELRFFLCSMYAPVCTVLDQAIPPCRSLCERARQGCEALMNKFGFQWPERLRCENFPVHGAGEICVGQNTSDGGNSHHHHHH","Homo sapiens","FZD7","Frizzled-7","1","5URV"
"5URY",,"X-RAY DIFFRACTION",3.36,63.37,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M sodium citrate tribasic dehydrate pH 5.5, 22% polyethylene glycol 3350",292,"10.1073/pnas.1618293114",,"5URY",34.71,"2.098","2.098","Crystal structure of Frizzled 5 CRD in complex with PAM","AHHHHHHGENLYFQGSKAPVCQEITVPMCRGIGYNLTHMPNQFNHDTQDEAGLEVHQFWPLVEIQCSPDLRFFLCSMYTPICLPDYHKPLPPCRSVCERAKAGCSPLMRQYGFAWPERMSCDRLPVLGRDAEVLCMDYERSEAGNS","Homo sapiens","FZD5, C2orf31","Frizzled-5","1","5URY"
"5URZ",,"X-RAY DIFFRACTION",3.05,59.73,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M sodium citrate tribasic dehydrate pH 5.5, 22% polyethylene glycol 3350",292,"10.1073/pnas.1618293114",,"5URZ",34.34,"2.202","2.202","Crystal structure of Frizzled 5 CRD in complex with BOG","AHHHHHHGENLYFQGSKAPVCQEITVPMCRGIGYNLTHMPNQFNHDTQDEAGLEVHQFWPLVEIQCSPDLRFFLCSMYTPICLPDYHKPLPPCRSVCERAKAGCSPLMRQYGFAWPERMSCDRLPVLGRDAEVLCMDYERSEAGNS","Homo sapiens","FZD5, C2orf31","Frizzled-5","1","5URZ"
"5US3",,"SOLUTION NMR",,,,,,,"10.1021/jacs.7b03114",,"5US3",3.55,,,"Heterogeneous-backbone Foldamer Mimic of the Sp1-3 Zinc Finger","KYACPECPKRFLRSDHLSKHIKTHXNKKX","Homo sapiens",,"Heterogeneous-Backbone Variant of the Sp1-3 Zinc Finger: N-Me-Ala3, N-Me-Arg10, beta-3-Asp15, beta-3-Lys19, beta3-Lys22, beta-3-Gln25","1","5US3"
"5US4",,"X-RAY DIFFRACTION",2.39,48.54,"VAPOR DIFFUSION, SITTING DROP",9.1,"0.2 M sodium phosphate dibasic, 20% w/v PEG3350, pH 9.1",293,"10.1016/j.cell.2017.02.006",,"5US4",44.12,"1.83","1.83","Crystal structure of human KRAS G12D mutant in complex with GDP","MGSSHHHHHHSSGLVPRGSHMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5US4"
"5USJ",,"X-RAY DIFFRACTION",2.08,40.75,"VAPOR DIFFUSION, SITTING DROP",5.5,"0.1 M Bis-Tris, 25% w/v PEG3350, pH 5.5",293,"10.1016/j.cell.2017.02.006",,"5USJ",132.29,"1.94","1.94","Crystal Structure of human KRAS G12D mutant in complex with GDPNP","MGSSHHHHHHSSGLVPRGSHMTEYKLVVVGADGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5USJ"
"5USP",,"X-RAY DIFFRACTION",3.4,63.79,"VAPOR DIFFUSION, SITTING DROP",8,"275mM Sodium Citrate, 100mM Hepes pH 8.0",293,,,"5USP",5.85,"1.174","1.174","Insulin with proline analog Pip at position B28 in the T2 state","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin Chain A","1","5USP"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTXKT","Homo sapiens","INS","Insulin Chain B","2","5USP"
"5USQ",,"X-RAY DIFFRACTION",2.16,42.95,"VAPOR DIFFUSION, SITTING DROP",9.2,"16 % PEG 8000
100mM CHES pH 9.2",293,"10.1016/j.bmcl.2017.03.026","8LY","5USQ",34.7,"2.55","2.55","ALK-5 kinase inhibitor complex","TIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ","Homo sapiens","TGFBR1, ALK5, SKR4","TGF-beta receptor type-1","1","5USQ"
"5USS",,"X-RAY DIFFRACTION",2.04,39.57,"VAPOR DIFFUSION, SITTING DROP",8,"300mM Tris pH 8, 17mM Zinc Acetate, 1% phenol, 313mM Sodium Citrate, 11.25% Acetone",293,,,"5USS",12.05,"2.061","2.061","Insulin with proline analog PiP at position B28 in the R6 state","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin Chain A","1","5USS"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTXKT","Homo sapiens","INS","Insulin Chain B","2","5USS"
"5USV",,"X-RAY DIFFRACTION",3.29,62.61,"VAPOR DIFFUSION, SITTING DROP",7.75,"238mM Sodium citrate, 100mM Hepes pH 7.75",293,,,"5USV",5.83,"1.3","1.3","Insulin with proline analog AzeP at position B28 in the T2 state","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin Chain A","1","5USV"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTXKT","Homo sapiens","INS","Insulin Chain B","2","5USV"
"5USY",,"X-RAY DIFFRACTION",2.52,51.24,"VAPOR DIFFUSION, HANGING DROP",5.6,"0.1M Sodium citrate, pH 5.6
0.2 M Ammonium sulfate
30% PEG 4,000",293,"10.1021/acsmedchemlett.7b00153","SKE","5USY",76.34,"2","2","JAK2 JH1 in complex with JNJ-7706621","SYYHHHHHHDYDIPTTENLYFQGDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5USY"
"5USZ",,"X-RAY DIFFRACTION",2.21,44.39,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, pH 8.0
0.2M Sodium acetate
12-20% PEG 4,000",277,"10.1021/acsmedchemlett.7b00153","SKE","5USZ",33.78,"2.103","2.103","JAK2 JH2 in complex with JNJ-7706621","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5USZ"
"5UT0",,"X-RAY DIFFRACTION",2.18,43.67,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris pH 8.0
0.2M Sodium acetate
12-20% PEG 4,000",277,"10.1021/acsmedchemlett.7b00153","35R","5UT0",33.82,"2.102","2.102","JAK2 JH2 in complex with AT9283","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5UT0"
"5UT1",,"X-RAY DIFFRACTION",2.2,44.08,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, pH 8.0
0.2M Sodium acetate
12-20% PEG 4,000",277,"10.1021/acsmedchemlett.7b00153",,"5UT1",33.88,"1.95","1.95","JAK2 JH2 in complex with BI-D1870","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5UT1"
"5UT2",,"X-RAY DIFFRACTION",2.19,43.81,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, pH 8.0
0.2M Sodium acetate
12-20% PEG 4,000",277,"10.1021/acsmedchemlett.7b00153","3YT","5UT2",33.76,"1.75","1.75","JAK2 JH2 in complex with PRT062607","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5UT2"
"5UT3",,"X-RAY DIFFRACTION",2.2,43.99,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, pH 8.0
0.2M Sodium acetate
12-20% PEG 4,000",277,"10.1021/acsmedchemlett.7b00153","IK1","5UT3",33.72,"1.501","1.501","JAK2 JH2 in complex with IKK-2 Inhibitor VI","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5UT3"
"5UT4",,"X-RAY DIFFRACTION",2.23,44.84,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, pH 8.0
0.2M Sodium acetate
12-20% PEG 4,000",277,"10.1021/acsmedchemlett.7b00154","DQX","5UT4",33.87,"2","2","JAK2 JH2 in complex with NVP-BSK805","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5UT4"
"5UT5",,"X-RAY DIFFRACTION",2.19,43.84,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, pH 8.0
0.2M Sodium acetate
12-20% PEG 4,000",277,"10.1021/acsmedchemlett.7b00154","2HB","5UT5",34.05,"1.9","1.9","JAK2 JH2 in complex with GLPG0634","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5UT5"
"5UT6",,"X-RAY DIFFRACTION",2.2,44.05,"VAPOR DIFFUSION, HANGING DROP",8,"0.1M Tris, pH 8.0
0.2M Sodium acetate
12-20% PEG 4,000",277,"10.1021/acsmedchemlett.7b00154","8MY","5UT6",34.03,"1.645","1.645","JAK2 JH2 in complex with a diaminopyrimidine","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRGSHHHHHH","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5UT6"
"5UTK",,"X-RAY DIFFRACTION",3.3,62.77,"VAPOR DIFFUSION, HANGING DROP",4.5,"25-40% glycerol, 
2.5-15% PEG 3K, 
100 mM sodium acetate,
100 mM sodium phosphate, pH 4.5",277,"10.1073/pnas.1617800114",,"5UTK",68.27,"2.5","2.5","Crystal structure of the membrane proximal three fibronectin type III (FNIII) domains of Tie2 (Tie2[FNIIIa-c])","GSGSKVLPKPLNAPNVIDTGHNFAVINISSEPYFGDGPIKSKKLLYKPVNHYEAWQHIQVTNEIVTLNYLEPRTEYELCVQLVRRGEGGEGHPGPVRRFTTASIGLPPPRGLNLLPKSQTTLNLTWQPIFPSSEDDFYVEVERRSVQKSDQQNIKVPGNLTSVLLNNLHPREQYMVRARVNTKAQGEWSEDLTAWTLSDILPPQPENIKISNITHSSAMISWTILDGYSISSITIRYKVQGKNEDQHVDVKIKNATITQYQLKGLEPETAYQVDIFAENNIGSSNPAFSHELVTLPESQAPADL","Homo sapiens","TEK, TIE2, VMCM, VMCM1","Angiopoietin-1 receptor","1","5UTK"
"5UU1",,"X-RAY DIFFRACTION",2.23,44.95,"VAPOR DIFFUSION, SITTING DROP",7.5,"22.5% PEG 3350; 20 MM MAGNESIUM, CHLORIDE, 0.1M CHC BUFFER pH 7.5, STABILIZED WITH 20% (V/V) GLYCEROL",293,"10.1038/s41598-017-07755-y",,"5UU1",37.18,"2","2","Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to BI-D1870","SMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDFSTKGQSINVH","Homo sapiens","VRK2","Serine/threonine-protein kinase VRK2","1","5UU1"
"5UU2",,"X-RAY DIFFRACTION",3.4,63.79,"VAPOR DIFFUSION, SITTING DROP",8.5,"238mM Sodium Citrate, 100mM Hepes pH 8.5",293,,,"5UU2",5.84,"1.223","1.223","Insulin with proline analog ThioP at position B28 in the T2 state","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin Chain A","1","5UU2"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin Chain B","2","5UU2"
"5UU3",,"X-RAY DIFFRACTION",1.97,37.41,"VAPOR DIFFUSION, SITTING DROP",8,"300mM Tris pH 8, 17mM Zinc Acetate, 1% phenol, 425mM Sodium Citrate, 15% Acetone",293,,,"5UU3",71.68,"2.25","2.25","Insulin with proline analog DfP at position B28 in the R6 state","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin, chain B","1","5UU3"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTXKT","Homo sapiens","INS","Insulin, chain A","2","5UU3"
"5UU4",,"X-RAY DIFFRACTION",2.01,38.74,"VAPOR DIFFUSION, SITTING DROP",8,"300mM Tris pH 8, 17mM Zinc Acetate, 1% Phenol, 275mM Sodium Citrate, 9.38% Acetone",293,,,"5UU4",12.06,"1.973","1.973","Insulin with proline analog ThioP at position B28 in the R6 state","GIVEQCCTSICSLYQLENYCN","Homo sapiens","INS","Insulin A Chain","1","5UU4"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPKT","Homo sapiens","INS","Insulin B Chain","2","5UU4"
"5UUI",,"X-RAY DIFFRACTION",2,38.44,"VAPOR DIFFUSION, SITTING DROP",8.5,"TNFa (VCID10616, B114005) at 10 mg/ml (in 10 mM HEPES, pH = 7.5, 150 mM NaCl) was mixed with an equal volume of protein solution and a solution containing 24% (w/v) PEG-4000, 0.24 M MgCl2, 0.05% DDM, and 0.1 M HEPES/NaOH, pH=8.5.  Crystals were produced by sitting drop vapor diffusion at 16 degrees Celsius. Crystals were then soaked with the same solution supplemented with 10% MTSL for one week and harvested with paraffin oil.",289,"10.1016/j.bpj.2017.06.007",,"5UUI",17.72,"1.4","1.4","Crystal Structure of Spin-Labeled T77C TNFa","SVRSSSRTPSDKPVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVPSEGLYLIYSQVLFKGQGCPSTHVLLCHTISRIAVSYQTKVNLLSAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEINRPDYLDFAESGQVYFGIIAL","Homo sapiens","TNF, TNFA, TNFSF2","Tumor necrosis factor","1","5UUI"
"5UUT",,"X-RAY DIFFRACTION",2.25,45.41,"VAPOR DIFFUSION, HANGING DROP",4.5,"22.5% PEG 4000, 5 mM NiCl2, 100 mM sodium citrate pH 4.5, and 2.5% glycerol",293,"10.1158/0008-5472.CAN-17-0981",,"5UUT",93.25,"2.252","2.252","N-myristoyltransferase 1 (NMT) bound to myristoyl-CoA","GPHMEEASKRSYQFWDTQPVPKLGEVVNTHGPVEPDKDNIRQEPYTLPQGFTWDALDLGDRGVLKELYTLLNENYVEDDDNMFRFDYSPEFLLWALRPPGWLPQWHCGVRVVSSRKLVGFISAIPANIHIYDTEKKMVEINFLCVHKKLRSKRVAPVLIREITRRVHLEGIFQAVYTAGVVLPKPVGTCRYWHRSLNPRKLIEVKFSHLSRNMTMQRTMKLYRLPETPKTAGLRPMETKDIPVVHQLLTRYLKQFHLTPVMSQEEVEHWFYPQENIIDTFVVENANGEVTDFLSFYTLPSTIMNHPTHKSLKAAYSFYNVHTQTPLLDLMSDALVLAKMKGFDVFNALDLMENKTFLEKLKFGIGDGNLQYYLYNWKCPSMGAEKVGLVLQ","Homo sapiens","NMT1, NMT","Glycylpeptide N-tetradecanoyltransferase 1","1","5UUT"
"5UUU",,"X-RAY DIFFRACTION",3.5,64.88,"VAPOR DIFFUSION, SITTING DROP",5.6,"18% PEG MME 2000, 0.1 M MES pH 5.6, and 0.0175M Ammonium Sulfate",273,"10.1021/acs.jmedchem.7b00443","QRW","5UUU",64.09,"2.7","2.7","Design, Synthesis, and Evaluation of the First Selective and Potent G-protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure","MSYYHHHHHHDYDIPTTENLYFQGAMEPGGSTPAARASKKILLPEPSIRSVMQKYLEDRGEVTFEKIFSQKLGYLLFRDFCLNHLEEARPLVEFYEEIKKYEKLETEEERVARSREIFDSYIMKELLACSHPFSKSATEHVQGHLGKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEA","Homo sapiens","GRK2, ADRBK1, BARK, BARK1","Beta-adrenergic receptor kinase 1","1","5UUU"
"5UV6",,"X-RAY DIFFRACTION",4.66,73.62,"VAPOR DIFFUSION, SITTING DROP",6.5,"A 50/50 (v/v) mix of 1.6 M MgSO4, 0.1 M MES pH 6.5 with 20% PEG 8000, 100 mM HEPES pH 7.5.",293,"10.1038/s41467-019-10966-8",,"5UV6",65.31,"2.65001977608","2.65001977608","Crystal structure of human Opioid Binding Protein/Cell Adhesion Molecule Like (OPCML)","ATFPKAMDNVTVRQGESATLRCTIDDRVTRVAWLNRSTILYAGNDKWSIDPRVIILVNTPTQYSIMIQNVDVYDEGPYTCSVQTDNHPKTSRVHLIVQVPPQIMNISSDITVNEGSSVTLLCLAIGRPEPTVTWRHLSVKEGQGFVSEDEYLEISDIKRDQSGEYECSALNDVAAPDVRKVKITVNYPPYISKAKNTGVSVGQKGILSCEASAVPMAEFQWFKEETRLATGLDGMRIENKGRMSTLTFFNVSEKDYGNYTCVATNKLGNTNASITLYGPGAALVPR","Homo sapiens","OPCML, IGLON1, OBCAM","Opioid-binding protein/cell adhesion molecule","1","5UV6"
"5UVC",,"X-RAY DIFFRACTION",2.42,49.08,"VAPOR DIFFUSION, SITTING DROP",5.9,"18% PEG MME 2000, 100mM MES pH 5.9, 17.5mM Ammonium Sulfate",273,"10.1021/acs.jmedchem.7b00443",,"5UVC",63.81,"2.65","2.65","Design, Synthesis, and Evaluation of the First Selective and Potent G-protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure","MSYYHHHHHHDYDIPTTENLYFQGAMEPGGSTPAARASKKILLPEPSIRSVMQKYLEDRGEVTFEKIFSQKLGYLLFRDFCLNHLEEARPLVEFYEEIKKYEKLETEEERVARSREIFDSYIMKELLACSHPFSKSATEHVQGHLGKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPLTISERWQQEVAETVFDTINAETDRLEA","Homo sapiens","GRK2, ADRBK1, BARK, BARK1","Beta-adrenergic receptor kinase 1","1","5UVC"
"5UVF",,"X-RAY DIFFRACTION",2.56,51.96,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG3350, 0.1M BISTRIS, 0.2M,  LITHIUM SULFATE, PH 6.5",293,"10.1038/s41598-017-07755-y",,"5UVF",167.21,"2","2","Crystal Structure of the Human vaccinia-related kinase bound to BI-D1870","SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVENGGLKAKTITKKRAAEIEE","Homo sapiens","VRK1","Serine/threonine-protein kinase VRK1","1","5UVF"
"5UVG",,"X-RAY DIFFRACTION",2.03,39.33,"VAPOR DIFFUSION, HANGING DROP",7.5,"PEG 400, calcium chloride, glycerol, HEPES",289.15,"10.1073/pnas.1705134114",,"5UVG",41.39,"1.849","1.849","Crystal structure of the human neutral sphingomyelinase 2 (nSMase2) catalytic domain with insertion deleted and calcium bound","SGTGPGKSFCFATANVCLLPDSLARVNNLFNTQARAKEIGQRIRNGAARPQIKIYIDSPHPDEAFDHEVSAFFPANLDFLCLQEVFDKRAATKLKEQLHGYFEYILYDVGVYGCQGCCSFKCLNSGLLFASRYPIMDVAYHCYPNKCNDDALASKGALFLKVQVGSTPQDQRIVGYIACTHLHAPQEDSAIRCGQLDLLQDWLADFRKSTSSSSAANPEELVAFDVVCGDFNFDNCSSDDKLEQQHSLFTHYRDPCRLGPGEEKPWAIGTLLDTNGLYDEDVCTPDNLQKVLESEEGRREYLAFPTSKSSGQKGRKELLKGNGRRIDYMLHAEEGLCPDWKAEVEEFSFITQLSGLTDHLPVAMRLMVSSG","Homo sapiens","SMPD3","Sphingomyelin phosphodiesterase 3,Sphingomyelin phosphodiesterase 3","1","5UVG"
,,,,,,,,,,,,,,,,,"Homo sapiens","SMPD3"
"5UVS",,"X-RAY DIFFRACTION",2.75,55.22,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl  5mM DTT
Crystallization :
15 % (v/v) Ethanol   Tris PH 7.0",277,,,"5UVS",13.19,"2.15","2.15","BRD4_BD2_A-1406537","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UVS"
"5UVT",,"X-RAY DIFFRACTION",3.02,59.26,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl     5 mM DTT
Crystallization :
15 % (v/v) Ethanol Tris PH 7.0",277,,,"5UVT",13.22,"1.67","1.67","BRD4_BD2_A-1454056","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UVT"
"5UVU",,"X-RAY DIFFRACTION",3,59.07,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 MM NaCl  5 mM DTT
Crystallization :
15 % (v/v) Ethanol,  Tris PH 7.0",277,,"8O4","5UVU",13.2,"1.66","1.66","BRD4_BD2_A-1461028","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UVU"
"5UVV",,"X-RAY DIFFRACTION",2.12,41.86,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl   5mM DTT
Crystallization :
15 % (v/v) Ethanol   Tris PH 7.0",277,,,"5UVV",26.41,"1.99","1.99","BRD4 Bromodomain 2 with A-1457066","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UVV"
"5UVW",,"X-RAY DIFFRACTION",4.85,74.66,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl    5 mM DTT
Crystallization :
15 % (v/v) Ethanol   Tris PH 7.0",277,,"8NG","5UVW",41.02,"2.14","2.14","BRD4_Bromodomain1-A1376855","KRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELP","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UVW"
"5UVX",,"X-RAY DIFFRACTION",2.65,53.67,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl   5 mM DTT
Crystallization :
15 % (v/v) Ethanol    Tris PH 7.0",277,,"8NM","5UVX",26.43,"1.53","1.53","BRD4 Bromodomain 2 with A-1359643","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UVX"
"5UVY",,"X-RAY DIFFRACTION",2.77,55.67,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl   5 mM DTT
Crystallization :
15 % (v/v) Ethanol   Tris PH 7.0",277,,"8NJ","5UVY",13.12,"2.25","2.25","BRD4 Bromodomain 2 with A-1349391","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UVY"
"5UVZ",,"X-RAY DIFFRACTION",2.78,55.69,"VAPOR DIFFUSION",,"Protein Buffer :
10 mM HEPES PH 7.5
100 mM NaCl   5 mM DTT
Crystallization :
15 % (v/v) Ethanol   Tris  PH 7.0",277,,"8NP","5UVZ",13.08,"1.63","1.63","BRD4 Bromodomain 2 with A-1354689","SHMEQLKCCSGILKEMFAKKHAAYAWPFYKPVDVEALGLHDYCDIIKHPMDMSTIKSKLEAREYRDAQEFGADVRLMFSNCYKYNPPDHEVVAMARKLQDVFEMRFAKM","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5UVZ"
"5UWD",,"X-RAY DIFFRACTION",2.58,52.31,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.1 M Tris (pH 8.50), 0.1 M potassium sulfate, 22.7 %w/v PEG 4000",286,"10.1016/j.chembiol.2017.08.017",,"5UWD",38.14,"3.06","3.06","Crystal structure of EGFR kinase domain (L858R, T790M, V948R) in complex with the covalent inhibitor CO-1686","GSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQG","Homo sapiens","EGFR, ERBB, ERBB1, HER1","Epidermal growth factor receptor","1","5UWD"
"5UWF",,"X-RAY DIFFRACTION",2.01,38.93,"VAPOR DIFFUSION",7.5,"15%PEG3350,0.2M calcium acetate,20mM BME",293,"10.1021/acs.jmedchem.7b00302","8Q7","5UWF",80.09,"1.87","1.87","Crystal structure of human PDE10A in complex with inhibitor 16d","SMASICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED","Homo sapiens","PDE10A","cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A","1","5UWF"
"5UWG",,"X-RAY DIFFRACTION",3.6,66,"VAPOR DIFFUSION, SITTING DROP",3.5,"0.1 M citric acid pH 3.5, 28% w/v polyethylene glycol 8,000",293,"10.1101/gad.298331.117",,"5UWG",29.21,"2.56","2.56","The crystal structure of Fz4-CRD in complex with palmitoleic acid","EEERRCDPIRISMCQNLGYNVTKMPNLVGHELQTDAELQLTTFTPLIQYGCSSQLQFFLCSVYVPMCTEKINIPIGPCGGMCLSVKRRCEPVLKEFGFAWPESLNCSKFPPQNDHNHMCMEGPGD","Homo sapiens","FZD4","Frizzled-4","1","5UWG"
"5UWK",,"X-RAY DIFFRACTION",2.19,39.6,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M magnesium chloride, 0.1 M Tris:HCl pH 8.5, 25% PEG 3350",295,"10.1021/acs.jmedchem.7b00514","8OM","5UWK",40.26,"1.6","1.6","Matrix metalloproteinase-13 complexed with selective inhibitor compound (S)-10a","MYNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPN","Homo sapiens","MMP13","Collagenase 3","1","5UWK"
"5UWL",,"X-RAY DIFFRACTION",4.47,72.49,"VAPOR DIFFUSION, SITTING DROP",7,"0.2 M sodium chloride, 0.1 M Tris pH 7, 1.0 M sodium citrate",277,"10.1021/acs.jmedchem.7b00514","8OJ","5UWL",40.09,"2.55","2.55","Matrix metalloproteinase-13 complexed with selective inhibitor compound (S)-17a","MYNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPN","Homo sapiens","MMP13","Collagenase 3","1","5UWL"
"5UWN",,"X-RAY DIFFRACTION",4.88,74.78,"VAPOR DIFFUSION, SITTING DROP",7,"0.1 M HEPES, 1.6 M ammonium sulfate",277,"10.1021/acs.jmedchem.7b00514","8O7","5UWN",101.52,"3.2","3.2","Matrix metalloproteinase-13 complexed with selective inhibitor compound 10d","MYNVFPRTLKWSKMNLTYRIVNYTPDMTHSEVEKAFKKAFKVWSDVTPLNFTRLHDGIADIMISFGIKEHGDFYPFDGPSGLLAHAFPPGPNYGGDAHFDDDETWTSSSKGYNLFLVAAHEFGHSLGLDHSKDPGALMFPIYTYTGKSHFMLPDDDVQGIQSLYGPGDEDPN","Homo sapiens","MMP13","Collagenase 3","1","5UWN"
"5UX6",,"X-RAY DIFFRACTION",2.79,55.98,"VAPOR DIFFUSION, HANGING DROP",5,"16.5% v/v PEG3350, 0.05% w/v octyl-beta-D-glucoside, 0.5% v/v glycerol, and 100 mM sodium citrate pH 5.0",277,"10.1093/glycob/cwx020",,"5UX6",84.28,"2.09","2.09","Structure of Human POFUT1 in its apo form","MPAGSWDPAGYLLYCPCMGRFGNQADHFLGSLAFAKLLNRTLAVPPWIEYQHHKPPFTNLHVSYQKYFKLEPLQAYHRVISLEDFMEKLAPTHWPPEKRVAYCFEVAAQRSPDKKTCPMKEGNPFGPFWDQFHVSFAKSELFTGISFSASYREQWSQRFSPKEHPVLALPGAPAQFPVLEEHRPLQKYMVWSDEMVKTGEAQIHAHLVRPYVGIHLRIGSDWKNACAMLKDGTAGSHFMASPQCVGYSRSTAAPLTMTMCLPDLKEIQRAVKLWVRSLDAQSVYVATDSESYVPELQQLFKGKVKVVSLKPEVAQVDLYILGQADHFIGNCVSSFTAFVKRERDLQGRPSSFFGMDRPPKLHHHHHH","Homo sapiens","POFUT1, FUT12, KIAA0180","GDP-fucose protein O-fucosyltransferase 1","1","5UX6"
"5UXH",,"X-RAY DIFFRACTION",2.78,55.78,"VAPOR DIFFUSION, HANGING DROP",5,"16.5% v/v PEG3350, 0.05% w/v octyl-beta-D-glucoside, 0.5% v/v glycerol, and 100 mM sodium citrate pH 5.0. The ligand-bound structure was obtained by soaking crystals for 15 minutes in cryopreservation solution containing 2 mM GDP-Fucose immediately prior to freezing",277,"10.1093/glycob/cwx020",,"5UXH",85.37,"2.41","2.41","Structure of Human POFUT1 in complex with GDP-fucose","MPAGSWDPAGYLLYCPCMGRFGNQADHFLGSLAFAKLLNRTLAVPPWIEYQHHKPPFTNLHVSYQKYFKLEPLQAYHRVISLEDFMEKLAPTHWPPEKRVAYCFEVAAQRSPDKKTCPMKEGNPFGPFWDQFHVSFAKSELFTGISFSASYREQWSQRFSPKEHPVLALPGAPAQFPVLEEHRPLQKYMVWSDEMVKTGEAQIHAHLVRPYVGIHLRIGSDWKNACAMLKDGTAGSHFMASPQCVGYSRSTAAPLTMTMCLPDLKEIQRAVKLWVRSLDAQSVYVATDSESYVPELQQLFKGKVKVVSLKPEVAQVDLYILGQADHFIGNCVSSFTAFVKRERDLQGRPSSFFGMDRPPKLHHHHHH","Homo sapiens","POFUT1, FUT12, KIAA0180","GDP-fucose protein O-fucosyltransferase 1","1","5UXH"
"5UXQ",,"X-RAY DIFFRACTION",2.22,44.62,"VAPOR DIFFUSION",,"65% (v/v) 2-methyl-2,4-pentanediol and 0.1 M Tris, pH 8.0",295,,,"5UXQ",99.81,"2.415","2.415","Structure of anti-HIV trimer apex antibody PGT143","QLEQSGAEVKKPGSSVKVSCKASGNTFSKYDVHWVRQATGQGLEWVGWMSHEGDKTESAQRFKGRVTFTRDTSASTAYMELRGLTSDDTAIYYCTRGSKHRLRDYVLYDDYGLINYQEWNDYLEFLDVWGHGTAVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"PGT143 Fab Heavy Chain","1","5UXQ"
,,,,,,,,,,,,,,,,"TVVTQSPLSLPVTPGEAASMSCTSTQSLRHSNGANYLAWYQHKPGQSPRLLIRLGSQRASGVPDRFSGSGSGTHFTLKISRVEPEDAAIYYCMQGLNRPWTFGKGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"PGT143 Fab Light Chain","2","5UXQ"
"5UY3",,"X-RAY DIFFRACTION",2.63,53.31,"VAPOR DIFFUSION, SITTING DROP",,"JCSG F8",293,"10.1016/j.immuni.2017.03.017",,"5UY3",98.87,"2.9","2.9","Crystal structure of human Fab PGT144, a broadly reactive and potent HIV-1 neutralizing antibody","TVVTQSPLSLSVTPGEAASMSCTSTQSLRHSNGANYLAWYQHKPGQSPRLLIRLGSQRASGVPDRFSGSGSGTHFTLKISRVEADDAAIYYCMQGLNRPWTFGKGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRG","Homo sapiens",,"Antibody PGT144 Fab light chain","1","5UY3"
,,,,,,,,,,,,,,,,"LVQSGAEVKKPGSSVKVSCKASGNTFRKYDVHWVRQATGQGLEWVGWMSHEGDKTESAQRFKGRVSFTRDNSASTAYIELRGLTSDDTAIYYCTGGSKHRLRDYVLYDDYGLINQQEWNDYLEFLDVWGHGTAVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP","Homo sapiens",,"Antibody PGT144 Fab heavy chain","2","5UY3"
"5UY6",,"X-RAY DIFFRACTION",2.47,50.29,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG 3350; 0.1M Bis-Tris; 0.2M ammonium acetate",293,,,"5UY6",33.51,"1.7","1.7","Crystal Structure of the Human CAMKK2B","SMQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTRH","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","5UY6"
"5UY8",,"X-RAY DIFFRACTION",2.3,46.44,"VAPOR DIFFUSION, SITTING DROP",7,"100mM Hepes pH 7, 22% PEG 3350, 200mM Magnesium Chloride",281,"10.1021/acs.jmedchem.7b01046","8UM","5UY8",267.49,"2.39","2.39","Crystal structure of AICARFT bound to an antifolate","MAHHHHHHSLAPGQLALFSVSDKTGLVEFARNLTALGLNLVASGGTAKALRDAGLAVRDVSELTGFPEMLGGRVKTLHPAVHAGILARNIPEDNADMARLDFNLIRVVACNLYPFVKTVASPGVTVEEAVEQIDIGGVTLLRAAAKNHARVTVVCEPEDYVVVSTEMQSSESKDTSLETRRQLALKAFTHTAQYDEAISDYFRKQYSKGVSQMPLRYGMNPHQTPAQLYTLQPKLPITVLNGAPGFINLCDALNAWQLVKELKEALGIPAAASFKHVSPAGAAVGIPLSEDEAKVCMVYDLYKTLTPISAAYARARGADRMSSFGDFVALSDVCDVPTAKIISREVSDGIIAPGYEEEALTILSKKKNGNYCVLQMDQSYKPDENEVRTLFGLHLSQKRNNGVVDKSLFSNVVTKNKDLPESALRDLIVATIAVKYTQSNSVCYAKNGQVIGIGAGQQSRIHCTRLAGDKANYWWLRHHPQVLSMKFKTGVKRAEISNAIDQYVTGTIGEDEDLIKWKALFEEVPELLTEAEKKEWVEKLTEVSISSDAFFPFRDNVDRAKRSGVAYIAAPSGSAADKVVIEACDELGIILAHTNLRLFHH","Homo sapiens","ATIC, PURH, OK/SW-cl.86","Bifunctional purine biosynthesis protein PURH","1","5UY8"
"5UYJ",,"X-RAY DIFFRACTION",2.43,49.37,"VAPOR DIFFUSION, SITTING DROP",8.5,"20% PEG 3350, 20 mM Ammonium Sulphate, 0.1M Citric acid-Hepes-CHES buffer system",293,,,"5UYJ",33.47,"1.6","1.6","Crystal Structure of the Human CAMKK2B","SMQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTRH","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","5UYJ"
"5UYS",,"X-RAY DIFFRACTION",2.6,52.76,"VAPOR DIFFUSION, HANGING DROP",,"175 mM Tris HCl, pH 8.5, 30% PEG-3350, 300 mM LiSO4, 3% glycerol",293,,,"5UYS",226.83,"2.392","2.392","Human steroidogenic cytochrome P450 17A1 with 3alphaOH-5alpha-abiraterone analog","MAKKTGAKYPKSLLSLPLVGSLPFLPRHGHMHNNFFKLQKKYGPIYSVRMGTKTTVIVGHHQLAKEVLIKKGKDFSGRPQMATLDIASNNRKGIAFADSGAHWQLHRRLAMATFALFKDGDQKLEKIICQEISTLCDMLATHNGQSIDISFPVFVAVTNVISLICFNTSYKNGDPELNVIQNYNEGIIDNLSKDSLVDLVPWLKIFPNKTLEKLKSHVKIRNDLLNKILENYKEKFRSDSITNMLDTLMQAKMNSDNGNAGPDQDSELLSDNHILTTIGDIFGAGVETTTSVVKWTLAFLLHNPQVKKKLYEEIDQNVGFSRTPTISDRNRLLLLEATIREVLRLRPVAPMLIPHKANVDSSIGEFAVDKGTEVIINLWALHHNEKEWHQPDQFMPERFLNPAGTQLISPSVSYLPFGAGPRSCIGEILARQELFLIMAWLLQRFDLEVPDDGQLPSLEGIPKVVFLIDSFKVKIKVRQAWREAQAEGSTHHHH","Homo sapiens","CYP17A1, CYP17, S17AH","Steroid 17-alpha-hydroxylase/17,20 lyase","1","5UYS"
"5UYU",,"X-RAY DIFFRACTION",2.81,56.19,"VAPOR DIFFUSION",6.6,"21% polyethylene glycol 5000 MME, 180 mM sodium citrate (pH 6.6), 200 mM ammonium iodide, 3% (v/v) DMSO",298,"10.1039/c7md00106a",,"5UYU",47,"1.9","1.9","Crystal structure of BACE1 in complex with 2-aminooxazoline-3-azaxanthene compound 12","LPRETDEEPEEPGKKGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDES","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5UYU"
"5UYX",,"X-RAY DIFFRACTION",3.57,65.56,"VAPOR DIFFUSION, SITTING DROP",6.4,"0.1 M Sodium acetate, 0.04 Mcitric acid, 0.06 MBis-tris propane pH 6.4, 25 %PEG400",298,"10.1038/s41598-017-03825-3",,"5UYX",240.71,"3.5","3.5","Structure of Human T-complex protein 1 subunit epsilon (CCT5)","MASMGTLAFDEYGRPFLIIKDQDRKSRLMGLEALKSHIMAAKAVANTMRTSLGPNGLDKMMVDKDGDVTVTNDGATILSMMDVDHQIAKLMVELSKSQDDEIGDGTTGVVVLAGALLEEAEQLLDRGIHPIRIADGYEQAARVAIEHLDKISDSVLVDIKDTEPLIQTAKTTLGSKVVNSCHRQMAEIAVNAVLTVADMERRDVDFELIKVEGKVGGRLEDTKLIKGVIVDKDFSHPQMPKKVEDAKIAILTCPFEPPKPKTKHKLDVTSVEDYKALQKYEKEKFEEMIQQIKETGANLAICQWGFDDEANHLLLQNNLPAVRWVGGPEIELIAIATGGRIVPRFSELTAEKLGFAGLVQEISFGTTKDKMLVIEQCKNSRAVTIFIRGGNKMIIEEAKRSLHDALCVIRNLIRDNRVVYGGGAAEISCALAVSQEADKCPTLEQYAMRAFADALEVIPMALSENSGMNPIQTMTEVRARQVKEMNPALGIDCLHKGTNDMKQQHVIETLIGKKQQISLATQMVRMILKIDDIRKPGESEE","Homo sapiens","CCT5, CCTE, KIAA0098","T-complex protein 1 subunit epsilon","1","5UYX"
"5UYZ",,"X-RAY DIFFRACTION",3.61,65.96,"VAPOR DIFFUSION, SITTING DROP",,"0.1 MSodium acetate, 0.04 M citric acid, 0.06 M Bis-Tris propane pH 6.4, and 25% PEG 400",298,"10.1038/s41598-017-03825-3",,"5UYZ",240.86,"3.6","3.6","Structure of Human T-complex protein 1 subunit epsilon (CCT5) mutant His147Arg","MASMGTLAFDEYGRPFLIIKDQDRKSRLMGLEALKSHIMAAKAVANTMRTSLGPNGLDKMMVDKDGDVTVTNDGATILSMMDVDHQIAKLMVELSKSQDDEIGDGTTGVVVLAGALLEEAEQLLDRGIHPIRIADGYEQAARVAIERLDKISDSVLVDIKDTEPLIQTAKTTLGSKVVNSCHRQMAEIAVNAVLTVADMERRDVDFELIKVEGKVGGRLEDTKLIKGVIVDKDFSHPQMPKKVEDAKIAILTCPFEPPKPKTKHKLDVTSVEDYKALQKYEKEKFEEMIQQIKETGANLAICQWGFDDEANHLLLQNNLPAVRWVGGPEIELIAIATGGRIVPRFSELTAEKLGFAGLVQEISFGTTKDKMLVIEQCKNSRAVTIFIRGGNKMIIEEAKRSLHDALCVIRNLIRDNRVVYGGGAAEISCALAVSQEADKCPTLEQYAMRAFADALEVIPMALSENSGMNPIQTMTEVRARQVKEMNPALGIDCLHKGTNDMKQQHVIETLIGKKQQISLATQMVRMILKIDDIRKPGESEE","Homo sapiens","CCT5, CCTE, KIAA0098","T-complex protein 1 subunit epsilon","1","5UYZ"
"5UZ0",,"X-RAY DIFFRACTION",2.32,47.02,"VAPOR DIFFUSION, SITTING DROP",,"100mM Hepes pH 7.3, 5% MPD, 28% PEG 3350, 200mM Magnesium Chloride",281,"10.1021/acs.jmedchem.7b01046","8US","5UZ0",267.28,"1.79","1.79","Crystal structure of AICARFT bound to an antifolate","MAHHHHHHSLAPGQLALFSVSDKTGLVEFARNLTALGLNLVASGGTAKALRDAGLAVRDVSELTGFPEMLGGRVKTLHPAVHAGILARNIPEDNADMARLDFNLIRVVACNLYPFVKTVASPGVTVEEAVEQIDIGGVTLLRAAAKNHARVTVVCEPEDYVVVSTEMQSSESKDTSLETRRQLALKAFTHTAQYDEAISDYFRKQYSKGVSQMPLRYGMNPHQTPAQLYTLQPKLPITVLNGAPGFINLCDALNAWQLVKELKEALGIPAAASFKHVSPAGAAVGIPLSEDEAKVCMVYDLYKTLTPISAAYARARGADRMSSFGDFVALSDVCDVPTAKIISREVSDGIIAPGYEEEALTILSKKKNGNYCVLQMDQSYKPDENEVRTLFGLHLSQKRNNGVVDKSLFSNVVTKNKDLPESALRDLIVATIAVKYTQSNSVCYAKNGQVIGIGAGQQSRIHCTRLAGDKANYWWLRHHPQVLSMKFKTGVKRAEISNAIDQYVTGTIGEDEDLIKWKALFEEVPELLTEAEKKEWVEKLTEVSISSDAFFPFRDNVDRAKRSGVAYIAAPSGSAADKVVIEACDELGIILAHTNLRLFHH","Homo sapiens","ATIC, PURH, OK/SW-cl.86","Bifunctional purine biosynthesis protein PURH","1","5UZ0"
"5UZB","7","ELECTRON MICROSCOPY",,,,,,,"10.1038/nsmb.3444",,"5UZB",275.65,"7",,"Cryo-EM structure of the MAL TIR domain filament","MHHHHHHSSGVDLGTENLYFQSNAEQKLISEEDLSSRWSKDYDVCVCHSEEDLVAAQDLVSYLEGSTASLRCFLQLRDATPGGAIVSELCQALSSSHCRVLLITPGFLQDPWCKYQMLQALTEAPGAEGCTIPLLSGLSRAAYPPELRFMYYVDGRGPDGGFRQVKEAVMRYLQTLS","Homo sapiens","TIRAP, MAL","Toll/interleukin-1 receptor domain-containing adapter protein","1","5UZB"
"5UZJ",,"X-RAY DIFFRACTION",4.66,73.62,"VAPOR DIFFUSION",5.5,"4.5% PEG3350, 100MM MES, 50MM CACL2, 10MM DTT, 0.45 MM PROTEIN, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K",298,"10.1016/j.bmcl.2018.06.040","8UV","5UZJ",96.71,"3.3","3.3","Crystal Structure of ROCK1 bound to an aminopyridine inhibitor","GSLHMSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNR","Homo sapiens","ROCK1","Rho-associated protein kinase 1","1","5UZJ"
"5UZP",,"X-RAY DIFFRACTION",2.3,46.6,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Ammonium Acetate, 0.1 NaCitrate tribasic dihydrate pH 5.6, 15% PEG4000",298,"10.1515/hsz-2019-0106",,"5UZP",103.71,"2.29","2.29","Crystal structure of citrate synthase mutant A348G from homo sapiens","MHHHHHHSSGVDLGTENLYFQSNASSTNLKDILADLIPKEQARIKTFRQQHGKTVVGQITVDMMYGGMRGMKGLVYETSVLDPDEGIRFRGFSIPECQKLLPKAKGGEEPLPEGLFWLLVTGHIPTEEQVSWLSKEWAKRAALPSHVVTMLDNFPTNLHPMSQLSAAVTALNSESNFARAYAQGISRTKYWELIYEDSMDLIAKLPCVAAKIYRNLYREGSGIGAIDSNLDWSHNFTNMLGYTDHQFTELTRLYLTIHSDHEGGNVSAHTSHLVGSALSDPYLSFAAAMNGLAGPLHGLANQEVLVWLTQLQKEVGKDVSDEKLRDYIWNTLNSGRVVPGYGHGVLRKTDPRYTCQREFALKHLPNDPMFKLVAQLYKIVPNVLLEQGKAKNPWPNVDAHSGVLLQYYGMTEMNYYTVLFGVSRALGVLAQLIWSRALGFPLERPKSMSTEGLMKFVDSKSG","Homo sapiens","CS","Citrate synthase, mitochondrial","1","5UZP"
"5UZQ",,"X-RAY DIFFRACTION",2.82,56.4,"VAPOR DIFFUSION",,"0.1 M Succinic Acid pH 7.0, 12% PEG3350",298,"10.1515/hsz-2019-0106",,"5UZQ",51.89,"2.16","2.16","Crystal structure of citrate synthase from homo sapiens","MHHHHHHSSGVDLGTENLYFQSNASSTNLKDILADLIPKEQARIKTFRQQHGKTVVGQITVDMMYGGMRGMKGLVYETSVLDPDEGIRFRGFSIPECQKLLPKAKGGEEPLPEGLFWLLVTGHIPTEEQVSWLSKEWAKRAALPSHVVTMLDNFPTNLHPMSQLSAAVTALNSESNFARAYAQGISRTKYWELIYEDSMDLIAKLPCVAAKIYRNLYREGSGIGAIDSNLDWSHNFTNMLGYTDHQFTELTRLYLTIHSDHEGGNVSAHTSHLVGSALSDPYLSFAAAMNGLAGPLHGLANQEVLVWLTQLQKEVGKDVSDEKLRDYIWNTLNSGRVVPGYGHAVLRKTDPRYTCQREFALKHLPNDPMFKLVAQLYKIVPNVLLEQGKAKNPWPNVDAHSGVLLQYYGMTEMNYYTVLFGVSRALGVLAQLIWSRALGFPLERPKSMSTEGLMKFVDSKSG","Homo sapiens","CS","Citrate synthase","1","5UZQ"
"5UZR",,"X-RAY DIFFRACTION",2.2,44.13,"VAPOR DIFFUSION, SITTING DROP",,"0.2 M Ammonium Acetate pH 7.1, 20% PEG3350",298,"10.1515/hsz-2019-0106",,"5UZR",103.54,"2.3","2.3","Crystal structure of citrate synthase from homo sapiens","MHHHHHHSSGVDLGTENLYFQSNASSTNLKDILADLIPKEQARIKTFRQQHGKTVVGQITVDMMYGGMRGMKGLVYETSVLDPDEGIRFRGFSIPECQKLLPKAKGGEEPLPEGLFWLLVTGHIPTEEQVSWLSKEWAKRAALPSHVVTMLDNFPTNLHPMSQLSAAVTALNSESNFARAYAQGISRTKYWELIYEDSMDLIAKLPCVAAKIYRNLYREGSGIGAIDSNLDWSHNFTNMLGYTDHQFTELTRLYLTIHSDHEGGNVSAHTSHLVGSALSDPYLSFAAAMNGLAGPLHGLANQEVLVWLTQLQKEVGKDVSDEKLRDYIWNTLNSGRVVPGYGHAVLRKTDPRYTCQREFALKHLPNDPMFKLVAQLYKIVPNVLLEQGKAKNPWPNVDAHSGVLLQYYGMTEMNYYTVLFGVSRALGVLAQLIWSRALGFPLERPKSMSTEGLMKFVDSKSG","Homo sapiens","CS","Citrate synthase, mitochondrial","1","5UZR"
"5UZT",,"SOLUTION NMR",,,,,,,"10.1021/acschembio.7b00180",,"5UZT",9.91,,,"Structure of wild type pre-miR21 apical loop","GGUGUUGACUGUUGAAUCUCAUGGCAACACC","Homo sapiens",,"pre-miR-21","1","5UZT"
"5UZY",,"X-RAY DIFFRACTION",2.72,54.78,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium sulfate, 3% 2-propanol, 0.1 M Tris-HCl, pH 7.5",293,"10.1002/anie.201803191",,"5UZY",37.59,"1.71","1.71","Crystal structure of N97A mutant of human macrophage migration inhibitory factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYIAYYDMNAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","5UZY"
"5V0N",,"X-RAY DIFFRACTION",2.8,56.07,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M MgSO4, 0.1 M Na citrate (pH varied from 5.0 to 6.0) and 14 % to 20 % PEG4000",293.15,"10.1016/j.bmcl.2017.04.011","8W4","5V0N",149.76,"2.155","2.155","BACE1 in complex with inhibitor 5g","AGVLPAHGTQHGIRLPLRSGLGGAPLGLRLPRETDEEPEEPGRRGSFVEMVDNLRGKSGQGYYVEMTVGSPPQTLNILVDTGSSNFAVGAAPHPFLHRYYQRQLSSTYRDLRKGVYVPYTQGKWEGELGTDLVSIPHGPNVTVRANIAAITESDKFFINGSNWEGILGLAYAEIARPDDSLEPFFDSLVKQTHVPNLFSLQLCGAGFPLNQSEVLASVGGSMIIGGIDHSLYTGSLWYTPIRREWYYEVIIVRVEINGQDLKMDCKEYNYDKSIVDSGTTNLRLPKKVFEAAVKSIKAASSTEKFPDGFWLGEQLVCWQAGTTPWNIFPVISLYLMGEVTNQSFRITILPQQYLRPVEDVATSQDDCYKFAISQSSTGTVMGAVIMEGFYVVFDRARKRIGFAVSACHVHDEFRTAAVEGPFVTLDMEDCGYNIPQTDEST","Homo sapiens","BACE1, BACE, KIAA1149","Beta-secretase 1","1","5V0N"
"5V18",,"X-RAY DIFFRACTION",2.25,45.3,"VAPOR DIFFUSION, SITTING DROP",,"25% PEG 335, 200 mM ASO4, 100 mM Bis-Tris pH 6.5",293,"10.1021/acs.jmedchem.7b00352",,"5V18",27.16,"2.15","2.15","Structure of PHD2 in complex with 1,2,4-Triazolo-[1,5-a]pyridine","GGSPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNK","Homo sapiens","EGLN1, C1orf12, PNAS-118, PNAS-137","Egl nine homolog 1","1","5V18"
"5V19",,"X-RAY DIFFRACTION",3.17,61.16,"VAPOR DIFFUSION, SITTING DROP",6,"6% polyethylene glycol 2000 MME ,0.05 M ammonium sulphate, 0.1M MES, pH 6.0",277,"10.1016/j.bmcl.2017.02.079",,"5V19",61.43,"3.1","3.1","Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy","LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","5V19"
"5V1B",,"X-RAY DIFFRACTION",2.33,47.21,"VAPOR DIFFUSION, SITTING DROP",,"28% PEG 3350, Bis-Tris 7",273,"10.1021/acs.jmedchem.7b00352","8UY","5V1B",27.03,"2.49","2.49","Structure of PHD1 in complex with 1,2,4-Triazolo-[1,5-a]pyridine","GGSEEALPSAPERLALDYIVPCMRYYGICVVDSFLGAALGGRVLAEVEALKRGGRLRDGQLVSQRAIPPRSIRGDQIAWVEGHEPGCRSIGALMAHVDAVIRHCAGRLGSYKINGRTKAMVACYPGNGLGYVRHVDNPHGDGRCITCIYYLNQNWDVKVHGGLLQIFPEGRPVVANIEPLFDRLLIFWSDRRNPHEVKPAYATRYAITVWYFDADERARAKDKYQLASGQKGVQVPVSQP","Homo sapiens","EGLN2, EIT6","Egl nine homolog 2","1","5V1B"
"5V1M",,"X-RAY DIFFRACTION",2.27,45.9,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% w/v PEG 20,000, 20% v/v glycerol, 100 mM bis-tris base, 50 mM HCl, and 10 mM disodium 5' UMP",289,"10.1038/s41467-017-00484-w",,"5V1M",23.1,"1.47","1.47","Structure of human Usb1 with uridine 5'-monophosphate","GAHMGNWATHVYVPYEAKEEFLDLLDVLLPHAQTYVPRLVRMKVFHLSLSQSVVLRHHWILPFVQALKARMTSFHRFFFTANQVKIYTNQEKTRTFIGLEVTSGHAQFLDLVSEVDRVMEEFNLTTFYQDPSFHLSLAWCVGDARLQLEGQCLQELQAIVDGFEDAEVLLRVHTEQVRCKSGNKFFSMPLK","Homo sapiens","USB1, C16orf57, Mpn1","U6 snRNA phosphodiesterase","1","5V1M"
"5V24",,"X-RAY DIFFRACTION",3.14,60.84,"VAPOR DIFFUSION, SITTING DROP",6,"6% polyethylene glycol 2000 MME, 0.1M MES, pH 6.0",277,"10.1016/j.bmcl.2017.02.079","8V7","5V24",61.65,"2.5","2.5","Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy","LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","5V24"
"5V2N",,"X-RAY DIFFRACTION",2,38.62,"VAPOR DIFFUSION, SITTING DROP",,"30% PEGMME 550, 5% ethylene glycol, and 100 mM TRIS (pH 8.2-8.8)",293,"10.7554/eLife.45403",,"5V2N",18.69,"2","2","Crystal Structure of APO Human SETD8","GGSSRKSKAELQSEERKRIDELIESGKEEGMKIDLIDGKGRGVIATKQFSRGDFVVEYHGDLIEITDAAARAALYAQDPSTGCYMYYFQYLSKTYCVDATRETNRLGRLINHSKCGNCQTKLHDIDGVPHLILIASRDIAAGEELLYDYGDRSKASIEAHPWLKH","Homo sapiens","KMT5A, PRSET7, SET07, SET8, SETD8","N-lysine methyltransferase KMT5A","1","5V2N"
"5V35",,"X-RAY DIFFRACTION",2.4,48.81,"VAPOR DIFFUSION",,"100 mM Na-Citrate
20 % (W/V) PEG 4000
20 % (V/V) 2-Propanol",291,"10.1073/pnas.1704782114",,"5V35",19.58,"2.5","2.5","Crystal structure of V71F mutant of the FKBP domain of human aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) complexed with S-farnesyl-L-cysteine methyl ester","MGHHHHHHGDAALLLNVEGVKKTILHGGTGELPNFITGSRVIFHFRTMKCDEERTVIDDSRQVGQPMHIIIGNMFKLEFWEILLTSMRVHEVAEFWCDTIHTGVYPILSRSLRQMAQGKDPTEWHVHTCGLANMFAYHTLGYEDLDELQKEPQPLVFVIELLQVDAPSD","Homo sapiens","AIPL1, AIPL2","Aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1)","1","5V35"
"5V37",,"X-RAY DIFFRACTION",2.2,44.07,"VAPOR DIFFUSION, HANGING DROP",8,"0.10 M Magnesium formate, 0.1M Tris 8.0, 14% w/v PEG 3350",293,"10.1371/journal.pone.0197372",,"5V37",50.62,"1.42","1.42","Crystal structure of SMYD3 with SAM and EPZ028862","MEPLKVEKFATANRGNGLRAVTPLRPGELLFRSDPLAYTVCKGSRGVVCDRCLLGKEKLMRCSQCRVAKYCSAKCQKKAWPDHKRECKCLKSCKPRYPPDSVRLLGRVVFKLMDGAPSESEKLYSFYDLESNINKLTEDKKEGLRQLVMTFQHFMREEIQDASQLPPAFDLFEAFAKVICNSFTICNAEMQEVGVGLYPSISLLNHSCDPNCSIVFNGPHLLLRAVRDIEVGEELTICYLDMLMTSEERRKQLRDQYCFECDCFRCQTQDKDADMLTGDEQVWKEVQESLKKIEELKAHWKWEQVLAMCQAIISSNSERLPDINIYQLKVLDCAMDACINLGLLEEALFYGTRTMEPYRIFFPGSHPVRGVQVMKVGKLQLHQGMFPQAMKNLRLAFDIMRVTHGREHSLIEDLILLLEECDANIRAS","Homo sapiens","SMYD3, ZMYND1, ZNFN3A1","Histone-lysine N-methyltransferase SMYD3","1","5V37"
"5V39",,"X-RAY DIFFRACTION",2.1,41.53,"VAPOR DIFFUSION",,"100mM Tris HCl pH 8.5, 25% PEG 3350 and 200mM Ammonium Sulfate",298,"10.1038/s41467-017-00978-7",,"5V39",29.65,"2.2","2.2","Crystal structure of human vitamin D receptor ligand binding domain in complex with a VDRM","SLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSVTLELLQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEG","Homo sapiens","VDR, NR1I1","Vitamin D3 receptor","1","5V39"
"5V3B",,"X-RAY DIFFRACTION",2.31,46.76,"VAPOR DIFFUSION, HANGING DROP",6,"50 mM CaCl2, 100 mM MES (pH 6.0), 7.5% PEG1500",293,"10.1038/s41590-019-0492-0",,"5V3B",258.96,"3","3","Human A20 OTU domain (WT) with acetamidylated C103","MAEQVLPQALYLSNMRKAVKIRERTPEDIFKPTNGIIHHFKTMHRYTLEMFRTCQFCPQFREIIHKALIDRNIQATLESQKKLNWCREVRKLVALKTNGDGNCLMHATSQYMWGVQDTDLVLRKALFSTLKETDTRNFKFRWQLESLKSQEFVETGLCYDTRNWNDEWDNLIKMASTDTPMARSGLQYNSLEEIHIFVLCNILRRPIIVISDKMLRSLESGSNFAPLKVGGIYLPLHWPAQECYRYPIVLGYDSHHFVPLVTLKDSGPEIRAVPLVNRDRGRFEDLKVHFLTDPENEMKEKLLKEYLMVIEIPVQGWDHGTTHLINAAKLDEANLPKEINLVDDYFELVQHEYKKWQENSEQGRRE","Homo sapiens","TNFAIP3, OTUD7C","Tumor necrosis factor alpha-induced protein 3","1","5V3B"
"5V3H",,"X-RAY DIFFRACTION",3.12,60.52,"VAPOR DIFFUSION, HANGING DROP",8,"5% v/v Ethanol, 0.1 M Tris pH 7.5, 26% w/v PEG3350",293,"10.1371/journal.pone.0197372","8WG","5V3H",52.91,"2.69","2.69","Crystal structure of SMYD2 with SAM and EPZ033294","SIADYKDDDDKMRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLGFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH","Homo sapiens","SMYD2, KMT3C","N-lysine methyltransferase SMYD2","1","5V3H"
"5V3P",,"X-RAY DIFFRACTION",2.22,44.63,"VAPOR DIFFUSION, HANGING DROP",6,"50 mM CaCl2, 100 mM MES (pH 6.0), 5.0 % PEG1500",293,"10.1038/s41590-019-0492-0",,"5V3P",258.97,"2.5","2.5","Human A20 OTU domain (I325N) with acetamidylated C103","MAEQVLPQALYLSNMRKAVKIRERTPEDIFKPTNGIIHHFKTMHRYTLEMFRTCQFCPQFREIIHKALIDRNIQATLESQKKLNWCREVRKLVALKTNGDGNCLMHATSQYMWGVQDTDLVLRKALFSTLKETDTRNFKFRWQLESLKSQEFVETGLCYDTRNWNDEWDNLIKMASTDTPMARSGLQYNSLEEIHIFVLCNILRRPIIVISDKMLRSLESGSNFAPLKVGGIYLPLHWPAQECYRYPIVLGYDSHHFVPLVTLKDSGPEIRAVPLVNRDRGRFEDLKVHFLTDPENEMKEKLLKEYLMVIEIPVQGWDHGTTHLNNAAKLDEANLPKEINLVDDYFELVQHEYKKWQENSEQGRRE","Homo sapiens","TNFAIP3, OTUD7C","Tumor necrosis factor alpha-induced protein 3","1","5V3P"
"5V3Q",,"X-RAY DIFFRACTION",2.38,48.34,"VAPOR DIFFUSION, HANGING DROP",4.6,"1.0-1.2 M ammonium sulfate, 50 mM sodium acetate, pH 4.6",298,"10.1038/s41598-017-17861-6",,"5V3Q",28.16,"2.25","2.25","Human GSTO1-1 complexed with ML175","MSGESARSLGKGSAPPGPVPEGSIRIYSMRFCPFAERTRLVLKAKGIRHEVININLKNKPEWFFKKNPFGLVPVLENSQGQLIYESAITCEYLDEAYPGKKLLPDDPYEKACQKMILELFSKVPSLVGSFIRSQNKEDYAGLKEEFRKEFTKLEEVLTNKKTTFFGGNSISMIDYLIWPWFERLEAMKLNECVDHTPKLKLWMAAMKEDPTVSALLTSEKDWQGFLELYLQNSPEACDYGL","Homo sapiens","GSTO1, GSTTLP28","Glutathione S-transferase omega-1","1","5V3Q"
"5V43",,"X-RAY DIFFRACTION",2.3,46.6,"VAPOR DIFFUSION, SITTING DROP",5,"50 mM sodium citrate pH 5.0 
0.44 M NaCl 
24% w/v PEG 4000",293,"10.1038/ni.3770",,"5V43",50.99,"2.32","2.32","Engineered human IgG Fc domain aglyco801","DKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSLYRVVSVLTVLHQDWLNGKEYECKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGRPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","5V43"
"5V44",,"X-RAY DIFFRACTION",1.98,37.97,"VAPOR DIFFUSION, HANGING DROP",6.5,"28% PEG 3350, 0.2 M ammonium acetate, 0.1 M MES pH 6.5",293,"10.1074/jbc.RA118.003939",,"5V44",86.46,"1.56","1.56","Crystal structure of the SR1 domain of human sacsin","GPLGSFGQTTPPLVDFLKDILRRYPEGGQILKELIQNAEDAGATEVKFLYDETQYGTETLWSKDMAPYQGPALYVYNNAVFTPEDWHGIQEIARSRKKDDPLKVGRFGIGFNSVYHITDVPCIFSGDQIGMLDPHQTLFGPHESGQCWNLKDDSKEISELSDQFAPFVGIFGSTKETFINGNFPGTFFRFPLRLQPSQLSSNLYNKQKVLELFESFRADADTVLLFLKSVQDVSLYVREADGTEKLVFRVTSS","Homo sapiens","SACS, KIAA0730","Sacsin","1","5V44"
"5V45",,"X-RAY DIFFRACTION",2.16,43.18,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES pH 6.5, 28% PEG 3350, 0.2 M ammonium acetate",293,"10.1074/jbc.RA118.003939",,"5V45",57.56,"1.91","1.91","Crystal structure of the F270M, K291M, L318M mutant of SR1 domain of human sacsin","GPLGSFGQTTPPLVDFLKDILRRYPEGGQILKELIQNAEDAGATEVKFLYDETQYGTETLWSKDMAPYQGPALYVYNNAVFTPEDWHGIQEIARSRKKDDPLKVGRFGIGFNSVYHITDVPCIFSGDQIGMLDPHQTLFGPHESGQCWNLKDDSKEISELSDQFAPFVGIFGSTKETFINGNFPGTMFRFPLRLQPSQLSSNLYNKQMVLELFESFRADADTVLLFLKSVQDVSMYVREADGTEKLVFRVTSS","Homo sapiens","SACS, KIAA0730","Sacsin","1","5V45"
"5V46",,"X-RAY DIFFRACTION",2.21,44.32,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M MES pH 6.5, 28% PEG 3350, 0.2 M ammonium acetate",293,"10.1074/jbc.RA118.003939",,"5V46",57.69,"1.8","1.8","Crystal structure of the I113M, F270M, K291M, L308M mutant of SR1 domain of human sacsin","GPLGSFGQTTPPLVDFLKDILRRYPEGGQMLKELIQNAEDAGATEVKFLYDETQYGTETLWSKDMAPYQGPALYVYNNAVFTPEDWHGIQEIARSRKKDDPLKVGRFGIGFNSVYHITDVPCIFSGDQIGMLDPHQTLFGPHESGQCWNLKDDSKEISELSDQFAPFVGIFGSTKETFINGNFPGTMFRFPLRLQPSQLSSNLYNKQMVLELFESFRADADTVLMFLKSVQDVSLYVREADGTEKLVFRVTSS","Homo sapiens","SACS, KIAA0730","Sacsin","1","5V46"
"5V4E",,"X-RAY DIFFRACTION",3.2,61.58,"VAPOR DIFFUSION, SITTING DROP",,"40 mM potassium phosphate
16% w/v PEG 8000 
20% v/v glycerol",293,"10.1038/ni.3770",,"5V4E",211.25,"3.216","3.216","Engineered human IgG Fc domain glyco801 (Fc801)","DKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYECKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGRPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG","Homo sapiens","IGHG1","Ig gamma-1 chain C region","1","5V4E"
"5V4K",,"X-RAY DIFFRACTION",2.41,48.96,"VAPOR DIFFUSION, HANGING DROP",5,"0.1M Sodium Acetate pH 5.0, 1.2M Ammonium Sulfate",277,"10.1002/pro.3186",,"5V4K",31.31,"2.099","2.099","Crystal structure of NEDD4 LIR-fused human LC3B_2-119","GSQESSENWEIIGSPSEKTFKQRRTFEQRVEDVRLIREQHPTKIPVIIERYKGEKQLPVLDKTKFLVPDHVNMSELIKIIRRRLQLNANQAFFLLVNGHSMVSVSTPISEVYESEKDEDGFLYMVYASQETF","Homo sapiens","MAP1LC3B, MAP1ALC3","Microtubule-associated proteins 1A/1B light chain 3B,Microtubule-associated proteins 1A/1B light chain 3B,Microtubule-associated proteins 1A/1B light chain 3B","1","5V4K"
,,,,,,,,,,,,,,,,,"Homo sapiens","MAP1LC3B, MAP1ALC3"
"5V4Q",,"X-RAY DIFFRACTION",2.96,58.4,"VAPOR DIFFUSION, HANGING DROP",6,"20_25% PEG3350, 0.1 M ammonium chloride,
0.1M Na cacodilate pH6.0",290,"10.1002/pro.3172",,"5V4Q",60.13,"2.2","2.2","Crystal Structure of human GGT1 in complex with DON","SASKEPDNHVYTRAAVAADAKQCSKIGRDALRDGGSAVDAAIAALLCVGLMNAHSMGIGGGLFLTIYNSTTRKAEVINAREVAPRLAFATMFNSSEQSQKGGLSVAVPGEIRGYELAHQRHGRLPWARLFQPSIQLARQGFPVGKGLAAALENKRTVIEQQPVLCEVFCRDRKVLREGERLTLPQLADTYETLAIEGAQAFYNGSLTAQIVKDIQAAGGIVTAEDLNNYRAELIEHPLNISLGDAVLYMPSAPLSGPVLALILNILKGYNFSRESVESPEQKGLTYHRIVEAFRFAYAKRTLLGDPKFVDVTEVVRNMTSEFFAAQLRAQISDDTTHPISYYKPEFYTPDDGG","Homo sapiens","GGT1, GGT","Gamma-glutamyltranspeptidase 1 heavy chain","1","5V4Q"
,,,,,,,,,,,,,,,,"TAHLSVVAEDGSAVSATSTINLYFGSKVRSPVSGILFNNEMDDFSSPSITNEFGVPPSPANFIQPGKQPLSSMCPTIMVGQDGQVRMVVGAAGGTQITTATALAIIYNLWFGYDVKRAVEEPRLHNQLLPNVTTVERNIDQAVTAALETRHHHTQIASTFIAVVQAIVRTAGGWAAASDSRKGGEPAGY","Homo sapiens","GGT1, GGT","Gamma-glutamyltranspeptidase 1 light chain","2","5V4Q"
"5V4R",,"X-RAY DIFFRACTION",2.2,43.98,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M HEPES, pH 7.5 and 10% PEG 6000",293,"10.7554/eLife.24146",,"5V4R",39.77,"1.77","1.77","Crystal structure of LARP1-unique domain DM15 bound to m7GTP","GHSGGGGGGHMQHPSHELLKENGFTQHVYHKYRRRCLNERKRLGIGQSQEMNTLFRFWSFFLRDHFNKKMYEEFKQLALEDAKEGYRYGLECLFRYYSYGLEKKFRLDIFKDFQEETVKDYEAGQLYGLEKFWAFLKYSKAKNLDIDPKLQEYLGKFRRLED","Homo sapiens","LARP1, KIAA0731, LARP","La-related protein 1","1","5V4R"
"5V4W",,"X-RAY DIFFRACTION",2.3,46.42,"VAPOR DIFFUSION, SITTING DROP",5.5,"15% PEG3350, 200 mM ammonium iodide, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2017.04.041","8WM","5V4W",52.16,"2.39","2.39","Human glucokinase in complex with novel indazole activator.","MLPQPNSQVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase","1","5V4W"
"5V4X",,"X-RAY DIFFRACTION",2.22,44.59,"VAPOR DIFFUSION, SITTING DROP",,"15% PEG3350, 200 mM ammonium iodide, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 277K",277,"10.1016/j.bmcl.2017.04.041",,"5V4X",52.42,"2.08","2.08","Human glucokinase in complex with novel pyrazole activator.","MKPMPLTLVEQILAEFQLQEEDLKKVMRRMQKEMDRGLRLETHEEASVKMLPTYVRSTPEGSEVGDFLSLDLGGTNFRVMLVKVGEGEEGQWSVKTKHQMYSIPEDAMTGTAEMLFDYISECISDFLDKHQMKHKKLPLGFTFSFPVRHEDIDKGILLNWTKGFKASGAEGNNVVGLLRDAIKRRGDFEMDVVAMVNDTVATMISCYYEDHQCEVGMIVGTGCNACYMEEMQNVELVEGDEGRMCVNTEWGAFGDSGELDEFLLEYDRLVDESSANPGQQLYEKLIGGKYMGELVRLVLLRLVDENLLFHGEASEQLRTRGAFETRFVSQVESDTGDRKQIYNILSTLGLRPSTTDCDIVRRACESVSTRAAHMCSAGLAGVINRMRESRSEDVMRITVGVDGSVYKLHPSFKERFHASVRRLTPSCEITFIESEEGSGRGAALVSAVACKKACMLGQ","Homo sapiens","GCK","Glucokinase","1","5V4X"
"5V58",,"X-RAY DIFFRACTION",2.08,40.74,"EVAPORATION",,"9% PEG3350, 250 mM sodium nitrate, 100 mM 3-(1-pyridino)-1-propane sulfonate",293,"10.1038/s41467-017-02201-z",,"5V58",59.56,"2.59","2.59","Crystal structure of human prolyl-tRNA synthetase in complex with Aze-SA","MHHHHHHGSGEGQGPKKQTRLGLEAKKEENLADWYSQVITKSEMIEYHDISGCYILRPWAYAIWEAIKDFFDAEIKKLGVENCYFPMFVSQSALEKEKTHVADFAPEVAWVTRSGKTELAEPIAIRPTSETVMYPAYAKWVQSHRDLPIKLNQWCNVVRWEFKHPQPFLRTREFLWQEGHSAFATMEEAAEEVLQILDLYAQVYEELLAIPVVKGRKTEKEKFAGGDYTTTIEAFISASGRAIQGGTSHHLGQNFSKMFEIVFEDPKIPGEKQFAYQNSWGLTTRTIGVMTMVHGDNMGLVLPPRVACVQVVIIPCGITNALSEEDKEALIAKCNDYRRRLLSVNIRVRADLRDNYSPGWKFNHWELKGVPIRLEVGPRDMKSCQFVAVRRDTGEKLTVAENEAETKLQAILEDIQVTLFTRASEDLKTHMVVANTMEDFQKILDSGKIVQIPFCGEIDCEDWIKKTTARDQDLEPGAPSMGAKSLCIPFKPLCELQPGAKCVCGKNPAKYYTLFGRSY","Homo sapiens","EPRS, GLNS, PARS, QARS, QPRS, PIG32, EPRS1","Bifunctional glutamate/proline--tRNA ligase","1","5V58"
"5V59",,"X-RAY DIFFRACTION",2.04,39.74,"VAPOR DIFFUSION",8,"25% PEG6000, 100 mM Tris-HCl, pH 8.0",310,"10.1038/s41467-017-02201-z",,"5V59",53.74,"2.03","2.03","Crystal structure of catalytic fragment of human AlaRS in complex with Aze-SA","MGSSHHHHHHSSGLVPRGSHMDSTLTASEIRQRFIDFFKRNEHTYVHSSATIPLDDPTLLFANAGMNQFKPIFLNTIDPSHPMAKLSRAANTQKCIRAGGKHNDLDDVGKDVYHHTFFEMLGSWSFGDYFKELACKMALELLTQEFGIPIERLYVTYFGGDEAAGLEADLECKQIWQNLGLDDTKILPGNMKDNFWEMGDTGPCGPCSEIHYDRIGGRDAAHLVNQDDPNVLEIWNLVFIQYNREADGILKPLPKKSIDTGMGLERLVSVLQNKMSNYDTDLFVPYFEAIQKGTGARPYTGKVGAEDADGIDMAYRVLADHARTITVALADGGRPDNTGRGYVLRRILRRAVRYAHEKLNASRGFFATLVDVVVQSLGDAFPELKKDPDMVKDIINEEEVQFLKTLSRGRRILDRKIQSLGDSKTIPGDTAWLLYDTYGFPVDLTGLIAEEKGLVVDMDGFEEERKLAQLKSQGK","Homo sapiens","AARS, AARS1","Alanine--tRNA ligase, cytoplasmic","1","5V59"
"5V5B",,"ELECTRON CRYSTALLOGRAPHY",1.74,29.23,"VAPOR DIFFUSION, HANGING DROP",4.2,"0.1 M phosphate citrate, 32% PEG10000",310,"10.1038/nchem.2889",,"5V5B",1.2,"1.5","1.5","KVQIINKKLD, Structure of the amyloid spine from microtubule associated protein tau Repeat 2","KVQIINKKLD","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","5V5B"
"5V5C",,"ELECTRON CRYSTALLOGRAPHY",1.48,17.08,"VAPOR DIFFUSION, HANGING DROP",7,"0.29 M lithium nitrate, 24% PEG3350",291,"10.1038/nchem.2889",,"5V5C",0.71,"1.25","1.25","VQIINK, Structure of the amyloid-spine from microtubule associated protein tau Repeat 2","VQIINK","Homo sapiens","MAPT, MAPTL, MTBT1, TAU","Microtubule-associated protein tau","1","5V5C"
"5V5W",,"X-RAY DIFFRACTION",4.32,75.52,"VAPOR DIFFUSION, HANGING DROP",,"1.5 M ammonium sulfate, 3.72% (v/v) 2-propanol, 25% (v/v) glycerol",293,"10.1016/j.neuron.2017.06.009",,"5V5W",26.22,"2.718","2.718","Molecular Mechanism of MDGA1: Regulation of Neuroligin 2:Neurexin Trans-synaptic Bridges","VDYAPAQAQIVHAGQACVVKEDNISERVYTIREGDTLMLQCLVTGHPRPQVRWTKTAGSASDKFQETSVFNETLRIERIARTQGGRYYCKAENGVGVPAIKSIRVDVQYLDEPMLTVHQTVSDVRGNFYQEKTVFLRCTVNSNPPARFIWKRGSDTLSHSQDNGVDIYEPLYTQGETKVLKLKNLRPQDYASYTCQVSVRNVCGIPDKAITFRLTNTTGSASTSHHHHHH","Homo sapiens","MDGA1, MAMDC3","MAM domain-containing glycosylphosphatidylinositol anchor protein 1","1","5V5W"
"5V5Y",,"X-RAY DIFFRACTION",2.01,38.75,"VAPOR DIFFUSION, HANGING DROP",6.9,"9.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.1 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 12.5 % PEG 3350, 1 mM MK1775",291,"10.1021/acs.jmedchem.7b00996","8X7","5V5Y",33.22,"1.9","1.9","CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH MK1775","GAGSMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","5V5Y"
"5V60",,"X-RAY DIFFRACTION",3.07,59.99,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 45% v/v polypropylene glycol P400",277,"10.1021/acsmedchemlett.7b00127",,"5V60",42.36,"2.18","2.18","Phospho-ERK2 bound to AMP-PCP","GPGGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","5V60"
"5V67",,"X-RAY DIFFRACTION",2.5,50.74,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES PH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM, SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM Volasertib",291,"10.1021/acs.jmedchem.1c01096","IBI","5V67",15.94,"1.78","1.78","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH Volasertib","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5V67"
"5V6S",,"X-RAY DIFFRACTION",2.2,44.04,"VAPOR DIFFUSION, HANGING DROP",7.5,"25% PEG 8000, 0.1M Hepes pH 7.5, vapor diffusion, hanging drop, 293K",293,"10.1021/acs.biochem.7b00271",,"5V6S",20.27,"1.7","1.7","Crystal structure of small molecule acrylamide 1 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5V6S"
"5V6U",,"X-RAY DIFFRACTION",3.05,59.61,"VAPOR DIFFUSION, HANGING DROP",5.7,"1.9 M sodium formate, 0.1 M sodium citrate, pH 5.7",295,"10.1002/anie.201706959",,"5V6U",68.92,"2.8","2.8","Crystal structure of human caspase-7 soaked with allosteric inhibitor 2-[(2-acetylphenyl)sulfanyl]benzoic acid","MADDQGCIEEQGVEDSANEDSVDAKPDRSSFVPSLFSKKKKNVTMRSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQADSGPINDTDANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ","Homo sapiens","CASP7, MCH3","Caspase-7","1","5V6U"
"5V6V",,"X-RAY DIFFRACTION",2,38.51,"VAPOR DIFFUSION, HANGING DROP",8,"28% PEG 4000, 0.1M Tris pH 8, 0.2M CaCl2, vapor diffusion, hanging drop, 293K",293,"10.1021/acs.biochem.7b00271",,"5V6V",40.86,"1.72","1.72","Crystal structure of small molecule aziridine 3 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5V6V"
"5V6Z",,"X-RAY DIFFRACTION",3.1,60.36,"VAPOR DIFFUSION, HANGING DROP",5.7,"1.9 M sodium formate, 0.1 M sodium citrate, pH 5.0-5.7",295,,,"5V6Z",68.95,"2.6","2.6","Crystal structure of human caspase-7 soaked with allosteric inhibitor 2-{[2-(4-chlorophenyl)-2-oxoethyl]sulfanyl}benzoic acid","MADDQGCIEEQGVEDSANEDSVDAKPDRSSFVPSLFSKKKKNVTMRSIKTTRDRVPTYQYNMNFEKLGKCIIINNKNFDKVTGMGVRNGTDKDAEALFKCFRSLGFDVIVYNDCSCAKMQDLLKKASEEDHTNAACFACILLSHGEENVIYGKDGVTPIKDLTAHFRGDRCKTLLEKPKLFFIQACRGTELDDGIQADSGPINDTDANPRYKIPVEADFLFAYSTVPGYYSWRSPGRGSWFVQALCSILEEHGKDLEIMQILTRVNDRVARHFESQSDDPHFHEKKQIPCVVSMLTKELYFSQ","Homo sapiens","CASP7, MCH3","Caspase-7","1","5V6Z"
"5V70",,"X-RAY DIFFRACTION",2.7,54.51,"VAPOR DIFFUSION, HANGING DROP",7.5,"2 M ammonium sulfate, 3 % 2-propanol, 0.1 M Tris-HCl, pH 7.5",293,,,"5V70",37.87,"1.94","1.94","Crystal structure of N102A mutant of human macrophage migration inhibitory factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMAAANVGWNNSTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","5V70"
"5V71",,"X-RAY DIFFRACTION",2.36,47.85,"EVAPORATION",6.9,"1.8M sodium phosphate monobasic monohydrate, potassium phosphate dibasic pH6.9",277,"10.1016/j.str.2017.07.003",,"5V71",120.67,"2.228","2.228","KRAS G12C in bound to quinazoline based switch II pocket (SWIIP) binder","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKE","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5V71"
"5V73",,"X-RAY DIFFRACTION",2.73,54.89,"VAPOR DIFFUSION, HANGING DROP",,"2 M ammonium sulfate, 3 % 2-propanol, 0.1 M Tris-HCl, pH 7.0 - 8.0",293,,,"5V73",37.72,"1.68","1.68","Crystal structure of N110A mutant of human macrophage migration inhibitory factor","PMFIVNTNVPRASVPDGFLSELTQQLAQATGKPPQYIAVHVVPDQLMAFGGSSEPCALCSLHSIGKIGGAQNRSYSKLLCGLLAERLRISPDRVYINYYDMNAANVGWNASTFA","Homo sapiens","MIF, GLIF, MMIF","Macrophage migration inhibitory factor","1","5V73"
"5V7I",,"X-RAY DIFFRACTION",3.66,66.42,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M TRIS ph 8.5, 17% (w/v) PEG 20000",277,"10.1073/pnas.1706617114","8Z1","5V7I",107.22,"2.47","2.47","Crystal structure of homo sapiens serine hydroxymethyltransferase 2 (mitochondrial) (SHMT2), in complex with glycine, PLP and folate-competitive pyrazolopyran inhibitor: 6-amino-4-isopropyl-3-methyl-4-(3-(pyrrolidin-1-yl)-5-(trifluoromethyl)phenyl)-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile","SNAAQTQTGEANRGWTGQESLSDSDPEMWELLQREKDRQCRGLELIASENFCSRAALEALGSCLNNKYSEGYPGKRYYGGAEVVDEIELLCQRRALEAFDLDPAQWGVNVQPYSGSPANLAVYTALLQPHDRIMGLDLPDGGHLTHGYMSDVKRISATSIFFESMPYKLNPKTGLIDYNQLALTARLFRPRLIIAGTSAYARLIDYARMREVCDEVKAHLLADMAHISGLVAAKVIPSPFKHADIVTTTTHKTLRGARSGLIFYRKGVKAVDPKTGREIPYTFEDRINFAVFPSLQGGPHNHAIAAVAVALKQACTPMFREYSLQVLKNARAMADALLERGYSLVSGGTDNHLVLVDLRPKGLDGARAERVLELVSITANKNTCPGDRSAITPGGLRLGAPALTSRQFREDDFRRVVDFIDEGVNIGLEVKSKTAKLQDFKSFLLKDSETSQRLANLRQRVEQFARAFPMPGFDEH","Homo sapiens","SHMT2","Serine hydroxymethyltransferase, mitochondrial","1","5V7I"
"5V7R",,"X-RAY DIFFRACTION",4.01,69.32,"VAPOR DIFFUSION, SITTING DROP",8,"0.2 M ammonium dihydrogen phosphate, 20% PEG3350",295,"10.1007/s00401-017-1705-y",,"5V7R",48.04,"2.3","2.3","Cyrstal structure of anti-Tau antibody CBTAU-7.1 Fab","DIVMTQSPDTLSLSPGERATLSCRASQIISSNYLAWYQQQPGQAPRLLIYGASSRATGIPDRFSGSGSATDFTLTISRLEPEDFAVYYCQQYGTSPRTFGQGTKLEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CBTAU-7.1 Fab light chain","1","5V7R"
,,,,,,,,,,,,,,,,"QVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMHWVRQAPGKGLVWVSRINSDGSDTNYADSVKGRFTFSRDNAKNTLYLQMTSLRAEDTAIYYCTRGRSYGFFDYWGQGALVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCHHHHHH","Homo sapiens",,"CBTAU-7.1 Fab heavy chain","2","5V7R"
"5V7T",,"X-RAY DIFFRACTION",2.94,58.22,"VAPOR DIFFUSION",,"20% PEG3350, 0.2M Sodium-malonate, pH 7.2-7.8",298,"10.1016/j.bbrc.2017.03.052","91V","5V7T",22.56,"2.3","2.3","crystal structure of PARP14 bound to N-{4-[4-(diphenylmethoxy)piperidin-1-yl]butyl}[1,2,4]triazolo[4,3-b]pyridazin-6-amine inhibitor","GGSDMKQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFRK","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5V7T"
"5V7U",,"X-RAY DIFFRACTION",2.29,46.27,"VAPOR DIFFUSION, SITTING DROP",4,"0.1 M citrate buffer, pH 4.0, 2.4 M ammonium sulfate",295,"10.1007/s00401-017-1705-y",,"5V7U",48.17,"1.64","1.64","Cyrstal structure of anti-Tau antibody CBTAU-22.1 Fab","QVQLVQSGAEVKKPGAPVKVSCETSGYRFSDYNVHWVRQAPGQGPEWIGRISPNSGGTKYAQKFQGRVTMTRDMSMNTAYMELSGLRSDDTAVYYCVRGHCDGTTCSRAYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"CBTAU-22.1 Fab heavy chain","2","5V7U"
,,,,,,,,,,,,,,,,"DVVMTQSPLSLPVTPGEPASISCRSSQSLLHRSGHKYLHWYLQRPGQSPQVLIYLGSNRASGVPDRFSGSGSGTDFTLKISRVEAEDVGLYYCMQTLQTPWTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CBTAU-22.1 Fab light chain","1","5V7U"
"5V7W",,"X-RAY DIFFRACTION",2.95,58.28,"VAPOR DIFFUSION",,"20% PEG3350, 0.2M Sodium-malonate, pH 7.2-7.8",298,"10.1016/j.bbrc.2017.03.052",,"5V7W",44.87,"2.65","2.65","Crystal structure of human PARP14 bound to 2-{[(1-methylpiperidin-4-yl)methyl]amino}-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one inhibitor","GGSDMKQQNFCVVELLPSDPEYNTVASKFNQTCSHFRIEKIERIQNPDLWNSYQAKKKTMDAKNGQTMNEKQLFHGTDAGSVPHVNRNGFNRSYAGKNAVAYGKGTYFAVNANYSANDTYSRPDANGRKHVYYVRVLTGIYTHGNHSLIVPPSKNPQNPTDLYDTVTDNVHHPSLFVAFYDYQAYPEYLITFRK","Homo sapiens","PARP14, BAL2, KIAA1268","Poly [ADP-ribose] polymerase 14","1","5V7W"
"5V80",,"X-RAY DIFFRACTION",3.52,65.06,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris 8.5, LiSO4, PEG 4000",289,"10.1021/acs.jmedchem.7b00418","971","5V80",34.93,"2.252","2.252","PIM1 kinase in complex with Cpd1 (1-methyl-4-(3-(6-(piperazin-1-yl)pyridin-2-yl)-1H-pyrazolo[3,4-c]pyridin-5-yl)piperazin-2-one)","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKKLAAALEHHHHHH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","5V80"
"5V82",,"X-RAY DIFFRACTION",3.44,64.23,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris 8.5, LiSO4, PEG 4000",289,"10.1021/acs.jmedchem.7b00418","96Y","5V82",34.85,"1.888","1.888","PIM1 kinase in complex with Cpd17 (1-(6-(4,4-difluoropiperidin-3-yl)pyridin-2-yl)-6-(6-methylpyrazin-2-yl)-1H-pyrazolo[4,3-c]pyridine)","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKKLAAALEHHHHHH","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","5V82"
"5V84",,"X-RAY DIFFRACTION",2.94,58.2,"VAPOR DIFFUSION",8.5,"1.5 M lithium sulfate, 0.1 M Tris-HCl pH 8.5",277,"10.1021/acsmedchemlett.7b00132","96V","5V84",68.48,"2.7","2.7","CECR2 in complex with Cpd6 (6-allyl-N,2-dimethyl-7-oxo-N-(1-(1-phenylethyl)piperidin-4-yl)-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-4-carboxamide)","MHHHHHHASDYKDDDDKGSLVPRGSMREEKKTKDLFELDDDFTAMYKVLDVVKAHKDSWPFLEPVDESYAPNYYQIIKAPMDISSMEKKLNGGLYCTKEEFVNDMKTMFRNCRKYNGESSEYTKMSDNLERCFHRAMMKH","Homo sapiens","CECR2, KIAA1740","Cat eye syndrome critical region protein 2","1","5V84"
"5V87",,"X-RAY DIFFRACTION",2.17,43.39,"VAPOR DIFFUSION, SITTING DROP",,"0.05 M Sodium cacodylate trihydrate pH 6.5, 30% w/v Polyethylene glycol 4,000 (#25 Index-116)",293,"10.7554/eLife.24146",,"5V87",40.54,"1.692","1.692","Crystal structure of LARP1-unique domain DM15 bound to m7GpppC","GHSGGGGGGHMQHPSHELLKENGFTQHVYHKYRRRCLNERKRLGIGQSQEMNTLFRFWSFFLRDHFNKKMYEEFKQLALEDAKEGYRYGLECLFRYYSYGLEKKFRLDIFKDFQEETVKDYEAGQLYGLEKFWAFLKYSKAKNLDIDPKLQEYLGKFRRLED","Homo sapiens","LARP1, KIAA0731, LARP","La-related protein 1","1","5V87"
"5V8O",,"X-RAY DIFFRACTION",2.57,52.16,"VAPOR DIFFUSION, SITTING DROP",,"Protein was concentrated to 6 mg/ml, and then mixed at a 2:1 ratio with PEG 3350 (18-20% v/v), 0.2 M ammonium citrate (pH 7) in a sitting drop well at 277 K. Cryoprotectant was made using mother liquor at a final concentration of 23% PEG 3350.",277,"10.1371/journal.pone.0184843","8ZM","5V8O",85.58,"3.1","3.1","Discovery of a high affinity inhibitor of cGAS","GASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","5V8O"
"5V8Q",,"X-RAY DIFFRACTION",2.2,43.98,"VAPOR DIFFUSION, SITTING DROP",7.1,"1.08M Phosphate NH4 Dibasic
0.07M Phosphate K Dibasic
0.03M Phosphate Na Monobasic
pH 7.1",293,"10.1016/j.bmc.2017.04.018","97A","5V8Q",29.56,"1.44","1.44","Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs): Part III","PIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACARKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","5V8Q"
"5V8V",,"X-RAY DIFFRACTION",2.7,54.51,"VAPOR DIFFUSION, SITTING DROP",7.5,"19-22% PEG3350, 200mM ammonium sulfate, 100mM TRIS-HCl, pH 7.5, 2mM inhibitor, 1% DMSO",277,"10.1016/j.bmcl.2017.09.046",,"5V8V",76.43,"2.6","2.6","Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol","GNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","5V8V"
"5V9I",,"X-RAY DIFFRACTION",2.27,45.74,"VAPOR DIFFUSION, SITTING DROP",6.5,"25% PEG 3350, 0.2 M NaCl, 0.1 M Bis-Tris pH6.5",291,,,"5V9I",135.6,"1.74","1.74","Crystal structure of catalytic domain of G9a with MS0105","GSNRAIRTEKIICRDVARGYENVPIPCVNGVDGEPCPEDYKYISENCETSTMNIDRNITHLQHCTCVDDCSSSNCLCGQLSIRCWYDKDGRLLQEFNKIEPPLIFECNQACSCWRNCKNRVVQSGIKVRLQLYRTAKMGWGVRALQTIPQGTFICEYVGELISDAEADVREDDSYLFDLDNKDGEVYCIDARYYGNISRFINHLCDPNIIPVRVFMLHQDLRFPRIAFFSSRDIRTGEELGFDYGDRFWDIKSKYFTCQCGSEKCKHSAEAIALEQSRLARLD","Homo sapiens","EHMT2, BAT8, C6orf30, G9A, KMT1C, NG36","Histone-lysine N-methyltransferase EHMT2","1","5V9I"
"5V9J",,"X-RAY DIFFRACTION",2.79,55.86,"VAPOR DIFFUSION, SITTING DROP",5.6,"20% PEG 4000, 20% IProp, 0.1 M NaCitrate pH5.6",293,,,"5V9J",68.31,"1.74","1.74","Crystal structure of catalytic domain of GLP with MS0105","GSNSQVWSALQMSKALQDSAPDRPSPVERIVSRDIARGYERIPIPCVNAVDSEPCPSNYKYVSQNCVTSPMNIDRNITHLQYCVCIDDCSSSNCMCGQLSMRCWYDKDGRLLPEFNMAEPPLIFECNHACSCWRNCRNRVVQNGLRARLQLYRTRDMGWGVRSLQDIPPGTFVCEYVGELISDSEADVREEDSYLFDLDNKDGEVYCIDARFYGNVSRFINHHCEPNLVPVRVFMAHQDLRFPRIAFFSTRLIEAGEQLGFDYGERFWDIKGKLFSCRCGSPKCRHS","Homo sapiens","EHMT1, EUHMTASE1, GLP, KIAA1876, KMT1D","Histone-lysine N-methyltransferase EHMT1","1","5V9J"
"5V9L",,"X-RAY DIFFRACTION",2.36,47.91,"EVAPORATION",7.1,"1.6M sodium phosphate monobasic monohydrate, potassium phosphate dibasic pH7.1",277,"10.1016/j.chembiol.2017.06.017",,"5V9L",60.68,"1.981","1.981","KRAS G12C in bound to quinazoline based switch II pocket (SWIIP) binder","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKE","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5V9L"
"5V9O",,"X-RAY DIFFRACTION",3.18,61.35,"EVAPORATION",9,"0.1M Tris pH9.0, ammonium sulfate 1.6M",277,"10.1016/j.chembiol.2017.06.017",,"5V9O",20.27,"1.56","1.56","KRAS G12C inhibitor","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKE","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5V9O"
"5V9P",,"X-RAY DIFFRACTION",3.64,66.23,"VAPOR DIFFUSION",7.3,"200 uM inhibitor, 20% PEG3350, 0.1 M HEPES, pH 7.3, 12% glycerol",291,"10.1016/j.bmcl.2017.05.016","90S","5V9P",92.21,"3","3","Crystal structure of pyrrolidine amide inhibitor [(3S)-3-(4-bromo-1H-pyrazol-1-yl)pyrrolidin-1-yl][3-(propan-2-yl)-1H-pyrazol-5-yl]methanone (compound 35) in complex with KDM5A","SEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRLDFLDQLAKFWELQGSTLKIPVVERKILDLYALSKIVASKGGFEMVTKEKKWSKVGSRLGYLPGKGTGSLLKSHYERILYPYELFQSGVSLMGVQMPNLDLKEKVEPEVLSTDTQTSPEPGTRMNILPKRTRRVKTQSESGDVSRNTELKKLQIFGAGPKVVGLAMGTKDKEDEVTRRRKVTNRSDAFNMQMRQRKGTLSVNFVDLYVCMFCGRGNNEDKLLLCDGCDDSYHTFCLIPPLPDVPKGDWRCPKCVAEECSKPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCTADWLPIGRQCVNHYRRLRRHCVFSHEELIFKMAADPECLDVGLAAMVCKELTLMTEEETRLRESVVQMGVLMSEEEVFELVPDDERQCSACRTTCFLSALTCSCNPERLVCLYHPTDLCPCPMQKKCLRYRYPLEDLPSLLYGVKVRAQSYDTWVSRVTEALSANFNHKKDLIELRVMLEDAEDRKYPENDLFRKLRDAVKEAETCASVGNS","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A","1","5V9P"
,,,,,,,,,,,,,,,,"XXXXXXXXXX","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A","2","5V9P"
"5V9T",,"X-RAY DIFFRACTION",3.72,66.91,"VAPOR DIFFUSION",7.3,"200 uM inhibitor, 20% PEG3350, 0.1 M HEPES, pH 7.3, 12% glycerol",291,"10.1016/j.bmcl.2017.05.016","90V","5V9T",183.24,"3.05","3.05","Crystal structure of selective pyrrolidine amide KDM5a inhibitor N-{(3R)-1-[3-(propan-2-yl)-1H-pyrazole-5-carbonyl]pyrrolidin-3-yl}cyclopropanecarboxamide (compound 48)","SEFVPPPECPVFEPSWEEFTDPLSFIGRIRPLAEKTGICKIRPPKDWQPPFACEVKSFRFTPRVQRLNELEAMTRVRLDFLDQLAKFWELQGSTLKIPVVERKILDLYALSKIVASKGGFEMVTKEKKWSKVGSRLGYLPGKGTGSLLKSHYERILYPYELFQSGVSLMGVQMPNLDLKEKVEPEVLSTDTQTSPEPGTRMNILPKRTRRVKTQSESGDVSRNTELKKLQIFGAGPKVVGLAMGTKDKEDEVTRRRKVTNRSDAFNMQMRQRKGTLSVNFVDLYVCMFCGRGNNEDKLLLCDGCDDSYHTFCLIPPLPDVPKGDWRCPKCVAEECSKPREAFGFEQAVREYTLQSFGEMADNFKSDYFNMPVHMVPTELVEKEFWRLVSSIEEDVIVEYGADISSKDFGSGFPVKDGRRKILPEEEEYALSGWNLNNMPVLEQSVLAHINVDISGMKVPWLYVGMCFSSFCWHIEDHWSYSINYLHWGEPKTWYGVPSHAAEQLEEVMRELAPELFESQPDLLHQLVTIMNPNVLMEHGVPVYRTNQCAGEFVVTFPRAYHSGFNQGYNFAEAVNFCTADWLPIGRQCVNHYRRLRRHCVFSHEELIFKMAADPECLDVGLAAMVCKELTLMTEEETRLRESVVQMGVLMSEEEVFELVPDDERQCSACRTTCFLSALTCSCNPERLVCLYHPTDLCPCPMQKKCLRYRYPLEDLPSLLYGVKVRAQSYDTWVSRVTEALSANFNHKKDLIELRVMLEDAEDRKYPENDLFRKLRDAVKEAETCASVGNS","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A","1","5V9T"
,,,,,,,,,,,,,,,,"XXXXXXXXXX","Homo sapiens","KDM5A, JARID1A, RBBP2, RBP2","Lysine-specific demethylase 5A","2","5V9T"
"5V9U",,"X-RAY DIFFRACTION",2.01,38.8,"VAPOR DIFFUSION, HANGING DROP",8.5,"29% PEG 4000, 0.2 M CaCl2, 0.1 M Tris pH=8.5",293,"10.1016/j.cell.2018.01.006",,"5V9U",41.07,"1.38","1.38","Crystal Structure of small molecule ARS-1620 covalently bound to K-Ras G12C","GMTEYKLVVVGACGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYMRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5V9U"
"5VA1","3.7","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2017.03.048",,"5VA1",88.9,"3.7",,"Cryo-EM structure of the human ether-a-go-go related K+ channel","MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGSEASNSLEVLFQ","Homo sapiens","KCNH2, ERG, ERG1, HERG","Potassium voltage-gated channel subfamily H member 2","1","5VA1"
,,,,,,,,,,,,,,,,,"Homo sapiens","KCNH2, ERG, ERG1, HERG"
,,,,,,,,,,,,,,,,,"Homo sapiens","KCNH2, ERG, ERG1, HERG"
"5VA2","3.8","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2017.03.048",,"5VA2",92.28,"3.8",,"Cryo-EM structure of the human ether-a-go-go related K+ channel","MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSSPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGSEASNSLEVLFQ","Homo sapiens","KCNH2, ERG, ERG1, HERG","Potassium voltage-gated channel subfamily H member 2","1","5VA2"
,,,,,,,,,,,,,,,,,"Homo sapiens","KCNH2, ERG, ERG1, HERG"
,,,,,,,,,,,,,,,,,"Homo sapiens","KCNH2, ERG, ERG1, HERG"
"5VA3","4","ELECTRON MICROSCOPY",,,,,,,"10.1016/j.cell.2017.03.048",,"5VA3",88.89,"4",,"Cryo-EM structure of the human ether-a-go-go related K+ channel","MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVAPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGSEASNSLEVLFQ","Homo sapiens","KCNH2, ERG, ERG1, HERG","Potassium voltage-gated channel subfamily H member 2","1","5VA3"
,,,,,,,,,,,,,,,,,"Homo sapiens","KCNH2, ERG, ERG1, HERG"
,,,,,,,,,,,,,,,,,"Homo sapiens","KCNH2, ERG, ERG1, HERG"
"5VAD",,"X-RAY DIFFRACTION",2.22,44.62,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG3350, 500mM CaCl2, Hepes pH7.5",293,"10.1016/j.bbrc.2017.05.064","91Y","5VAD",117.9,"2.36","2.36","Crystal structure of human Prolyl-tRNA synthetase (PRS) in complex with inhibitor","GSSSGAGEGQGPKKQTRLGLEAKKEENLADWYSQVITKSEMIEYHDISGCYILRPWAYAIWEAIKDFFDAEIKKLGVENCYFPMFVSQSALEKEKTHVADFAPEVAWVTRSGKTELAEPIAIRPTSETVMYPAYAKWVQSHRDLPIKLNQWCNVVRWEFKHPQPFLRTREFLWQEGHSAFATMEEAAEEVLQILDLYAQVYEELLAIPVVKGRKTEKEKFAGGDYTTTIEAFISASGRAIQGGTSHHLGQNFSKMFEIVFEDPKIPGEKQFAYQNSWGLTTRTIGVMTMVHGDNMGLVLPPRVACVQVVIIPCGITNALSEEDKEALIAKCNDYRRRLLSVNIRVRADLRDNYSPGWKFNHWELKGVPIRLEVGPRDMKSCQFVAVRRDTGEKLTVAENEAETKLQAILEDIQVTLFTRASEDLKTHMVVANTMEDFQKILDSGKIVQIPFCGEIDCEDWIKKTTARDQDLEPGAPSMGAKSLCIPFKPLCELQPGAKCVCGKNPAKYYTLFGRSY","Homo sapiens","EPRS, GLNS, PARS, QARS, QPRS, PIG32, EPRS1","Bifunctional glutamate/proline--tRNA ligase","1","5VAD"
"5VAL",,"X-RAY DIFFRACTION",2.84,56.65,"VAPOR DIFFUSION, HANGING DROP",8.4,"100 mM Tris ph 8.4, 12% PEG8000, and 100mM NaCl",291,"10.1021/acs.jmedchem.6b01862",,"5VAL",64.69,"2.26","2.26","BRAF in Complex with N-(3-(tert-butyl)phenyl)-4-methyl-3-(6-morpholinopyrimidin-4-yl)benzamide","GSDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","5VAL"
"5VAM",,"X-RAY DIFFRACTION",3.19,61.4,"VAPOR DIFFUSION, HANGING DROP",8.4,"100 mM Tris ph 8.4, 12% PEG8000, and 50mM NaCl",291,"10.1021/acs.jmedchem.6b01862","92J","5VAM",64.91,"2.1","2.1","BRAF in Complex with RAF709","GSDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK","Homo sapiens","BRAF, BRAF1, RAFB1","Serine/threonine-protein kinase B-raf","1","5VAM"
"5VAR",,"X-RAY DIFFRACTION",2.12,42.08,"VAPOR DIFFUSION, SITTING DROP",6.5,"18%(w/v) PEG 8000, 0.2M calcium acetate, 0.1M sodium cacodylate pH 6.5",290,"10.1016/j.bmcl.2018.04.050","92Y","5VAR",13.79,"1.83","1.83","Crystal structure of KDM4A tandem TUDOR domain in complex with a tri-methyl lysine competitive inhibitor","GSHMQSITAGQKVISKHKNGRFYQCEVVRLTTETFYEVNFDDGSFSDNLYPEDIVSQDCLQFGPPAEGEVVQVRWTDGQVYGAKFVASHPIQMYQVEFEDGSQLVVKRDDVYTLDEELP","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","5VAR"
"5VB7",,"X-RAY DIFFRACTION",2.37,48.15,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 4000 (2-8%), NACL 0.5M, PIPES (0.1M)",298,"10.1074/jbc.M117.789024","921","5VB7",32.94,"2.335","2.335","X-ray co-structure of nuclear receptor ROR-gammat Ligand Binding Domain with an agonist and SRC2 peptide","MGSSHHHHHHLVPRGSPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSGGGEKHKILHRLLQDS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma, SRC2 chimera","1","5VB7"
,,,,,,,,,,,,,,,,,"Homo sapiens","RORC, NR1F3, RORG, RZRG"
"5VBB",,"X-RAY DIFFRACTION",1.89,34.77,"VAPOR DIFFUSION, SITTING DROP",6.5,"21% PEG 3350, 0.2 M LiSO4, 0.1 M BisTris pH6.5",291,,,"5VBB",29.79,"1.94","1.94","Human RNA Pseudouridylate Synthase Domain Containing 1","MEPGSVENLSIVYRSRDFLVVNKHWDVRIDSKAWRETLTLQKQLRYRFPELADPDTCYGFRFCHQLDFSTSGALCVALNKAAAGSAYRCFKERRVTKAYLALLRGHIQESRVTISHAIGRNSTEGRAHTMCIEGSQGCENPKPSLTDLVVLEHGLYAGDPVSKVLLKPLTGRTHQLRVHCSALGHPVVGDLTYGEVSGREDRPFRMMLHAFYLRIPTDTECVEVCTPDPFLPSLDACWSPHTLLQSLDQLVQALRATPDPD","Homo sapiens","RPUSD1, C16orf40, RLUCL","RNA pseudouridylate synthase domain-containing protein 1","1","5VBB"
"5VBD",,"X-RAY DIFFRACTION",1.74,29.22,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% PEG 8000, 0.2 M NaCl, 0.1 M HEPES pH7.5, 5% MPD",291,,,"5VBD",12.44,"1.5","1.5","Crystal structure of a putative UBL domain of USP9X","MHHHHHHSSGRENLYFQGAFRGKHLSFVVRFPNQGRQVDDLEVWSHTNDTIGSVRRCILNRIKANVAHTKIELFVGGELIDPADDRKLIGQLNLKDKSLITAKLTQISS","Homo sapiens","USP9X, hCG_18381, DFFRX, FAM, USP9","USP9X","1","5VBD"
"5VBE",,"X-RAY DIFFRACTION",2.64,53.43,"VAPOR DIFFUSION, HANGING DROP",7.7,"22% PEG8000
.1M Tris HCl (pH 7.7)
.1 M CaCl2",293,"10.1016/j.chembiol.2017.08.025",,"5VBE",20.08,"1.57","1.57","Crystal Structure of Small Molecule Disulfide 2C07 Bound to H-Ras M72C GDP","GAMGSMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYCRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","5VBE"
"5VBI",,"X-RAY DIFFRACTION",2.99,58.86,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES 7.5, 0.1M Sodium Chloride, 1.5-1.7M Ammonium Sulfate",293,"10.1016/j.str.2018.07.005",,"5VBI",130.33,"1.75000083769","1.75000083769","Crystal Structure of the R515W missense variant of human PGM1","MHHHHHHSSGVDLGTENLYFQSNMVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIWLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT","Homo sapiens","PGM1","Phosphoglucomutase-1","1","5VBI"
"5VBM",,"X-RAY DIFFRACTION",1.93,36.4,"VAPOR DIFFUSION, HANGING DROP",4.6,"33% PEG4000
.1 M Na Citrate (pH 4.6)
.2 M Ammonium Acetate
.22 M KCl (10% Additive of 2.2 M KCL)",298,"10.1016/j.chembiol.2017.08.025",,"5VBM",20.11,"1.49","1.49","Crystal Structure of Small Molecule Disulfide 2C07 Bound to K-Ras Cys Light M72C GDP","GMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETSLLDILDTAGQEEYSAMRDQYCRTGEGFLLVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5VBM"
"5VBO",,"X-RAY DIFFRACTION",1.89,34.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 55MM HEPES PH 7.5, 15% Jeffamine ED-2001 pH 7.0, 10% DMSO, 1 MM LRRK2-IN-1",291,"10.1021/acs.jmedchem.1c01096",,"5VBO",16.05,"1.3","1.3","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH LRRK2-IN-1","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5VBO"
"5VBP",,"X-RAY DIFFRACTION",2.39,48.52,"VAPOR DIFFUSION, HANGING DROP",7.5,"12.5 MG/ML BRD4, 5MM HEPES PH 7.5, 50MM SODIUM CHLORIDE, 0.5MM DTT, 50MM TRIS PH8.5, 0.1M AMMONIUM, SULFATE, 12.5% PEG 3,350, 10% DMSO, 1 MM RO3280",291,"10.1021/acs.jmedchem.1c01096",,"5VBP",31.72,"1.83","1.83","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH RO3280","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5VBP"
"5VBQ",,"X-RAY DIFFRACTION",2.66,53.72,"VAPOR DIFFUSION, HANGING DROP",7.5,"8 MG/ML BRDT, 25MM HEPES PH 7.5, 75MM SODIUM CHLORIDE, 0.5MM DTT, 50MM MES PH 6.5, 0.1M AMMONIUM, SULFATE, 15% PEG MME 5,000, 10% DMSO, 1 MM BI2536",291,"10.1021/acs.jmedchem.1c01096","R78","5VBQ",28.71,"1.65","1.65","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRDT IN COMPLEX WITH BI2536","GAASTNQLQYLQKVVLKDLWKHSFSWPFQRPVDAVKLQLPDYYTIIKNPMDLNTIKKRLENKYYAKASECIEDFNTMFSNCYLYNKPGDDIVLMAQALEKLFMQKLSQMPQEE","Homo sapiens","BRDT","Bromodomain testis-specific protein","1","5VBQ"
"5VBR",,"X-RAY DIFFRACTION",2.64,53.45,"VAPOR DIFFUSION, HANGING DROP",7.5,"8 MG/ML BRDT, 25MM HEPES PH 7.5, 75MM SODIUM CHLORIDE, 0.5MM DTT, 50MM MES PH 6.5, 0.1M AMMONIUM, SULFATE, 15% PEG MME 5,000, 10% DMSO, 1 MM Volasertib",291,"10.1021/acs.jmedchem.1c01096",,"5VBR",28.63,"1.9","1.9","CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRDT IN COMPLEX WITH Volasertib","GAASTNQLQYLQKVVLKDLWKHSFSWPFQRPVDAVKLQLPDYYTIIKNPMDLNTIKKRLENKYYAKASECIEDFNTMFSNCYLYNKPGDDIVLMAQALEKLFMQKLSQMPQEE","Homo sapiens","BRDT","Bromodomain testis-specific protein","1","5VBR"
"5VBU",,"X-RAY DIFFRACTION",2.27,45.93,"EVAPORATION",7,"0.2M Ammonium citrate tribasic pH 7.0, 20% W/V PEG 3350",291,"10.1074/jbc.M117.792465",,"5VBU",163.97,"3.31","3.31","Crystal Structure of Human Cytochrome P450 21A2 Hydroxyprogesterone Complex","MAKKTSSKGKLPPLAPGFLHLLQPDLPIYLLGLTQKFGPIYRLHLGLQDVVVLNSKRTIEEAMVKKWADFAGRPEPLTYKLVSRNYPDLSLGDYSLLWKAHKKLTRSALLLGIRDSMEPVVEQLTQEFCERMRAQPGTPVAIEEEFSLLTCSIICYLTFGDKIKDDNLMPAYYKCIQEVLKTWSHWSIQIVDVIPFLRFFPNPGLRRLKQAIEKRDHIVEMQLRQHKESLVAGQWRDMMDYMLQGVAQPSMEEGSGQLLEGHVHMAAVDLLIGGTETTANTLSWAVVFLLHHPEIQQRLQEELDHELGPGASSSRVPYKDRARLPLLNATIAEVLRLRPVVPLALPHRTTRPSSISGYDIPEGTVIIPNLQGAHLDETVWERPHEFWPDRFLEPGKNSRALAFGCGARVCLGEPLARLELFVVLTRLLQAFTLLPSGDALPSLQPLPHCSVILKMQPFQVRLQPRGMGAHSPGQSQ","Homo sapiens","P450-CYP21B, CYP21A2, CYP21B, hCG_1999926","Cytochrome P450 21-hydroxylase","1","5VBU"
"5VBZ",,"X-RAY DIFFRACTION",1.93,36.31,"VAPOR DIFFUSION, HANGING DROP",6.6,"32% PEG4000
.1 M Na Cacodylate (pH 6.6)
.2 M CaCl2",298,"10.1016/j.chembiol.2017.08.025",,"5VBZ",59.75,"2.2","2.2","Crystal Structure of Small Molecule Disulfide 2C07 Bound to H-Ras M72C GppNHp","GAMGSMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYCRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","5VBZ"
"5VC0",,"X-RAY DIFFRACTION",2.15,42.82,"MICROBATCH",7.4,"Hampton PegIon2 solution #15",298,"10.1021/acs.biochem.7b00334","RIT","5VC0",57.1,"2.7","2.7","Crystal structure of human CYP3A4 bound to ritonavir","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","5VC0"
"5VC1",,"X-RAY DIFFRACTION",3.78,67.45,"VAPOR DIFFUSION, SITTING DROP",7.5,"100 mM sodium cacodylate pH 7.5, 200 mM calcium acetate, 40% (v/v) PEG 600",293,"10.1002/cbic.201700220",,"5VC1",19.76,"1.94","1.94","Crystal structure of L-selectin lectin/EGF domains","WTYHYSEKPMNWQRARRFCRDQYTDLVAIQNKAEIEYLEKTLPFSRSYYWIGIRKIGGIWTWVGTNKSLTEEAENWGDGEPNNKKNKEDCVEIYIKRNKDAGKWNDDACHKLKAALCYTASCQPWSCSGHGECVEIINQYTCNCDVGYYGPQCQFVI","Homo sapiens","SELL, LNHR, LYAM1","L-selectin","1","5VC1"
"5VC3",,"X-RAY DIFFRACTION",2.08,40.83,"VAPOR DIFFUSION, HANGING DROP",6.9,"5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5),7.5 % PEG 3350, 1 mM Bosutinib",291,"10.1021/acs.jmedchem.7b00996","DB8","5VC3",33.26,"1.97","1.97","CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH BOSUTINIB","GAGSMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","5VC3"
"5VC4",,"X-RAY DIFFRACTION",2.19,43.9,"VAPOR DIFFUSION, HANGING DROP",6.9,"5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM Bosutinib-isomer",291,"10.1021/acs.jmedchem.7b00996","XZN","5VC4",33.07,"2.1","2.1","Crystal structure of HUMAN WEE1 KINASE domain in complex with Bosutinib-isomer","GAGSMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","5VC4"
"5VC5",,"X-RAY DIFFRACTION",2.11,41.73,"VAPOR DIFFUSION, HANGING DROP",6.9,"9.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM PD-166285",291,"10.1021/acs.jmedchem.7b00996","96M","5VC5",33.19,"1.93","1.93","Crystal structure of human WEE1 kinase domain in complex with PD-166285","GAGSMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","5VC5"
"5VC6",,"X-RAY DIFFRACTION",2.21,44.22,"VAPOR DIFFUSION, HANGING DROP",6.9,"5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM PHA-848125",291,"10.1021/acs.jmedchem.7b00996","P48","5VC6",32.96,"2","2","crystal structure of human WEE1 kinase domain in complex with PHA-848125","GAGSMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","5VC6"
"5VCC",,"X-RAY DIFFRACTION",2.26,45.61,"MICROBATCH",,"PEG4000",298,"10.1021/acs.biochem.7b00334",,"5VCC",57.86,"1.7","1.7","Crystal structure of human CYP3A4 bound to glycerol","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMFDMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","5VCC"
"5VCD",,"X-RAY DIFFRACTION",2.27,45.9,"MICROBATCH",7.5,"PEG4000",298,"10.1021/acs.biochem.7b00334",,"5VCD",57.39,"1.95","1.95","Crystal structure of the cysteine depleted CYP3A4 bound to glycerol","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFAMFDMEMHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKEAYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNITVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVAKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPSKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","5VCD"
"5VCE",,"X-RAY DIFFRACTION",2.26,45.59,"MICROBATCH",7.5,"PEG4000",298,"10.1021/acs.biochem.7b00334","RIT","5VCE",57.01,"2.2","2.2","Crystal structure of the cysteine depleted CYP3A4 bound to ritonavir","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFAMFDMEMHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKEAYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNITVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVAKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPSKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","5VCE"
"5VCG",,"X-RAY DIFFRACTION",2.31,46.83,"VAPOR DIFFUSION, SITTING DROP",7.4,"PEG4000",298,"10.1021/acs.biochem.7b00334","08Y","5VCG",57.31,"2.2","2.2","Crystal structure of the cysteine depleted CYP3A4 bound to bromoergocryptine","MAYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFAMFDMEMHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKEAYSVFTNRRPFGPVGFMKSAISIAEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYSMDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNITVFPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSIIFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVVNETLRLFPIAMRLERVAKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFSKKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPSKETQIPLKLSLGGLLQPEKPVVLKVESRDGTVSGAHHHH","Homo sapiens","CYP3A4, CYP3A3","Cytochrome P450 3A4","1","5VCG"
"5VCM",,"X-RAY DIFFRACTION",1.96,37.25,"VAPOR DIFFUSION, HANGING DROP",,"1.7 M ammonium sulfate, 100 mM HEPES, pH 7.5, 5 mM UDP, 5 mM manganese chloride",293,"10.1073/pnas.1716988115",,"5VCM",98.12,"1.599","1.599","Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase with bound UDP and Manganese","GRQRKNEALAPPLLDAEPARGAGGRGGDHPSVAVGIRRVSNVSAASLVPAVPQPEADNLTLRYRSLVYQLNFDQTLRNVDKAGTWAPRELVLVVQVHNRPEYLRLLLDSLRKAQGIDNVLVIFSHDFWSTEINQLIAGVNFCPVLQVFFPFSIQLYPNEFPGSDPRDCPRDLPKNAALKLGCINAEYPDSFGHYREAKFSQTKHHWWWKLHFVWERVKILRDYAGLILFLEEDHYLAPDFYHVFKKMWKLKQQECPECDVLSLGTYSASRSFYGMADKVDVKTWKSTEHNMGLALTRNAYQKLIECTDTFCTYDDYNWDWTLQYLTVSCLPKFWKVLVPQIPRIFHAGDCGMHHKKTCRPSTQSAQIESLLNNNKQYMFPETLTISEKFTVVAISPPRKNGGWGDIRDHELCKSYRRLQ","Homo sapiens","MGAT2","Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase","1","5VCM"
"5VCR",,"X-RAY DIFFRACTION",2.48,50.44,"VAPOR DIFFUSION, HANGING DROP",,"1.4 M ammonium sulfate",293,"10.1073/pnas.1716988115",,"5VCR",98.15,"1.992","1.992","Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase with bound uranium dioxide","GRQRKNEALAPPLLDAEPARGAGGRGGDHPSVAVGIRRVSNVSAASLVPAVPQPEADNLTLRYRSLVYQLNFDQTLRNVDKAGTWAPRELVLVVQVHNRPEYLRLLLDSLRKAQGIDNVLVIFSHDFWSTEINQLIAGVNFCPVLQVFFPFSIQLYPNEFPGSDPRDCPRDLPKNAALKLGCINAEYPDSFGHYREAKFSQTKHHWWWKLHFVWERVKILRDYAGLILFLEEDHYLAPDFYHVFKKMWKLKQQECPECDVLSLGTYSASRSFYGMADKVDVKTWKSTEHNMGLALTRNAYQKLIECTDTFCTYDDYNWDWTLQYLTVSCLPKFWKVLVPQIPRIFHAGDCGMHHKKTCRPSTQSAQIESLLNNNKQYMFPETLTISEKFTVVAISPPRKNGGWGDIRDHELCKSYRRLQ","Homo sapiens","MGAT2","Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase","1","5VCR"
"5VCS",,"X-RAY DIFFRACTION",2.7,54.44,"VAPOR DIFFUSION, HANGING DROP",,"1.6 M ammonium sulfate, 100 mM HEPES, pH 7.5",293,"10.1073/pnas.1716988115",,"5VCS",99.3,"2.799","2.799","Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase with Bound Acceptor","GRQRKNEALAPPLLDAEPARGAGGRGGDHPSVAVGIRRVSNVSAASLVPAVPQPEADNLTLRYRSLVYQLNFDQTLRNVDKAGTWAPRELVLVVQVHNRPEYLRLLLDSLRKAQGIDNVLVIFSHDFWSTEINQLIAGVNFCPVLQVFFPFSIQLYPNEFPGSDPRDCPRDLPKNAALKLGCINAEYPDSFGHYREAKFSQTKHHWWWKLHFVWERVKILRDYAGLILFLEEDHYLAPDFYHVFKKMWKLKQQECPECDVLSLGTYSASRSFYGMADKVDVKTWKSTEHNMGLALTRNAYQKLIECTDTFCTYDDYNWDWTLQYLTVSCLPKFWKVLVPQIPRIFHAGDCGMHHKKTCRPSTQSAQIESLLNNNKQYMFPETLTISEKFTVVAISPPRKNGGWGDIRDHELCKSYRRLQ","Homo sapiens","MGAT2","Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase","1","5VCS"
"5VCV",,"X-RAY DIFFRACTION",2.11,41.6,"VAPOR DIFFUSION, HANGING DROP",7.5,"6.9 MG/ML MYT1, 25 mM HEPES, 100 MM SODIUM CHLORIDE, 0.5 mM DTT, 0.1 M CALCIUM CHLORIDE, 0.05 M TRIS pH 8.5, 10 % PEG 4000, 1 mM Dasatinib",291,"10.1021/acs.jmedchem.7b00996","1N1","5VCV",35.2,"1.92","1.92","CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH Dasatinib","MHHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP","Homo sapiens","PKMYT1, MYT1","Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase","1","5VCV"
"5VCW",,"X-RAY DIFFRACTION",2.84,56.64,"VAPOR DIFFUSION, HANGING DROP",7.5,"6.9 MG/ML MYT1, 25 mM HEPES, 100 MM SODIUM CHLORIDE, 0.5 mM DTT, 0.05 M MES pH 6.5, 0.8 M Magnesium sulfate, 2 mM Pelitinib",291,"10.1021/acs.jmedchem.7b00996","93J","5VCW",70.66,"2.25","2.25","CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH Pelitinib","MHHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP","Homo sapiens","PKMYT1, MYT1","Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase","1","5VCW"
"5VCX",,"X-RAY DIFFRACTION",2.46,49.98,"VAPOR DIFFUSION, HANGING DROP",7.5,"6.9 MG/ML MYT1, 25 mM HEPES, 100 MM SODIUM CHLORIDE, 0.5 mM DTT, 0.1 M CALCIUM CHLORIDE, 0.05 M TRIS pH 8.5, 10 % PEG 4000, 1 mM SARACATINIB",291,"10.1021/acs.jmedchem.7b00996","H8H","5VCX",35.1,"2.7","2.7","CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN (UNTREATED) IN COMPLEX WITH SARACATINIB","MHHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP","Homo sapiens","PKMYT1, MYT1","Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase","1","5VCX"
"5VCY",,"X-RAY DIFFRACTION",2.11,41.77,"VAPOR DIFFUSION, HANGING DROP",7.5,"14 MG/ML MYT1, 50 mM HEPES PH 7.5, 0.5 mM DTT, 0.05 M POTASSIUM CHLORIDE, 17.5 (V/V) % pentaerythritol propoxylate (5/4 PO/OH), 1.5 mM BOSUTINIB",291,"10.1021/acs.jmedchem.7b00996","DB8","5VCY",35.4,"1.56","1.56","CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH BOSUTINIB","MHHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP","Homo sapiens","PKMYT1, MYT1","Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase","1","5VCY"
"5VCZ",,"X-RAY DIFFRACTION",2.11,41.67,"VAPOR DIFFUSION, HANGING DROP",7.5,"14 MG/ML MYT1, 50 mM HEPES PH 7.5, 0.5 mM DTT, 0.05 M POTASSIUM CHLORIDE, 17.5 (V/V) % pentaerythritol propoxylate (5/4 PO/OH), 1.5 mM osutinib isomer",291,"10.1021/acs.jmedchem.7b00996","XZN","5VCZ",35.45,"1.5","1.5","CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH Bosutinib isomer","MHHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP","Homo sapiens","PKMYT1, MYT1","Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase","1","5VCZ"
"5VD0",,"X-RAY DIFFRACTION",2.07,40.72,"VAPOR DIFFUSION, HANGING DROP",7.5,"14 MG/ML MYT1, 50 mM HEPES PH 7.5, 0.5 mM DTT, 0.05 M POTASSIUM CHLORIDE, 17.5 (V/V) % pentaerythritol propoxylate (5/4 PO/OH), 1.5 mM  MK1775",291,"10.1021/acs.jmedchem.7b00996","8X7","5VD0",35.1,"2.13","2.13","CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH MK1775","MHHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP","Homo sapiens","PKMYT1, MYT1","Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase","1","5VD0"
"5VD1",,"X-RAY DIFFRACTION",2.13,42.16,"VAPOR DIFFUSION, HANGING DROP",7.5,"14 MG/ML MYT1, 50 mM HEPES PH 7.5, 0.5 mM DTT, 0.05 M POTASSIUM CHLORIDE, 17.5 (V/V) % pentaerythritol propoxylate (5/4 PO/OH), 1.5 mM PHA-848125",291,"10.1021/acs.jmedchem.7b00996","P48","5VD1",35.06,"1.7","1.7","CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH PHA-848125","MHHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP","Homo sapiens","PKMYT1, MYT1","Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase","1","5VD1"
"5VD2",,"X-RAY DIFFRACTION",2.07,40.44,"VAPOR DIFFUSION, HANGING DROP",6.9,"9.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM PF-03814735",291,"10.1021/acs.jmedchem.7b00996",,"5VD2",33.08,"2.05","2.05","crystal structure of human WEE1 kinase domain in complex with PF-03814735","GAGSMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","5VD2"
"5VD3",,"X-RAY DIFFRACTION",2.1,41.51,"VAPOR DIFFUSION, HANGING DROP",7.5,"14 MG/ML MYT1, 50 mM HEPES PH 7.5, 0.5 mM DTT, 0.05 M POTASSIUM CHLORIDE, 17.5 (V/V) % pentaerythritol propoxylate (5/4 PO/OH), 1.5 mM SARACATINIB",291,"10.1021/acs.jmedchem.7b00996","H8H","5VD3",35.27,"1.8","1.8","CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN (de-phosphorylated) IN COMPLEX WITH SARACATINIB","MHHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQP","Homo sapiens","PKMYT1, MYT1","Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase","1","5VD3"
"5VD4",,"X-RAY DIFFRACTION",2.15,42.66,"VAPOR DIFFUSION, HANGING DROP",6.9,"5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM RAC-IV-016",291,,,"5VD4",33.39,"2.02","2.02","CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV-016, a MK1775 analougue","GAGSMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","5VD4"
"5VD5",,"X-RAY DIFFRACTION",2.18,43.62,"VAPOR DIFFUSION, HANGING DROP",6.9,"5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM RAC-IV-050",291,,,"5VD5",32.96,"2.05","2.05","CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV-050, a MK1775 analougue","GAGSMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","5VD5"
"5VD7",,"X-RAY DIFFRACTION",2.18,43.54,"VAPOR DIFFUSION, HANGING DROP",6.9,"5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM RAC-IV-098",291,,,"5VD7",33.06,"2.08","2.08","CRYSTAL STRUCTURE OF HUMAN WEE1 KINASE DOMAIN IN COMPLEX WITH RAC-IV-098, a MK1775 analogue","GAGSMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","5VD7"
"5VD8",,"X-RAY DIFFRACTION",2.2,43.98,"VAPOR DIFFUSION, HANGING DROP",6.9,"5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM RAC-IV-099",291,,,"5VD8",33.14,"1.85","1.85","Crystal structure of human WEE1 kinase domain in complex with RAC-IV-099, a MK1775 analogue","GAGSMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","5VD8"
"5VD9",,"X-RAY DIFFRACTION",2.19,43.73,"VAPOR DIFFUSION, HANGING DROP",6.9,"5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM RAC-IV-097",291,,,"5VD9",33.02,"1.87","1.87","Crystal structure of human WEE1 kinase domain in complex with RAC-IV-097, a MK1775 analogue","GAGSMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","5VD9"
"5VDA",,"X-RAY DIFFRACTION",2.19,43.8,"VAPOR DIFFUSION, HANGING DROP",6.9,"5.0 MG/ML WEE1, 25 mM Na/K phosphate, 1 mM DTT, 0.05 M ammonium sulfate, 0.05 M Bis-tris (pH 5.5), 7.5 % PEG 3350, 1 mM RAC-IV-101",291,,,"5VDA",33.02,"2.1","2.1","Crystal structure of human WEE1 kinase domain in complex with RAC-IV-101, a MK1775 analogue","GAGSMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK","Homo sapiens","WEE1","Wee1-like protein kinase","1","5VDA"
"5VDC",,"X-RAY DIFFRACTION",2.74,55.06,"VAPOR DIFFUSION, HANGING DROP",8,"2.2 M Ammonium sulfate, 0.15 M Ammonium citrate",295,"10.1073/pnas.1700328114",,"5VDC",14.7,"1.6","1.6","Crystal structure of the human DPF2 tandem PHD finger domain","GMGSNNYCDFCLGDSKINKKTGQPEELVSCSDCGRSGHPSCLQFTPVMMAAVKTYRWQCIECKCCNICGTSENDDQLLFCDDCDRGYHMYCLTPSMSEPPEGSWSCHLCLDLLKEKASIYQNQNSS","Homo sapiens","DPF2, BAF45D, REQ, UBID4","Zinc finger protein ubi-d4","1","5VDC"
"5VDH",,"X-RAY DIFFRACTION",3.86,68.16,"VAPOR DIFFUSION, HANGING DROP",6.5,"200 mM calcium chloride, 22.5-27.5% PEG350 MME, 100 mM MES, pH 6.5",277,"10.1016/j.str.2017.04.007","7C6","5VDH",216.63,"2.85","2.85","Crystal Structure of Human Glycine Receptor alpha-3 Bound to AM-3607, Glycine, and Ivermectin","ARSRSAPMSPSDFLDKLMGRTSGYDARIRPNFKGPPVNVTCNIFINSFGSIAETTMDYRVNIFLRQKWNDPRLAYSEYPDDSLDLDPSMLDSIWKPDLFFANEKGANFHEVTTDNKLLRIFKNGNVLYSIRLTLTLSCPMDLKNFPMDVQTCIMQLESFGYTMNDLIFEWQDEAPVQVAEGLTLPQFLLKEEKDLRYCTKHYNTGKFTCIEVRFHLERQMGYYLIQMYIPSLLIVILSWVSFWINMDAAPARVALGITTVLTMTTQSSGSRASLPKVSYVKAIDIWMAVCLLFVFSALLEYAAVNFVSRAGTKVFIDRAKKIDTISRACFPLAFLIFNIFYWVIYKILRHEDIHWSHPQFEK","Homo sapiens","GLRA3","Glycine receptor subunit alpha-3","1","5VDH"
,,,,,,,,,,,,,,,,,"Homo sapiens","GLRA3"
"5VDI",,"X-RAY DIFFRACTION",4.49,72.6,"VAPOR DIFFUSION, HANGING DROP",6.5,"200 mM calcium chloride, 22.5-27.5% PEG350 MME, 100 mM MES, pH 6.5",277,"10.1016/j.str.2017.04.007","7C6","5VDI",216.44,"3.1","3.1","Crystal Structure of Human Glycine Receptor alpha-3 Mutant N38Q Bound to AM-3607, Glycine, and Ivermectin","ARSRSAPMSPSDFLDKLMGRTSGYDARIRPNFKGPPVQVTCNIFINSFGSIAETTMDYRVNIFLRQKWNDPRLAYSEYPDDSLDLDPSMLDSIWKPDLFFANEKGANFHEVTTDNKLLRIFKNGNVLYSIRLTLTLSCPMDLKNFPMDVQTCIMQLESFGYTMNDLIFEWQDEAPVQVAEGLTLPQFLLKEEKDLRYCTKHYNTGKFTCIEVRFHLERQMGYYLIQMYIPSLLIVILSWVSFWINMDAAPARVALGITTVLTMTTQSSGSRASLPKVSYVKAIDIWMAVCLLFVFSALLEYAAVNFVSRAGTKVFIDRAKKIDTISRACFPLAFLIFNIFYWVIYKILRHEDIHWSHPQFEK","Homo sapiens","GLRA3","Glycine receptor subunit alpha-3","1","5VDI"
,,,,,,,,,,,,,,,,,"Homo sapiens","GLRA3"
"5VDK",,"X-RAY DIFFRACTION",2.4,48.72,"VAPOR DIFFUSION, HANGING DROP",8,"14 MG/ML WEE2, 25 mM TRIS PH 8.0, 1 mM DTT, 0.2 M ammonium phosphate monobasic, 1.5 mM MK1775",291,"10.1021/acs.jmedchem.7b00996","8X7","5VDK",33.86,"2.7","2.7","Crystal structure of human WEE2 kinase domain in complex with MK1775","GPEFGSTNMASRYEKEFLEVEKIGVGEFGTVYKCIKRLDGCVYAIKRSMKTFTELSNENSALHEVYAHAVLGHHPHVVRYYSSWAEDDHMIIQNEYCNGGSLQAAISENTKSGNHFEEPKLKDILLQISLGLNYIHNSSMVHLDIKPSNIFICHKMQSESSGVIEEVENEADWFLSANVMYKIGDLGHATSINKPKVEEGDSRFLANEILQEDYRHLPKADIFALGLTIAVAAGAESLPTNGAAWHHIRKGNFPDVPQELSESFSSLLKNMIQPDAEQRPSAAALARNTVLRPSLGK","Homo sapiens","WEE2, WEE1B","Wee1-like protein kinase 2","1","5VDK"
"5VDO",,"X-RAY DIFFRACTION",2.47,50.19,"VAPOR DIFFUSION, SITTING DROP",7,"18-20% PEG 3350, 0.2 M ammonium citrate pH 7",277,"10.1002/pro.3304",,"5VDO",86.55,"3.218","3.218","Human cyclic GMP-AMP synthase (cGAS) in complex with 2',2'-cGAMP","MGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","5VDO"
"5VDP",,"X-RAY DIFFRACTION",2.47,50.19,"VAPOR DIFFUSION, SITTING DROP",7,"18-20% PEG 3350, 0.2 M ammonium citrate pH 7",277,"10.1002/pro.3304",,"5VDP",87.03,"2.3","2.3","Human cyclic GMP-AMP synthase (cGAS) in complex with 2',3'-cGAMP","MGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","5VDP"
"5VDQ",,"X-RAY DIFFRACTION",2.51,50.98,"VAPOR DIFFUSION, SITTING DROP",7,"18-20% PEG 3350, 0.2 M ammonium citrate pH 7",277,"10.1002/pro.3304",,"5VDQ",86.59,"3.246","3.246","Human cyclic GMP-AMP synthase (cGAS) in complex with 2',5'-GpAp","MGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","5VDQ"
"5VDR",,"X-RAY DIFFRACTION",2.59,52.5,"VAPOR DIFFUSION, SITTING DROP",7,"18-20% PEG 3350, 0.2 M ammonium citrate pH 7",277,"10.1002/pro.3304",,"5VDR",87.84,"3.042","3.042","Human cyclic GMP-AMP synthase (cGAS) in complex with 3',3'-cdIMP","MGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","5VDR"
"5VDS",,"X-RAY DIFFRACTION",2.56,51.95,"VAPOR DIFFUSION, SITTING DROP",7,"18-20% PEG 3350, 0.2 M ammonium citrate pH 7",277,"10.1002/pro.3304",,"5VDS",86.43,"2.766","2.766","Human cyclic GMP-AMP synthase (cGAS) in complex with 3',3'-cdUMP","MGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","5VDS"
"5VDT",,"X-RAY DIFFRACTION",2.51,50.98,"VAPOR DIFFUSION, SITTING DROP",7,"18-20% PEG 3350, 0.2 M ammonium citrate pH 7",277,"10.1002/pro.3304",,"5VDT",86.55,"2.576","2.576","Human cyclic GMP-AMP synthase (cGAS) in complex with 3',3'-cGAMP","MGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","5VDT"
"5VDU",,"X-RAY DIFFRACTION",2.57,52.1,"VAPOR DIFFUSION, SITTING DROP",7,"18-20% PEG 3350, 0.2 M ammonium citrate pH 7",277,"10.1002/pro.3304",,"5VDU",85.83,"2.729","2.729","Human cyclic GMP-AMP synthase (cGAS) in complex with Compound F2","MGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","5VDU"
"5VDV",,"X-RAY DIFFRACTION",2.52,51.24,"VAPOR DIFFUSION, SITTING DROP",7,"18-20% PEG 3350, 0.2 M ammonium citrate pH 7",277,"10.1002/pro.3304",,"5VDV",85.86,"2.998","2.998","Human cyclic GMP-AMP synthase (cGAS) in complex with Compound F3","MGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","5VDV"
"5VDW",,"X-RAY DIFFRACTION",2.52,51.24,"VAPOR DIFFUSION, SITTING DROP",7,"18-20% PEG 3350, 0.2 M ammonium citrate pH 7",277,"10.1002/pro.3304",,"5VDW",85.72,"2.711","2.711","Human cyclic GMP-AMP synthase (cGAS) in complex with Compound F1","MGASKLRAVLEKLKLSRDDISTAAGMVKGVVDHLLLRLKCDSAFRGVGLLNTGSYYEHVKISAPNEFDVMFKLEVPRIQLEEYSNTRAYYFVKFKRNPKENPLSQFLEGEILSASKMLSKFRKIIKEEINDIKDTDVIMKRKRGGSPAVTLLISEKISVDITLALESKSSWPASTQEGLRIQNWLSAKVRKQLRLKPFYLVPKHAKEGNGFQEETWRLSFSHIEKEILNNHGKSKTCCENKEEKCCRKDCLKLMKYLLEQLKERFKDKKHLDKFSSYHVKTAFFHVCTQNPQDSQWDRKDLGLCFDNCVTYFLQCLRTEKLENYFIPEFNLFSSNLIDKRSKEFLTKQIEYERNNEFPVFDEF","Homo sapiens","MB21D1, C6orf150, CGAS","Cyclic GMP-AMP synthase","1","5VDW"
"5VE6",,"X-RAY DIFFRACTION",2.29,46.27,"EVAPORATION",7.5,"0.1M Hepes pH 7.5, 1.6M NaH2PO4/KH2PO4",298,"10.1038/s41467-017-01279-9",,"5VE6",54.23,"2.953","2.953","Crystal structure of Sugen kinase 223","MHHHHHHHHGSENLYFQGSGSTQLQLHGLLSNISSKEGTYAKLGGLYTQSLARLVAKCEDLFMGGQKKELHFNENNWSLFKLTCNKPCCDSGDAIYYCATCSEDPGSTYAVKICKAPEPKTVSYCSPSVPVHFNIQQDCGHFVASVPSSMLSSPDAPKDPVPALPTHPPAQEQDCVVVITREVPHQTASDFVRDSAASHQAEPEAYERRVCFLLLQLCNGLEHLKEHGIIHRDLCLENLLLVHCTLQAGPGPAPAPAPAPAAAAPPCSSAAPPAGGTLSPAAGPASPEGPREKQLPRLIISNFLKAKQKPGGTPNLQQKKSQARLAPEIVSASQYRKFDEFQTGILIYELLHQPNPFEVRAQLRERDYRQEDLPPLPALSLYSPGLQQLAHLLLEADPIKRIRIGEAKRVLQCLLWGPRRELVQQPGTSEEALCGTLHNWIDMKRALMMMKFAEKAVDRRRGVELEDWLCCQYLASAEPGALLQSLKLLQLL","Homo sapiens","SGK223, PRAG1","Tyrosine-protein kinase SgK223","1","5VE6"
"5VE9",,"X-RAY DIFFRACTION",3.75,67.22,"VAPOR DIFFUSION, HANGING DROP",,"potassium chloride, PEG3350",293.15,"10.1016/j.str.2017.05.006",,"5VE9",30.45,"2.795","2.795","Structure of hACF7 EF1-EF2-GAR domains","GPGGHMANFDFDVWRKKYMRWMNHKKSRVMDFFRRIDKDQDGKITRQEFIDGILASKFPTTKLEMTAVADIFDRDGDGYIDYYEFVAALHP","Homo sapiens","MACF1, ABP620, ACF7, KIAA0465, KIAA1251, KIAA0754","Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5","1","5VE9"
,,,,,,,,,,,,,,,,"DADKIEDEVTRQVAQCKCAKRFQVEQIGENKYRFGDSQQLRLVRILRSTVMVRVGGGWMALDEFLVKNDPCRAR","Homo sapiens","MACF1, ABP620, ACF7, KIAA0465, KIAA1251, KIAA0754","Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5","2","5VE9"
"5VEC",,"X-RAY DIFFRACTION",2.96,58.39,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.01 M Cobalt (II) chloride hexahydrate, O.1 M MES monohydrate pH 6.5, Ammonium Sulfate 1.8-1.9M",293,"10.1016/j.str.2018.07.005",,"5VEC",129.47,"2.20001616144","2.20001616144","Crystal Structure of the R515L missense variant of human PGM1","MHHHHHHSSGVDLGTENLYFQSNMVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATILLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT","Homo sapiens","PGM1","Phosphoglucomutase-1","1","5VEC"
"5VED",,"X-RAY DIFFRACTION",2.66,53.76,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl (pH 7.5) and 1.5 - 2.0 M Na acetate",298,"10.1016/j.bbapap.2017.10.004",,"5VED",36.49,"2.301","2.301","PAK4 kinase domain in complex with Staurosporine","GARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","Serine/threonine-protein kinase PAK 4","1","5VED"
"5VEE",,"X-RAY DIFFRACTION",2.52,51.26,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl (pH 7.5) and 1.5 - 2.0 M Na acetate",298,"10.1016/j.bbapap.2017.10.004","981","5VEE",36.54,"2.5","2.5","PAK4 kinase domain in complex with FRAX486","GARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","Serine/threonine-protein kinase PAK 4","1","5VEE"
"5VEF",,"X-RAY DIFFRACTION",2.43,49.44,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris-HCl (pH 7.5) and 1.5 - 2.0 M Na acetate",298,"10.1016/j.bbapap.2017.10.004",,"5VEF",36.38,"1.752","1.752","PAK4 kinase domain in complex with fasudil","GARARQENGMPEKPPGPRSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR","Homo sapiens","PAK4, KIAA1142","Serine/threonine-protein kinase PAK 4","1","5VEF"
"5VEI",,"X-RAY DIFFRACTION",1.49,17.46,"VAPOR DIFFUSION",6.5,"28% PEG2000, 0.1 M Bis-Tris",291,,,"5VEI",12.31,"1.33","1.33","Crystal structure of the SH3 domain of human sorbin and SH3 domain-containing protein 2","MKIEEHHHHHHSSGRENLYFQGGAAQPAMAQGALLPAKAVYDFKAQTSKELSFKKGDTVYILRKIDQNWYEGEHHGRVGIFPISYVEKLTGSAAALRTGEAYLRYVDAAA","Homo sapiens","SORBS2, ARGBP2, KIAA0777","Sorbin and SH3 domain-containing protein 2","1","5VEI"
"5VEM",,"X-RAY DIFFRACTION",3.22,61.83,"VAPOR DIFFUSION, HANGING DROP",6.5,"MES, PEG 6000, MPD",298,"10.1111/febs.14266",,"5VEM",149,"2.6","2.6","Human ectonucleotide pyrophosphatase / phosphodiesterase 5 (ENPP5, NPP5)","DRHHHHHHKLPDQQKVLLVSFDGFRWDYLYKVPTPHFHYIMKYGVHVKQVTNVFITKTYPNHYTLVTGLFAENHGIVANDMFDPIRNKSFSLDHMNIYDSKFWEEATPIWITNQRAGHTSGAAMWPGTDVKIHKRFPTHYMPYNESVSFEDRVAKIIEWFTSKEPINLGLLYWEDPDDMGHHLGPDSPLMGPVISDIDKKLGYLIQMLKKAKLWNTLNLIITSDHGMTQCSEERLIELDQYLDKDHYTLIDQSPVAAILPKEGKFDEVYEALTHAHPNLTVYKKEDVPERWHYKYNSRIQPIIAVADEGWHILQNKSDDFLLGNHGYDNALADMHPIFLAHGPAFRKNFSKEAMNSTDLYPLLCHLLNITAMPHNGSFWNVQDLLNSAMPRVVPYTQSTILLPGSVKPAEYDQEGS","Homo sapiens","ENPP5, UNQ550/PRO1107","Ectonucleotide pyrophosphatase/phosphodiesterase family member 5","1","5VEM"
"5VEU",,"X-RAY DIFFRACTION",2.64,53.34,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350, PEG 300, ADA, zinc sulfate",297,"10.1124/mol.117.109744","RIT","5VEU",667.91,"2.91","2.91","Human Cytochrome P450 3A5 (CYP3A5)","MALYGTRTHGLFKRLGIPGPTPLPLLGNVLSYRQGLWKFDTECYKKYGKMWGTYEGQLPVLAITDPDVIRTVLVKECYSVFTNRRSLGPVGFMKSAISLAEDEEWKRIRSLLSPTFTSGKLKEMFPIIAQYGDVLVRNLRREAEKGKPVTLKDIFGAYSMDVITGTSFGVNIDSLNNPQDPFVESTKKFLKFGFLDPLFLSIILFPFLTPVFEALNVSLFPKDTINFLSKSVNRMKKSRLNDKQKHRLDFLQLMIDSQNSKETESHKALSDLELAAQSIIFIFAGYETTSSVLSFTLYELATHPDVQQKLQKEIDAVLPNKAPPTYDAVVQMEYLDMVVNETLRLFPVAIRLERTCKKDVEINGVFIPKGSMVVIPTYALHHDPKYWTEPEEFRPERFSKKKDSIDPYIYTPFGTGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLDTQGLLQPEKPIVLKVDSRDGHHHH","Homo sapiens","CYP3A5","Cytochrome P450 3A5","1","5VEU"
"5VF1",,"X-RAY DIFFRACTION",2.57,52.19,"VAPOR DIFFUSION, HANGING DROP",5.5,"0.1 M bis-Tris at pH 5.5, 0.2 M ammonium acetate, and 45% v/v 2-methyl-2,4-pentanediol",296,"10.1021/jacs.7b03890",,"5VF1",12.35,"2.1","2.1","X-ray Crystallographic Structure of a Giant Double-Walled Peptide Nanotube Formed by a Macrocyclic Beta-Sheet Containing ABeta16-22","AKLVFFAEAEAFFVLK","Homo sapiens",,"ORN-LYS-LEU-VAL-PHI-PHE-ALA-GLU-ORN-GLU-ALA-PHE-MEA-VAL-LEU-LYS","1","5VF1"
"5VF9",,"X-RAY DIFFRACTION",2.36,47.78,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.8 M Potassium Phosphate, pH 7.8",296,"10.1016/j.jsb.2017.04.011",,"5VF9",45.07,"1.82","1.82","Native human manganese superoxide dismutase","MKHSLPDLPYDYGALEPHINAQIMQLHHSKHHAAYVNNLNVTEEKYQEALAKGDVTAQIALQPALKFNGGGHINHSIFWTNLSPNGGGEPKGELLEAIKRDFGSFDKFKEKLTAASVGVQGSGWGWLGFNKERGHLQIAACPNQDPLQGTTGLIPLLGIDVWEHAYYLQYKNVRPDYLKAIWNVINWENVTERYMACKK","Homo sapiens","SOD2","Superoxide dismutase [Mn], mitochondrial","1","5VF9"
"5VFC",,"X-RAY DIFFRACTION",2.13,42.35,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Na Bis-Tris pH 6.5, 26% PEG 8000 and 0.1 M ammonium sulfate",293,"10.1021/acs.jmedchem.6b01796","9BA","5VFC",35.34,"1.64","1.64","WDR5 bound to inhibitor MM-589","TQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC","Homo sapiens","WDR5, BIG3","WD repeat-containing protein 5","1","5VFC"
"5VFI",,"X-RAY DIFFRACTION",2.3,46.62,"VAPOR DIFFUSION",6.5,"PEG 5000 MME
ammonium sulfate
MES pH 6.5",300,"10.1021/acs.jmedchem.7b01712","9AJ","5VFI",32.95,"1.59","1.59","Bruton's tyrosine kinase (BTK) with GDC-0853","GLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","5VFI"
"5VFW",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M117.779215",,"5VFW",3.05,,,"An engineered cyclic peptide alleviates symptoms of inflammation in a murine model of inflammatory bowel disease","AMVSEFLKQAWFIENEEQEYVQTVK","Homo sapiens","ANXA1, ANX1, LPC1","Annexin A1","1","5VFW"
"5VG7",,"X-RAY DIFFRACTION",3,58.97,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M Tris/HCl pH:7.5, 1.8 M Ammonium Sulfate, 16mg/mL",293,"10.1016/j.str.2018.07.005",,"5VG7",125.7,"1.95000322932","1.95000322932","Crystal Structure of the R503Q missense variant of human PGM1","SNMVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFQLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT","Homo sapiens","PGM1","Phosphoglucomutase-1","1","5VG7"
,,,,,,,,,,,,,,,,"SNMVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFQLSGTGSAGATIRLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT","Homo sapiens","PGM1","Phosphoglucomutase-1","2","5VG7"
"5VGI",,"X-RAY DIFFRACTION",2.52,51.11,"VAPOR DIFFUSION",,"25% PEG 4000, 100mM HEPES pH 7.5",273,"10.1021/acsmedchemlett.7b00220","9DJ","5VGI",174.6,"2.07","2.07","Crystal Structure of KDM4 with the Small Molecule Inhibitor QC6352","MGHHHHHHHHGSGENLYFQSSETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","5VGI"
"5VGO",,"X-RAY DIFFRACTION",2.27,45.76,"VAPOR DIFFUSION, HANGING DROP",5.5,"reservoir 0.1 M LiSO4, 0.1 M citric acid pH 5.5, 6% PEG 10K, 0.4% beta-octylglucoside

protein 8 mg/mL 10 mM Tris 8.5, 0.1 M NaCl, 0.5 mM TCEP, G-744 made 0.5 mM using 10 mM DMSO stock

drop 1:2 protein/reservoir.",286,"10.1021/acsmedchemlett.7b00103","9B1","5VGO",32.93,"1.621","1.621","Bruton's tyrosine kinase (BTK) with compound G-744","MGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDENLYFQ","Homo sapiens","BTK, AGMX1, ATK, BPK","Tyrosine-protein kinase BTK","1","5VGO"
"5VGP",,"X-RAY DIFFRACTION",2.8,55.22,"VAPOR DIFFUSION, HANGING DROP",7,"17% PEG 8K,
40 mM CaCl2
100 mM Na Hepes",297,"10.1107/S2053230X18009834",,"5VGP",53.35,"2.116","2.116","Fc fragment of human IgG1 antibody, from NIST mAb","TCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens",,"Human Fc fragment with G1F/G0F glycan","1","5VGP"
"5VGR",,"X-RAY DIFFRACTION",2.42,49.1,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.2 M NaCl, 0.1 M Tris pH 8.5, 25% PEG3350, 25% glycerol",293,"10.1016/j.str.2017.05.007",,"5VGR",99.24,"2.096","2.096","Human Atlastin-3, GDP-bound","SSKPGPVQVVLVQKDQHSFELDEKALASILLQDHIRDLDVVVVSVAGAFRKGKSFILDFMLRYLYSQKESGHSNWLGDPEEPLTGFSWRGGSDPETTGIQIWSEVFTVEKPGGKKVAVVLMDTQGAFDSQSTVKDCATIFALSTMTSSVQIYNLSQNIQEDDLQQLQLFTEYGRLAMDEIFQKPFQTLMFLVRDWSFPYEYSYGLQGGMAFLDKRLQVKEHQHEEIQNVRNHIHSCFSDVTCFLLPHPGLQVATSPDFDGKLKDIAGEFKEQLQALIPYVLNPSKLMEKEINGSKVTCRGLLEYFKAYIKIYQGEDLPHPKSMLQATAEANNLAAAASAKDIYYNNMEEVCGGEKPYLSPDILEEKHCEFKQLALDHFKKTKKMGGKDFSFRYQQELEEEIKELYENFCKHNGSKNVFSTFRAALHHHHHH","Homo sapiens","ATL3","Atlastin-3","1","5VGR"
"5VGY",,"X-RAY DIFFRACTION",2.11,41.64,"VAPOR DIFFUSION, SITTING DROP",8.3,"concentrated CA II at 10 mg/mL was set up with microseeding over 2.9 M ammonium sulfate with 0.1 M Tris buffer at pH 8.3 at 8 C in 250 nL plus 225 nL plus 25 nL (seeds) ratio.",281,"10.1021/acs.jmedchem.7b00606","9AA","5VGY",29.68,"1.39","1.39","Identification of a New Zinc Binding Chemotype by Fragment Screening","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5VGY"
"5VH7",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.7b00252",,"5VH7",9.66,,,"Structure and dynamics of RNA repeat expansions that cause Huntington's Disease and myotonic dystrophy type 1","GACCAGCAGCAGGUC","Homo sapiens",,"RNA (5'-R(*GP*AP*CP*CP*AP*GP*CP*AP*G)-3')","1","5VH7"
"5VH8",,"SOLUTION NMR",,,,,,,"10.1021/acs.biochem.7b00252",,"5VH8",9.52,,,"Structure and dynamics of RNA repeat expansions that cause Huntington's Disease and myotonic dystrophy type 1","GACCUGCUGCUGGUC","Homo sapiens",,"RNA (5'-R(*GP*AP*CP*CP*UP*GP*CP*UP*GP*CP*UP*GP*GP*UP*C)-3')","1","5VH8"
"5VHG",,"X-RAY DIFFRACTION",2.04,39.71,"VAPOR DIFFUSION, HANGING DROP",,"Bis-Tris pH 5.5, PEG 3350, Li2SO4.",293,"10.1107/S2059798317011822",,"5VHG",16.72,"1.27","1.27","Crystal structure of pentad mutant GAPR-1","SASKQFHNEVLKAHNEYRQKHGVPPLKLCKDLNREAQQYSEALASTRILKASPESSRGQCGENLAWASYDQTGKEVADRWYSAIKNYNFQQPGFTSGTKAFTAMVWKNTKKMGVGKASASDGSSFVVARYFPAGGVVNEGFFEENVLPPK","Homo sapiens","GLIPR2, C9orf19, GAPR1","Golgi-associated plant pathogenesis-related protein 1","1","5VHG"
"5VIL",,"X-RAY DIFFRACTION",2.74,55.13,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 3350, 0.2M ammonium chloride, 0.1M Bis-Tris (pH 6.1-6.6), and 10% glycerol.",295,"10.1016/j.ejmech.2017.12.041","9E1","5VIL",133.9,"2.64","2.64","Crystal structure of ASK1 kinase domain with a potent inhibitor (analog 6)","RSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","5VIL"
"5VIN",,"X-RAY DIFFRACTION",3.06,59.82,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.01 M Cobalt (II) chloride hexahydrate, O.1 M MES monohydrate pH 6.5, Ammonium Sulfate 1.8-2.1M",293,"10.1016/j.str.2018.07.005",,"5VIN",130.24,"2.60004291837","2.60004291837","Crystal Structure of the R515Q missense variant of human PGM1","MHHHHHHSSGVDLGTENLYFQSNMVKIVTVKTQAYQDQKPGTSGLRKRVKVFQSSANYAENFIQSIISTVEPAQRQEATLVVGGDGRFYMKEAIQLIARIAAANGIGRLVIGQNGILSTPAVSCIIRKIKAIGGIILTASHNPGGPNGDFGIKFNISNGGPAPEAITDKIFQISKTIEEYAVCPDLKVDLGVLGKQQFDLENKFKPFTVEIVDSVEAYATMLRSIFDFSALKELLSGPNRLKIRIDAMHGVVGPYVKKILCEELGAPANSAVNCVPLEDFGGHHPDPNLTYAADLVETMKSGEHDFGAAFDGDGDRNMILGKHGFFVNPSDSVAVIAANIFSIPYFQQTGVRGFARSMPTSGALDRVASATKIALYETPTGWKFFGNLMDASKLSLCGEESFGTGSDHIREKDGLWAVLAWLSILATRKQSVEDILKDHWQKYGRNFFTRYDYEEVEAEGANKMMKDLEALMFDRSFVGKQFSANDKVYTVEKADNFEYSDPVDGSISRNQGLRLIFTDGSRIVFRLSGTGSAGATIQLYIDSYEKDVAKINQDPQVMLAPLISIALKVSQLQERTGRTAPTVIT","Homo sapiens","PGM1","Phosphoglucomutase-1","1","5VIN"
"5VIO",,"X-RAY DIFFRACTION",2.75,55.23,"VAPOR DIFFUSION, HANGING DROP",6.5,"20% PEG 3350, 0.2M ammonium chloride, 0.1M Bis-Tris (pH 6.1-6.6), and 10% glycerol.",295,"10.1016/j.ejmech.2017.12.041","9E4","5VIO",133.1,"2.84","2.84","Crystal structure of ASK1 kinase domain with a potent inhibitor (analog 13)","RSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL","Homo sapiens","MAP3K5, ASK1, MAPKKK5, MEKK5","Mitogen-activated protein kinase kinase kinase 5","1","5VIO"
"5VIZ",,"X-RAY DIFFRACTION",3.49,64.79,"BATCH MODE",,"Microbatch",291,,,"5VIZ",5.66,"1.7","1.7","X-Ray structure of Insulin Glargine","GIVEQCCTSICSLYQLENYCG","Homo sapiens","INS","Insulin, chain beta","1","5VIZ"
,,,,,,,,,,,,,,,,"FVNQHLCGSHLVEALYLVCGERGFFYTPK","Homo sapiens","INS","Insulin, chain alpha","2","5VIZ"
"5VJA",,"X-RAY DIFFRACTION",2.33,47.2,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.9 M Na2-Malonate, pH 6.8",277,"10.1016/j.chembiol.2018.06.006",,"5VJA",132.02,"2.46","2.46","Crystal Structure of human zipper-interacting protein kinase (ZIPK, alias DAPK3) in complex with a pyrazolo[3,4-d]pyrimidinone ligand (HS38)","SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG","Homo sapiens","DAPK3, ZIPK","Death-associated protein kinase 3","1","5VJA"
"5VKC",,"X-RAY DIFFRACTION",3.11,60.47,"VAPOR DIFFUSION",8.8,"7%(w/v) PEG 8000, 0.1M Tris-HCl, pH 8.8, 0.2M zinc acetate",277,"10.1021/jm501258m","9EA","5VKC",37.94,"2.31","2.31","Crystal structure of MCL-1 in complex with a BIM competitive inhibitor","GSMDLYRQSLEIISRYLREQATGAKDTKPMGRSGATSRKALETLRRVGDGVQRNHETAFQGMLRKLDIKNEDDVKSLSRVMIHVFSDGVTNWGRIVTLISFGAFVAKHLKTINQESCIEPLAESITDVLVRTKRDWLVKQRGWDGFVEFFHVEDLEG","Homo sapiens","MCL1, BCL2L3","Induced myeloid leukemia cell differentiation protein Mcl-1","1","5VKC"
"5VKG",,"SOLUTION NMR",,,,,,,"10.1038/s41467-017-01426-2",,"5VKG",16.89,,,"Solution-state NMR structural ensemble of human Tsg101 UEV in complex with tenatoprazole","GAVSESQLKKMVSKYKYRDLTVRETVNVITLYKDLKPVLDSYVFNDGSSRELMNLTGTIPVPYRGNTYNIPICLWLLDTYPYNPPICFVKPTSSMTIKTGKHVDANGKIYLPYLHEWKHPQSDLLGLIQVMIVVFGDEPPVFSRP","Homo sapiens","TSG101","Tumor susceptibility gene 101 protein","1","5VKG"
"5VKJ",,"X-RAY DIFFRACTION",2.26,45.63,"VAPOR DIFFUSION",,"30% PEG 4000, 0.2 M lithium chloride and 0.1 M Tris pH 8.5",293,"10.1038/s41467-017-00836-6",,"5VKJ",37.94,"2.12","2.12","Crystal structure of human CD22 Ig domains 1-3","ETGDSSKWVFEHPETLYAWEGACVWIPCTYRALDGDLESFILFHNPEYNKATSKFDGTRLYESTKDGKVPSEQKRVQFLGDKNKNCTLSIHPVHLADSGQLGLRMESKTEKWMERIHLAVSERPFPPHIQLPPEIQESQEVTLTCLLAFSCYGYPIQLQWLLEGVPMRQAAVTSTSLTIKSVFTRSELKFSPQWSHHGKIVTCQLQDADGKFLSADTVQLNVKHTPKLEIKVTPSDAIVREGDSVTMTCEVSSSNPEYTTVSWLKDGTSLKKQNTFTLNLREVTKDQSGKYCCQVSNDVGPGRSEEVFLQVQYAGGTKHHHHHH","Homo sapiens","CD22, SIGLEC2","B-cell receptor CD22","1","5VKJ"
"5VKM",,"X-RAY DIFFRACTION",2.26,45.5,"VAPOR DIFFUSION",,"30% PEG 4000, 0.2 M lithium chloride and 0.1 M Tris pH 8.5",293,"10.1038/s41467-017-00836-6",,"5VKM",38.13,"2.2","2.2","Crystal structure of human CD22 Ig domains 1-3 in complex with alpha 2-6 sialyllactose","ETGDSSKWVFEHPETLYAWEGACVWIPCTYRALDGDLESFILFHNPEYNKATSKFDGTRLYESTKDGKVPSEQKRVQFLGDKNKNCTLSIHPVHLADSGQLGLRMESKTEKWMERIHLAVSERPFPPHIQLPPEIQESQEVTLTCLLAFSCYGYPIQLQWLLEGVPMRQAAVTSTSLTIKSVFTRSELKFSPQWSHHGKIVTCQLQDADGKFLSADTVQLNVKHTPKLEIKVTPSDAIVREGDSVTMTCEVSSSNPEYTTVSWLKDGTSLKKQNTFTLNLREVTKDQSGKYCCQVSNDVGPGRSEEVFLQVQYAGGTKHHHHHH","Homo sapiens","CD22, SIGLEC2","B-cell receptor CD22","1","5VKM"
"5VLO",,"X-RAY DIFFRACTION",2.35,47.64,"VAPOR DIFFUSION, SITTING DROP",,"CamKII S3-K301, in 20mM imidazole pH 8.5, 0.3M sodium chloride, 5mM TCEP, was concentrated to 36 mg/ml and flash frozen in liquid nitrogen for long term storage at -80 C in 10 uL aliquots.   The protein was thawed and diluted down to 12 mg/mL in the same buffer just prior to crystallization experiments.  Sitting drop vapor diffusion droplets were assembled with 250 nL of 12 mg/mL CamKII, 0.6 mM inhibitor and 250 nL of reservoir solution 24% peg 3350, 0.2 M ammonium tartrate, 0.1 M arginine.   Flat crystal plates (typically 0.03 mm x 0.2 mm x 0.4 mm in size) grew in 4-7 days at 20 C.   A crystal seed suspension was prepared with ten crushed crystals combined into 100 uL of reservoir solution and stored at -80 C.  A thirty fold seed dilution was prepared in the same solution for addition to protein droplets in a 1 to 1 volume ratio to enhance crystallization of difficult to crystallize inhibitors.",293,,"9EJ","5VLO",70.32,"2.05","2.05","The structure of human CamKII with bound inhibitor","GHMSTTTCTRFTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETVDCLKKFNARRKLK","Homo sapiens","CAMK2D, CAMKD","Calcium/calmodulin-dependent protein kinase type II subunit delta","1","5VLO"
"5VMD",,"X-RAY DIFFRACTION",2.8,56.06,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.2 M sodium nitrate, 0.1 M Bis-Tris propane, pH 6.5, 25% PEG3350",295,"10.1002/pro.3227",,"5VMD",35.96,"2.202","2.202","Crystal structure of UBR-box from UBR6 in a domain-swapping conformation","GPLGSGQCLYKISSYTSYPMHDFYRCHTCNTTDRNAICVNCIKKCHQGHDVEFIRHDRFFCDCGAGTLSNPCTLAGE","Homo sapiens","FBXO11, FBX11, PRMT9, VIT1, UG063H01","F-box only protein 11","1","5VMD"
"5VME",,"X-RAY DIFFRACTION",2.8,56,"VAPOR DIFFUSION, SITTING DROP",,"35.5% PEG 300, 0.1 M HEPES, pH 7.0",293,"10.1080/19420862.2017.1358838",,"5VME",53.09,"3.1","3.1","Crystal structure of human IgG1 Fc K248E, T437R mutant","TCPPCPAPELLGGPSVFLFPPKPEDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYRQKSLSLSPGK","Homo sapiens","DKFZp686C11235","human IgG1 Fc K248E,T437R mutant","1","5VME"
"5VMP",,"X-RAY DIFFRACTION",2.57,52.07,"VAPOR DIFFUSION",,"22% PEG4K, 100mM HEPES pH 7.5",293,"10.1021/acsmedchemlett.7b00220",,"5VMP",173.65,"2.48","2.48","Crystal Structure of Human KDM4 with Small Molecule Inhibitor QC5714","MGHHHHHHGSGENLYFQSNSETLNPSARIMTFYPTMEEFRNFSRYIAYIESQGAHRAGLAKVVPPKEWKPRASYDDIDDLVIPAPIQQLVTGQSGLFTQYNIQKKAMTVREFRKIANSDKYCTPRYSEFEELERKYWKNLTFNPPIYGADVNGTLYEKHVDEWNIGRLRTILDLVEKESGITIEGVNTPYLYFGMWKTSFAWHTEDMDLYSINYLHFGEPKSWYSVPPEHGKRLERLAKGFFPGSAQSCEAFLRHKMTLISPLMLKKYGIPFDKVTQEAGEFMITFPYGYHAGFNHGFNCAESTNFATRRWIEYGKQAVLCSCRKDMVKISMDVFVRKFQPERYKLWKAGKDNTVIDHTLPTPEAAEFL","Homo sapiens","KDM4A, JHDM3A, JMJD2, JMJD2A, KIAA0677","Lysine-specific demethylase 4A","1","5VMP"
"5VNA",,"X-RAY DIFFRACTION",2.46,50,"VAPOR DIFFUSION, SITTING DROP",9.4,"1.24 M ammonium sulfate, 100 mM CHES pH 9.4",290,"10.1021/acschembio.8b00674",,"5VNA",70.48,"2.1","2.1","Crystal structure of human YEATS domain","MFKRMAEFGPDSGGRVKGVTIVKPIVYGNVARYFGKKREEDGHTHQWTVYVKPYRNEDMSAYVKKIQFKLHESYGNPLRVVTKPPYEITETGWGEFEIIIKIFFIDPNERPVTLYHLLKLFQSDTNAMLGKKTVVSEFYDEMIFQDPT","Homo sapiens","YEATS4, GAS41","YEATS domain-containing protein 4","1","5VNA"
"5VND",,"X-RAY DIFFRACTION",2.75,55.3,"VAPOR DIFFUSION, HANGING DROP",,"20% PEG10000, 0.1M MES pH6.2, 0.3M Ammonium Sulphate, 5% Ethylene glycol",298,"10.1158/0008-5472.CAN-17-1865",,"5VND",72.73,"2.2","2.2","Crystal structure of FGFR1-Y563C (FGFR4 surrogate) covalently bound to H3B-6527","GAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVECASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE","Homo sapiens","FGFR1, BFGFR, CEK, FGFBR, FLG, FLT2, HBGFR","Fibroblast growth factor receptor 1","1","5VND"
"5VO1",,"X-RAY DIFFRACTION",2,38.36,"VAPOR DIFFUSION, HANGING DROP",7.7,"20% PEG 3350, 0.2 M Mg Acetate, 0.1 M Hepes pH 7.7",293,"10.1021/acs.jmedchem.7b00843","9FS","5VO1",34.43,"2.45","2.45","DLK in complex with compound 10 (5-(1-isopropyl-5-(3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl)-1H-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine)","MGSEDLWEVPFEEILDLQWVGSGAQGAVFLGRFHGEEVAVKKVRDLKETDIKHLRKLKHPNIITFKGVCTQAPCYCILMEFCAQGQLYEVLRAGRPVTPSLLVDWSMGIAGGMNYLHLHKIIHRDLKSPNMLITYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIWSFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSSCPDGFKILLRQCWNSKPRNRPSFRQILLHLDIASADVLSTPQETYFKSQAEWREEVKLHFEKIKSEGTGNSHHHHHH","Homo sapiens","MAP3K12, ZPK","Mitogen-activated protein kinase kinase kinase 12","1","5VO1"
"5VO2",,"X-RAY DIFFRACTION",1.93,36.31,"VAPOR DIFFUSION, SITTING DROP",7.7,"20% PEG 3350, 0.2 M Mg Acetate, 0.1 M Hepes pH 7.7",293,"10.1021/acs.jmedchem.7b00843","9FV","5VO2",34.43,"2.96","2.96","DLK in complex with inhibitor 5-(1-isopropyl-5-(1-(oxetan-3-yl)piperidin-4-yl)-1H-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (compound 7)","MGSEDLWEVPFEEILDLQWVGSGAQGAVFLGRFHGEEVAVKKVRDLKETDIKHLRKLKHPNIITFKGVCTQAPCYCILMEFCAQGQLYEVLRAGRPVTPSLLVDWSMGIAGGMNYLHLHKIIHRDLKSPNMLITYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPVSEKVDIWSFGVVLWELLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSSCPDGFKILLRQCWNSKPRNRPSFRQILLHLDIASADVLSTPQETYFKSQAEWREEVKLHFEKIKSEGTGNSHHHHHH","Homo sapiens","MAP3K12, ZPK","Mitogen-activated protein kinase kinase kinase 12","1","5VO2"
"5VO4",,"X-RAY DIFFRACTION",2.24,45.12,"VAPOR DIFFUSION, HANGING DROP",,"30% PEG400, HEPES pH 7, 200mM Ca Cl",300,"10.1021/acs.jmedchem.7b00373","9FG","5VO4",29.39,"2.35","2.35","Crystal Structure Of The Androgen Receptor Ligand Binding Domain In Complex With 5-(2-fluoro-4-hydroxyphenyl)-1-methyl-1H-pyrrole-2-carbonitrile","QPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ","Homo sapiens","AR, DHTR, NR3C4","Androgen receptor","1","5VO4"
"5VO6",,"X-RAY DIFFRACTION",2.32,47.05,"VAPOR DIFFUSION",,"NULL",300,"10.1016/j.bmcl.2017.05.043","9J4","5VO6",33.63,"2.65","2.65","CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN IN COMPLEX WITH A PYRROLOPYRIDAZINE INHIBITOR","GPASQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","5VO6"
"5VOM",,"X-RAY DIFFRACTION",1.81,31.95,"VAPOR DIFFUSION, HANGING DROP",6.8,"30% PEG 4000, 0.1 M MES pH 6.8",291,"10.1021/acsmedchemlett.7b00191","9GY","5VOM",36.08,"1.67","1.67","Benzopiperazine BET bromodomain inhibitor in complex with BD1 of Brd4","MHHHHHHSSGVDLGTENLYFQSNANPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5VOM"
"5VOS",,"ELECTRON CRYSTALLOGRAPHY",1.42,,"Batch",4,"50 mM sodium citrate, pH 4.0, 10% v/v DMSO",310,"10.1074/jbc.M117.806109",,"5VOS",1.03,"1.42","1.42","VGSNKGAIIGL from Amyloid Beta determined by MicroED","VGSNKGAIIGL","Homo sapiens","APP, A4, AD1","Amyloid beta A4 protein","1","5VOS"
"5VP0",,"X-RAY DIFFRACTION",2.2,44.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG3350, 0.2M MgCl2, 0.1M Tris pH 7.5",293,"10.1021/acs.jmedchem.7b00807","9GJ","5VP0",122.34,"2.2","2.2","Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders","GHASDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5VP0"
"5VP1",,"X-RAY DIFFRACTION",2.12,41.87,"VAPOR DIFFUSION, HANGING DROP",7.5,"30% PEG3350, 0.2M MgCl2, 0.1M Tris pH 7.5",293,"10.1248/cpb.c17-00564","9GA","5VP1",122.46,"1.86","1.86","Discovery of Clinical Candidate N-{(1S)-1-[3-Fluoro-4-(trifluoromethoxy)phenyl]-2-methoxyethyl}-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915), A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders","GHASDDEYTKLLHDGIQPVAAIDSNFASFTYTPRSLPEDDTSMAILSMLQDMNFINNYKIDCPTLARFCLMVKKGYRDPPYHNWMHAFSVSHFCYLLYKNLELTNYLEDIEIFALFISCMCHDLDHRGTNNSFQVASKSVLAALYSSEGSVMERHHFAQAIAILNTHGCNIFDHFSRKDYQRMLDLMRDIILATDLAHHLRIFKDLQKMAEVGYDRNNKQHHRLLLCLLMTSCDLSDQTKGWKTTRKIAELIYKEFFSQGDLEKAMGNRPMEMMDREKAYIPELQISFMEHIAMPIYKLLQDLFPKAAELYERVASNREHWTKVSHKFTIRGLPSNNSLDFLDEE","Homo sapiens","PDE2A","cGMP-dependent 3',5'-cyclic phosphodiesterase","1","5VP1"
"5VP7",,"X-RAY DIFFRACTION",2.61,52.95,"VAPOR DIFFUSION, HANGING DROP",,"0.2 mol L-1 sodium acetate, 0.1 mol L-1 Tris pH 8.5, 26% PEG 3,350",295,"10.1107/S2059798317015418",,"5VP7",39.95,"1.7","1.7","Crystal structure of human KRAS G12A mutant in complex with GDP","HMTEYKLVVVGAAGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5VP7"
"5VPI",,"X-RAY DIFFRACTION",2.71,54.55,"VAPOR DIFFUSION, HANGING DROP",,"0.2 mol/L sodium acetate, 0.1 mol/L Tris pH 8.5, 24% PEG 3,350",295,"10.1107/S2059798317015418",,"5VPI",39.91,"1.62","1.62","Crystal structure of human KRAS G12A mutant in complex with GTP","HMTEYKLVVVGAAGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5VPI"
"5VPM",,"X-RAY DIFFRACTION",2.83,56.57,"VAPOR DIFFUSION, SITTING DROP",7.5,"19-22% PEG3350, 0.2M ammonium sulfate, 0.1M TRIS-HCl, pH 7.5",298,"10.1016/j.bmcl.2017.09.046",,"5VPM",75.62,"2.9","2.9","Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol","GNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","5VPM"
"5VPY",,"X-RAY DIFFRACTION",2.68,54.12,"VAPOR DIFFUSION, HANGING DROP",,"0.2 mol/L sodium acetate, 0.1 mol/L Tris pH 8.5, 24% PEG 3,350",295,"10.1107/S2059798317015418",,"5VPY",40.1,"2","2","Crystal structure of human KRAS G12A mutant in complex with GppNHp","HMTEYKLVVVGAAGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5VPY"
"5VPZ",,"X-RAY DIFFRACTION",2.7,54.51,"VAPOR DIFFUSION, HANGING DROP",,"0.2 mol/L sodium acetate, 0.1 mol/L Tris pH 8.5, 24% PEG 3,350",295,"10.1107/S2059798317015418",,"5VPZ",39.94,"1.85","1.85","Crystal structure of human KRAS G12A mutant in complex with GTP-gamma-S","HMTEYKLVVVGAAGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5VPZ"
"5VQ0",,"X-RAY DIFFRACTION",2.54,51.66,"VAPOR DIFFUSION, HANGING DROP",,"0.2 mol/L sodium acetate, 0.1 mol/L Tris pH 8.5, 26% PEG 3,350",295,"10.1107/S2059798317015418",,"5VQ0",39.75,"2.3","2.3","Crystal structure of human KRAS G12A mutant in complex with GDP (EDTA soaked)","HMTEYKLVVVGAAGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5VQ0"
"5VQ1",,"X-RAY DIFFRACTION",2.64,53.43,"VAPOR DIFFUSION, HANGING DROP",,"0.2 mol/L sodium acetate, 0.1 mol/L Tris pH 8.5, 28% PEG 3,350",293,"10.1107/S2059798317015418",,"5VQ1",39.8,"1.78","1.78","Crystal structure of human KRAS Q61A mutant in complex with GDP","HMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGAEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5VQ1"
"5VQ2",,"X-RAY DIFFRACTION",2.71,54.64,"VAPOR DIFFUSION, HANGING DROP",,"0.2 mol/L sodium acetate, 0.1 mol/L Tris pH 8.5, 28% PEG 3,350",293,"10.1107/S2059798317015418",,"5VQ2",39.88,"1.96","1.96","Crystal structure of human WT-KRAS in complex with GTP","HMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5VQ2"
"5VQ6",,"X-RAY DIFFRACTION",2.74,55.17,"VAPOR DIFFUSION, HANGING DROP",,"0.2 mol/L sodium acetate, 0.1 mol/L Tris pH 8.5, 24% PEG 3,350",295,"10.1107/S2059798317015418",,"5VQ6",39.91,"1.99","1.99","Crystal structure of human WT-KRAS in complex with GTP-gamma-S","HMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5VQ6"
"5VQ8",,"X-RAY DIFFRACTION",2.65,53.67,"VAPOR DIFFUSION, HANGING DROP",,"0.2 mol/L sodium acetate, 0.1 mol/L Tris pH 8.5, 24% PEG 3,350",295,"10.1107/S2059798317015418",,"5VQ8",39.72,"2.3","2.3","Crystal structure of human WT-KRAS in complex with GDP (EDTA soaked)","HMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5VQ8"
"5VQ9",,"X-RAY DIFFRACTION",3.42,64.08,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris-HCl pH 8.5, 0.8 M LiCl, 4% PEG 3350, cryoprotected with 20% glycerol",293,"10.15252/embj.201797291",,"5VQ9",48.61,"3.02","3.02","Structure of human TRIP13, Apo form","MDEAVGDLKQALPCVAESPTVHVEVHQRGSSTAKKEDINLSVRKLLNRHNIVFGDYTWTEFDEPFLTRNVQSVSIIDTELKVKDSQPIDLSACTVALHIFQLNEDGPSSENLEEETENIIAANHWVLPAAEFHGLWDSLVYDVEVKSHLLDYVMTTLLFSDKNVNSNLITWNRVVLLHGPPGTGKTSLCKALAQKLTIRLSSRYRYGQLIEINSHSLFSKWFSESGKLVTKMFQKIQDLIDDKDALVFVLIDQVESLTAARNACRAGTEPSDAIRVVNAVLTQIDQIKRHSNVVILTTSNITEKIDVAFVDRADIKQYIGPPSAAAIFKIYLSCLEELMKCQIIYPRQQLLTLRELEMIGFIENNVSKLSLLLNDISRKSEGLSGRVLRKLPFLAHALYVQAPTVTIEGFLQALSLAVDKQFEERKKLAAYI","Homo sapiens","TRIP13, PCH2","Pachytene checkpoint protein 2 homolog","1","5VQ9"
"5VQA",,"X-RAY DIFFRACTION",3.48,64.7,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M Tris-HCl pH 8.5, 0.2 M KCl, 10% pentaerythritol propoxylate, 5 mM MgCl2, 1 mM ATP, cryoprotected with 10% glycerol and 12% additional pentaerythritol propoxylate",293,"10.15252/embj.201797291",,"5VQA",49.11,"2.54","2.54","Structure of human TRIP13, ATP-bound form","MDEAVGDLKQALPCVAESPTVHVEVHQRGSSTAKKEDINLSVRKLLNRHNIVFGDYTWTEFDEPFLTRNVQSVSIIDTELKVKDSQPIDLSACTVALHIFQLNEDGPSSENLEEETENIIAANHWVLPAAEFHGLWDSLVYDVEVKSHLLDYVMTTLLFSDKNVNSNLITWNRVVLLHGPPGTGKTSLCKALAQKLTIRLSSRYRYGQLIEINSHSLFSKWFSESGKLVTKMFQKIQDLIDDKDALVFVLIDQVESLTAARNACRAGTEPSDAIRVVNAVLTQIDQIKRHSNVVILTTSNITEKIDVAFVDRADIKQYIGPPSAAAIFKIYLSCLEELMKCQIIYPRQQLLTLRELEMIGFIENNVSKLSLLLNDISRKSEGLSGRVLRKLPFLAHALYVQAPTVTIEGFLQALSLAVDKQFEERKKLAAYI","Homo sapiens","TRIP13, PCH2","Pachytene checkpoint protein 2 homolog","1","5VQA"
"5VQK",,"X-RAY DIFFRACTION",2.57,52.17,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 4000 (2-8%), NACL 0.5M, PIPES (0.1M), PH 7.0",298,,,"5VQK",32.91,"3.1","3.1","X-ray co-structure of nuclear receptor ROR-gammat Ligand Binding Domain with a inverse agonist and SRC2 peptide","MGSSHHHHHHLVPRGSPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSGGGEKHKILHRLLQDS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma, SRC2 chimera","1","5VQK"
,,,,,,,,,,,,,,,,,"Homo sapiens","RORC, NR1F3, RORG, RZRG"
"5VQL",,"X-RAY DIFFRACTION",2.25,45.44,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 4000 (2-8%), NACL 0.5M, PIPES (0.1M), PH 7.0",298,,,"5VQL",33.01,"2.7","2.7","X-ray co-structure of nuclear receptor ROR-gammat Ligand Binding Domain with a inverse agonist and SRC2 peptide","MGSSHHHHHHLVPRGSPEAPYASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVERLQIFQHLHPIVVQAAFPPLYKELFSGGGEKHKILHRLLQDS","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma, SRC2 chimera","1","5VQL"
,,,,,,,,,,,,,,,,,"Homo sapiens","RORC, NR1F3, RORG, RZRG"
"5VQP",,"X-RAY DIFFRACTION",2.7,54.45,"VAPOR DIFFUSION, HANGING DROP",6.3,"100 mM MES pH6.3, 1.68 M Ammonium Sulfate, 11% Dioxane",289,"10.1074/jbc.M117.809657",,"5VQP",42.08,"2.9","2.9","Crystal structure of human pro-TGF-beta1","GPLSTSKTIDMELVKRKRIEAIRGQILSKLRLASPPSQGEVPPGPLPEAVLALYNSTRDRVAGESAEPEPEPEADYYAKEVTRVLMVETHNEIYDKFKQSTHSIYMFFQTSELREAVPEPVLLSRAELRLLRLKLKVEQHVELYQKYSQNSWRYLSNRLLAPSDSPEWLSFDVTGVVRQWLSRGGEIEGFRLSAHCSCDSRDNTLQVDINGFTTGRRGDLATIHGMNRPFLLLMATPLERAQHLQSSRHRRALDTNYCFSSTEKNCCVRQLYIDFRKDLGWKWIHEPKGYHANFCLGPCPYIWSLDTQYSKVLALYNQHNPGASAAPCCVPQALEPLPIVYYVGRKPKVEQLSNMIVRSCKCS","Homo sapiens","TGFB1, TGFB","Transforming growth factor beta-1","1","5VQP"
"5VR3",,"X-RAY DIFFRACTION",2.58,52.44,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 2.0 M ammonium sulphate",293.15,"10.1038/nature25478",,"5VR3",9.64,"2.102","2.102","Crystal structure of the BRS domain of BRAF","GAMDPGGGGSSAADPAIPEEVWNIKQMIKLTQEHIEALLDKFGGEHNPPSIYLEAYEEYTSKLDALQQREQQLLESLGNGTDFSVSSS","Homo sapiens","BRAF, BRAF1, RAFB1","BRAF","1","5VR3"
"5VR6",,"X-RAY DIFFRACTION",2.17,43.39,"VAPOR DIFFUSION, HANGING DROP",,"22 - 25% PEG 2000 MME
200 mM Ammonium Sulfate
0.1 M Sodium Acetate",291,"10.1021/acs.biochem.7b00638",,"5VR6",61.5,"1.87","1.87","Structure of Human Sts-1 histidine phosphatase domain with sulfate bound","RCLFVCRHGERMDVVFGKYWLSQCFDAKGRYIRTNLNMPHSLPQRSGGFRDYEKDAPITVFGCMQARLVGEALLESNTIIDHVYCSPSLRCVQTAHNILKGLQQENHLKIRVEPGLFEWTKWVAGSTLPAWIPPSELAAANLSVDTTYRPHIPISKLVVSESYDTYISRSFQVTKEIISECKSKGNNILIVAHASSLEACTCQLQGLSPQNSKDFVQMVRKIPYLGFCSCEELGETGIWQLTDPPILPLTHGPTGGFNWRETLLQE","Homo sapiens","UBASH3B, KIAA1959, STS1","Ubiquitin-associated and SH3 domain-containing protein B","1","5VR6"
"5VR8",,"X-RAY DIFFRACTION",2.9,57.52,"VAPOR DIFFUSION, HANGING DROP",7.2,"14% 1-6 Hexanediol, 10% PEG 3350, 100mM HEPEs, 10mM Adenosine Diphosphate, 5mM UDP-Xylose",298.15,"10.1038/s41586-018-0699-5",,"5VR8",337.61,"1.999","1.999","Human UDP-Glucose Dehydrogenase with UDP-Xylose Bound to the Co-enzyme Site","HMFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRAADLKYIEACARRIVQNSNGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKVSSKRIPYAPSGEIPKFSLQDPPNKKPKV","Homo sapiens","UGDH","UDP-glucose 6-dehydrogenase","1","5VR8"
"5VRP",,"X-RAY DIFFRACTION",2.69,54.31,"VAPOR DIFFUSION, HANGING DROP",7.5,"1 ul of 200 mM inhibitor solution in DMSO was added to 100 ul of protein.. The inhibitor was soluble in the protein solution. The inhibitor stock was freshly made. The sample was incubated for 3 hr on ice prior to setting up the plates. 2 ml protein, 2 ml well hanging drops were set up in the cold. Streak seeded the next day with crushed crystals from the last time.",277,"10.1016/j.bmcl.2017.09.046",,"5VRP",76.54,"3.22","3.22","Crystal Structure of Human Renin in Complex with a biphenylpipderidinylcarbinol","GNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRLYTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEMPALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGGQIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISGSTSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKKLCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR","Homo sapiens","REN","Renin","1","5VRP"
"5VS6",,"X-RAY DIFFRACTION",2.53,51.35,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350, NaFormate",293,"10.1016/j.chembiol.2017.09.003","9QD","5VS6",83.37,"2.27","2.27","Structure of DUB complex","KKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQKRKERQE","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","5VS6"
"5VSB",,"X-RAY DIFFRACTION",2.36,47.9,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350, NaFormate",293,"10.1016/j.chembiol.2017.09.003","9QA","5VSB",82.86,"1.85","1.85","Structure of DUB complex","KKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQKRKERQE","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","5VSB"
"5VSC",,"X-RAY DIFFRACTION",2.55,51.72,"VAPOR DIFFUSION",7.5,"20 % PEG3350, 10% glycerol, 0.2 M Sodium bromide",290,"10.1016/j.bmc.2017.06.021","9HJ","5VSC",65.53,"1.4","1.4","Structure of human G9a SET-domain (EHMT2) in complex with inhibitor 13","IRTEKIICRDVARGYENVPIPCVNGVDGEPCPEDYKYISENCETSTMNIDRNITHLQHCTCVDDCSSSNCLCGQLSIRCWYDKDGRLLQEFNKIEPPLIFECNQACSCWRNCKNRVVQSGIKVRLQLYRTAKMGWGVRALQTIPQGTFICEYVGELISDAEADVREDDSYLFDLDNKDGEVYCIDARYYGNISRFINHLCDPNIIPVRVFMLHQDLRFPRIAFFSSRDIRTGEELGFDYGDRFWDIKSKYFTCQCGSEKCKHSAEAIALEQSRLA","Homo sapiens","EHMT2, BAT8, C6orf30, G9A, KMT1C, NG36","Histone-lysine N-methyltransferase EHMT2","1","5VSC"
"5VSD",,"X-RAY DIFFRACTION",3.06,59.86,"VAPOR DIFFUSION",9,"7 % PEG 20K, 1.4% v/v 1,4-Dioxane, 10% glycerol, 0.07 M Bicine, pH 9.0",290,"10.1016/j.bmc.2017.06.021","9HJ","5VSD",62.8,"1.85","1.85","Structure of human GLP SET-domain (EHMT1) in complex with inhibitor 13","VERIVSRDIARGYERIPIPCVNAVDSEPCPSNYKYVSQNCVTSPMNIDRNITHLQYCVCIDDCSSSNCMCGQLSMRCWYDKDGRLLPEFNMAEPPLIFECNHACSCWRNCRNRVVQNGLRARLQLYRTRDMGWGVRSLQDIPPGTFVCEYVGELISDSEADVREEDSYLFDLDNKDGEVYCIDARFYGNVSRFINHHCEPNLVPVRVFMAHQDLRFPRIAFFSTRLIEAGEQLGFDYGERFWDIKGKLFSCRCGSPKCRHS","Homo sapiens","EHMT1, EUHMTASE1, GLP, KIAA1876, KMT1D","Histone-lysine N-methyltransferase EHMT1","1","5VSD"
"5VSE",,"X-RAY DIFFRACTION",2.54,51.64,"VAPOR DIFFUSION",6.5,"20 % PEG3350, 10% glycerol, 0.2 M Sodium fluoride, Bis-Tris propane pH6.5",290,"10.1016/j.bmc.2017.06.021","9HG","5VSE",65.56,"1.6","1.6","Structure of human G9a SET-domain (EHMT2) in complex with inhibitor 17: N~2~-cyclopentyl-6,7-dimethoxy-N~2~-methyl-N~4~-(1-methylpiperidin-4-yl)quinazoline-2,4-diamine","TRTEKIICRDVARGYENVPIPCVNGVDGEPCPEDYKYISENCETSTMNIDRNITHLQHCTCVDDCSSSNCLCGQLSIRCWYDKDGRLLQEFNKIEPPLIFECNQACSCWRNCKNRVVQSGIKVRLQLYRTAKMGWGVRALQTIPQGTFICEYVGELISDAEADVREDDSYLFDLDNKDGEVYCIDARYYGNISRFINHLCDPNIIPVRVFMLHQDLRFPRIAFFSSRDIRTGEELGFDYGDRFWDIKSKYFTCQCGSEKCKHSAEAIALEQSRLA","Homo sapiens","EHMT2, BAT8, C6orf30, G9A, KMT1C, NG36","Histone-lysine N-methyltransferase EHMT2","1","5VSE"
"5VSF",,"X-RAY DIFFRACTION",3.04,59.49,"VAPOR DIFFUSION",9,"10 % PEG 20K, 1.4% v/v 1,4-Dioxane, 10% glycerol, 0 0.1 M Bicine, pH 9.0",290,"10.1016/j.bmc.2017.06.021","9HG","5VSF",62.86,"1.7","1.7","Structure of human GLP SET-domain (EHMT1) in complex with inhibitor 17","VERIVSRDIARGYERIPIPCVNAVDSEPCPSNYKYVSQNCVTSPMNIDRNITHLQYCVCIDDCSSSNCMCGQLSMRCWYDKDGRLLPEFNMAEPPLIFECNHACSCWRNCRNRVVQNGLRARLQLYRTRDMGWGVRSLQDIPPGTFVCEYVGELISDSEADVREEDSYLFDLDNKDGEVYCIDARFYGNVSRFINHHCEPNLVPVRVFMAHQDLRFPRIAFFSTRLIEAGEQLGFDYGERFWDIKGKLFSCRCGSPKCRHS","Homo sapiens","EHMT1, EUHMTASE1, GLP, KIAA1876, KMT1D","Histone-lysine N-methyltransferase EHMT1","1","5VSF"
"5VSH",,"X-RAY DIFFRACTION",2.71,54.56,"VAPOR DIFFUSION",,"see publication",294,"10.1002/pro.3240",,"5VSH",188.6,"2.55","2.55","CH1/Clambda Fab based on Pertuzumab","EVQLVESGGGLVQPGGSLRLSCAASGFTFTDYTMDWVRYAPGKGLEWVADVNPNSGGSIYNQRFKGRFTLSVDRSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDYWGRGTLVTVSSASTKGPSVFPLAPCSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEP","Homo sapiens",,"CH1/Clambda Fab heavy chain","1","5VSH"
,,,,,,,,,,,,,,,,"DIQMTQSPSSLSASVGDRVTITCKASQDVSIGVAWYQRKPGDAPKLLIYSASYRYTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYYIYPYTFGQGTKVEIKRTVAAPSVFIFPPSKEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGE","Homo sapiens",,"CH1/Clambda Fab light chain","2","5VSH"
"5VSK",,"X-RAY DIFFRACTION",2.37,48,"VAPOR DIFFUSION, SITTING DROP",,"PEG 3350, NaFormate",293,"10.1016/j.chembiol.2017.09.003",,"5VSK",83.15,"3.33","3.33","Structure of DUB complex","KKHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQKRKERQE","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","5VSK"
"5VSX",,"X-RAY DIFFRACTION",1.87,34.2,"VAPOR DIFFUSION, HANGING DROP",8.7,"0.1 M Bicine pH 8.7, 0.2 M NaCl, 20% sucrose",293,"10.1074/jbc.RA118.003939",,"5VSX",19.74,"2.1","2.1","Structure of the Ubl domain of Sacsin","GPLGSETKENRWVPVTVLPGCVGCRTVAALASWTVRDVKERIFAETGFPVSEQRLWRGGRELSDWIKIGDLTSKNCHLFVNLQSKGLKG","Homo sapiens","SACS, KIAA0730","Sacsin","1","5VSX"
"5VSZ",,"X-RAY DIFFRACTION",1.85,33.37,"VAPOR DIFFUSION, HANGING DROP",8.6,"0.1 M bicine, 0.25 M NaCl, 1 mM lead acetate, 10% glycerol, pH 8.6",293,"10.1074/jbc.RA118.003939",,"5VSZ",19.87,"2.4","2.4","Structure of the Ubl domain of Sacsin mutant L78M","GPLGSETKENRWVPVTVLPGCVGCRTVAALASWTVRDVKERIFAETGFPVSEQRLWRGGRELSDWIKIGDLTSKNCHLFVNMQSKGLKG","Homo sapiens","SACS, KIAA0730","Sacsin","1","5VSZ"
"5VT1",,"X-RAY DIFFRACTION",3.06,59.85,"VAPOR DIFFUSION, SITTING DROP",7,"24% PEG 8000, 0.1M magnesium acetate, 0.1M CHC buffer (citric acid, ches, hepes).",293,"10.3390/molecules23051221",,"5VT1",33.52,"1.9","1.9","Crystal Structure of the Human CAMKK2B bound to a thiadiazinone benzamide inhibitor","SMQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTRH","Homo sapiens","CAMKK2, CAMKKB, KIAA0787","Calcium/calmodulin-dependent protein kinase kinase 2","1","5VT1"
"5VT2",,"X-RAY DIFFRACTION",4.24,70.98,"VAPOR DIFFUSION, SITTING DROP",7,"15% w/v Tascimate, pH 7.0, 0.1 M HEPES, pH 7.0, 2% PEG3350",293,"10.1126/scitranslmed.aan8732",,"5VT2",24.98,"2.3","2.3","Crystal structure of growth differentiation factor","ARNGDHCPLGPGRCCRLHTVRASLEDLGWADWVLSPREVQVTMCIGACPSQFRAANMHAQIKTSLHRLKPDTVPAPCCVPASYNPMVLIQKTDTGVSLQTYDDLLAKDCHCI","Homo sapiens","GDF15, MIC1, PDF, PLAB, PTGFB","Growth/differentiation factor 15","1","5VT2"
"5VTD",,"X-RAY DIFFRACTION",3.03,59.44,"VAPOR DIFFUSION, SITTING DROP",,"Reservoir: 500 uL total volume: 25 mM Tris (pH 8), 12 mM CaCl2, 150 mM NaCl, 0.3 mM CoCl2, 1% PEG 1900 MME

Sitting Drop: 2 uL reservoir, 2 uL of 
4 uM ferritin",295,"10.1021/jacs.7b01202",,"5VTD",21.57,"1.95","1.95","Crystal Structure of the Co-bound Human Heavy-Chain Ferritin variant 122H-delta C-star","TTASTSQVRQNYHQDSEAAINRQINLELYASYVYLSMSYYFDRDDVALKNFAKYFLHQSHEEREHAEKLMKLQNQRGGRIFLQDIQKPDEDDWESGLNAMEAALHLEKNVNQSLLELHKLAHDKNDPHLADFIETHYLNEQVKAIKELGDHVTNLRKMGAPESGLAEYLFDKHTLGDSDNES","Homo sapiens","FTH1, FTH, FTHL6, OK/SW-cl.84, PIG15","Ferritin heavy chain","1","5VTD"
"5VTI",,"X-RAY DIFFRACTION",2.83,56.58,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris, pH 8.5, 3.0 M sodium chloride (Hampton Index #12), cryoprotection: dragged through Paratone-N prior to freezing",298,"10.1002/cbic.201700580",,"5VTI",3.85,"1.8","1.8","Structure of Pin1 WW Domain Sequence 3 with [R,R]-ACPC Loop Substitution","KLPPGWEKRMSXGRVYYFNHITNASQWERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","5VTI"
"5VTJ",,"X-RAY DIFFRACTION",2.66,53.8,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M sodium acetate, pH 4.5, 2.0 M ammonium sulfate (Hampton Index #2), cryoprotection: 4:1 Index #2:glycerol",298,"10.1002/cbic.201700580",,"5VTJ",4.25,"1.5","1.5","Structure of Pin1 WW Domain Sequence 1 Substituted with [S,S]ACPC","KLPPGWEKRMSRXSGRVYYFNHITNASQWERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","5VTJ"
"5VTK",,"X-RAY DIFFRACTION",2.46,49.97,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M HEPES, pH 7.5, 4.3 M sodium chloride (Hampton CSII #36), crystal grew after ~6 months, treated with 4:1 (CS2 #36):glycerol prior to freezing in cryostream",298,"10.1002/cbic.201700580",,"5VTK",4.19,"1.99","1.99","Structure of Pin1 WW Domain Variant 1 with beta3-Ser Loop Substitution","KLPPGWEKRMSRSSGRVYYFNHITNASQWERPSG","Homo sapiens","PIN1","Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1","1","5VTK"
"5VUA",,"X-RAY DIFFRACTION",3.27,62.43,"VAPOR DIFFUSION, HANGING DROP",5.5,"100MM CITRATE BUFFER, PH 5.5, 200MM  NACL, 1M NH4HPO4",293,"10.1021/acs.jcim.7b00110","8GX","5VUA",34.77,"2.2","2.2","Pim1 Kinase in complex with a benzofuranone inhibitor","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKSGPSSGENLYFQ","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","5VUA"
"5VUB",,"X-RAY DIFFRACTION",3.27,62.43,"VAPOR DIFFUSION, HANGING DROP",5.5,"100MM CITRATE BUFFER, PH 5.5, 200MM      NACL, 1M NH4HPO4",293,"10.1021/acs.jcim.7b00110","8GU","5VUB",34.69,"2","2","Pim1 Kinase in complex with a benzofuranone inhibitor","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKSGPSSGENLYFQ","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","5VUB"
"5VUC",,"X-RAY DIFFRACTION",3.3,62.68,"VAPOR DIFFUSION, HANGING DROP",5.5,"100MM CITRATE BUFFER, PH 5.5, 200MM     NACL, 1M NH4HPO4",293,"10.1021/acs.jcim.7b00110","8GR","5VUC",34.69,"2","2","Pim1 Kinase in complex with a benzofuranone inhibitor","MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSKSGPSSGENLYFQ","Homo sapiens","PIM1","Serine/threonine-protein kinase pim-1","1","5VUC"
"5VUV",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b00835","M62","5VUV",99.88,"1.983","1.983","Structure of human neuronal nitric oxide synthase heme domain in complex with 7-(((3-Fluorophenyl)amino)methyl)quinolin-2-amine Dihydrochloride","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5VUV"
"5VUW",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b00835","JHT","5VUW",99.96,"2.03","2.03","Structure of human neuronal nitric oxide synthase heme domain in complex with 7-(((3-(Dimethylamino)benzyl)amino)methyl)quinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5VUW"
"5VUX",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b00835","9P1","5VUX",99.96,"2.3","2.3","Structure of human neuronal nitric oxide synthase heme domain in complex with 7-(((4-(Dimethylamino)benzyl)amino)methyl)quinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5VUX"
"5VUY",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b00835","P64","5VUY",99.99,"2.154","2.154","Structure of human neuronal nitric oxide synthase heme domain in complex with 7-(((4-(Dimethylamino)phenethyl)amino)methyl)quinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5VUY"
"5VUZ",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b00835","XH8","5VUZ",99.93,"1.97","1.97","Structure of human neuronal nitric oxide synthase heme domain in complex with 7-(((3-(Pyridin-3-yl)propyl)amino)methyl)quinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5VUZ"
"5VV0",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b00835","9OM","5VV0",100.13,"1.8","1.8","Structure of human neuronal nitric oxide synthase heme domain in complex with 7-(((3-(4-Methylpyridin-3-yl)propyl)amino)methyl)quinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVRTKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5VV0"
"5VV1",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b00835","9OS","5VV1",99.99,"1.95","1.95","Structure of human neuronal nitric oxide synthase heme domain in complex with 7-(((3-(4-Methoxypyridin-3-yl)propyl)amino)methyl)quinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5VV1"
"5VV2",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b00835","9P4","5VV2",99.97,"2","2","Structure of human neuronal nitric oxide synthase heme domain in complex with 7-(((3-(5-Fluoropyridin-3-yl)propyl)amino)methyl)quinolin-2-amine","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5VV2"
"5VV3",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b00835","P94","5VV3",100.14,"2.18","2.18","Structure of human neuronal nitric oxide synthase heme domain in complex with 4-(2-(((2-Aminoquinolin-7-yl)methyl)amino)ethyl)benzonitrile","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5VV3"
"5VV4",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b00835","9P7","5VV4",99.98,"2.1","2.1","Structure of human neuronal nitric oxide synthase heme domain in complex with 4-(2-(((2-Aminoquinolin-7-yl)methyl)amino)ethyl)-2-methylbenzonitrile","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5VV4"
"5VV5",,"X-RAY DIFFRACTION",2.74,55.2,"VAPOR DIFFUSION, SITTING DROP",7.2,"8% PEG3350
35mM citric acid
65mM Bis-Tris-Propane
10% glycerol
5mM TCEP",277,"10.1021/acs.jmedchem.7b00835","9OJ","5VV5",100.01,"2.15","2.15","Structure of human neuronal nitric oxide synthase heme domain in complex with 4-(2-(((2-Amino-4-methylquinolin-7-yl)methyl)amino)ethyl)-2-methylbenzonitrile","CPRFLKVKNWETEVVLTDTLHLKSTLETGCTEYICMGSIMHPSQHARRPEDVATKDQLFPLAKEFIDQYYSSIKRFGSKAHMERLEEVNKEIDTTSTYQLKDTELIYGAKHAWRNASRCVGRIQWSKLQVFDARDCTTAHGMFNYICNHVKYATNKGNLRSAITIFPQRTDGKHDFRVWNSQLIRYAGYKQPDGSTLGDPANVQFTEICIQQGWKPPRGRFDVLPLLLQANGNDPELFQIPPELVLEVPIRHPKFEWFKDLGLKWYGLPAVSNMLLEIGGLEFSACPFSGWYMGTEIGVRDYCDNSRYNILEEVAKKMNLDMRKTSSLWKDQALVEINIAVLYSFQSDKVTIVDHHSATESFIKHMENEYRCRGGCPADWVWIVPPMSGSITPVFHQEMLNYRLTPSFEYQPDPWNTHVWK","Homo sapiens","NOS1","Nitric oxide synthase, brain","1","5VV5"
"5VVB",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 MM TCEP",277,"10.1021/acs.jmedchem.7b00835","9P7","5VVB",205.05,"2.15","2.15","Structure of human endothelial nitric oxide synthase heme domain in complex with 4-(2-(((2-Aminoquinolin-7-yl)methyl)amino)ethyl)-2-methylbenzonitrile","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","5VVB"
"5VVC",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",7.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 mM TCEP",277,"10.1021/acs.jmedchem.7b00835","9OJ","5VVC",205.52,"2.4","2.4","Structure of human endothelial nitric oxide synthase heme domain in complex with 4-(2-(((2-Amino-4-methylquinolin-7-yl)methyl)amino)ethyl)-2-methylbenzonitrile","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","5VVC"
"5VVD",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",6.5,"12-15% PEG3350, 0.1M BIS-TRIS
0.2-0.3M MG ACETATE, 0.1M GdCl3 
10% glycerol, 5 MM TCEP",277,"10.1021/acs.jmedchem.7b00835","9OG","5VVD",205.47,"2.25","2.25","Structure of human endothelial nitric oxide synthase heme domain in complex with 4-(2-(((2-Amino-4-methylquinolin-7-yl)methyl)amino)ethyl)benzonitrile","APASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDEPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPW","Homo sapiens","NOS3","Nitric oxide synthase, endothelial","1","5VVD"
"5VVF",,"X-RAY DIFFRACTION",2.89,57.42,"VAPOR DIFFUSION, SITTING DROP",8,"1.8 M ammonium sulfate, 
0.1 M Bis-Tris pH 6.5, 
2% v/v PEG 550 MME,
100 nM NDSB-256",293,"10.7554/eLife.27389",,"5VVF",50.7,"2","2","Crystal Structure of 354BG1 Fab","AEQLVESGGGLVPPGRSLRLSCSASGFYFPDYAMAWVRQAPGQGLQWVGFMRGWAYGGSAQFAAFAVGKFAISRDDGRNVVYLDVKNPTFEDTGVYFCAREQRNKDYRYGQEGFGYSYGMDVWGRGTTVVVSTASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCDKGLEVLFQHHHHHH","Homo sapiens",,"354BG1 Heavy Chain","1","5VVF"
,,,,,,,,,,,,,,,,"DIHMTQSPVSLSASVGDRVTITCRASHFIANYVNWYQQKPGKAPTLLIFESSTLQRGVPSRFSAYGDGTEFTLSINTLQPEDFASYICQQSHSPPVTFGAGTRVDQKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"354BG1 Light Chain","2","5VVF"
"5VVM",,"X-RAY DIFFRACTION",3.01,59.07,"VAPOR DIFFUSION, SITTING DROP",,"0.05 M TRIS pH 8.5
0.5 M NaCl
10% PEG-4000",277,"10.1016/j.str.2018.06.003",,"5VVM",76.27,"3.54","3.54","Crystal structure of human CDH23 EC21-23","MDSRPEFLNPIQTVSVLESAEPGTVIANITAIDHDLNPKLEYHIVGIVAKDDTDRLVPNQEDAFAVNINTGSVMVKSPMNRELVATYEVTLSVIDNASDLPERSVSVPNAKLTVNVLDVNDNTPQFKPFGITYYMERILEGATPGTTLIAVAAVDPDKGLNGLVTYTLLDLVPPGYVQLEDSSAGKVIANRTVDYEEVHWLNFTVRASDNGSPPRAAEIPVYLEIVDINDNNPIFDQPSYQEAVFEDVPVGTIILTVTATDADSGNFALIEYSLGDGESKFAINPTTGDIYVLSSLDREKKDHYILTALAKDNPGDVASNRRENSVQVVIQVLDVNDCLEHHHHHH","Homo sapiens","CDH23, KIAA1774, KIAA1812, UNQ1894/PRO4340","Cadherin-23","1","5VVM"
"5VVO",,"X-RAY DIFFRACTION",2.78,55.75,"EVAPORATION",,"0.024 M ammonium citrate tribasic (pH 7.0), 0.015 M MES monohydrate, 0.096 M potassium thiocyanate, 0.25 M Sodium acetate trihydrate, 0.037 M imidazole, 0.002 M zinc sulfate heptahydrate, 9.6 % w/v polyethylene glycol 3,350, 2.4 % w/v polyethylene glycol monomethyl ether 2,000, and 4% w/v polyethylene glycol monomethyl ether 550",293,"10.1038/s41467-017-00865-1",,"5VVO",115.65,"2.6","2.6","Structural Investigations of the Substrate Specificity of Human O-GlcNAcase","HFLCGVVEGFYGRPWVMEQRKELFRRLQKWELNTYLYAPKDDYKHRMFWREMYSVEEAEQLMTLISAAREYEIEFIYAISPGLDITFSNPKEVSTLKRKLDQVSQFGCRSFALLFDNIDHNMCAADKEVFSSFAHAQVSITNEIYQYLGEPETFLFCPTEYCGTFCYPNVSQSPYLRTVGEKLLPGIEVLWTGPKVVSKEIPVESIEEVSKIIKRAPVIWDNIHANDYDQKRLFLGPYKGRSTELIPRLKGVLTNPNCEFEANYVAIHTLATWYKSNMNGVRKDVVMTDSEDSTVSIQIKLENEGSDEDIETDVLYSPQMALKLALTEWLQEFGVPHQYSSRGGGGSGGGGSVTLEDLQLLADLFYLPYEHGPKGAQMLREFQWLRANSSVVSVNCKGKDSEKIEEWRSRAAKFEEMCGLVMGMFTRLSNCANRTILYDMYSYVWDIKSIMSMVKSFVQWLGCRSHSSAQFLIGDQEPWAFRGGLAGEFQRLLPIDGANDLFFQ","Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5","Protein O-GlcNAcase","1","5VVO"
,,,,,,,,,,,,,,,,,"Homo sapiens","MGEA5, HEXC, KIAA0679, MEA5"
"5VWC",,"X-RAY DIFFRACTION",1.81,32.2,"VAPOR DIFFUSION, SITTING DROP",7.5,"20% (w/v) polyethylene glycol 3350, 0.2M magnesium chloride hexahydrate",293,"10.1074/jbc.M117.799452",,"5VWC",10.73,"1.911","1.911","Crystal structure of human Scribble PDZ1 domain","GPLGSMEELTLTILRQTGGLGISIAGGKGSTPYKGDDEGIFISRVSEEGPAARAGVRVGDKLLEVNGVALQGAEHHEAVEALRGAGTAVQMRVWRERETSV","Homo sapiens","SCRIB, CRIB1, KIAA0147, LAP4, SCRB1, VARTUL","Protein scribble homolog","1","5VWC"
"5VWE",,"SOLUTION NMR",,,,,,,,,"5VWE",8.05,,,"Solution NMR structure of the HMG domain of human FACT complex subunit SSRP1","GHMSAYMLWLNASREKIKSDHPGISITDLSKKAGEIWKGMSKEKKEEWDRKAEDARRDYEKAMKEYEGG","Homo sapiens","SSRP1, FACT80","FACT complex subunit SSRP1","1","5VWE"
"5VWG",,"X-RAY DIFFRACTION",2.72,54.87,"VAPOR DIFFUSION",,"10 mM sodium phosphate, 137 mM sodium chloride, 2.7 mM potassium chloride, 1.8 mM potassium phosphate",277,,,"5VWG",17.79,"2.1","2.1","Galectin-8 N terminal domain in complex with Methyl 3-O-[1-carboxyethyl]-beta-D-galactopyranoside","MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSVKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFSS","Homo sapiens","LGALS8","Galectin-8","1","5VWG"
"5VWO",,"X-RAY DIFFRACTION",2.68,54.03,"VAPOR DIFFUSION, HANGING DROP",,"NaCl (175mM), 8-10% (v/v) PEG 6000",298,"10.1021/acs.biochem.7b00499",,"5VWO",135.66,"1.773","1.773","Ornithine aminotransferase inactivated by (1R,3S,4S)-3-amino-4-fluorocyclopentane-1-carboxylic acid (FCP)","GPPTSDDIFEREYKYGAHNYHPLPVALERGKGIYLWDVEGRKYFDFLSSYSAVNQGHCHPKIVNALKSQVDKLTLTSRAFYNNVLGEYEEYITKLFNYHKVLPMNTGVEAGETACKLARKWGYTVKGIQKYKAKIVFAAGNFWGRTLSAISSSTDPTSYDGFGPFMPGFDIIPYNDLPALERALQDPNVAAFMVEPIQGEAGVVVPDPGYLMGVRELCTRHQVLFIADEIQTGLARTGRWLAVDYENVRPDIVLLGKALSGGLYPVSAVLCDDDIMLTIKPGEHGSTYGGNPLGCRVAIAALEVLEEENLAENADKLGIILRNELMKLPSDVVTAVRGKGLLNAIVIKETKDWDAWKVCLRLRDNGLLAKPTHGDIIRFAPPLVIKEDELRESIEIINKTILSF","Homo sapiens","OAT","Ornithine aminotransferase, mitochondrial","1","5VWO"
"5VX1",,"X-RAY DIFFRACTION",2.33,47.23,"VAPOR DIFFUSION",,"1M sodium malonate-malonic acid pH 7.0 and 10 % DL-malate-MES-tris pH 9",281,"10.1016/j.molcel.2017.11.001",,"5VX1",37.99,"1.224","1.224","Bak L100A","GPLGSMSEEQVAQDTEEVFRSYVFYRHQQEQEAEGVAAPADPEMVTLPLQPSSTMGQVGRQLAIIGDDINRRYDSEFQTMLQHAQPTAENAYEYFTKIATSLFESGINWGRVVALLGFGYRLALHVYQHGLTGFLGQVTRFVVDFMLHHSIARWIAQRGGWVAALNLGNG","Homo sapiens","BAK1, BAK, BCL2L7, CDN1","Bcl-2 homologous antagonist/killer","1","5VX1"
"5VXA",,"X-RAY DIFFRACTION",2.68,54.07,"VAPOR DIFFUSION, HANGING DROP",8,"4.5 mg/mL hMesh1 D66K, 50 mM NADPH, 25 mM Tris (pH 8.0), 100 mM NaCl, 0.05% 2-mercaptoethanol, 0.5 mM ZnCl2, 100 mM ammonium acetate, 50 mM sodium citrate, 12.5% PEG 4000.",293,"10.1038/s42255-020-0181-1",,"5VXA",43.14,"2.1","2.1","Structure of the human Mesh1-NADPH complex","HMGSEAAQLLEAADFAARKHRQQRRKDPEGTPYINHPIGVARILTHEAGITDIVVLQAALLHDTVEKTDTTLDEVELHFGAQVRRLVEEVTDDKTLPKLERKRLQVEQAPHSSPGAKLVKLADKLYNLRDLNRCTPEGWSEHRVQEYFEWAAQVVKGLQGTNRQLEEALKHLFKQRGLTI","Homo sapiens","HDDC3, MESH1","Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1","1","5VXA"
"5VXC",,"X-RAY DIFFRACTION",2.36,47.79,"VAPOR DIFFUSION, SITTING DROP",4.6,"1 uL protein at 4 mg/ml and well solution (0.1 M sodium acetate:HCl pH4.6, 3.5 M sodium formate)",293,"10.1016/j.cell.2017.09.051",,"5VXC",36.87,"1.872","1.872","Crystal Structure Analysis of human CLYBL in complex with free CoASH","MASLANPRLGYSSSSHHKYIPRRAVLYVPGNDEKKIKKIPSLNVDCAVLDCEDGVAANKKNEARLRIVKTLEDIDLGPTEKCVRVNSVSSGLAEEDLETLLQSRVLPSSLMLPKVESPEEIQWFADKFSFHLKGRKLEQPMNLIPFVETAMGLLNFKAVCEETLKVGPQVGLFLDAVVFGGEDFRASIGATSSKETLDILYARQKIVVIAKAFGLQAIDLVYIDFRDGAGLLRQSREGAAMGFTGKQVIHPNQIAVVQEQFSPSPEKIKWAEELIAAFKEHQQLGKGAFTFQGSMIDMPLLKQAQNTVTLATSIKEKLEHHHHHH","Homo sapiens","CLYBL, CLB","Citrate lyase subunit beta-like protein, mitochondrial","1","5VXC"
"5VXO",,"X-RAY DIFFRACTION",2.72,54.81,"VAPOR DIFFUSION, SITTING DROP",4.2,"1 uL protein at 4 mg/ml and well solution (0.1 M Na2HPO4:citric acid pH 4.2, 40% (v/v) PEG 300)",293,"10.1016/j.cell.2017.09.051",,"5VXO",114.31,"2.266","2.266","Crystal Structure Analysis of human CLYBL in complex with propionyl-CoA","MASLANPRLGYSSSSHHKYIPRRAVLYVPGNDEKKIKKIPSLNVDCAVLDCEDGVAANKKNEARLRIVKTLEDIDLGPTEKCVRVNSVSSGLAEEDLETLLQSRVLPSSLMLPKVESPEEIQWFADKFSFHLKGRKLEQPMNLIPFVETAMGLLNFKAVCEETLKVGPQVGLFLDAVVFGGEDFRASIGATSSKETLDILYARQKIVVIAKAFGLQAIDLVYIDFRDGAGLLRQSREGAAMGFTGKQVIHPNQIAVVQEQFSPSPEKIKWAEELIAAFKEHQQLGKGAFTFQGSMIDMPLLKQAQNTVTLATSIKEKLEHHHHHH","Homo sapiens","CLYBL, CLB","Citrate lyase subunit beta-like protein, mitochondrial","1","5VXO"
"5VXS",,"X-RAY DIFFRACTION",2.7,54.44,"VAPOR DIFFUSION, HANGING DROP",,"1 uL protein at 4 mg/ml and 1 uL of the well solution, which is 85% dilution 0.2 M Ammonium Citrate Dibasic, 20% (w/v) PEG 3350",293,"10.1016/j.cell.2017.09.051",,"5VXS",216.84,"2.954","2.954","Crystal Structure Analysis of human CLYBL in apo form","MASLANPRLGYSSSSHHKYIPRRAVLYVPGNDEKKIKKIPSLNVDCAVLDCEDGVAANKKNEARLRIVKTLEDIDLGPTEKCVRVNSVSSGLAEEDLETLLQSRVLPSSLMLPKVESPEEIQWFADKFSFHLKGRKLEQPMNLIPFVETAMGLLNFKAVCEETLKVGPQVGLFLDAVVFGGEDFRASIGATSSKETLDILYARQKIVVIAKAFGLQAIDLVYIDFRDGAGLLRQSREGAAMGFTGKQVIHPNQIAVVQEQFSPSPEKIKWAEELIAAFKEHQQLGKGAFTFQGSMIDMPLLKQAQNTVTLATSIKEKLEHHHHHH","Homo sapiens","CLYBL, CLB","Citrate lyase subunit beta-like protein, mitochondrial","1","5VXS"
"5VY2",,"X-RAY DIFFRACTION",1.95,36.79,"VAPOR DIFFUSION",9.5,"PEG 8000, CHES",293,"10.1038/s41598-019-39491-w",,"5VY2",42.53,"2.3","2.3","Crystal structure of the F36A mutant of HsNUDT16","MAGARRLELGEALALGSGWRHVCHALLYAPDPGMLAGRIPLRYAILMQMRFDGRLGFPGGFVDTQDRSLEDGLNRELREELGEAAAAFRVERTDYRSSHVGSGPRVVAHFYAKRLTLEELLAVEAGATRAKDHGLEVLGLVRVPLYTLRDGVGGLPTFLENSFIGSAREQLLEALQDLGLLQSGSISGLKIPAHH","Homo sapiens","NUDT16","U8 snoRNA-decapping enzyme","1","5VY2"
"5VYB",,"X-RAY DIFFRACTION",2.85,56.8,"VAPOR DIFFUSION, HANGING DROP",8,"Drop size:
0.9:0.9 micro-liter of protein:reservoir 
protein solution:
2 mg/ml CRD, 5 mM CaCl2, 10 mM Tris-Cl, pH 8.0, 25 mM NaCl, and 2 mM Man9GlcNAc2. 
The reservoir solution:
1.0 M NaCl, 6% polyethylene glycol 400 and 0.1 M Tris-Cl, pH 8.0.
freezing solution:
30% polyethylene glycol 400, 1.0 M NaCl, 0.1 M Tris-Cl, pH 8.0, and 2 mM Man9GlcNAc2.",295,"10.1074/jbc.M117.799080",,"5VYB",18.31,"2.4","2.4","Structure of the carbohydrate recognition domain of Dectin-2 complexed with a mammalian-type high mannose Man9GlcNAc2 oligosaccharide","ALTCFSEGTKVPAWGCCPASWKSFGSSCYFISSEEKVWSKSEQNCVEMGAHLVVFNTEAEQNFIVQQLNESFSYFLGLSDPQGNNNWQWIDKTPYEKNVRFWHLGEPNHSAEQCASIVFWKPTGWGWNDVICETRRNSICEMNKIYL","Homo sapiens","CLEC6A, CLECSF10, DECTIN2","C-type lectin domain family 6 member A","1","5VYB"
"5VYG",,"X-RAY DIFFRACTION",2.35,47.69,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris pH 8.5, 15% Glycerol, 1.6 M (NH4)2SO4, 5% 2,2,2-Trifluoroethanol",293,"10.1074/jbc.M117.800102",,"5VYG",18.58,"2.2","2.2","Crystal structure of hFA9 EGF repeat with O-glucose trisaccharide","MDIVDGDQCESNPCLNGGSCKDDINSYECWCPFGFEGKNCELLEHHHHHH","Homo sapiens","F9","Coagulation factor IX","1","5VYG"
"5VYY",,"X-RAY DIFFRACTION",2.29,46.22,"VAPOR DIFFUSION, HANGING DROP",6.5,"PEG 2000 MME, Sodium formate, Sodium cacodylate",277,"10.1021/acs.jmedchem.7b01608","9QY","5VYY",29.36,"1.792","1.792","Structure of human Hsp90-alpha bound to resorcinylic inhibitor BnIm","MGSSHHHHHHSSGLVPRGSHMPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAE","Homo sapiens","HSP90AA1, HSP90A, HSPC1, HSPCA","Heat shock protein HSP 90-alpha","1","5VYY"
"5VZ1",,"X-RAY DIFFRACTION",2.32,46.9,"VAPOR DIFFUSION, SITTING DROP",,"90 mM imidazole, pH 8.0, 180 mM Zinc Acetate, 27% PEG 3000, 10 mM Chromium (III) chloride hexahydrate",288,,,"5VZ1",97.39,"2.112","2.112","Crystal structure of the Apo Antibody fragment (Fab) raised against C-terminal domain of Ebola nucleoprotein (EBOV, TAFV, BDBV strains)","SDIQMTQSPSSLSASVGDRVTITCRASQSVSSAVAWYQQKPGKAPKLLIYSASSLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQYSYSLVTFGQGTKVEIKRTVAAPSVFIFPPSDSQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Apo Antibody Fab Light Chain","1","5VZ1"
,,,,,,,,,,,,,,,,"EISEVQLVESGGGLVQPGGSLRLSCAASGFNVYYYYIHWVRQAPGKGLEWVASISPYYGYTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARWSYDQSMSYKSGMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHT","Homo sapiens",,"Apo Antibody Fab Heavy Chain","2","5VZ1"
"5VZ3",,"X-RAY DIFFRACTION",2.69,54.3,"VAPOR DIFFUSION, SITTING DROP",4,"25% v/v MPD, 0.1 M sodium citrate, pH 4.0, 10 mM ATP",298,"10.1038/nature24042",,"5VZ3",12.3,"1.97","1.97","Growth Factor Crystal Structure at 1.97 Angstrom Resolution","ARNGDHCPLGPGRCCRLHTVRASLEDLGWADWVLSPREVQVTMCIGACPSQFRAANMHAQIKTSLHRLKPDTVPAPCCVPASYNPMVLIQKTDTGVSLQTYDDLLAKDCHCI","Homo sapiens","GDF15, MIC1, PDF, PLAB, PTGFB","Growth/differentiation factor 15","1","5VZ3"
"5VZS",,"X-RAY DIFFRACTION",1.88,34.55,"VAPOR DIFFUSION",,"20% PEG 3350, 0.2 M sodium formate",277,,"9U4","5VZS",38.65,"1.707","1.707","BRD4-BD1 in complex with Cpd19 (3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-N-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxamide)","MHHHHHHGSLVPRGSMDYKDDDDKENLYFQSTNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5VZS"
"5VZV",,"X-RAY DIFFRACTION",1.89,34.82,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris, pH 8.5, 25% w/v PEG3350",290,"10.1002/prot.25348",,"5VZV",39.71,"1.812","1.812","TRIM23 RING domain","MATLVVNKLGAGVDSGRQGSRGTAVVKVLECGVCEDVFSLQGDKVPRLLLCGHTVCHDCLTRLPLHGRAIRCPFDRQVTDLGDSGVWGLKKNFALLELLERLQNGPIGQYGAAEESIGISGES","Homo sapiens","TRIM23, ARD1, ARFD1, RNF46","E3 ubiquitin-protein ligase TRIM23","1","5VZV"
"5W0B",,"X-RAY DIFFRACTION",3.74,67.12,"VAPOR DIFFUSION, SITTING DROP",,"0.8-1.0 M lithium sulfate, 0.075-0.2 M potassium iodide, 0.05-0.2 M trisodium citrate, pH 5-6",291,"10.1038/nsmb.3428",,"5W0B",135.28,"2.614","2.614","Structure of human TUT7 catalytic module (CM)","GAGAGSKRIQLEPLPPLTPKFLNILDQVCIQCYKDFSPTIIEDQAREHIRQNLESFIRQDFPGTKLSLFGSSKNGFGFKQSDLAVCMTINGLETAEGLDCVRTIEELARVLRKHSGLRNILPITTAKVPIVKFFHLRSGLEVDISLYNTLALHNTRLLSAYSAIDPRVKYLCYTMKVFTKMCDIGDASRGSLSSYAYTLMVLYFLQQRNPPVIPVLQEIYKGEKKPEIFVDGWNIYFFDQIDELPTYWSECGKNTESVGQLWLGLLRFYTEEFDFKEHVISIRRKSLLTTFKKQWTSKYIVIEDPFDLNHNLGAGLSRKMTNFIMKAFINGRRVFGIPVKGFPKDYPSKMEYFFDPDVLTEGELAPNDRCCRICGKIGHFMKDCPMRRK","Homo sapiens","ZCCHC6, HS2, KIAA1711, TUT7","Terminal uridylyltransferase 7","1","5W0B"
"5W0C",,"X-RAY DIFFRACTION",2.5,50.88,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 3350, HEPES, CYMAL-5",297,"10.1002/anie.201707324",,"5W0C",55.41,"2.001","2.001","Cytochrome P450 (CYP) 2C9 TCA007 Inhibitor Complex","MAKKTSSGRGKLPPGPTPLPVIGNILQIGIKDISKSLTNLSKVYGPVFTLYFGLKPIVVLHGYEAVKEALIDLGEEFSGRGIFPLAERANRGFGIVFSNGKKWKEIRRFSLMTLRNFGMGKRSIEDRVQEEARCLVEELRKTKASPCDPTFILGCAPCNVICSIIFHKRFDYKDQQFLNLMEKLNENIKILSSPWIQICNNFSPIIDYFPGTHNKLLKNVAFMKSYILEKVKEHQESMDMNNPQDFIDCFLMKMEKEKHNQPSEFTIESLENTAVDLFGAGTETTSTTLRYALLLLLKHPEVTAKVQEEIERVIGRNRSPCMQDRSHMPYTDAVVHEVQRYIDLLPTSLPHAVTCDIKFRNYLIPKGTTILISLTSVLHDNKEFPNPEMFDPHHFLDEGGNFKKSKYFMPFSAGKRICVGEALAGMELFLFLTSILQNFNLKSLVDPKNLDTTPVVNGFASVPPFYQLCFIPIHHHH","Homo sapiens","CYP2C9, CYP2C10","Cytochrome P450 2C9","1","5W0C"
"5W0E",,"X-RAY DIFFRACTION",1.89,34.93,"VAPOR DIFFUSION",6.5,"0.2M MgCl2, 0.1M Bis-Tris pH6.5, 22% PEG3350",277,"10.1021/acs.jmedchem.7b01372","9U4","5W0E",18.16,"1.41","1.41","CREBBP bromodomain in complex with Cpd19 (3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-N-methyl-1-(tetrahydro-2H-pyran-4-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxamide)","MHHHHHHGSLVPRGSMDYKDDDDKENLYFQGSKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","5W0E"
"5W0F",,"X-RAY DIFFRACTION",1.94,36.56,"VAPOR DIFFUSION",6.5,"0.2 M Li2SO4, 0.1M Bis-Tris pH 6.5, 19% PEG3350",277,"10.1021/acs.jmedchem.7b00796","9U7","5W0F",18.08,"1.6","1.6","CREBBP Bromodomain in complex with Cpd3 ((S)-1-(3-(6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-1-(tetrahydrofuran-3-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one)","MHHHHHHGSLVPRGSMDYKDDDDKENLYFQGSKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","5W0F"
"5W0G",,"X-RAY DIFFRACTION",2.13,38.13,"VAPOR DIFFUSION, HANGING DROP",6.5,"21% (w/v) PEG MME 550, 210 mM zinc acetate, 100 mM MES",293,"10.1021/acs.biochem.7b00551",,"5W0G",10.07,"1.07","1.07","Structure of U2AF65 (U2AF2) RRM1 at 1.07 resolution","GPLGSARRLYVGNIPFGITEEAMMDFFNAQMRLGGLTQAPGNPVLAVQINQDKNFAFLEFRSVDETTQAMAFDGIIFQGQSLKIRRP","Homo sapiens","U2AF2, U2AF65","Splicing factor U2AF 65 kDa subunit","1","5W0G"
"5W0H",,"X-RAY DIFFRACTION",2.59,52.5,"VAPOR DIFFUSION, HANGING DROP",5.5,"26% (w/v) PEG 8000, 0.1 M NaOAc, 0.2 mM TCEP, 10% (v/v) dioxane, 0.2 ul BigCHAP, 0.05 M potassium phosphate monobasic",277,"10.1021/acs.biochem.7b00551",,"5W0H",8.97,"1.11","1.11","Structure of U2AF65 (U2AF2) RRM2 at 1.11 Angstrom Resolution","GPLGSAHKLFIGGLPNYLNDDQVKELLTSFGPLKAFNLVKDSATGLSKGYAFCEYVDINVTDQAIAGLNGMQLGDKKLLVQRAS","Homo sapiens","U2AF2, U2AF65","Splicing factor U2AF 65 kDa subunit","1","5W0H"
"5W0L",,"X-RAY DIFFRACTION",1.94,36.58,"VAPOR DIFFUSION",6.5,"100 mM Bis-Tris pH 5.5, 200-300 mM KSCN, 21-25% PEG 3350",277,"10.1021/acs.jmedchem.7b00796","9UD","5W0L",36.28,"1.549","1.549","CREBBP Bromodomain in complex with Cpd10 (1-(3-(7-(difluoromethyl)-6-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydroquinolin-1(2H)-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one)","MHHHHHHGSLVPRGSMDYKDDDDKENLYFQGSKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","5W0L"
"5W0N",,"X-RAY DIFFRACTION",3.46,64.47,"VAPOR DIFFUSION, SITTING DROP",,"0.8-1.0 M lithium sulfate, 0.075-0.2 M potassium iodide, 0.05-0.2 M trisodium citrate, pH 5-6",291,"10.1038/nsmb.3428",,"5W0N",143.76,"2.497","2.497","Structure of human TUT7 catalytic module (CM) in complex with UMPNPP and U2 RNA","VVCSLCKREGHLKKDCPEDFKRIQLEPLPPLTPKFLNILDQVCIQCYKDFSPTIIEDQAREHIRQNLESFIRQDFPGTKLSLFGSSKNGFGFKQSDLDVCMTINGLETAEGLDCVRTIEELARVLRKHSGLRNILPITTAKVPIVKFFHLRSGLEVDISLYNTLALHNTRLLSAYSAIDPRVKYLCYTMKVFTKMCDIGDASRGSLSSYAYTLMVLYFLQQRNPPVIPVLQEIYKGEKKPEIFVDGWNIYFFDQIDELPTYWSECGKNTESVGQLWLGLLRFYTEEFDFKEHVISIRRKSLLTTFKKQWTSKYIVIEDPFDLNHNLGAGLSRKMTNFIMKAFINGRRVFGIPVKGFPKDYPSKMEYFFDPDVLTEGELAPNDRCCRICGKIGHFMKDCPMRRK","Homo sapiens","ZCCHC6, HS2, KIAA1711, TUT7","Terminal uridylyltransferase 7","1","5W0N"
"5W0Q",,"X-RAY DIFFRACTION",2.09,41.08,"VAPOR DIFFUSION",6.5,"0.1M Bis-Tris pH 6.5, 0.2M Li2SO4, 25% PEG3350",277,"10.1021/acs.jmedchem.7b00796","9UG","5W0Q",18.14,"1.7","1.7","CREBBP Bromodomain in complex with Cpd17 (N,2,7-trimethyl-2,3-dihydro-4H-benzo[b][1,4]oxazine-4-carboxamide)","MHHHHHHGSLVPRGSMDYKDDDDKENLYFQGSKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKNPMDLSTIKRKLDTGQYQEPWQYVDDVWLMFNNAWLYNRKTSRVYKFCSKLAEVFEQEIDPVMQSLG","Homo sapiens","CREBBP, CBP","CREB-binding protein","1","5W0Q"
"5W1G",,"X-RAY DIFFRACTION",2.61,52.91,"BATCH MODE",6.5,"19% (v/v) polyethylene glycol monomethyl ether 550, MES pH 6.5 and, 10 mM zinc sulfate heptahydrate.",298,"10.1038/s41467-018-04271-z",,"5W1G",48.41,"2","2","CR1-07 unliganded Fab","VQLVESGGGVVHPGRSLRLSCAASGFTFGTSIMHWVRQAPGKGMQWVAQISHDESRKFYSDSVKGRFTVSRDNSKNTLFLEMSSLRIEDTAVYYCAKDLSPPYSYAWDIFQYWGQGSLVTVSGASTKGPSVFPLAPSKSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSC","Homo sapiens",,"CR1-07 Fab heavy chain","1","5W1G"
,,,,,,,,,,,,,,,,"DIVMTQSPESLAVSLGERATINCKSSQSVLYSSRSDNKDYLAWYQQKPGQSPKLLIYWASTRESGVPERFTGSGSGTDFTLSISSLQAEDVAVYYCQQYYSSPPTFGGGTKVELKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"CR1-07 Fab light chain","2","5W1G"
"5W1R","4.4","ELECTRON MICROSCOPY",,,,,,,"10.1073/pnas.1707386114",,"5W1R",469.67,"4.4, 4.4",,"Cryo-EM structure of DNAPKcs","MAGSGAGVRCSLLRLQETLSAADRCGAALAGHQLIRGLGQECVLSSSPAVLALQTSLVFSRDFGLLVFVRKSLNSIEFRECREEILKFLCIFLEKMGQKIAPYSVEIKNTCTSVYTKDRAAKCKIPALDLLIKLLQTFRSSRLMDEFKIGELFSKFYGELALKKKIPDTVLEKVYELLGLLGEVHPSEMINNAENLFRAFLGELKTQMTSAVREPKLPVLAGCLKGLSSLLCNFTKSMEEDPQTSREIFNFVLKAIRPQIDLKRYAVPSAGLRLFALHASQFSTCLLDNYVSLFEVLLKWCAHTNVELKKAALSALESFLKQVSNMVAKNAEMHKNKLQYFMEQFYGIIRNVDSNNKELSIAIRGYGLFAGPCKVINAKDVDFMYVELIQRCKQMFLTQTDTGDDRVYQMPSFLQSVASVLLYLDTVPEVYTPVLEHLVVMQIDSFPQYSPKMQLVCCRAIVKVFLALAAKGPVLRNCISTVVHQGLIRICSKPVVLPKGPESESEDHRASGEVRTGKWKVPTYKDYVDLFRHLLSSDQMMDSILADEAFFSVNSSSESLNHLLYDEFVKSVLKIVEKLDLTLEIQTVGEQENGDEAPGVWMIPTSDPAANLHPAKPKDFSAFINLVEFCREILPEKQAEFFEPWVYSFSYELILQSTRLPLISGFYKLLSITVRNAKKIKYFEGVSPKSLKHSPEDPEKYSCFALFVKFGKEVAVKMKQYKDELLASCLTFLLSLPHNIIELDVRAYVPALQMAFKLGLSYTPLAEVGLNALEEWSIYIDRHVMQPYYKDILPCLDGYLKTSALSDETKNNWEVSALSRAAQKGFNKVVLKHLKKTKNLSSNEAISLEEIRIRVVQMLGSLGGQINKNLLTVTSSDEMMKSYVAWDREKRLSFAVPFREMKPVIFLDVFLPRVTELALTASDRQTKVAACELLHSMVMFMLGKATQMPEGGQGAPPMYQLYKRTFPVLLRLACDVDQVTRQLYEPLVMQLIHWFTNNKKFESQDTVALLEAILDGIVDPVDSTLRDFCGRCIREFLKWSIKQITPQQQEKSPVNTKSLFKRLYSLALHPNAFKRLGASLAFNNIYREFREEESLVEQFVFEALVIYMESLALAHADEKSLGTIQQCCDAIDHLCRIIEKKHVSLNKAKKRRLPRGFPPSASLCLLDLVKWLLAHCGRPQTECRHKSIELFYKFVPLLPGNRSPNLWLKDVLKEEGVSFLINTFEGGGCGQPSGILAQPTLLYLRGPFSLQATLCWLDLLLAALECYNTFIGERTVGALQVLGTEAQSSLLKAVAFFLESIAMHDIIAAEKCFGTGAAGNRTSPQEGERYNYSKCTVVVRIMEFTTTLLNTSPEGWKLLKKDLCNTHLMRVLVQTLCEPASIGFNIGDVQVMAHLPDVCVNLMKALKMSPYKDILETHLREKITAQSIEELCAVNLYGPDAQVDRSRLAAVVSACKQLHRAGLLHNILPSQSTDLHHSVGTELLSLVYKGIAPGDERQCLPSLDLSCKQLASGLLELAFAFGGLCERLVSLLLNPAVLSTASLGSSQGSVIHFSHGEYFYSLFSETINTELLKNLDLAVLELMQSSVDNTKMVSAVLNGMLDQSFRERANQKHQGLKLATTILQHWKKCDSWWAKDSPLETKMAVLALLAKILQIDSSVSFNTSHGSFPEVFTTYISLLADTKLDLHLKGQAVTLLPFFTSLTGGSLEELRRVLEQLIVAHFPMQSREFPPGTPRFNNYVDCMKKFLDALELSQSPMLLELMTEVLCREQQHVMEELFQSSFRRIARRGSCVTQVGLLESVYEMFRKDDPRLSFTRQSFVDRSLLTLLWHCSLDALREFFSTIVVDAIDVLKSRFTKLNESTFDTQITKKMGYYKILDVMYSRLPKDDVHAKESKINQVFHGSCITEGNELTKTLIKLCYDAFTENMAGENQLLERRRLYHCAAYNCAISVICCVFNELKFYQGFLFSEKPEKNLLIFENLIDLKRRYNFPVEVEVPMERKKKYIEIRKEAREAANGDSDGPSYMSSLSYLADSTLSEEMSQFDFSTGVQSYSYSSQDPRPATGRFRRREQRDPTVHDDVLELEMDELNRHECMAPLTALVKHMHRSLGPPQGEEDSVPRDLPSWMKFLHGKLGNPIVPLNIRLFLAKLVINTEEVFRPYAKHWLSPLLQLAASENNGGEGIHYMVVEIVATILSWTGLATPTGVPKDEVLANRLLNFLMKHVFHPKRAVFRHNLEIIKTLVECWKDCLSIPYRLIFEKFSGKDPNSKDNSVGIQLLGIVMANDLPPYDPQCGIQSSEYFQALVNNMSFVRYKEVYAAAAEVLGLILRYVMERKNILEESLCELVAKQLKQHQNTMEDKFIVCLNKVTKSFPPLADRFMNAVFFLLPKFHGVLKTLCLEVVLCRVEGMTELYFQLKSKDFVQVMRHRDDERQKVCLDIIYKMMPKLKPVELRELLNPVVEFVSHPSTTCREQMYNILMWIHDNYRDPESETDNDSQEIFKLAKDVLIQGLIDENPGLQLIIRNFWSHETRLPSNTLDRLLALNSLYSPKIEVHFLSLATNFLLEMTSMSPDYPNPMFEHPLSECEFQEYTIDSDWRFRSTVLTPMFVETQASQGTLQTRTQEGSLSARWPVAGQIRATQQQHDFTLTQTADGRSSFDWLTGSSTDPLVDHTSPSSDSLLFAHKRSERLQRAPLKSVGPDFGKKRLGLPGDEVDNKVKGAAGRTDLLRLRRRFMRDQEKLSLMYARKGVAEQKREKEIKSELKMKQDAQVVLYRSYRHGDLPDIQIKHSSLITPLQAVAQRDPIIAKQLFSSLFSGILKEMDKFKTLSEKNNITQKLLQDFNRFLNTTFSFFPPFVSCIQDISCQHAALLSLDPAAVSAGCLASLQQPVGIRLLEEALLRLLPAELPAKRVRGKARLPPDVLRWVELAKLYRSIGEYDVLRGIFTSEIGTKQITQSALLAEARSDYSEAAKQYDEALNKQDWVDGEPTEAEKDFWELASLDCYNHLAEWKSLEYCSTASIDSENPPDLNKIWSEPFYQETYLPYMIRSKLKLLLQGEADQSLLTFIDKAMHGELQKAILELHYSQELSLLYLLQDDVDRAKYYIQNGIQSFMQNYSSIDVLLHQSRLTKLQSVQALTEIQEFISFISKQGNLSSQVPLKRLLNTWTNRYPDAKMDPMNIWDDIITNRCFFLSKIEEKLTPLPEDNSMNVDQDGDPSDRMEVQEQEEDISSLIRSCKFSMKMKMIDSARKQNNFSLAMKLLKELHKESKTRDDWLVSWVQSYCRLSHCRSRSQGCSEQVLTVLKTVSLLDENNVSSYLSKNILAFRDQNILLGTTYRIIANALSSEPACLAEIEEDKARRILELSGSSSEDSEKVIAGLYQRAFQHLSEAVQAAEEEAQPPSWSCGPAAGVIDAYMTLADFCDQQLRKEEENASVIDSAELQAYPALVVEKMLKALKLNSNEARLKFPRLLQIIERYPEETLSLMTKEISSVPCWQFISWISHMVALLDKDQAVAVQHSVEEITDNYPQAIVYPFIISSESYSFKDTSTGHKNKEFVARIKSKLDQGGVIQDFINALDQLSNPELLFKDWSNDVRAELAKTPVNKKNIEKMYERMYAALGDPKAPGLGAFRRKFIQTFGKEFDKHFGKGGSKLLRMKLSDFNDITNMLLLKMNKDSKPPGNLKECSPWMSDFKVEFLRNELEIPGQYDGRGKPLPEYHVRIAGFDERVTVMASLRRPKRIIIRGHDEREHPFLVKGGEDLRQDQRVEQLFQVMNGILAQDSACSQRALQLRTYSVVPMTSRLGLIEWLENTVTLKDLLLNTMSQEEKAAYLSDPRAPPCEYKDWLTKMSGKHDVGAYMLMYKGANRTETVTSFRKRESKVPADLLKRAFVRMSTSPEAFLALRSHFASSHALICISHWILGIGDRHLNNFMVAMETGGVIGIDFGHAFGSATQFLPVPELMPFRLTRQFINLMLPMKETGLMYSIMVHALRAFRSDPGLLTNTMDVFVKEPSFDWKNFEQKMLKKGGSWIQEINVAEKNWYPRQKICYAKRKLAGANPAVITCDELLLGHEKAPAFRDYVAVARGSKDHNIRAQEPESGLSEETQVKCLMDQATDPNILGRTWEGWEPWM","Homo sapiens","PRKDC, HYRC, HYRC1","DNA-dependent protein kinase catalytic subunit","1","5W1R"
"5W1Y",,"X-RAY DIFFRACTION",2.04,39.67,"VAPOR DIFFUSION",,"0.2 M sodium fluoride, 20% PEG-3350",291,,,"5W1Y",38.28,"1.7","1.7","SETD8 in complex with a covalent inhibitor","GAMGSRKSKAELQSEERKRIDELIESGKEEGMKIDLIDGKGRGVIATKQFSRGDFVVEYHGDLIEITDAKKREALYAQDPSTGCYMYYFQYLSKTYCVDATRETNRLGRLINHSKSGNCQTKLHDIDGVPHLILIASRDIAAGEELLYDYGDRSKASIEAHPWLKH","Homo sapiens","KMT5A, PRSET7, SET07, SET8, SETD8","N-lysine methyltransferase KMT5A","1","5W1Y"
"5W22",,"X-RAY DIFFRACTION",2.55,51.78,"VAPOR DIFFUSION, HANGING DROP",,"0.2 mol/L sodium acetate, 0.1 mol/L Tris pH 8.5, 24% PEG 4,000",295,"10.1107/S2059798317015418",,"5W22",39.72,"1.762","1.762","Crystal structure of human WT-KRAS in complex with GDP","HMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKSDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKHKEK","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5W22"
"5W2F",,"X-RAY DIFFRACTION",2.59,52.49,"VAPOR DIFFUSION, SITTING DROP",4.5,"3.5 M Sodium Formate, 100 mM Sodium Acetate pH4.5",293,"10.1016/j.jmb.2017.07.015",,"5W2F",23.2,"1.4","1.4","Crystal Structure of the C-terminal Domain of Human eIF2D at 1.4 A resolution","GDIKPLYCVPASMTLLFQESGHKKGSFLEGSEVRTIVINYAKKNDLVDADNKNLVRLDPILCDCILEKNEQHTVMKLPWDSLLTRCLEKLQPAYQVTLPGQEPIVKKGRICPIDITLAQRASNKKVTVVRNLEAYGLDPYSVAAILQQRCQASTTVNPAPGAKDSLQVQIQGNQVHHLGWLLLEEYQLPRKHIQGLEKALKPGKKK","Homo sapiens","EIF2D, HCA56, LGTN","Eukaryotic translation initiation factor 2D","1","5W2F"
"5W2G",,"X-RAY DIFFRACTION",2.24,45.09,"VAPOR DIFFUSION, HANGING DROP",,"35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM MES Imidanzol buffer , pH 6.0, 50 mM beta-mercaptoethanol",298,"10.1074/jbc.M117.801845",,"5W2G",29.43,"1.8","1.8","Crystal structure of the core catalytic domain of human inositol phosphate multikinase","GSFTSHQVAGHMYGKILQHPDGTVLKQLQPPPRGPRELEFYNMVYAADCFDGVLLELRKYLPKYYGIWSPPTAPNDLYLKLEDVTHKFNKPCIMDVKIGQKSYDPFASSEKIQQQVSKYPLMEEIGFLVLGMRVYHVHSDSYETENQHYGRSLTKETIKDGVSRFFHNGYCLRKDAVAASIQKIEKILQWFENQKQLNFYASSLLFVYEGSSQGGSGGEVEVRMIDFAHVFPSNTIDEGYVYGLKHLISVLRSILDN","Homo sapiens","IPMK, IMPK","Inositol polyphosphate multikinase,Inositol polyphosphate multikinase","1","5W2G"
,,,,,,,,,,,,,,,,,"Homo sapiens","IPMK, IMPK"
"5W2H",,"X-RAY DIFFRACTION",2.22,44.62,"VAPOR DIFFUSION, HANGING DROP",,"35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM MES Imidanzol buffer , pH 6.0, 50 mM beta-mercaptoethanol.To obtain complex structures, the apo crystal were further soaked under 35% (w/v) PEG 400, 0.1 M Li2SO4,  100 mM HEPES, pH 7.5 at 298K in the presence of 20 mM Ins(1,4,5)P3, 10 mM Mg and 5mM ATP for 1 day.",298,"10.1074/jbc.M117.801845",,"5W2H",30.42,"1.9","1.9","Crystal structure of the core catalytic domain of human inositol phosphate multikinase in complex with Ins(1,4,5)P3 and ADP","GSFTSHQVAGHMYGKILQHPDGTVLKQLQPPPRGPRELEFYNMVYAADCFDGVLLELRKYLPKYYGIWSPPTAPNDLYLKLEDVTHKFNKPCIMDVKIGQKSYDPFASSEKIQQQVSKYPLMEEIGFLVLGMRVYHVHSDSYETENQHYGRSLTKETIKDGVSRFFHNGYCLRKDAVAASIQKIEKILQWFENQKQLNFYASSLLFVYEGSSQGGSGGEVEVRMIDFAHVFPSNTIDEGYVYGLKHLISVLRSILDN","Homo sapiens","IPMK, IMPK","Inositol polyphosphate multikinase,Inositol polyphosphate multikinase","1","5W2H"
,,,,,,,,,,,,,,,,,"Homo sapiens","IPMK, IMPK"
"5W2I",,"X-RAY DIFFRACTION",2.24,44.99,"VAPOR DIFFUSION, HANGING DROP",4.5,"35% (w/v) PEG 400, 0.1 M Li2SO4, 100 mM MES Imidanzol buffer , pH 6.0, 50 mM beta-mercaptoethanol  at 298K.  To obtain complex structures, the apo crystal were further soaked under 35% (w/v) PEG 400, 0.1 M Li2SO4,  100 mM HEPES, pH 7.5 at 298K in the presence of 20 mM C4-analogue of PtdIns(4,5)P2, 10 mM Mg and 5mM ATP for 1 day.",298,"10.1074/jbc.M117.801845",,"5W2I",30.32,"1.6","1.6","Crystal structure of the core catalytic domain of human inositol phosphate multikinase soaked with C4-analogue of PtdIns(4,5)P2 and ADP","GSFTSHQVAGHMYGKILQHPDGTVLKQLQPPPRGPRELEFYNMVYAADCFDGVLLELRKYLPKYYGIWSPPTAPNDLYLKLEDVTHKFNKPCIMDVKIGQKSYDPFASSEKIQQQVSKYPLMEEIGFLVLGMRVYHVHSDSYETENQHYGRSLTKETIKDGVSRFFHNGYCLRKDAVAASIQKIEKILQWFENQKQLNFYASSLLFVYEGSSQGGSGGEVEVRMIDFAHVFPSNTIDEGYVYGLKHLISVLRSILDN","Homo sapiens","IPMK, IMPK","Inositol polyphosphate multikinase,Inositol polyphosphate multikinase","1","5W2I"
,,,,,,,,,,,,,,,,,"Homo sapiens","IPMK, IMPK"
"5W2L",,"X-RAY DIFFRACTION",2.4,48.76,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MES, pH 6.0, 20% w/v PEG2000 MME",291.15,"10.1093/nar/gkx1213",,"5W2L",38.08,"1.86","1.86","Structure of a central domain of human Ctc1","SNAQTDPTGPEGPHLGQSRLFLLCHKEALMKRNFCVPPGASPEVPKPALSFYVLGSWLGGTQRKEGTGWGLPEPQGNDDNDQKVHLIFFGSSVRWFEFLHPGQVYRLIAPGPATPMLFEKDGSSCISRRPLELAGCASCLTVQDNWTLELESSQDIQDVLDANKSLPE","Homo sapiens","CTC1, C17orf68","CST complex subunit CTC1","1","5W2L"
"5W38",,"X-RAY DIFFRACTION",2.6,52.75,"VAPOR DIFFUSION, SITTING DROP",5.5,"20% (w/v) PEG 4000, 100 mM sodium citrate/citric acid, 10% (v/v) 2-propanol",293,"10.1016/j.molimm.2017.10.001",,"5W38",51.81,"1.8","1.8","1.80A resolution structure of human IgG3 Fc (N392K)","TCPRCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVQFKWYVDGVEVHNAKTKPREEQFNSTFRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKTKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESSGQPENNYKTTPPMLDSDGSFFLYSKLTVDKSRWQQGNIFSCSVMHEALHNRFTQKSLSLSPGK","Homo sapiens","IGHG3","Immunoglobulin heavy constant gamma 3","1","5W38"
"5W3N",,"SOLID-STATE NMR",,,,,,,"10.1016/j.cell.2017.08.048",,"5W3N",223.83,,,"Molecular structure of FUS low sequence complexity domain protein fibrils","MSYYHHHHHHDYDIPTTENLYFQGAMDPASNDYTQQATQSYGAYPTQPGQGYSQQSSQPYGQQSYSGYSQSTDTSGYGQSSYSSYGQSQNTGYGTQSTPQGYGSTGGYGSSQSSQSSYGQQSSYPGYGQQPAPSSTSGSYGSSSQSSSYGQPQSGSYSQQPSYGGQQQSYGQQQSYNPPQGYGQQNQYNSSSGGGGGGGGGGNYGQDQSSMSSGGGSGGGYGNQDQSGGGGSGGYGQQDRG","Homo sapiens","FUS, TLS","RNA-binding protein FUS","1","5W3N"
"5W3R",,"X-RAY DIFFRACTION",1.83,32.95,"VAPOR DIFFUSION, SITTING DROP",7.2,"PEG 3350, potassium sulfate, phenol",277,"10.1002/prot.25420",,"5W3R",13.04,"1.386","1.386","SH2B1 SH2 Domain","GSHMDQPLSGYPWFHGMLSRLKAAQLVLTGGTGSHGVFLVRQSETRRGEYVLTFNFQGKAKHLRLSLNAAGQCRVQHLHFQSIFDMLEHFRVHPIPLESGGSSDVVLVSYVPSS","Homo sapiens","SH2B1, KIAA1299, SH2B","SH2B adapter protein 1","1","5W3R"
"5W45",,"X-RAY DIFFRACTION",2.43,49.33,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M Na thiocyanate
4% PEG 20K",279,"10.1038/s41598-018-21955-0",,"5W45",42.53,"2.486","2.486","Crystal structure of APOBEC3H","ALLTAETFRLQFNNKRRLRRPYYPRKALLCYQLTPQNGSTPTRGYFENKKKCHAAICFINEIKSMGLDETQCYQVTCYLTWSPCSSCASELVDFIKAHDHLNLRIFASRLYYHASKPQQDGLRLLSQEGVPVEVMGFPEFADCWENFVDHEKPASFNPYKMLEELDKNSRAIKRRLDRIKS","Homo sapiens","APOBEC3H","APOBEC3H","1","5W45"
"5W46",,"X-RAY DIFFRACTION",1.96,37.28,"VAPOR DIFFUSION",,"Tris pH 8.0, magnesium chloride, PEG 3350, Hepes",295,"10.1038/s41598-018-20860-w",,"5W46",17.23,"1.18","1.18","Structure of S65D Phosphomimetic Ubiquitin Refined at 1.2 Angstroms Resolution","MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKEDTLHLVLRLRGG","Homo sapiens","UBB","Polyubiquitin-B","1","5W46"
"5W49",,"X-RAY DIFFRACTION",3.11,60.44,"VAPOR DIFFUSION, HANGING DROP",8.5,"8-12% PEG8000, 0.12 M ethylene glycol, 0.1 M Tris(base):Bicine, pH 8.5",293,"10.1016/j.bbrc.2017.05.107","9W1","5W49",97.86,"2.4","2.4","The crystal structure of human S-adenosylhomocysteine hydrolase (AHCY) bound to oxadiazole inhibitor","KLPYKVADIGLAAWGRKALDIAENEMPGLMRMRERYSASKPLKGARIAGCLHMTVETAVLIETLVTLGAEVQWSSCNIFSTQDHAAAAIAKAGIPVYAWKGETDEEYLWCIEQTLYFKDGPLNMILDDGGDLTNLIHTKYPQLLPGIRGISEETTTGVHNLYKMMANGILKVPAINVNDSVTKSKFDNLYGCRESLIDGIKRATDVMIAGKVAVVAGYGDVGKGCAQALRGFGARVIITEIDPINALQAAMEGYEVTTMDEACQEGNIFVTTTGCIDIILGRHFEQMKDDAIVCNIGHFDVEIDVKWLNENAVEKVNIKPQVDRYRLKNGRRIILLAEGRLVNLGCAMGHPSFVMSNSFTNQVMAQIELWTHPDKYPVGVHFLPKKLDEAVAEAHLGKLNVKLTKLTEKQAQYLGMSCDGPFKPDHYRY","Homo sapiens","AHCY, SAHH","Adenosylhomocysteinase","1","5W49"
"5W4B",,"X-RAY DIFFRACTION",3.15,60.95,"VAPOR DIFFUSION, HANGING DROP",8.5,"8-12% PEG8000, 0.12 M ethylene glycol, 0.1 M Tris(base):Bicine, pH 8.5",293,"10.1016/j.bbrc.2017.05.107",,"5W4B",291.38,"2.65","2.65","The crystal structure of human S-adenosylhomocysteine hydrolase (AHCY) bound to benzothiazole inhibitor","KLPYKVADIGLAAWGRKALDIAENEMPGLMRMRERYSASKPLKGARIAGCLHMTVETAVLIETLVTLGAEVQWSSCNIFSTQDHAAAAIAKAGIPVYAWKGETDEEYLWCIEQTLYFKDGPLNMILDDGGDLTNLIHTKYPQLLPGIRGISEETTTGVHNLYKMMANGILKVPAINVNDSVTKSKFDNLYGCRESLIDGIKRATDVMIAGKVAVVAGYGDVGKGCAQALRGFGARVIITEIDPINALQAAMEGYEVTTMDEACQEGNIFVTTTGCIDIILGRHFEQMKDDAIVCNIGHFDVEIDVKWLNENAVEKVNIKPQVDRYRLKNGRRIILLAEGRLVNLGCAMGHPSFVMSNSFTNQVMAQIELWTHPDKYPVGVHFLPKKLDEAVAEAHLGKLNVKLTKLTEKQAQYLGMSCDGPFKPDHYRY","Homo sapiens","AHCY, SAHH","Adenosylhomocysteinase","1","5W4B"
"5W4H",,"X-RAY DIFFRACTION",2.38,48.42,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES buffer (pH 7.0), 0.25 M magnesium chloride, 34% isopropanol",296.15,"10.1021/acs.biochem.7b00831",,"5W4H",5.38,"1.718","1.718","X-ray crystallographic structure of a beta-hairpin peptide mimic derived from Abeta 16-36. Synchrotron data set. (ORN)KLV(MEA)FAE(ORN)AIIGLMV.","AKLVFFAEAAIIGLMV","Homo sapiens",,"A-beta 17_36 peptide: ORN-LYS-LEU-VAL-MEA-PHE-ALA-GLU-ORN-ALA-ILE-ILE-GLY-LEU-MET-VAL","1","5W4H"
"5W4I",,"X-RAY DIFFRACTION",2.41,48.89,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1 M HEPES sodium buffer (pH 7.5), 0.2 M sodium citrate, 22% isopropanol",296.15,"10.1021/acs.biochem.7b00831",,"5W4I",6.12,"2.026","2.026","X-ray crystallographic structure of a beta-hairpin peptide mimic derived from Abeta 16-36. Rigaku data set. (ORN)KLV(MEA)FAE(ORN)AIIGLMV.","AKLVFFAEAAIIGLMV","Homo sapiens",,"A-beta 17_36: ORN-LYS-LEU-VAL-MEA-PHE-ALA-GLU-ORN-ALA-ILE-ILE-GLY-LEU-MET-VAL","1","5W4I"
"5W4J",,"X-RAY DIFFRACTION",2.21,44.43,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.05 M HEPES buffer (pH 7.5), 0.2 M KCl, 37% Pentaerythritol propoxylate (5/4 PO/OH)",296.15,"10.1021/acs.biochem.7b00831",,"5W4J",10.43,"2.08","2.08","X-ray crystallographic structure of a beta-hairpin peptide mimic. (ORN)KLV(MEA)FAE(ORN)AIIGLMV.","AKVFFAADAAIIGLMV","Homo sapiens",,"A-beta 17_36 peptide: ORN-LYS-VAL-PHE-MEA-ALA-ALA-ASP-ORN-ALA-ILE-ILE-GLY-LEU-MET-VAL","1","5W4J"
"5W4R",,"X-RAY DIFFRACTION",3.48,64.62,"VAPOR DIFFUSION",,"12% 8K PEG, 100mM HEPES pH7.5",293,"10.1016/j.bmcl.2017.10.027","9WD","5W4R",51.63,"3.002","3.002","Structure of RORgt bound to a tertiary alcohol","ASLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLCKTHRQSILAKLPPKGKLRSLCSQHVE","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","5W4R"
"5W4V",,"X-RAY DIFFRACTION",3.17,61.25,"VAPOR DIFFUSION, HANGING DROP",,"0.1 M Tris-HCl, pH 8.4, 3.3 %(w/v) PEG 8000",293,"10.1016/j.bmcl.2017.10.027","9WA","5W4V",150.68,"2.65","2.65","Structure of RORgt bound to a tertiary alcohol","SLTEIEHLVQSVCKSYRETCQLRLEDLLRQRSNIFSREEVTGYQRKSMWEMWERCAHHLTEAIQYVVEFAKRLSGFMELCQNDQIVLLKAGAMEVVLVRMCRAYNADNRTVFFEGKYGGMELFRALGCSELISSIFDFSHSLSALHFSEDEIALYTALVLINAHRPGLQEKRKVEQLQYNLELAFHHHLHKTHRQSILAKLPPKGKLRSL","Homo sapiens","RORC, NR1F3, RORG, RZRG","Nuclear receptor ROR-gamma","1","5W4V"
"5W4W",,"X-RAY DIFFRACTION",2.16,43.15,"VAPOR DIFFUSION, HANGING DROP",,,295,"10.1021/acschemneuro.7b00155","9WG","5W4W",156.88,"1.99","1.99","Identification and Profiling of a Selective and Brain Penetrant Radioligand for In Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors","MHHHHHHSSGLVPRGSLRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASRAADDAERERRDREERLRH","Homo sapiens","CSNK1D, HCKID","Casein kinase I isoform delta","1","5W4W"
"5W4X",,"X-RAY DIFFRACTION",2.67,53.88,"LIQUID DIFFUSION",6.2,"1.0 MM CAPILLARY,5 L OF 10.4 MG/ML
 ENZYME AND 200 L OF 100 MM MES PH 6.2, 100 MM MGCL2, AND 16% PEG
 3350",298,"10.1038/s41586-018-0699-5",,"5W4X",156.52,"2.65","2.65","Truncated hUGDH","MFEIKKICCIGAGYVGGPTCSVIAHMCPEIRVTVVDVNESRINAWNSPTLPIYEPGLKEVVESCRGKNLFFSTNIDDAIKEADLVFISVNTPTKTYGMGKGRAADLKYIEACARRIVQNSNGYKIVTEKSTVPVRAAESIRRIFDANTKPNLNLQVLSNPEFLAEGTAIKDLKNPDRVLIGGDETPEGQRAVQALCAVYEHWVPREKILTTNTWSSELSKLAANAFLAQRISSINSISALCEATGADVEEVATAIGMDQRIGNKFLKASVGFGGSCFQKDVLNLVYLCEALNLPEVARYWQQVIDMNDYQRRRFASRIIDSLFNTVTDKKIAILGFAFKKDTGDTRESSSIYISKYLMDEGAHLHIYDPKVPREQIVVDLSHPGVSEDDQVSRLVTISKDPYEACDGAHAVVICTEWDMFKELDYERIHKKMLKPAFIFDGRRVLDGLHNELQTIGFQIETIGKKV","Homo sapiens","UGDH","UDP-glucose 6-dehydrogenase","1","5W4X"
"5W50",,"X-RAY DIFFRACTION",1.71,28.22,"VAPOR DIFFUSION, HANGING DROP",9.5,"100 mM CHES, pH 9.5, 20% PEG8000, 10 mM lithium hydroxide",298,"10.1038/s41594-018-0045-5",,"5W50",1.31,"1.4","1.4","Crystal structure of the segment, LIIKGI, from the RRM2 of TDP-43, residues 248-253","LIIKGI","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","5W50"
"5W52",,"ELECTRON CRYSTALLOGRAPHY",1.51,18.73,"BATCH",8.5,"50 mM CHES, pH 8.5",310,"10.1038/s41594-018-0045-5",,"5W52",1.21,"1.4","1.4","MicroED structure of the segment, DLIIKGISVHI, from the RRM2 of TDP-43, residues 247-257","DLIIKGISVHI","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","5W52"
"5W55",,"X-RAY DIFFRACTION",2.1,41.4,"VAPOR DIFFUSION",,"100mM Sodium Nitrate, 5% Ethylene Glycol, 18% (w/v) PEG3350",295,,,"5W55",15.72,"1.354","1.354","Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor JWG048","STNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5W55"
"5W5G",,"X-RAY DIFFRACTION",2.45,49.78,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M Hepes, pH 7
5% ethylene glycol
0.3 M magnesium chloride
13% PEG 8000",291,"10.1021/acs.biochem.7b00638",,"5W5G",88.58,"2.48","2.48","Structure of Human Sts-1 histidine phosphatase domain","KRCLFVCRHGERMDVVFGKYWLSQCFDAKGRYIRTNLNMPHSLPQRSGGFRDYEKDAPITVFGCMQARLVGEALLESNTIIDHVYCSPSLRCVQTAHNILKGLQQENHLKIRVEPGLFEWTKWVAGSTLPAWIPPSELAAANLSVDTTYRPHIPISKLVVSESYDTYISRSFQVTKEIISECKSKGNNILIVAHASSLEACTCQLQGLSPQNSKDFVQMVRKIPYLGFCSCEELGETGIWQLTDPPILPLTHGPTGGFNWRE","Homo sapiens","UBASH3B, KIAA1959, STS1","Ubiquitin-associated and SH3 domain-containing protein B","1","5W5G"
"5W5J",,"X-RAY DIFFRACTION",2.39,48.46,"VAPOR DIFFUSION, SITTING DROP",5,"1.6M ammonium sulfate, 0.1M citric acid pH 5.0",293,"10.1021/acsmedchemlett.7b00258","9WS","5W5J",72.08,"2.85","2.85","Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases","NGEAICSALPTIPYHKLADLRYLSRGASGTVSSARHADWRVQVAVKHLHIHTPLLDSERKDVLREAEILHKARFSYILPILGICNEPEFLGIVTEYMPNGSLNELLHRKTEYPDVAWPLRFRILHEIALGVNYLHNMTPPLLHHDLKTQNILLDNEFHVKIADFGLSKWRMMSLSQSRSSKSAPEGGTIIYMPPENYEPGQKSRASIKHDIYSYAVITWEVLSRKQPFEDVTNPLQIMYSVSQGHRPVINEESLPYDIPHRARMISLIESGWAQNPDERPSFLKCLIELEPVLRTFEEITFLEAVIQLKK","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","Receptor-interacting serine/threonine-protein kinase 2","1","5W5J"
"5W5L",,"X-RAY DIFFRACTION",2.95,58.32,"VAPOR DIFFUSION, SITTING DROP",,"9% PEG 20,000, 0.1 M Sodium Acetate, pH 5.5",293,"10.3390/antib6030012",,"5W5L",53.16,"1.9","1.9","Crystal structure of human IgG1-Sigma Fc fragment","TCPPCPAPEAAGASSVFLFPPKPKDTLMISRTPEVTCVVVDVSAEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPSSIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK","Homo sapiens",,"Immunoglobulin gamma-1 heavy chain","1","5W5L"
"5W5M",,"X-RAY DIFFRACTION",2.85,56.84,"VAPOR DIFFUSION, SITTING DROP",,"9% (w/v) PEG 20K, 0.1 M sodium acetate, pH 5.5",293,"10.3390/antib6030012",,"5W5M",53.55,"1.9","1.9","Crystal structure of human IgG4-Sigma1 Fc fragment","TCPPCPAPEAAGASSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLGK","Homo sapiens","IGHG4","Immunoglobulin heavy constant gamma 4","1","5W5M"
"5W5N",,"X-RAY DIFFRACTION",2.85,56.9,"VAPOR DIFFUSION, SITTING DROP",,"10% (w/v) PEG 20K, 0.1 M sodium acetate, 5.5, 5% (v/v) MPD",293,"10.3390/antib6030012",,"5W5N",53.29,"1.85","1.85","Crystal structure of human IgG4-Sigma2 Fc fragment","TCPPCPAPEAAASSVFLFPPKPKDTLMISRTPEVTCVVVDVSQEDPEVQFNWYVDGVEVHNAKTKPREEQFNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKGLPSSIEKTISKAKGQPREPQVYTLPPSQEEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSRLTVDKSRWQEGNVFSCSVMHEALHNHYTQKSLSLSLGK","Homo sapiens","IGHG4","Immunoglobulin heavy constant gamma 4","1","5W5N"
"5W5O",,"X-RAY DIFFRACTION",3.18,61.36,"VAPOR DIFFUSION, SITTING DROP",8,"1.0M lithium chloride, 10.0% polyethylene glycol 6000, 0.1M TRIS pH 8.0",293,"10.1021/acsmedchemlett.7b00258","9XA","5W5O",578.1,"2.89","2.89","Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases.","NGEAICSALPTIPYHKLADLRYLSRGASGTVSSARHADWRVQVAVKHLHIHTPLLDSERKDVLREAEILHKARFSYILPILGICNEPEFLGIVTEYMPNGSLNELLHRKTEYPDVAWPLRFRILHEIALGVNYLHNMTPPLLHHDLKTQNILLDNEFHVKIADFGLSKWRMMSLSQSRSSKSAPEGGTIIYMPPENYEPGQKSRASIKHDIYSYAVITWEVLSRKQPFEDVTNPLQIMYSVSQGHRPVINEESLPYDIPHRARMISLIESGWAQNPDERPSFLKCLIELEPVLRTFEEITFLEAVIQLKK","Homo sapiens","RIPK2, CARDIAK, RICK, RIP2, UNQ277/PRO314/PRO34092","Receptor-interacting serine/threonine-protein kinase 2","1","5W5O"
"5W5Q",,"X-RAY DIFFRACTION",2.16,43.13,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1 M MES pH 6.5, 35% PEG 3350",293,"10.1021/acsmedchemlett.8b00658",,"5W5Q",76.18,"2.33","2.33","MAP4K4 in complex with inhibitor compound 12 (N3-methyl-10-(3-methyl-3-(5-methyloxazol-2-yl)but-1-yn-1-yl)-6,7-dihydro-5H-5,7-methanobenzo[c]imidazo[1,2-a]azepine-2,3-dicarboxamide)","GSANDSPAKSLVDIDLSSLRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSITDLVKNTKGNTLKEDWIAYISREILRGLAHLHIHHVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDLWSCGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPRLKSKKWSKKFFSFIEGCLVKNYMQRPSTEQLLKHPFIRDQPNERQVRIQLKDHIDRTRKKRGEKDETEYEYSGSEEGNS","Homo sapiens","MAP4K4, HGK, KIAA0687, NIK","Mitogen-activated protein kinase kinase kinase kinase 4","1","5W5Q"
"5W5V",,"X-RAY DIFFRACTION",2.94,58.16,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 mM HEPES pH 7.5, 4% PEG 8000, 10% DMSO",293,"10.1124/mol.118.112185","ANW","5W5V",76.32,"3.645","3.645","TBK1 co-crystal structure with amlexanox","SNAMQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRDIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIYEGRRLVLEPGRLAQHFPKTTEENPIFVVSREPLNTIGLIYEKISLPKVHPRYDLDGDASMAKAITGVVCYACRIASTLLLYQELMRKGIRWLIELIKDDYNETVHKKTEVVITLDFCIRNIEKTVKVYEKLMKINLEAAELGEISDIHTKLLRLSSSQGTIETSLQDIDSRLSPGGSLADAWAHQEGTHPKDRNVEKLQVLLNCMTEIYYQFKKDKAERRLAYNEEQIHKFDKQKLYYHATKAMTHFTDECVKKYEAFLNKSEEWIRKMLHLRKQLLSLTNQCFDIEEEVSKYQEYTNELQET","Homo sapiens","TBK1, NAK","Serine/threonine-protein kinase TBK1","1","5W5V"
"5W60",,"X-RAY DIFFRACTION",1.68,26.69,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate, TRIS",293,"10.1016/j.str.2018.07.006",,"5W60",21.4,"1.803","1.803","Crystal structure of BAXP168G monomer cryo-protected with ethylene glycol","MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSESLKRIGDELDSNMELQRMIAAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALSTKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDGLLSYFGTGTWQTVTIFVAGVLTASLTIWKKMGSS","Homo sapiens","BAX, BCL2L4","Apoptosis regulator BAX","1","5W60"
"5W61",,"X-RAY DIFFRACTION",1.68,26.71,"VAPOR DIFFUSION, HANGING DROP",,"Ammonium sulfate, bis-TRIS, glycerol",293,"10.1016/j.str.2018.07.006",,"5W61",21.31,"2.3","2.3","Crystal structure of BAXP168G monomer co-crystallized with glycerol","MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSESLKRIGDELDSNMELQRMIAAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALSTKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDGLLSYFGTGTWQTVTIFVAGVLTASLTIWKKMGSS","Homo sapiens","BAX, BCL2L4","Apoptosis regulator BAX","1","5W61"
"5W6E",,"X-RAY DIFFRACTION",3.15,60.98,"VAPOR DIFFUSION, HANGING DROP",8.5,"0.1 M TRIS-HCL, 0.2 M MGCL2, 125 UM 5-(5-BROMO-2-PROPOXYPHENYL)-3-PROPYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-7(6H)-ONE, 15% PEG 8000, PH 8.5, VAPOR DIFFUSION, TEMPERATURE 298K",298,"10.1021/acs.jmedchem.8b00374","0NY","5W6E",42.55,"1.9","1.9","PDE1b complexed with compound 3S","GSMTYTSVGPTYSTAVLNCLKNLDLWCFDVFSLNQAADDHALRTIVFELLTRHNLISRFKIPTVFLMSFLDALETGYGKYKNPYHNQIHAADVTQTVHCFLLRTGMVHCLSEIELLAIIFAAAIHDYEHTGTTNSFHIQTKSECAIVYNDRSVLENHHISSVFRLMQDDEMNIFINLTKDEFVELRALVIEMVLATDMSCHFQQVKTMKTALQQLERIDKPKALSLLLHAADISHPTKQWLVHSRWTKALMEEFFRQGDKEAELGLPFSPLCDRTSTLVAQSQIGFIDFIVEPTFSVLTDVAEKSVQPLADEDSKSKNQPSFQWRQPSLDVEVGDPNPDVVSFRSTWVKRIQENKQKWKERAASGITNQ","Homo sapiens","PDE1B, PDE1B1, PDES1B","Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B","1","5W6E"
"5W6M",,"X-RAY DIFFRACTION",2.72,54.78,"VAPOR DIFFUSION, SITTING DROP",8,"0.1 M Tris pH 8, 0.2 M MgCl2 and 20% PEG 2000",298,"10.1073/pnas.1908288116",,"5W6M",101.85,"3.696","3.696","Crystal structure of the human histidyl-tRNA synthetase mutant D175E","FVLKTPKGTRDYSPRQMAVREKVFDVIIRCFKRHGAEVIDTPVFELKETLMGKYGEDSKLIYDLKDQGGELLSLRYDLTVPFARYLAMNKLTNIKRYHIAKVYRRDNPAMTRGRYREFYQCEFDIAGNFDPMIPDAECLKIMCEILSSLQIGDFLVKVNDRRILDGMFAICGVSDSKFRTICSSVDKLDKVSWEEVKNEMVGEKGLAPEVADRIGDYVQQHGGVSLVEQLLQDPKLSQNKQALEGLGDLKLLFEYLTLFGIDDKISFDLSLARGLDYYTGVIYEAVLLQTPAQAGEEPLGVGSVAAGGRYDGLVGMFDPKGRKVPCVGLSIGVERIFSIVEQRLEALEEKIRTTETQVLVASAQKKLLEERLKLVSELWDAGIKAELLYKKNPKLLNQLQYCEEAGIPLVAIIGEQELKDGVIKLRSVTSREEVDVRREDLVEEIKRRTG","Homo sapiens","HARS, HRS, HARS1","Histidine--tRNA ligase, cytoplasmic","1","5W6M"
"5W6O",,"X-RAY DIFFRACTION",2.53,51.34,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M MES pH 6.5
18% PEG 3350",298,"10.1021/acs.biochem.7b01257","9X1","5W6O",91,"2.35","2.35","Choline Kinase Alpha in Complex with TCD-717","DEQPEPRTRRRAYLWCKEFLPGAWRGLREDEFHISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYGAILQMRSCNKEGSEQAQKENEFQGAEAMVLESVMFAILAERSLGPKLYGIFPQGRLEQFIPSRRLDTEELSLPDISAEIAEKMATFHGMKMPFNKEPKWLFGTMEKYLKEVLRIKFTEESRIKKLHKLLSYNLPLELENLRSLLESTPSPVVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYRGFDIGNHFCEWMYDYSYEKYPFFRANIRKYPTKKQQLHFISSYLPAFQNDFENLSTEEKSIIKEEMLLEVNRFALASHFLWGLWSIVQAKISSIEFGYMDYAQARFDAYFHQKRKLGV","Homo sapiens","CHKA, CHK, CKI","Choline kinase alpha","1","5W6O"
"5W6X",,"X-RAY DIFFRACTION",2.19,43.76,"VAPOR DIFFUSION",9.5,"PEG 8000, CHES",293,"10.1038/s41598-019-39491-w",,"5W6X",44.1,"2.1","2.1","Crystal structure of the HsNUDT16 in complex with Mg+2 and ADP-ribose","MAGARRLELGEALALGSGWRHVCHALLYAPDPGMLFGRIPLRYAILMQMRFDGRLGFPGGFVDTQDRSLEDGLNRELREELGEAAAAFRVERTDYRSSHVGSGPRVVAHFYAKRLTLEELLAVEAGATRAKDHGLEVLGLVRVPLYTLRDGVGGLPTFLENSFIGSAREQLLEALQDLGLLQSGSISGLKIPAHH","Homo sapiens","NUDT16","U8 snoRNA-decapping enzyme","1","5W6X"
"5W6Z",,"X-RAY DIFFRACTION",2.31,46.76,"VAPOR DIFFUSION",9.5,"PEG 8000, CHES",293,"10.1038/s41598-019-39491-w",,"5W6Z",85.54,"2.61","2.61","Crystal structure of the H24W mutant of HsNUDT16","MAGARRLELGEALALGSGWRHVCWALLYAPDPGMLFGRIPLRYAILMQMRFDGRLGFPGGFVDTQDRSLEDGLNRELREELGEAAAAFRVERTDYRSSHVGSGPRVVAHFYAKRLTLEELLAVEAGATRAKDHGLEVLGLVRVPLYTLRDGVGGLPTFLENSFIGSAREQLLEALQDLGLLQSGSISGLKIPAHH","Homo sapiens","NUDT16","U8 snoRNA-decapping enzyme","1","5W6Z"
"5W77",,"SOLUTION NMR",,,,,,,"10.1038/s41467-018-06315-w",,"5W77",7.98,,,"Solution structure of the MYC G-quadruplex bound to small molecule DC-34","TGAGGGTGGGTAGGGTGGGTAA","Homo sapiens",,"DNA (5'-D(*TP*GP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*GP*GP*GP*TP*GP*GP*GP*TP*AP*A)-3')","1","5W77"
"5W78",,"X-RAY DIFFRACTION",2.52,51.19,"VAPOR DIFFUSION, SITTING DROP",,"post-chymotrypsin; 100 mM sodium citrate pH 5, 20 % PEG 6000",293,"10.1073/pnas.1719834115",,"5W78",66.28,"2.271","2.271","Human acyloxyacyl hydrolase (AOAH), proteolytically processed","DRHHHHHHKLSPANDDQSRPSLSNGHTCVGCVLVVSVIEQLAQVHNSTVQASMERLCSYLPEKLFLKTTCYLVIDKFGSDIIKLLSADMNADVVCHTLEFCKQNTGQPLCHLYPLPKETWKFTLQKARQIVKKSPILKY","Homo sapiens","AOAH","Acyloxyacyl hydrolase","1","5W78"
,,,,,,,,,,,,,,,,"SRSGSDICSLPVLAKICQKIKLAMEQSVPFKDVDSDKYSVFPTLRGYHWRGRDCNDSDESVYPGRRPNNWDVHQDSNCNGIWGVDPKDGVPYEKKFCEGSQPRGIILLGDSAGAHFHISPEWITASQMSLNSFINLPTALTNELDWPQLSGATGFLDSTVGIKEKSIYLRLWKRNHCNHRDYQNISRNGASSRNLKKFIESLSRNKVLDYPAIVIYAMIGNDVCSGKSDPVPAMTTPEKLYSNVMQTLKHLNSHLPNGSHVILYGLPDGTFLWDNLHNRYHPLGQLNKDMTYAQLYSFLNCLQVSPCHGWMSSNKTLRTLTSERAEQLSNTLKKIAASEKFTNFNLFYMDFAFHEIIQEWQKRGGQPWQLIEPVDGFHPNEVALLLLADHFWKKVQLQWPQILGKENPFNPQIKQVFGDQGGH","Homo sapiens","AOAH","Acyloxyacyl hydrolase","2","5W78"
"5W7C",,"X-RAY DIFFRACTION",2.6,52.78,"VAPOR DIFFUSION, SITTING DROP",,"post-chymotrypsin; 1mM Triton X-100, 0.333 mM E. coli LPS Ra; 200 mM ammonium chloride, 100 mM sodium acetate pH 5.3, 20 % PEG 6000",293,"10.1073/pnas.1719834115",,"5W7C",132.69,"2.23","2.23","Human acyloxyacyl hydrolase (AOAH), proteolytically processed, S263A mutant, with LPS","DRHHHHHHKLSPANDDQSRPSLSNGHTCVGCVLVVSVIEQLAQVHNSTVQASMERLCSYLPEKLFLKTTCYLVIDKFGSDIIKLLSADMNADVVCHTLEFCKQNTGQPLCHLYPLPKETWKFTLQKARQIVKKSPILKY","Homo sapiens","AOAH","Acyloxyacyl hydrolase","1","5W7C"
,,,,,,,,,,,,,,,,"SRSGSDICSLPVLAKICQKIKLAMEQSVPFKDVDSDKYSVFPTLRGYHWRGRDCNDSDESVYPGRRPNNWDVHQDSNCNGIWGVDPKDGVPYEKKFCEGSQPRGIILLGDAAGAHFHISPEWITASQMSLNSFINLPTALTNELDWPQLSGATGFLDSTVGIKEKSIYLRLWKRNHCNHRDYQNISRNGASSRNLKKFIESLSRNKVLDYPAIVIYAMIGNDVCSGKSDPVPAMTTPEKLYSNVMQTLKHLNSHLPNGSHVILYGLPDGTFLWDNLHNRYHPLGQLNKDMTYAQLYSFLNCLQVSPCHGWMSSNKTLRTLTSERAEQLSNTLKKIAASEKFTNFNLFYMDFAFHEIIQEWQKRGGQPWQLIEPVDGFHPNEVALLLLADHFWKKVQLQWPQILGKENPFNPQIKQVFGDQGGH","Homo sapiens","AOAH","Acyloxyacyl hydrolase","2","5W7C"
"5W7V","3.8","ELECTRON MICROSCOPY",,,,,,,"10.1038/s41594-018-0045-5",,"5W7V",10.89,"3.8",,"CryoEM structure of the segment, DLIIKGISVHI, assembled into a triple-helical fibril","DLIIKGISVHI","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","5W7V"
"5W7W",,"X-RAY DIFFRACTION",2.04,39.67,"VAPOR DIFFUSION, SITTING DROP",7,"3.5M sodium formate",293,"10.1093/nar/gkx941",,"5W7W",24.05,"1.348","1.348","Crystal Structure of FHA domain of human APLF","SFTMSGGFELQPRDGGPRVALAPGETVIGRGPLLGITDKRVSRRHAILEVAGGQLRIKPIHTNPCFYQSSEKSQLLPLKPNLWCYLNPGDSFSLLVDKYIFRILSIPS","Homo sapiens","APLF, C2orf13, PALF, XIP1","Aprataxin and PNK-like factor","1","5W7W"
"5W84",,"X-RAY DIFFRACTION",2.85,56.88,"VAPOR DIFFUSION, HANGING DROP",,"Null",293,"10.1016/j.bmcl.2017.09.029","9YY","5W84",69.29,"2.9","2.9","CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 4)","GAMGVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","5W84"
"5W85",,"X-RAY DIFFRACTION",2.86,57.02,"VAPOR DIFFUSION, HANGING DROP",,"Null",293,"10.1016/j.bmcl.2017.09.029","9YS","5W85",69.41,"2.25","2.25","CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 9)","GAMGVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS","Homo sapiens","IRAK4","Interleukin-1 receptor-associated kinase 4","1","5W85"
"5W86",,"X-RAY DIFFRACTION",2.45,49.8,"VAPOR DIFFUSION, HANGING DROP",,,293,"10.1016/j.bmcl.2017.09.029","9YV","5W86",133.27,"2.61","2.61","CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)","PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","5W86"
"5W87",,"X-RAY DIFFRACTION",2.14,42.46,"VAPOR DIFFUSION, HANGING DROP",8,"K2HPO4/NaH2PO4, NaCl, imidazole:HCl",293.15,,,"5W87",28.86,"2.199","2.199","Crystal structure of the C-terminal lobe of the human HERC6 HECT domain","GNTDYDWKQFEQNSKYEQGYQKSHPTIQLFWKAFHKLTLDEKKKFLFFLTGRDRLHARGIQKMEIVFRSPETFSERDHPTSITCHNILSLPKYSTMERMEEALQVAINNNRGFVSPMLTQS","Homo sapiens","HERC6","Probable E3 ubiquitin-protein ligase HERC6","1","5W87"
"5W8B",,"X-RAY DIFFRACTION",2.11,41.62,"VAPOR DIFFUSION, HANGING DROP",7.4,"1.4M Sodium Citrate, 50mM Tris, pH 7.8",296,"10.1007/s12035-017-0854-2",,"5W8B",29.51,"1.601","1.601","Carbonic anhydrase II in complex with activating histamine pyridinium derivative","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5W8B"
"5W8H",,"X-RAY DIFFRACTION",2.38,48.3,"VAPOR DIFFUSION",6.8,"24% PEG 3350, 200 mM Sodium Malonate, pH 6.8, 10% Glycerol",289,"10.1021/acs.jmedchem.7b00941","9Y1","5W8H",150.2,"1.8","1.8","Crystal Structure of Lactate Dehydrogenase A in complex with inhibitor compound 11","MATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","5W8H"
"5W8I",,"X-RAY DIFFRACTION",2.34,47,"VAPOR DIFFUSION",6.8,"24% PEG 3350, 200 mM Sodium Malonate, pH 6.8, 10% Glycerol",289,"10.1021/acs.jmedchem.7b00941","9YD","5W8I",149.51,"1.95","1.95","Crystal Structure of Lactate Dehydrogenase A in complex with inhibitor compound 23 and Zinc","MATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","5W8I"
"5W8J",,"X-RAY DIFFRACTION",2.34,47,"VAPOR DIFFUSION",6.8,"24% PEG 3350, 200 mM Sodium Malonate, pH 6.8, 10% Glycerol",289,"10.1021/acs.jmedchem.7b00941","9Y7","5W8J",150.99,"1.55","1.55","Crystal Structure of Lactate Dehydrogenase A in complex with inhibitor compound 29","MATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","5W8J"
"5W8K",,"X-RAY DIFFRACTION",2.38,48,"VAPOR DIFFUSION",6.8,"24% PEG 3350, 200 mM Sodium Malonate, pH 6.8, 10% Glycerol",289,"10.1021/acs.jmedchem.7b00941","9Y7","5W8K",152.89,"1.6","1.6","Crystal Structure of Lactate Dehydrogenase A in complex with inhibitor compound 29 and NADH","MATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","5W8K"
"5W8L",,"X-RAY DIFFRACTION",2.68,54.13,"VAPOR DIFFUSION",6,"8% PEG 8000, 100 mM Cacodylate, pH 6.0, 200 mM NaCl",289,"10.1021/acs.jmedchem.7b00941","9YA","5W8L",152.69,"1.95","1.95","Crystal Structure of Lactate Dehydrogenase A in complex with inhibitor compound 59 and NADH","MATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF","Homo sapiens","LDHA, PIG19","L-lactate dehydrogenase A chain","1","5W8L"
"5W8V",,"X-RAY DIFFRACTION",2.51,51.09,"VAPOR DIFFUSION, HANGING DROP",7.5,"20% PEG 3350, 0.2 M sodium bromide, 0.1 M Bis-tris propane, pH 7.5.",291,"10.1021/acs.jmedchem.7b00926","9YP","5W8V",98.75,"2.346","2.346","HUMAN HGPRT in complex with [(2-[(guanin-9-yl)methyl]propane-1,3-diyl)bis(oxy)]bis(methylene)diphosphonic acid","ASPGVVISDDEPGYDLDLFCIPNHYAEDLERVFIPHGLIMDRTERLARDVMKEMGGHHIVALCVLKGGYKFFADLLDYIKALNRNSDRSIPMTVDFIRLKSYCNDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRTPRSVGYKPDFVGFEIPDKFVVGYALDYNEYFRDLNHVCVISETGKAKYKA","Homo sapiens","HPRT1, HPRT","Hypoxanthine-guanine phosphoribosyltransferase","1","5W8V"
"5W9C",,"X-RAY DIFFRACTION",2.39,48.64,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8K, pH 6.5",298,"10.1124/mol.117.111385","OHT","5W9C",115.04,"1.802","1.802","Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S in Complex with 4-hydroxytamoxifen","MALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","5W9C"
"5W9D",,"X-RAY DIFFRACTION",2.37,48.1,"VAPOR DIFFUSION, HANGING DROP",,"PEG 8,000, Magnesium Chloride, Tris pH 8.0",298,"10.1124/mol.117.111385",,"5W9D",57.46,"1.6464","1.6464","Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S Mutant in Complex with Endoxifen","LALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLESAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKSVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKSKNVVPSYDLLLEMLDAHRLHAPTS","Homo sapiens","ESR1, ESR, NR3A1","Estrogen receptor","1","5W9D"
"5WA5",,"X-RAY DIFFRACTION",2.16,43.04,"VAPOR DIFFUSION",,"100mM Sodium Nitrate, 5% Ethylene Glycol, 18% (w/v) PEG3350",295,"10.1021/acschembio.7b00638",,"5WA5",15.76,"1.172","1.172","Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor XMD11-50","STNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5WA5"
"5WA8",,"X-RAY DIFFRACTION",2.05,39.99,"VAPOR DIFFUSION, HANGING DROP",,"100 mM MES, 38% PEG 8000",293,"10.1021/acs.molpharmaceut.7b00664","9ZA","5WA8",28.61,"1.3","1.3","Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant nucleoside L-Ala phosphoramidate substrate complex","SNAMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVNLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","5WA8"
"5WA9",,"X-RAY DIFFRACTION",2.03,39.46,"VAPOR DIFFUSION, HANGING DROP",6.7,"100 mM MES, 36% PEG 8000",293,"10.1021/acs.molpharmaceut.7b00664","9ZD","5WA9",28.61,"1.15","1.15","Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) H112N mutant nucleoside D-Ala phosphoramidate substrate complex","SNAMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVNLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","5WA9"
"5WAA",,"X-RAY DIFFRACTION",2.03,39.3,"VAPOR DIFFUSION, HANGING DROP",7,"100 mM HEPES, 35% PEG 8000",293,"10.1016/j.jmb.2018.05.028",,"5WAA",28.34,"1.098","1.098","Human Histidine Triad Nucleotide Binding Protein 1 (hHint1) C84R mutant","SNAMADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHISQISVAEDDDESLLGHLMIVGKKRAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQMHWPPG","Homo sapiens","HINT1, HINT, PKCI1, PRKCNH1","Histidine triad nucleotide-binding protein 1","1","5WAA"
"5WAL",,"X-RAY DIFFRACTION",2.05,40.12,"VAPOR DIFFUSION, HANGING DROP",6.5,"20-25%(w/v) PEG3350 and 0.2M Mg sulfate, 0.1M MES pH6.5",291,"10.1016/j.bmcl.2017.08.022","9ZS","5WAL",35.1,"2.45","2.45","Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model","MGSPASDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYRHHHHHH","Homo sapiens","TYK2","Non-receptor tyrosine-protein kinase TYK2","1","5WAL"
"5WAV",,"X-RAY DIFFRACTION",2.71,54.64,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1M Hepes pH7.5
10% v/v polyethylene glycol 8000
8% v/v ethylene glycol",295,,,"5WAV",52.77,"2.6","2.6","Fc AbVance: Increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery.","CPPCPAPELAAPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPG","Homo sapiens",,"Immunoglobulin gamma-1 heavy chain,Immunoglobulin gamma-1 heavy chain","1","5WAV"
,,,,,,,,,,,,,,,,,"Homo sapiens"
"5WAW",,"X-RAY DIFFRACTION",2.7,54.5,"VAPOR DIFFUSION, SITTING DROP",6.5,"0.1m MES pH6.5, 0.01M ZnSO4, 25% v/v PEG 550 MME",295,,,"5WAW",47.37,"2.25","2.25","FcAbVance: Increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery","DIVMTQSPLSLPVTPGEPASISCRVSQSLLHSNGYTYLHWYLQKPGQSPQLLIYKVSNRFSGVPDRFSGSGSGTDFTLKISRVEAEDVGVYYCSQTRHVPYTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"fAb Light Chain","1","5WAW"
,,,,,,,,,,,,,,,,"EVQLVESGGGLVQPGGSLRLSCAVSGFTFSDNGMAWVRQAPGKGLEWVSFISNLAYSIDYADTVTGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCVSGTWFAYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKS","Homo sapiens",,"fAb Heavy Chain","2","5WAW"
"5WB6",,"X-RAY DIFFRACTION",3.42,64.08,"VAPOR DIFFUSION, HANGING DROP",7,"100 MM SODIUM ACETATE, PH 4.6, 25%(w/v) MEPEG2000, 200 MM AMMONIUM SULFATE, then transferred to 100 MM TRIS-HCL, pH 7.0, 25%(w/v) MEPEG2000, 200 MM AMMONIUM SULFATE",277,"10.1016/j.bmcl.2017.07.048","9ZM","5WB6",29.22,"2.35","2.35","FACTOR XIA IN COMPLEX WITH THE INHIBITOR methyl [(11S)-11-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-6-fluoro-2-oxo-1,3,4,10,11,13-hexahydro-2H-5,9:15,12-di(azeno)-1,13-benzodiazacycloheptadecin-18-yl]carbamate","IVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSIIGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYDIALLKLETTVGYGDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLVTNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCAQRERPGVYTNVVEYVDWILEKTQAVHHHHHH","Homo sapiens","F11","Coagulation factor XI","1","5WB6"
"5WBG",,"X-RAY DIFFRACTION",3.77,67.4,"VAPOR DIFFUSION, SITTING DROP",7.4,"0.8M Sodium Formate
0.1 M Tris pH 7.5
8% w/v PEG 20000
8% v/v PEG 550 MME",291,"10.3390/ijms19041025",,"5WBG",336.11,"2.99","2.99","Crystal Structure of human Cytochrome P450 2B6 (Y226H/K262R) in complex with an analog of a drug Efavirenz","MAKKTSSKGKLPPGPRPLPLLGNLLQMDRRGLLKSFLRFREKYGDVFTVHLGPRPVVMLCGVEAIREALVDKAEAFSGRGKIAMVDPFFRGYGVIFANGNRWKVLRRFSVTTMRDFGMGKRSVEERIQEEAQCLIEELRKSKGALMDPTFLFQSITANIICSIVFGKRFHYQDQEFLKMLNLFYQTFSLISSVFGQLFELFSGFLKHFPGAHRQVYKNLQEINAYIGHSVEKHRETLDPSAPRDLIDTYLLHMEKEKSNAHSEFSHQNLNLNTLSLFFAGTETTSTTLRYGFLLMLKYPHVAERVYREIEQVIGPHRPPELHDRAKMPYTEAVIYEIQRFSDLLPMGVPHIVTQHTSFRGYIIPKDTEVFLILSTALHDPHYFEKPDAFNPDHFLDANGALKKTEAFIPFSLGKRICLGEGIARAELFLFFTTILQNFSMASPVAPEDIDLTPQECGVGKIPPTYQIRFLPRHHHH","Homo sapiens","CYP2B6","Cytochrome P450 2B6","1","5WBG"
"5WBM",,"X-RAY DIFFRACTION",3.69,66.69,"VAPOR DIFFUSION, SITTING DROP",4.5,"17% PEG 8k, 0.1M Na-Citrate, 0.2M Ammonium sulfate, pH 4.5",293,"10.1021/acs.jmedchem.7b00947","A4G","5WBM",69.08,"2.16","2.16","Structure of human Ketohexokinase complexed with hits from fragment screening","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","5WBM"
"5WBN",,"X-RAY DIFFRACTION",2.09,41.07,"VAPOR DIFFUSION, SITTING DROP",4.6,"2M Na-formate, 0.2M Na-acetate pH4.6, 5% ethylene glycol",291,,"9ZV","5WBN",16.26,"1.64","1.64","Crystal structure of fragment 3-(3-Benzyl-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazolin-6-yl)propanoic acid bound in the ubiquitin binding pocket of the HDAC6 zinc-finger domain","GSPLPWCPHLVAVCPIPAAGLDVTQPCGDCGTIQENWVCLSCYQVYCGRYINGHMLQHHGNSGHPLVLSYIDLSAWCYYCQAYVHHQALLDVKNIAHQNKFGEDMPH","Homo sapiens","HDAC6, KIAA0901, JM21","Histone deacetylase 6","1","5WBN"
"5WBO",,"X-RAY DIFFRACTION",3.62,66,"VAPOR DIFFUSION, SITTING DROP",4.5,"17% PEG 8k, 0.1M Na-Citrate, 0.2M Ammonium sulfate, pH 4.5",293,"10.1021/acs.jmedchem.7b00947","A1Y","5WBO",69.35,"2.25","2.25","Structure of human Ketohexokinase complexed with hits from fragment screening","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","5WBO"
"5WBP",,"X-RAY DIFFRACTION",3.59,65.72,"VAPOR DIFFUSION, SITTING DROP",4.5,"17% PEG 8k, 0.1M Na-Citrate, 0.2M Ammonium sulfate, pH 4.5",293,"10.1021/acs.jmedchem.7b00947",,"5WBP",68.94,"2.74","2.74","Structure of human Ketohexokinase complexed with hits from fragment screening","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","5WBP"
"5WBQ",,"X-RAY DIFFRACTION",3.62,65.98,"VAPOR DIFFUSION, SITTING DROP",4.5,"17% PEG 8k, 0.1M Na-Citrate, 0.2M Ammonium sulfate, pH 4.5",293,"10.1021/acs.jmedchem.7b00947","A3J","5WBQ",69.06,"2.4","2.4","Structure of human Ketohexokinase complexed with hits from fragment screening","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","5WBQ"
"5WBR",,"X-RAY DIFFRACTION",3.62,65.98,"VAPOR DIFFUSION, SITTING DROP",4.5,"17% PEG 8k, 0.1M Na-Citrate, 0.2M Ammonium sulfate, pH 4.5",293,"10.1021/acs.jmedchem.7b00947",,"5WBR",69.74,"2.58","2.58","Structure of human Ketohexokinase complexed with hits from fragment screening","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","5WBR"
"5WBS",,"X-RAY DIFFRACTION",2.97,58.65,"VAPOR DIFFUSION, SITTING DROP",,"1-propanol 14% (v/v; cat. no. 09158; Fluka), 9% PEG5000 MME (cat. no. HR-2-615; Hampton Research), and 0.1 M MES at pH 6.9 (cat. no. HR2-243; Hampton Research)",277,"10.1038/s41589-018-0035-2",,"5WBS",160.84,"2.88","2.88","Crystal structure of Frizzled-7 CRD with an inhibitor peptide Fz7-21","AGSQPYHGEKGISVPDHGFCQPISIPLCTDIAYNQTILPNLLGHTNQEDAGLEVHQFYPLVKVQCSPELRFFLCSMYAPVCTVLDQAIPPCRSLCERARQGCEALMNKFGFQWPERLRCENFPVHGAGEICVGQNTSDGGGSGGSGGSGGSGGSGGSGGSGGSLPSDDLEFWCHVMYGSGSGNSHHHHHH","Homo sapiens","FZD7","Frizzled-7,inhibitor peptide Fz7-21","1","5WBS"
,,,,,,,,,,,,,,,,,"Homo sapiens","FZD7"
"5WBT",,"SOLUTION NMR",,,,,,,"10.1074/jbc.M117.808667",,"5WBT",6.52,,,"Solution Structure and Dynamics of an Ultra-Stable Single-Chain Insulin Analog STUDIES OF AN ENGINEERED MONOMER AND IMPLICATIONS FOR RECEPTOR BINDING","FVNQHLCGSHLVEALYLVCGERGFFYTDPTEEGPRRGIVEQCCHSICSLEQLENYCN","Homo sapiens","INS","Insulin","1","5WBT"
,,,,,,,,,,,,,,,,,"Homo sapiens","INS"
"5WBV",,"X-RAY DIFFRACTION",2.59,52.49,"VAPOR DIFFUSION, SITTING DROP",8,"8-12% EtOH, 100mM Tris pH 8.0",291,,,"5WBV",64.89,"2.3","2.3","Crystal Structure of the SET Domain of Human SUV420H1 In Complex With Inhibitor","QSRYVPSSGMSAKELCENDDLATSLVLDPYLGFQTHKMNTSAFPSRSSRHFSKSDSFSHNNPVRFRPIKGRQEELKEVIERFKKDEHLEKAFKCLTSGEWARHYFLNKNKMQEKLFKEHVFIYLRMFATDSGFEILPCNRYSSEQNGAKIVATKEWKRNDKIELLVGCIAELSEIEENMLLRHGENDFSVMYSTRKNCAQLWLGPAAFINHDCRPNCKFVSTGRDTACVKALRDIEPGEEISCYYGDGFFGENNEFCECYTCERRGTGAFKSR","Homo sapiens","KMT5B, SUV420H1, CGI-85","Histone-lysine N-methyltransferase KMT5B","1","5WBV"
"5WBZ",,"X-RAY DIFFRACTION",3.63,66.09,"VAPOR DIFFUSION, SITTING DROP",4.5,"17% PEG 8k, 0.1M Na-Citrate, 0.2M Ammonium sulfate, pH 4.5",293,"10.1021/acs.jmedchem.7b00947","A4J","5WBZ",69.57,"2.4","2.4","Structure of human Ketohexokinase complexed with hits from fragment screening","MGSSHHHHHHSSGLVPRGSQILCVGLVVLDVISLVDKYPKEDSEIRCLSQRWQRGGNASNSCTVLSLLGAPCAFMGSMAPGHVADFLVADFRRRGVDVSQVAWQSKGDTPSSCCIINNSNGNRTIVLHDTSLPDVSATDFEKVDLTQFKWIHIEGRNASEQVKMLQRIDAHNTRQPPEQKIRVSVEVEKPREELFQLFGYGDVVFVSKDVAKHLGFQSAEEALRGLYGRVRKGAVLVCAWAEEGADALGPDGKLLHSDAFPPPRVVDTLGAGDTFNASVIFSLSQGRSVQEALRFGCQVAGKKCGLQGFDGIV","Homo sapiens","KHK","Ketohexokinase","1","5WBZ"
"5WC2",,"X-RAY DIFFRACTION",3.52,65,"VAPOR DIFFUSION, HANGING DROP",7.5,"HEPES, sodium chloride, isopropanol",293,"10.1038/s41467-017-02012-2",,"5WC2",48.98,"2.5","2.5","Crystal Structure of ADP-bound human TRIP13","MDEAVGDLKQALPCVAESPTVHVEVHQRGSSTAKKEDINLSVRKLLNRHNIVFGDYTWTEFDEPFLTRNVQSVSIIDTELKVKDSQPIDLSACTVALHIFQLNEDGPSSENLEEETENIIAANHWVLPAAEFHGLWDSLVYDVEVKSHLLDYVMTTLLFSDKNVNSNLITWNRVVLLHGPPGTGKTSLCKALAQKLTIRLSSRYRYGQLIEINSHSLFSKWFSESGKLVTKMFQKIQDLIDDKDALVFVLIDAVESLTAARNACRAGTEPSDAIRVVNAVLTQIDQIKRHSNVVILTTSNITEKIDVAFVDRADIKQYIGPPSAAAIFKIYLSCLEELMKCQIIYPRQQLLTLRELEMIGFIENNVSKLSLLLNDISRKSEGLSGRVLRKLPFLAHALYVQAPTVTIEGFLQALSLAVDKQFEERKKLAAYI","Homo sapiens","TRIP13, PCH2","Pachytene checkpoint protein 2 homolog","1","5WC2"
"5WC7",,"X-RAY DIFFRACTION",2.79,55.91,"VAPOR DIFFUSION, HANGING DROP",7.5,"100 MM HEPES PH 7.5, 22% PEG 3350",291,"10.1038/s41467-018-03562-9",,"5WC7",18.02,"1.43","1.43","CypA Mutant - I97V S99T C115S","MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGVLTMANAGPNTNGSQFFISTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE","Homo sapiens","PPIA, CYPA","Peptidyl-prolyl cis-trans isomerase A","1","5WC7"
"5WCA",,"X-RAY DIFFRACTION",2.38,48.36,"VAPOR DIFFUSION, HANGING DROP",6.5,"22% PEG-8000,
25% isopropanol, 0.1 M imidazole, pH 6.5",293,"10.1126/sciimmunol.aan2676",,"5WCA",46.75,"1.369","1.369","Crystal structure of the broadly neutralizing Influenza A antibody VRC 315 27-1C08 Fab.","QVQLVQSGAEVKKPGASVKVSCKASGYTFTGNYVHWVRQAPGQGLEWMGWINPKSDGTNYAQKFQGRVTMTRDTSISTVYMELSRLRSDDTAVYYCARDKGLRYFDWLSGGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"VRC315 27-1C08 Fab Heavy chain","1","5WCA"
,,,,,,,,,,,,,,,,"QSALTQPASVSGSPGQSITISCTRTAAAVTSYNYVSWYQQHPGKAPKLLIYEVSNRPSGVSNRFSGSKSGNSASLTISGLQPEDEADYYCCSSTSSTTVVFGGGTKVTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPT","Homo sapiens",,"VRC315 27-1C08 Fab Light chain","2","5WCA"
"5WCC",,"X-RAY DIFFRACTION",2.93,58.02,"VAPOR DIFFUSION, HANGING DROP",,"40% (w/v) PEG-400, 11% (w/v) PEG-8000, 0.1 M Tris, pH 8.8",293,"10.1126/sciimmunol.aan2676",,"5WCC",100.09,"2.461","2.461","Crystal structure of the broadly neutralizing Influenza A antibody VRC 315 02-1F07 Fab.","EVQLVESGGGLIQPGGSLRLSCSASEFTVSGNYMTWVRQAPGKGLEWVSIIYTGGSTYYADSVKGRFSISRDDSRNTLYLQMNSLRAEDTAVYYCARALKLQFFDWPSHAFDIWGQGTMVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSC","Homo sapiens",,"VRC 315 02-1F07 Fab Heavy chain","1","5WCC"
,,,,,,,,,,,,,,,,"QSALTQPPSASGSPGQSVTISCTGTRSDIDGYNYVSWYQQHPGKAPKLIISEVNKRPSGVPARFSGSKSGNRASLTVSGLQTEDEADYYCSSYTDTNNFYVFGTGTKVTVLGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"VRC 315 02-1F07 Fab Light chain","2","5WCC"
"5WCD",,"X-RAY DIFFRACTION",2.06,40.26,"VAPOR DIFFUSION, HANGING DROP",,"25% (w/v) PEG-1500",293,"10.1126/sciimmunol.aan2676",,"5WCD",47.72,"1.814","1.814","Crystal structure of the broadly neutralizing Influenza A antibody VRC 315 04-1D02 Fab.","EVQLVETGGGLIQPGGSVRLSCAASEFTVGSNFMHWVRQAPGKGLEWVSVIFKGGTAYYADSVRGRFVVSRDDSKNTLFLQMNSLRVDDTAVYFCARDGGLRFLDWPRWGMDVWGQGTTVIVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDK","Homo sapiens",,"VRC315 04-1D02 Fab Heavy chain","1","5WCD"
,,,,,,,,,,,,,,,,"QSALTQPPSASGSLGQSITISCTGTRSDIGAYSYVSWYQQHPGKAPKVIIYEVNKRPSGVPDRFSGSKSGSTASLTVSGLQADDESTYYCSSYAGDKNFVLFGGGTKLTVVGQPKANPTVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"VRC315 04-1D02 Fab Light chain","2","5WCD"
"5WCF",,"X-RAY DIFFRACTION",2.9,57.55,"VAPOR DIFFUSION, HANGING DROP",8.5,"15% PEG 8000, 0.2M MgCl2, 0.1M Tris-HCl pH8.5",291,,,"5WCF",43.02,"1.98","1.98","Human HMT1 hnRNP methyltransferase-like protein 6 (S. cerevisiae)","GMSQPKKRKLESGGGGEGGEGTEEEDGAEREAALERPRRTKRERDQLYYECYSDVSVHEEMIADRVRTDAYRLGILRNWAALRGKTVLDVGAGTGILSIFCAQAGARRVYAVEASAIWQQAREVVRFNGLEDRVHVLPGPVETVELPEQVDAIVSEWMGYGLLHESMLSSVLHARTKWLKEGGLLLPASAELFIVPISDQMLEWRLGFWSQVKQHYGVDMSCLEGFATRCLMGHSEIVVQGLSGEDVLARPQRFAQLELSRAGLEQELEAGVGGRFRCSCYGSAPMHGFAIWFQVTFPGGESEKPLVLSTSPFHPATHWKQALLYLNEPVQVEQDTDVSGEITLLPSRDNPRRLRVLLRYKVGDQEEKTKDFAMED","Homo sapiens","PRMT6, HRMT1L6","Protein arginine N-methyltransferase 6","1","5WCF"
"5WCG",,"X-RAY DIFFRACTION",2.62,53.08,"VAPOR DIFFUSION, HANGING DROP",6.4,"20% PEG 3350, 0.04M Citric acid, 0.06M Bis-Tris propane pH6.4",291,,,"5WCG",50.74,"2.02","2.02","SET and MYND Domain Containing protein 2","MRAEGLGGLERFCSPGKGRGLRALQPFQVGDLLFSCPAYAYVLTVNERGNHCEYCFTRKEGLSKCGRCKQAFYCNVECQKEDWPMHKLECSPMVVFGENWNPSETVRLTARILAKQKIHPERTPSEKLLAVKEFESHLDKLDNEKKDLIQSDIAALHHFYSKHLEFPDNDSLVVLFAQVNCNGFTIEDEELSHLGSAIFPDVALMNHSCCPNVIVTYKGTLAEVRAVQEIKPGEEVFTSYIDLLYPTEDRNDRLRDSYFFTCECQECTTKDKDKAKVEIRKLSDPPKAEAIRDMVRYARNVIEEFRRAKHYKSPSELLEICELSQEKMSSVFEDSNVYMLHMMYQAMGVCLYMQDWEGALQYGQKIIKPYSKHYPLYSLNVASMWLKLGRLYMGLEHKAAGEKALKKAIAIMEVAHGKDHPYISEIKQEIESH","Homo sapiens","SMYD2, KMT3C","N-lysine methyltransferase SMYD2","1","5WCG"
"5WCH",,"X-RAY DIFFRACTION",2.07,40.57,"VAPOR DIFFUSION, SITTING DROP",,"20% PEG 3350, 0.2 M Diammonium tartrate",298,"10.1073/pnas.1815027116",,"5WCH",194.49,"2.5","2.5","Crystal structure of the catalytic domain of human USP9X","GRPPKGFVGLKNAGATCYMNSVIQQLYMIPSIRNGILAIEGTGSDVDDDMSGDEKQDNESNVDPRDDVFGYPQQFEDKPALSKTEDRAAYNIGVLRHLQVIFGHLAASRLQYYVPRGFWKQFRLWGEPVNLREQHDALEFFNSLVDSLDEALKALGHPAMLSKVLGGSFADQKICQGCPHRYECEESFTTLNVDIRNHQNLLDSLEQYVKGDLLEGANAYHCEKCNKKVDTVKRLLIKKLPPVLAIQLKRFDYDWERECAIKFNDYFEFPRELDMEPYTVAGVAKLEGDNVNPESQLIQQSEQSESETAGSTKYRLVGVLVHSGQASGGHYYSYIIQRNGGDGERNRWYKFDDGDVTECKMDDDEEMKNQCFGGEYMGEVFDHMMKRMSYRRQKRWWNAYILFYERMDTIDQDDELIRYIS","Homo sapiens","USP9X, DFFRX, FAM, USP9","Probable ubiquitin carboxyl-terminal hydrolase FAF-X","1","5WCH"
"5WCI",,"X-RAY DIFFRACTION",2.38,48.26,"VAPOR DIFFUSION, SITTING DROP",5,"20% PEG 3350, 0.2 M Na malonate pH5.0",291,,,"5WCI",35.63,"1.78","1.78","Human MYST histone acetyltransferase 1","MGSSHHHHHHSSGLVPRGSTKVKYVDKIHIGNYEIDAWYFSPFPEDYGKQPKLWLCEYCLKYMKYEKSYRFHLGQCQWRQPPGKEIYRKSNISVHEVDGKDHKIYCQNLCLLAKLFLDHKTLYFDVEPFVFYILTEVDRQGAHIVGYFSKEKESPDGNNVACILTLPPYQRRGYGKFLIAFSYELSKLESTVGSPEKPLSDLGKLSYRSYWSWVLLENLRDFRGTLSIKDLSQMTSITQNDIISTLQSLNMVKYWKGQHVICVTPKLVEEHLKSAQYKKPPITVDSVCLKWAPPK","Homo sapiens","KAT8, MOF, MYST1, PP7073","Histone acetyltransferase KAT8","1","5WCI"
"5WCJ",,"X-RAY DIFFRACTION",2.19,43.74,"VAPOR DIFFUSION, SITTING DROP",7.4,"20% PEG3350, 200mM Ammonium Chloride",291,"10.1038/s41467-018-05646-y",,"5WCJ",27.92,"1.7","1.7","Crystal Structure of Human Methyltransferase-like protein 13 in complex with SAH","MHHHHHHSSGRENLYFQGCCEHHKAMIAGLALLRNPELLLEIPLALLVVGLGGGSLPLFVHDHFPKSCIDAVEIDPSMLEVATQWFGFSQSDRMKVHIADGLDYIASLAGGGEARPCYDVIMFDVDSKDPTLGMSCPPPAFVEQSFLQKVKSILTPEGVFILNLVCRDLGLKDSVLAGLKAVFPLLYVRRIEGEVNEILFCQLHPEQKLATPELLETAQALERTLRKPGRGWDDTYVLSDMLKTVKIV","Homo sapiens","METTL13, KIAA0859, CGI-01, EEF1AKNMT, FEAT","Methyltransferase-like protein 13","1","5WCJ"
"5WDE",,"X-RAY DIFFRACTION",7.3,83.1,"VAPOR DIFFUSION, SITTING DROP",7.5,"1.2M sodium citrate, 0.1M HEPES",291,"10.1038/s41598-017-14754-6",,"5WDE",36.67,"1.85","1.85","Crystal structure of the KIFC3 motor domain in complex with ADP","GSKGNIRVIARVRPVTKEDGEGPEATNAVTFDADDDSIIHLLHKGKPVSFELDKVFSPQASQQDVFQEVQALVTSCIDGFNVCIFAYGQTGAGKTYTMEGTAENPGINQRALQLLFSEVQEKASDWEYTITVSAAEIYNEVLRDLLGKEPQEKLEIRLCPDGSGQLYVPGLTEFQVQSVDDINKVFEFGHTNRTTEFTNLNEHSSRSHALLIVTVRGVDCSTGLRTTGKLNLVDLAGSERVGKSGAEGSRLREAQHINKSLSALGDVIAALRSRQGHVPFRNSKLTYLLQDSLSGDSKTLMVVQVSPVEKNTSETLYSLKFAERVRSVEL","Homo sapiens","KIFC3","Kinesin-like protein KIFC3","1","5WDE"
"5WDH",,"X-RAY DIFFRACTION",3.03,59.43,"VAPOR DIFFUSION",7.5,"3.5M sodium chloride, 0.1M bis-tris propane, 5% glycerol",291,"10.1038/s41598-017-14754-6",,"5WDH",41.03,"2.248","2.248","Motor domain of human kinesin family member C1","MGSSHHHHHHSSGLVPRGSLKGNIRVFCRVRPVLPGEPTPPPGLLLFPSGPGGPSDPPTRLSLSRSDERRGTLSGAPAPPPRHDFSFDRVFPPGSGQDEVFEEIAMLVQSALDGYPVCIFAYGQTGSGKTFTMEGGPGGDPQLEGLIPRALRHLFSVAQELSGQGWTYSFVASYVEIYNETVRDLLATGTRKGQGGECEIRRAGPGSEELTVTNARYVPVSCEKEVDALLHLARQNRAVARTAQNERSSRSHSVFQLQISGEHSSRGLQCGAPLSLVDLAGSERLDPGLALGPGERERLRETQAINSSLSTLGLVIMALSNKESHVPYRNSKLTYLLQNSLGGSAKMLMFVNISPLEENVSESLNSLRFASKVNQC","Homo sapiens","KIFC1, HSET, KNSL2","Kinesin-like protein KIFC1","1","5WDH"
"5WDI",,"X-RAY DIFFRACTION",2.25,45.25,"VAPOR DIFFUSION, HANGING DROP",7,"0.1 M HEPES, pH 7.0
22% PEG 4000
0.2 M potassium acetate
0.2 M lithium sulfate",291,"10.1021/acs.biochem.7b00638",,"5WDI",60.14,"2.43","2.43","Structure of Human Sts-2 histidine phosphatase domain","ARKSVLVVRHGERVDQIFGKAWLQQCSTPDGKYYRPDLNFPCSLPRRSRGIKDFENDPPLSSCGIFQSRIAGDALLDSGIRISSVFASPALRCVQTAKLILEELKLEKKIKIRVEPGIFEWTKWEAGKTTPTLMSLEELKEANFNIDTDYRPAFPLSALMPAESYQEYMDRCTASMVQIVNTCPQDTGVILIVSHGSTLDSCTRPLLGLPPRECGDFAQLVRKIPSLGMCFCEENKEEGKWELVNPPVKTLTHGANAAFNWRNWI","Homo sapiens","UBASH3A, STS2","Ubiquitin-associated and SH3 domain-containing protein A","1","5WDI"
"5WDJ",,"X-RAY DIFFRACTION",2.51,50.92,"VAPOR DIFFUSION",,"0.1M Hepes pH 7.5, 150mM NaCl, 20-25%(V/V)PEG3350.Crystals were cryoprotected by supplementing the mother liquor with 15% (v/v) ethylene glycol and harvested by flash-cooling in liquid nitrogen",296,"10.1039/c7md00268h","AEY","5WDJ",135.61,"2.4","2.4","CRYSTAL STRUCTURE OF MYELOPEROXIDASE SUBFORM C (MPO) COMPLEX WITH COMPOUND-6 AKA 7-(BENZYLOXY)-1H-[1,2, 3]TRIAZOLO[4,5-D]PYRIMIDIN-5-AMINE","CPEQDKYRTITGMCNNRRSPTLGASNRAFVRWLPAEYEDGFSLPYGWTPGVKRNGFPVALARAVSNEIVRFPTDQLTPDQERSLMFMQWGQLLDHDLDFTPEPAA","Homo sapiens","MPO","Myeloperoxidase","1","5WDJ"
,,,,,,,,,,,,,,,,"AVNCETSCVQQPPCFPLKIPPNDPRIKNQADCIPFFRSCPACPGSNITIRNQINALTSFVDASMVYGSEEPLARNLRNMSNQLGLLAVNQRFQDNGRALLPFDNLHDDPCLLTNRSARIPCFLAGDTRSSEMPELTSMHTLLLREHNRLATELKSLNPRWDGERLYQEARKIVGAMVQIITYRDYLPLVLGPTAMRKYLPTYRSYNDSVDPRIANVFTNAFRYGHTLIQPFMFRLDNRYQPMEPNPRVPLSRVFFASWRVVLEGGIDPILRGLMATPAKLNRQNQIAVDEIRERLFEQVMRIGLDLPALNMQRSRDHGLPGYNAWRRFCGLPQPETVGQLGTVLRNLKLARKLMEQYGTPNNIDIWMGGVSEPLKRKGRVGPLLACIIGTQFRKLRDGDRFWWENEGVFSMQQRQALAQISLPRIICDNTGITTVSKNNIFMSNSYPRDFVNCSTLPALNLASWREA","Homo sapiens","MPO","Myeloperoxidase","2","5WDJ"
"5WDM",,"X-RAY DIFFRACTION",2.03,39.33,"VAPOR DIFFUSION, SITTING DROP",8.5,"0.2 M magnesium chloride, 15% PEG 8000, and 0.1 M Tris HCl",293,"10.1074/jbc.M117.808626",,"5WDM",39.18,"2.803","2.803","An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological signaling duration equivalent to the native protein","FVNQHLCGSHLVEALYLVCGERGFFYTPETEEGPRRGIVEQCCHSICSLEQLENYCN","Homo sapiens","INS","Single-chain insulin analog","1","5WDM"
"5WDO",,"X-RAY DIFFRACTION",2.82,56.4,"VAPOR DIFFUSION, SITTING DROP",,"16% PEG3350, 100 mM calcium acetate, pH 7.5",293,"10.7554/eLife.27810",,"5WDO",19.98,"1.65","1.65","H-Ras bound to GMP-PNP at 277K","FQGHMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDLAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","5WDO"
"5WDP",,"X-RAY DIFFRACTION",2.81,56.17,"VAPOR DIFFUSION, SITTING DROP",6,"17% PEG8000, 200 mM calcium acetate, 100 mM MES/NaOH, pH 6.0",293,"10.7554/eLife.27810",,"5WDP",19.48,"1.35","1.35","H-Ras mutant L120A bound to GMP-PNP at 277K","MTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDAAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","5WDP"
"5WDQ",,"X-RAY DIFFRACTION",2.57,52.08,"VAPOR DIFFUSION, SITTING DROP",,"17% PEG8000, 200 mM calcium acetate, 100 mM MES/NaOH, pH 6.0",293,"10.7554/eLife.27810",,"5WDQ",20.14,"1.25","1.25","H-Ras mutant L120A bound to GMP-PNP at 100K","FQGHMTEYKLVVVGAGGVGKSALTIQLIQNHFVDEYDPTIEDSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHQYREQIKRVKDSDDVPMVLVGNKCDAAARTVESRQAQDLARSYGIPYIETSAKTRQGVEDAFYTLVREIRQH","Homo sapiens","HRAS, HRAS1","GTPase HRas","1","5WDQ"
"5WDY",,"X-RAY DIFFRACTION",2.08,40.74,"VAPOR DIFFUSION, HANGING DROP",,"co-crystallization of protein/compound complex, reservoir solution: 100 mM Bis-Tris, pH 6.5, 20-25% PEG3350, 150-300 mM magnesium formate",298,"10.1021/acs.jmedchem.7b00708","A6S","5WDY",65.85,"2.458","2.458","Crystal structure of WNK1 in complex with 1-cyclohexyl-N-({6-fluoro-1-[2-(3-methoxyphenyl)pyridin-4-yl]-1H-indol-3-yl}methyl)methanamine (compound 6)","GELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRADFAKSVIGTPEFMAPEMYAAAYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEET","Homo sapiens","WNK1, HSN2, KDP, KIAA0344, PRKWNK1","Serine/threonine-protein kinase WNK1","1","5WDY"
"5WDZ",,"SOLUTION NMR",,,,,,,"10.1007/s10858-017-0128-3",,"5WDZ",7.71,,,"Structure of monomeric Interleukin-8 (1-66)","SAKELRCQCIKTYSKPFHPKFIKELRVIESGPHCANTEIIVKLSDGRELCLDPKENWVQRVVEKFL","Homo sapiens","CXCL8, IL8","Interleukin-8","1","5WDZ"
"5WE8",,"X-RAY DIFFRACTION",2.14,42.4,"VAPOR DIFFUSION, HANGING DROP",,"co-crystallization of 10 mg/mL protein, 0.5 mM AMP-PNP, 1.5 mM manganese(II) chloride, 1 mM compound in
crystallization reservoir solution (100 mM HEPES, pH 7.5, 15-17% PEG3350, 100-300 mM calcium acetate)",298,"10.1021/acs.jmedchem.7b00708","A7Y","5WE8",65.88,"2.006","2.006","Crystal structure of WNK1 in complex with N-{(3R)-1-[(4-chlorophenyl)methyl]pyrrolidin-3-yl}-2-(3-methoxyphenyl)-N-methylquinoline-4-carboxamide (compound 8)","GELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRADFAKSVIGTPEFMAPEMYAAAYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEET","Homo sapiens","WNK1, HSN2, KDP, KIAA0344, PRKWNK1","Serine/threonine-protein kinase WNK1","1","5WE8"
"5WEQ",,"X-RAY DIFFRACTION",3.65,66.33,"VAPOR DIFFUSION, HANGING DROP",,"4.0 - 4.5 M NaCl, 0.1 M HEPES, pH7.5",291,"10.1016/j.str.2017.10.005",,"5WEQ",47.35,"2","2","The crystal structure of a MR78 mutant","DIQMTQSPSSLSASVGDRVTITCQASQVISNYLNWYQQKPGKAPKLLIYDTSNLKTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYENLQFTFGPGTKVDIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLRSPVTKSFNRGE","Homo sapiens",,"MR78 mutant light chain","1","5WEQ"
,,,,,,,,,,,,,,,,"QLQLQESGPGLVKPSETLSLTCTVSGGSISSSSFYWGWIRQPPGKGLEWIGSVYYSGGASYNPSLKSRATISVDTSKNQFSLNLDSVSAADTAIYYCASIYGSGTFYYYFYMDVWGKGSTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPK","Homo sapiens",,"MR78 mutant Fab heavy chain","2","5WEQ"
"5WEV",,"X-RAY DIFFRACTION",2.5,50.89,"VAPOR DIFFUSION, HANGING DROP",6,"25-30% w/v PEG 8000
0.2M Ammonium Acetate
0.1M Na Citrate pH 6.0",291,"10.1016/j.bmcl.2017.08.022","9ZS","5WEV",37.72,"1.854","1.854","Identification of an imidazopyridine scaffold to generate potent and selective TYK2 inhibitors that demonstrate activity in an in vivo psoriasis model","MGSSHHHHHHSSGLVPRGSSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5WEV"
"5WEX",,"X-RAY DIFFRACTION",2.11,41.67,"VAPOR DIFFUSION, SITTING DROP",8.3,"concentrated CA II at about 10 mg/mL was set up in SD-2 plates with the following ratio of protein plus reservoir plus seeds: 250nL plus 225 nL plus 25 nL. The plate was incubated at 8C and the reservoir condition consisted of 2.9 M ammonium sulfate with 0.1 M Tris buffer at pH 8.
3",281,"10.1021/acsmedchemlett.7b00280","8JS","5WEX",29.85,"1.26","1.26","Discovery of new selenoureido analogs of 4-(4-fluorophenylureido) benzenesulfonamides as carbonic anhydrase inhibitors","MSHHWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5WEX"
"5WF9",,"X-RAY DIFFRACTION",2.64,53.45,"VAPOR DIFFUSION, SITTING DROP",,"150mM MES monohydrate pH 6.0, 15% (w/v) PEG6000.",293.15,"10.1111/tra.12499",,"5WF9",16.87,"1.8","1.8","Tepsin tENTH domain 1-153","GPLGSMAAAPPLRDRLSFLHRLPILLKGTSDDDVPCPGYLFEEIAKISHESPGSSQCLLEYLLSRLHSSSGHGKLKVLKILLYLCSHGSSFFLLILKRNSAFIQEAAAFAGPPDPLHGNSLYQKVRAAAQDLGSTLFSDTVLPLAPSQPLGTPPATGM","Homo sapiens","TEPSIN, C17orf56, ENTHD2","AP-4 complex accessory subunit Tepsin","1","5WF9"
"5WFB",,"X-RAY DIFFRACTION",2.28,45.95,"VAPOR DIFFUSION, SITTING DROP",,"12% (w/v) PEG3350, 4% (v/v) tacsimate pH 5.0",295.15,"10.1111/tra.12499",,"5WFB",31.26,"1.382","1.382","Tepsin tENTH domain 1-136.","GPLGSMAAAPPLRDRLSFLHRLPILLKGTSDDDVPCPGYLFEEIAKISHESPGSSQCLLEYLLSRLHSSSGHGKLKVLKILLYLCSHGSSFFLLILKRNSAFIQEAAAFAGPPDPLHGNSLYQKVRAAAQDLGSTLFSDTVLPLA","Homo sapiens","TEPSIN, C17orf56, ENTHD2","AP-4 complex accessory subunit Tepsin","1","5WFB"
"5WFJ",,"X-RAY DIFFRACTION",2.4,48.67,"VAPOR DIFFUSION",,,293,"10.1016/j.bmcl.2017.09.023",,"5WFJ",33.59,"2.48","2.48","THE JAK3 KINASE DOMAIN IN COMPLEX WITH A COVALENT INHIBITOR","GPASQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS","Homo sapiens","JAK3","Tyrosine-protein kinase JAK3","1","5WFJ"
"5WFL",,"X-RAY DIFFRACTION",2.58,52.35,"VAPOR DIFFUSION, HANGING DROP",,"1.2 - 1.5 M ammonium sulfate, 0.1 M Bis-Tris pH = 6.0 - 6.5",290,"10.1021/acs.biochem.9b00943",,"5WFL",74.28,"1.93","1.93","Kelch domain of human Keap1 in open unliganded conformation","MGSSHHHHHHSSGGENLYFQGHMKPTQVMPSRAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVATATWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVTMEPSRKQIDQQNSTS","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","5WFL"
"5WG7",,"X-RAY DIFFRACTION",2.1,41.53,"VAPOR DIFFUSION, SITTING DROP",7.8,"1.6 M sodium citrate and 50 mM Tris",298,"10.1021/acs.jmedchem.7b01470","AUD","5WG7",30.25,"1.45","1.45","Human Carbonic Anhydrase II complexed with AceK","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5WG7"
"5WG8",,"X-RAY DIFFRACTION",2.43,49.4,"VAPOR DIFFUSION, SITTING DROP",8,"10 mM Tris-HCl pH 8.0, 35% 2-methyl-2,4-pentanediol, and 10% polyethylene glycol methyl ether 5000",289.15,"10.1158/1535-7163.MCT-17-1143",,"5WG8",38.5,"1.65","1.65","Structure of PP5C with LB-100; 7-oxabicyclo[2.2.1]heptane-2,3-dicarbonyl moiety modeled in the density","GASMTIEDEYSGPKLEDGKVTISFMKELMQWYKDQKKLHRKCAYQILVQVKEVLSKLSTLVETTLKETEKITVCGDTHGQFYDLLNIFELNGLPSETNPYIFNGDFVDRGSFSVEVILTLFGFKLLYPDHFHLLRGNHETDNMNQIYGFEGEVKAKYTAQMYELFSEVFEWLPLAQCINGKVLIMHGGLFSEDGVTLDDIRKIERNRQPPDSGPMCDLLWSDPQPQNGRSISKRGVSCQFGPDVTKAFLEENNLDYIIRSHEVKAEGYEVAHGGRCVTVFSAPNYCDQMGNKASYIHLQGSDLRPQFHQFTAVPHPNVKPMAYANTLLQLGMM","Homo sapiens","PPP5C, PPP5","Serine/threonine-protein phosphatase 5","1","5WG8"
"5WGP",,"X-RAY DIFFRACTION",2.08,40.97,"VAPOR DIFFUSION, SITTING DROP",,"1.6 M sodium citrate, 50 mM Tris",298,"10.1021/acs.jmedchem.7b01470","AUD","5WGP",29.4,"1.53","1.53","Human Carbonic Anhydrase IX-mimic complexed with AceK","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5WGP"
"5WH1",,"X-RAY DIFFRACTION",5.76,78.66,"VAPOR DIFFUSION, HANGING DROP",4.5,"100 mM sodium acetate trihydrate pH 4.5, 2 M ammonium sulfate",298,"10.1074/jbc.M117.811521",,"5WH1",96.51,"3.39","3.39","Apo form of the C-terminal region of human Transcription Factor IIB","SMSSSDRAMMNAFKEITTMADRINLPRNIVDRTNNLFKQVYEQKSLKGRANDAIASACLYIACRQEGVPRTFKEICAVSRISKKEIGRCFKLILKALETSVDLITTGDFMSRFCSNLCLPKQVQMAATHIARKAVELDLVPGRSPISVAAAAIYMASQASAEKRTQKEIGDIAGVADVTIRQSYRLIYPRAPDLFPTDFKFDTPVDKLPQL","Homo sapiens","GTF2B, TF2B, TFIIB","Transcription initiation factor IIB","1","5WH1"
"5WH5",,"X-RAY DIFFRACTION",2.58,52.39,"EVAPORATION",7.5,"The ~10mg/ml PDE4D2 (86-413) was stored in a buffer of 20 mM Tris.base, pH 7.5, 50 mM NaCl, 1 mM 2-mercaptoethanol, 1 mM EDTA and mixed with 2 mM (R)- or (S)-5. They were crystallized at 4C by hanging drop against a well buffer of 0.1 M HEPES pH 7.5, 15% PEG3350, 30% ethylene glycol, and 10% isopropanol.",277,"10.1021/acs.biochem.8b00336",,"5WH5",76.25,"1.8","1.8","Crystal structure of the PDE4D2 catalytic domain in complex with inhibitor (R)-Zl-n-91","TEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQ","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","5WH5"
"5WH6",,"X-RAY DIFFRACTION",,,"EVAPORATION",7.5,"The ~10mg/ml PDE4D2 (86-413) was stored in a buffer of 20 mM Tris.base, pH 7.5, 50 mM NaCl, 1 mM 2-mercaptoethanol, 1 mM EDTA and mixed with 2 mM (R)- or (S)-5. They were crystallized at 4C by hanging drop against a well buffer of 0.1 M HEPES pH 7.5, 15% PEG3350, 30% ethylene glycol, and 10% isopropanol.",277,"10.1021/acs.biochem.8b00336","AKJ","5WH6",116.55,"1.6","1.6","Crystal structure of PDE4D2 in complex with inhibitor (S_Zl-n-91)","MASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRPMSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAPDDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPLDEQVEEEAVGEEEESQPEACVIDDRSPDT","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","5WH6"
"5WHC",,"X-RAY DIFFRACTION",2.59,52.59,"VAPOR DIFFUSION, HANGING DROP",7,"PEG 1000, 0.1M Tris-HCl 7.0",289,"10.1021/acs.jmedchem.7b01293","AJJ","5WHC",80.79,"2.548","2.548","USP7 in complex with Cpd2 (4-(3-(1-methylpiperidin-4-yl)-1,2,4-oxadiazol-5-yl)phenol)","KHTGYVGLKNQGATCYMNSLLQTLFFTNQLRKAVYMMPTEGDDSSKSVPLALQRVFYELQHSDKPVGTKKLTKSFGWETLDSFMQHDVQELCRVLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVKFLTLPPVLHLQLMRFMYDPQTDQNIKINDRFEFPEQLPLDEFLQKTDPKDPANYILHAVLVHSGDNHGGHYVVYLNPKGDGKWCKFDDDVVSRCTKEEAIEHNYGGHDDDLSVRHCTNAYMLVYIRESKLSEVLQAVTDHDIPQQLVERLQEEKRIEAQK","Homo sapiens","USP7, HAUSP","Ubiquitin carboxyl-terminal hydrolase 7","1","5WHC"
"5WHD",,"X-RAY DIFFRACTION",2.1,41.5,"VAPOR DIFFUSION, HANGING DROP",,"0.2 M SODIUM FLUORIDE, 23% PEG 3350,",298,"10.1074/jbc.M117.816348",,"5WHD",78.32,"1.641","1.641","Crystal structure of KRas G12V/D38P, bound to GDP","GGGGMTEYKLVVVGAVGVGKSALTIQLIQNHFVDEYDPTIEPSYRKQVVIDGETCLLDILDTAGQEEYSAMRDQYMRTGEGFLCVFAINNTKSFEDIHHYREQIKRVKDSEDVPMVLVGNKCDLPSRTVDTKQAQDLARSYGIPFIETSAKTRQGVDDAFYTLVREIRKH","Homo sapiens","KRAS, KRAS2, RASK2","GTPase KRas","1","5WHD"
"5WHF",,"X-RAY DIFFRACTION",2.27,45.71,"VAPOR DIFFUSION, HANGING DROP",6.5,"0.1 M Bis-Tris pH 6.5, 0.2 M magnesium acetate tetrahydrate and 10% PEG 8000",294,"10.1111/febs.14585",,"5WHF",86.66,"2.25","2.25","Crystal structure of vimentin coil 1B packed in a high-order filamentous form","GPHMEMRELRRQVDQLTNDKARVEVERDNLAEDIMRLREKLQEEMLQREEAENTLQSFRQDVDNASLARLDLERKVESLQEEIAFLKKLH","Homo sapiens","VIM","Vimentin","1","5WHF"
"5WHI",,"X-RAY DIFFRACTION",1.93,36.21,"VAPOR DIFFUSION, SITTING DROP",,"PEG2000",298,"10.1016/j.str.2017.11.016",,"5WHI",18.73,"1.69","1.69","Crystal Structure of Bcl-2-related protein A1","MGHHHHHHSHMTDSEFGYIYRLAQDYLQSVLQIPQPGSGPSKTSRVLQNVAFSVQKEVEKNLKSCLDNVNVVSVDTARTLFNQVMEKEFEDGIINWGRIVTIFAFEGILIKKLLRQQIAPDVDTYKEISYFVAEFIMNNTGEWIRQNGGWENGFVKKFEPK","Homo sapiens","BCL2A1, BCL2L5, BFL1, GRS, HBPA1","Bcl-2-related protein A1","1","5WHI"
"5WHL",,"X-RAY DIFFRACTION",2.55,51.79,"VAPOR DIFFUSION, HANGING DROP",,"1.2 - 1.5 M Ammonium sulfate, 0.1 M Bis-Tris pH = 6.0 - 6.5",290,"10.1021/acs.biochem.9b00943",,"5WHL",74.25,"2.5","2.5","Kelch domain of human Keap1 bound to inhibitory small molecule fragment: hydroxyphenyl propionic acid","MGSSHHHHHHSSGGENLYFQGHMKPTQVMPSRAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVATATWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVTMEPSRKQIDQQNSTS","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","5WHL"
"5WHN",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4.2,"100mM phosphate/citrate 4.2, 40% ethanol, 5% PEG 1000",298,"10.1038/s41594-018-0064-2",,"5WHN",0.64,"1.1","1.1","Crystal structure of the segment, NFGAFS, from the low complexity domain of TDP-43, residues 312-317","NFGAFS","Homo sapiens","TARDBP, TDP43","Segment of TAR DNA-binding protein 43","1","5WHN"
"5WHO",,"X-RAY DIFFRACTION",2.83,56.59,"VAPOR DIFFUSION, HANGING DROP",,"1.2 - 1.5 M Ammonium sulfate, 0.1 M Bis-Tris pH = 6.0 - 6.5",290,"10.1021/acs.biochem.9b00943",,"5WHO",74.37,"2.23","2.23","Kelch domain of human Keap1 bound to small molecule inhibitor fragment: 4-oxo-4H-1-benzopyran-2-carboxylic acid","MGSSHHHHHHSSGGENLYFQGHMKPTQVMPSRAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVATATWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVTMEPSRKQIDQQNSTS","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","5WHO"
"5WHP",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",4.6,"100mM sodium acetate 4.6, 200mM ammonium acetate, 30% PEG 4000",298,"10.1038/s41594-018-0064-2",,"5WHP",0.67,"1","1","Crystal structure of the segment, NFGTFS, from the A315T familial variant of the low complexity domain of TDP-43, residues 312-317","NFGTFS","Homo sapiens","TARDBP, TDP43","Segment of TAR DNA-binding protein 43","1","5WHP"
"5WHR",,"X-RAY DIFFRACTION",2.98,58.68,"VAPOR DIFFUSION, SITTING DROP",,"Hampton Research Peg/Ion screen condition #4 (20% PEG3350, 0.2M Lithium Chloride)",286,"10.1021/acs.jmedchem.7b00974","AOJ","5WHR",90.03,"2.28","2.28","Discovery of a novel and selective IDO-1 inhibitor PF-06840003 and its characterization as a potential clinical candidate.","GSKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEG","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","5WHR"
"5WHZ",,"X-RAY DIFFRACTION",4.12,70.13,"VAPOR DIFFUSION, SITTING DROP",6.1,"1.68M ammonium sulfate
0.1M sodium cacodylate",277,"10.1126/science.aan8630",,"5WHZ",80.4,"3.549","3.549","PGDM1400-10E8v4 CODV Fab","DFVLTQSPHSLSVTPGESASISCKSSHSLIHGDRNNYLAWYVQKPGRSPQLLIYLASSRASGVPDRFSGSGSDKDFTLKISRVETEDVGTYYCMQGRESPWTFGQGTKVDIKDKTHTASELTQDPAVSVALKQTVTITCRGDSLRSHYASWYQKKPGQAPVLLFYGKNNRPSGIPDRFSGSASGNRASLTITGAQAEDEADYYCSSRDKSGSRLSVFGGGTKLTVLDKTHTRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"Anti-HIV CODV-Fab Light chain","1","5WHZ"
,,,,,,,,,,,,,,,,"EVRLVESGGGLVKPGGSLRLSCSASGFDFDNAWMTWVRQPPGKGLEWVGRITGPGEGWSVDYAESVKGRFTISRDNTKNTLYLEMNNVRTEDTGYYFCARTGKYYDFWSGYPPGEEYFQDWGQGTLVIVSSDKTHTQVHLTQSGPEVRKPGTSVKVSCKAPGNTLKTYDLHWVRSVPGQGLQWMGWISHEGDKKVIVERFKAKVTIDWDRSTNTAYLQLSGLTSGDTAVYYCAKGSKHRLRDYALYDDDGALNWAVDVDYLSNLEFWGQGTAVTVSSDKTHTASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTHHHHHH","Homo sapiens",,"Anti-HIV CODV-Fab Heavy chain","2","5WHZ"
"5WI0",,"X-RAY DIFFRACTION",2.4,48.7,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 10K, sodium chloride, glycerol, Tris",277,"10.1016/j.bmcl.2017.12.023","AQ1","5WI0",111.68,"2.05","2.05","Crystal structure of human NAMPT with fragment 2: 2-[(2-fluorophenyl)amino]-6-propylpyrimidin-4(3H)-one","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","5WI0"
"5WI1",,"X-RAY DIFFRACTION",2.39,48.63,"VAPOR DIFFUSION, HANGING DROP",8.5,"PEG 10K, sodium chloride, glycerol, Tris",277,"10.1016/j.bmcl.2017.12.023","AOY","5WI1",111.79,"1.99","1.99","Crystal structure of human NAMPT with fragment 5: (3E)-3-[(phenylamino)methylidene]oxan-2-one","MNPAAEAEFNILLATDSYKVTHYKQYPPNTSKVYSYFECREKKTENSKLRKVKYEETVFYGLQYILNKYLKGKVVTKEKIQEAKDVYKEHFQDDVFNEKGWNYILEKYDGHLPIEIKAVPEGFVIPRGNVLFTVENTDPECYWLTNWIETILVQSWYPITVATNSREQKKILAKYLLETSGNLDGLEYKLHDFGYRGVSSQETAGIGASAHLVNFKGTDTVAGLALIKKYYGTKDPVPGYSVPAAEHSTITAWGKDHEKDAFEHIVTQFSSVPVSVVSDSYDIYNACEKIWGEDLRHLIVSRSTQAPLIIRPDSGNPLDTVLKVLEILGKKFPVTENSKGYKLLPPYLRVIQGDGVDINTLQEIVEGMKQKMWSIENIAFGSGGGLLQKLTRDLLNCSFKCSYVVTNGLGINVFKDPVADPNKRSKKGRLSLHRTPAGNFVTLEEGKGDLEEYGQDLLHTVFKNGKVTKSYSFDEIRKNAQLNIELEAAHH","Homo sapiens","NAMPT, PBEF, PBEF1","Nicotinamide phosphoribosyltransferase","1","5WI1"
"5WI2",,"X-RAY DIFFRACTION",2.27,45.8,"VAPOR DIFFUSION, HANGING DROP",4.8,"Sodium Acetate Trihydrate, Ammonium Sulfate",293,"10.1074/jbc.M117.811265",,"5WI2",24.34,"2.495","2.495","Crystal structure of the KA1 domain from human Chk1","GSMTRFFTKLDADKSYQCLKETCEKLGYQWKKSCMNQVTISTTDRRNNKLIFKVNLLEMDDKILVDFRLSKGDGLEFKRHFLKIKGKLIDIVSSQKVWLPAT","Homo sapiens","CHEK1, CHK1","cDNA FLJ56409, highly similar to Serine/threonine-protein kinase Chk1 (EC 2.7.11.1)","1","5WI2"
"5WI6",,"X-RAY DIFFRACTION",2.93,58.07,"VAPOR DIFFUSION, SITTING DROP",4.6,"ammonium sulfate,  polyethylene glycol 1500",292,"10.1074/jbc.M117.812016",,"5WI6",112.12,"2.72","2.72","Human beta-1 tryptase mutant Ile99Cys","IVGGQEAPRSKWPWQVSLRVHGPYWMHFCGGSLIHPQWVLTAAHCVGPDVKDLAALRVQLREQHLYYQDQLLPVSRIIVHPQFYTAQCGADIALLELEEPVNVSSHVHTVTLPPASETFPPGMPCWVTGWGDVDNDERLPPPFPLKQVKVPIMENHICDAKYHLGAYTGDDVRIVRDDMLCAGNTRRDSCQGDSGGPLVCKVNGTWLQAGVVSWGEGCAQPNRPGIYTRVTYYLDWIHHYVPKKP","Homo sapiens","TPSAB1, TPS1, TPS2, TPSB1","Tryptase alpha/beta-1","1","5WI6"
"5WIA",,"X-RAY DIFFRACTION",,,"VAPOR DIFFUSION, HANGING DROP",8.5,"100mM bis tris propane 8.5, 200mM sodium nitrate, 20% PEG 3350",298,"10.1038/s41594-018-0064-2",,"5WIA",0.64,"1.002","1.002","Crystal structure of the segment, GNNSYS, from the low complexity domain of TDP-43, residues 370-375","GNNSYS","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","5WIA"
"5WIJ",,"X-RAY DIFFRACTION",2.5,50.83,"VAPOR DIFFUSION, HANGING DROP",8,"200 mM Sodium Acetate, 100 mM Tris-HCl, 18%-30%(w/v) polyethylene glycol 4000.",277,"10.1021/acschembio.8b00722",,"5WIJ",32.1,"2.04","2.04","JAK2 Pseudokinase in complex with NU6140","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5WIJ"
"5WIK",,"X-RAY DIFFRACTION",2.46,50.02,"VAPOR DIFFUSION, HANGING DROP",8,"200 mM Sodium Acetate, 100 mM Tris-HCl, 18%-30%(w/v) polyethylene glycol 4000",277,"10.1021/acschembio.8b00722",,"5WIK",32.07,"2.6","2.6","JAK2 Pseudokinase in complex with BI-D1870","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5WIK"
"5WIL",,"X-RAY DIFFRACTION",2.5,50.71,"VAPOR DIFFUSION, HANGING DROP",8,"200 mM Sodium Acetate, 100 mM Tris-HCl, 18%-30%(w/v) polyethylene glycol 4000.",277,"10.1021/acschembio.8b00722",,"5WIL",32.04,"2.2","2.2","JAK2 Pseudokinase in complex with AZD7762","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5WIL"
"5WIM",,"X-RAY DIFFRACTION",2.46,50.02,"VAPOR DIFFUSION, HANGING DROP",8,"200 mM Sodium Acetate, 100 mM Tris-HCl, 18%-30%(w/v) polyethylene glycol 4000.",277,"10.1021/acschembio.8b00722","35R","5WIM",32.06,"2.55","2.55","JAK2 Pseudokinase in complex with AT9283","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5WIM"
"5WIN",,"X-RAY DIFFRACTION",2.49,50.69,"VAPOR DIFFUSION, HANGING DROP",8,"200 mM Sodium Acetate, 100 mM Tris-HCl, 18%-30%(w/v) polyethylene glycol 4000.",277,"10.1021/acschembio.8b00722","SKE","5WIN",32.08,"2.38","2.38","JAK2 Pseudokinase in complex with JNJ7706621","VFHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD","Homo sapiens","JAK2","Tyrosine-protein kinase JAK2","1","5WIN"
"5WIQ",,"X-RAY DIFFRACTION",1.36,9.58,"VAPOR DIFFUSION, HANGING DROP",4.5,"100mM sodium acetate pH 4.5, 800mM sodium phosphate monobasic, 1200mM potassium phosphate dibasic",298,"10.1038/s41594-018-0064-2",,"5WIQ",1.31,"1.25","1.25","Crystal structure of the segment, GFNGGFG, from the low complexity domain of TDP-43, residues 396-402","GFNGGFG","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","5WIQ"
"5WIY",,"X-RAY DIFFRACTION",2.64,53.4,"VAPOR DIFFUSION, HANGING DROP",,"1.2 - 1.5 M Ammonium sulfate, 0.1 M Bis-Tris pH = 6.0 - 6.5",290,"10.1021/acs.biochem.9b00943",,"5WIY",74.25,"2.23","2.23","Kelch domain of human Keap1 bound to small molecule inhibitor fragment: 4-amino-1,7-dihydro-6H-pyrazolo[3,4-d]pyrimidine-6-thione","MGSSHHHHHHSSGGENLYFQGHMKPTQVMPSRAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVATATWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVTMEPSRKQIDQQNSTS","Homo sapiens","KEAP1, INRF2, KIAA0132, KLHL19","Kelch-like ECH-associated protein 1","1","5WIY"
"5WJ5","3.72","ELECTRON MICROSCOPY",,,,,,,"10.1038/nature24036",,"5WJ5",260.34,"3.7, 3.72",,"Human TRPML1 channel structure in closed conformation","MTAPAGPRGSETERLLTPNPGYGTQAGPSPAPPTPPEEEDLRRRLKYFFMSPCDKFRAKGRKPCKLMLQVVKILVVTVQLILFGLSNQLAVTFREENTIAFRHLFLLGYSDGADDTFAAYTREQLYQAIFHAVDQYLALPDVSLGRYAYVRGGGDPWTNGSGLALCQRYYHRGHVDPANDTFDIDPMVVTDCIQVDPPERPPPPPSDDLTLLESSSSYKNLTLKFHKLVNVTIHFRLKTINLQSLINNEIPDCYTFSVLITFDNKAHSGRIPISLETQAHIQECKHPSVFQHGDNSFRLLFDVVVILTCSLSFLLCARSLLRGFLLQNEFVGFMWRQRGRVISLWERLEFVNGWYILLVTSDVLTISGTIMKIGIEAKNLASYDVCSILLGTSTLLVWVGVIRYLTFFHNYNILIATLRVALPSVMRFCCCVAVIYLGYCFCGWIVLGPYHVKFRSLSMVSECLFSLINGDDMFVTFAAMQAQQGRSSLVWLFSQLYLYSFISLFIYMVLSLFIALITGAYDTIKHPGGAGAEESELQAYIAQCQDSPTSGKFRRGSGSACSLLCCCGRDPSEEHSLLVN","Homo sapiens","MCOLN1, ML4, MSTP080, TRPML1","Mucolipin-1","1","5WJ5"
"5WJ6",,"X-RAY DIFFRACTION",2.49,50.63,"VAPOR DIFFUSION, HANGING DROP",8.5,"10-15% PEG6000, 1.0 M lithium chloride, 0.1 M Tris-HCl, pH 8.5",293,"10.1074/jbc.M117.810101","B4A","5WJ6",238.77,"2.445","2.445","Crystal structure of glutaminase C in complex with inhibitor 2-phenyl-N-{5-[4-({5-[(phenylacetyl)amino]-1,3,4-thiadiazol-2-yl}amino)piperidin-1-yl]-1,3,4-thiadiazol-2-yl}acetamide (UPGL-00004)","MRGSHHHHHHGSLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTADGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","1","5WJ6"
,,,,,,,,,,,,,,,,"MRGSHHHHHHGSLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEGKELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMDMLRLTLQTTSDGVMLDKDLFKKCVNSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKKQSGGKVADYIPQLAKFSPDLWGVSVCTADGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDLGTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQFLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSIEVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKLDPRREGGDQRHSFGPLDYESLQQELALKETVWKKVSPESNEDISTTVVYRMESLGEKS","Homo sapiens","GLS, GLS1, KIAA0838","Glutaminase kidney isoform, mitochondrial","2","5WJ6"
"5WJ8",,"X-RAY DIFFRACTION",3.48,64.67,"VAPOR DIFFUSION, SITTING DROP",4.5,"0.1 M NaOAc pH 4.5
0.2 M CaCl2
30 (v/v) isopropanol
20% (v/v) glycerol",277,"10.1016/j.str.2018.06.003",,"5WJ8",24.98,"1.86","1.86","Crystal Structure of Human Cadherin-23 EC13-14","MDEAVQFSNASYEAAILENLALGTEIVRVQAYSIDNLNQITYRFNAYTSTQAKALFKIDAITGVITVQGLVDREKGDFYTLTVVADDGGPKVDSTVKVYITVLDENDNSPRFDFTSDSAVSIPEDCPVGQRVATVKAWDPDAGSNGQVVFSLASGNIAGAFEIVTTNDSIGEVFVARPLDREELDHYILQVVASDRGTPPRKKDHILQVTILDINDNLEHHHHHH","Homo sapiens","CDH23, KIAA1774, KIAA1812, UNQ1894/PRO4340","Cadherin-23","1","5WJ8"
"5WJ9","3.49","ELECTRON MICROSCOPY",,,,,,,"10.1038/nature24036",,"5WJ9",261.79,"3.49, 3.49",,"Human TRPML1 channel structure in agonist-bound open conformation","MTAPAGPRGSETERLLTPNPGYGTQAGPSPAPPTPPEEEDLRRRLKYFFMSPCDKFRAKGRKPCKLMLQVVKILVVTVQLILFGLSNQLAVTFREENTIAFRHLFLLGYSDGADDTFAAYTREQLYQAIFHAVDQYLALPDVSLGRYAYVRGGGDPWTNGSGLALCQRYYHRGHVDPANDTFDIDPMVVTDCIQVDPPERPPPPPSDDLTLLESSSSYKNLTLKFHKLVNVTIHFRLKTINLQSLINNEIPDCYTFSVLITFDNKAHSGRIPISLETQAHIQECKHPSVFQHGDNSFRLLFDVVVILTCSLSFLLCARSLLRGFLLQNEFVGFMWRQRGRVISLWERLEFVNGWYILLVTSDVLTISGTIMKIGIEAKNLASYDVCSILLGTSTLLVWVGVIRYLTFFHNYNILIATLRVALPSVMRFCCCVAVIYLGYCFCGWIVLGPYHVKFRSLSMVSECLFSLINGDDMFVTFAAMQAQQGRSSLVWLFSQLYLYSFISLFIYMVLSLFIALITGAYDTIKHPGGAGAEESELQAYIAQCQDSPTSGKFRRGSGSACSLLCCCGRDPSEEHSLLVN","Homo sapiens","MCOLN1, ML4, MSTP080, TRPML1","Mucolipin-1","1","5WJ9"
"5WJI",,"X-RAY DIFFRACTION",2.13,42.12,"VAPOR DIFFUSION",9.5,"PEG 8000, CHES",293,"10.1038/s41598-019-39491-w",,"5WJI",42.77,"2.3","2.3","Crystal structure of the F61S mutant of HsNUDT16","MAGARRLELGEALALGSGWRHVCHALLYAPDPGMLFGRIPLRYAILMQMRFDGRLGFPGGSVDTQDRSLEDGLNRELREELGEAAAAFRVERTDYRSSHVGSGPRVVAHFYAKRLTLEELLAVEAGATRAKDHGLEVLGLVRVPLYTLRDGVGGLPTFLENSFIGSAREQLLEALQDLGLLQSGSISGLKIPAHH","Homo sapiens","NUDT16","U8 snoRNA-decapping enzyme","1","5WJI"
"5WJJ",,"X-RAY DIFFRACTION",2.16,43.13,"VAPOR DIFFUSION, SITTING DROP",7.4,"18.% PEG 3350, 0.06M MES, 0.04M MES_Na",293,"10.1016/j.bmc.2017.12.031","AQY","5WJJ",42.17,"1.6","1.6","Structure-based Design, Synthesis, and Biological Evaluation of Imidazo[1,2-b]pyridazine-based p38 MAP Kinase Inhibitors","GAMGSMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES","Homo sapiens","MAPK14, CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A","Mitogen-activated protein kinase 14","1","5WJJ"
"5WJO",,"X-RAY DIFFRACTION",2.21,44.29,"VAPOR DIFFUSION, HANGING DROP",,"22% PEG 3350, 0.2M Magnesium Formate",293,"10.1126/sciimmunol.aao1384",,"5WJO",101.9,"2.5","2.5","Crystal structure of the unliganded PG90 TCR","DAKTTQPPSMDCAEGRAANLPCNHSTISGNEYVYWYRQIHSQGPQYIIHGLKNNETNEMASLIITEDRKSSTLILPHATLRDTAVYYCIVRVAYRQKVTFGTGTKLQVIPNIQNPDPAVYQLRDSKSSDKSVCLFTDFDSQTNVSQSKDSDVYITDKCVLDMRSMDFKSNSAVAWSNKSDFACANAFNNSIIPEDTFFPSPESS","Homo sapiens",,"PG90 TCR alpha chain","1","5WJO"
,,,,,,,,,,,,,,,,"GAGVSQSPRYKVAKRGQDVALRCDPISGHVSLFWYQQALGQGPEFLTYFQNEAQLDKSGLPSDRFFAERPEGSVSTLKIQRTQQEDSAVYLCASSLARAQGASNTGELFFGEGSRLTVLEDLKNVFPPEVAVFEPSEAEISHTQKATLVCLATGFYPDHVELSWWVNGKEVHSGVCTDPQPLKEQPALNDSRYALSSRLRVSATFWQNPRNHFRCQVQFYGLSENDEWTQDRAKPVTQIVSAEAWGRAD","Homo sapiens",,"PG90 TCR beta chain","2","5WJO"
"5WK2",,"X-RAY DIFFRACTION",2.54,52,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M HEPES PH 7.5, 18% PEG 3350",293,"10.1016/j.bbrep.2017.11.005",,"5WK2",49.53,"1.5","1.5","CRYSTAL STRUCTURE OF ANTI-CCL17 ANTIBODY M116","DIVMTQSPDSLAVSLGERATINCKSSQSVLLSPWNSNQLAWYQQKPGQPPKLLIYGASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYLIPSTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC","Homo sapiens",,"M116 LIGHT CHAIN","1","5WK2"
,,,,,,,,,,,,,,,,"EVQLVQSGAEVKKPGESLKISCKGSGYSFTSYWIGWVRQMPGKGLEWMGIIDPSDSDTRYSPSFQGQVTISADKSISTAYLQWSSLKASDTAMYYCARVGPADVWDSFDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCHHHHHH","Homo sapiens",,"M116 HEAVY CHAIN","2","5WK2"
"5WKB","1","ELECTRON CRYSTALLOGRAPHY",,,"Batch",7.5,"1x PBS, pH 7.5",298,"10.1038/s41594-018-0064-2",,"5WKB",0.7,"1, 1","1","MicroED structure of the segment, NFGEFS, from the A315E familial variant of the low complexity domain of TDP-43, residues 312-317","NFGEFS","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","5WKB"
"5WKD",,"X-RAY DIFFRACTION",1.26,2.45,"VAPOR DIFFUSION, HANGING DROP",7.5,"100mM Bis-Tris propane, pH 7.5, 200 mM sodium sulfate, 20% PEG3350",298,"10.1038/s41594-018-0064-2",,"5WKD",0.69,"1.8","1.8","Crystal structure of the segment, GNNQGSN, from the low complexity domain of TDP-43, residues 300-306","GNNQGSN","Homo sapiens","TARDBP, TDP43","TAR DNA-binding protein 43","1","5WKD"
"5WL2",,"X-RAY DIFFRACTION",2.87,57.09,"VAPOR DIFFUSION, SITTING DROP",,"0.095 M sodium citrate pH 5.6
19% 2-propanol
5% (v/v) glycerol
19% (w/v) PEG4000",277.15,,,"5WL2",94.62,"2","2","VH1-69 germline antibody with CDR H3 sequence of CR9114","QVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFGTANYAQKFQGRVTITADESTSTAYMELSSLRSEDTAVYYCARHGNYYYYSGMDVWGQGTTVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKRVEPKSCHHHHHH","Homo sapiens",,"Heavy chain of VH1-69 germline antibody with CDR H3 sequence of CR9114","1","5WL2"
,,,,,,,,,,,,,,,,"QSVLTQPPSVSEAPRQRVTISCSGSSSNIGNNAVNWYQQLPGKAPKLLIYYDDLLPSGVSDRFSGSKSGTSASLAISGLQSEDEADYYCAAWDDSLNGAVFGGGTQLTVLGQPKAAPSVTLFPPSSEELQANKATLVCLISDFYPGAVTVAWKADSSPVKAGVETTTPSKQSNNKYAASSYLSLTPEQWKSHRSYSCQVTHEGSTVEKTVAPTECS","Homo sapiens",,"Germline-reverted light chain of CR9114","2","5WL2"
"5WLR",,"X-RAY DIFFRACTION",2.16,43,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M sodium citrate
50mM Tris-HCl",298,,,"5WLR",29.58,"1.49","1.49","Carbonic Anhydrase IX-mimic in complex with aryloxy-2-hydroxypropylammine sulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic Anhydrase IX-mimic","1","5WLR"
"5WLT",,"X-RAY DIFFRACTION",2.16,42.96,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M Sodium Citrate
50mM Tris-HCl",298,"10.1021/acs.jmedchem.8b00625","86B","5WLT",30.24,"1.57","1.57","Carbonic Anhydrase IX-mimic in complex with aryloxy-2-hydroxypropylammine sulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5WLT"
"5WLU",,"X-RAY DIFFRACTION",2.13,42.13,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M Sodium Citrate
50mM Tris-HCl",298,,,"5WLU",29.35,"1.39","1.39","Carbonic Anhydrase IX-mimic in complex with aryloxy-2-hydroxypropylammine sulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHSFQVTFDDSQDKAVLKGGPLDGTYRLLQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDVGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTEGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLAECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic Anhydrase IX-mimic","1","5WLU"
"5WLV",,"X-RAY DIFFRACTION",2.15,42.83,"VAPOR DIFFUSION, HANGING DROP",7.8,"1.6M Sodium Citrate
50mM Tris-HCl",298,"10.1021/acs.jmedchem.8b00625","42G","5WLV",30.04,"1.4","1.4","Carbonic Anhydrase II in complex with aryloxy-2-hydroxypropylammine sulfonamide","HWGYGKHNGPEHWHKDFPIAKGERQSPVDIDTHTAKYDPSLKPLSVSYDQATSLRILNNGHAFNVEFDDSQDKAVLKGGPLDGTYRLIQFHFHWGSLDGQGSEHTVDKKKYAAELHLVHWNTKYGDFGKAVQQPDGLAVLGIFLKVGSAKPGLQKVVDVLDSIKTKGKSADFTNFDPRGLLPESLDYWTYPGSLTTPPLLECVTWIVLKEPISVSSEQVLKFRKLNFNGEGEPEELMVDNWRPAQPLKNRQIKASFK","Homo sapiens","CA2","Carbonic anhydrase 2","1","5WLV"
"5WMA",,"X-RAY DIFFRACTION",2.15,42.7,"VAPOR DIFFUSION, SITTING DROP",,"0.1 M Bis-Tris propane, pH 7.5-8.0, 11% PEG3350, 0.2 M sodium chloride, 20% ethylene glycol",277,"10.1158/2159-8290.CD-17-0902",,"5WMA",15.37,"1.401","1.401","N-terminal bromodomain of BRD4 in complex with PLX5981","SMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5WMA"
"5WMD",,"X-RAY DIFFRACTION",2.13,42.2,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Bis-Tris, pH 7.5, 19% PEG3350, 0.2 M lithium sulfate",277,"10.1158/2159-8290.CD-17-0902","6JE","5WMD",15.52,"1.27","1.27","N-terminal bromodomain of BRD4 in complex with OTX-015","GMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPAYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5WMD"
"5WMG",,"X-RAY DIFFRACTION",2.52,51.21,"VAPOR DIFFUSION, SITTING DROP",7.5,"0.1 M Bis-Tris, pH 7.5, 19% PEG3350, 0.2 M lithium sulfate",277,"10.1158/2159-8290.CD-17-0902","6JF","5WMG",15.65,"1.19","1.19","N-terminal bromodomain of BRD4 in complex with OTX-015","GMNPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPAYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINELPTEE","Homo sapiens","BRD4, HUNK1","Bromodomain-containing protein 4","1","5WMG"
"5WMJ",,"X-RAY DIFFRACTION",1.55,20.54,"VAPOR DIFFUSION, HANGING DROP",7,"Reservoir solution contained 4M Sodium Formate",298,"10.1002/pro.3391",,"5WMJ",1.49,"1.4","1.4","KVWGSI segment from Superoxide Dismutase 1,residues 30-35","KVWGSI","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","5WMJ"
"5WMU",,"X-RAY DIFFRACTION",3.02,59.29,"MICROBATCH",10,"100 mM Sodium thiosulfate, 100 mM pH 10.0 CAPS buffer, 20% (w/v) PEG 8000)",277.15,"10.1038/s41467-017-01725-8","TRP","5WMU",97.28,"2.4","2.4","Structural Insights into Substrate and Inhibitor Binding Sites in Human Indoleamine 2,3-Dioxygenase I","MSKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEGKGELNSKLEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","5WMU"
"5WMV",,"X-RAY DIFFRACTION",3.05,59.64,"MICROBATCH",10,"100 mM Sodium thiosulfate, 100 mM pH 10.0 CAPS buffer, and 20% (w/v) PEG 8000",277,"10.1038/s41467-017-01725-8",,"5WMV",97.6,"2.6","2.6","Structural Insights into Substrate and Inhibitor Binding Sites in Human Indoleamine 2,3-Dioxygenase 1","MSKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEGKGELNSKLEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","5WMV"
"5WMW",,"X-RAY DIFFRACTION",3.04,59.55,"MICROBATCH",10,"100 mM Sodium thiosulfate, 100 mM pH 10.0 CAPS buffer, and 20% (w/v) PEG 8000",277,"10.1038/s41467-017-01725-8",,"5WMW",97.51,"3.03","3.03","Structural Insights into Substrate and Inhibitor Binding Sites in Human Indoleamine 2,3-Dioxygenase 1","MSKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVGQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEGKGELNSKLEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","5WMW"
"5WMX",,"X-RAY DIFFRACTION",3.05,59.68,"MICROBATCH",10,"100 mM Sodium thiosulfate, 100 mM pH 10.0 CAPS buffer, and 20% (w/v) PEG 8000",277,"10.1038/s41467-017-01725-8",,"5WMX",97.42,"2.69","2.69","Structural Insights into Substrate and Inhibitor Binding Sites in Human Indoleamine 2,3-Dioxygenase 1","MSKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVGQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEGKGELNSKLEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","5WMX"
"5WN8",,"X-RAY DIFFRACTION",3.01,59.1,"MICROBATCH",9.5,"100 mM Sodium thiosulfate, 100 mM CAPS buffer pH 9.5, and 20% (w/v) PEG 8000",277,"10.1038/s41467-017-01725-8","BBJ","5WN8",97.69,"2.5","2.5","Structural Insights into Substrate and Inhibitor Binding Sites in Human Indoleamine 2,3-Dioxygenase 1","MSKEYHIDEEVGFALPNPQENLPDFYNDWMFIAKHLPDLIESGQLRERVEKLNMLSIDHLTDHKSQRLARLVLGCITMAYVWGKGHGDVRKVLPRNIAVPYCQLSKKLELPPILVYADCVLANWKKKDPNKPLTYENMDVLFSFRDGDCSKGFFLVSLLVEIAAASAIKVIPTVFKAMQMQERDTLLKALLEIASCLEKALQVFHQIHDHVNPKAFFSVLRIYLSGWKGNPQLSDGLVYEGFWEDPKEFAGGSAGQSSVFQCFDVLLGIQQTAGGGHAAQFLQDMRRYMPPAHRNFLCSLESNPSVREFVLSKGDAGLREAYDACVKALVSLRSYHLQIVTKYILIPASQQPKENKTSEDPSKLEAKGTGGTDLMNFLKTVRSTTEKSLLKEGKGELNSKLEGKPIPNPLLGLDSTRTGHHHHHH","Homo sapiens","IDO1, IDO, INDO","Indoleamine 2,3-dioxygenase 1","1","5WN8"
"5WNE",,"X-RAY DIFFRACTION",2.66,53.69,"VAPOR DIFFUSION, HANGING DROP",6,"8.5% PEG3350, 0.1M MES, 50 MM CACL2, PH 6.0",298,,,"5WNE",194.01,"2.6","2.6","X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR","GSLHMSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNR","Homo sapiens","ROCK1","Rho-associated protein kinase 1","1","5WNE"
"5WNF",,"X-RAY DIFFRACTION",2.67,53.85,"VAPOR DIFFUSION, HANGING DROP",6,"8.5% PEG3350, 0.1M MES, 50 MM CACL2, PH 6.0",298,,,"5WNF",194.21,"2.45","2.45","X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR","GSLHMSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNR","Homo sapiens","ROCK1","Rho-associated protein kinase 1","1","5WNF"
"5WNG",,"X-RAY DIFFRACTION",2.61,52.85,"VAPOR DIFFUSION, HANGING DROP",6,"8.5% PEG3350, 0.1M MES, 50 MM CACL2, PH 6.0",298,,,"5WNG",194.11,"2.9","2.9","X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR","GSLHMSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNR","Homo sapiens","ROCK1","Rho-associated protein kinase 1","1","5WNG"
"5WNH",,"X-RAY DIFFRACTION",2.62,53.13,"VAPOR DIFFUSION, HANGING DROP",6,"8.5% PEG3350, 0.1M MES, 50 MM CACL2, PH 6.0",298,,,"5WNH",194,"3.1","3.1","X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR","GSLHMSFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFPIPKAFVGNQLPFVGFTYYSNRRYLSSANPNDNR","Homo sapiens","ROCK1","Rho-associated protein kinase 1","1","5WNH"
"5WO4",,"X-RAY DIFFRACTION",2.33,47.3,"VAPOR DIFFUSION, HANGING DROP",6,"100 mM MES pH 6.0, 30% (w/v) PEG 6000",277,"10.1021/acs.jmedchem.7b01135","B7V","5WO4",70.24,"1.84","1.84","JAK1 complexed with compound 28","GDIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK","Homo sapiens","JAK1, JAK1A, JAK1B","Tyrosine-protein kinase JAK1","1","5WO4"
"5WOE",,"SOLUTION NMR",,,,,,,"10.1038/s41467-019-09355-y",,"5WOE",14.25,,,"Solution structure of the sorting nexin 25 phox-homology domain","GSNLGMWKASITSGEVTEENGEQLPCYFVMVSLQEVGGVETKNWTVPRRLSEFQNLHRKLSECVPSLKKVQLPSLSKLPFKSIDQKFMEKSKNQLNKFLQNLLSDERLCQSEALYAFLSPSPDYL","Homo sapiens","SNX25, MSTP043","Sorting nexin-25","1","5WOE"
"5WOR",,"X-RAY DIFFRACTION",3.85,68.06,"VAPOR DIFFUSION, HANGING DROP",7,"reservoir contained 15% PEG 3350, 0.3M Sodium Malonate",298,"10.1002/pro.3391",,"5WOR",13.57,"2.77","2.77","Corkscrew assembly of SOD1 residues 28-38 with familial mutation G37R","KVKVWGSIKRL","Homo sapiens","SOD1","Superoxide dismutase [Cu-Zn]","1","5WOR"
"5WP1",,"X-RAY DIFFRACTION",2.31,46.75,"VAPOR DIFFUSION, HANGING DROP",7.5,"1.1-1.3 M ammonium sulfate, 2% PEG500 MME, 0.1 M HEPES/NaOH, crystals soaked in precipitant solution containing 1.5 mM DHC in 2.5% DMSO for one week",290,,,"5WP1",41.8,"1.4","1.4","Complex of ERK2 with 5,7-dihydroxychromone","AAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS","Homo sapiens","MAPK1, ERK2, PRKM1, PRKM2","Mitogen-activated protein kinase 1","1","5WP1"
"5WP6","3.8","ELECTRON MICROSCOPY",,,,,,,"10.1038/nature24674",,"5WP6",545.49,"3.8",,"Cryo-EM structure of a human TRPM4 channel in complex with calcium and decavanadate","MVVPEKEQSWIPKIFKKKTCTTFIVDSTDPGGTLCQCGRPRTAHPAVAMEDAFGAAVVTVWDSDAHTTEKPTDAYGELDFTGAGRKHSNFLRLSDRTDPAAVYSLVTRTWGFRAPNLVVSVLGGSGGPVLQTWLQDLLRRGLVRAAQSTGAWIVTGGLHTGIGRHVGVAVRDHQMASTGGTKVVAMGVAPWGVVRNRDTLINPKGSFPARYRWRGDPEDGVQFPLDYNYSAFFLVDDGTHGCLGGENRFRLRLESYISQQKTGVGGTGIDIPVLLLLIDGDEKMLTRIENATQAQLPCLLVAGSGGAADCLAETLEDTLAPGSGGARQGEARDRIRRFFPKGDLEVLQAQVERIMTRKELLTVYSSEDGSEEFETIVLKALVKACGSSEASAYLDELRLAVAWNRVDIAQSELFRGDIQWRSFHLEASLMDALLNDRPEFVRLLISHGLSLGHFLTPMRLAQLYSAAPSNSLIRNLLDQASHSAGTKAPALKGGAAELRPPDVGHVLRMLLGKMCAPRYPSGGAWDPHPGQGFGESMYLLSDKATSPLSLDAGLGQAPWSDLLLWALLLNRAQMAMYFWEMGSNAVSSALGACLLLRVMARLEPDAEEAARRKDLAFKFEGMGVDLFGECYRSSEVRAARLLLRRCPLWGDATCLQLAMQADARAFFAQDGVQSLLTQKWWGDMASTTPIWALVLAFFCPPLIYTRLITFRKSEEEPTREELEFDMDSVINGEGPVGTADPAEKTPLGVPRQSGRPGCCGGRCGGRRCLRRWFHFWGAPVTIFMGNVVSYLLFLLLFSRVLLVDFQPAPPGSLELLLYFWAFTLLCEELRQGLSGGGGSLASGGPGPGHASLSQRLRLYLADSWNQCDLVALTCFLLGVGCRLTPGLYHLGRTVLCIDFMVFTVRLLHIFTVNKQLGPKIVIVSKMMKDVFFFLFFLGVWLVAYGVATEGLLRPRDSDFPSILRRVFYRPYLQIFGQIPQEDMDVALMEHSNCSSEPGFWAHPPGAQAGTCVSQYANWLVVLLLVIFLLVANILLVNLLIAMFSYTFGKVQGNSDLYWKAQRYRLIREFHSRPALAPPFIVISHLRLLLRQLCRRPRSPQPSSPALEHFRVYLSKEAERKLLTWESVHKENFLLARARDKRESDSERLKRTSQKVDLALKQLGHIREYEQRLKVLEREVQQCSRVLGWVAEALSRSALLPPGGPPPPDLPGSKD","Homo sapiens","TRPM4, LTRPC4","Transient receptor potential cation channel subfamily M member 4","1","5WP6"
"5WPB",,"X-RAY DIFFRACTION",2.21,44.36,"VAPOR DIFFUSION, SITTING DROP",4.6,"2M Na-formate, 0.2M Na-acetate pH4.6, 5% ethylene glycol",291,"10.1021/acs.jmedchem.7b00933","B8P","5WPB",12.13,"1.55","1.55","Crystal structure of fragment 3-(3-(pyridin-2-ylmethoxy)quinoxalin-2-yl)propanoic acid bound in the ubiquitin binding pocket of the HDAC6 zinc-finger domain","GSPLPWCPHLVAVCPIPAAGLDVTQPCGDCGTIQENWVCLSCYQVYCGRYINGHMLQHHGNSGHPLVLSYIDLSAWCYYCQAYVHHQALLDVKNIAHQNKFG","Homo sapiens","HDAC6, KIAA0901, JM21","Histone deacetylase 6","1","5WPB"
"5WPZ",,"X-RAY DIFFRACTION",2.63,53.32,"VAPOR DIFFUSION, HANGING DROP",5,"15% PEG 4000, 0.2M NH4Ac, 0.1M NaAc, pH 5.0",298,"10.1038/srep40991",,"5WPZ",318.88,"2","2","Crystal structure of MNDA PYD with MBP tag","MKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIFWAHDRFGGYAQSGLLAEITPAAAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYAAGKYDIKDVGVDNAGAKAGLTFLVDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSAVNYGVTVLPTFKGQPSKPFVGVLSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELAKDPRIAATMENAQKGEIMPNIPQMSAFWYAVRTAVINAASGRQTVDAALAAAQTNAARAAAEYKKILLLKGFELMDDYHFTSIKSLLAYDLGLTTKMQEEYNRIKITDLMEKKFQGVACLDKLIELAKDMPSLKNLVNNLRKEKSKVAKKIKTQEKLEHHHHHH","Homo sapiens","MNDA","MBP-hMNDA-PYD","1","5WPZ"
"5WQ6",,"X-RAY DIFFRACTION",2.52,51.15,"VAPOR DIFFUSION, HANGING DROP",5,"15% PEG 8000, 0.2M NH4Ac, NaAc pH 5.0",298,"10.1038/srep40991",,"5WQ6",212.45,"1.648","1.648","Crystal Structure of hMNDA-PYD with MBP tag","MKIEEGKLVIWINGDKGYNGLAEVGKKFEKDTGIKVTVEHPDKLEEKFPQVAATGDGPDIIFWAHDRFGGYAQSGLLAEITPAAAFQDKLYPFTWDAVRYNGKLIAYPIAVEALSLIYNKDLLPNPPKTWEEIPALDKELKAKGKSALMFNLQEPYFTWPLIAADGGYAFKYAAGKYDIKDVGVDNAGAKAGLTFLVDLIKNKHMNADTDYSIAEAAFNKGETAMTINGPWAWSNIDTSAVNYGVTVLPTFKGQPSKPFVGVLSAGINAASPNKELAKEFLENYLLTDEGLEAVNKDKPLGAVALKSYEEELAKDPRIAATMENAQKGEIMPNIPQMSAFWYAVRTAVINAASGRQTVDAALAAAQTNAAAAAEYKKILLLKGFELMDDYHFTSIKSLLAYDLGLTTKMQEEYNRIKITDLMEKKFQGVACLDKLIELAKDMPSLKNLVNNLRKEKSKVAKKIKTQEKLEHHHHHH","Homo sapiens",,"MBP tagged hMNDA-PYD","1","5WQ6"
"5WQA",,"X-RAY DIFFRACTION",2.49,50.56,"VAPOR DIFFUSION, HANGING DROP",7.5,"0.1M HEPES (pH 7.4), 0.1M MgCl2, 15% PEG3350, 10% isopropanol, 25% ethylene glycol",277,"10.1016/j.bcp.2017.01.016","J20","5WQA",78.27,"2.3","2.3","Crystal structure of PDE4D catalytic domain complexed with Selaginpulvilins K","IPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPLTVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLSTPALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGFKLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVLLLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMCDKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQ","Homo sapiens","PDE4D, DPDE3","cAMP-specific 3',5'-cyclic phosphodiesterase 4D","1","5WQA"
"5WQT",,"X-RAY DIFFRACTION",2.59,52.53,"EVAPORATION",7,"20mM Sodium bromide, 0.1M Hepes sodium pH7.0, 1.5M Sodium citrate tribasic dihydrate",291,"10.1073/pnas.1708194114",,"5WQT",45.68,"2.64","2.64","Structure of a protein involved in pyroptosis","GVPAEGAFTEDFQGLRAEVETISKELELLDRELCQLLLEGLEGVLRDQLALRALEEALEQGQSLGPVEPLDGPAGAVLECLVLSSGMLVPELAIPVVYLLGALTMLSETQHKLLAEALESQTLLGPLELVGSLLEQSAPWQERSTMSLPPGLLGNSWGEGAPAWVLLDECGLELGEDTPHVCWEPQAQGRMCALYASLALLSGLSQEPH","Homo sapiens","GSDMD, DFNA5L, GSDMDC1, FKSG10","Gasdermin-D","1","5WQT"
